data_1xnt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xnt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 4' ' ' ILE . 40.2 mm -123.81 133.97 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.39 126.88 50.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.57 155.14 28.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.141 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.01 -56.14 2.43 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -160.58 165.1 31.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.51 93.22 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.07 -54.61 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.24 -0.912 . . . . 0.0 110.339 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -120.78 150.99 40.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.484 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 p -137.9 121.19 16.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 m -124.47 41.54 3.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.537 -0.727 . . . . 0.0 109.407 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 154.4 73.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.81 140.63 29.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 108.744 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.49 -163.06 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 109.084 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -96.47 -63.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -57.57 10.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 18.5 m170 -98.16 77.64 2.44 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -97.11 169.32 9.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.813 0.815 . . . . 0.0 110.549 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.07 -23.98 67.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.925 -0.484 . . . . 0.0 109.777 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.38 -19.29 55.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -65.59 -16.47 63.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 0.0 109.28 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.93 -26.6 68.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.2 -19.89 62.14 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.492 -0.755 . . . . 0.0 109.004 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -119.99 73.61 0.98 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -44.86 -60.44 2.05 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.705 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.33 -116.34 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p 50.47 -107.78 0.3 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.818 -1.176 . . . . 0.0 109.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -179.02 37.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 109.92 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 0.4 OUTLIER -148.8 149.67 31.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.532 -0.73 . . . . 0.0 109.461 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -131.69 -161.22 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 21.9 t90 -90.65 140.53 29.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 109.096 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 132.06 26.18 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.29 155.52 3.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.419 -0.801 . . . . 0.0 110.124 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.69 -21.65 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.798 -0.564 . . . . 0.0 110.182 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -141.67 -174.18 3.99 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.325 -0.86 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.2 -164.56 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.44 46.37 92.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -54.39 83.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.429 0.633 . . . . 0.0 111.529 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -91.9 -44.59 8.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 p -161.39 134.13 6.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 10.9 pt -132.34 142.2 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.239 -0.913 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 19.8 m -126.82 147.79 50.0 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.515 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.05 118.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 14.7 t -97.57 125.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.428 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.8 mp -103.32 150.89 23.34 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -93.19 146.25 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.3 mm? -101.12 123.97 46.1 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.45 -2.6 0.07 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.448 -0.783 . . . . 0.0 112.112 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.99 135.75 3.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 109.132 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -75.57 111.71 11.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.77 -177.98 5.58 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.297 0.57 . . . . 0.0 109.478 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.57 158.98 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.08 124.07 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -113.83 -30.0 6.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 109.764 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.9 m -148.99 156.79 42.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 109.084 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -144.43 154.56 14.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.416 0.627 . . . . 0.0 109.833 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -139.15 101.64 4.32 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mt -126.32 141.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -113.13 137.8 14.49 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -85.27 139.2 31.81 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 122.302 -0.528 . . . . 0.0 110.002 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -111.71 65.83 0.63 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.1 29.4 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 m -60.5 178.0 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.974 . . . . 0.0 110.152 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -135.94 -50.17 0.7 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -102.32 132.36 48.34 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.6 t -134.84 108.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.503 -0.748 . . . . 0.0 110.083 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -102.51 145.51 29.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 21.4 t -132.02 128.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.097 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 3.0 mp -113.08 159.93 18.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 4.6 m -121.52 155.45 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.66 -0.65 . . . . 0.0 110.213 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.97 170.81 43.82 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 t -115.89 170.45 8.46 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.788 0.804 . . . . 0.0 110.144 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.4 p -76.24 -0.94 24.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.669 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 110.444 -179.67 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.255 0.55 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -119.66 151.72 38.26 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.73 144.22 40.02 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.352 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.99 88.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.659 -0.651 . . . . 0.0 111.172 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 tp -61.16 -45.49 94.41 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 2.6 pp -146.58 124.83 12.21 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.39 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -55.46 -175.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.726 -0.609 . . . . 0.0 110.118 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.58 133.31 45.66 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.54 -0.725 . . . . 0.0 109.404 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.1 p -98.26 125.07 43.19 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.2 p -91.48 102.97 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 23.7 m-85 -99.04 -47.02 5.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.375 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 51.2 mtp -120.08 -157.48 0.71 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.733 -0.604 . . . . 0.0 109.502 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 4.9 p -159.41 -170.86 0.26 Allowed Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 49.6 Cg_endo -81.8 8.48 4.43 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.742 1.628 . . . . 0.0 110.431 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -83.2 -37.55 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.39 -34.61 72.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 t -73.64 -7.27 51.29 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.69 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -109.0 -52.39 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.533 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -120.94 35.86 4.76 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.141 -0.975 . . . . 0.0 111.692 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.07 6.68 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.175 -0.953 . . . . 0.0 111.849 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.93 89.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 p30 48.99 82.03 0.25 Allowed Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.49 -25.9 7.73 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 123.542 2.828 . . . . 0.0 110.977 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.8 109.39 10.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.143 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.1 169.87 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.512 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.8 m -138.37 165.73 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 0.0 109.51 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 161.89 33.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.027 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 mtm -123.25 164.47 18.68 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.311 0.577 . . . . 0.0 110.156 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.5 m-85 -132.26 101.78 5.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -80.13 -148.22 5.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.9 Cg_endo -75.05 -34.18 3.98 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.385 2.724 . . . . 0.0 110.759 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.18 -27.7 68.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.563 -0.711 . . . . 0.0 110.036 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -94.48 4.3 54.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.657 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.439 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -126.95 142.71 51.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.953 -1.092 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.5 p -62.65 137.4 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -33.76 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.48 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.72 -22.9 67.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.738 . . . . 0.0 110.191 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -111.81 -46.99 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.373 -0.829 . . . . 0.0 110.199 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.17 -35.36 16.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.25 -0.906 . . . . 0.0 111.259 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 0.5 47.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 110.602 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 12.4 mttm -93.43 135.54 34.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -69.33 110.46 4.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 0.0 111.02 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 78.2 m95 -113.35 162.24 16.3 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.5 12.22 2.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.072 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -142.34 142.25 32.45 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.01 141.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.352 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 13.4 tttt -104.08 118.45 36.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.77 -0.581 . . . . 0.0 109.765 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 47.5 mm -107.33 119.34 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 47.0 t -126.2 121.34 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.133 -0.98 . . . . 0.0 110.59 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 155.82 17.08 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -154.06 123.97 6.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.258 -0.901 . . . . 0.0 111.898 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 133' ' ' SER . 1.7 tm0? 162.04 114.88 0.01 OUTLIER Pre-proline 0 N--CA 1.503 2.198 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.05 103.4 1.74 Allowed 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 122.636 2.224 . . . . 0.0 110.361 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 2.0 p90 -135.2 -19.39 1.72 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.518 -0.738 . . . . 0.0 112.291 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 -175.27 2.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 0.0 110.379 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -163.18 -43.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.18 -34.73 6.29 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.544 0.688 . . . . 0.0 109.457 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 143.16 26.04 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.69 -172.06 0.78 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.141 2.561 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 176.8 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.77 -121.39 1.02 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.859 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.17 158.39 21.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.752 -0.852 . . . . 0.0 110.1 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -92.49 -26.94 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.532 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 39.4 p90 -176.66 167.27 2.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.02 122.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -132.54 110.0 10.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 110.205 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -88.8 154.77 20.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 108.787 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 122.72 8.6 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 4' ' ' ILE . 78.2 mt -140.63 125.99 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -107.8 154.12 21.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.783 -0.573 . . . . 0.0 109.653 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.52 152.53 21.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.748 -0.595 . . . . 0.0 109.508 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -102.02 -56.46 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -160.86 165.24 30.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.97 91.05 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 109.098 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.95 -57.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.183 -0.948 . . . . 0.0 110.405 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.4 147.15 43.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -132.11 133.69 44.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.01 38.76 3.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 109.82 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.8 m 152.73 74.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.404 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -134.87 147.57 49.9 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.5 149.54 24.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.409 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -60.27 -61.02 2.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.465 -0.772 . . . . 0.0 109.967 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 19' ' ' HIS . 0.2 OUTLIER -59.2 -44.51 92.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.4 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 29.7 m-70 -118.74 84.67 2.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -95.8 167.26 11.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.595 0.712 . . . . 0.0 110.277 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.75 -23.34 67.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.32 -18.38 58.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.727 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -64.47 -18.67 64.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.29 -26.98 68.31 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.12 -20.9 60.53 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.529 -0.732 . . . . 0.0 109.089 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -107.31 62.95 0.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.39 -25.26 5.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.405 -0.809 . . . . 0.0 110.57 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -118.46 81.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -156.54 -82.74 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.421 -0.8 . . . . 0.0 109.507 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -177.88 -38.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.926 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -86.5 166.99 15.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.57 -0.706 . . . . 0.0 110.007 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.66 -160.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 18.6 t90 -81.74 139.67 34.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -146.14 127.04 14.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.52 152.98 1.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.654 0.74 . . . . 0.0 111.041 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.56 -23.85 66.25 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.008 -0.433 . . . . 0.0 110.127 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 -174.93 3.95 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.992 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.58 -164.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.72 -0.612 . . . . 0.0 109.427 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.8 44.77 91.54 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.446 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.6 mm-40 -48.04 89.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.756 0.789 . . . . 0.0 111.625 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.1 tttm -97.69 -57.35 2.26 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.0 p -155.85 122.57 5.26 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.452 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 12.8 pt -124.03 147.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 12.9 m -129.37 144.63 51.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.076 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.74 116.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -97.03 121.17 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.3 mp -104.03 149.97 24.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.38 156.73 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.644 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.6 mt -106.76 125.39 50.94 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -51.73 -9.3 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.381 -0.825 . . . . 0.0 112.253 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -161.11 140.64 10.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 0.0 109.138 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.2 111.48 10.49 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 178.72 7.94 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -85.51 -172.93 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.41 122.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.412 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -113.32 -28.45 7.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.2 m -149.29 160.69 43.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 149' ' ' PHE . 63.4 t -146.38 160.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.326 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.55 130.74 42.67 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.488 ' CG1' ' HE1' ' A' ' 111' ' ' PHE . 26.2 mm -139.31 118.42 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.41 116.46 4.33 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -82.54 118.32 23.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.974 -0.721 . . . . 0.0 110.517 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 60.58 2.15 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.09 85.76 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.409 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 69.3 m -59.13 162.16 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -123.37 -55.84 1.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.7 m-85 -102.99 118.97 38.0 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.616 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.7 t -122.24 109.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.82 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.15 143.66 32.63 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.1 124.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mp -111.34 163.23 14.19 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.94 161.79 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.684 -0.635 . . . . 0.0 109.861 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 174.26 176.08 42.36 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -110.9 158.83 18.3 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 t -88.9 11.33 18.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.84 -175.73 4.97 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -123.52 129.74 51.66 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.17 86.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.596 -0.69 . . . . 0.0 109.963 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 117' ' ' VAL . 24.6 tp -59.45 -59.59 5.21 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.424 HD12 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -136.36 121.09 18.49 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.308 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.13 -179.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.697 -0.627 . . . . 0.0 110.602 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.69 131.77 46.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 p -99.31 117.52 33.93 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.775 -0.578 . . . . 0.0 109.764 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -75.02 69.43 1.93 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 36.4 t80 -59.48 -58.46 8.51 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.851 -0.53 . . . . 0.0 110.437 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.409 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 82.5 mtp -120.83 -177.19 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.737 0.78 . . . . 0.0 110.925 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.6 p -111.98 -179.43 0.64 Allowed Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 46.6 Cg_endo -86.02 12.24 3.09 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.999 2.466 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.8 p -120.77 -48.96 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 109.535 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.9 -7.33 50.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.4 p -83.21 -20.73 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.716 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -73.88 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 t -161.99 38.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 108.937 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.41 -24.19 6.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.49 117.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.443 -1.033 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.68 72.61 1.01 Allowed Pre-proline 0 N--CA 1.508 2.446 0 O-C-N 121.801 -0.562 . . . . 0.0 111.393 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.27 -30.16 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.88 2.387 . . . . 0.0 109.958 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -128.06 112.45 14.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -168.25 2.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 67.1 t -121.29 163.04 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.445 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 28.3 tpt180 -145.97 124.55 12.48 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtp -109.95 154.01 23.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -0.785 . . . . 0.0 110.5 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.488 ' HE1' ' CG1' ' A' ' 60' ' ' ILE . 7.9 m-85 -126.05 158.1 36.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 -149.95 6.74 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.24 -38.16 1.61 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.798 2.999 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.45 -29.17 69.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -89.08 3.26 52.37 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.672 -0.642 . . . . 0.0 110.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.23 139.76 53.44 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.039 -1.038 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.3 p -60.66 132.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -34.55 62.3 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.406 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.24 65.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 110.437 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.431 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -117.62 -47.29 2.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.014 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.01 -38.58 23.93 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.197 -0.939 . . . . 0.0 111.438 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.15 2.48 27.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.359 -0.838 . . . . 0.0 110.661 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 22.6 mttt -94.61 135.0 36.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -66.59 112.85 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.534 -0.729 . . . . 0.0 110.787 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.462 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 76.4 m95 -116.85 164.36 14.79 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.27 9.66 2.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.695 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -143.18 145.33 32.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.432 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.4 p -135.41 143.42 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.924 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -107.71 115.57 30.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.721 -0.612 . . . . 0.0 109.7 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 49.0 mm -105.4 117.6 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 0.0 109.286 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.5 t -125.01 117.8 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.111 -0.993 . . . . 0.0 110.429 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.415 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 10.9 t -92.46 148.66 21.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -148.1 123.97 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.525 -0.734 . . . . 0.0 111.466 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 157.7 134.11 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.403 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.86 98.2 0.5 Allowed 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.094 2.53 . . . . 0.0 110.207 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.446 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -129.77 2.98 4.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.357 -0.839 . . . . 0.0 111.373 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 -170.91 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.942 -1.099 . . . . 0.0 109.701 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -170.38 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.688 -0.632 . . . . 0.0 109.338 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -113.55 -36.25 4.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.694 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.04 143.53 26.78 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.39 174.53 5.06 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.236 2.624 . . . . 0.0 110.462 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.74 -164.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.33 -109.91 0.42 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.808 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.25 144.94 40.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.726 -0.867 . . . . 0.0 110.61 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -80.54 -28.72 37.22 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 48.8 p90 -177.56 174.8 1.49 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.567 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.63 130.55 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -143.34 107.79 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.506 -0.746 . . . . 0.0 110.157 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.451 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 83.1 m-85 -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.36 136.67 15.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.386 -0.821 . . . . 0.0 109.388 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.752 -0.593 . . . . 0.0 109.626 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.62 128.21 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -115.39 171.1 7.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -0.856 . . . . 0.0 110.319 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mp -97.69 163.74 12.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.759 -0.588 . . . . 0.0 109.57 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.84 -51.44 2.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -161.09 162.18 31.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.87 96.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.495 -0.753 . . . . 0.0 109.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 p -54.37 -60.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -123.71 159.14 30.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.28 136.63 10.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.26 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 t -141.75 59.77 1.48 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.7 OUTLIER 157.22 59.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-O 121.443 0.639 . . . . 0.0 109.965 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -139.23 144.14 38.32 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.72 -1.237 . . . . 0.0 110.34 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.84 174.63 6.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.249 -0.907 . . . . 0.0 109.193 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -74.25 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.534 -0.729 . . . . 0.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -58.37 8.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.016 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 9.7 m-70 -97.05 80.44 2.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -93.56 164.5 13.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.572 -0.705 . . . . 0.0 109.839 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -64.42 -21.08 66.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.869 -0.519 . . . . 0.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.05 -18.82 63.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.79 -18.12 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.868 . . . . 0.0 109.091 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.13 -26.92 68.4 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.94 -20.58 58.26 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.493 -0.754 . . . . 0.0 109.003 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -115.18 68.55 0.71 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.3 -24.4 7.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.455 -0.778 . . . . 0.0 110.626 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.46 86.51 2.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.922 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 -83.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 0.0 109.427 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.9 p90 -177.8 -37.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 16.7 tpp85 -86.43 134.6 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.36 -0.837 . . . . 0.0 109.995 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -114.62 -171.86 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.48 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.464 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 21.4 t90 -84.96 142.21 29.8 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.535 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -147.8 130.39 15.89 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.27 153.02 1.6 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.44 -0.787 . . . . 0.0 110.826 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.79 52.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.951 -0.468 . . . . 0.0 110.315 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 -171.21 3.16 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.359 -0.838 . . . . 0.0 108.933 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.23 -172.4 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 48.97 77.03 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HG3' ' CE1' ' A' ' 136' ' ' TYR . 79.1 mm-40 -34.11 -88.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp 72.02 -60.07 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.531 -0.731 . . . . 0.0 109.109 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -155.41 138.84 15.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.425 HD11 ' CH2' ' A' ' 33' ' ' TRP . 1.4 pt -145.73 140.73 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.55 -0.719 . . . . 0.0 109.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 4.2 m -122.08 131.13 53.82 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.594 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 7.2 p -136.89 116.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 3.1 t -95.88 116.76 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.232 -0.918 . . . . 0.0 108.974 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.11 157.02 17.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.641 -0.662 . . . . 0.0 109.76 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -96.3 163.56 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.691 -0.631 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.5 tp -108.52 124.78 50.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.84 2.59 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 112.471 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -175.97 134.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.657 -1.277 . . . . 0.0 108.93 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -74.79 111.0 9.55 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.644 0.735 . . . . 0.0 110.108 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -172.85 4.26 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -90.61 -178.36 5.27 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -141.92 127.06 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.657 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -115.82 -32.03 5.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.1 m -141.09 159.34 42.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG11 ' CD1' ' A' ' 149' ' ' PHE . 77.3 t -140.21 163.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.23 127.53 21.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.691 . . . . 0.0 109.519 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.21 139.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -98.53 126.88 9.05 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.12 126.19 30.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.066 -0.667 . . . . 0.0 110.231 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.32 63.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 108.839 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.58 -31.47 8.31 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.7 p -62.21 173.39 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.914 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.406 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . . . -141.83 -53.45 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -93.61 125.69 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.265 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.87 113.07 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.003 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.0 121.97 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HB ' ' HG ' ' A' ' 88' ' ' LEU . 31.5 t -113.74 127.75 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 110.223 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -118.35 162.56 18.09 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.19 159.79 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.97 178.1 45.51 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 t -117.84 156.59 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.2 p -84.53 6.26 24.38 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.471 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -108.55 -175.01 2.66 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -120.98 126.14 49.19 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -61.58 85.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 0.0 110.422 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HA ' HG11 ' A' ' 117' ' ' VAL . 6.5 tp -59.59 -61.14 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -121.9 130.1 53.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -68.73 -171.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 116.93 5.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 p -99.26 112.93 24.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -81.96 123.41 28.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 13.1 m-85 -116.61 -46.94 2.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -166.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.523 0.678 . . . . 0.0 110.21 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 p -124.0 178.86 1.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.33 18.76 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.307 2.672 . . . . 0.0 111.433 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 m -120.28 -54.88 2.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -28.01 61.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.478 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -50.09 -25.36 3.39 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.477 -0.764 . . . . 0.0 111.011 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -80.95 -87.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.466 -0.771 . . . . 0.0 109.814 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 t -163.44 37.73 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.96 -22.56 38.25 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.41 -86.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -1.038 . . . . 0.0 110.647 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.6 34.84 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.16 -23.9 20.74 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.797 2.331 . . . . 0.0 109.994 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -134.46 141.54 46.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 -163.99 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 72.5 t -136.88 154.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.12 150.58 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 108.908 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.2 mtm -129.21 171.93 11.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.292 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -130.56 169.71 15.23 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.829 0.823 . . . . 0.0 109.566 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.82 -154.05 6.03 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.192 -2.363 . . . . 0.0 107.192 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.3 Cg_endo -74.27 -26.78 12.13 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.527 2.818 . . . . 0.0 110.843 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -53.37 -41.84 66.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.656 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.89 15.88 23.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.97 118.99 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 120' ' ' ALA . 7.5 p -46.5 126.97 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.979 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -64.52 -39.5 93.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.431 -0.793 . . . . 0.0 109.4 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.89 91.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.497 -0.752 . . . . 0.0 110.663 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -88.39 -36.39 16.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.324 -0.86 . . . . 0.0 109.188 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . . . -44.07 -42.76 6.4 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.64 -0.663 . . . . 0.0 111.361 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.22 11.43 30.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.981 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -92.25 130.14 38.03 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -66.32 108.81 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -0.756 . . . . 0.0 110.113 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.443 ' CE3' ' HA2' ' A' ' 73' ' ' GLY . 68.6 m95 -116.47 163.32 16.23 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.15 15.1 2.43 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.103 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -147.75 149.84 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 149' ' ' PHE . 8.4 p -141.58 144.15 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.974 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -105.77 134.97 48.03 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.9 mm -128.59 107.92 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.475 -0.765 . . . . 0.0 109.236 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.0 t -112.24 109.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.211 -0.93 . . . . 0.0 109.921 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.411 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.63 154.27 28.81 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -157.06 120.94 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 -178.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 133' ' ' SER . 5.2 tp60 171.41 135.04 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.5 100.78 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.928 2.419 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 38.0 p90 -147.27 15.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 111.483 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.39 -173.38 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.051 -1.031 . . . . 0.0 110.072 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -177.96 -39.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -116.05 -32.23 5.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.656 -0.653 . . . . 0.0 110.141 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.5 146.05 32.52 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.78 -0.575 . . . . 0.0 109.875 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.405 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.48 171.81 6.12 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.417 2.745 . . . . 0.0 110.614 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -178.95 -166.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.01 -106.75 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.084 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.12 155.02 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.962 . . . . 0.0 110.849 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 m -88.35 -27.47 21.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.445 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 48.0 p90 -177.1 170.48 2.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.2 m -146.99 142.06 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -150.56 166.14 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.664 . . . . 0.0 109.534 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CD1' HG11 ' A' ' 58' ' ' VAL . 62.7 m-85 -141.59 158.19 44.15 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.32 128.54 8.28 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.01 -1.056 . . . . 0.0 110.338 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.424 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -138.67 128.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 168.87 9.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.627 -0.671 . . . . 0.0 110.017 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.26 156.29 17.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.706 -0.622 . . . . 0.0 109.755 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -109.8 -52.0 2.82 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.93 168.41 24.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.01 93.8 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.252 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -52.99 -59.99 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.243 -0.91 . . . . 0.0 110.321 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.14 153.03 36.78 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -138.59 133.7 32.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.728 . . . . 0.0 109.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.95 42.64 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.702 . . . . 0.0 109.679 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.464 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.8 m 152.08 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.11 132.91 45.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.46 152.51 34.19 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -62.48 -62.16 1.94 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -0.767 . . . . 0.0 109.804 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -61.51 2.43 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -93.15 85.06 4.94 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 p -98.28 167.24 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.507 0.67 . . . . 0.0 110.236 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -61.51 -23.63 66.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.761 -0.587 . . . . 0.0 109.969 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.36 -19.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.239 -0.913 . . . . 0.0 109.774 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -65.5 -17.79 64.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.157 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.12 -25.41 67.76 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.61 -23.09 49.11 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 65.31 0.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.32 -24.95 8.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.783 . . . . 0.0 110.537 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -120.47 82.81 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.02 -85.28 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.501 -0.749 . . . . 0.0 109.398 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -177.48 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.138 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -160.82 142.12 11.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.346 -0.846 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -169.04 1.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.443 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.6 t90 -80.54 136.74 36.33 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.6 mtp180 -142.1 125.69 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.51 169.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.765 0.793 . . . . 0.0 111.018 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.57 -22.71 14.42 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.988 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.9 -153.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.14 -174.35 4.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.059 -1.025 . . . . 0.0 109.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 89.75 -13.5 64.14 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 12.6 mt-10 46.08 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.41 -1.053 . . . . 0.0 112.013 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -133.41 -72.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -153.91 139.5 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 14' ' ' SER . 8.9 pt -134.1 149.56 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 30.9 m -126.53 140.42 52.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.398 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 10.9 p -148.41 121.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.31 120.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.08 168.63 10.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.631 . . . . 0.0 109.985 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -111.39 142.76 43.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.803 -0.561 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -97.07 135.26 39.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.63 37.89 0.36 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.48 -0.762 . . . . 0.0 111.262 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 pttt 165.58 127.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.39 108.12 9.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.806 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -178.6 5.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -87.34 -172.63 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.41 122.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.519 -0.738 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.3 t-160 -109.41 -32.09 7.29 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -146.88 153.53 40.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 149' ' ' PHE . 70.5 t -137.51 158.7 34.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.674 -0.641 . . . . 0.0 109.564 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.2 138.55 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -159.72 139.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -122.99 135.77 10.21 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -91.77 151.56 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.152 -0.617 . . . . 0.0 109.9 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.32 34.47 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.86 -17.14 8.21 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -60.78 -171.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -1.079 . . . . 0.0 110.449 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' SER . . . -133.96 -40.88 0.84 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.48 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.05 140.43 39.87 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.509 -0.744 . . . . 0.0 111.322 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 61.9 t -143.3 112.44 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.667 -0.645 . . . . 0.0 109.61 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.25 147.3 27.22 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.68 -0.638 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.27 131.55 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.897 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.32 167.34 11.32 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 159.0 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.703 -0.623 . . . . 0.0 109.568 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.436 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 176.31 173.8 42.27 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 t -115.62 161.07 19.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.601 0.715 . . . . 0.0 109.58 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -80.34 3.75 20.11 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.803 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.154 -0.966 . . . . 0.0 110.143 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -109.26 -175.54 2.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -121.11 127.4 51.57 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.39 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.759 -0.588 . . . . 0.0 110.17 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 tp -57.96 -50.65 72.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -146.6 124.07 11.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.01 173.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.32 47.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -103.46 132.9 49.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 99.9 p -90.18 107.4 19.11 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 68' ' ' VAL . 7.2 m-30 -89.29 -51.36 5.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.418 -0.801 . . . . 0.0 109.691 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 mtp -120.89 -178.92 3.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.754 0.788 . . . . 0.0 110.519 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.412 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -99.98 179.63 1.0 Allowed Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 42.3 Cg_endo -86.98 18.45 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.128 2.552 . . . . 0.0 111.445 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -120.31 -53.52 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.49 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -58.11 -18.99 28.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.452 -0.78 . . . . 0.0 110.635 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.4 t -49.04 -26.54 2.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.334 -0.854 . . . . 0.0 110.455 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -85.66 -85.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 t -164.06 37.47 0.08 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.36 -19.84 68.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.06 -83.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.42 -1.047 . . . . 0.0 110.686 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.6 p30 -111.84 82.15 3.88 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.78 -19.23 27.68 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.824 2.349 . . . . 0.0 110.776 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 127.79 40.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 109.567 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -157.73 176.69 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 17.4 m -134.57 -173.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.535 -0.728 . . . . 0.0 109.41 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -160.66 148.91 16.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.646 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtm -126.69 151.93 47.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.836 -0.54 . . . . 0.0 109.731 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 3.6 m-85 -122.57 165.68 16.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.42 -148.3 5.3 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.6 Cg_endo -75.01 -40.19 0.97 Allowed 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 123.727 2.951 . . . . 0.0 111.152 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.2 -27.76 68.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.742 . . . . 0.0 109.782 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -92.02 3.36 55.41 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.666 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.4 pp -122.79 139.37 54.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.037 -1.04 . . . . 0.0 110.45 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.9 p -59.63 129.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -74.29 -32.48 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.558 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.0 -22.44 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 110.189 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -115.2 -47.07 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 110.152 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.423 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.57 -37.99 19.39 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.099 -1.001 . . . . 0.0 111.63 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.52 2.23 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.368 -0.832 . . . . 0.0 110.707 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 27.6 mttt -93.51 136.02 34.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.19 113.22 4.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.413 -0.804 . . . . 0.0 110.546 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.8 m95 -116.94 164.53 14.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -139.86 14.82 2.49 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.065 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -144.38 146.95 32.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.0 p -138.19 140.78 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.036 -1.065 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 142.93 31.12 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.6 mm -138.24 107.51 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 44.0 t -115.46 120.62 65.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 O-C-N 121.293 -0.879 . . . . 0.0 109.874 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.22 150.71 20.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -155.1 143.02 20.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.09 -1.006 . . . . 0.0 112.206 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 133' ' ' SER . 3.4 tp60 148.53 113.1 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.34 123.32 4.38 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.679 2.253 . . . . 0.0 110.562 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -146.78 6.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.165 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 -175.19 4.79 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.347 -1.471 . . . . 0.0 111.345 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.447 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 58.8 mmtt -137.03 -30.16 0.88 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.828 -0.545 . . . . 0.0 110.912 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.08 -9.01 6.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.798 -1.189 . . . . 0.0 111.924 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.56 148.97 37.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.947 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.11 -161.45 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 123.927 3.085 . . . . 0.0 110.632 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p90 -178.69 -160.32 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.31 -165.37 33.32 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.283 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.27 150.58 21.95 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.063 -0.669 . . . . 0.0 109.569 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.415 ' OG ' ' CD1' ' A' ' 146' ' ' PHE . 8.9 p -76.79 -30.71 56.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.494 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 49.6 p90 -175.13 168.9 3.38 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.735 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.9 m -138.65 157.31 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 14.3 mtt180 -160.06 159.74 32.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.627 -0.67 . . . . 0.0 110.269 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 128' ' ' VAL . 58.2 m-85 -150.38 153.4 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.95 142.91 18.97 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.15 -0.968 . . . . 0.0 110.107 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 4' ' ' ILE . 96.0 mt -139.15 130.16 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 167.27 10.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 109.632 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.2 mp -98.53 160.82 14.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.701 -0.624 . . . . 0.0 109.424 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -116.78 -46.01 2.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.389 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -161.19 -171.88 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.706 -0.621 . . . . 0.0 109.422 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -106.48 90.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 109.258 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.25 -62.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.206 -0.934 . . . . 0.0 110.55 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -118.55 155.1 31.48 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.443 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 24.5 p -161.53 126.47 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.748 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -137.61 68.18 1.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 44' ' ' SER . 1.4 p 153.4 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -122.34 144.0 49.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.978 -1.076 . . . . 0.0 110.765 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -94.12 -168.37 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -68.73 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.444 -0.785 . . . . 0.0 109.825 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.82 65.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.0 71.41 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.4 p -89.81 169.56 11.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.734 . . . . 0.0 109.705 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 45' ' ' VAL . . . -62.6 -25.18 67.95 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.668 -0.645 . . . . 0.0 109.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.4 -19.69 56.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.846 . . . . 0.0 109.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -64.72 -19.94 66.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.102 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.83 -25.78 67.37 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.53 -20.82 58.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.43 -0.794 . . . . 0.0 109.014 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.24 73.08 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.26 -47.73 55.07 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.517 -0.739 . . . . 0.0 110.684 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.61 75.96 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.482 -0.761 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -161.57 31.18 0.13 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.632 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.6 p90 47.15 25.57 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.315 0.579 . . . . 0.0 111.658 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -119.89 135.12 55.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.235 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -126.96 -178.63 4.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.465 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 21.4 t90 -94.43 137.25 33.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -139.78 128.12 22.68 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.93 164.72 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.424 -0.797 . . . . 0.0 110.327 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.4 -22.42 61.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.793 -0.567 . . . . 0.0 110.531 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.23 176.58 8.57 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.354 -0.841 . . . . 0.0 109.063 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.34 -176.06 5.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.71 -48.84 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.496 ' CB ' ' CE2' ' A' ' 136' ' ' TYR . 11.9 mp0 40.09 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.021 -0.694 . . . . 0.0 112.367 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -103.21 -43.35 5.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -160.49 106.34 1.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -107.32 136.66 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.497 -0.752 . . . . 0.0 110.5 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' OG ' ' A' ' 14' ' ' SER . 55.6 p -115.61 134.98 54.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.38 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 8.6 p -142.3 101.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 5.0 t -90.33 118.16 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 108.965 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -103.02 166.37 10.48 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -107.92 157.49 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.671 -0.643 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.02 124.44 49.63 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.1 -7.31 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.391 -0.818 . . . . 0.0 112.297 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -161.8 140.99 9.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.731 -1.23 . . . . 0.0 109.414 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.27 109.32 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.74 175.9 9.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.59 -172.5 4.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.9 121.68 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -110.13 -30.55 7.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -146.03 154.69 42.15 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 149' ' ' PHE . 67.9 t -137.9 158.67 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 12.1 t0 -133.05 134.84 44.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.308 -0.87 . . . . 0.0 110.579 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CD1' HG13 ' A' ' 58' ' ' VAL . 1.1 mp -149.7 125.96 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.65 117.04 5.55 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.9 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.849 -0.795 . . . . 0.0 109.881 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -123.15 82.63 2.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.52 80.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.474 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 4.9 p -98.4 178.64 4.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -1.123 . . . . 0.0 109.824 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.07 -47.56 0.44 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -109.3 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.172 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.65 114.05 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.44 150.86 26.29 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 34.3 t -140.71 127.14 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.586 0.708 . . . . 0.0 110.079 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.85 160.89 18.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.41 155.55 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.55 -0.719 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.19 169.69 42.77 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -119.92 165.43 14.64 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.723 0.773 . . . . 0.0 110.014 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -69.91 -9.36 54.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.264 -179.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 59.24 165.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.554 -0.717 . . . . 0.0 109.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -101.69 129.63 47.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.1 86.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.798 -0.563 . . . . 0.0 110.373 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HA ' HG11 ' A' ' 117' ' ' VAL . 10.3 tp -59.98 -52.59 64.76 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.1 pp -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.385 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.55 172.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.01 135.01 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.592 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 5.9 p -108.33 130.94 55.18 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.447 0.641 . . . . 0.0 109.64 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.91 123.28 31.07 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 25.6 m-85 -123.05 -46.4 2.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.5 mtp -120.82 -165.7 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.702 -0.624 . . . . 0.0 109.872 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.9 p -126.58 175.77 3.03 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.56 15.42 2.15 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.31 2.674 . . . . 0.0 111.285 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 t -120.17 -42.13 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 109.337 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.09 -20.54 40.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 110.58 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.1 m -50.22 -25.98 4.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.273 -0.892 . . . . 0.0 110.765 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -85.12 -87.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.947 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -163.64 37.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.35 56.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.38 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.476 -1.014 . . . . 0.0 110.722 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.97 92.78 47.01 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.04 -23.54 18.24 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.615 2.21 . . . . 0.0 110.016 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.97 143.54 51.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -148.2 -174.5 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.432 -0.792 . . . . 0.0 110.422 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 70.4 t -148.75 142.44 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -153.26 145.99 24.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.863 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.2 mtm -125.78 152.58 45.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.7 m-85 -113.02 159.06 19.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.19 -149.6 7.06 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.67 -39.27 1.43 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.76 2.973 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.74 -28.31 68.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -89.5 3.82 51.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.661 -0.649 . . . . 0.0 110.592 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.444 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -124.7 139.81 53.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.098 -1.001 . . . . 0.0 110.442 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.1 p -60.3 132.35 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -74.86 -34.36 62.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.23 -20.45 65.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -117.55 -47.94 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.444 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.1 -41.02 25.16 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.217 -0.927 . . . . 0.0 111.617 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -2.18 33.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.437 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 14.4 mttm -90.98 133.63 35.13 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -65.71 113.11 4.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 110.392 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.443 ' CZ2' ' HG3' ' A' ' 85' ' ' GLU . 83.3 m95 -116.17 163.46 15.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.9 7.65 2.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.608 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.24 136.93 35.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 149' ' ' PHE . 5.0 p -127.75 143.93 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.664 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 3.4 tttt -111.6 111.07 21.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.0 109.653 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -101.77 128.3 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.09 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.25 117.74 41.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.15 142.39 27.35 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -140.15 127.83 21.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.387 -0.821 . . . . 0.0 111.162 -177.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 150.03 137.95 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.042 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.78 101.48 0.78 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.107 2.538 . . . . 0.0 110.319 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.496 ' CE2' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.61 -60.62 2.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.4 -0.812 . . . . 0.0 108.889 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.88 160.59 22.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -106.11 26.61 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.54 -0.725 . . . . 0.0 110.084 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -54.24 2.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 p -116.47 155.33 48.73 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 122.008 -0.433 . . . . 0.0 109.874 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.409 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.1 Cg_endo -83.73 166.18 13.54 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.459 2.772 . . . . 0.0 109.724 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -169.76 -163.02 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.89 -106.56 0.29 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -132.45 161.87 32.59 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.212 -1.17 . . . . 0.0 110.189 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 25.3 m -83.43 -17.69 41.26 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.036 -0.415 . . . . 0.0 110.916 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.5 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.6 p90 175.88 179.31 0.17 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.232 -0.918 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.66 128.24 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 150' ' ' HIS . 11.8 mtm180 -140.88 110.79 6.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.277 -0.89 . . . . 0.0 110.562 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' CD1' HG11 ' A' ' 58' ' ' VAL . 69.3 m-85 -88.64 158.57 18.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.412 -0.805 . . . . 0.0 108.859 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -156.07 139.59 15.89 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.293 -0.88 . . . . 0.0 109.512 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 4' ' ' ILE . 40.3 mm -125.3 146.64 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -140.69 134.93 31.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.83 144.63 27.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 109.162 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -94.67 -50.94 4.94 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -160.83 167.78 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.67 89.95 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.29 -58.94 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.292 -0.88 . . . . 0.0 110.427 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -124.47 158.92 31.69 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -153.42 136.34 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -130.01 46.74 2.6 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 154.56 94.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 123.075 0.55 . . . . 0.0 109.624 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.37 146.0 15.05 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.953 -1.092 . . . . 0.0 109.445 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.52 -168.11 1.56 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 -60.21 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 109.522 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -61.15 2.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.801 . . . . 0.0 108.918 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -97.11 77.54 2.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.9 p -90.2 168.26 12.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.576 -0.702 . . . . 0.0 109.937 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.35 -23.72 67.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.65 -17.92 61.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.791 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -65.01 -20.16 66.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.212 -0.93 . . . . 0.0 109.277 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.56 -20.16 62.96 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -109.44 64.07 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.6 7.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 0.0 110.563 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -118.65 80.43 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -155.13 -84.03 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.494 -0.754 . . . . 0.0 109.612 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.7 p90 -179.23 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -79.53 148.85 31.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.391 -0.818 . . . . 0.0 109.772 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 12.4 mttp -127.42 -165.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.639 -0.663 . . . . 0.0 109.541 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.484 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 22.8 t90 -91.73 141.77 28.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.83 126.88 15.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.04 151.71 4.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.76 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.28 67.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.939 -0.475 . . . . 0.0 110.288 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -138.48 -173.22 3.48 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.352 -0.843 . . . . 0.0 109.285 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.15 -163.92 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.785 -0.572 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.07 45.76 95.43 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -47.71 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.582 0.706 . . . . 0.0 111.557 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 39' ' ' GLY . 30.3 tttt -93.47 -56.68 2.84 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.8 p -156.94 113.77 3.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.484 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 4.9 pt -114.61 132.22 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.573 -0.704 . . . . 0.0 109.874 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.464 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -114.57 146.71 40.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.504 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -147.74 112.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.6 t -95.54 119.33 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 108.946 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.402 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.5 mp -99.25 160.37 14.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.777 -0.577 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -111.85 125.97 54.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.5 -0.75 . . . . 0.0 109.905 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.15 136.04 36.43 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 41.34 0.61 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.594 -0.691 . . . . 0.0 110.405 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 pttm 164.8 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -75.61 107.45 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.6 179.79 6.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.494 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -94.94 162.96 13.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.27 126.41 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.311 -0.868 . . . . 0.0 109.918 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 25.2 t60 -116.97 -30.19 5.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.694 -0.629 . . . . 0.0 109.849 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.5 m -148.98 158.73 44.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 0.0 108.876 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -147.82 161.32 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.804 0.811 . . . . 0.0 110.447 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.07 134.68 38.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.18 130.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -103.88 125.81 8.55 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -83.68 127.59 33.89 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.247 -0.561 . . . . 0.0 110.281 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.06 50.4 1.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.75 -24.23 24.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 29.1 t -57.12 161.39 3.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.386 -1.067 . . . . 0.0 109.919 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.79 2.02 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.813 -0.554 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -96.25 126.59 41.57 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.176 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.19 111.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.596 -0.69 . . . . 0.0 109.734 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -106.29 146.76 29.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.737 -0.602 . . . . 0.0 109.553 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.13 125.13 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 109.457 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.71 157.03 20.97 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.55 154.91 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 109.771 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.441 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.77 171.22 41.77 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 t -109.63 161.66 15.17 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 122.037 -0.684 . . . . 0.0 109.242 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 23.1 p -86.13 6.73 27.88 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.763 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.97 -174.53 2.55 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -121.73 127.88 51.17 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.16 88.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -59.65 -60.74 3.36 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.85 119.78 17.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.346 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.34 174.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.756 . . . . 0.0 110.278 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.13 133.59 53.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.509 -0.744 . . . . 0.0 109.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.7 p -102.88 122.26 44.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.5 p -87.01 108.31 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 24.2 m-85 -93.48 -51.93 4.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.71 -0.619 . . . . 0.0 109.922 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.3 mtp -122.11 -167.9 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.658 0.742 . . . . 0.0 110.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.8 p -109.32 175.64 1.87 Allowed Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.46 10.65 3.63 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.897 2.398 . . . . 0.0 111.332 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -121.44 -35.57 3.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.61 -0.38 53.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 110.671 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.1 m -74.19 -30.54 62.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -68.37 -77.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -161.96 38.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.23 -24.74 6.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.54 120.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 109.981 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.2 68.63 2.15 Favored Pre-proline 0 N--CA 1.509 2.499 0 O-C-N 121.975 -0.453 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -76.83 -30.38 4.73 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.877 2.385 . . . . 0.0 110.233 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.93 99.23 5.21 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -164.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 109.404 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -148.8 151.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG3' ' CD1' ' A' ' 93' ' ' PHE . 5.1 mmt180 -144.45 166.15 25.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.3 mtm -139.68 175.02 9.93 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.535 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.505 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 7.5 m-85 -134.36 169.04 17.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.49 -151.48 5.56 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.416 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 40.3 Cg_endo -76.45 -37.12 1.46 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.582 2.855 . . . . 0.0 110.617 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.03 -28.59 68.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 109.429 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -88.09 1.61 53.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.607 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 1.6 pp -124.02 139.76 53.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.979 -1.076 . . . . 0.0 110.345 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.0 p -59.11 130.37 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -74.7 -31.66 61.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.93 66.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.92 -46.48 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.119 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.66 -38.5 21.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.158 -0.964 . . . . 0.0 111.51 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.68 -0.36 33.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 25.7 mtpt -92.41 135.15 34.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -68.23 111.46 4.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.513 -0.742 . . . . 0.0 110.887 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.447 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.5 m95 -113.5 162.36 16.25 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -135.36 9.0 3.43 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.681 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.7 mtm180 -140.77 142.39 34.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.9 142.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.816 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -106.5 112.48 25.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.844 -0.535 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 50.9 mm -104.83 117.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 42.6 t -120.14 120.65 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.201 -0.937 . . . . 0.0 110.62 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 136.0 36.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -139.31 123.44 17.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 111.017 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' SER . 4.6 tp60 165.14 128.77 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.159 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.98 90.53 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.875 2.383 . . . . 0.0 109.251 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 7.4 p90 -119.85 -12.45 9.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.738 . . . . 0.0 111.702 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 176.54 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 0.0 110.22 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -153.33 -42.77 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.65 -29.93 6.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.619 -0.675 . . . . 0.0 109.955 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.42 145.93 31.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.711 -0.618 . . . . 0.0 109.66 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.1 Cg_endo -87.78 -175.74 1.52 Allowed 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.356 2.704 . . . . 0.0 110.626 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 170.26 -166.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.95 -117.57 0.76 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.815 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.83 158.43 21.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.711 -0.876 . . . . 0.0 110.18 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 32.3 m -96.17 -25.8 15.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.979 -0.451 . . . . 0.0 109.982 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.537 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -176.98 165.7 2.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.206 -0.934 . . . . 0.0 110.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 159.02 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 0.1 OUTLIER -160.49 101.22 1.35 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 34.5 m-85 -88.99 149.93 23.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 0.0 108.289 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.2 120.12 5.73 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.729 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.694 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 4' ' ' ILE . 33.6 mt -145.26 119.75 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -96.62 166.17 11.79 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.31 0.576 . . . . 0.0 109.605 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.3 153.05 20.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.71 -0.619 . . . . 0.0 109.525 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -102.49 -56.48 2.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -160.97 161.46 31.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.651 -0.655 . . . . 0.0 109.274 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.75 93.51 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.1 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -54.66 -55.96 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.259 -0.901 . . . . 0.0 110.398 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.45 151.57 40.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 0.0 109.058 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.7 112.26 6.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.831 . . . . 0.0 110.274 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -105.95 43.7 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 t 153.05 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.3 135.61 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.45 -163.1 0.64 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -0.796 . . . . 0.0 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.8 m -95.51 -70.37 0.72 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -54.92 25.3 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -93.9 68.57 3.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.92 176.13 6.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.474 -0.766 . . . . 0.0 110.271 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.62 -25.17 68.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.74 -16.4 57.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.446 -0.784 . . . . 0.0 109.918 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.07 -18.19 65.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -0.997 . . . . 0.0 109.204 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.0 -24.13 66.71 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.79 -21.01 55.09 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.459 -0.776 . . . . 0.0 109.06 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 73.47 1.2 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.71 -22.03 21.55 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.462 -0.774 . . . . 0.0 110.233 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.51 101.41 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.414 ' OG1' ' CD1' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -172.71 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 109.117 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' OG1' ' A' ' 29' ' ' THR . 52.0 p90 -166.42 29.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.84 -1.162 . . . . 0.0 109.941 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.21 177.37 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.402 -0.811 . . . . 0.0 109.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -159.57 0.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.46 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.2 t90 -77.62 139.27 39.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.125 -0.985 . . . . 0.0 109.731 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -144.07 125.73 15.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.52 151.79 7.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.771 . . . . 0.0 110.246 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.55 -29.82 67.48 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.874 -0.516 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -114.47 -165.8 1.05 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.26 -162.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.66 44.5 97.79 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.4 mm-40 -43.1 91.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.933 0.873 . . . . 0.0 112.002 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.5 ttmt -101.98 -57.61 2.04 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.2 p -154.51 121.43 5.56 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 7.1 pt -126.73 152.47 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.526 -0.733 . . . . 0.0 110.015 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 150.27 51.33 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.491 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.75 108.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 t -92.15 120.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.13 161.51 13.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -111.17 129.5 55.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.617 -0.677 . . . . 0.0 109.948 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.73 142.64 29.69 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 36.91 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.486 -0.759 . . . . 0.0 111.324 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 pttm 163.22 138.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.205 -0.935 . . . . 0.0 108.797 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 13.4 tt0 -75.55 103.78 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.25 172.19 13.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.517 0.675 . . . . 0.0 109.787 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -85.18 179.01 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.31 124.24 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.437 -0.79 . . . . 0.0 110.047 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.419 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 44.5 t60 -112.89 -29.5 7.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.609 -0.682 . . . . 0.0 109.2 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.07 157.14 44.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 149' ' ' PHE . 61.6 t -143.01 162.72 17.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.331 0.586 . . . . 0.0 109.938 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.35 100.77 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.31 124.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -92.27 128.35 9.35 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -84.02 120.69 26.43 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 122.173 -0.604 . . . . 0.0 110.194 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 5.8 t0 -93.64 69.58 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.21 89.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -64.79 -175.1 0.17 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 134' ' ' GLN . . . -148.58 -55.23 0.2 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 134' ' ' GLN . 28.0 m-85 -105.67 116.46 31.98 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.016 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.76 109.86 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.942 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.29 142.45 35.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 24.1 t -130.73 127.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.603 0.716 . . . . 0.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 mp -112.68 162.23 15.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.45 157.58 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.647 -0.658 . . . . 0.0 110.375 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.72 166.85 38.83 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.2 t -109.45 153.26 24.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.843 -0.798 . . . . 0.0 109.867 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.417 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 47.6 t -84.4 8.64 15.59 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 0.0 109.735 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.96 -173.12 2.24 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -127.12 135.47 50.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -63.16 88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 111.493 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 117' ' ' VAL . 10.7 tp -64.5 -42.09 96.05 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 2.3 pp -150.77 120.51 7.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.459 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -54.1 -178.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.697 -0.627 . . . . 0.0 110.293 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.51 133.56 47.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.47 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 p -98.51 117.92 34.02 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.258 0.551 . . . . 0.0 109.594 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.7 p -74.93 68.6 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.452 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -59.42 -59.07 6.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.875 -0.516 . . . . 0.0 110.261 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 68.2 mtp -121.23 -176.12 3.21 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.584 0.707 . . . . 0.0 110.713 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 p -114.66 179.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -86.72 11.06 3.39 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.102 2.535 . . . . 0.0 111.322 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.2 p -120.91 -39.37 2.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.955 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -83.43 0.33 46.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 110.768 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.8 t -78.64 -32.55 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -0.983 . . . . 0.0 110.165 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.678 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -161.69 38.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.93 -22.96 7.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 119.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.298 -1.119 . . . . 0.0 110.244 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.98 64.35 4.47 Favored Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.921 -0.487 . . . . 0.0 111.534 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.18 -30.66 6.68 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.889 2.393 . . . . 0.0 110.254 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.67 75.52 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.698 -0.627 . . . . 0.0 109.491 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -111.83 -169.56 1.49 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -129.98 165.11 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.197 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 21.5 tpt180 -143.26 134.46 25.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtm -110.72 158.92 18.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.036 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.8 m-85 -133.14 105.63 7.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -83.52 -147.4 7.52 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.4 Cg_endo -74.51 -35.52 3.62 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.517 2.811 . . . . 0.0 110.809 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.62 -27.72 68.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.693 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.5 4.32 53.75 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.643 -0.661 . . . . 0.0 110.682 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.444 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -128.37 143.87 51.06 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.912 -1.118 . . . . 0.0 110.31 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.434 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.5 p -64.25 140.52 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -35.05 44.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.735 . . . . 0.0 109.075 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.02 66.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.579 -0.701 . . . . 0.0 110.291 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.434 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -113.98 -47.15 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.444 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.1 -31.85 8.78 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.186 -0.946 . . . . 0.0 111.12 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -2.03 58.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.458 -0.776 . . . . 0.0 110.557 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 9.3 mtpp -92.02 135.14 34.19 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.85 109.28 3.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.674 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 86.4 m95 -108.63 160.26 16.08 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 12.6 t70 -133.28 2.31 3.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 110.404 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -140.84 143.0 34.52 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.433 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -133.95 142.49 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.361 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -107.45 114.66 28.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.717 -0.615 . . . . 0.0 109.788 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.97 122.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 125.1 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.15 -0.969 . . . . 0.0 110.654 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.93 145.92 25.98 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -145.66 130.03 17.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.0 111.495 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.446 ' HG3' ' CD2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 149.07 131.3 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.597 0 C-N-CA 123.911 0.884 . . . . 0.0 108.989 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.42 87.1 0.99 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 109.967 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 3.4 p90 -113.86 -1.42 13.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 111.12 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.65 -171.74 2.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.036 . . . . 0.0 109.476 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -164.23 -43.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.84 -32.5 5.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 0.0 109.887 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.34 149.8 36.65 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.885 -0.509 . . . . 0.0 109.702 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_endo -85.25 -169.79 0.67 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.437 2.758 . . . . 0.0 110.639 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 171.2 -162.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.3 -117.05 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.492 -1.337 . . . . 0.0 110.942 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.0 145.92 44.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.847 -0.796 . . . . 0.0 110.351 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -81.38 -27.21 34.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.491 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 35.3 p90 -175.87 171.69 2.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.453 -0.779 . . . . 0.0 109.804 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.21 131.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -147.98 105.4 3.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.447 -0.783 . . . . 0.0 110.504 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CE2' HG13 ' A' ' 128' ' ' VAL . 69.4 m-85 -86.3 157.83 19.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -152.9 136.01 15.63 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.351 0.596 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 4' ' ' ILE . 48.6 mt -146.31 123.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -102.04 166.21 10.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.731 -0.606 . . . . 0.0 110.012 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.09 138.94 34.65 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -93.06 -56.24 3.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.126 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -161.06 160.6 30.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.49 91.18 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.73 -56.24 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.229 -0.919 . . . . 0.0 110.215 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -124.06 155.25 38.66 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.251 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -146.75 134.4 21.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.799 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -129.32 47.66 2.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.519 -0.738 . . . . 0.0 110.184 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.1 m 151.85 73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 143.45 48.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.06 152.03 19.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -60.97 -54.43 45.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.013 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -57.11 14.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.415 ' CE1' ' HD2' ' A' ' 31' ' ' ARG . 35.8 m-70 -107.25 78.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -86.21 163.45 17.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -20.72 65.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.761 -0.587 . . . . 0.0 109.622 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.74 -20.42 66.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -65.8 -16.78 64.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.19 -0.943 . . . . 0.0 109.273 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.81 -23.28 67.19 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -22.3 39.13 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.418 -0.801 . . . . 0.0 109.19 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.8 66.31 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.76 13.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.488 -0.757 . . . . 0.0 110.318 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.08 74.3 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.461 ' CG2' ' CE1' ' A' ' 30' ' ' TYR . 86.1 m -156.93 -98.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' CE1' ' CG2' ' A' ' 29' ' ' THR . 0.1 OUTLIER 176.25 44.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HD2' ' CE1' ' A' ' 19' ' ' HIS . 3.6 mmm-85 -141.54 100.35 3.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 144' ' ' LEU . 30.9 mtmt -83.62 146.38 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.637 -0.664 . . . . 0.0 109.692 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.458 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.8 t90 -62.7 114.9 3.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.203 -0.935 . . . . 0.0 108.583 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -116.88 127.1 53.94 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.409 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -49.21 168.81 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.731 0.777 . . . . 0.0 111.696 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.73 63.99 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -124.85 -175.31 3.25 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 -166.56 1.39 Allowed 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.49 45.81 88.21 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.6 OUTLIER -43.03 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.52 0.676 . . . . 0.0 111.825 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' GLY . 7.3 tttp -93.44 -64.32 1.1 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 p -152.47 113.65 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.458 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 24.5 pt -111.29 145.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 110.384 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.89 150.49 44.59 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.522 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.438 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 10.7 p -152.27 107.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 9.0 t -92.43 122.04 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.57 155.76 17.89 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -109.55 120.24 41.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -71.54 143.35 49.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.36 31.27 0.18 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.637 -0.664 . . . . 0.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttm 165.01 138.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.92 109.74 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.98 165.66 26.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -77.4 -176.73 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -143.22 130.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.432 -0.793 . . . . 0.0 109.36 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 45.9 t60 -116.81 -26.24 7.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.621 -0.674 . . . . 0.0 109.731 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -148.48 153.21 38.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.2 t -135.38 160.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.706 -0.621 . . . . 0.0 109.346 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.74 132.51 30.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.544 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.4 128.01 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.613 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -104.01 114.62 4.81 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 118.882 -1.628 . . . . 0.0 109.91 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.68 138.37 50.59 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.28 0.562 . . . . 0.0 111.206 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -113.44 42.06 2.03 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 -19.4 10.84 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.422 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 20.9 p -56.76 -173.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.319 -1.106 . . . . 0.0 109.797 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.42 -44.43 0.17 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.3 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -108.35 117.26 33.68 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.746 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.51 110.62 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -107.21 147.56 30.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.21 125.87 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 109.665 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.52 157.6 20.15 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.25 156.98 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.795 -0.566 . . . . 0.0 110.292 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.82 174.52 44.23 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 t -114.64 162.69 16.44 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.646 0.736 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -68.79 -11.11 60.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.239 -179.327 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 t0 . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.4 151.06 41.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.13 147.67 28.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.93 86.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -56.68 -54.98 39.81 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.75 117.26 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.271 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.6 m -50.86 174.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.564 -0.71 . . . . 0.0 110.446 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 132.69 50.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -97.6 118.16 33.48 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.847 -0.533 . . . . 0.0 109.745 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.9 p -75.45 67.96 2.06 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.46 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -62.08 -51.61 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.885 -0.509 . . . . 0.0 110.494 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.413 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 20.2 mtp -120.3 -170.25 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 110.455 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 p -121.07 173.74 3.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.99 5.02 5.97 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.272 2.648 . . . . 0.0 111.451 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.8 m -120.74 -39.29 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.097 -1.002 . . . . 0.0 109.827 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.79 -17.19 61.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.527 -0.733 . . . . 0.0 110.266 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -58.16 -20.55 41.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 110.517 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -71.44 -86.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -162.61 38.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 108.578 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.39 -20.27 7.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.93 119.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -1.073 . . . . 0.0 110.198 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.413 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.86 70.31 1.62 Allowed Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.89 -0.506 . . . . 0.0 111.308 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.59 -30.63 3.82 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.906 2.404 . . . . 0.0 110.464 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -146.23 109.75 4.79 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 5.6 ptm85 -153.08 -160.79 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.533 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -131.86 172.0 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.773 -1.205 . . . . 0.0 111.388 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 13.9 tpt180 -145.64 147.14 31.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 mtp -126.99 158.12 37.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.688 . . . . 0.0 110.242 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.0 m-85 -126.51 163.95 22.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.99 -148.31 5.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.87 -38.52 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 123.8 3.0 . . . . 0.0 111.042 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.47 -26.7 68.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.502 -0.749 . . . . 0.0 109.701 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.55 2.37 56.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 110.71 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.5 pp -124.16 140.81 52.61 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.974 -1.079 . . . . 0.0 110.351 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.8 p -60.68 137.87 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -40.16 47.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 0.0 109.163 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.73 -20.88 59.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.595 -0.691 . . . . 0.0 110.679 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -114.8 -46.49 2.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.269 -0.894 . . . . 0.0 110.432 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.436 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.61 -35.08 12.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.253 -0.904 . . . . 0.0 111.311 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.13 7.08 29.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.356 -0.84 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.433 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.1 mttm -98.93 137.61 37.23 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -68.8 113.1 5.95 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.751 0.786 . . . . 0.0 110.973 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.433 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 77.7 m95 -117.21 157.16 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -132.1 10.29 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.275 -0.891 . . . . 0.0 110.057 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -140.08 147.13 39.84 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.6 p -140.6 142.47 30.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.774 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -112.77 107.31 15.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.679 -0.638 . . . . 0.0 109.718 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.46 122.83 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.99 114.7 42.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 138.22 31.75 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -143.11 132.58 23.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.192 -0.943 . . . . 0.0 111.635 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 157.02 134.01 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.591 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.92 96.39 0.57 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.081 2.521 . . . . 0.0 109.807 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.4 p90 -128.16 -8.79 5.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.401 -0.812 . . . . 0.0 111.843 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -175.41 3.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.074 -1.016 . . . . 0.0 110.02 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -161.31 -43.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.72 -30.84 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.593 -0.692 . . . . 0.0 110.029 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 142.95 25.68 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.732 -0.605 . . . . 0.0 109.762 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -88.18 156.69 6.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.353 2.702 . . . . 0.0 110.323 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -161.48 -168.49 2.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.41 -101.96 0.18 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.04 163.64 32.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.474 -1.016 . . . . 0.0 109.64 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 50.5 m -85.09 -16.9 39.04 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.613 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 43.3 p90 -179.35 164.56 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.12 149.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -154.34 164.26 38.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.76 . . . . 0.0 110.472 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 128' ' ' VAL . 51.9 m-85 -144.59 152.2 40.17 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.62 136.18 16.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 109.188 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 86.1 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.739 -0.601 . . . . 0.0 109.845 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.47 127.65 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -112.52 171.04 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.722 -0.611 . . . . 0.0 109.885 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.9 mp -101.81 162.51 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.787 -0.571 . . . . 0.0 109.506 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -118.41 -47.64 2.54 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.444 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 3.1 p-80 -160.85 -168.73 2.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.94 96.87 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.43 -61.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.302 -0.874 . . . . 0.0 110.054 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -121.31 162.89 19.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 20.0 p -158.64 144.96 17.06 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.277 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -151.84 53.85 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 153.81 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -127.06 148.82 50.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.939 -1.101 . . . . 0.0 110.096 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -98.97 -165.37 1.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.79 -0.569 . . . . 0.0 109.561 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -66.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.688 . . . . 0.0 109.651 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -34.82 77.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -123.69 74.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -90.71 172.19 8.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.598 0.713 . . . . 0.0 110.256 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.89 67.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.799 -0.563 . . . . 0.0 109.619 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.06 -20.02 55.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.365 -0.834 . . . . 0.0 110.17 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.2 -19.47 65.99 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.91 -25.05 66.97 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.91 -21.09 60.62 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.482 -0.761 . . . . 0.0 108.977 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 66.12 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.61 -22.75 23.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -0.756 . . . . 0.0 110.391 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.91 77.39 1.18 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -154.28 -85.57 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.404 -0.81 . . . . 0.0 109.576 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.22 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 158.33 29.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.497 -0.752 . . . . 0.0 109.506 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -160.96 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.536 -0.727 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.495 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 20.4 t90 -88.36 137.45 32.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 110.817 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -142.5 121.7 13.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.29 158.77 0.24 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.464 -0.773 . . . . 0.0 111.035 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . . . -62.51 -41.76 99.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.077 0.465 . . . . 0.0 110.28 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.48 -171.4 2.3 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.515 0.674 . . . . 0.0 109.241 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.59 -165.59 1.33 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.98 45.8 94.88 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp0 -51.92 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.461 0.648 . . . . 0.0 111.174 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 39' ' ' GLY . 15.5 tttm -91.38 -50.08 5.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 p -158.66 124.89 4.59 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 5.1 pt -128.34 136.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.459 ' N ' ' OG ' ' A' ' 14' ' ' SER . 26.8 m -118.6 138.51 52.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.415 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.75 111.61 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 10.4 t -96.96 119.75 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.088 -1.008 . . . . 0.0 108.978 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -100.9 160.67 14.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.539 0.685 . . . . 0.0 110.284 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 7.1 tp-100 -98.28 148.41 23.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.57 123.81 44.18 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -52.59 -7.73 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.37 -0.831 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.2 139.03 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.786 -1.196 . . . . 0.0 108.874 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.69 113.58 12.12 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.41 179.77 7.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.16 -178.03 6.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.44 115.2 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -105.22 -30.8 9.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 109.202 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -144.3 161.09 39.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 149' ' ' PHE . 99.1 t -145.35 159.03 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.28 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -132.07 138.67 48.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.699 -0.626 . . . . 0.0 110.004 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -153.88 130.38 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -96.69 127.08 9.07 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -83.86 112.09 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.022 -0.693 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.7 56.96 2.12 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.94 58.38 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -53.42 161.72 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.316 -1.108 . . . . 0.0 110.555 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' A' ' 134' ' ' GLN . . . -123.46 -58.72 1.59 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 23.4 m-85 -101.68 133.19 46.77 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.611 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.49 111.56 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 109.677 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.14 141.67 37.11 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -131.07 124.47 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.636 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 1.5 mp -109.31 162.48 14.28 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.71 154.95 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.542 -0.724 . . . . 0.0 110.305 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.55 162.71 34.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 t -116.83 163.91 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.684 0.754 . . . . 0.0 109.872 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 t -77.08 -1.06 27.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.749 -179.518 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.06 -172.31 2.12 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.65 135.11 48.84 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.76 88.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.671 -0.643 . . . . 0.0 111.263 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.79 -55.63 28.05 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 pp -137.69 117.47 13.16 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -52.29 178.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.639 -0.663 . . . . 0.0 110.656 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 133.62 52.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 3.2 p -107.31 126.65 52.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.369 0.605 . . . . 0.0 109.656 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.8 p -86.47 117.87 25.53 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CD1' ' HG2' ' A' ' 109' ' ' ARG . 26.3 m-85 -112.86 -48.18 3.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.3 mtp -121.2 -176.35 3.26 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.549 0.69 . . . . 0.0 110.468 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.7 p -111.84 -178.55 0.54 Allowed Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 43.0 Cg_endo -86.41 19.33 1.41 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 123.155 2.57 . . . . 0.0 111.432 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -120.19 -41.27 2.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.02 -24.9 66.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.8 p -45.97 -27.24 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.711 . . . . 0.0 111.865 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -92.33 0.11 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -163.36 38.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.863 -1.148 . . . . 0.0 108.569 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.12 -26.55 18.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.93 115.77 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 0.0 110.272 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.27 73.55 0.83 Allowed Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 121.685 -0.634 . . . . 0.0 111.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -74.14 -28.23 11.02 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.557 2.171 . . . . 0.0 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -128.86 124.13 34.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.682 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 -170.13 3.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.729 -0.607 . . . . 0.0 109.403 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 40.6 t -132.82 159.99 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 141.22 12.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.762 . . . . 0.0 109.148 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.0 mtp -126.26 156.61 40.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.316 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 11.8 m-85 -110.93 172.28 6.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.33 -150.22 5.3 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.78 -38.04 1.44 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.712 2.941 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.03 -26.73 68.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.935 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -95.08 5.05 52.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.751 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.6 pp -125.53 143.0 51.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.921 -1.112 . . . . 0.0 110.712 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.1 p -61.85 141.08 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.75 34.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 108.973 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.89 63.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.717 . . . . 0.0 110.353 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.428 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -120.23 -45.61 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.42 -40.27 25.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.302 -0.874 . . . . 0.0 111.305 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.27 4.92 28.76 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 11.8 mttm -97.19 135.71 38.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.92 111.35 4.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.528 -0.732 . . . . 0.0 110.886 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 88.6 m95 -115.38 165.02 13.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.9 14.55 2.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.071 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -142.06 138.68 31.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' A' ' 149' ' ' PHE . 4.2 p -130.79 138.95 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.395 -0.816 . . . . 0.0 109.788 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 4.7 tttt -110.39 107.55 17.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.848 -0.532 . . . . 0.0 109.654 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.43 117.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.733 -0.604 . . . . 0.0 109.487 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 48.8 t -124.07 110.97 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 121.16 -0.963 . . . . 0.0 109.72 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.418 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.5 t -84.94 147.3 26.8 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -141.68 129.94 22.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.349 -0.844 . . . . 0.0 111.753 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.474 ' CB ' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 148.4 123.28 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 C-N-CA 123.719 0.808 . . . . 0.0 109.057 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.56 89.5 1.34 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.777 2.318 . . . . 0.0 109.1 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 6.7 p90 -114.62 -22.33 9.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.585 -0.697 . . . . 0.0 111.41 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -173.18 2.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.893 . . . . 0.0 109.863 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -168.75 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -114.88 -36.15 4.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.902 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.07 145.09 30.07 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.836 -0.54 . . . . 0.0 109.727 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.0 Cg_endo -87.92 167.74 6.91 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.371 2.714 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.35 -169.86 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.84 -109.81 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.872 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.69 152.13 26.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.903 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.405 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 34.5 m -87.84 -27.56 22.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.444 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 51.7 p90 -179.17 176.52 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -152.2 131.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.312 -0.867 . . . . 0.0 110.222 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' HG11 ' A' ' 58' ' ' VAL . 80.7 m-85 -86.08 154.23 21.54 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 131.95 19.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.338 -0.851 . . . . 0.0 109.046 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.873 -0.517 . . . . 0.0 110.486 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 149' ' ' PHE . 43.9 mm -79.52 143.15 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -123.32 126.05 46.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.87 147.43 27.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -105.28 -58.71 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.96 178.16 9.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.41 89.44 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.704 . . . . 0.0 109.24 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -51.42 -58.39 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.15 -0.969 . . . . 0.0 110.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.9 162.77 23.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 21.5 p -160.42 144.04 13.78 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.47 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 m -148.9 58.22 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' CB ' ' HB ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.78 58.21 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 123.093 0.557 . . . . 0.0 109.818 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 0.9 OUTLIER -124.54 140.61 52.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.82 -1.175 . . . . 0.0 110.65 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.64 -162.84 0.89 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -99.06 -64.25 1.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 109.374 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -58.53 4.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.692 . . . . 0.0 109.149 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -92.74 68.03 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.8 165.15 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 0.0 109.904 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.402 ' CB ' ' NE2' ' A' ' 15' ' ' GLN . . . -59.89 -23.94 63.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.644 -0.66 . . . . 0.0 110.368 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.46 -21.6 66.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.247 -0.908 . . . . 0.0 109.919 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -66.0 -16.82 64.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.28 -25.77 67.79 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.26 -21.3 61.72 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 65.42 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -24.32 11.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.31 79.95 1.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.434 -0.791 . . . . 0.0 109.746 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p -157.2 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.483 -0.76 . . . . 0.0 109.196 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -178.06 32.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.003 -1.061 . . . . 0.0 110.379 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -147.25 140.54 25.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.026 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -160.41 0.99 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 17.6 t90 -97.58 136.19 38.33 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 3.9 tmm_? -142.6 120.54 12.04 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -53.48 154.76 3.3 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.193 -0.942 . . . . 0.0 110.427 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.79 44.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.784 -0.572 . . . . 0.0 110.196 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.02 -158.94 0.59 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.423 -0.798 . . . . 0.0 109.368 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 172.7 14.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.437 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 91.1 -15.62 60.57 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 2.6 mp0 59.52 117.72 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.618 -0.931 . . . . 0.0 111.418 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -151.7 -71.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 p -157.88 143.54 17.12 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -143.57 139.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 69.2 m -126.53 115.06 18.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.234 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 7.2 p -116.41 126.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 HG21 ' CD ' ' A' ' 129' ' ' LYS . 2.8 t -104.76 113.77 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.875 . . . . 0.0 108.897 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.4 mp -97.61 169.34 9.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.558 0.694 . . . . 0.0 110.66 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -114.66 153.71 29.72 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.545 0.688 . . . . 0.0 109.608 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.0 mm? -104.86 131.98 51.67 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 5.7 tt0 -81.96 43.12 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.25 -0.906 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 4.6 pttt 163.59 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.23 104.66 0.62 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' CG ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.5 178.46 7.02 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.25 178.12 5.95 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.32 131.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.796 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 6.4 t-160 -122.47 -32.35 3.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -141.97 161.44 37.97 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 149' ' ' PHE . 58.4 t -146.67 164.1 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.899 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -139.28 134.77 33.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.639 -0.663 . . . . 0.0 109.616 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.418 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -146.71 118.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -81.86 99.75 2.03 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.83 125.25 22.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.905 . . . . 0.0 110.361 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -107.38 39.07 1.97 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.384 -0.823 . . . . 0.0 109.406 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 136' ' ' TYR . . . 111.98 22.97 5.74 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -101.67 173.1 6.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -1.073 . . . . 0.0 110.382 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.8 -47.64 1.25 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -108.41 120.6 42.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.732 -0.605 . . . . 0.0 110.767 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.63 111.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.458 -0.776 . . . . 0.0 109.287 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -107.86 143.62 36.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.696 -0.627 . . . . 0.0 110.197 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' HG ' ' A' ' 88' ' ' LEU . 38.9 t -132.09 129.57 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mp -117.46 160.17 21.63 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.48 172.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 110.159 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.413 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 164.34 170.64 29.55 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -113.21 160.73 17.97 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.822 0.82 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -81.86 8.13 11.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.93 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.131 -0.981 . . . . 0.0 111.224 -179.265 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.428 0.633 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -48.24 160.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.603 0.716 . . . . 0.0 110.079 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.69 131.61 54.75 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.58 86.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.66 -0.65 . . . . 0.0 110.729 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.411 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.9 tp -59.0 -61.18 2.83 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 pp -136.14 119.98 17.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.546 -0.721 . . . . 0.0 109.292 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.93 179.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.155 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.63 133.95 52.23 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.594 -0.691 . . . . 0.0 109.313 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.5 p -98.22 119.11 36.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.82 -0.55 . . . . 0.0 109.676 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.2 p -75.53 69.49 2.29 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 28.4 t80 -63.42 -55.49 23.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.803 -0.561 . . . . 0.0 110.587 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.6 mtp -117.79 -176.48 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.679 0.752 . . . . 0.0 110.571 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.54 176.35 1.52 Allowed Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -86.28 14.98 2.3 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.136 2.557 . . . . 0.0 111.518 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -120.09 -46.19 2.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.071 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -19.59 49.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.512 -0.742 . . . . 0.0 110.233 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -49.34 -26.87 3.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -0.863 . . . . 0.0 110.64 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -85.95 -86.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.54 -0.725 . . . . 0.0 109.745 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -164.44 37.53 0.08 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.43 -17.83 67.88 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.18 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.239 -1.154 . . . . 0.0 111.91 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.4 90.33 0.22 Allowed Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -81.21 -29.85 1.82 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.686 2.257 . . . . 0.0 110.315 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.6 129.94 50.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.653 -0.654 . . . . 0.0 109.273 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -160.21 -169.8 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.876 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 69.2 t -127.06 154.96 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 93' ' ' PHE . 6.6 ttt-85 -143.1 131.94 22.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.1 mtp -111.81 143.34 42.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.72 -0.612 . . . . 0.0 110.054 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.6 m-85 -111.59 165.1 12.3 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.642 0.734 . . . . 0.0 109.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -147.88 -154.6 6.31 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.8 Cg_endo -74.91 -24.12 13.34 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.644 2.896 . . . . 0.0 110.873 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -50.53 -38.79 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -117.73 15.27 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.443 ' CD1' ' HB1' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -117.26 122.57 44.33 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.6 p -49.65 130.33 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.631 -0.668 . . . . 0.0 110.698 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -67.64 -37.69 82.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.738 . . . . 0.0 109.133 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.05 92.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.284 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -91.96 -36.41 13.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.311 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 116' ' ' LEU . . . -44.98 -35.91 3.13 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.577 -0.702 . . . . 0.0 111.111 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.15 12.29 35.96 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.809 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -91.85 134.47 34.73 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.34 106.61 5.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.913 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.413 ' CE3' ' HA2' ' A' ' 73' ' ' GLY . 74.5 m95 -111.22 164.0 13.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -136.53 8.32 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.521 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -136.99 144.55 43.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.416 HG13 ' CE2' ' A' ' 149' ' ' PHE . 4.1 p -137.4 138.67 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.401 ' CD ' HG21 ' A' ' 46' ' ' VAL . 33.9 tptt -104.3 129.57 52.14 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.4 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 50.8 mm -125.24 111.92 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 47.9 t -117.92 119.73 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.44 -0.787 . . . . 0.0 110.36 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 152.18 20.11 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -160.06 132.45 6.4 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.643 -1.286 . . . . 0.0 113.949 -176.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 136' ' ' TYR . 10.1 tp60 148.09 125.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.32 114.78 1.87 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.778 2.318 . . . . 0.0 109.23 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -117.18 0.87 12.41 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.694 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.39 -160.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.604 -1.31 . . . . 0.0 110.051 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.437 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 ttmm -151.95 23.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 110.011 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -149.05 -40.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 111.701 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.7 158.91 33.61 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.687 . . . . 0.0 111.54 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.3 -159.67 0.11 Allowed 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 124.039 3.159 . . . . 0.0 109.601 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 40' ' ' GLU . 21.2 p90 -178.85 -165.01 0.08 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.47 -128.57 3.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -144.91 165.04 29.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.725 -0.868 . . . . 0.0 110.241 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.3 p -79.14 -25.52 42.88 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.558 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.572 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 46.3 p90 -175.07 173.64 2.6 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.812 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -149.63 130.3 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -142.05 116.33 9.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 110.756 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 60.0 m-85 -88.91 154.0 20.59 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -152.72 120.88 6.23 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.853 -0.53 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.09 126.25 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.33 175.86 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mp -112.35 158.92 19.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 0.0 109.968 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -55.54 2.31 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -160.74 169.82 22.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.61 91.41 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.562 -0.711 . . . . 0.0 109.152 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -52.24 -58.51 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.07 -1.019 . . . . 0.0 110.186 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -125.3 157.58 36.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -160.44 125.26 3.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.4 OUTLIER -118.53 57.19 0.86 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 154.33 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 123.012 0.525 . . . . 0.0 109.674 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -160.24 144.08 14.07 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.87 -1.144 . . . . 0.0 109.494 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.02 -167.54 1.56 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 109.667 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -88.71 -62.77 1.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.685 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -65.04 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -88.59 74.46 8.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -91.08 168.05 11.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.616 -0.678 . . . . 0.0 110.051 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.68 -24.09 67.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.881 -0.512 . . . . 0.0 109.62 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.74 -18.42 62.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 109.967 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -64.96 -18.09 64.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mt -65.33 -26.84 68.22 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.7 -20.02 63.01 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -116.31 65.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -23.37 18.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.425 -0.797 . . . . 0.0 110.399 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -120.43 78.47 1.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.52 -88.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.483 -0.761 . . . . 0.0 109.408 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.36 36.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -155.1 149.89 26.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 0.0 109.317 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -130.37 -170.41 2.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.574 -0.704 . . . . 0.0 109.959 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.464 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 20.9 t90 -88.54 139.67 30.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 109.032 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 126.19 17.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' CB ' ' OE2' ' A' ' 40' ' ' GLU . . . -51.68 152.38 2.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.307 -0.871 . . . . 0.0 110.111 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.1 -23.9 56.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.749 -0.595 . . . . 0.0 110.077 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -139.19 -169.79 2.74 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.421 -0.799 . . . . 0.0 108.965 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 -172.47 2.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.67 -0.644 . . . . 0.0 109.362 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.35 48.67 85.02 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 4.3 mt-10 -62.1 78.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 39' ' ' GLY . 15.9 tttt -66.14 -51.07 61.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.3 p -156.94 124.78 5.47 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 4.1 pt -118.12 139.35 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.817 . . . . 0.0 110.4 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -115.5 140.36 49.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.135 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.1 107.98 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 11.9 t -92.35 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 108.894 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.95 168.72 10.3 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.09 129.76 56.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.718 -0.614 . . . . 0.0 110.406 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.5 mt -85.4 135.35 33.91 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 1.9 pt-20 -79.89 41.6 0.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.436 -0.79 . . . . 0.0 111.099 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 3.6 pttm 161.98 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.1 tt0 -75.88 100.36 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.49 172.38 12.28 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.588 0.709 . . . . 0.0 109.862 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -87.7 170.03 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.48 122.81 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.77 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -109.73 -32.97 6.9 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -144.8 155.2 43.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 149' ' ' PHE . 74.8 t -137.38 158.58 35.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.677 0.751 . . . . 0.0 109.98 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -134.68 137.12 43.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.428 HG13 ' HA ' ' A' ' 147' ' ' VAL . 0.7 OUTLIER -160.25 132.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -101.91 123.61 7.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.15 130.73 35.13 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.304 -0.527 . . . . 0.0 110.67 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.34 64.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 1.4 88.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.9 129.41 34.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 110.295 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.3 -57.73 2.85 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.713 -0.617 . . . . 0.0 110.076 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 133' ' ' SER . 16.4 m-85 -90.99 132.97 35.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.274 -0.891 . . . . 0.0 111.195 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.24 106.84 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CA ' ' HA ' ' A' ' 90' ' ' THR . 7.1 tt0 -102.32 146.88 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 22.2 t -135.71 121.1 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-O 121.64 0.733 . . . . 0.0 109.544 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mp -108.78 163.01 13.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.428 ' HB ' ' CG ' ' A' ' 125' ' ' TRP . 2.6 m -121.34 161.02 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.646 -0.659 . . . . 0.0 110.553 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.36 167.8 38.05 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 t -108.78 155.12 21.13 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.83 -0.806 . . . . 0.0 109.552 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.423 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 60.5 p -89.54 12.69 15.89 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 O-C-N 121.261 -0.899 . . . . 0.0 109.765 -179.745 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.17 -173.68 2.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.411 ' CG ' ' CB ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.83 131.41 47.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.51 88.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.457 -0.777 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.94 -51.04 63.99 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.5 pp -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.486 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.81 172.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.4 ' HA ' ' CA ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -57.59 130.57 46.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.364 -0.835 . . . . 0.0 110.229 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -97.75 123.99 41.92 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -90.95 81.62 5.66 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 20.7 m-85 -70.86 -55.97 7.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.831 . . . . 0.0 109.922 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.9 mtp -120.78 -163.31 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.685 -0.635 . . . . 0.0 109.638 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -128.85 178.12 1.82 Allowed Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.23 17.59 1.71 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.039 2.493 . . . . 0.0 111.089 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.7 m -120.61 -38.49 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 109.704 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -82.97 -29.55 28.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.469 -0.769 . . . . 0.0 109.337 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -60.49 -18.6 52.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.583 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -71.12 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 t -161.27 38.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.6 -21.88 4.19 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.9 121.55 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.365 -1.079 . . . . 0.0 109.119 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.3 p30 43.16 83.92 0.2 Allowed Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.758 -0.589 . . . . 0.0 110.798 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.76 -27.55 2.03 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.984 2.456 . . . . 0.0 109.992 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -145.73 86.24 1.72 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -114.71 127.45 55.76 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.6 m -79.76 165.82 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.743 . . . . 0.0 109.517 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.18 169.61 22.02 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.0 mtt -141.89 165.15 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 110.204 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.1 m-85 -120.85 170.35 9.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.44 -148.28 4.83 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.1 Cg_endo -74.88 -40.02 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.694 2.929 . . . . 0.0 110.716 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.36 -27.24 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 109.73 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -93.44 3.7 55.15 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.693 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 3.3 pp -124.22 152.21 43.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.932 -1.105 . . . . 0.0 109.966 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 120' ' ' ALA . 10.3 p -77.54 139.47 18.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -73.43 -29.92 62.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.28 59.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 110.754 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -125.01 -46.04 1.84 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.43 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -50.95 -29.08 11.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.604 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.48 -5.28 52.18 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.727 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 8.9 mtpt -91.16 133.08 35.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.158 -0.963 . . . . 0.0 108.52 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.81 110.65 3.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.48 -0.762 . . . . 0.0 110.541 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 83.9 m95 -110.72 158.94 18.08 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t70 -130.64 1.19 4.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.115 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.18 144.82 43.11 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.63 142.2 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.547 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -110.36 106.12 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.827 -0.546 . . . . 0.0 109.719 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 130' ' ' ILE . 49.3 mm -100.57 131.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.327 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.6 t -134.01 122.54 41.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 130.24 46.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -133.77 125.29 28.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.289 -0.882 . . . . 0.0 111.692 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HG2' ' CD2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER 170.44 141.44 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -90.71 95.06 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.71 2.273 . . . . 0.0 110.228 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.583 ' CD2' ' HG2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -120.92 -15.67 8.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.015 -1.053 . . . . 0.0 112.002 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -137.2 178.24 7.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 110.918 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -149.33 -47.34 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.644 -0.66 . . . . 0.0 110.248 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.34 153.15 44.19 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.361 -0.837 . . . . 0.0 110.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.15 -171.76 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.64 2.893 . . . . 0.0 110.9 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.448 ' N ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER 170.03 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.19 -121.93 1.8 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.944 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.69 162.44 21.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.447 -1.031 . . . . 0.0 110.521 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -92.78 -27.25 17.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 -179.88 166.6 1.3 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.428 ' HA ' HG13 ' A' ' 60' ' ' ILE . 33.1 m -139.56 145.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.292 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -149.68 159.09 44.63 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.442 0.639 . . . . 0.0 110.346 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CD1' HG11 ' A' ' 58' ' ' VAL . 49.8 m-85 -139.13 156.01 47.46 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.55 127.98 10.68 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.104 -0.998 . . . . 0.0 109.521 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.908 -0.495 . . . . 0.0 110.456 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.213 0.53 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 83.9 mt -142.19 152.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 -173.05 3.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.506 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 4.3 mm? -119.54 163.17 17.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.55 -0.718 . . . . 0.0 109.64 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -114.43 -47.67 2.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -161.0 163.34 31.78 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.96 91.08 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.77 . . . . 0.0 109.159 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.27 -54.73 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.176 -0.952 . . . . 0.0 110.361 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.426 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -125.11 164.07 21.02 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -159.54 146.31 16.57 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.6 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -145.72 49.71 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.0 m 152.0 86.12 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -153.36 133.56 13.41 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.053 -1.029 . . . . 0.0 110.245 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.31 -175.14 4.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.5 t -84.94 -64.13 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.629 -0.67 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -61.48 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -89.13 67.53 8.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.5 p -84.98 168.33 15.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.58 -0.7 . . . . 0.0 109.812 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -22.4 66.95 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.34 -21.01 66.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 109.528 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -65.12 -18.46 65.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 109.014 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 147' ' ' VAL . 11.2 mt -66.02 -26.87 67.73 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.3 mm? -61.96 -19.34 62.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.03 76.15 1.35 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.94 -59.77 2.14 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.33 0.586 . . . . 0.0 110.812 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.64 -119.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p 51.72 -105.78 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.666 -1.271 . . . . 0.0 109.57 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.71 40.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.847 -1.158 . . . . 0.0 110.277 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -154.11 148.51 26.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -132.05 -159.72 0.99 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 14.5 t90 -97.12 140.05 32.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -149.0 126.7 11.74 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -50.42 142.25 10.74 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.429 -0.794 . . . . 0.0 110.876 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.83 -52.18 61.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 0.0 109.323 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -152.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.78 -179.75 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.7 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 96.34 -24.05 32.12 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 9.8 mt-10 45.17 41.96 6.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.694 -0.886 . . . . 0.0 112.284 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -59.81 -65.24 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -158.76 124.05 4.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.466 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 18.4 pt -112.92 148.63 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -124.59 146.76 48.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.708 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.451 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 10.9 p -154.92 111.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 109.527 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 11.2 t -95.52 119.82 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.27 161.04 13.9 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.453 0.644 . . . . 0.0 109.863 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -107.02 129.3 54.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.731 -0.606 . . . . 0.0 109.796 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.2 mm? -80.88 133.28 35.54 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.34 37.77 0.4 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.713 . . . . 0.0 110.425 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 pttt 165.67 126.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -76.29 108.86 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 109.225 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.78 -179.33 6.39 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -87.94 178.39 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.04 137.9 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.333 -0.854 . . . . 0.0 109.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 31.5 t60 -123.97 -34.73 2.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.706 -0.621 . . . . 0.0 109.895 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.6 m -137.1 163.4 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG11 ' CD1' ' A' ' 149' ' ' PHE . 75.4 t -142.62 165.03 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 109.622 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.67 115.66 7.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.759 . . . . 0.0 109.949 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.401 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 1.1 mp -133.14 120.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.647 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -79.14 89.03 1.19 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . 5.3 m120 -71.41 119.12 15.1 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 122.089 -0.653 . . . . 0.0 110.845 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.66 22.99 13.96 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 p -52.91 -175.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.17 0.986 . . . . 0.0 112.022 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 -54.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 133' ' ' SER . 44.7 m-85 -117.85 122.17 42.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.769 -0.582 . . . . 0.0 109.597 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 t -118.31 107.63 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.863 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.77 141.2 28.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' CG ' ' A' ' 88' ' ' LEU . 60.0 t -136.55 119.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 0.0 109.668 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mp -116.95 163.28 16.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.5 m -126.74 168.65 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.739 -0.601 . . . . 0.0 110.131 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 168.97 172.79 36.09 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -110.39 162.36 14.74 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.551 0.691 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 p -86.27 9.53 17.47 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.116 -0.99 . . . . 0.0 110.436 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.98 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 135.88 47.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.19 85.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.462 -0.774 . . . . 0.0 110.563 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -68.05 -64.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -112.47 114.0 26.47 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.15 172.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.554 -0.716 . . . . 0.0 109.227 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.05 127.23 28.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.28 -0.887 . . . . 0.0 109.318 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p -95.7 114.7 26.47 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.219 0.533 . . . . 0.0 109.737 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -74.68 68.97 1.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.468 ' CD2' ' HG2' ' A' ' 94' ' ' MET . 15.8 t80 -61.66 -61.66 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.883 -0.511 . . . . 0.0 109.623 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' CD2' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -122.55 -168.9 1.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.524 -0.735 . . . . 0.0 109.877 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -116.41 176.72 1.43 Allowed Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.72 12.67 2.93 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.943 2.429 . . . . 0.0 111.27 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 t -121.68 -37.25 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.156 -0.965 . . . . 0.0 110.248 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.6 -22.04 37.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.804 . . . . 0.0 110.249 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.2 p -58.54 -21.03 51.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 110.718 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -69.28 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -161.95 38.95 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 108.663 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.2 6.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.05 121.91 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -1.161 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.431 ' O ' ' CE ' ' A' ' 94' ' ' MET . 7.4 p30 41.61 59.35 9.22 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 122.182 -0.324 . . . . 0.0 111.024 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.02 -31.35 5.02 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.117 2.544 . . . . 0.0 111.506 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.91 112.55 5.65 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.86 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -160.89 -157.91 0.56 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -124.59 160.65 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.014 -1.054 . . . . 0.0 109.692 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tpt180 -139.81 131.85 27.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtp -112.42 166.26 11.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.508 -0.745 . . . . 0.0 110.277 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 9.8 m-85 -139.1 166.25 25.0 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.44 -146.66 5.04 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.411 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 38.7 Cg_endo -73.91 -36.7 3.33 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 123.828 3.019 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.5 -27.31 68.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -90.32 1.12 56.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.597 -0.69 . . . . 0.0 110.68 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.452 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 3.1 pp -129.96 147.27 51.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.105 -0.997 . . . . 0.0 109.583 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.449 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 10.9 p -71.74 139.16 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -71.5 -32.0 67.73 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.05 -19.88 65.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -113.09 -49.42 2.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.452 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -50.96 -28.1 9.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.513 -0.742 . . . . 0.0 110.757 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 19.54 9.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.291 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.8 mtpt -118.34 133.88 55.51 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -67.18 111.61 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.568 -0.708 . . . . 0.0 111.07 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.448 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -117.15 164.53 14.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.17 13.49 2.62 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.945 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -143.67 144.22 31.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 149' ' ' PHE . 8.8 p -138.64 139.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.399 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -105.49 124.28 49.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 130' ' ' ILE . 50.2 mm -119.68 112.35 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.621 -0.674 . . . . 0.0 109.689 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 29.6 t -113.78 118.84 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 O-C-N 121.21 -0.932 . . . . 0.0 109.546 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 93.56 7.32 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -92.48 128.68 38.42 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.613 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER 173.91 69.6 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -174.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.21 92.04 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.881 2.387 . . . . 0.0 108.768 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -120.78 -10.15 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.727 -177.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.413 ' CB ' ' OE1' ' A' ' 40' ' ' GLU . 32.6 t -128.77 -175.59 3.58 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.889 -1.132 . . . . 0.0 110.72 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 14.8 tttm -133.54 -33.52 1.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -126.24 -5.03 6.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.017 -1.052 . . . . 0.0 112.247 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -110.93 150.4 41.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.946 -1.096 . . . . 0.0 110.678 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 51.2 Cg_endo -92.08 172.25 2.53 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.083 3.189 . . . . 0.0 110.559 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.47 -160.48 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.059 -1.026 . . . . 0.0 109.513 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.24 -112.02 0.53 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -142.9 161.91 36.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.064 -1.257 . . . . 0.0 111.733 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 5.5 m -83.26 -17.2 43.48 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.708 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.647 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.3 p90 -176.01 166.55 2.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.327 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 24' ' ' LEU . 20.2 m -145.1 137.78 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -149.89 163.27 38.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.997 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CD1' HG11 ' A' ' 58' ' ' VAL . 55.9 m-85 -140.72 152.73 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -151.59 139.16 19.62 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -142.14 127.98 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.05 172.21 7.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.694 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.16 134.88 42.44 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.592 -0.692 . . . . 0.0 109.525 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -88.52 -61.52 1.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -160.86 163.54 31.96 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.38 89.8 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -52.49 -55.63 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.177 -0.952 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.46 161.05 25.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.0 p -154.58 144.15 21.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.0 110.668 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -141.12 46.72 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.747 -0.596 . . . . 0.0 109.498 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.9 m 152.88 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -155.64 139.95 16.67 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.055 -1.028 . . . . 0.0 109.866 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.45 -161.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.904 . . . . 0.0 109.832 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -68.04 0.82 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.578 -0.701 . . . . 0.0 109.895 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -64.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.451 -0.781 . . . . 0.0 109.16 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.32 58.7 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.4 p -79.71 179.18 7.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -65.06 -25.7 67.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.84 -15.85 59.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 109.762 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.42 -17.31 64.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.133 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.76 -24.27 67.51 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.77 -23.99 32.94 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.479 -0.763 . . . . 0.0 109.011 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -108.25 60.81 0.61 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.57 64.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.986 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.05 64.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 p -152.68 -90.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.1 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.075 -1.016 . . . . 0.0 110.082 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -128.47 147.47 50.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.045 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -132.5 176.08 8.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.413 -0.805 . . . . 0.0 110.204 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.449 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.0 t90 -88.48 139.49 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -144.67 130.5 19.21 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.97 146.47 8.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.795 . . . . 0.0 110.025 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 -22.09 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.738 -0.601 . . . . 0.0 110.436 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 175.58 9.43 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.86 -166.1 1.31 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 68.14 44.3 77.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -48.28 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.513 0.673 . . . . 0.0 111.246 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' GLY . 31.6 ttmt -97.8 -58.33 2.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.5 p -156.29 118.43 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 18.0 pt -116.01 147.22 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.426 -0.796 . . . . 0.0 110.205 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -126.83 149.52 49.67 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.417 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -154.44 107.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.0 t -90.9 120.71 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.6 mp -100.11 163.29 12.49 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.456 0.646 . . . . 0.0 110.117 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -116.55 117.64 30.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.13 143.58 50.54 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.18 37.15 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.707 -0.621 . . . . 0.0 110.975 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.91 137.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.93 108.14 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.6 176.78 8.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -87.25 179.79 6.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.5 133.06 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.885 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -120.4 -32.81 4.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 0.0 109.692 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.43 163.28 33.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.3 t -143.37 166.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.614 -0.679 . . . . 0.0 109.215 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -137.66 102.07 4.65 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.0 110.114 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.491 HG12 ' CE1' ' A' ' 111' ' ' PHE . 1.6 mm -115.18 117.98 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.31 114.45 3.97 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.09 127.74 33.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.798 -0.825 . . . . 0.0 110.671 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 67.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.4 -30.1 10.2 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.429 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.37 -172.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.967 . . . . 0.0 109.62 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -155.0 -52.81 0.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.695 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.6 m-85 -99.93 123.13 43.84 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.839 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.3 t -127.75 111.58 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.025 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.78 144.3 31.3 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HB ' ' HG ' ' A' ' 88' ' ' LEU . 20.0 t -133.29 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -111.47 158.84 18.67 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.67 158.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.728 -0.607 . . . . 0.0 110.361 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.421 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.44 174.26 44.54 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 t -115.78 159.67 21.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 109.821 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.3 p -75.51 -5.14 43.72 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.643 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.075 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -109.42 -175.12 2.67 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.47 129.91 46.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -59.34 87.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.806 -0.559 . . . . 0.0 111.222 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.7 tp -59.96 -59.23 5.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -137.23 124.06 21.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 109.209 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -54.72 -177.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 0.0 110.114 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.75 133.29 49.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 109.23 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 38.1 p -99.57 120.93 40.45 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -86.15 124.17 32.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 31.0 m-85 -118.67 -47.3 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.633 -0.667 . . . . 0.0 110.237 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 69.8 mtp -122.07 -174.65 2.94 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.603 0.716 . . . . 0.0 110.963 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.2 p -117.14 174.76 2.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.36 12.59 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.19 2.594 . . . . 0.0 111.563 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.4 -39.51 2.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.937 . . . . 0.0 109.754 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -80.2 -20.52 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.8 p -58.06 -22.75 51.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.396 -0.815 . . . . 0.0 110.547 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -68.3 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.216 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 38.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.69 -17.96 7.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.35 117.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.239 . . . . 0.0 110.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 39.76 72.71 0.94 Allowed Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 121.944 -0.473 . . . . 0.0 111.963 178.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.7 -30.33 4.94 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.747 2.298 . . . . 0.0 109.62 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.97 115.21 18.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 -168.78 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.504 -0.747 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 41.3 t -144.75 131.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG3' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mmt85 -135.21 131.8 37.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.9 mtt -105.14 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.769 -0.582 . . . . 0.0 109.508 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' CE1' HG12 ' A' ' 60' ' ' ILE . 14.3 m-85 -140.26 163.98 31.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.74 0.781 . . . . 0.0 109.885 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -144.35 -153.68 5.93 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.6 Cg_endo -74.83 -24.3 13.35 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 123.602 2.868 . . . . 0.0 111.033 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -43.71 41.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.564 -0.71 . . . . 0.0 111.166 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.48 13.12 20.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 110.656 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -114.76 121.0 41.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.445 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.2 p -48.94 130.57 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.756 -0.59 . . . . 0.0 110.736 -177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.86 -39.24 87.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.443 -0.786 . . . . 0.0 109.224 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.77 89.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.747 -0.596 . . . . 0.0 110.572 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.445 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -92.08 -34.9 14.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.41 -0.806 . . . . 0.0 109.373 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . . . -46.11 -33.73 3.71 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.595 -0.69 . . . . 0.0 110.993 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.02 10.81 40.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.801 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 2.4 mmtt -92.9 133.13 36.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -72.35 104.57 3.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.312 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.421 ' CE3' ' HA2' ' A' ' 73' ' ' GLY . 72.0 m95 -110.4 157.54 19.44 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -131.27 4.15 4.35 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.271 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -132.52 150.61 52.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.18 141.59 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.234 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -108.58 110.92 22.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.737 -0.602 . . . . 0.0 109.899 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 48.7 mm -104.71 118.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 39.9 t -122.56 122.1 65.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.26 -0.9 . . . . 0.0 110.03 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.62 145.72 25.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -148.35 126.71 12.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 111.892 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.29 138.94 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 43.8 Cg_endo -90.06 103.26 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 123.189 2.593 . . . . 0.0 110.178 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 134' ' ' GLN . 5.4 p90 -137.17 -4.11 1.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.233 -0.917 . . . . 0.0 112.414 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 -173.86 3.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.847 -1.158 . . . . 0.0 110.463 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -173.44 -39.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -105.45 -42.08 5.32 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.647 0.736 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 145.33 31.18 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.02 166.89 8.26 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.119 2.546 . . . . 0.0 110.507 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -171.44 -164.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 109.07 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.43 -106.84 0.28 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.642 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -129.23 149.76 50.89 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.01 62.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 122.097 -0.377 . . . . 0.0 111.021 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.503 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.0 p90 179.07 178.11 0.48 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.413 ' CG1' ' CD1' ' A' ' 144' ' ' LEU . 15.7 m -155.65 129.79 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -141.82 156.39 45.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 109.474 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' CD1' HG11 ' A' ' 58' ' ' VAL . 39.6 m-85 -127.87 148.44 50.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -146.63 130.44 17.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.458 -0.776 . . . . 0.0 109.273 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 4' ' ' ILE . 71.4 mt -121.57 123.26 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.47 173.06 6.47 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.437 0.637 . . . . 0.0 109.781 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mp -103.07 165.7 10.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.645 . . . . 0.0 109.57 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -120.22 -47.39 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.412 ' CD2' ' HB2' ' A' ' 48' ' ' GLN . 11.0 p-80 -161.0 -173.11 3.74 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.14 92.56 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.48 -0.762 . . . . 0.0 109.372 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.55 -60.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.446 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -121.31 163.63 18.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 19.7 p -160.05 149.37 17.71 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.059 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -152.31 51.91 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.681 -0.637 . . . . 0.0 109.975 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 153.63 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 1.1 mm100 -125.57 133.66 52.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.967 -1.083 . . . . 0.0 110.651 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.09 -175.5 5.67 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -64.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -56.66 12.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 88.8 m-70 -95.32 69.73 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -86.82 166.84 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' CB ' ' CG2' ' A' ' 45' ' ' VAL . . . -61.6 -24.33 66.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.701 -0.624 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.51 -21.43 65.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.835 . . . . 0.0 109.712 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -65.71 -19.7 66.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.72 -24.92 67.09 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.62 -20.83 61.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -109.23 62.69 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.86 -24.84 6.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.31 78.15 1.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -157.29 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.526 -0.734 . . . . 0.0 109.342 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -178.27 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 6.0 mmm180 -144.24 143.72 31.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -0.838 . . . . 0.0 108.798 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -130.58 -162.67 1.23 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.361 -0.837 . . . . 0.0 109.324 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.457 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 20.6 t90 -96.87 136.08 37.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -143.1 125.93 16.11 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -53.73 160.06 1.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 110.753 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.24 -45.05 14.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -152.03 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.51 -168.31 2.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.818 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 94.52 -22.62 36.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 12.1 mt-10 53.36 52.56 13.24 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.173 -1.193 . . . . 0.0 110.73 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -107.84 -103.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.38 -0.825 . . . . 0.0 109.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.0 p -108.03 142.9 37.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.655 -1.278 . . . . 0.0 109.462 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -145.21 147.03 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.673 -0.642 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 8.2 p -151.06 106.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 9.5 t -93.66 116.56 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.99 . . . . 0.0 108.911 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.29 152.7 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.923 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 8' ' ' HIS . 8.4 tm0? -91.5 158.94 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.71 -0.619 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 4.2 mm? -107.22 124.94 50.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -52.29 -8.43 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.428 -0.795 . . . . 0.0 112.188 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -162.59 140.77 8.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.806 -1.184 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -75.87 113.72 13.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.52 -176.46 5.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.87 172.34 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.72 120.04 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 109.509 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -110.62 -29.37 8.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -147.19 157.22 43.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 149' ' ' PHE . 67.5 t -142.22 163.11 18.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.058 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -137.3 141.77 41.9 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.87 123.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -87.68 121.7 5.98 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.6 125.59 29.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.971 -0.723 . . . . 0.0 110.162 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.39 62.98 1.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.6 -28.9 13.91 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.435 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 p -56.75 166.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.643 -0.916 . . . . 0.0 110.191 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.32 -57.37 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.16 123.36 45.18 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.56 111.66 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 0.0 110.204 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -105.06 141.43 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.4 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 35.5 t -130.78 127.23 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.52 -0.737 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.67 160.92 16.26 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.76 161.52 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.634 -0.666 . . . . 0.0 110.374 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 168.16 37.14 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 t -119.5 158.35 26.46 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.012 -0.699 . . . . 0.0 109.523 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.9 p -91.65 13.28 18.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 110.36 -179.378 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.17 -175.48 2.69 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.52 135.79 33.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.08 89.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.636 -0.665 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.26 -54.0 35.83 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.4 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 2.1 pp -138.64 122.36 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.385 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.76 -177.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 t -69.64 136.53 51.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.494 -0.754 . . . . 0.0 109.171 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 125.72 52.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.429 0.633 . . . . 0.0 109.961 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -83.79 104.68 14.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CG ' ' HG3' ' A' ' 109' ' ' ARG . 19.2 m-85 -101.89 -47.02 4.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 110.343 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 ttp -117.9 -178.5 3.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.89 173.76 2.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.17 18.88 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.288 2.658 . . . . 0.0 111.292 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.32 -50.0 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -57.65 -21.43 39.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.395 -0.816 . . . . 0.0 110.307 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 p -45.71 -27.82 0.89 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.0 111.453 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -78.09 0.45 Allowed 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.761 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.8 37.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.45 -27.52 59.28 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 -82.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.542 -0.975 . . . . 0.0 110.489 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.407 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.7 p30 -112.03 87.48 8.85 Favored Pre-proline 0 C--N 1.296 -1.735 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.91 -24.93 28.42 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.651 2.234 . . . . 0.0 109.891 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -136.43 148.1 47.59 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -157.68 -168.02 2.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.594 -0.691 . . . . 0.0 109.821 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.54 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 96.1 t -137.73 129.77 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HG3' ' CG ' ' A' ' 93' ' ' PHE . 23.5 mmt-85 -137.81 150.48 47.23 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 37.4 mtm -134.43 166.51 22.68 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.596 0.712 . . . . 0.0 110.807 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.1 m-85 -119.76 171.13 8.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.65 -150.71 5.37 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.1 Cg_endo -76.0 -37.43 1.57 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.677 2.918 . . . . 0.0 110.77 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.34 -26.14 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.526 -0.734 . . . . 0.0 109.763 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.96 2.16 56.15 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.652 -0.655 . . . . 0.0 110.74 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.6 pp -122.5 141.1 52.01 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.981 -1.074 . . . . 0.0 110.519 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.2 p -61.42 138.71 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -32.87 49.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.356 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.03 -18.12 65.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.503 -0.748 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -117.19 -45.64 2.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.267 -0.895 . . . . 0.0 110.007 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.05 -39.58 28.05 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.342 -0.849 . . . . 0.0 111.08 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -81.37 1.18 34.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 15.9 mttt -94.04 134.27 36.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -68.58 112.43 5.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.446 -0.784 . . . . 0.0 110.919 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 79.4 m95 -115.14 166.44 11.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.66 12.31 2.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.714 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -146.92 141.5 26.59 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.8 p -131.79 143.79 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.579 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 5.8 tttp -107.64 114.11 27.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.609 . . . . 0.0 109.48 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.5 115.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.648 -0.658 . . . . 0.0 109.599 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 40.4 t -122.23 116.27 48.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.34 156.6 18.61 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -151.44 127.81 10.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.361 -0.837 . . . . 0.0 110.988 -178.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 133' ' ' SER . 3.0 tp60 149.32 136.11 0.0 OUTLIER Pre-proline 0 N--CA 1.519 3.002 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.89 91.29 0.66 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.906 2.404 . . . . 0.0 110.269 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.47 -0.38 57.45 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.491 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 t -168.3 -162.69 0.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.791 -1.193 . . . . 0.0 110.261 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mtpt -138.89 -39.34 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -117.17 -13.76 10.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -0.984 . . . . 0.0 111.343 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.6 142.3 24.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.324 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 46.6 Cg_endo -88.03 177.13 3.56 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.479 2.786 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 173.14 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.37 -112.98 0.53 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.962 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -133.07 160.02 38.4 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.238 -1.154 . . . . 0.0 110.731 -179.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 67.3 m -78.64 -21.86 47.77 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.752 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.486 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.5 p90 177.08 178.95 0.24 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.249 -0.907 . . . . 0.0 110.459 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 m -154.21 129.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -139.95 114.4 9.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.766 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.442 ' CE2' HG13 ' A' ' 128' ' ' VAL . 73.0 m-85 -87.94 157.25 18.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.281 -0.887 . . . . 0.0 108.901 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -154.2 136.8 15.14 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.353 -0.842 . . . . 0.0 109.174 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.651 -0.655 . . . . 0.0 110.913 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.453 HG22 HD11 ' A' ' 4' ' ' ILE . 79.5 mt -141.04 128.74 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -113.42 151.33 31.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.926 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -84.74 149.47 25.75 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -103.87 -50.26 3.44 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -161.03 -178.59 6.88 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -99.96 97.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.21 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -54.77 -59.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.329 -0.857 . . . . 0.0 110.442 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 154.25 36.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.147 -0.971 . . . . 0.0 108.75 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . 23.8 p -143.4 125.26 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.0 110.715 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.3 m -127.51 50.1 2.05 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 1.2 p 154.23 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.426 ' OE1' ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -110.41 146.23 36.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 109.883 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.34 -170.72 2.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.72 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -99.38 -68.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.785 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -37.79 87.24 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -116.56 70.11 0.76 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.9 p -87.5 172.37 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.189 0.995 . . . . 0.0 109.53 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 45' ' ' VAL . . . -64.9 -24.98 67.69 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.231 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.78 -20.4 56.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.807 . . . . 0.0 109.509 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.42 -20.5 66.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 mt -66.27 -26.94 67.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.65 -18.84 61.14 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.474 -0.766 . . . . 0.0 109.175 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -112.25 66.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.54 -45.4 56.87 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.541 -0.724 . . . . 0.0 110.366 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.86 78.98 7.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.058 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.0 -152.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -130.8 40.3 3.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.069 -1.02 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -149.83 136.55 19.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -160.24 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.493 -0.755 . . . . 0.0 109.738 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 22.0 t90 -85.43 140.24 30.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.264 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 129.69 22.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -54.69 161.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.305 -0.872 . . . . 0.0 110.498 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.57 -30.08 66.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.971 -0.456 . . . . 0.0 110.021 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -174.24 3.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.5 -165.27 1.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.57 45.01 95.69 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -46.12 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 111.812 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' GLY . 28.1 tttt -94.77 -56.4 2.79 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.2 p -158.13 113.05 2.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.444 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 5.0 pt -111.13 139.65 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.608 -0.683 . . . . 0.0 109.527 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 50.6 m -126.27 122.65 36.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.523 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' CB ' ' A' ' 21' ' ' ALA . 7.2 p -123.23 125.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.48 113.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 171.09 8.25 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.364 0.602 . . . . 0.0 110.281 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.79 174.49 5.9 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -124.3 140.43 52.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -76.52 26.55 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.214 -0.929 . . . . 0.0 111.469 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.6 pttt 167.1 132.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.77 111.69 11.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.09 167.82 21.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -72.26 -178.77 2.61 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mm -126.6 128.8 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' A' ' 113' ' ' PRO . 77.0 t60 -120.69 -38.97 2.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 m -147.11 162.46 38.8 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.421 HG11 ' CD1' ' A' ' 149' ' ' PHE . 89.4 t -147.37 162.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.92 127.83 22.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -143.48 130.46 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.14 128.48 9.53 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.78 115.29 20.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.129 -0.63 . . . . 0.0 109.692 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -105.45 61.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.63 -29.08 12.72 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.432 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 86.3 p -60.62 173.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . . . -139.88 -52.71 0.52 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.4 m-85 -95.34 123.99 39.14 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.77 111.92 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.553 -0.717 . . . . 0.0 110.036 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -103.28 140.13 37.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.46 122.7 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.14 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mp -112.13 162.01 15.89 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' A' ' 87' ' ' LEU . 3.2 m -129.14 160.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 110.275 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.15 174.8 46.74 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -112.03 160.27 17.65 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.799 0.809 . . . . 0.0 109.949 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.425 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 56.0 p -86.37 7.27 26.3 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.973 . . . . 0.0 110.103 -179.552 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.12 -174.43 2.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -119.32 124.77 47.45 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.12 85.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.798 -0.563 . . . . 0.0 110.446 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HA ' HG11 ' A' ' 117' ' ' VAL . 3.4 tp -57.91 -56.29 23.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.195 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.407 HD12 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -140.41 124.57 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.629 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.92 172.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.48 134.37 56.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.4 p -107.57 124.89 50.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.594 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -84.27 125.03 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CD1' ' CD ' ' A' ' 109' ' ' ARG . 28.7 m-85 -121.66 -43.31 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 mtp -120.4 -165.28 1.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.658 . . . . 0.0 110.086 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.5 p -129.37 175.13 3.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.93 13.64 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 123.178 2.585 . . . . 0.0 111.257 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.6 m -120.36 -46.34 2.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 -22.92 29.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.13 -36.32 29.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 110.919 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -74.5 -84.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.853 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -163.59 37.29 0.09 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.66 -25.25 54.13 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.632 -0.922 . . . . 0.0 110.45 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 90.48 30.51 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.25 -21.54 23.25 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.537 2.158 . . . . 0.0 110.043 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.47 156.51 37.1 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.41 -175.18 5.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 0.0 110.228 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.537 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 42.6 t -155.7 115.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' CD ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.49 165.69 19.37 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.378 -0.826 . . . . 0.0 109.679 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.4 mtt -140.43 175.46 9.58 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.497 0.665 . . . . 0.0 110.153 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.5 m-85 -136.7 159.0 43.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 116' ' ' LEU . . . -125.82 -155.01 8.85 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 56' ' ' HIS . 38.3 Cg_endo -75.42 -36.77 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.274 2.65 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.45 -29.12 68.49 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -2.72 44.36 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -124.99 141.19 52.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.948 -1.095 . . . . 0.0 109.956 179.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.438 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.2 p -51.56 139.98 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -39.2 62.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.157 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.56 -20.91 63.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.438 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -115.51 -43.64 3.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.3 -32.56 7.52 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.249 -0.907 . . . . 0.0 111.119 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.01 24.23 5.74 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.0 mttm -114.86 137.02 52.46 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -65.34 116.24 6.45 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.78 0.8 . . . . 0.0 110.462 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.451 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 63.2 m95 -122.66 151.05 41.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -133.52 5.19 3.71 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.429 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -132.75 141.39 48.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 149' ' ' PHE . 4.7 p -135.06 141.17 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.655 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -109.59 121.09 44.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.813 -0.554 . . . . 0.0 109.702 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.5 114.07 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 109.142 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 61.2 t -114.88 116.83 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.353 -0.842 . . . . 0.0 109.946 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.422 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -92.49 137.38 32.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -137.94 123.44 19.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.507 -178.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 133' ' ' SER . 4.8 tp60 166.43 133.46 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -87.02 95.05 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.928 2.419 . . . . 0.0 108.952 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.1 p90 -127.79 -7.25 5.59 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.273 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.12 178.65 6.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.0 110.527 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -156.96 -42.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.83 -36.7 5.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.49 -0.756 . . . . 0.0 109.669 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.41 147.67 34.33 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -87.5 178.43 3.38 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.286 2.657 . . . . 0.0 110.777 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER 178.93 -171.9 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.45 -112.1 0.49 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.907 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.88 148.79 32.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.68 -0.894 . . . . 0.0 110.412 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -84.89 -27.66 26.5 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 52.1 p90 -176.03 169.8 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.673 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.8 m -150.15 134.69 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.161 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -145.63 113.98 6.67 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.531 -0.731 . . . . 0.0 109.855 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.421 ' CD1' HG11 ' A' ' 58' ' ' VAL . 64.1 m-85 -93.3 152.56 19.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 133.54 20.81 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.396 -0.815 . . . . 0.0 108.805 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.725 -0.609 . . . . 0.0 109.364 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.356 0.598 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 149' ' ' PHE . 47.7 mm -79.67 134.72 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -108.24 113.85 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 109.955 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.76 140.77 36.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.672 -0.643 . . . . 0.0 109.359 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -91.94 -65.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.531 -0.731 . . . . 0.0 109.519 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -160.39 173.22 15.95 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.76 90.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.211 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.07 -55.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.171 -0.956 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.19 154.22 37.76 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.989 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.61 125.32 12.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 110.089 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -120.45 45.75 2.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.649 -0.657 . . . . 0.0 109.516 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 153.84 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 136.97 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -162.47 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.162 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -93.45 -69.41 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -60.74 2.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.731 . . . . 0.0 109.122 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -88.05 68.43 9.16 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.2 p -92.12 170.9 9.46 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.727 0.775 . . . . 0.0 110.219 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.55 -24.26 67.74 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.98 -0.45 . . . . 0.0 109.889 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.57 -19.56 62.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -65.5 -18.48 65.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.843 . . . . 0.0 109.157 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.13 -25.12 67.62 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.08 -20.61 58.96 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.47 -0.769 . . . . 0.0 109.033 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -127.29 73.8 1.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.81 -51.25 30.35 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.651 -0.656 . . . . 0.0 110.845 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.92 79.12 8.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -162.22 31.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 109.618 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.2 p90 46.99 25.18 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.242 0.544 . . . . 0.0 111.765 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -126.62 126.05 42.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 108.972 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -123.48 169.83 11.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.33 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.452 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.5 t90 -74.18 141.07 45.53 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -143.19 130.57 21.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.48 151.73 3.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.463 -0.773 . . . . 0.0 110.239 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.79 71.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.61 -0.681 . . . . 0.0 109.702 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.24 -157.66 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.72 167.05 18.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.412 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 138' ' ' LYS . . . 96.03 -34.96 4.59 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 3.9 mp0 51.79 104.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.944 . . . . 0.0 111.782 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -117.31 -51.02 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -158.9 105.01 1.76 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.452 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 18.7 pt -105.68 139.88 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.361 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -121.92 149.26 43.67 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.164 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.6 112.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.08 119.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.402 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.8 mp -97.27 161.25 13.89 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.416 0.627 . . . . 0.0 109.941 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -107.78 145.28 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.38 0.61 . . . . 0.0 109.355 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.95 133.67 49.34 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 31.9 tt0 -81.68 45.62 0.9 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.448 -0.783 . . . . 0.0 110.612 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 160.0 126.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -73.79 107.88 6.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.54 178.0 7.38 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.406 0.622 . . . . 0.0 109.588 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -89.92 177.23 6.54 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.72 119.04 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.53 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -108.72 -29.0 8.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.63 -0.669 . . . . 0.0 109.435 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 20.8 m -149.26 146.35 27.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 149' ' ' PHE . 54.0 t -131.8 162.07 40.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.454 0.645 . . . . 0.0 109.701 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -141.79 136.07 30.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.58 132.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -106.1 131.74 10.79 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.48 128.03 34.36 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 122.185 -0.597 . . . . 0.0 110.244 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.7 71.33 1.7 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.3 7.45 88.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -84.06 -173.47 4.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.762 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.88 -51.65 0.37 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -103.09 130.8 50.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.672 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.53 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.657 . . . . 0.0 109.575 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -105.56 151.36 24.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.761 -0.587 . . . . 0.0 109.486 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 23.7 t -141.53 122.99 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.855 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp -110.56 163.71 13.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.86 156.73 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.713 -0.617 . . . . 0.0 109.781 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.29 176.25 45.22 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 t -110.32 156.71 20.36 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.2 p -85.77 7.59 23.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.442 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 179.858 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.2 t0 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -113.16 -177.92 3.25 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.741 0.781 . . . . 0.0 109.097 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -123.69 129.04 50.5 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.32 86.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 110.292 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HA ' HG11 ' A' ' 117' ' ' VAL . 13.6 tp -59.04 -54.41 47.36 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.1 pp -144.66 120.73 10.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.42 172.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.31 134.06 55.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.438 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.3 p -105.34 126.89 52.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.413 0.625 . . . . 0.0 109.325 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.2 p -87.88 119.94 28.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 18.1 m-85 -110.21 -51.51 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.629 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.416 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 19.1 mtp -122.03 -162.71 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.508 0.671 . . . . 0.0 110.084 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.1 p -123.51 177.45 1.7 Allowed Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.79 11.53 3.31 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.929 2.419 . . . . 0.0 111.279 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 -36.72 3.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.314 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -81.65 -16.39 51.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.78 . . . . 0.0 110.226 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 m -59.44 -24.67 63.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -67.45 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 t -162.28 38.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 108.722 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.7 -22.32 6.73 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.96 119.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 109.935 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.416 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.9 OUTLIER 40.87 68.72 2.25 Favored Pre-proline 0 N--CA 1.508 2.449 0 O-C-N 121.949 -0.469 . . . . 0.0 111.233 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.1 -30.71 4.16 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.949 2.433 . . . . 0.0 110.52 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.61 82.58 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.665 -0.647 . . . . 0.0 109.647 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.9 171.99 7.54 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -127.29 172.84 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -155.82 145.9 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 109.144 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.4 mtt -123.71 153.7 40.49 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.45 0.643 . . . . 0.0 110.096 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.9 m-85 -114.8 161.33 18.34 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -131.3 -149.39 6.44 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 38.7 Cg_endo -74.72 -39.36 1.37 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.614 2.876 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.62 -28.29 69.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -89.99 3.77 52.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.662 -0.649 . . . . 0.0 110.598 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.61 139.66 53.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.013 -1.054 . . . . 0.0 110.521 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.7 p -59.6 130.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -74.84 -30.81 61.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.475 -0.766 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -20.63 65.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.506 -0.746 . . . . 0.0 110.217 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.98 -46.25 2.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.915 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.428 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.8 -39.55 25.76 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.165 -0.959 . . . . 0.0 111.439 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.13 -0.15 30.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.35 -0.843 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.7 mtpt -92.36 134.42 34.94 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -67.76 113.55 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -0.769 . . . . 0.0 110.766 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -116.31 163.85 15.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.11 7.41 3.41 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.585 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -137.39 149.45 46.96 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.77 138.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -106.36 100.81 10.32 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.929 -0.482 . . . . 0.0 109.761 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 49.8 mm -97.14 118.7 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 34.2 t -121.95 122.28 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.343 -0.848 . . . . 0.0 109.613 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.5 t -100.57 138.94 36.95 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -138.25 132.2 31.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.507 -0.746 . . . . 0.0 111.427 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 151.19 134.79 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.52 103.83 1.12 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.918 2.412 . . . . 0.0 109.587 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -77.14 -62.54 1.62 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.462 0.649 . . . . 0.0 109.612 -179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.62 -161.58 1.37 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.879 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 16.4 mttm -136.29 34.13 2.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 109.389 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -77.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.12 158.19 37.75 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.977 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.6 Cg_endo -80.8 176.56 8.89 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.625 2.883 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -173.55 -166.11 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.78 -111.0 0.46 Allowed Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.771 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.93 149.94 40.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.598 -0.942 . . . . 0.0 110.465 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.7 m -83.67 -26.22 30.04 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.508 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -178.65 164.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.502 -0.749 . . . . 0.0 109.023 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.17 138.37 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.27 149.42 32.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.582 -0.699 . . . . 0.0 109.589 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 58.7 m-85 -127.71 160.95 30.11 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.404 ' HA ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -155.14 120.42 4.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.275 -0.89 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.701 -0.624 . . . . 0.0 110.349 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.0 mt -135.8 128.7 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.562 -0.711 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -120.08 -175.79 3.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.458 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.84 160.48 17.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.668 -0.645 . . . . 0.0 109.613 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -108.06 -48.07 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -160.59 162.25 32.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.28 86.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.37 -55.92 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.25 155.63 36.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.53 114.8 4.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -0.869 . . . . 0.0 110.336 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -104.67 47.38 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 t 151.87 111.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.1 127.63 3.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.064 -1.023 . . . . 0.0 109.834 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.7 150.21 24.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m -61.45 -55.17 34.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.877 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -60.52 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.358 -0.839 . . . . 0.0 108.859 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -102.48 85.45 2.61 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -93.46 163.48 13.56 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.513 0.673 . . . . 0.0 110.096 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -61.72 -22.01 64.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.838 -0.539 . . . . 0.0 110.007 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.97 -20.73 65.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.819 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -65.45 -18.97 65.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.26 -26.06 67.17 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.28 -17.4 62.47 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.562 -0.712 . . . . 0.0 109.25 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 29' ' ' THR . 5.3 mmmm -113.12 65.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.22 -26.77 3.14 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.537 -0.727 . . . . 0.0 110.809 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -99.75 68.17 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 26' ' ' LYS . 73.9 p -154.97 -161.09 1.14 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -127.56 34.41 4.68 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.365 -0.834 . . . . 0.0 109.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -124.62 105.5 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 35.9 mttt -91.27 162.83 14.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.609 -0.682 . . . . 0.0 109.738 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.457 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 23.4 t90 -67.76 139.62 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 127.05 16.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.49 164.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 110.616 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.16 -30.55 23.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 -156.8 0.53 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.65 172.52 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.83 -25.35 25.56 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mt-10 45.3 51.0 9.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.687 -0.89 . . . . 0.0 112.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -67.06 -59.21 3.66 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.1 p -160.44 133.79 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -134.54 152.77 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.274 -0.891 . . . . 0.0 110.554 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.69 150.37 51.03 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.536 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.415 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 7.4 p -149.66 106.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 2.9 t -90.89 118.46 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.729 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.38 158.2 16.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -104.75 131.21 52.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.554 -0.716 . . . . 0.0 109.683 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.2 mm? -81.19 121.23 25.88 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -54.06 -6.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.66 150.39 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.877 -1.14 . . . . 0.0 108.033 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.87 111.3 22.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.77 . . . . 0.0 109.013 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.43 -178.59 6.32 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -84.34 -171.02 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.1 115.77 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.507 -0.746 . . . . 0.0 109.313 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.0 t-160 -101.36 -32.01 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -147.48 153.98 40.22 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 149' ' ' PHE . 79.7 t -136.72 161.14 36.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.643 -0.661 . . . . 0.0 109.726 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.407 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 27.5 t0 -139.11 139.24 37.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.617 -0.677 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -157.86 132.12 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -106.46 128.74 9.43 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -80.14 123.32 27.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.157 -0.614 . . . . 0.0 110.521 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 24.9 t0 -97.54 72.41 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 12.5 83.24 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t -85.8 172.9 10.43 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.304 -1.115 . . . . 0.0 109.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -134.8 -56.05 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.8 m-85 -102.26 122.89 45.1 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.702 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.43 112.52 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.705 . . . . 0.0 109.85 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -104.36 142.47 34.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.08 128.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.967 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.68 161.26 18.95 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.89 161.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.734 -0.604 . . . . 0.0 109.996 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 173.35 41.87 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 t -112.22 162.2 15.73 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.728 0.775 . . . . 0.0 109.833 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.418 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 13.0 t -86.27 6.19 30.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.055 -179.588 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -106.45 -175.01 2.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.71 0.767 . . . . 0.0 109.061 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.3 OUTLIER -122.66 126.6 47.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.06 87.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.688 -0.633 . . . . 0.0 110.637 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HA ' HG11 ' A' ' 117' ' ' VAL . 14.1 tp -60.15 -51.82 67.95 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -146.41 122.69 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.25 -177.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.531 -0.731 . . . . 0.0 110.073 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 135.71 55.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.558 -0.714 . . . . 0.0 109.187 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.4 p -105.74 123.41 47.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.78 -0.575 . . . . 0.0 109.597 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.7 p -85.25 109.81 18.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 26.7 m-85 -104.65 -49.19 3.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 22.0 mtp -121.21 172.67 7.82 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.718 0.77 . . . . 0.0 110.724 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.401 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -104.47 179.38 0.95 Allowed Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.261 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 42.7 Cg_endo -86.66 16.39 1.97 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.964 2.443 . . . . 0.0 111.341 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 t -120.12 -50.94 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.235 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.16 -12.9 61.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 110.111 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t -58.79 -24.37 61.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -91.55 -73.17 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.07 37.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.82 -21.83 54.74 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.76 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -1.021 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.94 95.78 0.61 Allowed Pre-proline 0 C--N 1.292 -1.912 0 O-C-N 121.814 -0.554 . . . . 0.0 109.51 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.21 -25.95 4.54 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.948 2.432 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.6 119.41 25.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.738 -0.601 . . . . 0.0 109.786 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -147.08 174.43 11.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.3 m -135.95 166.68 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -154.73 153.88 31.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.452 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.43 156.99 39.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.48 0.657 . . . . 0.0 110.274 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.7 m-85 -118.08 167.45 11.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.65 -149.2 5.52 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.94 -39.84 1.1 Allowed 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 123.692 2.928 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.25 -27.87 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.533 -0.73 . . . . 0.0 109.833 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -91.98 3.76 54.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.3 pp -123.46 139.86 53.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.022 -1.049 . . . . 0.0 110.549 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.437 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.2 p -60.42 130.62 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -74.46 -33.76 62.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.83 -21.17 66.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.271 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.68 -47.33 2.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 110.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.57 -37.4 17.78 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.16 -0.963 . . . . 0.0 111.626 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.92 3.08 27.68 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.745 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 1.1 mtpm? -95.52 136.22 36.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -67.11 113.38 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.7 m95 -117.43 163.76 15.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.44 14.98 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -142.3 142.48 32.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG22 ' CZ ' ' A' ' 149' ' ' PHE . 7.7 p -136.61 143.03 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 110.366 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -111.62 110.43 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.766 -0.584 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.4 mm -101.82 129.46 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 t -130.98 130.01 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.184 -0.947 . . . . 0.0 110.591 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.43 ' HB3' HG13 ' A' ' 43' ' ' ILE . 9.7 t -99.71 149.23 23.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -150.26 118.77 6.48 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.609 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.03 112.24 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.3 97.19 1.11 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.342 2.028 . . . . 0.0 108.725 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.527 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -103.62 -11.42 17.7 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.407 -178.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.76 -167.38 2.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.072 -1.017 . . . . 0.0 110.065 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.78 -47.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.746 -0.597 . . . . 0.0 109.631 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -108.2 -13.37 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.536 -0.727 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 p -99.07 138.46 20.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.265 -0.897 . . . . 0.0 109.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -88.2 -177.67 1.91 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.354 2.703 . . . . 0.0 110.502 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 174.52 -164.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.44 -115.24 0.65 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.206 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.8 162.29 20.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.685 -0.891 . . . . 0.0 110.84 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 13.7 m -99.14 -27.81 13.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 53.4 p90 -178.05 171.2 1.76 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.01 123.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' CE1' ' A' ' 150' ' ' HIS . 0.2 OUTLIER -130.26 110.92 11.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.438 ' CD1' HG11 ' A' ' 58' ' ' VAL . 85.9 m-85 -90.94 161.97 14.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.238 -0.914 . . . . 0.0 109.105 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -157.33 136.29 11.69 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 4' ' ' ILE . 61.4 mt -110.43 122.18 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.09 166.32 10.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.93 160.19 15.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.697 -0.627 . . . . 0.0 109.557 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -110.23 -54.05 2.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -160.55 164.99 31.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.89 93.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.5 -0.75 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -54.17 -58.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.246 -0.909 . . . . 0.0 110.272 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.404 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -121.03 151.67 39.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -143.83 124.3 13.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.995 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -121.5 46.21 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.534 -0.729 . . . . 0.0 109.586 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 153.09 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 143.05 31.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.243 -0.911 . . . . 0.0 109.114 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.25 -161.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 p -98.47 -57.37 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.436 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.67 66.31 4.42 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -82.67 171.94 13.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.53 -0.731 . . . . 0.0 109.893 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.37 -24.05 67.68 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.85 -19.28 63.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -65.78 -17.33 64.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.937 . . . . 0.0 109.322 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.06 -18.74 61.64 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.528 -0.732 . . . . 0.0 109.252 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 67.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.37 62.49 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.466 -0.771 . . . . 0.0 110.323 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.12 76.51 9.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.469 -0.769 . . . . 0.0 108.984 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 -154.2 0.37 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -130.71 36.48 3.9 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -142.5 121.51 12.86 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 -165.38 0.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 109.452 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.459 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.4 t90 -81.9 139.67 34.53 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 125.19 16.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.64 148.83 6.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.766 . . . . 0.0 110.359 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.91 -20.22 56.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.94 -0.475 . . . . 0.0 110.228 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -138.82 -171.77 3.16 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.354 -0.841 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.32 -161.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.83 43.55 97.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.1 mm-40 -48.47 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.959 0.885 . . . . 0.0 111.328 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -102.78 -50.73 3.46 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.4 p -158.86 115.39 2.7 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.459 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 11.3 pt -120.52 148.69 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.4 -0.812 . . . . 0.0 109.617 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.82 146.97 49.57 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.455 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -152.32 106.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 10.8 t -92.38 121.03 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.72 160.17 14.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.77 53.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.679 -0.638 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.2 mm? -82.03 138.22 34.92 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.14 38.95 0.49 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.537 -0.727 . . . . 0.0 110.503 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 pttm 161.63 132.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -75.94 107.62 8.26 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.15 179.36 6.49 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.445 0.641 . . . . 0.0 109.455 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -90.96 174.75 7.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.14 119.06 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.8 . . . . 0.0 109.677 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -110.01 -29.31 8.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.5 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.1 m -145.53 154.42 42.17 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG11 ' CD1' ' A' ' 149' ' ' PHE . 54.8 t -138.99 163.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.616 -0.677 . . . . 0.0 109.76 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -145.06 125.83 14.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 1.3 mp -147.84 137.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.951 -1.093 . . . . 0.0 108.3 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.518 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.87 126.7 8.94 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.46 123.04 29.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 122.042 -0.681 . . . . 0.0 110.462 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.9 70.87 3.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.37 7.35 88.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -76.91 166.54 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -1.141 . . . . 0.0 109.603 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.91 -55.47 1.29 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -103.87 120.92 42.0 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.904 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.56 103.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 6.2 tt0 -86.88 147.04 25.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.415 0.626 . . . . 0.0 109.92 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' HB ' ' CG ' ' A' ' 88' ' ' LEU . 56.7 t -136.92 119.52 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 1.1 mp -114.72 164.54 13.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 13.6 m -127.93 163.33 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 110.351 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.56 170.28 37.56 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -114.01 160.27 19.04 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 122.027 -0.69 . . . . 0.0 109.213 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 t -92.25 12.82 21.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.917 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.64 157.59 29.24 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.433 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 145.91 42.58 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.8 90.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.763 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.78 -58.43 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -117.6 117.55 29.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.79 171.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.617 -0.677 . . . . 0.0 109.174 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -64.24 132.67 50.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.84 121.09 39.34 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.1 p -87.19 93.13 9.29 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 109' ' ' ARG . 25.0 m-85 -84.23 -52.93 5.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 110.403 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 22.2 mtp -121.33 -168.85 1.75 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.543 -0.723 . . . . 0.0 110.428 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.4 p -115.92 176.76 1.4 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.62 14.86 2.33 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.041 2.494 . . . . 0.0 111.32 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.0 p -121.19 -37.69 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.001 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.88 -24.9 32.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -58.53 -20.73 48.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.734 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -69.32 -84.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.23 39.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 108.745 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.65 -18.27 5.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.97 123.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -1.17 . . . . 0.0 110.159 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.424 ' O ' ' CE ' ' A' ' 94' ' ' MET . 6.5 p30 41.59 66.82 3.55 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 122.066 -0.396 . . . . 0.0 111.504 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.61 -29.89 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.746 2.298 . . . . 0.0 110.488 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.44 103.3 6.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.687 -0.633 . . . . 0.0 109.601 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.55 174.98 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.752 . . . . 0.0 109.104 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.3 m -140.32 141.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' ' CD1' ' A' ' 93' ' ' PHE . 2.5 mmt-85 -134.35 176.99 8.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 mtt -142.08 178.56 7.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.697 -0.627 . . . . 0.0 109.842 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 1.3 m-85 -141.92 171.16 14.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.52 -148.05 5.26 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -75.04 -36.63 2.42 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.595 2.863 . . . . 0.0 110.76 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.84 -31.78 73.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -81.95 1.75 33.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.715 -0.615 . . . . 0.0 110.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.436 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -130.59 137.84 49.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.167 -0.958 . . . . 0.0 109.639 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.3 p -56.96 163.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -97.78 -40.63 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.884 . . . . 0.0 109.142 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.02 -17.63 57.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 110.23 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -112.42 -50.81 2.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.436 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.35 -39.26 21.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.311 -0.868 . . . . 0.0 111.447 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -78.17 -1.85 34.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 110.656 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 23.2 mtpt -91.77 133.7 35.39 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -68.0 111.27 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.825 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 80.1 m95 -113.27 163.46 14.78 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -135.9 10.18 3.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.267 -0.895 . . . . 0.0 110.312 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -142.55 139.53 31.44 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -130.14 142.07 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.835 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 13.7 tttt -109.1 114.19 27.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.668 -0.645 . . . . 0.0 109.843 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.9 mm -105.78 119.64 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.92 117.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 O-C-N 121.208 -0.932 . . . . 0.0 110.057 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.414 ' HB3' HG13 ' A' ' 43' ' ' ILE . 7.0 t -89.14 142.72 27.4 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -141.26 124.81 16.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.717 -0.614 . . . . 0.0 110.6 -178.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 133' ' ' SER . 3.6 tp-100 158.33 131.51 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.446 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.35 93.22 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.021 2.481 . . . . 0.0 109.432 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.2 p90 -127.07 15.31 7.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.595 -0.69 . . . . 0.0 111.034 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.63 -169.57 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -176.06 -40.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.97 -36.41 4.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.547 0.689 . . . . 0.0 109.662 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.85 150.84 38.62 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.89 -0.506 . . . . 0.0 109.657 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.95 -171.42 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.354 2.703 . . . . 0.0 110.623 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.85 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.38 -113.5 0.58 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.366 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.08 151.51 43.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.732 -0.863 . . . . 0.0 110.992 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -86.45 -26.64 24.57 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 37.5 p90 -175.54 168.48 3.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.02 142.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.8 mtp85 -150.38 160.41 43.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 109.323 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' HG11 ' A' ' 58' ' ' VAL . 38.7 m-85 -142.19 155.77 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 129.24 10.27 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.76 -0.587 . . . . 0.0 109.947 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 4' ' ' ILE . 55.3 mt -143.17 126.74 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.72 . . . . 0.0 109.433 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.705 -0.622 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.1 mp -107.14 161.07 15.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.635 -0.665 . . . . 0.0 109.858 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.05 -57.71 2.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.686 -0.634 . . . . 0.0 109.31 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -160.8 164.13 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.83 86.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.83 -57.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 110.391 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -125.7 153.51 43.79 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.6 p -149.09 146.04 27.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -135.78 46.58 2.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.764 -0.585 . . . . 0.0 109.644 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.9 m 153.19 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -158.36 142.8 15.97 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.133 -0.979 . . . . 0.0 109.519 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -173.55 3.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.18 -0.95 . . . . 0.0 109.564 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -85.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.383 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -56.08 22.47 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 21.4 m170 -97.01 76.65 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -92.42 169.04 10.87 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.43 -23.76 67.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.852 -0.53 . . . . 0.0 109.709 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.97 -16.83 60.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.857 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -64.52 -18.77 65.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.069 -1.019 . . . . 0.0 109.228 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.59 -24.97 67.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.19 -21.39 59.36 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -119.14 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.79 7.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -121.17 87.21 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.829 . . . . 0.0 109.848 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.95 -87.29 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -177.57 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 0.0 109.73 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD2' ' CD2' ' A' ' 19' ' ' HIS . 0.3 OUTLIER -160.73 142.79 12.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 109.273 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.7 mtmt -127.03 -164.9 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.471 -0.768 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.462 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.1 t90 -88.46 140.25 29.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.45 129.49 17.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.05 148.48 6.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.406 -0.809 . . . . 0.0 110.379 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.14 -23.7 56.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.811 -0.555 . . . . 0.0 110.251 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -139.19 -175.88 4.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.96 -166.64 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 64.12 48.0 79.61 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mp0 -55.15 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.378 0.608 . . . . 0.0 111.026 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 39' ' ' GLY . 18.4 tttt -87.82 -53.49 4.73 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 p -155.8 114.92 3.54 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' HB3' ' A' ' 132' ' ' CYS . 12.5 pt -115.85 146.86 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.475 -0.766 . . . . 0.0 109.401 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.18 149.31 49.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.121 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.08 105.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 3.6 t -89.81 114.06 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 6' ' ' LEU . 1.1 mp -96.35 163.92 12.87 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.587 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.16 136.39 48.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.692 -0.63 . . . . 0.0 109.876 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.8 134.22 34.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -70.91 20.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.381 -0.824 . . . . 0.0 112.284 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttt 176.61 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.714 -1.241 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -59.19 102.12 0.12 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' OE1' HG12 ' A' ' 4' ' ' ILE . 10.7 pt-20 -137.21 -177.41 4.76 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.483 0.659 . . . . 0.0 110.121 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -96.39 -177.71 4.05 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.49 121.26 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 56.3 t60 -111.03 -29.3 7.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.697 -0.627 . . . . 0.0 109.344 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -148.08 146.31 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 149' ' ' PHE . 74.3 t -129.28 160.47 40.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.445 0.64 . . . . 0.0 109.751 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 2.7 m-20 -139.28 133.92 31.9 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -157.73 135.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -110.4 135.23 12.72 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.04 132.66 34.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.138 -0.625 . . . . 0.0 110.739 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -113.22 58.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.31 -25.33 18.3 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.425 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 15.3 t -57.26 165.77 1.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -1.02 . . . . 0.0 109.908 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.72 -57.82 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.1 m-85 -98.94 118.48 35.79 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.23 114.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.265 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.91 144.43 31.52 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.13 125.41 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.09 161.31 16.65 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.43 151.11 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 0.0 109.96 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -173.25 166.81 39.37 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -115.93 157.12 25.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.981 -0.717 . . . . 0.0 109.552 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 t -88.05 10.42 19.17 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -104.83 -173.53 2.32 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 137.94 54.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 87.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.573 -0.705 . . . . 0.0 110.727 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.27 -47.76 82.61 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.18 120.76 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.393 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.5 m -50.42 174.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 110.587 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -63.91 138.09 58.32 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.573 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.8 p -105.89 123.32 47.78 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -87.67 104.26 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 23.7 m-85 -100.38 -46.55 5.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 mtp -120.16 -170.95 2.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.2 p -126.66 -179.62 0.97 Allowed Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.86 9.42 4.15 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.882 2.388 . . . . 0.0 111.328 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.3 p -114.08 -55.08 2.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -63.0 -20.2 65.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.973 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -56.59 -27.26 57.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.239 -0.913 . . . . 0.0 110.141 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -87.73 -74.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 110.009 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.22 37.52 0.1 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.08 -24.06 35.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -1.004 . . . . 0.0 110.368 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 88.95 35.45 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.13 -18.63 16.23 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.959 2.439 . . . . 0.0 110.27 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.39 115.35 11.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.669 -0.644 . . . . 0.0 109.734 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -144.72 160.31 41.42 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 m -120.94 163.85 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.55 159.12 43.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.39 -0.819 . . . . 0.0 109.374 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.4 mtp -130.08 162.57 28.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.626 -0.671 . . . . 0.0 110.113 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -127.32 165.99 18.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.52 -150.11 5.93 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -75.68 -37.98 1.5 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.655 2.904 . . . . 0.0 110.731 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -65.4 -28.27 69.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.57 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -89.34 1.51 55.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.649 -0.657 . . . . 0.0 110.589 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.455 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.21 139.89 53.49 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.037 -1.039 . . . . 0.0 109.921 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.433 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.1 p -59.22 133.4 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -75.8 -29.99 58.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.338 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.32 -23.23 64.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.598 -0.688 . . . . 0.0 109.977 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.433 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -112.29 -45.55 3.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.67 -40.57 28.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.215 -0.928 . . . . 0.0 111.291 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -77.86 -3.03 39.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 110.547 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 26.5 mtpt -90.31 132.92 35.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -67.62 109.59 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.544 0.688 . . . . 0.0 110.73 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 87.3 m95 -109.09 164.03 12.79 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.5 6.63 3.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -145.99 145.9 30.8 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.74 -1.225 . . . . 0.0 107.919 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.432 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.9 p -132.73 142.46 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.348 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.09 116.17 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.754 -0.591 . . . . 0.0 109.797 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 51.4 mm -108.07 119.53 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 t -124.7 122.89 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.138 -0.976 . . . . 0.0 110.708 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.465 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -97.22 142.46 29.09 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -141.6 123.37 15.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.712 -0.618 . . . . 0.0 110.375 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 133' ' ' SER . 35.1 tp60 156.84 123.24 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.53 104.55 1.74 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.682 2.255 . . . . 0.0 108.884 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 2.0 p90 -132.0 -10.58 3.4 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.568 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.76 126.38 14.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.839 -1.163 . . . . 0.0 109.513 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -110.39 -26.58 9.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.843 -0.536 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.58 -43.66 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 110.262 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.09 145.74 32.38 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.822 -0.549 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.2 Cg_endo -87.03 166.19 8.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.33 2.687 . . . . 0.0 110.409 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -176.85 -165.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.98 -102.63 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.26 155.43 27.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.575 -0.956 . . . . 0.0 110.604 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 23.6 m -89.49 -27.51 20.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.511 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 50.1 p90 -178.09 162.31 1.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.409 ' HA ' HG13 ' A' ' 60' ' ' ILE . 33.6 m -138.64 141.29 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.0 mtp180 -145.79 160.63 41.48 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.478 0.656 . . . . 0.0 110.342 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CE2' HG13 ' A' ' 128' ' ' VAL . 54.6 m-85 -142.24 156.88 45.32 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -157.01 136.73 12.37 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.673 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 4' ' ' ILE . 62.2 mt -125.09 123.76 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -105.2 161.02 14.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.733 -0.604 . . . . 0.0 109.658 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.73 151.43 19.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HD3' ' CE1' ' A' ' 8' ' ' HIS . 43.3 ttt85 -103.93 -54.32 2.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 109.383 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.415 ' CE1' ' HD3' ' A' ' 7' ' ' ARG . 4.9 p-80 -160.54 166.49 28.97 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.69 93.97 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.772 . . . . 0.0 109.464 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 p -53.15 -60.13 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.131 -0.981 . . . . 0.0 110.16 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -122.1 155.49 35.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -153.24 105.63 2.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.257 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -105.94 56.46 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 44' ' ' SER . 1.2 p 153.46 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 139.64 47.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.734 -1.229 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.83 148.57 22.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 109.326 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.6 t -61.14 -52.86 63.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.582 -0.699 . . . . 0.0 110.155 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -58.55 8.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.344 -0.847 . . . . 0.0 109.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -110.16 86.99 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -92.29 166.65 12.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.552 0.692 . . . . 0.0 110.359 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.54 -23.52 67.03 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.96 -18.44 60.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.339 -0.85 . . . . 0.0 109.724 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -65.27 -17.51 64.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.256 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.09 -25.68 67.9 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 -22.41 50.52 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.491 -0.756 . . . . 0.0 109.002 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -115.36 67.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.51 -25.83 4.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.739 . . . . 0.0 110.6 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -122.03 88.78 3.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 0.0 109.796 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.98 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.583 -0.698 . . . . 0.0 109.236 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.413 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 44.2 p90 -178.16 35.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 28.5 mtm180 -157.17 137.53 12.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -120.53 -176.87 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.45 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.7 t90 -78.51 138.18 38.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -141.66 128.32 20.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.21 168.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.691 0.758 . . . . 0.0 111.21 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.52 43.57 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.139 0.495 . . . . 0.0 109.686 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -120.36 -172.16 2.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.2 -165.23 1.1 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.15 45.29 96.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.447 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.3 mp0 -43.74 89.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.487 0.66 . . . . 0.0 112.075 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 39' ' ' GLY . 10.6 pttt -103.02 -44.21 5.29 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 p -160.51 132.36 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' A' ' 132' ' ' CYS . 6.0 pt -137.73 136.03 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.418 -0.801 . . . . 0.0 110.204 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -112.22 140.84 46.59 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.462 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 9.2 p -147.41 106.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 10.8 t -91.36 121.53 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.42 168.98 9.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -114.14 148.07 37.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.712 -0.617 . . . . 0.0 109.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.73 137.57 39.87 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.75 40.2 0.51 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.37 -0.831 . . . . 0.0 110.909 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.32 130.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -75.55 110.6 10.07 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.25 -179.49 6.02 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.01 178.14 6.09 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.76 115.71 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -103.4 -30.83 10.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.1 159.03 44.34 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.8 t -141.91 158.23 20.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.48 0.657 . . . . 0.0 109.389 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.13 137.89 34.81 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -158.25 130.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.8 132.33 10.96 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.7 126.72 36.07 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.301 -0.529 . . . . 0.0 110.366 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -97.7 64.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.93 60.26 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.458 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 72.0 m -55.57 158.2 3.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -1.1 . . . . 0.0 110.322 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.427 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -119.64 -58.65 1.88 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 133' ' ' SER . 19.5 m-85 -99.61 129.99 45.8 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.946 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.43 111.84 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.629 . . . . 0.0 109.692 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -105.63 146.28 29.9 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.79 126.56 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.57 -0.706 . . . . 0.0 109.84 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -113.59 160.46 18.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.49 157.82 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.789 -0.569 . . . . 0.0 109.894 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.438 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.18 172.45 42.61 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -114.04 158.78 20.76 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 122.041 -0.682 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -73.43 -4.97 36.91 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.797 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 t70 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.36 -173.26 2.32 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -121.1 130.58 53.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.28 85.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.366 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.03 -59.81 4.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 111' ' ' PHE . 1.1 pp -137.8 120.49 16.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.33 179.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.745 . . . . 0.0 110.325 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 134.4 53.58 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.601 -0.687 . . . . 0.0 109.153 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.1 p -107.87 125.85 51.96 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.441 0.639 . . . . 0.0 109.769 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.9 p -83.7 127.83 34.07 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' HD3' ' A' ' 109' ' ' ARG . 22.8 m-85 -120.95 -48.21 2.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 81.4 mtp -121.95 -176.83 3.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.933 0.873 . . . . 0.0 111.352 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -120.55 173.93 3.37 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.57 9.48 4.08 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.911 2.407 . . . . 0.0 111.315 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.0 m -120.77 -35.03 3.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.35 -21.67 35.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.316 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.9 p -58.23 -22.13 50.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -0.805 . . . . 0.0 110.425 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -67.96 -83.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.338 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -162.45 39.2 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.74 -22.38 5.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.26 118.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -1.135 . . . . 0.0 110.396 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.423 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 41.21 77.44 0.43 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.929 -0.482 . . . . 0.0 111.366 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.12 -28.55 2.39 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.05 2.5 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.41 92.85 2.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -123.89 -176.13 3.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.724 . . . . 0.0 109.332 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.7 m -134.6 158.33 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.713 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HD3' ' CG ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.94 159.78 41.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.8 mtm -135.57 166.23 23.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.0 110.295 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.0 m-85 -129.46 169.63 14.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.12 -148.57 5.19 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.7 -39.6 1.31 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.674 2.916 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.37 -28.83 69.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.493 -0.754 . . . . 0.0 109.648 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.59 54.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.658 -0.651 . . . . 0.0 110.598 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.1 pp -123.51 138.76 54.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.05 -1.031 . . . . 0.0 110.38 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.2 p -59.37 130.34 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -33.44 63.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.786 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.95 66.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.334 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.96 -46.68 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.162 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.73 -38.55 21.92 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.143 -0.973 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.14 0.6 31.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 110.706 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.2 mtpp -92.54 135.81 33.75 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.41 113.2 5.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.744 0.783 . . . . 0.0 110.753 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.452 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.3 m95 -115.84 165.97 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.68 15.5 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.132 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -145.5 147.58 32.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -137.3 142.14 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.105 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -110.88 108.43 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.668 -0.645 . . . . 0.0 109.729 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.96 127.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.47 115.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.478 ' HB3' HG13 ' A' ' 43' ' ' ILE . 3.1 t -85.55 149.68 25.2 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -148.9 122.9 9.41 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.264 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.605 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 157.73 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.45 94.68 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.008 2.472 . . . . 0.0 110.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.458 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -121.62 -17.55 7.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.0 111.285 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.48 169.49 8.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.462 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 24.9 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.793 -0.567 . . . . 0.0 109.634 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.79 -46.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.6 146.35 32.44 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.58 169.28 8.19 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.432 2.755 . . . . 0.0 110.898 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 179.49 -164.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.86 -105.93 0.26 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.193 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.79 154.67 29.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.937 . . . . 0.0 110.716 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -87.34 -27.99 22.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.521 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 52.6 p90 -179.24 167.67 1.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.514 -0.741 . . . . 0.0 109.509 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.46 131.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -139.07 121.66 16.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.028 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CD1' HG11 ' A' ' 58' ' ' VAL . 67.5 m-85 -104.36 156.68 17.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.109 -0.995 . . . . 0.0 109.41 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -150.97 131.28 13.65 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.317 -0.865 . . . . 0.0 109.714 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.704 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.67 124.71 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -104.78 164.8 11.51 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.455 0.645 . . . . 0.0 110.084 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.53 127.63 43.64 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -82.11 -56.89 3.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.379 -0.825 . . . . 0.0 109.584 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.93 165.1 30.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.659 -0.651 . . . . 0.0 109.409 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.29 90.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.774 . . . . 0.0 109.307 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 p -54.37 -58.28 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.04 143.47 46.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -130.81 124.03 30.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -0.796 . . . . 0.0 109.711 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -124.59 42.24 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.461 ' CB ' ' HB ' ' A' ' 43' ' ' ILE . 1.3 m 153.93 76.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.64 141.46 26.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 108.987 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -164.49 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.336 -0.853 . . . . 0.0 109.071 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -64.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -49.22 76.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 109.067 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.04 73.7 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -91.71 168.86 11.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.503 -0.748 . . . . 0.0 110.095 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -64.67 -23.01 67.12 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.87 -17.49 63.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.8 -17.8 64.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 109.286 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.1 mt -65.17 -24.28 67.34 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -58.54 -22.35 55.22 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.526 -0.734 . . . . 0.0 109.055 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -107.67 61.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.14 -25.23 4.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.425 -0.797 . . . . 0.0 110.708 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.35 76.58 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 p -156.42 -95.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.774 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -178.4 36.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.391 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -141.75 138.02 32.02 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 11.1 mttm -128.66 -178.69 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.422 -0.799 . . . . 0.0 110.807 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.454 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.8 t90 -80.98 140.46 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.43 129.07 17.13 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.37 150.8 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.496 -0.752 . . . . 0.0 110.909 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.56 68.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -169.79 2.09 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.11 178.77 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.73 -30.74 8.78 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 18.4 mm-40 40.67 31.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.969 -0.724 . . . . 0.0 112.526 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -52.94 43.17 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.696 -0.627 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 p -160.32 129.43 4.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 13.1 pt -130.2 141.72 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.86 . . . . 0.0 110.322 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 29.5 m -126.06 141.22 52.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.293 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.27 110.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.42 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.09 157.6 16.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -99.89 145.58 27.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 109.834 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 4.1 mm? -97.96 140.35 32.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.28 33.81 0.24 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.417 -0.802 . . . . 0.0 111.115 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 pttm 161.22 138.39 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 10.0 tt0 -75.16 102.48 4.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 165.74 22.8 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.7 0.762 . . . . 0.0 109.786 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -76.15 -176.96 3.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.93 174.89 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.403 -0.81 . . . . 0.0 108.891 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -172.53 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.506 -0.746 . . . . 0.0 109.199 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -145.27 145.76 31.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.5 t -130.64 163.36 36.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.665 0.745 . . . . 0.0 110.31 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 148' ' ' ARG . 11.8 t0 -133.5 131.97 40.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.46 129.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -99.36 122.71 7.66 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.92 117.92 17.3 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 122.13 -0.629 . . . . 0.0 110.145 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -102.2 73.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.95 21.91 72.91 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 -177.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.474 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 1.8 p -96.98 152.89 18.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.998 . . . . 0.0 109.857 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.36 -54.79 2.56 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.6 132.3 52.76 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.52 -0.738 . . . . 0.0 109.969 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.39 112.16 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.832 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -107.54 146.52 31.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.749 -0.595 . . . . 0.0 109.546 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.6 128.85 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.602 -0.686 . . . . 0.0 109.933 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.03 158.84 21.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.6 154.48 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.47 173.36 46.02 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 t -114.71 155.47 26.59 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.98 -0.718 . . . . 0.0 109.831 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.9 p -63.67 -14.0 48.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 O-C-N 121.39 -0.819 . . . . 0.0 109.297 179.886 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.05 154.07 35.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.21 145.06 32.04 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.73 84.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.581 -0.7 . . . . 0.0 110.751 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.403 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.7 tp -57.57 -59.62 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.428 HD12 ' CE2' ' A' ' 111' ' ' PHE . 1.8 pp -136.05 121.44 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.312 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.07 -179.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.663 -0.648 . . . . 0.0 110.178 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.14 135.31 51.93 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.241 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -104.62 127.69 52.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -85.33 95.72 9.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 16.6 m-85 -87.3 -52.43 5.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.591 -0.693 . . . . 0.0 109.693 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.3 mtp -120.68 -172.65 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.654 -0.654 . . . . 0.0 110.187 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 p -120.12 179.72 0.85 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.88 13.25 2.8 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.154 2.569 . . . . 0.0 111.47 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -53.26 2.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -63.68 -16.03 59.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 110.153 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -56.72 -21.01 24.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.828 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -87.6 0.13 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.181 -0.95 . . . . 0.0 110.362 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -162.03 38.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.102 -0.999 . . . . 0.0 108.655 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.35 -20.72 24.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.89 -79.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -1.036 . . . . 0.0 110.52 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.36 88.26 25.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.95 -20.54 10.16 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 123.032 2.488 . . . . 0.0 110.622 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.1 128.64 40.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.65 -0.656 . . . . 0.0 109.852 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.85 172.73 17.94 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.2 m -140.16 136.59 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.382 -0.824 . . . . 0.0 109.399 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 mmp_? -133.86 -179.23 5.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 110.282 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 mtm -141.99 178.34 7.59 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.391 0.615 . . . . 0.0 109.675 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.5 m-85 -135.43 166.82 22.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.03 -153.86 5.99 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.1 Cg_endo -74.3 -27.93 10.99 Favored 'Trans proline' 0 N--CA 1.504 2.136 0 C-N-CA 123.58 2.853 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.87 -42.45 62.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.9 9.54 30.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 111.165 -179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -116.36 122.19 44.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 108.536 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.448 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.6 p -50.0 134.49 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.783 -0.573 . . . . 0.0 110.77 -177.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -69.2 -41.09 77.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.557 -0.714 . . . . 0.0 109.357 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.47 78.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 110.508 -179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.448 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -93.17 -35.25 13.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.448 -0.783 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . . . -46.62 -30.72 2.44 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.518 -0.739 . . . . 0.0 110.789 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 16.75 24.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.485 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 4.3 mmtm -96.77 132.11 42.81 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -66.06 103.66 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.191 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 69.8 m95 -108.09 150.03 27.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t0 -128.84 4.12 5.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.697 -0.627 . . . . 0.0 109.694 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -141.76 149.58 40.63 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' A' ' 149' ' ' PHE . 5.8 p -140.36 140.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.187 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -106.16 116.74 32.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.703 -0.623 . . . . 0.0 109.747 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.59 111.55 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 40.9 t -119.58 120.33 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 43.0 t -95.68 149.03 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -142.94 130.66 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.459 -0.775 . . . . 0.0 111.19 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.8 OUTLIER 149.48 129.07 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.751 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.406 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.24 100.38 0.7 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.831 2.354 . . . . 0.0 109.659 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.511 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 1.2 p90 -131.66 40.35 3.4 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.739 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 -168.84 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -106.84 -35.84 6.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.07 142.21 24.55 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.5 Cg_endo -85.93 -176.1 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.174 2.582 . . . . 0.0 110.82 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 178.76 -162.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.616 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.14 -112.89 0.56 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.471 -1.347 . . . . 0.0 111.099 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -114.2 158.86 20.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.567 -0.961 . . . . 0.0 110.75 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 2.4 m -97.62 -28.45 13.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 122.042 -0.411 . . . . 0.0 109.958 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.532 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 43.5 p90 -176.38 171.88 2.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.693 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.7 m -150.17 137.6 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.695 -0.628 . . . . 0.0 109.493 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 11.3 mmm-85 -144.04 108.55 4.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.531 -0.731 . . . . 0.0 109.102 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CD1' HG11 ' A' ' 58' ' ' VAL . 56.1 m-85 -87.31 155.03 20.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.338 -0.852 . . . . 0.0 109.354 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.46 124.93 6.34 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.495 -0.753 . . . . 0.0 109.363 178.715 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.67 -0.644 . . . . 0.0 110.474 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -142.27 146.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 167.04 15.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.933 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.61 136.8 35.54 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.722 -0.611 . . . . 0.0 109.461 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -92.6 -56.42 3.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.805 . . . . 0.0 109.104 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.429 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 4.1 p-80 -161.33 162.99 31.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.14 91.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 109.165 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -50.79 -55.99 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.317 -0.864 . . . . 0.0 110.47 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 153.37 38.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.415 -0.803 . . . . 0.0 109.372 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.74 120.36 17.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.424 -0.798 . . . . 0.0 109.509 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.8 m -123.56 42.02 3.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.465 ' CB ' ' HB ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER 152.75 72.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.321 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 140.95 43.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.336 -0.852 . . . . 0.0 109.431 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -165.92 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -101.74 -55.51 2.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -42.78 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -121.34 80.36 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -91.5 168.78 11.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.594 0.712 . . . . 0.0 110.042 -179.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.12 -24.32 67.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.928 -0.483 . . . . 0.0 109.993 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.37 -18.54 61.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 109.835 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -65.37 -17.27 64.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.91 -24.85 67.65 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.97 -22.46 49.29 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.498 -0.751 . . . . 0.0 109.039 178.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.2 65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.57 -24.41 13.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.394 -0.816 . . . . 0.0 110.406 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.33 81.36 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.634 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -158.1 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.437 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -177.84 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -158.39 167.7 28.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.553 -0.717 . . . . 0.0 109.446 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -160.32 -157.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.673 -0.642 . . . . 0.0 109.565 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.447 ' CZ2' ' HB ' ' A' ' 45' ' ' VAL . 15.5 t90 -93.69 140.45 29.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.083 -1.01 . . . . 0.0 110.379 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -146.83 123.06 10.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.85 154.6 0.69 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.451 -0.781 . . . . 0.0 111.399 -178.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.04 70.21 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -123.45 -172.1 2.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.73 -162.38 0.93 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.75 43.34 94.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 3.8 mm-40 -48.14 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.986 0.898 . . . . 0.0 111.364 -179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 39' ' ' GLY . 8.8 pttp -111.62 -44.82 3.44 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 p -160.39 119.87 2.76 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 11.4 pt -128.02 147.39 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.507 -0.746 . . . . 0.0 109.355 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 31.5 m -128.23 147.6 50.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.661 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.447 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 p -154.29 117.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 t -95.53 130.14 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.218 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.61 167.4 9.94 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 12.2 tm0? -121.6 118.62 29.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.734 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.1 mm? -71.0 138.46 49.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -81.15 36.53 0.41 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.766 -0.584 . . . . 0.0 110.133 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 pttt 166.73 129.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.44 109.47 9.02 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.42 176.28 9.12 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -86.35 -174.24 4.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -141.26 130.29 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.741 . . . . 0.0 109.39 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -119.57 -25.08 6.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -149.87 140.24 22.33 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 149' ' ' PHE . 55.2 t -125.04 160.71 30.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -140.74 135.06 31.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.506 -0.746 . . . . 0.0 109.416 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.405 ' CD1' HG13 ' A' ' 58' ' ' VAL . 1.4 mp -155.96 131.84 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -107.94 120.83 6.16 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.017 -1.564 . . . . 0.0 110.264 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.75 142.57 53.24 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.458 0.647 . . . . 0.0 111.11 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 23.8 t0 -127.13 56.25 1.53 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.96 12.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t -57.75 170.16 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -1.006 . . . . 0.0 109.73 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 134' ' ' GLN . . . -135.16 -56.83 0.81 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 24.3 m-85 -100.04 133.41 44.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.281 179.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.74 107.51 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.944 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -97.34 129.8 44.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.404 ' HB ' ' CG ' ' A' ' 88' ' ' LEU . 37.8 t -122.18 124.4 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.762 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.61 163.0 14.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 160.18 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.453 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.15 177.52 46.13 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 t -116.25 158.69 22.95 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.069 -0.665 . . . . 0.0 109.44 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -80.23 3.56 20.43 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.806 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 110.114 -179.905 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -113.17 -176.26 2.86 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -129.06 132.16 47.41 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.258 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 t -62.31 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.685 -0.634 . . . . 0.0 110.453 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 117' ' ' VAL . 12.0 tp -60.13 -51.68 68.57 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -142.44 123.55 14.57 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.63 -173.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.886 -0.509 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.74 125.64 25.41 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 86.9 p -99.6 121.95 41.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -88.76 121.45 31.15 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 23.5 m-85 -120.58 -43.67 2.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.422 -0.798 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.0 mtp -120.22 -178.1 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.487 -0.758 . . . . 0.0 110.509 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -115.29 177.16 1.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.05 11.9 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.201 2.601 . . . . 0.0 111.251 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.48 -54.15 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.337 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -61.04 -18.42 57.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.7 t -54.82 -36.09 64.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.756 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -72.14 -82.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.037 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -162.85 37.49 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.37 -22.41 47.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.48 -77.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.958 . . . . 0.0 110.409 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -117.18 88.82 28.69 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.23 -19.87 13.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.976 2.451 . . . . 0.0 110.261 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.87 135.06 29.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.754 -0.591 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.02 150.51 18.74 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.567 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 13.0 m -106.83 165.13 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 110.2 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -154.12 156.05 36.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.261 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.7 mtp -127.95 166.9 17.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.721 -179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 3.1 m-85 -131.61 159.08 39.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.64 -149.42 6.22 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.57 -39.76 1.32 Allowed 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 123.738 2.959 . . . . 0.0 110.594 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.72 -27.13 68.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.715 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 3.1 55.8 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.641 -0.662 . . . . 0.0 110.547 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.4 pp -122.96 139.35 54.16 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.92 -1.112 . . . . 0.0 110.392 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.5 p -60.17 130.57 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.12 61.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.708 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -21.39 65.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -115.86 -46.58 2.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.95 -38.08 21.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.151 -0.968 . . . . 0.0 111.51 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -82.05 2.78 29.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.338 -0.851 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.5 mttt -93.7 134.9 35.53 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -66.51 113.65 4.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.443 -0.786 . . . . 0.0 110.546 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 73.6 m95 -117.78 162.85 17.4 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.64 14.15 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.147 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -148.72 151.22 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.5 p -141.85 145.21 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 110.367 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.57 117.58 34.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.486 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.0 mm -107.93 119.19 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.599 -0.688 . . . . 0.0 109.534 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 48.2 t -128.09 119.94 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.137 -0.977 . . . . 0.0 110.687 -179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.426 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.93 148.15 23.3 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -145.47 126.65 14.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 111.199 -179.091 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.465 ' CB ' ' HB1' ' A' ' 66' ' ' ALA . 0.4 OUTLIER 150.23 134.58 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.416 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.42 97.85 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.995 2.463 . . . . 0.0 109.965 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.6 p90 -128.77 14.49 6.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.0 110.81 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.03 -166.33 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -176.27 -42.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -113.27 -33.09 6.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.71 -0.619 . . . . 0.0 109.676 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.27 149.84 38.18 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.891 -0.505 . . . . 0.0 109.693 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.413 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.9 Cg_endo -85.52 -178.63 3.1 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.372 2.715 . . . . 0.0 110.285 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 179.88 -164.1 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.03 -112.89 0.54 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -135.47 162.04 33.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.325 -1.103 . . . . 0.0 110.251 178.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 2.7 m -82.24 -18.52 42.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.809 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.586 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 179.88 163.37 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.32 -0.863 . . . . 0.0 109.92 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.54 142.25 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -147.63 165.01 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.744 0.783 . . . . 0.0 110.524 -178.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' CD1' HG11 ' A' ' 58' ' ' VAL . 60.7 m-85 -145.28 154.61 42.54 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -158.63 145.94 17.72 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.087 -1.008 . . . . 0.0 109.283 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 -179.255 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.4 HG12 ' CA ' ' A' ' 150' ' ' HIS . 48.4 mm -112.56 154.48 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -134.94 120.69 19.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.571 -0.706 . . . . 0.0 109.638 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -82.55 150.91 26.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.511 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -110.86 -53.28 2.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.69 166.24 29.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.655 -0.653 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.68 89.65 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.32 -55.89 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.258 -0.901 . . . . 0.0 110.777 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.29 152.49 40.02 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.12 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -144.27 121.82 11.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 109.813 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -118.25 45.52 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.639 -0.663 . . . . 0.0 109.878 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.8 OUTLIER 152.19 73.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.44 142.33 39.5 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.244 -0.91 . . . . 0.0 109.448 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.38 -162.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.469 -0.769 . . . . 0.0 109.333 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -97.55 -57.9 2.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.58 -0.7 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -65.66 0.7 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -88.77 67.7 8.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -86.44 171.32 11.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.61 -24.7 67.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.02 -19.4 61.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 109.688 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -65.76 -16.68 64.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 109.323 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.02 -25.66 67.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.17 -22.74 52.74 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 65.28 0.67 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.36 -24.69 8.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.352 -0.842 . . . . 0.0 110.528 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -119.53 81.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.807 . . . . 0.0 109.816 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.4 -88.08 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.424 -0.798 . . . . 0.0 109.502 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 42.8 p90 -177.6 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.006 -1.059 . . . . 0.0 110.187 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 4.9 mtm180 -157.47 142.67 17.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.5 -0.75 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.72 -159.47 0.93 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.347 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.454 ' CZ2' ' HB ' ' A' ' 45' ' ' VAL . 20.4 t90 -94.32 139.33 31.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.238 -0.913 . . . . 0.0 109.433 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -144.41 129.39 18.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.17 156.08 1.18 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.99 65.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.845 -0.534 . . . . 0.0 110.202 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -136.45 -173.72 3.49 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.52 -164.27 1.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.45 45.89 88.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.6 mt-10 -54.79 84.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.694 0.759 . . . . 0.0 111.142 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 39' ' ' GLY . 42.1 tttm -91.29 -52.28 4.89 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 p -159.09 121.9 3.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.433 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 19.0 pt -120.23 151.47 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.11 150.36 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.437 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 8.0 p -155.16 107.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 t -91.39 118.44 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.26 153.29 17.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -104.25 134.09 48.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.673 . . . . 0.0 109.715 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.17 134.79 34.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.07 43.85 0.73 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 110.448 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 pttt 166.94 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -74.94 106.37 6.42 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 -178.33 5.11 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -96.48 175.48 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.75 120.34 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -107.68 -31.33 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m -146.15 155.12 42.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 149' ' ' PHE . 69.6 t -138.39 157.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.666 . . . . 0.0 109.548 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m-20 -139.44 138.38 36.41 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -159.05 135.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -115.0 134.79 11.85 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -112.5 151.46 29.92 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 122.149 -0.618 . . . . 0.0 110.707 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -102.12 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.23 24.83 29.65 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 178.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.417 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 59.6 m -77.35 -174.45 3.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.517 -0.99 . . . . 0.0 109.831 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' SER . . . -147.2 -57.53 0.26 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.6 m-85 -99.25 135.28 40.88 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.929 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 86.1 t -141.74 109.21 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.479 0.656 . . . . 0.0 109.685 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -99.78 139.23 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 18.5 t -124.4 124.28 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.461 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -113.32 164.06 14.04 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.3 m -128.67 160.69 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.689 -0.632 . . . . 0.0 109.817 -179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.23 175.86 43.02 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 t -113.83 158.46 20.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -89.57 11.3 20.0 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 -179.928 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.05 -175.12 2.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -121.37 127.9 51.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.917 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.2 85.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.77 -0.581 . . . . 0.0 110.274 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.9 tp -57.79 -53.88 53.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -143.81 122.66 12.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.257 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.35 -179.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 110.528 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 129.76 41.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.297 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.403 ' OG ' ' CE1' ' A' ' 93' ' ' PHE . 4.0 p -98.62 128.72 45.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 8.5 p -90.09 89.71 7.8 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CE2' ' CG2' ' A' ' 68' ' ' VAL . 6.8 m-85 -73.45 -57.81 3.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.341 -0.85 . . . . 0.0 109.607 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.2 mtm -121.3 -164.06 1.1 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.469 0.652 . . . . 0.0 110.187 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 5.8 p -130.64 -176.79 0.58 Allowed Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 41.6 Cg_endo -85.59 18.96 1.47 Allowed 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 123.086 2.524 . . . . 0.0 111.467 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.7 t -120.12 -40.71 2.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.12 -27.02 26.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 p -56.85 -22.26 35.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.512 -0.743 . . . . 0.0 110.475 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -83.87 -85.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.38 -0.825 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -163.01 38.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.37 -23.31 19.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.25 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.985 . . . . 0.0 110.579 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -119.48 95.26 49.16 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.45 -17.99 7.25 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.172 2.582 . . . . 0.0 110.155 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.47 128.93 30.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.787 -0.571 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.26 145.7 15.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 16.0 m -98.71 -179.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 109.983 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.76 148.49 17.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.867 . . . . 0.0 109.407 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.8 mtt -127.15 157.39 39.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.491 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 1.8 m-85 -128.82 166.49 18.95 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.22 -150.63 5.79 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.4 Cg_endo -75.51 -37.86 1.62 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.747 2.965 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -65.58 -26.52 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.464 -0.773 . . . . 0.0 109.6 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.94 1.97 56.84 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.643 -0.661 . . . . 0.0 110.663 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -121.57 138.93 54.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.956 -1.09 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.2 p -58.25 130.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 -30.98 61.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 109.602 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -21.56 66.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.22 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -115.93 -46.24 2.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.304 -0.873 . . . . 0.0 110.104 -179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.65 -40.49 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.138 -0.976 . . . . 0.0 111.583 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -0.16 31.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.266 -0.896 . . . . 0.0 110.528 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.7 mtpp -91.0 133.93 34.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.95 112.58 4.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.636 0.731 . . . . 0.0 110.804 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 75.8 m95 -115.43 165.44 12.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.35 10.25 3.22 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.491 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -144.45 149.08 35.42 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -134.47 142.46 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.909 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -109.65 113.33 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 -179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.93 123.73 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.46 121.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.275 -0.891 . . . . 0.0 110.533 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' CYS . . . . . 0.427 ' HB3' HG13 ' A' ' 43' ' ' ILE . 1.7 t -93.25 144.57 25.18 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -145.05 124.29 12.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 111.693 -178.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.6 OUTLIER 161.99 113.26 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.035 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.93 102.7 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.563 2.175 . . . . 0.0 110.305 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.462 ' CD2' ' HB3' ' A' ' 134' ' ' GLN . 1.5 p90 -134.16 -9.06 2.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.539 -0.726 . . . . 0.0 112.137 -178.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -172.3 2.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.955 -1.091 . . . . 0.0 110.263 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -170.61 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.95 -31.9 6.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.66 -0.65 . . . . 0.0 109.683 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.67 148.08 37.04 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.845 -0.534 . . . . 0.0 109.719 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.91 -177.43 2.23 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.341 2.694 . . . . 0.0 110.539 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.49 -163.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 -128.09 2.08 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.508 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -119.59 162.38 19.04 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.354 -1.086 . . . . 0.0 110.17 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 m -84.91 -14.97 46.07 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.523 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 50.9 p90 171.65 169.05 0.09 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.204 -0.935 . . . . 0.0 109.936 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.1 143.32 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -149.57 167.31 26.69 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 110.59 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.425 ' CE2' HG13 ' A' ' 128' ' ' VAL . 62.6 m-85 -149.61 158.69 44.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -155.04 123.18 5.87 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 0.0 109.74 179.386 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.46 70.74 4.12 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.48 2.786 . . . . 0.0 110.401 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.33 -175.15 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 4' ' ' ILE . 40.2 mm -123.81 133.97 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.39 126.88 50.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mp -79.57 155.14 28.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.141 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.01 -56.14 2.43 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -160.58 165.1 31.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.51 93.22 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.07 -54.61 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.24 -0.912 . . . . 0.0 110.339 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -120.78 150.99 40.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.484 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 p -137.9 121.19 16.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 m -124.47 41.54 3.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.537 -0.727 . . . . 0.0 109.407 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 154.4 73.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.81 140.63 29.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 108.744 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.49 -163.06 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 109.084 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -96.47 -63.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -57.57 10.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 18.5 m170 -98.16 77.64 2.44 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -97.11 169.32 9.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.813 0.815 . . . . 0.0 110.549 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.07 -23.98 67.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.925 -0.484 . . . . 0.0 109.777 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.38 -19.29 55.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -65.59 -16.47 63.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 0.0 109.28 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 mt -64.93 -26.6 68.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.2 -19.89 62.14 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.492 -0.755 . . . . 0.0 109.004 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -119.99 73.61 0.98 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -44.86 -60.44 2.05 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.705 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.33 -116.34 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p 50.47 -107.78 0.3 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.818 -1.176 . . . . 0.0 109.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -179.02 37.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 109.92 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 0.4 OUTLIER -148.8 149.67 31.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.532 -0.73 . . . . 0.0 109.461 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -131.69 -161.22 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 21.9 t90 -90.65 140.53 29.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 109.096 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 132.06 26.18 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.29 155.52 3.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.419 -0.801 . . . . 0.0 110.124 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.69 -21.65 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.798 -0.564 . . . . 0.0 110.182 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -141.67 -174.18 3.99 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.325 -0.86 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.2 -164.56 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.44 46.37 92.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -54.39 83.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.429 0.633 . . . . 0.0 111.529 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -91.9 -44.59 8.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 p -161.39 134.13 6.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 10.9 pt -132.34 142.2 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.239 -0.913 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 19.8 m -126.82 147.79 50.0 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.515 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -156.05 118.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 14.7 t -97.57 125.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.428 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.8 mp -103.32 150.89 23.34 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -93.19 146.25 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.3 mm? -101.12 123.97 46.1 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.45 -2.6 0.07 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.448 -0.783 . . . . 0.0 112.112 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.99 135.75 3.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 109.132 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -75.57 111.71 11.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.77 -177.98 5.58 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.297 0.57 . . . . 0.0 109.478 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.57 158.98 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.08 124.07 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -113.83 -30.0 6.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 109.764 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.9 m -148.99 156.79 42.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 109.084 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.6 t -144.43 154.56 14.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.416 0.627 . . . . 0.0 109.833 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -139.15 101.64 4.32 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 mt -126.32 141.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -113.13 137.8 14.49 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -85.27 139.2 31.81 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 122.302 -0.528 . . . . 0.0 110.002 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -111.71 65.83 0.63 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.1 29.4 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.9 m -60.5 178.0 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.974 . . . . 0.0 110.152 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -135.94 -50.17 0.7 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -102.32 132.36 48.34 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.6 t -134.84 108.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.503 -0.748 . . . . 0.0 110.083 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -102.51 145.51 29.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 21.4 t -132.02 128.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.097 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 3.0 mp -113.08 159.93 18.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 4.6 m -121.52 155.45 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.66 -0.65 . . . . 0.0 110.213 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.97 170.81 43.82 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 t -115.89 170.45 8.46 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.788 0.804 . . . . 0.0 110.144 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.4 p -76.24 -0.94 24.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.669 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.54 149.6 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 110.444 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.13 -62.06 3.73 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.61 -145.3 17.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.25 68.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.61 -0.935 . . . . 0.0 109.297 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.14 -49.4 4.48 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 59.29 25.31 13.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -1.002 . . . . 0.0 109.853 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -149.55 21.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 0.0 109.92 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.59 50.76 2.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.631 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -119.66 151.72 38.26 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.73 144.22 40.02 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.352 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.99 88.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.659 -0.651 . . . . 0.0 111.172 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.7 tp -61.16 -45.49 94.41 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 2.6 pp -146.58 124.83 12.21 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.39 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.6 m -55.46 -175.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.726 -0.609 . . . . 0.0 110.118 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.58 133.31 45.66 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.54 -0.725 . . . . 0.0 109.404 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.1 p -98.26 125.07 43.19 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.2 p -91.48 102.97 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 23.7 m-85 -99.04 -47.02 5.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.375 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 51.2 mtp -120.08 -157.48 0.71 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.733 -0.604 . . . . 0.0 109.502 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 4.9 p -159.41 -170.86 0.26 Allowed Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 49.6 Cg_endo -81.8 8.48 4.43 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.742 1.628 . . . . 0.0 110.431 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -83.2 -37.55 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.39 -34.61 72.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 t -73.64 -7.27 51.29 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.69 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -109.0 -52.39 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.533 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -120.94 35.86 4.76 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.141 -0.975 . . . . 0.0 111.692 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.07 6.68 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.175 -0.953 . . . . 0.0 111.849 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.93 89.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 p30 48.99 82.03 0.25 Allowed Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.49 -25.9 7.73 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 123.542 2.828 . . . . 0.0 110.977 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.8 109.39 10.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.143 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.1 169.87 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.512 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.8 m -138.37 165.73 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 0.0 109.51 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 161.89 33.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.027 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 mtm -123.25 164.47 18.68 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.311 0.577 . . . . 0.0 110.156 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.5 m-85 -132.26 101.78 5.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -80.13 -148.22 5.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.9 Cg_endo -75.05 -34.18 3.98 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.385 2.724 . . . . 0.0 110.759 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.18 -27.7 68.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.563 -0.711 . . . . 0.0 110.036 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -94.48 4.3 54.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.657 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.439 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -126.95 142.71 51.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.953 -1.092 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.5 p -62.65 137.4 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -33.76 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.48 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.72 -22.9 67.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.738 . . . . 0.0 110.191 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.435 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -111.81 -46.99 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.373 -0.829 . . . . 0.0 110.199 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.17 -35.36 16.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.25 -0.906 . . . . 0.0 111.259 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 0.5 47.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 110.602 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 12.4 mttm -93.43 135.54 34.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -69.33 110.46 4.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 0.0 111.02 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.424 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 78.2 m95 -113.35 162.24 16.3 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.5 12.22 2.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.072 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -142.34 142.25 32.45 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.01 141.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.352 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 13.4 tttt -104.08 118.45 36.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.77 -0.581 . . . . 0.0 109.765 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 47.5 mm -107.33 119.34 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 47.0 t -126.2 121.34 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.133 -0.98 . . . . 0.0 110.59 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 155.82 17.08 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -154.06 123.97 6.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.258 -0.901 . . . . 0.0 111.898 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 133' ' ' SER . 1.7 tm0? 162.04 114.88 0.01 OUTLIER Pre-proline 0 N--CA 1.503 2.198 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.05 103.4 1.74 Allowed 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 122.636 2.224 . . . . 0.0 110.361 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 2.0 p90 -135.2 -19.39 1.72 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.518 -0.738 . . . . 0.0 112.291 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 -175.27 2.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 0.0 110.379 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -163.18 -43.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.18 -34.73 6.29 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.544 0.688 . . . . 0.0 109.457 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 143.16 26.04 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.69 -172.06 0.78 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.141 2.561 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 176.8 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.77 -121.39 1.02 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.859 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.17 158.39 21.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.752 -0.852 . . . . 0.0 110.1 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 m -92.49 -26.94 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.532 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 39.4 p90 -176.66 167.27 2.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.2 m -147.02 122.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -132.54 110.0 10.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 110.205 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -88.8 154.77 20.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 108.787 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 122.72 8.6 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.65 136.49 4.51 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.373 2.715 . . . . 0.0 110.499 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -160.13 -179.89 8.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.665 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 4' ' ' ILE . 78.2 mt -140.63 125.99 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -107.8 154.12 21.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.783 -0.573 . . . . 0.0 109.653 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -89.52 152.53 21.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.748 -0.595 . . . . 0.0 109.508 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -102.02 -56.46 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -160.86 165.24 30.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.97 91.05 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 109.098 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.95 -57.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.183 -0.948 . . . . 0.0 110.405 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.4 147.15 43.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -132.11 133.69 44.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.01 38.76 3.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 109.82 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.8 m 152.73 74.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.404 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -134.87 147.57 49.9 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.5 149.54 24.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.409 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -60.27 -61.02 2.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.465 -0.772 . . . . 0.0 109.967 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 19' ' ' HIS . 0.2 OUTLIER -59.2 -44.51 92.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 29.7 m-70 -118.74 84.67 2.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -95.8 167.26 11.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.595 0.712 . . . . 0.0 110.277 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.75 -23.34 67.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.32 -18.38 58.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.727 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -64.47 -18.67 64.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.29 -26.98 68.31 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.12 -20.9 60.53 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.529 -0.732 . . . . 0.0 109.089 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -107.31 62.95 0.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.39 -25.26 5.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.405 -0.809 . . . . 0.0 110.57 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -118.46 81.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 109.831 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -156.54 -82.74 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.421 -0.8 . . . . 0.0 109.507 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -177.88 -38.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.926 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -86.5 166.99 15.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.57 -0.706 . . . . 0.0 110.007 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.66 -160.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.452 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 18.6 t90 -81.74 139.67 34.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -146.14 127.04 14.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.52 152.98 1.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.654 0.74 . . . . 0.0 111.041 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.56 -23.85 66.25 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.008 -0.433 . . . . 0.0 110.127 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 -174.93 3.95 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.992 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.58 -164.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.72 -0.612 . . . . 0.0 109.427 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.8 44.77 91.54 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.446 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.6 mm-40 -48.04 89.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.756 0.789 . . . . 0.0 111.625 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.1 tttm -97.69 -57.35 2.26 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.0 p -155.85 122.57 5.26 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.452 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 12.8 pt -124.03 147.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 12.9 m -129.37 144.63 51.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.076 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.74 116.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -97.03 121.17 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.3 mp -104.03 149.97 24.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.38 156.73 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.644 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.6 mt -106.76 125.39 50.94 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -51.73 -9.3 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.381 -0.825 . . . . 0.0 112.253 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -161.11 140.64 10.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 0.0 109.138 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.2 111.48 10.49 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.73 178.72 7.94 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -85.51 -172.93 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.41 122.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.412 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -113.32 -28.45 7.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.2 m -149.29 160.69 43.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 149' ' ' PHE . 63.4 t -146.38 160.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.326 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.55 130.74 42.67 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 ' CG1' ' HE1' ' A' ' 111' ' ' PHE . 26.2 mm -139.31 118.42 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.41 116.46 4.33 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -82.54 118.32 23.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.974 -0.721 . . . . 0.0 110.517 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 60.58 2.15 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.09 85.76 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.409 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 69.3 m -59.13 162.16 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -123.37 -55.84 1.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.7 m-85 -102.99 118.97 38.0 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.616 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.7 t -122.24 109.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.82 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.15 143.66 32.63 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.1 124.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.87 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mp -111.34 163.23 14.19 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.94 161.79 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.684 -0.635 . . . . 0.0 109.861 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 174.26 176.08 42.36 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -110.9 158.83 18.3 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 t -88.9 11.33 18.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 118.36 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 104.13 0.67 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.76 -32.75 0.23 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.89 -46.28 7.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.65 -0.912 . . . . 0.0 109.534 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.91 -172.67 24.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -96.86 25.08 5.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.918 . . . . 0.0 109.761 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -133.29 22.09 4.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.575 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.8 45.11 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.348 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.84 -175.73 4.97 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -123.52 129.74 51.66 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.17 86.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.596 -0.69 . . . . 0.0 109.963 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 117' ' ' VAL . 24.6 tp -59.45 -59.59 5.21 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.424 HD12 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -136.36 121.09 18.49 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.308 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.13 -179.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.697 -0.627 . . . . 0.0 110.602 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.69 131.77 46.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 p -99.31 117.52 33.93 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.775 -0.578 . . . . 0.0 109.764 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -75.02 69.43 1.93 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 36.4 t80 -59.48 -58.46 8.51 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.851 -0.53 . . . . 0.0 110.437 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.409 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 82.5 mtp -120.83 -177.19 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.737 0.78 . . . . 0.0 110.925 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.6 p -111.98 -179.43 0.64 Allowed Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 46.6 Cg_endo -86.02 12.24 3.09 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.999 2.466 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.8 p -120.77 -48.96 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 109.535 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.9 -7.33 50.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.4 p -83.21 -20.73 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.716 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -73.88 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 t -161.99 38.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 108.937 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.41 -24.19 6.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.49 117.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.443 -1.033 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.68 72.61 1.01 Allowed Pre-proline 0 N--CA 1.508 2.446 0 O-C-N 121.801 -0.562 . . . . 0.0 111.393 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.27 -30.16 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.88 2.387 . . . . 0.0 109.958 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -128.06 112.45 14.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -168.25 2.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 67.1 t -121.29 163.04 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.445 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 28.3 tpt180 -145.97 124.55 12.48 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtp -109.95 154.01 23.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -0.785 . . . . 0.0 110.5 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.488 ' HE1' ' CG1' ' A' ' 60' ' ' ILE . 7.9 m-85 -126.05 158.1 36.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 -149.95 6.74 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.24 -38.16 1.61 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.798 2.999 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.45 -29.17 69.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -89.08 3.26 52.37 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.672 -0.642 . . . . 0.0 110.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.23 139.76 53.44 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.039 -1.038 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.3 p -60.66 132.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -34.55 62.3 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.406 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.24 65.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 110.437 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.431 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -117.62 -47.29 2.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.014 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.01 -38.58 23.93 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.197 -0.939 . . . . 0.0 111.438 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.15 2.48 27.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.359 -0.838 . . . . 0.0 110.661 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 22.6 mttt -94.61 135.0 36.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -66.59 112.85 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.534 -0.729 . . . . 0.0 110.787 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.462 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 76.4 m95 -116.85 164.36 14.79 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.27 9.66 2.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.695 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -143.18 145.33 32.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.432 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.4 p -135.41 143.42 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.924 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -107.71 115.57 30.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.721 -0.612 . . . . 0.0 109.7 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 49.0 mm -105.4 117.6 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 0.0 109.286 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.5 t -125.01 117.8 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.111 -0.993 . . . . 0.0 110.429 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.415 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 10.9 t -92.46 148.66 21.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -148.1 123.97 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.525 -0.734 . . . . 0.0 111.466 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 157.7 134.11 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.403 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.86 98.2 0.5 Allowed 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.094 2.53 . . . . 0.0 110.207 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.446 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -129.77 2.98 4.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.357 -0.839 . . . . 0.0 111.373 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 -170.91 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.942 -1.099 . . . . 0.0 109.701 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -170.38 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.688 -0.632 . . . . 0.0 109.338 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -113.55 -36.25 4.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.694 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.04 143.53 26.78 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.39 174.53 5.06 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.236 2.624 . . . . 0.0 110.462 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.74 -164.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.33 -109.91 0.42 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.808 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.25 144.94 40.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.726 -0.867 . . . . 0.0 110.61 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -80.54 -28.72 37.22 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.453 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 48.8 p90 -177.56 174.8 1.49 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.567 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.63 130.55 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -143.34 107.79 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.506 -0.746 . . . . 0.0 110.157 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.451 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 83.1 m-85 -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.36 136.67 15.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.386 -0.821 . . . . 0.0 109.388 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.752 -0.593 . . . . 0.0 109.626 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 19.8 ptt? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.64 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.6 Cg_endo -88.86 -11.62 3.79 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.428 2.085 . . . . 0.0 111.207 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.16 -165.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 83.1 mt -128.62 128.21 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -115.39 171.1 7.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -0.856 . . . . 0.0 110.319 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mp -97.69 163.74 12.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.759 -0.588 . . . . 0.0 109.57 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -121.84 -51.44 2.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -161.09 162.18 31.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.87 96.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.495 -0.753 . . . . 0.0 109.481 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 p -54.37 -60.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -123.71 159.14 30.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.28 136.63 10.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.26 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 t -141.75 59.77 1.48 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.7 OUTLIER 157.22 59.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-O 121.443 0.639 . . . . 0.0 109.965 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -139.23 144.14 38.32 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.72 -1.237 . . . . 0.0 110.34 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.84 174.63 6.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.249 -0.907 . . . . 0.0 109.193 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -74.25 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.534 -0.729 . . . . 0.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -58.37 8.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.016 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 9.7 m-70 -97.05 80.44 2.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -93.56 164.5 13.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.572 -0.705 . . . . 0.0 109.839 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -64.42 -21.08 66.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.869 -0.519 . . . . 0.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.05 -18.82 63.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.79 -18.12 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.868 . . . . 0.0 109.091 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.13 -26.92 68.4 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.94 -20.58 58.26 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.493 -0.754 . . . . 0.0 109.003 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -115.18 68.55 0.71 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.3 -24.4 7.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.455 -0.778 . . . . 0.0 110.626 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.46 86.51 2.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.922 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 -83.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 0.0 109.427 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.9 p90 -177.8 -37.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 16.7 tpp85 -86.43 134.6 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.36 -0.837 . . . . 0.0 109.995 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -114.62 -171.86 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.48 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.464 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 21.4 t90 -84.96 142.21 29.8 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.535 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -147.8 130.39 15.89 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.27 153.02 1.6 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.44 -0.787 . . . . 0.0 110.826 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.76 -19.79 52.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.951 -0.468 . . . . 0.0 110.315 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 -171.21 3.16 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.359 -0.838 . . . . 0.0 108.933 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.23 -172.4 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 48.97 77.03 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HG3' ' CE1' ' A' ' 136' ' ' TYR . 79.1 mm-40 -34.11 -88.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp 72.02 -60.07 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.531 -0.731 . . . . 0.0 109.109 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.8 p -155.41 138.84 15.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.425 HD11 ' CH2' ' A' ' 33' ' ' TRP . 1.4 pt -145.73 140.73 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.55 -0.719 . . . . 0.0 109.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 4.2 m -122.08 131.13 53.82 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.594 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 7.2 p -136.89 116.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 3.1 t -95.88 116.76 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.232 -0.918 . . . . 0.0 108.974 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.11 157.02 17.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.641 -0.662 . . . . 0.0 109.76 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -96.3 163.56 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.691 -0.631 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.5 tp -108.52 124.78 50.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.84 2.59 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 112.471 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -175.97 134.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.657 -1.277 . . . . 0.0 108.93 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -74.79 111.0 9.55 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.644 0.735 . . . . 0.0 110.108 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -172.85 4.26 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -90.61 -178.36 5.27 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -141.92 127.06 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.657 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.407 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -115.82 -32.03 5.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.1 m -141.09 159.34 42.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG11 ' CD1' ' A' ' 149' ' ' PHE . 77.3 t -140.21 163.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.23 127.53 21.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.691 . . . . 0.0 109.519 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -145.21 139.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -98.53 126.88 9.05 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.12 126.19 30.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.066 -0.667 . . . . 0.0 110.231 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.32 63.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 108.839 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.58 -31.47 8.31 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.7 p -62.21 173.39 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.914 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.406 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . . . -141.83 -53.45 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -93.61 125.69 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.265 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.87 113.07 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.003 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.0 121.97 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HB ' ' HG ' ' A' ' 88' ' ' LEU . 31.5 t -113.74 127.75 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 110.223 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mp -118.35 162.56 18.09 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.19 159.79 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.97 178.1 45.51 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 t -117.84 156.59 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.2 p -84.53 6.26 24.38 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.471 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.29 4.1 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.03 49.69 0.83 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.78 77.54 1.45 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.89 -45.86 9.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.929 . . . . 0.0 109.734 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.83 177.17 17.72 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -85.64 -17.24 36.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.704 -0.88 . . . . 0.0 110.218 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -95.78 35.36 1.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.826 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -116.4 27.84 8.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -108.55 -175.01 2.66 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -120.98 126.14 49.19 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -61.58 85.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 0.0 110.422 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HA ' HG11 ' A' ' 117' ' ' VAL . 6.5 tp -59.59 -61.14 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -121.9 130.1 53.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -68.73 -171.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 116.93 5.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 p -99.26 112.93 24.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -81.96 123.41 28.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 13.1 m-85 -116.61 -46.94 2.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -166.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.523 0.678 . . . . 0.0 110.21 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 p -124.0 178.86 1.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.33 18.76 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.307 2.672 . . . . 0.0 111.433 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 m -120.28 -54.88 2.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -28.01 61.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.478 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -50.09 -25.36 3.39 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.477 -0.764 . . . . 0.0 111.011 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -80.95 -87.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.466 -0.771 . . . . 0.0 109.814 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 t -163.44 37.73 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.96 -22.56 38.25 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.41 -86.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -1.038 . . . . 0.0 110.647 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.6 34.84 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.16 -23.9 20.74 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.797 2.331 . . . . 0.0 109.994 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -134.46 141.54 46.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 -163.99 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 72.5 t -136.88 154.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.12 150.58 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 108.908 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.2 mtm -129.21 171.93 11.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.292 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -130.56 169.71 15.23 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.829 0.823 . . . . 0.0 109.566 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.82 -154.05 6.03 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.192 -2.363 . . . . 0.0 107.192 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.3 Cg_endo -74.27 -26.78 12.13 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.527 2.818 . . . . 0.0 110.843 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -53.37 -41.84 66.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.656 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.89 15.88 23.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.97 118.99 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 120' ' ' ALA . 7.5 p -46.5 126.97 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.979 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -64.52 -39.5 93.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.431 -0.793 . . . . 0.0 109.4 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.89 91.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.497 -0.752 . . . . 0.0 110.663 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -88.39 -36.39 16.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.324 -0.86 . . . . 0.0 109.188 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . . . -44.07 -42.76 6.4 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.64 -0.663 . . . . 0.0 111.361 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.22 11.43 30.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.981 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -92.25 130.14 38.03 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -66.32 108.81 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -0.756 . . . . 0.0 110.113 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.443 ' CE3' ' HA2' ' A' ' 73' ' ' GLY . 68.6 m95 -116.47 163.32 16.23 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.15 15.1 2.43 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.103 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -147.75 149.84 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 149' ' ' PHE . 8.4 p -141.58 144.15 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.974 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -105.77 134.97 48.03 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.9 mm -128.59 107.92 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.475 -0.765 . . . . 0.0 109.236 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.0 t -112.24 109.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.211 -0.93 . . . . 0.0 109.921 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.411 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.63 154.27 28.81 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -157.06 120.94 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 -178.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 133' ' ' SER . 5.2 tp60 171.41 135.04 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.5 100.78 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.928 2.419 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 38.0 p90 -147.27 15.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 111.483 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.39 -173.38 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.051 -1.031 . . . . 0.0 110.072 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -177.96 -39.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -116.05 -32.23 5.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.656 -0.653 . . . . 0.0 110.141 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.5 146.05 32.52 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.78 -0.575 . . . . 0.0 109.875 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.405 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.48 171.81 6.12 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.417 2.745 . . . . 0.0 110.614 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -178.95 -166.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.01 -106.75 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.084 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mp -120.12 155.02 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.962 . . . . 0.0 110.849 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 m -88.35 -27.47 21.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.445 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 48.0 p90 -177.1 170.48 2.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.2 m -146.99 142.06 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -150.56 166.14 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.664 . . . . 0.0 109.534 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.436 ' CD1' HG11 ' A' ' 58' ' ' VAL . 62.7 m-85 -141.59 158.19 44.15 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.32 128.54 8.28 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.01 -1.056 . . . . 0.0 110.338 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.424 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.8 46.83 1.31 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.573 2.849 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.16 -171.54 3.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -138.67 128.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 168.87 9.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.627 -0.671 . . . . 0.0 110.017 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.26 156.29 17.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.706 -0.622 . . . . 0.0 109.755 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -109.8 -52.0 2.82 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.93 168.41 24.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.01 93.8 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.252 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -52.99 -59.99 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.243 -0.91 . . . . 0.0 110.321 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.14 153.03 36.78 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -138.59 133.7 32.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.728 . . . . 0.0 109.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.95 42.64 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.702 . . . . 0.0 109.679 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.464 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.8 m 152.08 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.11 132.91 45.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.46 152.51 34.19 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -62.48 -62.16 1.94 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -0.767 . . . . 0.0 109.804 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -61.51 2.43 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -93.15 85.06 4.94 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 p -98.28 167.24 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.507 0.67 . . . . 0.0 110.236 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -61.51 -23.63 66.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.761 -0.587 . . . . 0.0 109.969 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.36 -19.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.239 -0.913 . . . . 0.0 109.774 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -65.5 -17.79 64.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.157 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.12 -25.41 67.76 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.61 -23.09 49.11 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 65.31 0.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.32 -24.95 8.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.783 . . . . 0.0 110.537 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -120.47 82.81 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 109.758 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.02 -85.28 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.501 -0.749 . . . . 0.0 109.398 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -177.48 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.138 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -160.82 142.12 11.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.346 -0.846 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -169.04 1.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.443 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.6 t90 -80.54 136.74 36.33 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.6 mtp180 -142.1 125.69 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.51 169.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.765 0.793 . . . . 0.0 111.018 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.57 -22.71 14.42 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.988 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.9 -153.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.14 -174.35 4.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.059 -1.025 . . . . 0.0 109.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 89.75 -13.5 64.14 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 12.6 mt-10 46.08 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.41 -1.053 . . . . 0.0 112.013 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -133.41 -72.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -153.91 139.5 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 14' ' ' SER . 8.9 pt -134.1 149.56 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 30.9 m -126.53 140.42 52.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.398 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 10.9 p -148.41 121.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -101.31 120.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.08 168.63 10.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.631 . . . . 0.0 109.985 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -111.39 142.76 43.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.803 -0.561 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 mt -97.07 135.26 39.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.63 37.89 0.36 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.48 -0.762 . . . . 0.0 111.262 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 pttt 165.58 127.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.39 108.12 9.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.806 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -178.6 5.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -87.34 -172.63 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.41 122.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.519 -0.738 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.3 t-160 -109.41 -32.09 7.29 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -146.88 153.53 40.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 149' ' ' PHE . 70.5 t -137.51 158.7 34.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.674 -0.641 . . . . 0.0 109.564 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.2 138.55 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -159.72 139.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -122.99 135.77 10.21 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -91.77 151.56 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.152 -0.617 . . . . 0.0 109.9 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.32 34.47 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.86 -17.14 8.21 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -60.78 -171.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -1.079 . . . . 0.0 110.449 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' SER . . . -133.96 -40.88 0.84 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.48 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.05 140.43 39.87 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.509 -0.744 . . . . 0.0 111.322 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 61.9 t -143.3 112.44 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.667 -0.645 . . . . 0.0 109.61 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.25 147.3 27.22 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.68 -0.638 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.27 131.55 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.897 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.32 167.34 11.32 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 159.0 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.703 -0.623 . . . . 0.0 109.568 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.436 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 176.31 173.8 42.27 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 t -115.62 161.07 19.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.601 0.715 . . . . 0.0 109.58 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -80.34 3.75 20.11 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.803 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -174.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.154 -0.966 . . . . 0.0 110.143 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.64 106.23 0.92 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.59 -72.32 0.04 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.04 43.55 14.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -1.006 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.17 122.55 1.33 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -62.77 -27.51 69.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.931 . . . . 0.0 109.628 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -97.31 28.45 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.468 -0.77 . . . . 0.0 109.618 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.95 25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.543 -0.723 . . . . 0.0 109.62 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -109.26 -175.54 2.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -121.11 127.4 51.57 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.39 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.759 -0.588 . . . . 0.0 110.17 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 tp -57.96 -50.65 72.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -146.6 124.07 11.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.01 173.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.08 131.32 47.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -103.46 132.9 49.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 99.9 p -90.18 107.4 19.11 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 68' ' ' VAL . 7.2 m-30 -89.29 -51.36 5.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.418 -0.801 . . . . 0.0 109.691 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 mtp -120.89 -178.92 3.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.754 0.788 . . . . 0.0 110.519 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.412 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -99.98 179.63 1.0 Allowed Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 42.3 Cg_endo -86.98 18.45 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.128 2.552 . . . . 0.0 111.445 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -120.31 -53.52 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.49 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -58.11 -18.99 28.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.452 -0.78 . . . . 0.0 110.635 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.4 t -49.04 -26.54 2.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.334 -0.854 . . . . 0.0 110.455 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -85.66 -85.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 t -164.06 37.47 0.08 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.36 -19.84 68.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.06 -83.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.42 -1.047 . . . . 0.0 110.686 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.6 p30 -111.84 82.15 3.88 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.78 -19.23 27.68 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.824 2.349 . . . . 0.0 110.776 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 127.79 40.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 109.567 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -157.73 176.69 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 17.4 m -134.57 -173.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.535 -0.728 . . . . 0.0 109.41 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -160.66 148.91 16.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.646 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtm -126.69 151.93 47.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.836 -0.54 . . . . 0.0 109.731 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 3.6 m-85 -122.57 165.68 16.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.42 -148.3 5.3 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.6 Cg_endo -75.01 -40.19 0.97 Allowed 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 123.727 2.951 . . . . 0.0 111.152 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.2 -27.76 68.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.742 . . . . 0.0 109.782 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -92.02 3.36 55.41 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.666 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.4 pp -122.79 139.37 54.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.037 -1.04 . . . . 0.0 110.45 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.9 p -59.63 129.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -74.29 -32.48 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.558 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.0 -22.44 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 110.189 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -115.2 -47.07 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 110.152 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.423 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.57 -37.99 19.39 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.099 -1.001 . . . . 0.0 111.63 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.52 2.23 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.368 -0.832 . . . . 0.0 110.707 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 27.6 mttt -93.51 136.02 34.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.19 113.22 4.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.413 -0.804 . . . . 0.0 110.546 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.8 m95 -116.94 164.53 14.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -139.86 14.82 2.49 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.065 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -144.38 146.95 32.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.0 p -138.19 140.78 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.036 -1.065 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.33 142.93 31.12 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.6 mm -138.24 107.51 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 44.0 t -115.46 120.62 65.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 O-C-N 121.293 -0.879 . . . . 0.0 109.874 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.22 150.71 20.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -155.1 143.02 20.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.09 -1.006 . . . . 0.0 112.206 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 133' ' ' SER . 3.4 tp60 148.53 113.1 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.34 123.32 4.38 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.679 2.253 . . . . 0.0 110.562 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -146.78 6.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.165 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 -175.19 4.79 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.347 -1.471 . . . . 0.0 111.345 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.447 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 58.8 mmtt -137.03 -30.16 0.88 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.828 -0.545 . . . . 0.0 110.912 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.08 -9.01 6.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.798 -1.189 . . . . 0.0 111.924 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.56 148.97 37.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.947 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.11 -161.45 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 123.927 3.085 . . . . 0.0 110.632 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p90 -178.69 -160.32 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.31 -165.37 33.32 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.283 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.27 150.58 21.95 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.063 -0.669 . . . . 0.0 109.569 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.415 ' OG ' ' CD1' ' A' ' 146' ' ' PHE . 8.9 p -76.79 -30.71 56.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.494 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 49.6 p90 -175.13 168.9 3.38 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.735 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.9 m -138.65 157.31 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 14.3 mtt180 -160.06 159.74 32.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.627 -0.67 . . . . 0.0 110.269 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 128' ' ' VAL . 58.2 m-85 -150.38 153.4 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.95 142.91 18.97 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.15 -0.968 . . . . 0.0 110.107 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -89.91 20.47 1.04 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.684 2.922 . . . . 0.0 111.097 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -155.78 159.99 39.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 4' ' ' ILE . 96.0 mt -139.15 130.16 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 167.27 10.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 109.632 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.2 mp -98.53 160.82 14.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.701 -0.624 . . . . 0.0 109.424 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -116.78 -46.01 2.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.389 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -161.19 -171.88 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.706 -0.621 . . . . 0.0 109.422 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -106.48 90.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 109.258 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 p -52.25 -62.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.206 -0.934 . . . . 0.0 110.55 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -118.55 155.1 31.48 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.443 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 24.5 p -161.53 126.47 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.748 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -137.61 68.18 1.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 44' ' ' SER . 1.4 p 153.4 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -122.34 144.0 49.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.978 -1.076 . . . . 0.0 110.765 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -94.12 -168.37 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -68.73 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.444 -0.785 . . . . 0.0 109.825 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.82 65.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.0 71.41 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.4 p -89.81 169.56 11.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.734 . . . . 0.0 109.705 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 45' ' ' VAL . . . -62.6 -25.18 67.95 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.668 -0.645 . . . . 0.0 109.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.4 -19.69 56.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.846 . . . . 0.0 109.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -64.72 -19.94 66.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.102 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.83 -25.78 67.37 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.53 -20.82 58.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.43 -0.794 . . . . 0.0 109.014 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.24 73.08 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.26 -47.73 55.07 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.517 -0.739 . . . . 0.0 110.684 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.61 75.96 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.482 -0.761 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -161.57 31.18 0.13 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.632 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.6 p90 47.15 25.57 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.315 0.579 . . . . 0.0 111.658 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -119.89 135.12 55.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.235 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -126.96 -178.63 4.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.465 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 21.4 t90 -94.43 137.25 33.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -139.78 128.12 22.68 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.93 164.72 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.424 -0.797 . . . . 0.0 110.327 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.4 -22.42 61.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.793 -0.567 . . . . 0.0 110.531 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.23 176.58 8.57 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.354 -0.841 . . . . 0.0 109.063 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.34 -176.06 5.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.71 -48.84 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' CB ' ' CE2' ' A' ' 136' ' ' TYR . 11.9 mp0 40.09 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.021 -0.694 . . . . 0.0 112.367 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -103.21 -43.35 5.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -160.49 106.34 1.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -107.32 136.66 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.497 -0.752 . . . . 0.0 110.5 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' OG ' ' A' ' 14' ' ' SER . 55.6 p -115.61 134.98 54.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.38 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 8.6 p -142.3 101.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 5.0 t -90.33 118.16 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 108.965 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -103.02 166.37 10.48 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -107.92 157.49 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.671 -0.643 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.02 124.44 49.63 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.1 -7.31 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.391 -0.818 . . . . 0.0 112.297 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -161.8 140.99 9.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.731 -1.23 . . . . 0.0 109.414 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.27 109.32 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.74 175.9 9.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.59 -172.5 4.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.9 121.68 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -110.13 -30.55 7.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 m -146.03 154.69 42.15 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 149' ' ' PHE . 67.9 t -137.9 158.67 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 12.1 t0 -133.05 134.84 44.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.308 -0.87 . . . . 0.0 110.579 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CD1' HG13 ' A' ' 58' ' ' VAL . 1.1 mp -149.7 125.96 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.65 117.04 5.55 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.9 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.849 -0.795 . . . . 0.0 109.881 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -123.15 82.63 2.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.52 80.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.474 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 4.9 p -98.4 178.64 4.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -1.123 . . . . 0.0 109.824 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.07 -47.56 0.44 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -109.3 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.172 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.65 114.05 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.44 150.86 26.29 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 34.3 t -140.71 127.14 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.586 0.708 . . . . 0.0 110.079 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.85 160.89 18.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.41 155.55 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.55 -0.719 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.19 169.69 42.77 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -119.92 165.43 14.64 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.723 0.773 . . . . 0.0 110.014 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -69.91 -9.36 54.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 145.57 28.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.264 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.02 36.5 4.07 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.38 -102.48 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.8 73.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.961 . . . . 0.0 109.441 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.94 131.85 2.76 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.62 74.74 8.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.943 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -153.81 -46.01 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.23 -47.12 65.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.749 -0.594 . . . . 0.0 109.422 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 59.24 165.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.554 -0.717 . . . . 0.0 109.282 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -101.69 129.63 47.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.1 86.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.798 -0.563 . . . . 0.0 110.373 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HA ' HG11 ' A' ' 117' ' ' VAL . 10.3 tp -59.98 -52.59 64.76 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.1 pp -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.385 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.55 172.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.01 135.01 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.592 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 5.9 p -108.33 130.94 55.18 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.447 0.641 . . . . 0.0 109.64 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.91 123.28 31.07 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 25.6 m-85 -123.05 -46.4 2.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.5 mtp -120.82 -165.7 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.702 -0.624 . . . . 0.0 109.872 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.9 p -126.58 175.77 3.03 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.56 15.42 2.15 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.31 2.674 . . . . 0.0 111.285 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 t -120.17 -42.13 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 109.337 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.09 -20.54 40.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 110.58 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.1 m -50.22 -25.98 4.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.273 -0.892 . . . . 0.0 110.765 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -85.12 -87.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.947 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -163.64 37.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.35 56.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.38 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.476 -1.014 . . . . 0.0 110.722 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.97 92.78 47.01 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.04 -23.54 18.24 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.615 2.21 . . . . 0.0 110.016 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.97 143.54 51.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -148.2 -174.5 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.432 -0.792 . . . . 0.0 110.422 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 70.4 t -148.75 142.44 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -153.26 145.99 24.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.863 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.2 mtm -125.78 152.58 45.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.7 m-85 -113.02 159.06 19.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -128.19 -149.6 7.06 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.67 -39.27 1.43 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.76 2.973 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.74 -28.31 68.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -89.5 3.82 51.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.661 -0.649 . . . . 0.0 110.592 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.444 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -124.7 139.81 53.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.098 -1.001 . . . . 0.0 110.442 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.1 p -60.3 132.35 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -74.86 -34.36 62.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.23 -20.45 65.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -117.55 -47.94 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.444 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.1 -41.02 25.16 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.217 -0.927 . . . . 0.0 111.617 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -2.18 33.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.437 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 14.4 mttm -90.98 133.63 35.13 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -65.71 113.11 4.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 110.392 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.443 ' CZ2' ' HG3' ' A' ' 85' ' ' GLU . 83.3 m95 -116.17 163.46 15.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.9 7.65 2.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.608 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.24 136.93 35.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 149' ' ' PHE . 5.0 p -127.75 143.93 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.664 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 3.4 tttt -111.6 111.07 21.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.0 109.653 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 49.4 mm -101.77 128.3 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.09 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.25 117.74 41.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.15 142.39 27.35 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -140.15 127.83 21.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.387 -0.821 . . . . 0.0 111.162 -177.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.435 ' CB ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 150.03 137.95 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.042 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.78 101.48 0.78 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.107 2.538 . . . . 0.0 110.319 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.496 ' CE2' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.61 -60.62 2.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.4 -0.812 . . . . 0.0 108.889 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.88 160.59 22.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -106.11 26.61 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.54 -0.725 . . . . 0.0 110.084 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -54.24 2.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 p -116.47 155.33 48.73 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 122.008 -0.433 . . . . 0.0 109.874 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.409 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.1 Cg_endo -83.73 166.18 13.54 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.459 2.772 . . . . 0.0 109.724 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -169.76 -163.02 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.89 -106.56 0.29 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -132.45 161.87 32.59 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.212 -1.17 . . . . 0.0 110.189 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 25.3 m -83.43 -17.69 41.26 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.036 -0.415 . . . . 0.0 110.916 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.5 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.6 p90 175.88 179.31 0.17 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.232 -0.918 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.3 m -154.66 128.24 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 150' ' ' HIS . 11.8 mtm180 -140.88 110.79 6.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.277 -0.89 . . . . 0.0 110.562 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' CD1' HG11 ' A' ' 58' ' ' VAL . 69.3 m-85 -88.64 158.57 18.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.412 -0.805 . . . . 0.0 108.859 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -156.07 139.59 15.89 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.293 -0.88 . . . . 0.0 109.512 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.3 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.0 Cg_endo -84.0 74.68 4.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.932 2.421 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -133.95 178.66 6.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 4' ' ' ILE . 40.3 mm -125.3 146.64 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -140.69 134.93 31.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.83 144.63 27.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 109.162 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -94.67 -50.94 4.94 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -160.83 167.78 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.67 89.95 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.29 -58.94 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.292 -0.88 . . . . 0.0 110.427 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -124.47 158.92 31.69 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -153.42 136.34 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.675 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -130.01 46.74 2.6 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 154.56 94.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 123.075 0.55 . . . . 0.0 109.624 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.37 146.0 15.05 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.953 -1.092 . . . . 0.0 109.445 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.52 -168.11 1.56 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 -60.21 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 109.522 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -61.15 2.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.801 . . . . 0.0 108.918 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -97.11 77.54 2.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.9 p -90.2 168.26 12.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.576 -0.702 . . . . 0.0 109.937 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.35 -23.72 67.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.65 -17.92 61.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.791 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -65.01 -20.16 66.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.212 -0.93 . . . . 0.0 109.277 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.56 -20.16 62.96 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -109.44 64.07 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.6 7.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 0.0 110.563 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -118.65 80.43 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -155.13 -84.03 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.494 -0.754 . . . . 0.0 109.612 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.7 p90 -179.23 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -79.53 148.85 31.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.391 -0.818 . . . . 0.0 109.772 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 12.4 mttp -127.42 -165.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.639 -0.663 . . . . 0.0 109.541 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.484 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 22.8 t90 -91.73 141.77 28.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.83 126.88 15.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.04 151.71 4.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.76 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.28 67.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.939 -0.475 . . . . 0.0 110.288 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -138.48 -173.22 3.48 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.352 -0.843 . . . . 0.0 109.285 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.15 -163.92 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.785 -0.572 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.07 45.76 95.43 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -47.71 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.582 0.706 . . . . 0.0 111.557 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 39' ' ' GLY . 30.3 tttt -93.47 -56.68 2.84 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.8 p -156.94 113.77 3.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.484 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 4.9 pt -114.61 132.22 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.573 -0.704 . . . . 0.0 109.874 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.464 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -114.57 146.71 40.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.504 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -147.74 112.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.6 t -95.54 119.33 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 108.946 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.402 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.5 mp -99.25 160.37 14.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.777 -0.577 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -111.85 125.97 54.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.5 -0.75 . . . . 0.0 109.905 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.15 136.04 36.43 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 41.34 0.61 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.594 -0.691 . . . . 0.0 110.405 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 pttm 164.8 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -75.61 107.45 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.6 179.79 6.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.494 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -94.94 162.96 13.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.27 126.41 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.311 -0.868 . . . . 0.0 109.918 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 25.2 t60 -116.97 -30.19 5.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.694 -0.629 . . . . 0.0 109.849 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.5 m -148.98 158.73 44.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 0.0 108.876 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -147.82 161.32 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.804 0.811 . . . . 0.0 110.447 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.07 134.68 38.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.18 130.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -103.88 125.81 8.55 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -83.68 127.59 33.89 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.247 -0.561 . . . . 0.0 110.281 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.06 50.4 1.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.75 -24.23 24.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 29.1 t -57.12 161.39 3.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.386 -1.067 . . . . 0.0 109.919 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.79 2.02 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.813 -0.554 . . . . 0.0 109.601 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -96.25 126.59 41.57 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.176 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.19 111.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.596 -0.69 . . . . 0.0 109.734 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -106.29 146.76 29.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.737 -0.602 . . . . 0.0 109.553 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.13 125.13 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 109.457 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.71 157.03 20.97 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.55 154.91 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 109.771 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.441 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.77 171.22 41.77 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 t -109.63 161.66 15.17 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 122.037 -0.684 . . . . 0.0 109.242 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 23.1 p -86.13 6.73 27.88 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.56 114.64 2.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.763 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.66 -69.79 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.46 75.99 0.75 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -177.27 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.617 -0.931 . . . . 0.0 109.459 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.76 115.82 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.67 -28.1 22.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.929 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -97.47 28.53 3.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.628 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -111.84 34.37 4.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.97 -174.53 2.55 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -121.73 127.88 51.17 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.16 88.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -59.65 -60.74 3.36 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pp -135.85 119.78 17.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.346 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.34 174.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.756 . . . . 0.0 110.278 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.13 133.59 53.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.509 -0.744 . . . . 0.0 109.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.7 p -102.88 122.26 44.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.5 p -87.01 108.31 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 24.2 m-85 -93.48 -51.93 4.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.71 -0.619 . . . . 0.0 109.922 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.3 mtp -122.11 -167.9 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.658 0.742 . . . . 0.0 110.452 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.8 p -109.32 175.64 1.87 Allowed Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.46 10.65 3.63 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.897 2.398 . . . . 0.0 111.332 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -121.44 -35.57 3.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.61 -0.38 53.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 110.671 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.1 m -74.19 -30.54 62.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -68.37 -77.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -161.96 38.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.23 -24.74 6.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.54 120.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 109.981 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.2 68.63 2.15 Favored Pre-proline 0 N--CA 1.509 2.499 0 O-C-N 121.975 -0.453 . . . . 0.0 111.551 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -76.83 -30.38 4.73 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.877 2.385 . . . . 0.0 110.233 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.93 99.23 5.21 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -164.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 109.404 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -148.8 151.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG3' ' CD1' ' A' ' 93' ' ' PHE . 5.1 mmt180 -144.45 166.15 25.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.3 mtm -139.68 175.02 9.93 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.535 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.505 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 7.5 m-85 -134.36 169.04 17.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.49 -151.48 5.56 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.416 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 40.3 Cg_endo -76.45 -37.12 1.46 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.582 2.855 . . . . 0.0 110.617 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.03 -28.59 68.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 109.429 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -88.09 1.61 53.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.607 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 1.6 pp -124.02 139.76 53.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.979 -1.076 . . . . 0.0 110.345 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.0 p -59.11 130.37 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -74.7 -31.66 61.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.93 66.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.92 -46.48 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.119 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.66 -38.5 21.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.158 -0.964 . . . . 0.0 111.51 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.68 -0.36 33.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 25.7 mtpt -92.41 135.15 34.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -68.23 111.46 4.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.513 -0.742 . . . . 0.0 110.887 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.447 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.5 m95 -113.5 162.36 16.25 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -135.36 9.0 3.43 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.681 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.7 mtm180 -140.77 142.39 34.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.9 142.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.816 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -106.5 112.48 25.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.844 -0.535 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 50.9 mm -104.83 117.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 42.6 t -120.14 120.65 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.201 -0.937 . . . . 0.0 110.62 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.6 136.0 36.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -139.31 123.44 17.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 111.017 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' SER . 4.6 tp60 165.14 128.77 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.159 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.98 90.53 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.875 2.383 . . . . 0.0 109.251 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 7.4 p90 -119.85 -12.45 9.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.738 . . . . 0.0 111.702 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 176.54 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 0.0 110.22 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -153.33 -42.77 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.65 -29.93 6.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.619 -0.675 . . . . 0.0 109.955 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.42 145.93 31.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.711 -0.618 . . . . 0.0 109.66 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.1 Cg_endo -87.78 -175.74 1.52 Allowed 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.356 2.704 . . . . 0.0 110.626 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 170.26 -166.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.95 -117.57 0.76 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.815 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.83 158.43 21.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.711 -0.876 . . . . 0.0 110.18 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 32.3 m -96.17 -25.8 15.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.979 -0.451 . . . . 0.0 109.982 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.537 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -176.98 165.7 2.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.206 -0.934 . . . . 0.0 110.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 159.02 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 0.1 OUTLIER -160.49 101.22 1.35 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.456 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 34.5 m-85 -88.99 149.93 23.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 0.0 108.289 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.2 120.12 5.73 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.729 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.694 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.02 105.77 0.65 Allowed 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 123.468 2.779 . . . . 0.0 110.514 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -154.77 179.86 8.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.0 109.518 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 4' ' ' ILE . 33.6 mt -145.26 119.75 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -96.62 166.17 11.79 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.31 0.576 . . . . 0.0 109.605 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.3 153.05 20.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.71 -0.619 . . . . 0.0 109.525 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -102.49 -56.48 2.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -160.97 161.46 31.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.651 -0.655 . . . . 0.0 109.274 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.75 93.51 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.1 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -54.66 -55.96 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.259 -0.901 . . . . 0.0 110.398 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.45 151.57 40.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 0.0 109.058 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.7 112.26 6.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.831 . . . . 0.0 110.274 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -105.95 43.7 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 t 153.05 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.3 135.61 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.45 -163.1 0.64 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -0.796 . . . . 0.0 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.8 m -95.51 -70.37 0.72 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -54.92 25.3 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -93.9 68.57 3.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.6 p -90.92 176.13 6.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.474 -0.766 . . . . 0.0 110.271 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.62 -25.17 68.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.74 -16.4 57.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.446 -0.784 . . . . 0.0 109.918 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.07 -18.19 65.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -0.997 . . . . 0.0 109.204 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mt -66.0 -24.13 66.71 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.79 -21.01 55.09 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.459 -0.776 . . . . 0.0 109.06 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.62 73.47 1.2 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.71 -22.03 21.55 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.462 -0.774 . . . . 0.0 110.233 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.51 101.41 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.414 ' OG1' ' CD1' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -172.71 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 109.117 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' OG1' ' A' ' 29' ' ' THR . 52.0 p90 -166.42 29.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.84 -1.162 . . . . 0.0 109.941 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.21 177.37 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.402 -0.811 . . . . 0.0 109.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -159.57 0.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.46 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.2 t90 -77.62 139.27 39.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.125 -0.985 . . . . 0.0 109.731 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -144.07 125.73 15.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.52 151.79 7.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.771 . . . . 0.0 110.246 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.55 -29.82 67.48 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.874 -0.516 . . . . 0.0 109.722 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -114.47 -165.8 1.05 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.26 -162.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.66 44.5 97.79 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.4 mm-40 -43.1 91.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.933 0.873 . . . . 0.0 112.002 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.5 ttmt -101.98 -57.61 2.04 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.2 p -154.51 121.43 5.56 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 7.1 pt -126.73 152.47 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.526 -0.733 . . . . 0.0 110.015 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.97 150.27 51.33 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.491 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.75 108.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.4 t -92.15 120.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.13 161.51 13.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -111.17 129.5 55.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.617 -0.677 . . . . 0.0 109.948 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.73 142.64 29.69 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 36.91 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.486 -0.759 . . . . 0.0 111.324 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 pttm 163.22 138.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.205 -0.935 . . . . 0.0 108.797 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 13.4 tt0 -75.55 103.78 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.25 172.19 13.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.517 0.675 . . . . 0.0 109.787 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -85.18 179.01 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.31 124.24 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.437 -0.79 . . . . 0.0 110.047 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.419 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 44.5 t60 -112.89 -29.5 7.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.609 -0.682 . . . . 0.0 109.2 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.07 157.14 44.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 149' ' ' PHE . 61.6 t -143.01 162.72 17.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.331 0.586 . . . . 0.0 109.938 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.35 100.77 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.31 124.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -92.27 128.35 9.35 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -84.02 120.69 26.43 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 122.173 -0.604 . . . . 0.0 110.194 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 5.8 t0 -93.64 69.58 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.21 89.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -64.79 -175.1 0.17 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 134' ' ' GLN . . . -148.58 -55.23 0.2 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.446 ' CD2' ' HG3' ' A' ' 134' ' ' GLN . 28.0 m-85 -105.67 116.46 31.98 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.016 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.76 109.86 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.942 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.29 142.45 35.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 24.1 t -130.73 127.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.603 0.716 . . . . 0.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 mp -112.68 162.23 15.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.45 157.58 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.647 -0.658 . . . . 0.0 110.375 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.72 166.85 38.83 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.2 t -109.45 153.26 24.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.843 -0.798 . . . . 0.0 109.867 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.417 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 47.6 t -84.4 8.64 15.59 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.32 119.57 9.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 0.0 109.735 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.45 -82.31 0.1 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 117.41 73.4 0.48 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.12 87.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.933 . . . . 0.0 109.459 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.27 -163.72 34.59 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -105.33 -20.88 13.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.581 -0.953 . . . . 0.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.49 27.96 3.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 109.923 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -118.09 40.25 3.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.043 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -102.96 -173.12 2.24 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.404 ' HG2' ' HB3' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -127.12 135.47 50.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 t -63.16 88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 111.493 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.431 ' HA ' HG11 ' A' ' 117' ' ' VAL . 10.7 tp -64.5 -42.09 96.05 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 2.3 pp -150.77 120.51 7.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.459 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.3 m -54.1 -178.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.697 -0.627 . . . . 0.0 110.293 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.51 133.56 47.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.47 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 p -98.51 117.92 34.02 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.258 0.551 . . . . 0.0 109.594 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.7 p -74.93 68.6 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.452 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -59.42 -59.07 6.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.875 -0.516 . . . . 0.0 110.261 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 68.2 mtp -121.23 -176.12 3.21 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.584 0.707 . . . . 0.0 110.713 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 p -114.66 179.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -86.72 11.06 3.39 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.102 2.535 . . . . 0.0 111.322 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.2 p -120.91 -39.37 2.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.955 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -83.43 0.33 46.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 110.768 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.8 t -78.64 -32.55 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -0.983 . . . . 0.0 110.165 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.678 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -161.69 38.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.93 -22.96 7.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 119.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.298 -1.119 . . . . 0.0 110.244 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.98 64.35 4.47 Favored Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.921 -0.487 . . . . 0.0 111.534 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.18 -30.66 6.68 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.889 2.393 . . . . 0.0 110.254 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.67 75.52 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.698 -0.627 . . . . 0.0 109.491 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -111.83 -169.56 1.49 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -129.98 165.11 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.197 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 21.5 tpt180 -143.26 134.46 25.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtm -110.72 158.92 18.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.036 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.8 m-85 -133.14 105.63 7.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -83.52 -147.4 7.52 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.4 Cg_endo -74.51 -35.52 3.62 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.517 2.811 . . . . 0.0 110.809 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.62 -27.72 68.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.693 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.5 4.32 53.75 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.643 -0.661 . . . . 0.0 110.682 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.444 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -128.37 143.87 51.06 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.912 -1.118 . . . . 0.0 110.31 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.434 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.5 p -64.25 140.52 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -35.05 44.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.735 . . . . 0.0 109.075 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.02 66.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.579 -0.701 . . . . 0.0 110.291 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.434 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -113.98 -47.15 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.444 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.1 -31.85 8.78 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.186 -0.946 . . . . 0.0 111.12 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -2.03 58.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.458 -0.776 . . . . 0.0 110.557 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 9.3 mtpp -92.02 135.14 34.19 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.85 109.28 3.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.674 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 86.4 m95 -108.63 160.26 16.08 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 12.6 t70 -133.28 2.31 3.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 110.404 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.417 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -140.84 143.0 34.52 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.433 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -133.95 142.49 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.361 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -107.45 114.66 28.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.717 -0.615 . . . . 0.0 109.788 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.97 122.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 125.1 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.15 -0.969 . . . . 0.0 110.654 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.0 t -97.93 145.92 25.98 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -145.66 130.03 17.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.0 111.495 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.446 ' HG3' ' CD2' ' A' ' 67' ' ' PHE . 0.5 OUTLIER 149.07 131.3 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.597 0 C-N-CA 123.911 0.884 . . . . 0.0 108.989 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.42 87.1 0.99 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 109.967 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 3.4 p90 -113.86 -1.42 13.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 111.12 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.65 -171.74 2.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.036 . . . . 0.0 109.476 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -164.23 -43.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.84 -32.5 5.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 0.0 109.887 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.34 149.8 36.65 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.885 -0.509 . . . . 0.0 109.702 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_endo -85.25 -169.79 0.67 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.437 2.758 . . . . 0.0 110.639 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 171.2 -162.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.3 -117.05 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.492 -1.337 . . . . 0.0 110.942 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.0 145.92 44.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.847 -0.796 . . . . 0.0 110.351 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -81.38 -27.21 34.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.491 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 35.3 p90 -175.87 171.69 2.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.453 -0.779 . . . . 0.0 109.804 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.21 131.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -147.98 105.4 3.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.447 -0.783 . . . . 0.0 110.504 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CE2' HG13 ' A' ' 128' ' ' VAL . 69.4 m-85 -86.3 157.83 19.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.414 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -152.9 136.01 15.63 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.41 94.43 0.54 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.517 2.812 . . . . 0.0 110.391 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.66 171.75 18.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.771 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 4' ' ' ILE . 48.6 mt -146.31 123.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -102.04 166.21 10.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.731 -0.606 . . . . 0.0 110.012 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.09 138.94 34.65 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -93.06 -56.24 3.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.126 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -161.06 160.6 30.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.49 91.18 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.73 -56.24 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.229 -0.919 . . . . 0.0 110.215 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -124.06 155.25 38.66 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.251 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -146.75 134.4 21.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.799 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -129.32 47.66 2.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.519 -0.738 . . . . 0.0 110.184 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.1 m 151.85 73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.91 143.45 48.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.06 152.03 19.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -60.97 -54.43 45.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.013 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -57.11 14.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.415 ' CE1' ' HD2' ' A' ' 31' ' ' ARG . 35.8 m-70 -107.25 78.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -86.21 163.45 17.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -20.72 65.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.761 -0.587 . . . . 0.0 109.622 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -64.74 -20.42 66.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -65.8 -16.78 64.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.19 -0.943 . . . . 0.0 109.273 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.7 mt -64.81 -23.28 67.19 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -22.3 39.13 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.418 -0.801 . . . . 0.0 109.19 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.8 66.31 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.76 13.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.488 -0.757 . . . . 0.0 110.318 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.08 74.3 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.461 ' CG2' ' CE1' ' A' ' 30' ' ' TYR . 86.1 m -156.93 -98.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' CE1' ' CG2' ' A' ' 29' ' ' THR . 0.1 OUTLIER 176.25 44.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HD2' ' CE1' ' A' ' 19' ' ' HIS . 3.6 mmm-85 -141.54 100.35 3.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 144' ' ' LEU . 30.9 mtmt -83.62 146.38 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.637 -0.664 . . . . 0.0 109.692 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.458 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.8 t90 -62.7 114.9 3.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.203 -0.935 . . . . 0.0 108.583 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -116.88 127.1 53.94 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -49.21 168.81 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.731 0.777 . . . . 0.0 111.696 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.73 63.99 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -124.85 -175.31 3.25 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 -166.56 1.39 Allowed 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.49 45.81 88.21 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.6 OUTLIER -43.03 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.52 0.676 . . . . 0.0 111.825 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' GLY . 7.3 tttp -93.44 -64.32 1.1 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 p -152.47 113.65 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.458 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 24.5 pt -111.29 145.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 110.384 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.89 150.49 44.59 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.522 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.438 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 10.7 p -152.27 107.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 9.0 t -92.43 122.04 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.57 155.76 17.89 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -109.55 120.24 41.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.8 mt -71.54 143.35 49.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.36 31.27 0.18 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.637 -0.664 . . . . 0.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 pttm 165.01 138.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.92 109.74 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.98 165.66 26.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -77.4 -176.73 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -143.22 130.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.432 -0.793 . . . . 0.0 109.36 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 45.9 t60 -116.81 -26.24 7.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.621 -0.674 . . . . 0.0 109.731 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -148.48 153.21 38.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.2 t -135.38 160.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.706 -0.621 . . . . 0.0 109.346 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.74 132.51 30.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.544 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.4 128.01 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.613 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -104.01 114.62 4.81 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 118.882 -1.628 . . . . 0.0 109.91 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.68 138.37 50.59 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.28 0.562 . . . . 0.0 111.206 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -113.44 42.06 2.03 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 -19.4 10.84 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.422 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 20.9 p -56.76 -173.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.319 -1.106 . . . . 0.0 109.797 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.42 -44.43 0.17 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.3 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -108.35 117.26 33.68 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.746 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.3 t -120.51 110.62 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -107.21 147.56 30.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.21 125.87 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 109.665 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.52 157.6 20.15 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.25 156.98 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.795 -0.566 . . . . 0.0 110.292 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.82 174.52 44.23 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 t -114.64 162.69 16.44 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.646 0.736 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -68.79 -11.11 60.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 175.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.239 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.16 -109.41 3.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.98 -51.52 0.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.24 -49.08 7.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.91 . . . . 0.0 109.312 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.2 -32.3 7.06 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.55 143.88 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -1.007 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 59.84 28.05 17.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 109.906 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.76 19.39 4.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.754 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.4 151.06 41.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.13 147.67 28.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.93 86.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -56.68 -54.98 39.81 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.75 117.26 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.271 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.6 m -50.86 174.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.564 -0.71 . . . . 0.0 110.446 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 132.69 50.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -97.6 118.16 33.48 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.847 -0.533 . . . . 0.0 109.745 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.9 p -75.45 67.96 2.06 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.46 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -62.08 -51.61 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.885 -0.509 . . . . 0.0 110.494 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.413 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 20.2 mtp -120.3 -170.25 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 110.455 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 p -121.07 173.74 3.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.99 5.02 5.97 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.272 2.648 . . . . 0.0 111.451 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.8 m -120.74 -39.29 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.097 -1.002 . . . . 0.0 109.827 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.79 -17.19 61.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.527 -0.733 . . . . 0.0 110.266 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -58.16 -20.55 41.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 110.517 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -71.44 -86.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -162.61 38.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 108.578 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.39 -20.27 7.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.93 119.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -1.073 . . . . 0.0 110.198 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.413 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.86 70.31 1.62 Allowed Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.89 -0.506 . . . . 0.0 111.308 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.59 -30.63 3.82 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.906 2.404 . . . . 0.0 110.464 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -146.23 109.75 4.79 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 93' ' ' PHE . 5.6 ptm85 -153.08 -160.79 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.533 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -131.86 172.0 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.773 -1.205 . . . . 0.0 111.388 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 13.9 tpt180 -145.64 147.14 31.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 mtp -126.99 158.12 37.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.688 . . . . 0.0 110.242 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.0 m-85 -126.51 163.95 22.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.99 -148.31 5.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.87 -38.52 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 123.8 3.0 . . . . 0.0 111.042 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.47 -26.7 68.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.502 -0.749 . . . . 0.0 109.701 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.55 2.37 56.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 110.71 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.5 pp -124.16 140.81 52.61 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.974 -1.079 . . . . 0.0 110.351 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.439 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.8 p -60.68 137.87 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -40.16 47.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 0.0 109.163 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.73 -20.88 59.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.595 -0.691 . . . . 0.0 110.679 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.439 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -114.8 -46.49 2.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.269 -0.894 . . . . 0.0 110.432 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.436 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.61 -35.08 12.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.253 -0.904 . . . . 0.0 111.311 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.13 7.08 29.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.356 -0.84 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.1 mttm -98.93 137.61 37.23 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -68.8 113.1 5.95 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.751 0.786 . . . . 0.0 110.973 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.433 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 77.7 m95 -117.21 157.16 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -132.1 10.29 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.275 -0.891 . . . . 0.0 110.057 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -140.08 147.13 39.84 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.427 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.6 p -140.6 142.47 30.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.774 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -112.77 107.31 15.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.679 -0.638 . . . . 0.0 109.718 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.4 mm -98.46 122.83 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.99 114.7 42.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 138.22 31.75 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -143.11 132.58 23.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.192 -0.943 . . . . 0.0 111.635 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 157.02 134.01 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.591 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.92 96.39 0.57 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.081 2.521 . . . . 0.0 109.807 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.4 p90 -128.16 -8.79 5.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.401 -0.812 . . . . 0.0 111.843 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -175.41 3.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.074 -1.016 . . . . 0.0 110.02 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -161.31 -43.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.72 -30.84 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.593 -0.692 . . . . 0.0 110.029 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 142.95 25.68 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.732 -0.605 . . . . 0.0 109.762 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -88.18 156.69 6.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.353 2.702 . . . . 0.0 110.323 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -161.48 -168.49 2.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.41 -101.96 0.18 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.04 163.64 32.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.474 -1.016 . . . . 0.0 109.64 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.402 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 50.5 m -85.09 -16.9 39.04 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.613 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 43.3 p90 -179.35 164.56 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.12 149.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -154.34 164.26 38.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.76 . . . . 0.0 110.472 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 128' ' ' VAL . 51.9 m-85 -144.59 152.2 40.17 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.62 136.18 16.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 109.188 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 86.1 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.739 -0.601 . . . . 0.0 109.845 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.62 -165.26 0.22 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.513 2.809 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.39 -160.91 0.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.582 -0.699 . . . . 0.0 109.149 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.47 127.65 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -112.52 171.04 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.722 -0.611 . . . . 0.0 109.885 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.9 mp -101.81 162.51 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.787 -0.571 . . . . 0.0 109.506 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -118.41 -47.64 2.54 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.444 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 3.1 p-80 -160.85 -168.73 2.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.94 96.87 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.43 -61.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.302 -0.874 . . . . 0.0 110.054 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -121.31 162.89 19.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 20.0 p -158.64 144.96 17.06 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.277 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -151.84 53.85 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 153.81 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -127.06 148.82 50.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.939 -1.101 . . . . 0.0 110.096 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -98.97 -165.37 1.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.79 -0.569 . . . . 0.0 109.561 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -66.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.688 . . . . 0.0 109.651 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -34.82 77.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -123.69 74.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -90.71 172.19 8.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.598 0.713 . . . . 0.0 110.256 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.52 -25.89 67.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.799 -0.563 . . . . 0.0 109.619 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.06 -20.02 55.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.365 -0.834 . . . . 0.0 110.17 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.2 -19.47 65.99 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.91 -25.05 66.97 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.91 -21.09 60.62 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.482 -0.761 . . . . 0.0 108.977 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 66.12 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.61 -22.75 23.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -0.756 . . . . 0.0 110.391 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.91 77.39 1.18 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -154.28 -85.57 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.404 -0.81 . . . . 0.0 109.576 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.22 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 158.33 29.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.497 -0.752 . . . . 0.0 109.506 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -160.96 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.536 -0.727 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.495 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 20.4 t90 -88.36 137.45 32.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 110.817 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -142.5 121.7 13.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.29 158.77 0.24 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.464 -0.773 . . . . 0.0 111.035 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . . . -62.51 -41.76 99.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.077 0.465 . . . . 0.0 110.28 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.48 -171.4 2.3 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.515 0.674 . . . . 0.0 109.241 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.59 -165.59 1.33 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.98 45.8 94.88 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp0 -51.92 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.461 0.648 . . . . 0.0 111.174 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 39' ' ' GLY . 15.5 tttm -91.38 -50.08 5.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 p -158.66 124.89 4.59 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 5.1 pt -128.34 136.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.459 ' N ' ' OG ' ' A' ' 14' ' ' SER . 26.8 m -118.6 138.51 52.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.415 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.75 111.61 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 10.4 t -96.96 119.75 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.088 -1.008 . . . . 0.0 108.978 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -100.9 160.67 14.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.539 0.685 . . . . 0.0 110.284 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 7.1 tp-100 -98.28 148.41 23.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.8 mt -99.57 123.81 44.18 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -52.59 -7.73 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.37 -0.831 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.2 139.03 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.786 -1.196 . . . . 0.0 108.874 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.69 113.58 12.12 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.41 179.77 7.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.16 -178.03 6.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.44 115.2 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -105.22 -30.8 9.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 109.202 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -144.3 161.09 39.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 149' ' ' PHE . 99.1 t -145.35 159.03 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.28 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -132.07 138.67 48.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.699 -0.626 . . . . 0.0 110.004 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -153.88 130.38 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -96.69 127.08 9.07 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -83.86 112.09 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.022 -0.693 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.7 56.96 2.12 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.94 58.38 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -53.42 161.72 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.316 -1.108 . . . . 0.0 110.555 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB1' ' CB ' ' A' ' 134' ' ' GLN . . . -123.46 -58.72 1.59 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.444 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 23.4 m-85 -101.68 133.19 46.77 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.611 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -132.49 111.56 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 109.677 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.14 141.67 37.11 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -131.07 124.47 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.636 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 1.5 mp -109.31 162.48 14.28 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.71 154.95 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.542 -0.724 . . . . 0.0 110.305 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.55 162.71 34.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 t -116.83 163.91 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.684 0.754 . . . . 0.0 109.872 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 t -77.08 -1.06 27.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -25.22 7.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.11 -27.48 9.35 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.38 21.47 59.97 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.42 39.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -1.105 . . . . 0.0 108.868 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.2 -75.03 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 63.94 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.7 -0.882 . . . . 0.0 109.104 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.16 28.66 4.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.179 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -126.62 37.7 4.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.228 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.06 -172.31 2.12 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.65 135.11 48.84 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -61.76 88.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.671 -0.643 . . . . 0.0 111.263 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.79 -55.63 28.05 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 pp -137.69 117.47 13.16 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -52.29 178.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.639 -0.663 . . . . 0.0 110.656 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 133.62 52.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 3.2 p -107.31 126.65 52.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.369 0.605 . . . . 0.0 109.656 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.8 p -86.47 117.87 25.53 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CD1' ' HG2' ' A' ' 109' ' ' ARG . 26.3 m-85 -112.86 -48.18 3.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.3 mtp -121.2 -176.35 3.26 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.549 0.69 . . . . 0.0 110.468 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.7 p -111.84 -178.55 0.54 Allowed Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 43.0 Cg_endo -86.41 19.33 1.41 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 123.155 2.57 . . . . 0.0 111.432 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -120.19 -41.27 2.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.02 -24.9 66.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.8 p -45.97 -27.24 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.711 . . . . 0.0 111.865 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -92.33 0.11 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -163.36 38.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.863 -1.148 . . . . 0.0 108.569 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.12 -26.55 18.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.93 115.77 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 0.0 110.272 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.27 73.55 0.83 Allowed Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 121.685 -0.634 . . . . 0.0 111.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -74.14 -28.23 11.02 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.557 2.171 . . . . 0.0 110.339 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -128.86 124.13 34.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.682 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 -170.13 3.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.729 -0.607 . . . . 0.0 109.403 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 40.6 t -132.82 159.99 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 141.22 12.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.762 . . . . 0.0 109.148 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.0 mtp -126.26 156.61 40.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.316 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 11.8 m-85 -110.93 172.28 6.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.33 -150.22 5.3 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.78 -38.04 1.44 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.712 2.941 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.03 -26.73 68.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.935 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -95.08 5.05 52.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.751 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.6 pp -125.53 143.0 51.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.921 -1.112 . . . . 0.0 110.712 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.1 p -61.85 141.08 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.75 34.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 108.973 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -15.89 63.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.717 . . . . 0.0 110.353 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.428 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -120.23 -45.61 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.42 -40.27 25.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.302 -0.874 . . . . 0.0 111.305 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.27 4.92 28.76 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 11.8 mttm -97.19 135.71 38.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.92 111.35 4.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.528 -0.732 . . . . 0.0 110.886 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 88.6 m95 -115.38 165.02 13.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -139.9 14.55 2.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.071 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -142.06 138.68 31.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' A' ' 149' ' ' PHE . 4.2 p -130.79 138.95 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.395 -0.816 . . . . 0.0 109.788 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 4.7 tttt -110.39 107.55 17.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.848 -0.532 . . . . 0.0 109.654 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.43 117.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.733 -0.604 . . . . 0.0 109.487 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 48.8 t -124.07 110.97 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 121.16 -0.963 . . . . 0.0 109.72 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.418 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.5 t -84.94 147.3 26.8 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -141.68 129.94 22.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.349 -0.844 . . . . 0.0 111.753 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.474 ' CB ' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 148.4 123.28 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 C-N-CA 123.719 0.808 . . . . 0.0 109.057 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.56 89.5 1.34 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.777 2.318 . . . . 0.0 109.1 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 6.7 p90 -114.62 -22.33 9.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.585 -0.697 . . . . 0.0 111.41 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -173.18 2.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.893 . . . . 0.0 109.863 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -168.75 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -114.88 -36.15 4.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.902 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.07 145.09 30.07 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.836 -0.54 . . . . 0.0 109.727 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.0 Cg_endo -87.92 167.74 6.91 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.371 2.714 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.35 -169.86 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.84 -109.81 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.872 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.69 152.13 26.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.903 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.405 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 34.5 m -87.84 -27.56 22.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.444 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 51.7 p90 -179.17 176.52 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -152.2 131.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.312 -0.867 . . . . 0.0 110.222 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CD1' HG11 ' A' ' 58' ' ' VAL . 80.7 m-85 -86.08 154.23 21.54 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 131.95 19.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.338 -0.851 . . . . 0.0 109.046 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.873 -0.517 . . . . 0.0 110.486 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.86 13.75 2.53 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.556 2.837 . . . . 0.0 111.327 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -78.47 165.92 23.2 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.228 -0.92 . . . . 0.0 109.214 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 149' ' ' PHE . 43.9 mm -79.52 143.15 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -123.32 126.05 46.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.87 147.43 27.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.2 ttt85 -105.28 -58.71 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.377 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.96 178.16 9.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.41 89.44 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.704 . . . . 0.0 109.24 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -51.42 -58.39 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.15 -0.969 . . . . 0.0 110.286 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.9 162.77 23.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 21.5 p -160.42 144.04 13.78 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.47 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 m -148.9 58.22 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' CB ' ' HB ' ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.78 58.21 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 123.093 0.557 . . . . 0.0 109.818 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 0.9 OUTLIER -124.54 140.61 52.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.82 -1.175 . . . . 0.0 110.65 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.64 -162.84 0.89 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -99.06 -64.25 1.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 109.374 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -58.53 4.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.692 . . . . 0.0 109.149 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -92.74 68.03 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.8 165.15 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 0.0 109.904 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.402 ' CB ' ' NE2' ' A' ' 15' ' ' GLN . . . -59.89 -23.94 63.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.644 -0.66 . . . . 0.0 110.368 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.46 -21.6 66.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.247 -0.908 . . . . 0.0 109.919 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -66.0 -16.82 64.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.28 -25.77 67.79 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.26 -21.3 61.72 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 65.42 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.3 -24.32 11.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.31 79.95 1.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.434 -0.791 . . . . 0.0 109.746 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p -157.2 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.483 -0.76 . . . . 0.0 109.196 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -178.06 32.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.003 -1.061 . . . . 0.0 110.379 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -147.25 140.54 25.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.026 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -160.41 0.99 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 17.6 t90 -97.58 136.19 38.33 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 3.9 tmm_? -142.6 120.54 12.04 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -53.48 154.76 3.3 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.193 -0.942 . . . . 0.0 110.427 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.79 44.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.784 -0.572 . . . . 0.0 110.196 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.02 -158.94 0.59 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.423 -0.798 . . . . 0.0 109.368 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.25 172.7 14.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.437 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 91.1 -15.62 60.57 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 2.6 mp0 59.52 117.72 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.618 -0.931 . . . . 0.0 111.418 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -151.7 -71.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.6 p -157.88 143.54 17.12 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' HB ' ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -143.57 139.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 69.2 m -126.53 115.06 18.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.234 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 7.2 p -116.41 126.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.401 HG21 ' CD ' ' A' ' 129' ' ' LYS . 2.8 t -104.76 113.77 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.875 . . . . 0.0 108.897 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.4 mp -97.61 169.34 9.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.558 0.694 . . . . 0.0 110.66 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -114.66 153.71 29.72 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.545 0.688 . . . . 0.0 109.608 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.0 mm? -104.86 131.98 51.67 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 5.7 tt0 -81.96 43.12 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.25 -0.906 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 4.6 pttt 163.59 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.23 104.66 0.62 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' CG ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.5 178.46 7.02 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.25 178.12 5.95 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.32 131.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.796 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 6.4 t-160 -122.47 -32.35 3.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -141.97 161.44 37.97 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 149' ' ' PHE . 58.4 t -146.67 164.1 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.899 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -139.28 134.77 33.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.639 -0.663 . . . . 0.0 109.616 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.418 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.8 OUTLIER -146.71 118.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -81.86 99.75 2.03 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.83 125.25 22.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.905 . . . . 0.0 110.361 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -107.38 39.07 1.97 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.384 -0.823 . . . . 0.0 109.406 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 136' ' ' TYR . . . 111.98 22.97 5.74 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -101.67 173.1 6.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -1.073 . . . . 0.0 110.382 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.8 -47.64 1.25 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -108.41 120.6 42.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.732 -0.605 . . . . 0.0 110.767 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.63 111.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.458 -0.776 . . . . 0.0 109.287 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -107.86 143.62 36.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.696 -0.627 . . . . 0.0 110.197 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' HG ' ' A' ' 88' ' ' LEU . 38.9 t -132.09 129.57 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mp -117.46 160.17 21.63 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.48 172.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 110.159 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.413 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 164.34 170.64 29.55 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -113.21 160.73 17.97 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.822 0.82 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -81.86 8.13 11.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.93 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.02 -26.48 2.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.131 -0.981 . . . . 0.0 111.224 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.39 70.47 0.11 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.51 64.43 2.16 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.25 -63.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.538 -0.978 . . . . 0.0 109.132 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.28 79.13 0.29 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 4.8 mp0 61.48 17.84 8.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.584 -0.951 . . . . 0.0 110.154 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 38.42 29.49 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.4 t0 42.15 48.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.428 0.633 . . . . 0.0 111.39 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 3.5 m-30 -48.24 160.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.603 0.716 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.69 131.61 54.75 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.58 86.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.66 -0.65 . . . . 0.0 110.729 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.411 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.9 tp -59.0 -61.18 2.83 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 pp -136.14 119.98 17.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.546 -0.721 . . . . 0.0 109.292 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.93 179.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.155 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.63 133.95 52.23 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.594 -0.691 . . . . 0.0 109.313 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.5 p -98.22 119.11 36.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.82 -0.55 . . . . 0.0 109.676 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.2 p -75.53 69.49 2.29 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 28.4 t80 -63.42 -55.49 23.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.803 -0.561 . . . . 0.0 110.587 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.6 mtp -117.79 -176.48 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.679 0.752 . . . . 0.0 110.571 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.54 176.35 1.52 Allowed Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -86.28 14.98 2.3 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.136 2.557 . . . . 0.0 111.518 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -120.09 -46.19 2.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.071 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -19.59 49.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.512 -0.742 . . . . 0.0 110.233 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -49.34 -26.87 3.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -0.863 . . . . 0.0 110.64 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -85.95 -86.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.54 -0.725 . . . . 0.0 109.745 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -164.44 37.53 0.08 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.43 -17.83 67.88 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.18 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.239 -1.154 . . . . 0.0 111.91 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.4 90.33 0.22 Allowed Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -81.21 -29.85 1.82 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.686 2.257 . . . . 0.0 110.315 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.6 129.94 50.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.653 -0.654 . . . . 0.0 109.273 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -160.21 -169.8 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.876 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 69.2 t -127.06 154.96 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 93' ' ' PHE . 6.6 ttt-85 -143.1 131.94 22.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.1 mtp -111.81 143.34 42.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.72 -0.612 . . . . 0.0 110.054 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.6 m-85 -111.59 165.1 12.3 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.642 0.734 . . . . 0.0 109.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -147.88 -154.6 6.31 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.8 Cg_endo -74.91 -24.12 13.34 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.644 2.896 . . . . 0.0 110.873 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -50.53 -38.79 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -117.73 15.27 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' CD1' ' HB1' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -117.26 122.57 44.33 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.444 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.6 p -49.65 130.33 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.631 -0.668 . . . . 0.0 110.698 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -67.64 -37.69 82.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.738 . . . . 0.0 109.133 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.05 92.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.284 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.444 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -91.96 -36.41 13.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.311 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 116' ' ' LEU . . . -44.98 -35.91 3.13 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.577 -0.702 . . . . 0.0 111.111 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.15 12.29 35.96 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.809 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -91.85 134.47 34.73 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.34 106.61 5.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.913 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.413 ' CE3' ' HA2' ' A' ' 73' ' ' GLY . 74.5 m95 -111.22 164.0 13.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -136.53 8.32 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.521 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -136.99 144.55 43.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.416 HG13 ' CE2' ' A' ' 149' ' ' PHE . 4.1 p -137.4 138.67 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.401 ' CD ' HG21 ' A' ' 46' ' ' VAL . 33.9 tptt -104.3 129.57 52.14 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.4 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 50.8 mm -125.24 111.92 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 47.9 t -117.92 119.73 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.44 -0.787 . . . . 0.0 110.36 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 152.18 20.11 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -160.06 132.45 6.4 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.643 -1.286 . . . . 0.0 113.949 -176.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.447 ' O ' ' CE2' ' A' ' 136' ' ' TYR . 10.1 tp60 148.09 125.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.32 114.78 1.87 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.778 2.318 . . . . 0.0 109.23 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -117.18 0.87 12.41 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.694 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.39 -160.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.604 -1.31 . . . . 0.0 110.051 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.437 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 ttmm -151.95 23.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 110.011 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -149.05 -40.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 111.701 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.7 158.91 33.61 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.687 . . . . 0.0 111.54 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.3 -159.67 0.11 Allowed 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 124.039 3.159 . . . . 0.0 109.601 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 40' ' ' GLU . 21.2 p90 -178.85 -165.01 0.08 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.47 -128.57 3.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -144.91 165.04 29.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.725 -0.868 . . . . 0.0 110.241 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.3 p -79.14 -25.52 42.88 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.558 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.572 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 46.3 p90 -175.07 173.64 2.6 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.812 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.0 m -149.63 130.3 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -142.05 116.33 9.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 110.756 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 60.0 m-85 -88.91 154.0 20.59 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -152.72 120.88 6.23 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.853 -0.53 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -87.85 -165.16 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.479 2.786 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -79.02 -168.79 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.183 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.6 mt -120.09 126.25 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.33 175.86 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mp -112.35 158.92 19.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 0.0 109.968 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -55.54 2.31 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -160.74 169.82 22.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.61 91.41 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.562 -0.711 . . . . 0.0 109.152 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -52.24 -58.51 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.07 -1.019 . . . . 0.0 110.186 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -125.3 157.58 36.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -160.44 125.26 3.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.4 OUTLIER -118.53 57.19 0.86 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 154.33 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 123.012 0.525 . . . . 0.0 109.674 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -160.24 144.08 14.07 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.87 -1.144 . . . . 0.0 109.494 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.02 -167.54 1.56 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 109.667 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -88.71 -62.77 1.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.685 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -65.04 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -88.59 74.46 8.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -91.08 168.05 11.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.616 -0.678 . . . . 0.0 110.051 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.68 -24.09 67.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.881 -0.512 . . . . 0.0 109.62 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.74 -18.42 62.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 109.967 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -64.96 -18.09 64.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mt -65.33 -26.84 68.22 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.7 -20.02 63.01 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -116.31 65.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -23.37 18.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.425 -0.797 . . . . 0.0 110.399 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -120.43 78.47 1.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.52 -88.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.483 -0.761 . . . . 0.0 109.408 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.36 36.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -155.1 149.89 26.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 0.0 109.317 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -130.37 -170.41 2.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.574 -0.704 . . . . 0.0 109.959 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.464 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 20.9 t90 -88.54 139.67 30.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 109.032 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 126.19 17.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' CB ' ' OE2' ' A' ' 40' ' ' GLU . . . -51.68 152.38 2.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.307 -0.871 . . . . 0.0 110.111 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.1 -23.9 56.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.749 -0.595 . . . . 0.0 110.077 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -139.19 -169.79 2.74 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.421 -0.799 . . . . 0.0 108.965 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 -172.47 2.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.67 -0.644 . . . . 0.0 109.362 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.35 48.67 85.02 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 4.3 mt-10 -62.1 78.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 39' ' ' GLY . 15.9 tttt -66.14 -51.07 61.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.3 p -156.94 124.78 5.47 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.464 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 4.1 pt -118.12 139.35 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.817 . . . . 0.0 110.4 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -115.5 140.36 49.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.135 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.1 107.98 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 11.9 t -92.35 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 108.894 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -96.95 168.72 10.3 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.09 129.76 56.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.718 -0.614 . . . . 0.0 110.406 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.5 mt -85.4 135.35 33.91 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 1.9 pt-20 -79.89 41.6 0.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.436 -0.79 . . . . 0.0 111.099 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 3.6 pttm 161.98 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.1 tt0 -75.88 100.36 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.49 172.38 12.28 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.588 0.709 . . . . 0.0 109.862 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -87.7 170.03 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 mp -128.48 122.81 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.77 . . . . 0.0 109.713 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -109.73 -32.97 6.9 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -144.8 155.2 43.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 149' ' ' PHE . 74.8 t -137.38 158.58 35.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.677 0.751 . . . . 0.0 109.98 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -134.68 137.12 43.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.428 HG13 ' HA ' ' A' ' 147' ' ' VAL . 0.7 OUTLIER -160.25 132.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -101.91 123.61 7.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.15 130.73 35.13 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.304 -0.527 . . . . 0.0 110.67 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.34 64.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.31 1.4 88.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.9 129.41 34.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 110.295 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.3 -57.73 2.85 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.713 -0.617 . . . . 0.0 110.076 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 133' ' ' SER . 16.4 m-85 -90.99 132.97 35.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.274 -0.891 . . . . 0.0 111.195 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.24 106.84 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' CA ' ' HA ' ' A' ' 90' ' ' THR . 7.1 tt0 -102.32 146.88 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 22.2 t -135.71 121.1 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-O 121.64 0.733 . . . . 0.0 109.544 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mp -108.78 163.01 13.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.428 ' HB ' ' CG ' ' A' ' 125' ' ' TRP . 2.6 m -121.34 161.02 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.646 -0.659 . . . . 0.0 110.553 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.36 167.8 38.05 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 t -108.78 155.12 21.13 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.83 -0.806 . . . . 0.0 109.552 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.423 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 60.5 p -89.54 12.69 15.89 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.69 -76.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.261 -0.899 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -116.24 90.66 0.52 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.84 159.01 28.81 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.22 -47.07 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.524 -0.986 . . . . 0.0 109.392 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.04 -135.92 1.91 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -107.21 -22.29 12.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.639 -0.918 . . . . 0.0 109.974 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -95.91 26.83 3.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -104.99 24.66 11.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.17 -173.68 2.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.411 ' CG ' ' CB ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.83 131.41 47.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.51 88.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.457 -0.777 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 tp -64.94 -51.04 63.99 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.5 pp -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.486 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.81 172.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.4 ' HA ' ' CA ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -57.59 130.57 46.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.364 -0.835 . . . . 0.0 110.229 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -97.75 123.99 41.92 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -90.95 81.62 5.66 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 20.7 m-85 -70.86 -55.97 7.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.831 . . . . 0.0 109.922 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.9 mtp -120.78 -163.31 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.685 -0.635 . . . . 0.0 109.638 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -128.85 178.12 1.82 Allowed Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.23 17.59 1.71 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.039 2.493 . . . . 0.0 111.089 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.7 m -120.61 -38.49 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 109.704 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -82.97 -29.55 28.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.469 -0.769 . . . . 0.0 109.337 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -60.49 -18.6 52.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.583 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -71.12 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 t -161.27 38.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.6 -21.88 4.19 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.9 121.55 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.365 -1.079 . . . . 0.0 109.119 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.3 p30 43.16 83.92 0.2 Allowed Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.758 -0.589 . . . . 0.0 110.798 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.76 -27.55 2.03 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.984 2.456 . . . . 0.0 109.992 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -145.73 86.24 1.72 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -114.71 127.45 55.76 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.6 m -79.76 165.82 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.743 . . . . 0.0 109.517 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.18 169.61 22.02 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.0 mtt -141.89 165.15 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 110.204 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.1 m-85 -120.85 170.35 9.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.44 -148.28 4.83 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.1 Cg_endo -74.88 -40.02 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.694 2.929 . . . . 0.0 110.716 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.36 -27.24 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 109.73 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -93.44 3.7 55.15 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.693 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 3.3 pp -124.22 152.21 43.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.932 -1.105 . . . . 0.0 109.966 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 120' ' ' ALA . 10.3 p -77.54 139.47 18.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -73.43 -29.92 62.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.28 59.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 110.754 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -125.01 -46.04 1.84 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.43 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -50.95 -29.08 11.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.604 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.48 -5.28 52.18 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.727 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 8.9 mtpt -91.16 133.08 35.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.158 -0.963 . . . . 0.0 108.52 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.81 110.65 3.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.48 -0.762 . . . . 0.0 110.541 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 83.9 m95 -110.72 158.94 18.08 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t70 -130.64 1.19 4.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.115 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.18 144.82 43.11 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 p -132.63 142.2 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.547 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -110.36 106.12 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.827 -0.546 . . . . 0.0 109.719 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 130' ' ' ILE . 49.3 mm -100.57 131.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.327 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.6 t -134.01 122.54 41.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 130.24 46.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -133.77 125.29 28.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.289 -0.882 . . . . 0.0 111.692 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HG2' ' CD2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER 170.44 141.44 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -90.71 95.06 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.71 2.273 . . . . 0.0 110.228 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.583 ' CD2' ' HG2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -120.92 -15.67 8.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.015 -1.053 . . . . 0.0 112.002 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -137.2 178.24 7.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 110.918 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -149.33 -47.34 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.644 -0.66 . . . . 0.0 110.248 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.34 153.15 44.19 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.361 -0.837 . . . . 0.0 110.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.15 -171.76 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.64 2.893 . . . . 0.0 110.9 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.448 ' N ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER 170.03 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.19 -121.93 1.8 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.944 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.69 162.44 21.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.447 -1.031 . . . . 0.0 110.521 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -92.78 -27.25 17.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.578 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 -179.88 166.6 1.3 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.428 ' HA ' HG13 ' A' ' 60' ' ' ILE . 33.1 m -139.56 145.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.292 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -149.68 159.09 44.63 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.442 0.639 . . . . 0.0 110.346 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CD1' HG11 ' A' ' 58' ' ' VAL . 49.8 m-85 -139.13 156.01 47.46 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.55 127.98 10.68 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.104 -0.998 . . . . 0.0 109.521 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.908 -0.495 . . . . 0.0 110.456 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.59 96.82 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.434 2.756 . . . . 0.0 110.523 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -146.96 176.58 9.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.559 -0.713 . . . . 0.0 109.684 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 83.9 mt -142.19 152.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 -173.05 3.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.506 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 4.3 mm? -119.54 163.17 17.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.55 -0.718 . . . . 0.0 109.64 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -114.43 -47.67 2.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -161.0 163.34 31.78 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.96 91.08 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.77 . . . . 0.0 109.159 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.27 -54.73 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.176 -0.952 . . . . 0.0 110.361 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -125.11 164.07 21.02 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.0 p -159.54 146.31 16.57 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.6 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -145.72 49.71 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' SER . 2.0 m 152.0 86.12 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -153.36 133.56 13.41 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.053 -1.029 . . . . 0.0 110.245 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.31 -175.14 4.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.5 t -84.94 -64.13 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.629 -0.67 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -61.48 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -89.13 67.53 8.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.5 p -84.98 168.33 15.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.58 -0.7 . . . . 0.0 109.812 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -22.4 66.95 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.34 -21.01 66.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 109.528 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -65.12 -18.46 65.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 109.014 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 147' ' ' VAL . 11.2 mt -66.02 -26.87 67.73 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.3 mm? -61.96 -19.34 62.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.03 76.15 1.35 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.94 -59.77 2.14 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.33 0.586 . . . . 0.0 110.812 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.64 -119.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p 51.72 -105.78 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.666 -1.271 . . . . 0.0 109.57 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.71 40.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.847 -1.158 . . . . 0.0 110.277 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -154.11 148.51 26.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -132.05 -159.72 0.99 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 14.5 t90 -97.12 140.05 32.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -149.0 126.7 11.74 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -50.42 142.25 10.74 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.429 -0.794 . . . . 0.0 110.876 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.83 -52.18 61.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 0.0 109.323 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -152.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.78 -179.75 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.7 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 96.34 -24.05 32.12 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 9.8 mt-10 45.17 41.96 6.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.694 -0.886 . . . . 0.0 112.284 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -59.81 -65.24 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -158.76 124.05 4.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.466 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 18.4 pt -112.92 148.63 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -124.59 146.76 48.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.708 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.451 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 10.9 p -154.92 111.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 109.527 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 11.2 t -95.52 119.82 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.27 161.04 13.9 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.453 0.644 . . . . 0.0 109.863 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -107.02 129.3 54.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.731 -0.606 . . . . 0.0 109.796 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.2 mm? -80.88 133.28 35.54 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.34 37.77 0.4 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.713 . . . . 0.0 110.425 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 pttt 165.67 126.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -76.29 108.86 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 109.225 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.78 -179.33 6.39 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -87.94 178.39 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.04 137.9 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.333 -0.854 . . . . 0.0 109.829 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 31.5 t60 -123.97 -34.73 2.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.706 -0.621 . . . . 0.0 109.895 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.6 m -137.1 163.4 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG11 ' CD1' ' A' ' 149' ' ' PHE . 75.4 t -142.62 165.03 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 109.622 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.67 115.66 7.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.759 . . . . 0.0 109.949 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.401 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 1.1 mp -133.14 120.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.647 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -79.14 89.03 1.19 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . 5.3 m120 -71.41 119.12 15.1 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 122.089 -0.653 . . . . 0.0 110.845 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.66 22.99 13.96 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.3 p -52.91 -175.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.17 0.986 . . . . 0.0 112.022 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 -54.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 133' ' ' SER . 44.7 m-85 -117.85 122.17 42.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.769 -0.582 . . . . 0.0 109.597 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 t -118.31 107.63 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.863 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.77 141.2 28.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HB ' ' CG ' ' A' ' 88' ' ' LEU . 60.0 t -136.55 119.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 0.0 109.668 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mp -116.95 163.28 16.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.5 m -126.74 168.65 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.739 -0.601 . . . . 0.0 110.131 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 168.97 172.79 36.09 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -110.39 162.36 14.74 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.551 0.691 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 p -86.27 9.53 17.47 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.38 124.88 12.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.116 -0.99 . . . . 0.0 110.436 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.09 104.12 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.54 73.07 0.05 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -177.1 -48.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 109.262 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.94 -140.94 15.3 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -110.35 -23.11 11.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.926 . . . . 0.0 109.988 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 29.45 2.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 109.746 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -115.93 35.77 4.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.98 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 135.88 47.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.19 85.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.462 -0.774 . . . . 0.0 110.563 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -68.05 -64.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -112.47 114.0 26.47 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.15 172.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.554 -0.716 . . . . 0.0 109.227 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.05 127.23 28.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.28 -0.887 . . . . 0.0 109.318 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p -95.7 114.7 26.47 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.219 0.533 . . . . 0.0 109.737 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -74.68 68.97 1.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.468 ' CD2' ' HG2' ' A' ' 94' ' ' MET . 15.8 t80 -61.66 -61.66 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.883 -0.511 . . . . 0.0 109.623 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' CD2' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -122.55 -168.9 1.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.524 -0.735 . . . . 0.0 109.877 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -116.41 176.72 1.43 Allowed Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.72 12.67 2.93 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.943 2.429 . . . . 0.0 111.27 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 t -121.68 -37.25 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.156 -0.965 . . . . 0.0 110.248 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.6 -22.04 37.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.804 . . . . 0.0 110.249 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.2 p -58.54 -21.03 51.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 110.718 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -69.28 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -161.95 38.95 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 108.663 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.2 6.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.05 121.91 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -1.161 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.431 ' O ' ' CE ' ' A' ' 94' ' ' MET . 7.4 p30 41.61 59.35 9.22 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 122.182 -0.324 . . . . 0.0 111.024 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.02 -31.35 5.02 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.117 2.544 . . . . 0.0 111.506 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.91 112.55 5.65 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.86 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -160.89 -157.91 0.56 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -124.59 160.65 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.014 -1.054 . . . . 0.0 109.692 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tpt180 -139.81 131.85 27.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtp -112.42 166.26 11.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.508 -0.745 . . . . 0.0 110.277 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 9.8 m-85 -139.1 166.25 25.0 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.44 -146.66 5.04 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.411 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 38.7 Cg_endo -73.91 -36.7 3.33 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 123.828 3.019 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.5 -27.31 68.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -90.32 1.12 56.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.597 -0.69 . . . . 0.0 110.68 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.452 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 3.1 pp -129.96 147.27 51.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.105 -0.997 . . . . 0.0 109.583 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.449 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 10.9 p -71.74 139.16 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -71.5 -32.0 67.73 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.05 -19.88 65.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -113.09 -49.42 2.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.452 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -50.96 -28.1 9.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.513 -0.742 . . . . 0.0 110.757 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 19.54 9.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.291 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.8 mtpt -118.34 133.88 55.51 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -67.18 111.61 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.568 -0.708 . . . . 0.0 111.07 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.448 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -117.15 164.53 14.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.17 13.49 2.62 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.945 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -143.67 144.22 31.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.431 HG13 ' CE2' ' A' ' 149' ' ' PHE . 8.8 p -138.64 139.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.399 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -105.49 124.28 49.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 130' ' ' ILE . 50.2 mm -119.68 112.35 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.621 -0.674 . . . . 0.0 109.689 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 29.6 t -113.78 118.84 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 O-C-N 121.21 -0.932 . . . . 0.0 109.546 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 93.56 7.32 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -92.48 128.68 38.42 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.613 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER 173.91 69.6 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -174.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.21 92.04 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.881 2.387 . . . . 0.0 108.768 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -120.78 -10.15 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.727 -177.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.413 ' CB ' ' OE1' ' A' ' 40' ' ' GLU . 32.6 t -128.77 -175.59 3.58 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.889 -1.132 . . . . 0.0 110.72 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 14.8 tttm -133.54 -33.52 1.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -126.24 -5.03 6.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.017 -1.052 . . . . 0.0 112.247 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -110.93 150.4 41.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.946 -1.096 . . . . 0.0 110.678 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 51.2 Cg_endo -92.08 172.25 2.53 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.083 3.189 . . . . 0.0 110.559 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.47 -160.48 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.059 -1.026 . . . . 0.0 109.513 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.24 -112.02 0.53 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -142.9 161.91 36.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.064 -1.257 . . . . 0.0 111.733 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 5.5 m -83.26 -17.2 43.48 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.708 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.647 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.3 p90 -176.01 166.55 2.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.327 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 24' ' ' LEU . 20.2 m -145.1 137.78 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -149.89 163.27 38.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.997 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.433 ' CD1' HG11 ' A' ' 58' ' ' VAL . 55.9 m-85 -140.72 152.73 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -151.59 139.16 19.62 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_endo -83.41 -25.7 2.48 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.883 2.388 . . . . 0.0 110.603 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.31 172.31 6.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -142.14 127.98 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.05 172.21 7.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.694 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.16 134.88 42.44 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.592 -0.692 . . . . 0.0 109.525 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -88.52 -61.52 1.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -160.86 163.54 31.96 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.38 89.8 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -52.49 -55.63 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.177 -0.952 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.46 161.05 25.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.0 p -154.58 144.15 21.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.0 110.668 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -141.12 46.72 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.747 -0.596 . . . . 0.0 109.498 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.9 m 152.88 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -155.64 139.95 16.67 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.055 -1.028 . . . . 0.0 109.866 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.45 -161.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.904 . . . . 0.0 109.832 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -68.04 0.82 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.578 -0.701 . . . . 0.0 109.895 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -64.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.451 -0.781 . . . . 0.0 109.16 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.32 58.7 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.4 p -79.71 179.18 7.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -65.06 -25.7 67.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.84 -15.85 59.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 109.762 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.42 -17.31 64.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.133 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.76 -24.27 67.51 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.77 -23.99 32.94 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.479 -0.763 . . . . 0.0 109.011 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -108.25 60.81 0.61 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.57 64.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.986 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.05 64.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.8 p -152.68 -90.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.1 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.075 -1.016 . . . . 0.0 110.082 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -128.47 147.47 50.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.045 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -132.5 176.08 8.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.413 -0.805 . . . . 0.0 110.204 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.449 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.0 t90 -88.48 139.49 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -144.67 130.5 19.21 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.97 146.47 8.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.795 . . . . 0.0 110.025 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.12 -22.09 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.738 -0.601 . . . . 0.0 110.436 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 175.58 9.43 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.86 -166.1 1.31 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 68.14 44.3 77.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -48.28 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.513 0.673 . . . . 0.0 111.246 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' GLY . 31.6 ttmt -97.8 -58.33 2.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.5 p -156.29 118.43 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 18.0 pt -116.01 147.22 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.426 -0.796 . . . . 0.0 110.205 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -126.83 149.52 49.67 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.417 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -154.44 107.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.0 t -90.9 120.71 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.6 mp -100.11 163.29 12.49 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.456 0.646 . . . . 0.0 110.117 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -116.55 117.64 30.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.13 143.58 50.54 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.18 37.15 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.707 -0.621 . . . . 0.0 110.975 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.91 137.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.93 108.14 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.6 176.78 8.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -87.25 179.79 6.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -140.5 133.06 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.885 . . . . 0.0 109.941 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -120.4 -32.81 4.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 0.0 109.692 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.43 163.28 33.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.3 t -143.37 166.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.614 -0.679 . . . . 0.0 109.215 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -137.66 102.07 4.65 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.0 110.114 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.491 HG12 ' CE1' ' A' ' 111' ' ' PHE . 1.6 mm -115.18 117.98 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.31 114.45 3.97 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.09 127.74 33.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.798 -0.825 . . . . 0.0 110.671 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 67.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.4 -30.1 10.2 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.429 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.37 -172.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.967 . . . . 0.0 109.62 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -155.0 -52.81 0.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.695 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.6 m-85 -99.93 123.13 43.84 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.839 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.3 t -127.75 111.58 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.025 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.78 144.3 31.3 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HB ' ' HG ' ' A' ' 88' ' ' LEU . 20.0 t -133.29 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -111.47 158.84 18.67 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 m -120.67 158.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.728 -0.607 . . . . 0.0 110.361 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.421 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.44 174.26 44.54 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 t -115.78 159.67 21.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 109.821 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.3 p -75.51 -5.14 43.72 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.643 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.69 -72.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.075 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.23 -70.28 1.03 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.63 29.23 66.56 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.46 75.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.52 -0.988 . . . . 0.0 109.69 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.78 -150.99 15.95 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.13 28.79 3.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.687 -0.89 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -136.72 16.48 3.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -112.62 28.97 8.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -109.42 -175.12 2.67 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.47 129.91 46.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.9 t -59.34 87.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.806 -0.559 . . . . 0.0 111.222 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.7 tp -59.96 -59.23 5.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -137.23 124.06 21.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 109.209 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -54.72 -177.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 0.0 110.114 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.75 133.29 49.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 109.23 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 38.1 p -99.57 120.93 40.45 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -86.15 124.17 32.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 31.0 m-85 -118.67 -47.3 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.633 -0.667 . . . . 0.0 110.237 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 69.8 mtp -122.07 -174.65 2.94 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.603 0.716 . . . . 0.0 110.963 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.2 p -117.14 174.76 2.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.36 12.59 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.19 2.594 . . . . 0.0 111.563 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.4 -39.51 2.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.937 . . . . 0.0 109.754 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -80.2 -20.52 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.8 p -58.06 -22.75 51.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.396 -0.815 . . . . 0.0 110.547 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -68.3 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.216 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 38.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.69 -17.96 7.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.35 117.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.239 . . . . 0.0 110.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 39.76 72.71 0.94 Allowed Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 121.944 -0.473 . . . . 0.0 111.963 178.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.7 -30.33 4.94 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.747 2.298 . . . . 0.0 109.62 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.97 115.21 18.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 -168.78 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.504 -0.747 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 41.3 t -144.75 131.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG3' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mmt85 -135.21 131.8 37.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.9 mtt -105.14 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.769 -0.582 . . . . 0.0 109.508 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' CE1' HG12 ' A' ' 60' ' ' ILE . 14.3 m-85 -140.26 163.98 31.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.74 0.781 . . . . 0.0 109.885 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -144.35 -153.68 5.93 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.6 Cg_endo -74.83 -24.3 13.35 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 123.602 2.868 . . . . 0.0 111.033 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -43.71 41.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.564 -0.71 . . . . 0.0 111.166 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.48 13.12 20.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 110.656 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -114.76 121.0 41.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.445 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.2 p -48.94 130.57 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.756 -0.59 . . . . 0.0 110.736 -177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.86 -39.24 87.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.443 -0.786 . . . . 0.0 109.224 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.77 89.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.747 -0.596 . . . . 0.0 110.572 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.445 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -92.08 -34.9 14.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.41 -0.806 . . . . 0.0 109.373 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . . . -46.11 -33.73 3.71 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.595 -0.69 . . . . 0.0 110.993 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.02 10.81 40.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.801 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 2.4 mmtt -92.9 133.13 36.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -72.35 104.57 3.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.312 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.421 ' CE3' ' HA2' ' A' ' 73' ' ' GLY . 72.0 m95 -110.4 157.54 19.44 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -131.27 4.15 4.35 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.271 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -132.52 150.61 52.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.18 141.59 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.234 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -108.58 110.92 22.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.737 -0.602 . . . . 0.0 109.899 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 48.7 mm -104.71 118.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 39.9 t -122.56 122.1 65.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.26 -0.9 . . . . 0.0 110.03 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.62 145.72 25.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -148.35 126.71 12.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 111.892 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.29 138.94 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 43.8 Cg_endo -90.06 103.26 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 123.189 2.593 . . . . 0.0 110.178 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.437 ' CE1' ' O ' ' A' ' 134' ' ' GLN . 5.4 p90 -137.17 -4.11 1.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.233 -0.917 . . . . 0.0 112.414 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 -173.86 3.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.847 -1.158 . . . . 0.0 110.463 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -173.44 -39.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -105.45 -42.08 5.32 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.647 0.736 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.97 145.33 31.18 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.02 166.89 8.26 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.119 2.546 . . . . 0.0 110.507 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -171.44 -164.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 109.07 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.43 -106.84 0.28 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.642 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -129.23 149.76 50.89 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.01 62.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 122.097 -0.377 . . . . 0.0 111.021 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.503 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.0 p90 179.07 178.11 0.48 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.413 ' CG1' ' CD1' ' A' ' 144' ' ' LEU . 15.7 m -155.65 129.79 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -141.82 156.39 45.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 109.474 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' CD1' HG11 ' A' ' 58' ' ' VAL . 39.6 m-85 -127.87 148.44 50.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.416 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -146.63 130.44 17.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.458 -0.776 . . . . 0.0 109.273 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.55 13.42 2.65 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.53 2.82 . . . . 0.0 111.277 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -160.86 176.55 11.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 4' ' ' ILE . 71.4 mt -121.57 123.26 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.47 173.06 6.47 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.437 0.637 . . . . 0.0 109.781 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mp -103.07 165.7 10.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.645 . . . . 0.0 109.57 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -120.22 -47.39 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.412 ' CD2' ' HB2' ' A' ' 48' ' ' GLN . 11.0 p-80 -161.0 -173.11 3.74 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.14 92.56 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.48 -0.762 . . . . 0.0 109.372 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.55 -60.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.446 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -121.31 163.63 18.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 19.7 p -160.05 149.37 17.71 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.059 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -152.31 51.91 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.681 -0.637 . . . . 0.0 109.975 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 153.63 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 12' ' ' CYS . 1.1 mm100 -125.57 133.66 52.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.967 -1.083 . . . . 0.0 110.651 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.09 -175.5 5.67 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -64.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -56.66 12.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 88.8 m-70 -95.32 69.73 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -86.82 166.84 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' CB ' ' CG2' ' A' ' 45' ' ' VAL . . . -61.6 -24.33 66.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.701 -0.624 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.51 -21.43 65.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.835 . . . . 0.0 109.712 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -65.71 -19.7 66.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.72 -24.92 67.09 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.62 -20.83 61.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -109.23 62.69 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.86 -24.84 6.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.31 78.15 1.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -157.29 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.526 -0.734 . . . . 0.0 109.342 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -178.27 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 6.0 mmm180 -144.24 143.72 31.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -0.838 . . . . 0.0 108.798 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -130.58 -162.67 1.23 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.361 -0.837 . . . . 0.0 109.324 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.457 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 20.6 t90 -96.87 136.08 37.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -143.1 125.93 16.11 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 43' ' ' ILE . . . -53.73 160.06 1.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 110.753 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.24 -45.05 14.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -152.03 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.51 -168.31 2.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.818 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 94.52 -22.62 36.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 12.1 mt-10 53.36 52.56 13.24 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.173 -1.193 . . . . 0.0 110.73 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -107.84 -103.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.38 -0.825 . . . . 0.0 109.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.0 p -108.03 142.9 37.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.655 -1.278 . . . . 0.0 109.462 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -145.21 147.03 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.673 -0.642 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 8.2 p -151.06 106.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 9.5 t -93.66 116.56 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.99 . . . . 0.0 108.911 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.29 152.7 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.923 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 8' ' ' HIS . 8.4 tm0? -91.5 158.94 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.71 -0.619 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 4.2 mm? -107.22 124.94 50.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -52.29 -8.43 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.428 -0.795 . . . . 0.0 112.188 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -162.59 140.77 8.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.806 -1.184 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -75.87 113.72 13.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.52 -176.46 5.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.87 172.34 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.72 120.04 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 109.509 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -110.62 -29.37 8.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -147.19 157.22 43.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 149' ' ' PHE . 67.5 t -142.22 163.11 18.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.058 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -137.3 141.77 41.9 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.87 123.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -87.68 121.7 5.98 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.6 125.59 29.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.971 -0.723 . . . . 0.0 110.162 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.39 62.98 1.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.6 -28.9 13.91 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.435 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 p -56.75 166.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.643 -0.916 . . . . 0.0 110.191 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.32 -57.37 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.16 123.36 45.18 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.56 111.66 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 0.0 110.204 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -105.06 141.43 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 35.5 t -130.78 127.23 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.52 -0.737 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.67 160.92 16.26 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -121.76 161.52 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.634 -0.666 . . . . 0.0 110.374 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 168.16 37.14 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 t -119.5 158.35 26.46 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.012 -0.699 . . . . 0.0 109.523 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.9 p -91.65 13.28 18.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.55 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 110.36 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -111.69 -37.36 1.58 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.19 112.13 4.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.93 70.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.926 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.5 159.9 8.24 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 64.5 128.06 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.623 -0.928 . . . . 0.0 109.906 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.77 21.88 10.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.521 -0.737 . . . . 0.0 110.288 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -137.04 22.46 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.65 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.17 -175.48 2.69 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.52 135.79 33.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 t -58.08 89.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.636 -0.665 . . . . 0.0 111.952 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.26 -54.0 35.83 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.4 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 2.1 pp -138.64 122.36 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.385 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.76 -177.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 t -69.64 136.53 51.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.494 -0.754 . . . . 0.0 109.171 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 125.72 52.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.429 0.633 . . . . 0.0 109.961 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -83.79 104.68 14.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CG ' ' HG3' ' A' ' 109' ' ' ARG . 19.2 m-85 -101.89 -47.02 4.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 110.343 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 ttp -117.9 -178.5 3.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.89 173.76 2.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.17 18.88 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.288 2.658 . . . . 0.0 111.292 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.32 -50.0 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -57.65 -21.43 39.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.395 -0.816 . . . . 0.0 110.307 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 p -45.71 -27.82 0.89 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.0 111.453 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -78.09 0.45 Allowed 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.761 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.8 37.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.45 -27.52 59.28 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 -82.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.542 -0.975 . . . . 0.0 110.489 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.407 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.7 p30 -112.03 87.48 8.85 Favored Pre-proline 0 C--N 1.296 -1.735 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.91 -24.93 28.42 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.651 2.234 . . . . 0.0 109.891 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -136.43 148.1 47.59 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -157.68 -168.02 2.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.594 -0.691 . . . . 0.0 109.821 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.54 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 96.1 t -137.73 129.77 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HG3' ' CG ' ' A' ' 93' ' ' PHE . 23.5 mmt-85 -137.81 150.48 47.23 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 37.4 mtm -134.43 166.51 22.68 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.596 0.712 . . . . 0.0 110.807 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.1 m-85 -119.76 171.13 8.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.65 -150.71 5.37 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.1 Cg_endo -76.0 -37.43 1.57 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.677 2.918 . . . . 0.0 110.77 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.34 -26.14 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.526 -0.734 . . . . 0.0 109.763 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.96 2.16 56.15 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.652 -0.655 . . . . 0.0 110.74 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.6 pp -122.5 141.1 52.01 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.981 -1.074 . . . . 0.0 110.519 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.2 p -61.42 138.71 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -32.87 49.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.356 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.03 -18.12 65.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.503 -0.748 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.435 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -117.19 -45.64 2.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.267 -0.895 . . . . 0.0 110.007 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -49.05 -39.58 28.05 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.342 -0.849 . . . . 0.0 111.08 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -81.37 1.18 34.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 15.9 mttt -94.04 134.27 36.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -68.58 112.43 5.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.446 -0.784 . . . . 0.0 110.919 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 79.4 m95 -115.14 166.44 11.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.66 12.31 2.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.714 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -146.92 141.5 26.59 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.442 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.8 p -131.79 143.79 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.579 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 5.8 tttp -107.64 114.11 27.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.609 . . . . 0.0 109.48 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 44.8 mm -105.5 115.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.648 -0.658 . . . . 0.0 109.599 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 40.4 t -122.23 116.27 48.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.34 156.6 18.61 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -151.44 127.81 10.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.361 -0.837 . . . . 0.0 110.988 -178.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 133' ' ' SER . 3.0 tp60 149.32 136.11 0.0 OUTLIER Pre-proline 0 N--CA 1.519 3.002 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.89 91.29 0.66 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.906 2.404 . . . . 0.0 110.269 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.47 -0.38 57.45 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.491 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 t -168.3 -162.69 0.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.791 -1.193 . . . . 0.0 110.261 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mtpt -138.89 -39.34 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -117.17 -13.76 10.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -0.984 . . . . 0.0 111.343 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.6 142.3 24.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.324 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 46.6 Cg_endo -88.03 177.13 3.56 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.479 2.786 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 173.14 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.37 -112.98 0.53 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.962 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -133.07 160.02 38.4 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.238 -1.154 . . . . 0.0 110.731 -179.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 67.3 m -78.64 -21.86 47.77 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.752 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.486 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.5 p90 177.08 178.95 0.24 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.249 -0.907 . . . . 0.0 110.459 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 m -154.21 129.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtt85 -139.95 114.4 9.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.766 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.442 ' CE2' HG13 ' A' ' 128' ' ' VAL . 73.0 m-85 -87.94 157.25 18.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.281 -0.887 . . . . 0.0 108.901 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -154.2 136.8 15.14 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.353 -0.842 . . . . 0.0 109.174 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.651 -0.655 . . . . 0.0 110.913 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.15 -51.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.438 2.758 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.03 -173.16 4.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.75 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.453 HG22 HD11 ' A' ' 4' ' ' ILE . 79.5 mt -141.04 128.74 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -113.42 151.33 31.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.926 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -84.74 149.47 25.75 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.7 tpt85 -103.87 -50.26 3.44 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -161.03 -178.59 6.88 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -99.96 97.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.21 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -54.77 -59.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.329 -0.857 . . . . 0.0 110.442 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 154.25 36.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.147 -0.971 . . . . 0.0 108.75 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . 23.8 p -143.4 125.26 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.0 110.715 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.3 m -127.51 50.1 2.05 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 1.2 p 154.23 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' OE1' ' CB ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -110.41 146.23 36.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 109.883 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.34 -170.72 2.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.72 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -99.38 -68.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.785 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -37.79 87.24 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -116.56 70.11 0.76 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.9 p -87.5 172.37 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.189 0.995 . . . . 0.0 109.53 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 45' ' ' VAL . . . -64.9 -24.98 67.69 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.231 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.78 -20.4 56.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.807 . . . . 0.0 109.509 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.42 -20.5 66.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 mt -66.27 -26.94 67.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.65 -18.84 61.14 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.474 -0.766 . . . . 0.0 109.175 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -112.25 66.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.54 -45.4 56.87 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.541 -0.724 . . . . 0.0 110.366 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.86 78.98 7.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.058 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.0 -152.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -130.8 40.3 3.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.069 -1.02 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -149.83 136.55 19.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -160.24 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.493 -0.755 . . . . 0.0 109.738 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 22.0 t90 -85.43 140.24 30.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.264 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 129.69 22.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 14' ' ' SER . . . -54.69 161.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.305 -0.872 . . . . 0.0 110.498 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.57 -30.08 66.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.971 -0.456 . . . . 0.0 110.021 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -174.24 3.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.5 -165.27 1.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.57 45.01 95.69 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -46.12 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 111.812 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 39' ' ' GLY . 28.1 tttt -94.77 -56.4 2.79 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 17.2 p -158.13 113.05 2.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.444 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 5.0 pt -111.13 139.65 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.608 -0.683 . . . . 0.0 109.527 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 50.6 m -126.27 122.65 36.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.523 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' CB ' ' A' ' 21' ' ' ALA . 7.2 p -123.23 125.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.48 113.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 171.09 8.25 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.364 0.602 . . . . 0.0 110.281 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.79 174.49 5.9 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -124.3 140.43 52.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -76.52 26.55 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.214 -0.929 . . . . 0.0 111.469 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.6 pttt 167.1 132.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.77 111.69 11.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.09 167.82 21.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -72.26 -178.77 2.61 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mm -126.6 128.8 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' A' ' 113' ' ' PRO . 77.0 t60 -120.69 -38.97 2.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 m -147.11 162.46 38.8 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG11 ' CD1' ' A' ' 149' ' ' PHE . 89.4 t -147.37 162.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.92 127.83 22.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -143.48 130.46 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.14 128.48 9.53 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.78 115.29 20.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.129 -0.63 . . . . 0.0 109.692 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -105.45 61.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.63 -29.08 12.72 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.432 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 86.3 p -60.62 173.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . . . -139.88 -52.71 0.52 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.4 m-85 -95.34 123.99 39.14 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.77 111.92 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.553 -0.717 . . . . 0.0 110.036 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -103.28 140.13 37.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.46 122.7 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.14 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mp -112.13 162.01 15.89 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' A' ' 87' ' ' LEU . 3.2 m -129.14 160.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 110.275 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.15 174.8 46.74 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -112.03 160.27 17.65 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.799 0.809 . . . . 0.0 109.949 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.425 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 56.0 p -86.37 7.27 26.3 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.01 112.03 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.973 . . . . 0.0 110.103 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.9 -102.51 0.52 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.79 115.36 0.66 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.24 -57.37 10.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.947 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.03 26.29 3.31 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 69.84 -63.04 0.4 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.366 -1.079 . . . . 0.0 109.975 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -93.7 39.29 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.951 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -125.51 30.88 5.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.433 -0.792 . . . . 0.0 108.986 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.12 -174.43 2.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -119.32 124.77 47.45 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.12 85.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.798 -0.563 . . . . 0.0 110.446 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' HA ' HG11 ' A' ' 117' ' ' VAL . 3.4 tp -57.91 -56.29 23.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.195 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.407 HD12 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -140.41 124.57 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.629 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.92 172.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.48 134.37 56.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.4 p -107.57 124.89 50.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.594 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -84.27 125.03 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CD1' ' CD ' ' A' ' 109' ' ' ARG . 28.7 m-85 -121.66 -43.31 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.0 mtp -120.4 -165.28 1.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.658 . . . . 0.0 110.086 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.5 p -129.37 175.13 3.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.93 13.64 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 123.178 2.585 . . . . 0.0 111.257 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.6 m -120.36 -46.34 2.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 -22.92 29.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.13 -36.32 29.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 110.919 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -74.5 -84.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.853 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -163.59 37.29 0.09 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.66 -25.25 54.13 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.632 -0.922 . . . . 0.0 110.45 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 90.48 30.51 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.25 -21.54 23.25 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.537 2.158 . . . . 0.0 110.043 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.47 156.51 37.1 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.41 -175.18 5.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 0.0 110.228 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.537 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 42.6 t -155.7 115.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' CD ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.49 165.69 19.37 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.378 -0.826 . . . . 0.0 109.679 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.4 mtt -140.43 175.46 9.58 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.497 0.665 . . . . 0.0 110.153 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.5 m-85 -136.7 159.0 43.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 116' ' ' LEU . . . -125.82 -155.01 8.85 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 56' ' ' HIS . 38.3 Cg_endo -75.42 -36.77 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.274 2.65 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.45 -29.12 68.49 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -2.72 44.36 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -124.99 141.19 52.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.948 -1.095 . . . . 0.0 109.956 179.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.438 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.2 p -51.56 139.98 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -39.2 62.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.157 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.56 -20.91 63.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.438 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -115.51 -43.64 3.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.3 -32.56 7.52 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.249 -0.907 . . . . 0.0 111.119 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.01 24.23 5.74 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.0 mttm -114.86 137.02 52.46 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -65.34 116.24 6.45 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.78 0.8 . . . . 0.0 110.462 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.451 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 63.2 m95 -122.66 151.05 41.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -133.52 5.19 3.71 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.429 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -132.75 141.39 48.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 149' ' ' PHE . 4.7 p -135.06 141.17 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.655 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -109.59 121.09 44.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.813 -0.554 . . . . 0.0 109.702 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.5 114.07 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 109.142 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 61.2 t -114.88 116.83 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.353 -0.842 . . . . 0.0 109.946 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.422 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -92.49 137.38 32.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -137.94 123.44 19.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.507 -178.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 133' ' ' SER . 4.8 tp60 166.43 133.46 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -87.02 95.05 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.928 2.419 . . . . 0.0 108.952 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.1 p90 -127.79 -7.25 5.59 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.273 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.12 178.65 6.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.0 110.527 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -156.96 -42.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.83 -36.7 5.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.49 -0.756 . . . . 0.0 109.669 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.41 147.67 34.33 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -87.5 178.43 3.38 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.286 2.657 . . . . 0.0 110.777 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER 178.93 -171.9 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.45 -112.1 0.49 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.907 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -111.88 148.79 32.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.68 -0.894 . . . . 0.0 110.412 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -84.89 -27.66 26.5 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 52.1 p90 -176.03 169.8 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.673 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.8 m -150.15 134.69 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.161 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -145.63 113.98 6.67 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.531 -0.731 . . . . 0.0 109.855 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.421 ' CD1' HG11 ' A' ' 58' ' ' VAL . 64.1 m-85 -93.3 152.56 19.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 133.54 20.81 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.396 -0.815 . . . . 0.0 108.805 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.725 -0.609 . . . . 0.0 109.364 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.18 50.61 2.14 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 123.528 2.819 . . . . 0.0 110.648 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.92 158.37 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.552 -0.717 . . . . 0.0 109.454 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 149' ' ' PHE . 47.7 mm -79.67 134.72 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -108.24 113.85 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 109.955 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tp -79.76 140.77 36.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.672 -0.643 . . . . 0.0 109.359 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -91.94 -65.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.531 -0.731 . . . . 0.0 109.519 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -160.39 173.22 15.95 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.76 90.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.211 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.07 -55.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.171 -0.956 . . . . 0.0 110.122 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.19 154.22 37.76 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.989 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.61 125.32 12.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 110.089 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -120.45 45.75 2.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.649 -0.657 . . . . 0.0 109.516 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 153.84 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.83 136.97 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -162.47 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.162 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -93.45 -69.41 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -60.74 2.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.731 . . . . 0.0 109.122 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -88.05 68.43 9.16 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.2 p -92.12 170.9 9.46 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.727 0.775 . . . . 0.0 110.219 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.55 -24.26 67.74 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.98 -0.45 . . . . 0.0 109.889 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.57 -19.56 62.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -65.5 -18.48 65.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.843 . . . . 0.0 109.157 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.13 -25.12 67.62 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.08 -20.61 58.96 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.47 -0.769 . . . . 0.0 109.033 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -127.29 73.8 1.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.81 -51.25 30.35 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.651 -0.656 . . . . 0.0 110.845 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.92 79.12 8.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -162.22 31.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 109.618 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.2 p90 46.99 25.18 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.242 0.544 . . . . 0.0 111.765 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -126.62 126.05 42.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 108.972 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -123.48 169.83 11.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.33 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.452 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.5 t90 -74.18 141.07 45.53 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -143.19 130.57 21.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.48 151.73 3.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.463 -0.773 . . . . 0.0 110.239 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.41 -33.79 71.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.61 -0.681 . . . . 0.0 109.702 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.24 -157.66 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.72 167.05 18.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.412 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 138' ' ' LYS . . . 96.03 -34.96 4.59 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 3.9 mp0 51.79 104.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.944 . . . . 0.0 111.782 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -117.31 -51.02 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -158.9 105.01 1.76 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.452 ' CD1' ' CZ3' ' A' ' 33' ' ' TRP . 18.7 pt -105.68 139.88 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.361 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -121.92 149.26 43.67 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.164 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.6 112.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 t -94.08 119.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.402 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 1.8 mp -97.27 161.25 13.89 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.416 0.627 . . . . 0.0 109.941 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -107.78 145.28 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.38 0.61 . . . . 0.0 109.355 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -104.95 133.67 49.34 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 31.9 tt0 -81.68 45.62 0.9 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.448 -0.783 . . . . 0.0 110.612 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 160.0 126.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -73.79 107.88 6.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.54 178.0 7.38 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.406 0.622 . . . . 0.0 109.588 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -89.92 177.23 6.54 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.72 119.04 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.53 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -108.72 -29.0 8.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.63 -0.669 . . . . 0.0 109.435 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 20.8 m -149.26 146.35 27.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG11 ' CD1' ' A' ' 149' ' ' PHE . 54.0 t -131.8 162.07 40.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.454 0.645 . . . . 0.0 109.701 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -141.79 136.07 30.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -156.58 132.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -106.1 131.74 10.79 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.48 128.03 34.36 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 122.185 -0.597 . . . . 0.0 110.244 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.7 71.33 1.7 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.3 7.45 88.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.456 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -84.06 -173.47 4.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.762 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.88 -51.65 0.37 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -103.09 130.8 50.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.672 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.53 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.657 . . . . 0.0 109.575 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -105.56 151.36 24.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.761 -0.587 . . . . 0.0 109.486 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 23.7 t -141.53 122.99 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.855 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp -110.56 163.71 13.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.9 m -127.86 156.73 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.713 -0.617 . . . . 0.0 109.781 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.29 176.25 45.22 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 t -110.32 156.71 20.36 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.2 p -85.77 7.59 23.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.442 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.99 171.61 2.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.88 -102.75 1.26 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.4 -139.93 3.12 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.68 80.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.954 . . . . 0.0 109.558 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.73 149.41 18.12 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -110.26 -27.27 9.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.623 -0.928 . . . . 0.0 109.705 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -101.35 37.47 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.366 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -126.9 34.37 4.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.547 -0.721 . . . . 0.0 109.647 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -113.16 -177.92 3.25 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.741 0.781 . . . . 0.0 109.097 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.424 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -123.69 129.04 50.5 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.32 86.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 110.292 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HA ' HG11 ' A' ' 117' ' ' VAL . 13.6 tp -59.04 -54.41 47.36 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.1 pp -144.66 120.73 10.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.42 172.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.31 134.06 55.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.438 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.3 p -105.34 126.89 52.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.413 0.625 . . . . 0.0 109.325 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.2 p -87.88 119.94 28.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 18.1 m-85 -110.21 -51.51 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.629 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.416 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 19.1 mtp -122.03 -162.71 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.508 0.671 . . . . 0.0 110.084 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.1 p -123.51 177.45 1.7 Allowed Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.79 11.53 3.31 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.929 2.419 . . . . 0.0 111.279 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 -36.72 3.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.314 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -81.65 -16.39 51.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.78 . . . . 0.0 110.226 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 m -59.44 -24.67 63.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -67.45 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 t -162.28 38.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 108.722 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.7 -22.32 6.73 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.96 119.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 109.935 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.416 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.9 OUTLIER 40.87 68.72 2.25 Favored Pre-proline 0 N--CA 1.508 2.449 0 O-C-N 121.949 -0.469 . . . . 0.0 111.233 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.1 -30.71 4.16 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.949 2.433 . . . . 0.0 110.52 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.61 82.58 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.665 -0.647 . . . . 0.0 109.647 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.9 171.99 7.54 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -127.29 172.84 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -155.82 145.9 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 109.144 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.4 mtt -123.71 153.7 40.49 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.45 0.643 . . . . 0.0 110.096 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.9 m-85 -114.8 161.33 18.34 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -131.3 -149.39 6.44 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 38.7 Cg_endo -74.72 -39.36 1.37 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.614 2.876 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.62 -28.29 69.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -89.99 3.77 52.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.662 -0.649 . . . . 0.0 110.598 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.61 139.66 53.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.013 -1.054 . . . . 0.0 110.521 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.7 p -59.6 130.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -74.84 -30.81 61.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.475 -0.766 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -20.63 65.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.506 -0.746 . . . . 0.0 110.217 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.98 -46.25 2.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.915 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.8 -39.55 25.76 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.165 -0.959 . . . . 0.0 111.439 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.13 -0.15 30.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.35 -0.843 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.7 mtpt -92.36 134.42 34.94 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -67.76 113.55 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -0.769 . . . . 0.0 110.766 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -116.31 163.85 15.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.11 7.41 3.41 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.585 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -137.39 149.45 46.96 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.77 138.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.956 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -106.36 100.81 10.32 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.929 -0.482 . . . . 0.0 109.761 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 ' CG1' ' CD1' ' A' ' 47' ' ' LEU . 49.8 mm -97.14 118.7 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 34.2 t -121.95 122.28 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.343 -0.848 . . . . 0.0 109.613 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.5 t -100.57 138.94 36.95 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -138.25 132.2 31.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.507 -0.746 . . . . 0.0 111.427 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 151.19 134.79 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.52 103.83 1.12 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.918 2.412 . . . . 0.0 109.587 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -77.14 -62.54 1.62 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.462 0.649 . . . . 0.0 109.612 -179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.62 -161.58 1.37 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.879 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 16.4 mttm -136.29 34.13 2.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 109.389 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -77.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.12 158.19 37.75 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.977 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.6 Cg_endo -80.8 176.56 8.89 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.625 2.883 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -173.55 -166.11 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.78 -111.0 0.46 Allowed Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.771 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.93 149.94 40.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.598 -0.942 . . . . 0.0 110.465 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.7 m -83.67 -26.22 30.04 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.508 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -178.65 164.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.502 -0.749 . . . . 0.0 109.023 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.17 138.37 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.27 149.42 32.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.582 -0.699 . . . . 0.0 109.589 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.43 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . 58.7 m-85 -127.71 160.95 30.11 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.404 ' HA ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -155.14 120.42 4.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.275 -0.89 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.701 -0.624 . . . . 0.0 110.349 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.33 120.75 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.482 2.788 . . . . 0.0 110.454 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -137.89 178.49 7.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.683 . . . . 0.0 109.545 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.0 mt -135.8 128.7 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.562 -0.711 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -120.08 -175.79 3.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.458 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.84 160.48 17.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.668 -0.645 . . . . 0.0 109.613 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -108.06 -48.07 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -160.59 162.25 32.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.28 86.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.37 -55.92 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -123.25 155.63 36.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.53 114.8 4.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -0.869 . . . . 0.0 110.336 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -104.67 47.38 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 13' ' ' SER . 3.3 t 151.87 111.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.1 127.63 3.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.064 -1.023 . . . . 0.0 109.834 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.7 150.21 24.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m -61.45 -55.17 34.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.877 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -60.52 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.358 -0.839 . . . . 0.0 108.859 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -102.48 85.45 2.61 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -93.46 163.48 13.56 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.513 0.673 . . . . 0.0 110.096 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -61.72 -22.01 64.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.838 -0.539 . . . . 0.0 110.007 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.97 -20.73 65.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.819 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -65.45 -18.97 65.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.26 -26.06 67.17 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.28 -17.4 62.47 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.562 -0.712 . . . . 0.0 109.25 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HB3' ' CG2' ' A' ' 29' ' ' THR . 5.3 mmmm -113.12 65.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.22 -26.77 3.14 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.537 -0.727 . . . . 0.0 110.809 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -99.75 68.17 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 26' ' ' LYS . 73.9 p -154.97 -161.09 1.14 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -127.56 34.41 4.68 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.365 -0.834 . . . . 0.0 109.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -124.62 105.5 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 35.9 mttt -91.27 162.83 14.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.609 -0.682 . . . . 0.0 109.738 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.457 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 23.4 t90 -67.76 139.62 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 127.05 16.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.49 164.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 110.616 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.16 -30.55 23.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 -156.8 0.53 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.65 172.52 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.83 -25.35 25.56 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mt-10 45.3 51.0 9.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.687 -0.89 . . . . 0.0 112.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -67.06 -59.21 3.66 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.1 p -160.44 133.79 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -134.54 152.77 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.274 -0.891 . . . . 0.0 110.554 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.69 150.37 51.03 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.536 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.415 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 7.4 p -149.66 106.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 2.9 t -90.89 118.46 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.729 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.38 158.2 16.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.1 tm0? -104.75 131.21 52.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.554 -0.716 . . . . 0.0 109.683 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.2 mm? -81.19 121.23 25.88 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -54.06 -6.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.66 150.39 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.877 -1.14 . . . . 0.0 108.033 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.87 111.3 22.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.77 . . . . 0.0 109.013 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.43 -178.59 6.32 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -84.34 -171.02 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.1 115.77 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.507 -0.746 . . . . 0.0 109.313 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.0 t-160 -101.36 -32.01 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -147.48 153.98 40.22 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 149' ' ' PHE . 79.7 t -136.72 161.14 36.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.643 -0.661 . . . . 0.0 109.726 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.407 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 27.5 t0 -139.11 139.24 37.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.617 -0.677 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -157.86 132.12 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -106.46 128.74 9.43 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -80.14 123.32 27.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.157 -0.614 . . . . 0.0 110.521 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 24.9 t0 -97.54 72.41 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 12.5 83.24 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t -85.8 172.9 10.43 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.304 -1.115 . . . . 0.0 109.637 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -134.8 -56.05 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.8 m-85 -102.26 122.89 45.1 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.702 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.43 112.52 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.705 . . . . 0.0 109.85 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -104.36 142.47 34.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.08 128.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.967 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.68 161.26 18.95 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.89 161.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.734 -0.604 . . . . 0.0 109.996 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 173.35 41.87 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 t -112.22 162.2 15.73 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.728 0.775 . . . . 0.0 109.833 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.418 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 13.0 t -86.27 6.19 30.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.1 -77.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.055 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -126.96 80.35 0.36 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.14 -65.84 1.96 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 59.73 29.37 18.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.574 -0.957 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 172.25 12.95 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -107.37 33.97 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.998 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -122.98 -0.75 8.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.575 -0.703 . . . . 0.0 110.505 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -100.13 43.09 1.07 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.141 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -106.45 -175.01 2.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.71 0.767 . . . . 0.0 109.061 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.3 OUTLIER -122.66 126.6 47.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.06 87.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.688 -0.633 . . . . 0.0 110.637 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HA ' HG11 ' A' ' 117' ' ' VAL . 14.1 tp -60.15 -51.82 67.95 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -146.41 122.69 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.25 -177.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.531 -0.731 . . . . 0.0 110.073 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 135.71 55.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.558 -0.714 . . . . 0.0 109.187 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.4 p -105.74 123.41 47.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.78 -0.575 . . . . 0.0 109.597 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.7 p -85.25 109.81 18.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 26.7 m-85 -104.65 -49.19 3.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 22.0 mtp -121.21 172.67 7.82 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.718 0.77 . . . . 0.0 110.724 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.401 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -104.47 179.38 0.95 Allowed Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.261 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 42.7 Cg_endo -86.66 16.39 1.97 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.964 2.443 . . . . 0.0 111.341 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 t -120.12 -50.94 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.235 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.16 -12.9 61.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 110.111 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t -58.79 -24.37 61.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -91.55 -73.17 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.07 37.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.82 -21.83 54.74 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.76 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -1.021 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.94 95.78 0.61 Allowed Pre-proline 0 C--N 1.292 -1.912 0 O-C-N 121.814 -0.554 . . . . 0.0 109.51 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.21 -25.95 4.54 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.948 2.432 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.6 119.41 25.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.738 -0.601 . . . . 0.0 109.786 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -147.08 174.43 11.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.3 m -135.95 166.68 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -154.73 153.88 31.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.452 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.43 156.99 39.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.48 0.657 . . . . 0.0 110.274 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.7 m-85 -118.08 167.45 11.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.65 -149.2 5.52 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.94 -39.84 1.1 Allowed 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 123.692 2.928 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.25 -27.87 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.533 -0.73 . . . . 0.0 109.833 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -91.98 3.76 54.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.3 pp -123.46 139.86 53.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.022 -1.049 . . . . 0.0 110.549 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.437 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.2 p -60.42 130.62 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -74.46 -33.76 62.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.83 -21.17 66.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.271 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.68 -47.33 2.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 110.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.57 -37.4 17.78 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.16 -0.963 . . . . 0.0 111.626 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.92 3.08 27.68 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.745 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 1.1 mtpm? -95.52 136.22 36.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -67.11 113.38 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.7 m95 -117.43 163.76 15.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.44 14.98 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -142.3 142.48 32.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG22 ' CZ ' ' A' ' 149' ' ' PHE . 7.7 p -136.61 143.03 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 110.366 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -111.62 110.43 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.766 -0.584 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.4 mm -101.82 129.46 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 t -130.98 130.01 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.184 -0.947 . . . . 0.0 110.591 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.43 ' HB3' HG13 ' A' ' 43' ' ' ILE . 9.7 t -99.71 149.23 23.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -150.26 118.77 6.48 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.609 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.03 112.24 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.3 97.19 1.11 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.342 2.028 . . . . 0.0 108.725 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.527 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -103.62 -11.42 17.7 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.407 -178.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.76 -167.38 2.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.072 -1.017 . . . . 0.0 110.065 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.78 -47.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.746 -0.597 . . . . 0.0 109.631 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -108.2 -13.37 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.536 -0.727 . . . . 0.0 110.925 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 p -99.07 138.46 20.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.265 -0.897 . . . . 0.0 109.861 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -88.2 -177.67 1.91 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.354 2.703 . . . . 0.0 110.502 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 174.52 -164.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.44 -115.24 0.65 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.206 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -120.8 162.29 20.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.685 -0.891 . . . . 0.0 110.84 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 13.7 m -99.14 -27.81 13.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 53.4 p90 -178.05 171.2 1.76 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.01 123.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' CE1' ' A' ' 150' ' ' HIS . 0.2 OUTLIER -130.26 110.92 11.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.438 ' CD1' HG11 ' A' ' 58' ' ' VAL . 85.9 m-85 -90.94 161.97 14.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.238 -0.914 . . . . 0.0 109.105 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -157.33 136.29 11.69 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -90.33 36.63 0.33 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.77 2.98 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -160.37 165.77 30.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.35 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 4' ' ' ILE . 61.4 mt -110.43 122.18 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.09 166.32 10.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mp -103.93 160.19 15.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.697 -0.627 . . . . 0.0 109.557 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -110.23 -54.05 2.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -160.55 164.99 31.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.89 93.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.5 -0.75 . . . . 0.0 109.322 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 p -54.17 -58.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.246 -0.909 . . . . 0.0 110.272 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.404 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -121.03 151.67 39.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -143.83 124.3 13.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.995 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -121.5 46.21 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.534 -0.729 . . . . 0.0 109.586 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.7 m 153.09 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 143.05 31.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.243 -0.911 . . . . 0.0 109.114 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.25 -161.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 p -98.47 -57.37 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.436 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.67 66.31 4.42 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -82.67 171.94 13.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.53 -0.731 . . . . 0.0 109.893 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.37 -24.05 67.68 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.85 -19.28 63.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -65.78 -17.33 64.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.937 . . . . 0.0 109.322 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.06 -18.74 61.64 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.528 -0.732 . . . . 0.0 109.252 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 67.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.37 62.49 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.466 -0.771 . . . . 0.0 110.323 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.12 76.51 9.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.469 -0.769 . . . . 0.0 108.984 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 -154.2 0.37 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -130.71 36.48 3.9 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -142.5 121.51 12.86 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.19 -165.38 0.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 109.452 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.459 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.4 t90 -81.9 139.67 34.53 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 125.19 16.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.64 148.83 6.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.766 . . . . 0.0 110.359 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.91 -20.22 56.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.94 -0.475 . . . . 0.0 110.228 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -138.82 -171.77 3.16 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.354 -0.841 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.32 -161.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.83 43.55 97.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.1 mm-40 -48.47 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.959 0.885 . . . . 0.0 111.328 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -102.78 -50.73 3.46 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.4 p -158.86 115.39 2.7 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.459 ' CD1' ' CH2' ' A' ' 33' ' ' TRP . 11.3 pt -120.52 148.69 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.4 -0.812 . . . . 0.0 109.617 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.82 146.97 49.57 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.455 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -152.32 106.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 10.8 t -92.38 121.03 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.72 160.17 14.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.77 53.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.679 -0.638 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.2 mm? -82.03 138.22 34.92 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.14 38.95 0.49 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.537 -0.727 . . . . 0.0 110.503 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 pttm 161.63 132.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -75.94 107.62 8.26 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.15 179.36 6.49 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.445 0.641 . . . . 0.0 109.455 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -90.96 174.75 7.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.14 119.06 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.8 . . . . 0.0 109.677 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -110.01 -29.31 8.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.5 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.1 m -145.53 154.42 42.17 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG11 ' CD1' ' A' ' 149' ' ' PHE . 54.8 t -138.99 163.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.616 -0.677 . . . . 0.0 109.76 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -145.06 125.83 14.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 1.3 mp -147.84 137.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.951 -1.093 . . . . 0.0 108.3 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.518 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.87 126.7 8.94 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.46 123.04 29.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 122.042 -0.681 . . . . 0.0 110.462 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.9 70.87 3.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.37 7.35 88.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -76.91 166.54 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -1.141 . . . . 0.0 109.603 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.91 -55.47 1.29 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -103.87 120.92 42.0 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.904 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.56 103.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 6.2 tt0 -86.88 147.04 25.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.415 0.626 . . . . 0.0 109.92 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' HB ' ' CG ' ' A' ' 88' ' ' LEU . 56.7 t -136.92 119.52 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 1.1 mp -114.72 164.54 13.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' CG2' ' HG3' ' A' ' 85' ' ' GLU . 13.6 m -127.93 163.33 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 110.351 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.56 170.28 37.56 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -114.01 160.27 19.04 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 122.027 -0.69 . . . . 0.0 109.213 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 t -92.25 12.82 21.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.8 -66.83 0.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.917 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.7 55.82 0.56 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.55 88.23 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.78 84.48 7.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.932 . . . . 0.0 109.411 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.74 168.36 26.35 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.36 -2.08 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.655 -0.909 . . . . 0.0 110.488 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -97.13 25.47 5.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.968 . . . . 0.0 109.964 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.65 21.57 12.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -0.812 . . . . 0.0 109.745 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.64 157.59 29.24 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.433 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 145.91 42.58 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.8 90.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.763 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -72.78 -58.43 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -117.6 117.55 29.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.79 171.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.617 -0.677 . . . . 0.0 109.174 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER -64.24 132.67 50.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.84 121.09 39.34 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.1 p -87.19 93.13 9.29 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 109' ' ' ARG . 25.0 m-85 -84.23 -52.93 5.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 110.403 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 22.2 mtp -121.33 -168.85 1.75 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.543 -0.723 . . . . 0.0 110.428 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.4 p -115.92 176.76 1.4 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.62 14.86 2.33 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.041 2.494 . . . . 0.0 111.32 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.0 p -121.19 -37.69 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.001 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.88 -24.9 32.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -58.53 -20.73 48.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.734 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -69.32 -84.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.23 39.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 108.745 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.65 -18.27 5.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.97 123.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -1.17 . . . . 0.0 110.159 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.424 ' O ' ' CE ' ' A' ' 94' ' ' MET . 6.5 p30 41.59 66.82 3.55 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 122.066 -0.396 . . . . 0.0 111.504 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.61 -29.89 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.746 2.298 . . . . 0.0 110.488 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.44 103.3 6.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.687 -0.633 . . . . 0.0 109.601 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.55 174.98 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.752 . . . . 0.0 109.104 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.3 m -140.32 141.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' ' CD1' ' A' ' 93' ' ' PHE . 2.5 mmt-85 -134.35 176.99 8.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 mtt -142.08 178.56 7.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.697 -0.627 . . . . 0.0 109.842 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 1.3 m-85 -141.92 171.16 14.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.52 -148.05 5.26 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -75.04 -36.63 2.42 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.595 2.863 . . . . 0.0 110.76 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.84 -31.78 73.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -81.95 1.75 33.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.715 -0.615 . . . . 0.0 110.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.436 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -130.59 137.84 49.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.167 -0.958 . . . . 0.0 109.639 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.3 p -56.96 163.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -97.78 -40.63 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.884 . . . . 0.0 109.142 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.02 -17.63 57.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 110.23 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -112.42 -50.81 2.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.436 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.35 -39.26 21.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.311 -0.868 . . . . 0.0 111.447 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -78.17 -1.85 34.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 110.656 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 23.2 mtpt -91.77 133.7 35.39 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -68.0 111.27 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.825 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.441 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 80.1 m95 -113.27 163.46 14.78 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -135.9 10.18 3.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.267 -0.895 . . . . 0.0 110.312 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -142.55 139.53 31.44 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.0 p -130.14 142.07 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.835 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 13.7 tttt -109.1 114.19 27.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.668 -0.645 . . . . 0.0 109.843 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 47.9 mm -105.78 119.64 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.92 117.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 O-C-N 121.208 -0.932 . . . . 0.0 110.057 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.414 ' HB3' HG13 ' A' ' 43' ' ' ILE . 7.0 t -89.14 142.72 27.4 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -141.26 124.81 16.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.717 -0.614 . . . . 0.0 110.6 -178.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 133' ' ' SER . 3.6 tp-100 158.33 131.51 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.446 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.35 93.22 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.021 2.481 . . . . 0.0 109.432 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.2 p90 -127.07 15.31 7.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.595 -0.69 . . . . 0.0 111.034 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.63 -169.57 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -176.06 -40.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.97 -36.41 4.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.547 0.689 . . . . 0.0 109.662 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.85 150.84 38.62 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.89 -0.506 . . . . 0.0 109.657 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.95 -171.42 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.354 2.703 . . . . 0.0 110.623 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.85 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 152.38 -113.5 0.58 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.366 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -124.08 151.51 43.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.732 -0.863 . . . . 0.0 110.992 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -86.45 -26.64 24.57 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 37.5 p90 -175.54 168.48 3.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.02 142.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.8 mtp85 -150.38 160.41 43.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 109.323 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CD1' HG11 ' A' ' 58' ' ' VAL . 38.7 m-85 -142.19 155.77 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 129.24 10.27 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.76 -0.587 . . . . 0.0 109.947 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.5 mmm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.2 Cg_endo -81.92 84.46 1.88 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.956 2.437 . . . . 0.0 110.372 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -133.79 171.05 14.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.422 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 4' ' ' ILE . 55.3 mt -143.17 126.74 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.72 . . . . 0.0 109.433 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.705 -0.622 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 2.1 mp -107.14 161.07 15.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.635 -0.665 . . . . 0.0 109.858 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.05 -57.71 2.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.686 -0.634 . . . . 0.0 109.31 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -160.8 164.13 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.83 86.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.83 -57.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 110.391 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -125.7 153.51 43.79 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.6 p -149.09 146.04 27.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -135.78 46.58 2.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.764 -0.585 . . . . 0.0 109.644 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' SER . 1.9 m 153.19 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -158.36 142.8 15.97 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.133 -0.979 . . . . 0.0 109.519 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -173.55 3.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.18 -0.95 . . . . 0.0 109.564 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -85.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.383 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -56.08 22.47 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 21.4 m170 -97.01 76.65 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -92.42 169.04 10.87 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -63.43 -23.76 67.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.852 -0.53 . . . . 0.0 109.709 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.97 -16.83 60.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.857 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -64.52 -18.77 65.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.069 -1.019 . . . . 0.0 109.228 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.59 -24.97 67.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.19 -21.39 59.36 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -119.14 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.79 7.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -121.17 87.21 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.829 . . . . 0.0 109.848 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.95 -87.29 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -177.57 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 0.0 109.73 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HD2' ' CD2' ' A' ' 19' ' ' HIS . 0.3 OUTLIER -160.73 142.79 12.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 109.273 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.7 mtmt -127.03 -164.9 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.471 -0.768 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.462 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.1 t90 -88.46 140.25 29.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.45 129.49 17.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.05 148.48 6.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.406 -0.809 . . . . 0.0 110.379 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.14 -23.7 56.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.811 -0.555 . . . . 0.0 110.251 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -139.19 -175.88 4.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.96 -166.64 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 64.12 48.0 79.61 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mp0 -55.15 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.378 0.608 . . . . 0.0 111.026 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 39' ' ' GLY . 18.4 tttt -87.82 -53.49 4.73 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 p -155.8 114.92 3.54 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' HB3' ' A' ' 132' ' ' CYS . 12.5 pt -115.85 146.86 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.475 -0.766 . . . . 0.0 109.401 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.18 149.31 49.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.121 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.08 105.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 3.6 t -89.81 114.06 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 6' ' ' LEU . 1.1 mp -96.35 163.92 12.87 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.587 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.16 136.39 48.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.692 -0.63 . . . . 0.0 109.876 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.8 134.22 34.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -70.91 20.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.381 -0.824 . . . . 0.0 112.284 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttt 176.61 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.714 -1.241 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -59.19 102.12 0.12 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' OE1' HG12 ' A' ' 4' ' ' ILE . 10.7 pt-20 -137.21 -177.41 4.76 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.483 0.659 . . . . 0.0 110.121 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -96.39 -177.71 4.05 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.49 121.26 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 56.3 t60 -111.03 -29.3 7.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.697 -0.627 . . . . 0.0 109.344 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -148.08 146.31 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG11 ' CD1' ' A' ' 149' ' ' PHE . 74.3 t -129.28 160.47 40.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.445 0.64 . . . . 0.0 109.751 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 2.7 m-20 -139.28 133.92 31.9 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -157.73 135.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -110.4 135.23 12.72 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -88.04 132.66 34.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.138 -0.625 . . . . 0.0 110.739 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -113.22 58.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.31 -25.33 18.3 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.425 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 15.3 t -57.26 165.77 1.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -1.02 . . . . 0.0 109.908 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.72 -57.82 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.1 m-85 -98.94 118.48 35.79 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.23 114.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.265 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.91 144.43 31.52 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.13 125.41 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.09 161.31 16.65 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.43 151.11 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 0.0 109.96 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -173.25 166.81 39.37 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -115.93 157.12 25.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.981 -0.717 . . . . 0.0 109.552 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 t -88.05 10.42 19.17 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.46 107.56 0.81 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.9 -74.44 0.48 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.4 166.17 12.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.64 -45.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.901 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.08 161.08 11.55 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.55 -26.51 68.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.517 -0.99 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.67 29.43 3.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 0.0 109.707 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.46 28.4 8.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.481 -0.762 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -104.83 -173.53 2.32 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 137.94 54.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.1 t -66.22 87.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.573 -0.705 . . . . 0.0 110.727 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 tp -58.27 -47.76 82.61 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -143.18 120.76 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.393 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.5 m -50.42 174.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 110.587 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -63.91 138.09 58.32 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.573 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.8 p -105.89 123.32 47.78 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -87.67 104.26 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 23.7 m-85 -100.38 -46.55 5.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 mtp -120.16 -170.95 2.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.2 p -126.66 -179.62 0.97 Allowed Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.86 9.42 4.15 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.882 2.388 . . . . 0.0 111.328 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.3 p -114.08 -55.08 2.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -63.0 -20.2 65.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.973 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -56.59 -27.26 57.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.239 -0.913 . . . . 0.0 110.141 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -87.73 -74.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 110.009 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.22 37.52 0.1 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.08 -24.06 35.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -1.004 . . . . 0.0 110.368 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 88.95 35.45 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.13 -18.63 16.23 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.959 2.439 . . . . 0.0 110.27 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.39 115.35 11.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.669 -0.644 . . . . 0.0 109.734 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -144.72 160.31 41.42 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 m -120.94 163.85 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.55 159.12 43.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.39 -0.819 . . . . 0.0 109.374 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.4 mtp -130.08 162.57 28.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.626 -0.671 . . . . 0.0 110.113 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -127.32 165.99 18.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.52 -150.11 5.93 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -75.68 -37.98 1.5 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.655 2.904 . . . . 0.0 110.731 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -65.4 -28.27 69.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.57 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -89.34 1.51 55.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.649 -0.657 . . . . 0.0 110.589 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.21 139.89 53.49 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.037 -1.039 . . . . 0.0 109.921 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.433 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.1 p -59.22 133.4 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -75.8 -29.99 58.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.338 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.32 -23.23 64.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.598 -0.688 . . . . 0.0 109.977 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.433 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -112.29 -45.55 3.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.67 -40.57 28.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.215 -0.928 . . . . 0.0 111.291 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -77.86 -3.03 39.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 110.547 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 26.5 mtpt -90.31 132.92 35.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -67.62 109.59 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.544 0.688 . . . . 0.0 110.73 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 87.3 m95 -109.09 164.03 12.79 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.5 6.63 3.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -145.99 145.9 30.8 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.74 -1.225 . . . . 0.0 107.919 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.432 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.9 p -132.73 142.46 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.348 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.09 116.17 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.754 -0.591 . . . . 0.0 109.797 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 51.4 mm -108.07 119.53 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 t -124.7 122.89 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.138 -0.976 . . . . 0.0 110.708 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.465 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -97.22 142.46 29.09 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -141.6 123.37 15.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.712 -0.618 . . . . 0.0 110.375 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 133' ' ' SER . 35.1 tp60 156.84 123.24 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.53 104.55 1.74 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.682 2.255 . . . . 0.0 108.884 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.442 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 2.0 p90 -132.0 -10.58 3.4 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.568 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.76 126.38 14.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.839 -1.163 . . . . 0.0 109.513 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -110.39 -26.58 9.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.843 -0.536 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.58 -43.66 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 110.262 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.09 145.74 32.38 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.822 -0.549 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.2 Cg_endo -87.03 166.19 8.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.33 2.687 . . . . 0.0 110.409 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -176.85 -165.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.98 -102.63 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.26 155.43 27.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.575 -0.956 . . . . 0.0 110.604 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 23.6 m -89.49 -27.51 20.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.511 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 50.1 p90 -178.09 162.31 1.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.409 ' HA ' HG13 ' A' ' 60' ' ' ILE . 33.6 m -138.64 141.29 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.0 mtp180 -145.79 160.63 41.48 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.478 0.656 . . . . 0.0 110.342 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.432 ' CE2' HG13 ' A' ' 128' ' ' VAL . 54.6 m-85 -142.24 156.88 45.32 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -157.01 136.73 12.37 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.673 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.95 144.85 7.41 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.599 2.866 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.1 169.09 24.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.522 -0.737 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 4' ' ' ILE . 62.2 mt -125.09 123.76 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -105.2 161.02 14.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.733 -0.604 . . . . 0.0 109.658 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.73 151.43 19.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HD3' ' CE1' ' A' ' 8' ' ' HIS . 43.3 ttt85 -103.93 -54.32 2.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 109.383 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.415 ' CE1' ' HD3' ' A' ' 7' ' ' ARG . 4.9 p-80 -160.54 166.49 28.97 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.69 93.97 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.772 . . . . 0.0 109.464 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 p -53.15 -60.13 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.131 -0.981 . . . . 0.0 110.16 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -122.1 155.49 35.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -153.24 105.63 2.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.257 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -105.94 56.46 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 44' ' ' SER . 1.2 p 153.46 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 139.64 47.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.734 -1.229 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.83 148.57 22.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 109.326 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.6 t -61.14 -52.86 63.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.582 -0.699 . . . . 0.0 110.155 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -58.55 8.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.344 -0.847 . . . . 0.0 109.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -110.16 86.99 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -92.29 166.65 12.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.552 0.692 . . . . 0.0 110.359 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.54 -23.52 67.03 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -61.96 -18.44 60.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.339 -0.85 . . . . 0.0 109.724 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -65.27 -17.51 64.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.256 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.09 -25.68 67.9 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 -22.41 50.52 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.491 -0.756 . . . . 0.0 109.002 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -115.36 67.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.51 -25.83 4.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.739 . . . . 0.0 110.6 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -122.03 88.78 3.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 0.0 109.796 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -157.98 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.583 -0.698 . . . . 0.0 109.236 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.413 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 44.2 p90 -178.16 35.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 28.5 mtm180 -157.17 137.53 12.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -120.53 -176.87 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.45 ' CH2' ' CD1' ' A' ' 43' ' ' ILE . 21.7 t90 -78.51 138.18 38.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -141.66 128.32 20.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.21 168.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.691 0.758 . . . . 0.0 111.21 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.52 43.57 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.139 0.495 . . . . 0.0 109.686 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -120.36 -172.16 2.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.2 -165.23 1.1 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.15 45.29 96.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.447 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.3 mp0 -43.74 89.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.487 0.66 . . . . 0.0 112.075 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 39' ' ' GLY . 10.6 pttt -103.02 -44.21 5.29 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 p -160.51 132.36 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' A' ' 132' ' ' CYS . 6.0 pt -137.73 136.03 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.418 -0.801 . . . . 0.0 110.204 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -112.22 140.84 46.59 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.462 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 21' ' ' ALA . 9.2 p -147.41 106.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 10.8 t -91.36 121.53 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.42 168.98 9.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -114.14 148.07 37.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.712 -0.617 . . . . 0.0 109.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.73 137.57 39.87 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.75 40.2 0.51 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.37 -0.831 . . . . 0.0 110.909 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.32 130.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -75.55 110.6 10.07 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.25 -179.49 6.02 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.01 178.14 6.09 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.76 115.71 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -103.4 -30.83 10.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.1 159.03 44.34 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.8 t -141.91 158.23 20.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.48 0.657 . . . . 0.0 109.389 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.13 137.89 34.81 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -158.25 130.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.8 132.33 10.96 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.7 126.72 36.07 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.301 -0.529 . . . . 0.0 110.366 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -97.7 64.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.93 60.26 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.458 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 72.0 m -55.57 158.2 3.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -1.1 . . . . 0.0 110.322 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -119.64 -58.65 1.88 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 133' ' ' SER . 19.5 m-85 -99.61 129.99 45.8 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.946 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.43 111.84 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.629 . . . . 0.0 109.692 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -105.63 146.28 29.9 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.79 126.56 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.57 -0.706 . . . . 0.0 109.84 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -113.59 160.46 18.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 m -121.49 157.82 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.789 -0.569 . . . . 0.0 109.894 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.438 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.18 172.45 42.61 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -114.04 158.78 20.76 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 122.041 -0.682 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -73.43 -4.97 36.91 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.797 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.95 153.98 16.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.1 87.98 0.04 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.2 160.55 16.32 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.31 37.28 20.37 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.538 -0.978 . . . . 0.0 109.517 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.06 -100.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 64.56 140.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.67 -0.9 . . . . 0.0 109.328 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 58.4 21.8 8.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.454 -0.778 . . . . 0.0 109.965 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.09 34.1 3.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.197 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.36 -173.26 2.32 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -121.1 130.58 53.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.28 85.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.366 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.03 -59.81 4.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.411 HD11 ' CE2' ' A' ' 111' ' ' PHE . 1.1 pp -137.8 120.49 16.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.33 179.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.745 . . . . 0.0 110.325 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 134.4 53.58 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.601 -0.687 . . . . 0.0 109.153 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.1 p -107.87 125.85 51.96 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.441 0.639 . . . . 0.0 109.769 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.9 p -83.7 127.83 34.07 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' HD3' ' A' ' 109' ' ' ARG . 22.8 m-85 -120.95 -48.21 2.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 81.4 mtp -121.95 -176.83 3.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.933 0.873 . . . . 0.0 111.352 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -120.55 173.93 3.37 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.57 9.48 4.08 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.911 2.407 . . . . 0.0 111.315 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.0 m -120.77 -35.03 3.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.35 -21.67 35.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.316 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.9 p -58.23 -22.13 50.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -0.805 . . . . 0.0 110.425 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -67.96 -83.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.338 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -162.45 39.2 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.74 -22.38 5.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.26 118.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -1.135 . . . . 0.0 110.396 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.423 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 41.21 77.44 0.43 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.929 -0.482 . . . . 0.0 111.366 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.12 -28.55 2.39 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.05 2.5 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.41 92.85 2.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -123.89 -176.13 3.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.724 . . . . 0.0 109.332 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.7 m -134.6 158.33 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.713 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HD3' ' CG ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.94 159.78 41.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.8 mtm -135.57 166.23 23.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.0 110.295 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.0 m-85 -129.46 169.63 14.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.12 -148.57 5.19 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.7 -39.6 1.31 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.674 2.916 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.37 -28.83 69.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.493 -0.754 . . . . 0.0 109.648 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.59 54.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.658 -0.651 . . . . 0.0 110.598 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.1 pp -123.51 138.76 54.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.05 -1.031 . . . . 0.0 110.38 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 120' ' ' ALA . 9.2 p -59.37 130.34 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -33.44 63.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.786 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.95 66.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.334 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.44 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -116.96 -46.68 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.162 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.73 -38.55 21.92 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.143 -0.973 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.14 0.6 31.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 110.706 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.2 mtpp -92.54 135.81 33.75 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.41 113.2 5.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.744 0.783 . . . . 0.0 110.753 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.452 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.3 m95 -115.84 165.97 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -140.68 15.5 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.132 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -145.5 147.58 32.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.414 HG13 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -137.3 142.14 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.105 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -110.88 108.43 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.668 -0.645 . . . . 0.0 109.729 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.96 127.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.47 115.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.478 ' HB3' HG13 ' A' ' 43' ' ' ILE . 3.1 t -85.55 149.68 25.2 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -148.9 122.9 9.41 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.264 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.605 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 157.73 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.45 94.68 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.008 2.472 . . . . 0.0 110.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.458 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -121.62 -17.55 7.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.0 111.285 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.48 169.49 8.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.462 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 24.9 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.793 -0.567 . . . . 0.0 109.634 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.79 -46.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.6 146.35 32.44 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.58 169.28 8.19 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.432 2.755 . . . . 0.0 110.898 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 179.49 -164.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.86 -105.93 0.26 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.193 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.79 154.67 29.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.937 . . . . 0.0 110.716 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -87.34 -27.99 22.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.521 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 52.6 p90 -179.24 167.67 1.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.514 -0.741 . . . . 0.0 109.509 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.5 m -142.46 131.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -139.07 121.66 16.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.028 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.419 ' CD1' HG11 ' A' ' 58' ' ' VAL . 67.5 m-85 -104.36 156.68 17.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.109 -0.995 . . . . 0.0 109.41 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -150.97 131.28 13.65 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.317 -0.865 . . . . 0.0 109.714 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.704 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.56 58.56 3.99 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.457 2.772 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.6 177.5 10.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 109.309 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.1 mt -117.67 124.71 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -104.78 164.8 11.51 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.455 0.645 . . . . 0.0 110.084 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.53 127.63 43.64 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -82.11 -56.89 3.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.379 -0.825 . . . . 0.0 109.584 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.93 165.1 30.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.659 -0.651 . . . . 0.0 109.409 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.29 90.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.774 . . . . 0.0 109.307 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 p -54.37 -58.28 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.04 143.47 46.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -130.81 124.03 30.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -0.796 . . . . 0.0 109.711 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -124.59 42.24 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.461 ' CB ' ' HB ' ' A' ' 43' ' ' ILE . 1.3 m 153.93 76.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.64 141.46 26.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 108.987 -179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -164.49 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.336 -0.853 . . . . 0.0 109.071 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -64.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -49.22 76.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 109.067 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.04 73.7 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.9 p -91.71 168.86 11.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.503 -0.748 . . . . 0.0 110.095 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -64.67 -23.01 67.12 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.87 -17.49 63.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.8 -17.8 64.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 109.286 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.1 mt -65.17 -24.28 67.34 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -58.54 -22.35 55.22 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.526 -0.734 . . . . 0.0 109.055 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -107.67 61.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.14 -25.23 4.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.425 -0.797 . . . . 0.0 110.708 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.35 76.58 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 p -156.42 -95.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.774 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -178.4 36.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.391 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -141.75 138.02 32.02 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 11.1 mttm -128.66 -178.69 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.422 -0.799 . . . . 0.0 110.807 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.454 ' CZ3' ' CD1' ' A' ' 43' ' ' ILE . 21.8 t90 -80.98 140.46 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.43 129.07 17.13 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.37 150.8 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.496 -0.752 . . . . 0.0 110.909 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.25 -26.56 68.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -169.79 2.09 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.11 178.77 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.73 -30.74 8.78 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 18.4 mm-40 40.67 31.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.969 -0.724 . . . . 0.0 112.526 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -52.94 43.17 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.696 -0.627 . . . . 0.0 109.316 179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 p -160.32 129.43 4.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 13.1 pt -130.2 141.72 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.86 . . . . 0.0 110.322 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 29.5 m -126.06 141.22 52.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.293 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.27 110.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.42 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.09 157.6 16.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -99.89 145.58 27.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 109.834 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 49' ' ' LEU . 4.1 mm? -97.96 140.35 32.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.28 33.81 0.24 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.417 -0.802 . . . . 0.0 111.115 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.4 pttm 161.22 138.39 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 10.0 tt0 -75.16 102.48 4.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 165.74 22.8 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.7 0.762 . . . . 0.0 109.786 -179.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -76.15 -176.96 3.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.93 174.89 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.403 -0.81 . . . . 0.0 108.891 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -172.53 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.506 -0.746 . . . . 0.0 109.199 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -145.27 145.76 31.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 ' CD1' ' A' ' 149' ' ' PHE . 83.5 t -130.64 163.36 36.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.665 0.745 . . . . 0.0 110.31 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 148' ' ' ARG . 11.8 t0 -133.5 131.97 40.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.46 129.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -99.36 122.71 7.66 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.92 117.92 17.3 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 122.13 -0.629 . . . . 0.0 110.145 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -102.2 73.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.95 21.91 72.91 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 -177.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.474 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 1.8 p -96.98 152.89 18.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.998 . . . . 0.0 109.857 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.36 -54.79 2.56 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.6 132.3 52.76 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.52 -0.738 . . . . 0.0 109.969 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.39 112.16 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.832 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -107.54 146.52 31.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.749 -0.595 . . . . 0.0 109.546 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.6 128.85 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.602 -0.686 . . . . 0.0 109.933 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.03 158.84 21.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.6 154.48 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.47 173.36 46.02 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 t -114.71 155.47 26.59 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.98 -0.718 . . . . 0.0 109.831 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.9 p -63.67 -14.0 48.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.36 150.08 46.99 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.39 -0.819 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.95 -96.18 0.75 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.25 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.57 -55.12 16.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.569 -0.96 . . . . 0.0 109.554 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.75 51.67 3.96 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -110.72 -62.88 1.47 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.62 -0.93 . . . . 0.0 109.358 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -100.99 30.66 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -116.16 30.3 7.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.702 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.05 154.07 35.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.21 145.06 32.04 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.73 84.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.581 -0.7 . . . . 0.0 110.751 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.403 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.7 tp -57.57 -59.62 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.428 HD12 ' CE2' ' A' ' 111' ' ' PHE . 1.8 pp -136.05 121.44 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.312 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.8 m -54.07 -179.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.663 -0.648 . . . . 0.0 110.178 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.14 135.31 51.93 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.241 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -104.62 127.69 52.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -85.33 95.72 9.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 16.6 m-85 -87.3 -52.43 5.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.591 -0.693 . . . . 0.0 109.693 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.3 mtp -120.68 -172.65 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.654 -0.654 . . . . 0.0 110.187 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 p -120.12 179.72 0.85 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.88 13.25 2.8 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.154 2.569 . . . . 0.0 111.47 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -53.26 2.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -63.68 -16.03 59.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 110.153 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -56.72 -21.01 24.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.828 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -87.6 0.13 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.181 -0.95 . . . . 0.0 110.362 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -162.03 38.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.102 -0.999 . . . . 0.0 108.655 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.35 -20.72 24.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.89 -79.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -1.036 . . . . 0.0 110.52 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.36 88.26 25.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.95 -20.54 10.16 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 123.032 2.488 . . . . 0.0 110.622 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.1 128.64 40.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.65 -0.656 . . . . 0.0 109.852 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.85 172.73 17.94 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.2 m -140.16 136.59 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.382 -0.824 . . . . 0.0 109.399 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 mmp_? -133.86 -179.23 5.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 110.282 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 mtm -141.99 178.34 7.59 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.391 0.615 . . . . 0.0 109.675 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.5 m-85 -135.43 166.82 22.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.03 -153.86 5.99 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . 38.1 Cg_endo -74.3 -27.93 10.99 Favored 'Trans proline' 0 N--CA 1.504 2.136 0 C-N-CA 123.58 2.853 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.87 -42.45 62.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.9 9.54 30.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 111.165 -179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -116.36 122.19 44.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 108.536 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.448 ' CG1' ' CB ' ' A' ' 120' ' ' ALA . 7.6 p -50.0 134.49 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.783 -0.573 . . . . 0.0 110.77 -177.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -69.2 -41.09 77.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.557 -0.714 . . . . 0.0 109.357 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.47 78.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 110.508 -179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.448 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -93.17 -35.25 13.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.448 -0.783 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . . . -46.62 -30.72 2.44 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.518 -0.739 . . . . 0.0 110.789 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 16.75 24.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.485 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 4.3 mmtm -96.77 132.11 42.81 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -66.06 103.66 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.191 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.407 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 69.8 m95 -108.09 150.03 27.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t0 -128.84 4.12 5.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.697 -0.627 . . . . 0.0 109.694 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -141.76 149.58 40.63 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' A' ' 149' ' ' PHE . 5.8 p -140.36 140.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.187 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -106.16 116.74 32.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.703 -0.623 . . . . 0.0 109.747 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.59 111.55 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 40.9 t -119.58 120.33 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 43.0 t -95.68 149.03 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -142.94 130.66 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.459 -0.775 . . . . 0.0 111.19 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.8 OUTLIER 149.48 129.07 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.751 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.406 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.24 100.38 0.7 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.831 2.354 . . . . 0.0 109.659 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.511 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 1.2 p90 -131.66 40.35 3.4 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.739 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 -168.84 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -106.84 -35.84 6.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.07 142.21 24.55 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.5 Cg_endo -85.93 -176.1 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.174 2.582 . . . . 0.0 110.82 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 178.76 -162.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.616 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.14 -112.89 0.56 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.471 -1.347 . . . . 0.0 111.099 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 mp -114.2 158.86 20.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.567 -0.961 . . . . 0.0 110.75 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 2.4 m -97.62 -28.45 13.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 122.042 -0.411 . . . . 0.0 109.958 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.532 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 43.5 p90 -176.38 171.88 2.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.693 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.7 m -150.17 137.6 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.695 -0.628 . . . . 0.0 109.493 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 11.3 mmm-85 -144.04 108.55 4.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.531 -0.731 . . . . 0.0 109.102 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.443 ' CD1' HG11 ' A' ' 58' ' ' VAL . 56.1 m-85 -87.31 155.03 20.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.338 -0.852 . . . . 0.0 109.354 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.46 124.93 6.34 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.495 -0.753 . . . . 0.0 109.363 178.715 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.67 -0.644 . . . . 0.0 110.474 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 4.9 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.1 Cg_endo -82.15 -27.68 2.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.913 2.409 . . . . 0.0 110.473 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.36 168.47 11.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -142.27 146.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 167.04 15.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.933 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.61 136.8 35.54 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.722 -0.611 . . . . 0.0 109.461 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -92.6 -56.42 3.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.805 . . . . 0.0 109.104 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.429 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 4.1 p-80 -161.33 162.99 31.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.14 91.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 109.165 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -50.79 -55.99 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.317 -0.864 . . . . 0.0 110.47 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.14 153.37 38.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.415 -0.803 . . . . 0.0 109.372 -179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.74 120.36 17.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.424 -0.798 . . . . 0.0 109.509 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.8 m -123.56 42.02 3.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.465 ' CB ' ' HB ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER 152.75 72.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.321 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.48 140.95 43.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.336 -0.852 . . . . 0.0 109.431 -179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -165.92 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -101.74 -55.51 2.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -42.78 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -121.34 80.36 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.3 p -91.5 168.78 11.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.594 0.712 . . . . 0.0 110.042 -179.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.12 -24.32 67.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.928 -0.483 . . . . 0.0 109.993 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.37 -18.54 61.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 109.835 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -65.37 -17.27 64.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.91 -24.85 67.65 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.97 -22.46 49.29 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.498 -0.751 . . . . 0.0 109.039 178.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.2 65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.57 -24.41 13.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.394 -0.816 . . . . 0.0 110.406 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.33 81.36 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.634 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -158.1 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.437 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -177.84 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -158.39 167.7 28.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.553 -0.717 . . . . 0.0 109.446 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -160.32 -157.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.673 -0.642 . . . . 0.0 109.565 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.447 ' CZ2' ' HB ' ' A' ' 45' ' ' VAL . 15.5 t90 -93.69 140.45 29.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.083 -1.01 . . . . 0.0 110.379 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -146.83 123.06 10.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.85 154.6 0.69 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.451 -0.781 . . . . 0.0 111.399 -178.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.66 -30.04 70.21 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -123.45 -172.1 2.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.73 -162.38 0.93 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.75 43.34 94.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 3.8 mm-40 -48.14 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.986 0.898 . . . . 0.0 111.364 -179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 39' ' ' GLY . 8.8 pttp -111.62 -44.82 3.44 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.1 p -160.39 119.87 2.76 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 11.4 pt -128.02 147.39 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.507 -0.746 . . . . 0.0 109.355 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 31.5 m -128.23 147.6 50.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.661 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 11.0 p -154.29 117.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 t -95.53 130.14 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.218 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.61 167.4 9.94 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 12.2 tm0? -121.6 118.62 29.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.734 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 4.1 mm? -71.0 138.46 49.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -81.15 36.53 0.41 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.766 -0.584 . . . . 0.0 110.133 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 pttt 166.73 129.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.44 109.47 9.02 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.42 176.28 9.12 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -86.35 -174.24 4.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.0 mp -141.26 130.29 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.741 . . . . 0.0 109.39 179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -119.57 -25.08 6.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -149.87 140.24 22.33 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 149' ' ' PHE . 55.2 t -125.04 160.71 30.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -140.74 135.06 31.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.506 -0.746 . . . . 0.0 109.416 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.405 ' CD1' HG13 ' A' ' 58' ' ' VAL . 1.4 mp -155.96 131.84 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -107.94 120.83 6.16 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.017 -1.564 . . . . 0.0 110.264 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.75 142.57 53.24 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.458 0.647 . . . . 0.0 111.11 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 23.8 t0 -127.13 56.25 1.53 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.96 12.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t -57.75 170.16 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -1.006 . . . . 0.0 109.73 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 134' ' ' GLN . . . -135.16 -56.83 0.81 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 24.3 m-85 -100.04 133.41 44.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.281 179.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.74 107.51 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.944 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -97.34 129.8 44.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.404 ' HB ' ' CG ' ' A' ' 88' ' ' LEU . 37.8 t -122.18 124.4 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.762 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.61 163.0 14.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.67 160.18 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.453 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.15 177.52 46.13 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 t -116.25 158.69 22.95 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.069 -0.665 . . . . 0.0 109.44 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -80.23 3.56 20.43 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.806 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.37 157.04 3.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 110.114 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.02 104.12 0.69 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.08 -152.76 5.81 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.54 -43.39 80.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.985 . . . . 0.0 109.481 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.4 -118.61 3.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -69.5 -25.07 63.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.947 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -97.27 35.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 109.64 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.48 36.99 3.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.71 . . . . 0.0 109.566 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -113.17 -176.26 2.86 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -129.06 132.16 47.41 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.258 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 t -62.31 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.685 -0.634 . . . . 0.0 110.453 -178.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 117' ' ' VAL . 12.0 tp -60.13 -51.68 68.57 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -142.44 123.55 14.57 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.63 -173.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.886 -0.509 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.74 125.64 25.41 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 86.9 p -99.6 121.95 41.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -88.76 121.45 31.15 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 23.5 m-85 -120.58 -43.67 2.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.422 -0.798 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.0 mtp -120.22 -178.1 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.487 -0.758 . . . . 0.0 110.509 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -115.29 177.16 1.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.05 11.9 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.201 2.601 . . . . 0.0 111.251 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.48 -54.15 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.337 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -61.04 -18.42 57.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 110.429 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.7 t -54.82 -36.09 64.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.756 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -72.14 -82.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.037 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -162.85 37.49 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.37 -22.41 47.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.48 -77.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.958 . . . . 0.0 110.409 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -117.18 88.82 28.69 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -77.23 -19.87 13.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.976 2.451 . . . . 0.0 110.261 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.87 135.06 29.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.754 -0.591 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.02 150.51 18.74 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.567 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 13.0 m -106.83 165.13 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 110.2 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -154.12 156.05 36.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.261 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.7 mtp -127.95 166.9 17.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.721 -179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 3.1 m-85 -131.61 159.08 39.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -132.64 -149.42 6.22 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.57 -39.76 1.32 Allowed 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 123.738 2.959 . . . . 0.0 110.594 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.72 -27.13 68.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.715 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 3.1 55.8 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.641 -0.662 . . . . 0.0 110.547 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 2.4 pp -122.96 139.35 54.16 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.92 -1.112 . . . . 0.0 110.392 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.441 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.5 p -60.17 130.57 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.12 61.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.708 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -21.39 65.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -115.86 -46.58 2.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.95 -38.08 21.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.151 -0.968 . . . . 0.0 111.51 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -82.05 2.78 29.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.338 -0.851 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.5 mttt -93.7 134.9 35.53 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -66.51 113.65 4.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.443 -0.786 . . . . 0.0 110.546 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 73.6 m95 -117.78 162.85 17.4 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.64 14.15 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.147 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -148.72 151.22 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 149' ' ' PHE . 9.5 p -141.85 145.21 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 110.367 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.57 117.58 34.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.486 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 50.0 mm -107.93 119.19 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.599 -0.688 . . . . 0.0 109.534 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 48.2 t -128.09 119.94 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.137 -0.977 . . . . 0.0 110.687 -179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.426 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.93 148.15 23.3 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -145.47 126.65 14.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 111.199 -179.091 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.465 ' CB ' ' HB1' ' A' ' 66' ' ' ALA . 0.4 OUTLIER 150.23 134.58 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.416 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.42 97.85 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.995 2.463 . . . . 0.0 109.965 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.6 p90 -128.77 14.49 6.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.0 110.81 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.03 -166.33 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -176.27 -42.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -113.27 -33.09 6.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.71 -0.619 . . . . 0.0 109.676 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.27 149.84 38.18 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.891 -0.505 . . . . 0.0 109.693 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.413 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.9 Cg_endo -85.52 -178.63 3.1 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.372 2.715 . . . . 0.0 110.285 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 179.88 -164.1 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.03 -112.89 0.54 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -135.47 162.04 33.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.325 -1.103 . . . . 0.0 110.251 178.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 2.7 m -82.24 -18.52 42.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.809 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.586 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 179.88 163.37 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.32 -0.863 . . . . 0.0 109.92 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.54 142.25 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -147.63 165.01 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.744 0.783 . . . . 0.0 110.524 -178.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.426 ' CD1' HG11 ' A' ' 58' ' ' VAL . 60.7 m-85 -145.28 154.61 42.54 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -158.63 145.94 17.72 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.087 -1.008 . . . . 0.0 109.283 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 -179.255 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -89.64 20.96 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.661 2.908 . . . . 0.0 111.234 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -153.96 -170.83 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.904 . . . . 0.0 109.253 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.4 HG12 ' CA ' ' A' ' 150' ' ' HIS . 48.4 mm -112.56 154.48 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -134.94 120.69 19.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.571 -0.706 . . . . 0.0 109.638 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -82.55 150.91 26.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.511 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -110.86 -53.28 2.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.69 166.24 29.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.655 -0.653 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.68 89.65 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.32 -55.89 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.258 -0.901 . . . . 0.0 110.777 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.29 152.49 40.02 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.12 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -144.27 121.82 11.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 109.813 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -118.25 45.52 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.639 -0.663 . . . . 0.0 109.878 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 13' ' ' SER . 0.8 OUTLIER 152.19 73.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.44 142.33 39.5 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.244 -0.91 . . . . 0.0 109.448 -179.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.38 -162.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.469 -0.769 . . . . 0.0 109.333 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -97.55 -57.9 2.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.58 -0.7 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -65.66 0.7 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -88.77 67.7 8.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.3 p -86.44 171.32 11.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' A' ' 33' ' ' TRP . . . -62.61 -24.7 67.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.02 -19.4 61.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 109.688 179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -65.76 -16.68 64.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 109.323 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.9 mt -65.02 -25.66 67.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.17 -22.74 52.74 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 65.28 0.67 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.36 -24.69 8.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.352 -0.842 . . . . 0.0 110.528 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -119.53 81.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.807 . . . . 0.0 109.816 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.4 -88.08 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.424 -0.798 . . . . 0.0 109.502 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 42.8 p90 -177.6 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.006 -1.059 . . . . 0.0 110.187 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 4.9 mtm180 -157.47 142.67 17.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.5 -0.75 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.72 -159.47 0.93 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.347 -179.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.454 ' CZ2' ' HB ' ' A' ' 45' ' ' VAL . 20.4 t90 -94.32 139.33 31.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.238 -0.913 . . . . 0.0 109.433 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -144.41 129.39 18.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.17 156.08 1.18 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.38 -23.99 65.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.845 -0.534 . . . . 0.0 110.202 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -136.45 -173.72 3.49 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.52 -164.27 1.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.45 45.89 88.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.6 mt-10 -54.79 84.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.694 0.759 . . . . 0.0 111.142 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 39' ' ' GLY . 42.1 tttm -91.29 -52.28 4.89 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 16.0 p -159.09 121.9 3.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.433 ' HB ' ' CB ' ' A' ' 14' ' ' SER . 19.0 pt -120.23 151.47 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.11 150.36 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.437 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' HB ' ' CZ2' ' A' ' 33' ' ' TRP . 8.0 p -155.16 107.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 t -91.39 118.44 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.26 153.29 17.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -104.25 134.09 48.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.673 . . . . 0.0 109.715 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.0 mt -90.17 134.79 34.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.07 43.85 0.73 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 110.448 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 pttt 166.94 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -74.94 106.37 6.42 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 -178.33 5.11 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -96.48 175.48 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.75 120.34 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -107.68 -31.33 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 m -146.15 155.12 42.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 149' ' ' PHE . 69.6 t -138.39 157.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.666 . . . . 0.0 109.548 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m-20 -139.44 138.38 36.41 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -159.05 135.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -115.0 134.79 11.85 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -112.5 151.46 29.92 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 122.149 -0.618 . . . . 0.0 110.707 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -102.12 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.23 24.83 29.65 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 178.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.417 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 59.6 m -77.35 -174.45 3.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.517 -0.99 . . . . 0.0 109.831 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' SER . . . -147.2 -57.53 0.26 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.6 m-85 -99.25 135.28 40.88 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.929 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 86.1 t -141.74 109.21 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.479 0.656 . . . . 0.0 109.685 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -99.78 139.23 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 88' ' ' LEU . 18.5 t -124.4 124.28 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.461 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -113.32 164.06 14.04 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.3 m -128.67 160.69 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.689 -0.632 . . . . 0.0 109.817 -179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.23 175.86 43.02 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 t -113.83 158.46 20.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -89.57 11.3 20.0 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 107.92 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.26 -86.12 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.6 163.19 9.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 59.99 35.83 21.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.993 . . . . 0.0 109.67 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 98.94 2.5 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -115.89 -58.76 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.927 . . . . 0.0 109.412 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -98.92 32.14 2.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.661 -0.649 . . . . 0.0 109.401 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -124.49 38.05 4.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.482 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -108.05 -175.12 2.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -121.37 127.9 51.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.917 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.2 85.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.77 -0.581 . . . . 0.0 110.274 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HA ' HG11 ' A' ' 117' ' ' VAL . 11.9 tp -57.79 -53.88 53.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -143.81 122.66 12.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.257 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.35 -179.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 110.528 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 129.76 41.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.297 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.403 ' OG ' ' CE1' ' A' ' 93' ' ' PHE . 4.0 p -98.62 128.72 45.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 8.5 p -90.09 89.71 7.8 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CE2' ' CG2' ' A' ' 68' ' ' VAL . 6.8 m-85 -73.45 -57.81 3.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.341 -0.85 . . . . 0.0 109.607 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.2 mtm -121.3 -164.06 1.1 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.469 0.652 . . . . 0.0 110.187 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 5.8 p -130.64 -176.79 0.58 Allowed Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 41.6 Cg_endo -85.59 18.96 1.47 Allowed 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 123.086 2.524 . . . . 0.0 111.467 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.7 t -120.12 -40.71 2.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.12 -27.02 26.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.4 p -56.85 -22.26 35.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.512 -0.743 . . . . 0.0 110.475 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -83.87 -85.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.38 -0.825 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -163.01 38.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.37 -23.31 19.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.25 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.985 . . . . 0.0 110.579 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -119.48 95.26 49.16 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.45 -17.99 7.25 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.172 2.582 . . . . 0.0 110.155 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.47 128.93 30.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.787 -0.571 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.26 145.7 15.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 16.0 m -98.71 -179.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 109.983 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.76 148.49 17.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.867 . . . . 0.0 109.407 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.8 mtt -127.15 157.39 39.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.491 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 1.8 m-85 -128.82 166.49 18.95 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -137.22 -150.63 5.79 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.4 Cg_endo -75.51 -37.86 1.62 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.747 2.965 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -65.58 -26.52 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.464 -0.773 . . . . 0.0 109.6 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.94 1.97 56.84 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.643 -0.661 . . . . 0.0 110.663 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -121.57 138.93 54.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.956 -1.09 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 HG12 ' CB ' ' A' ' 120' ' ' ALA . 8.2 p -58.25 130.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 -30.98 61.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 109.602 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -21.56 66.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.22 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.435 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -115.93 -46.24 2.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.304 -0.873 . . . . 0.0 110.104 -179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' CB ' ' CD1' ' A' ' 116' ' ' LEU . . . -48.65 -40.49 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.138 -0.976 . . . . 0.0 111.583 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -0.16 31.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.266 -0.896 . . . . 0.0 110.528 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.7 mtpp -91.0 133.93 34.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.95 112.58 4.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.636 0.731 . . . . 0.0 110.804 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 75.8 m95 -115.43 165.44 12.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.35 10.25 3.22 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.491 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -144.45 149.08 35.42 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -134.47 142.46 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.909 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -109.65 113.33 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 -179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 48.9 mm -106.93 123.73 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.46 121.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.275 -0.891 . . . . 0.0 110.533 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.427 ' HB3' HG13 ' A' ' 43' ' ' ILE . 1.7 t -93.25 144.57 25.18 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -145.05 124.29 12.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 111.693 -178.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.6 OUTLIER 161.99 113.26 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.035 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.93 102.7 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.563 2.175 . . . . 0.0 110.305 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.462 ' CD2' ' HB3' ' A' ' 134' ' ' GLN . 1.5 p90 -134.16 -9.06 2.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.539 -0.726 . . . . 0.0 112.137 -178.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -172.3 2.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.955 -1.091 . . . . 0.0 110.263 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -170.61 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.95 -31.9 6.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.66 -0.65 . . . . 0.0 109.683 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.67 148.08 37.04 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.845 -0.534 . . . . 0.0 109.719 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.91 -177.43 2.23 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.341 2.694 . . . . 0.0 110.539 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.49 -163.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 -128.09 2.08 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.508 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -119.59 162.38 19.04 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.354 -1.086 . . . . 0.0 110.17 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 m -84.91 -14.97 46.07 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.523 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 50.9 p90 171.65 169.05 0.09 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.204 -0.935 . . . . 0.0 109.936 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.1 143.32 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -149.57 167.31 26.69 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 110.59 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.425 ' CE2' HG13 ' A' ' 128' ' ' VAL . 62.6 m-85 -149.61 158.69 44.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -155.04 123.18 5.87 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 0.0 109.74 179.386 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.721 ' CG2' HD12 ' A' ' 49' ' ' LEU . 40.2 mm -123.81 133.97 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.39 126.88 50.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.5 mp -79.57 155.14 28.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.141 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.01 -56.14 2.43 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -160.58 165.1 31.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.51 93.22 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.4 p -54.07 -54.61 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.24 -0.912 . . . . 0.0 110.339 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.78 150.99 40.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.484 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 p -137.9 121.19 16.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 m -124.47 41.54 3.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.537 -0.727 . . . . 0.0 109.407 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.672 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 154.4 73.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.81 140.63 29.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 108.744 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.49 -163.06 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 109.084 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -96.47 -63.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -57.57 10.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.52 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 5.6 m-70 -98.16 77.64 2.44 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -97.11 169.32 9.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.813 0.815 . . . . 0.0 110.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.07 -23.98 67.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.925 -0.484 . . . . 0.0 109.777 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 9' ' ' VAL . 7.5 tt0 -60.38 -19.29 55.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -65.59 -16.47 63.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 0.0 109.28 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.2 mt -64.93 -26.6 68.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -61.2 -19.89 62.14 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.492 -0.755 . . . . 0.0 109.004 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -119.99 73.61 0.98 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . . . -44.86 -60.44 2.05 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.705 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.33 -116.34 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p 50.47 -107.78 0.3 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.818 -1.176 . . . . 0.0 109.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -179.02 37.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 109.92 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 0.4 OUTLIER -148.8 149.67 31.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.532 -0.73 . . . . 0.0 109.461 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 15.4 mttt -131.69 -161.22 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.716 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.9 t90 -90.65 140.53 29.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 109.096 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 132.06 26.18 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.29 155.52 3.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.419 -0.801 . . . . 0.0 110.124 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.69 -21.65 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.798 -0.564 . . . . 0.0 110.182 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -141.67 -174.18 3.99 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.325 -0.86 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.2 -164.56 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.44 46.37 92.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -54.39 83.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.429 0.633 . . . . 0.0 111.529 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -91.9 -44.59 8.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.825 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.7 p -161.39 134.13 6.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.716 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.9 pt -132.34 142.2 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.239 -0.913 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.591 ' OG ' HG22 ' A' ' 131' ' ' VAL . 19.8 m -126.82 147.79 50.0 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.515 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.794 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.6 p -156.05 118.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.789 HG22 ' HG3' ' A' ' 129' ' ' LYS . 14.7 t -97.57 125.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -103.32 150.89 23.34 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -93.19 146.25 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.3 mm? -101.12 123.97 46.1 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.45 -2.6 0.07 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.448 -0.783 . . . . 0.0 112.112 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.99 135.75 3.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 109.132 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -75.57 111.71 11.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CD ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -142.77 -177.98 5.58 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.297 0.57 . . . . 0.0 109.478 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.57 158.98 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.5 mp -113.08 124.07 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -113.83 -30.0 6.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 109.764 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.9 m -148.99 156.79 42.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 109.084 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 t -144.43 154.56 14.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.416 0.627 . . . . 0.0 109.833 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -139.15 101.64 4.32 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.565 HG23 HD23 ' A' ' 144' ' ' LEU . 5.0 mt -126.32 141.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -113.13 137.8 14.49 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -85.27 139.2 31.81 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 122.302 -0.528 . . . . 0.0 110.002 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -111.71 65.83 0.63 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.1 29.4 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 14.9 m -60.5 178.0 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.974 . . . . 0.0 110.152 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -135.94 -50.17 0.7 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -102.32 132.36 48.34 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.6 t -134.84 108.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.503 -0.748 . . . . 0.0 110.083 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -102.51 145.51 29.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG13 HD13 ' A' ' 130' ' ' ILE . 21.4 t -132.02 128.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.097 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 86' ' ' VAL . 3.0 mp -113.08 159.93 18.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 HD13 ' A' ' 87' ' ' LEU . 4.6 m -121.52 155.45 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.66 -0.65 . . . . 0.0 110.213 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.97 170.81 43.82 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 t -115.89 170.45 8.46 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.788 0.804 . . . . 0.0 110.144 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.4 p -76.24 -0.94 24.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 110.444 -179.67 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.255 0.55 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -119.66 151.72 38.26 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.73 144.22 40.02 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.352 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 71' ' ' LEU . 23.0 t -62.99 88.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.659 -0.651 . . . . 0.0 111.172 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG11 ' A' ' 72' ' ' VAL . 12.7 tp -61.16 -45.49 94.41 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.6 pp -146.58 124.83 12.21 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.39 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.613 ' O ' HD12 ' A' ' 88' ' ' LEU . 30.6 m -55.46 -175.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.726 -0.609 . . . . 0.0 110.118 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.58 133.31 45.66 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.54 -0.725 . . . . 0.0 109.404 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.1 p -98.26 125.07 43.19 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.2 p -91.48 102.97 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 23.7 m-85 -99.04 -47.02 5.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.375 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.442 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 51.2 mtp -120.08 -157.48 0.71 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.733 -0.604 . . . . 0.0 109.502 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 4.9 p -159.41 -170.86 0.26 Allowed Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 49.6 Cg_endo -81.8 8.48 4.43 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.742 1.628 . . . . 0.0 110.431 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -83.2 -37.55 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.39 -34.61 72.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 t -73.64 -7.27 51.29 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.69 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -109.0 -52.39 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.533 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -120.94 35.86 4.76 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.141 -0.975 . . . . 0.0 111.692 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.07 6.68 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.175 -0.953 . . . . 0.0 111.849 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.93 89.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 p30 48.99 82.03 0.25 Allowed Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.442 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.9 Cg_endo -77.49 -25.9 7.73 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 123.542 2.828 . . . . 0.0 110.977 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.8 109.39 10.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.143 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.1 169.87 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.8 m -138.37 165.73 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 0.0 109.51 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 161.89 33.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.027 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 mtm -123.25 164.47 18.68 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.311 0.577 . . . . 0.0 110.156 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.5 m-85 -132.26 101.78 5.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -80.13 -148.22 5.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.559 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.9 Cg_endo -75.05 -34.18 3.98 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.385 2.724 . . . . 0.0 110.759 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.18 -27.7 68.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.563 -0.711 . . . . 0.0 110.036 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 4.2 mtmt -94.48 4.3 54.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.657 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -126.95 142.71 51.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.953 -1.092 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.9 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -62.65 137.4 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -33.76 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.48 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.72 -22.9 67.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.738 . . . . 0.0 110.191 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.9 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -111.81 -46.99 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.373 -0.829 . . . . 0.0 110.199 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.17 -35.36 16.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.25 -0.906 . . . . 0.0 111.259 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 0.5 47.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 110.602 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.4 mttm -93.43 135.54 34.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -69.33 110.46 4.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 0.0 111.02 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.2 m95 -113.35 162.24 16.3 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.5 12.22 2.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.072 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.547 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.7 mtt180 -142.34 142.25 32.45 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.6 p -139.01 141.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.352 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.789 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.4 tttt -104.08 118.45 36.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.77 -0.581 . . . . 0.0 109.765 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 HG13 ' A' ' 70' ' ' VAL . 47.5 mm -107.33 119.34 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.591 HG22 ' OG ' ' A' ' 44' ' ' SER . 47.0 t -126.2 121.34 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.133 -0.98 . . . . 0.0 110.59 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.415 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -93.56 155.82 17.08 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.825 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -154.06 123.97 6.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.258 -0.901 . . . . 0.0 111.898 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' SER . 1.7 tm0? 162.04 114.88 0.01 OUTLIER Pre-proline 0 N--CA 1.503 2.198 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.05 103.4 1.74 Allowed 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 122.636 2.224 . . . . 0.0 110.361 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 134' ' ' GLN . 2.0 p90 -135.2 -19.39 1.72 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.518 -0.738 . . . . 0.0 112.291 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 -175.27 2.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 0.0 110.379 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -163.18 -43.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.18 -34.73 6.29 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.544 0.688 . . . . 0.0 109.457 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 143.16 26.04 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.69 -172.06 0.78 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.141 2.561 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 176.8 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.77 -121.39 1.02 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.859 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.565 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -114.17 158.39 21.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.752 -0.852 . . . . 0.0 110.1 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 4.1 m -92.49 -26.94 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 39.4 p90 -176.66 167.27 2.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 60' ' ' ILE . 27.2 m -147.02 122.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.691 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 14.6 mmm180 -132.54 110.0 10.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 110.205 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 128' ' ' VAL . 41.1 m-85 -88.8 154.77 20.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 108.787 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 122.72 8.6 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.668 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 151' ' ' SER . 78.2 mt -140.63 125.99 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -107.8 154.12 21.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.783 -0.573 . . . . 0.0 109.653 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.657 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.2 mp -89.52 152.53 21.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.748 -0.595 . . . . 0.0 109.508 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -102.02 -56.46 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -160.86 165.24 30.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -79.97 91.05 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 109.098 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -53.95 -57.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.183 -0.948 . . . . 0.0 110.405 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -118.4 147.15 43.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -132.11 133.69 44.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.01 38.76 3.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 109.82 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.573 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.73 74.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -134.87 147.57 49.9 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.5 149.54 24.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.409 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -60.27 -61.02 2.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.465 -0.772 . . . . 0.0 109.967 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.412 ' HB ' ' CD2' ' A' ' 19' ' ' HIS . 0.2 OUTLIER -59.2 -44.51 92.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 29.7 m-70 -118.74 84.67 2.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -95.8 167.26 11.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.595 0.712 . . . . 0.0 110.277 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.729 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.75 -23.34 67.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.32 -18.38 58.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.727 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -64.47 -18.67 64.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 147' ' ' VAL . 9.6 mt -65.29 -26.98 68.31 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -60.12 -20.9 60.53 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.529 -0.732 . . . . 0.0 109.089 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -107.31 62.95 0.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.39 -25.26 5.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.405 -0.809 . . . . 0.0 110.57 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t0 -118.46 81.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 109.831 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -156.54 -82.74 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.421 -0.8 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -177.88 -38.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.926 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -86.5 166.99 15.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.57 -0.706 . . . . 0.0 110.007 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.66 -160.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.724 ' CH2' HD12 ' A' ' 43' ' ' ILE . 18.6 t90 -81.74 139.67 34.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 19' ' ' HIS . 1.2 mtt180 -146.14 127.04 14.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.52 152.98 1.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.654 0.74 . . . . 0.0 111.041 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -61.56 -23.85 66.25 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.008 -0.433 . . . . 0.0 110.127 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 -174.93 3.95 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.992 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.58 -164.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.72 -0.612 . . . . 0.0 109.427 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.8 44.77 91.54 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 2.6 mm-40 -48.04 89.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.756 0.789 . . . . 0.0 111.625 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.1 tttm -97.69 -57.35 2.26 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.618 HG22 ' OG ' ' A' ' 133' ' ' SER . 41.0 p -155.85 122.57 5.26 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 33' ' ' TRP . 12.8 pt -124.03 147.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 131' ' ' VAL . 12.9 m -129.37 144.63 51.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.076 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.729 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.9 p -151.74 116.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.3 t -97.03 121.17 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.657 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 mp -104.03 149.97 24.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.38 156.73 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.644 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.453 HD12 ' CA ' ' A' ' 126' ' ' ASP . 48.6 mt -106.76 125.39 50.94 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -51.73 -9.3 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.381 -0.825 . . . . 0.0 112.253 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -161.11 140.64 10.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 0.0 109.138 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.2 111.48 10.49 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -145.73 178.72 7.94 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -85.51 -172.93 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.41 122.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.412 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -113.32 -28.45 7.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.2 m -149.29 160.69 43.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 63.4 t -146.38 160.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.326 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -131.55 130.74 42.67 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 59' ' ' ASP . 26.2 mm -139.31 118.42 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.41 116.46 4.33 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 24.3 m-80 -82.54 118.32 23.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.974 -0.721 . . . . 0.0 110.517 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 60.58 2.15 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.09 85.76 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.425 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 69.3 m -59.13 162.16 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -123.37 -55.84 1.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.7 m-85 -102.99 118.97 38.0 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.616 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 HG21 ' A' ' 60' ' ' ILE . 50.7 t -122.24 109.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.15 143.66 32.63 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.752 HG13 HD13 ' A' ' 130' ' ' ILE . 11.0 t -133.1 124.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.87 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -111.34 163.23 14.19 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.0 m -127.94 161.79 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.684 -0.635 . . . . 0.0 109.861 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 174.26 176.08 42.36 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -110.9 158.83 18.3 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 t -88.9 11.33 18.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.4 m-85 -88.84 -175.73 4.97 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -123.52 129.74 51.66 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -63.17 86.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.596 -0.69 . . . . 0.0 109.963 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 117' ' ' VAL . 24.6 tp -59.45 -59.59 5.21 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.549 HD11 HG23 ' A' ' 70' ' ' VAL . 1.5 pp -136.36 121.09 18.49 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.308 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.13 -179.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.697 -0.627 . . . . 0.0 110.602 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.69 131.77 46.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 p -99.31 117.52 33.93 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.775 -0.578 . . . . 0.0 109.764 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -75.02 69.43 1.93 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.443 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 36.4 t80 -59.48 -58.46 8.51 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.851 -0.53 . . . . 0.0 110.437 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 82.5 mtp -120.83 -177.19 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.737 0.78 . . . . 0.0 110.925 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.6 p -111.98 -179.43 0.64 Allowed Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.42 ' HB3' ' NE2' ' A' ' 134' ' ' GLN . 46.6 Cg_endo -86.02 12.24 3.09 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.999 2.466 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.8 p -120.77 -48.96 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 109.535 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.9 -7.33 50.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 87.4 p -83.21 -20.73 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.716 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -73.88 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 t -161.99 38.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 108.937 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.41 -24.19 6.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.49 117.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.443 -1.033 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.68 72.61 1.01 Allowed Pre-proline 0 N--CA 1.508 2.446 0 O-C-N 121.801 -0.562 . . . . 0.0 111.393 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 41.3 Cg_endo -79.27 -30.16 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.88 2.387 . . . . 0.0 109.958 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -128.06 112.45 14.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -168.25 2.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 67.1 t -121.29 163.04 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 108' ' ' VAL . 28.3 tpt180 -145.97 124.55 12.48 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtp -109.95 154.01 23.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -0.785 . . . . 0.0 110.5 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.495 ' HE1' ' CG1' ' A' ' 60' ' ' ILE . 7.9 m-85 -126.05 158.1 36.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 -149.95 6.74 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.24 -38.16 1.61 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.798 2.999 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.45 -29.17 69.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -89.08 3.26 52.37 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.672 -0.642 . . . . 0.0 110.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.23 139.76 53.44 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.039 -1.038 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.3 p -60.66 132.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -34.55 62.3 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.406 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.24 65.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 110.437 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.62 -47.29 2.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.014 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.01 -38.58 23.93 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.197 -0.939 . . . . 0.0 111.438 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.15 2.48 27.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.359 -0.838 . . . . 0.0 110.661 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 22.6 mttt -94.61 135.0 36.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -66.59 112.85 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.534 -0.729 . . . . 0.0 110.787 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 76.4 m95 -116.85 164.36 14.79 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' CA ' HD12 ' A' ' 49' ' ' LEU . 5.1 p-10 -137.27 9.66 2.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' HD2' HG11 ' A' ' 10' ' ' VAL . 15.3 mtm180 -143.18 145.33 32.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.4 p -135.41 143.42 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.924 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HG3' HG22 ' A' ' 46' ' ' VAL . 15.2 tttt -107.71 115.57 30.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.721 -0.612 . . . . 0.0 109.7 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.752 HD13 HG13 ' A' ' 70' ' ' VAL . 49.0 mm -105.4 117.6 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 0.0 109.286 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 44' ' ' SER . 46.5 t -125.01 117.8 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.111 -0.993 . . . . 0.0 110.429 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.44 ' HB3' HG13 ' A' ' 43' ' ' ILE . 10.9 t -92.46 148.66 21.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.1 123.97 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.525 -0.734 . . . . 0.0 111.466 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.7 134.11 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.403 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.86 98.2 0.5 Allowed 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.094 2.53 . . . . 0.0 110.207 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -129.77 2.98 4.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.357 -0.839 . . . . 0.0 111.373 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 -170.91 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.942 -1.099 . . . . 0.0 109.701 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -170.38 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.688 -0.632 . . . . 0.0 109.338 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -113.55 -36.25 4.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.694 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -103.04 143.53 26.78 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.39 174.53 5.06 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.236 2.624 . . . . 0.0 110.462 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.74 -164.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.33 -109.91 0.42 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.808 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.25 144.94 40.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.726 -0.867 . . . . 0.0 110.61 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -80.54 -28.72 37.22 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' A' ' 108' ' ' VAL . 48.8 p90 -177.56 174.8 1.49 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.567 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 24' ' ' LEU . 27.7 m -150.63 130.55 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -143.34 107.79 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.506 -0.746 . . . . 0.0 110.157 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 128' ' ' VAL . 83.1 m-85 -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.36 136.67 15.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.386 -0.821 . . . . 0.0 109.388 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.752 -0.593 . . . . 0.0 109.626 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.854 ' CG2' HD11 ' A' ' 49' ' ' LEU . 83.1 mt -128.62 128.21 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -115.39 171.1 7.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -0.856 . . . . 0.0 110.319 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 47' ' ' LEU . 3.1 mp -97.69 163.74 12.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.759 -0.588 . . . . 0.0 109.57 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.634 ' C ' HD11 ' A' ' 25' ' ' LEU . 6.3 ttt85 -121.84 -51.44 2.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -161.09 162.18 31.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.87 96.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.495 -0.753 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -54.37 -60.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.71 159.14 30.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.2 p -158.28 136.63 10.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.26 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 t -141.75 59.77 1.48 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.679 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 157.22 59.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-O 121.443 0.639 . . . . 0.0 109.965 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -139.23 144.14 38.32 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.72 -1.237 . . . . 0.0 110.34 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.84 174.63 6.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.249 -0.907 . . . . 0.0 109.193 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -74.25 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.534 -0.729 . . . . 0.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -58.37 8.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.016 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 9.7 m-70 -97.05 80.44 2.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -93.56 164.5 13.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.572 -0.705 . . . . 0.0 109.839 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.42 -21.08 66.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.869 -0.519 . . . . 0.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.05 -18.82 63.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 31' ' ' ARG . 13.7 m120 -64.79 -18.12 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.868 . . . . 0.0 109.091 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.6 mt -65.13 -26.92 68.4 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.634 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.94 -20.58 58.26 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.493 -0.754 . . . . 0.0 109.003 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -115.18 68.55 0.71 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.3 -24.4 7.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.455 -0.778 . . . . 0.0 110.626 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.46 86.51 2.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.922 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 -83.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 0.0 109.427 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.9 p90 -177.8 -37.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HB3' ' ND2' ' A' ' 23' ' ' ASN . 16.7 tpp85 -86.43 134.6 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.36 -0.837 . . . . 0.0 109.995 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -114.62 -171.86 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.48 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -84.96 142.21 29.8 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.535 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -147.8 130.39 15.89 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.688 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.27 153.02 1.6 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.44 -0.787 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.76 -19.79 52.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.951 -0.468 . . . . 0.0 110.315 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 -171.21 3.16 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.359 -0.838 . . . . 0.0 108.933 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.23 -172.4 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 48.97 77.03 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 35' ' ' ALA . 79.1 mm-40 -34.11 -88.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp 72.02 -60.07 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.531 -0.731 . . . . 0.0 109.109 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.635 HG22 ' OG ' ' A' ' 133' ' ' SER . 40.8 p -155.41 138.84 15.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 ' CH2' ' A' ' 33' ' ' TRP . 1.4 pt -145.73 140.73 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.55 -0.719 . . . . 0.0 109.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 4.2 m -122.08 131.13 53.82 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.594 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.655 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -136.89 116.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.1 t -95.88 116.76 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.232 -0.918 . . . . 0.0 108.974 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.684 HD22 HD21 ' A' ' 6' ' ' LEU . 1.1 mp -101.11 157.02 17.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.641 -0.662 . . . . 0.0 109.76 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -96.3 163.56 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.691 -0.631 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.854 HD11 ' CG2' ' A' ' 4' ' ' ILE . 11.5 tp -108.52 124.78 50.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.84 2.59 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 112.471 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -175.97 134.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.657 -1.277 . . . . 0.0 108.93 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -74.79 111.0 9.55 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.644 0.735 . . . . 0.0 110.108 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -172.85 4.26 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' O ' HD11 ' A' ' 4' ' ' ILE . 14.4 mt-30 -90.61 -178.36 5.27 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -141.92 127.06 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.657 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.472 ' HA ' HD21 ' A' ' 116' ' ' LEU . 13.1 t-160 -115.82 -32.03 5.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.1 m -141.09 159.34 42.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.673 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.3 t -140.21 163.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 m-20 -140.23 127.53 21.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.691 . . . . 0.0 109.519 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 59' ' ' ASP . 1.1 mp -145.21 139.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -98.53 126.88 9.05 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.12 126.19 30.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.066 -0.667 . . . . 0.0 110.231 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.32 63.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 108.839 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.58 -31.47 8.31 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.7 p -62.21 173.39 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.914 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -141.83 -53.45 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -93.61 125.69 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.265 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.87 113.07 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.003 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.0 121.97 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.766 ' CG2' HD12 ' A' ' 88' ' ' LEU . 31.5 t -113.74 127.75 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 110.223 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.1 mp -118.35 162.56 18.09 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 87' ' ' LEU . 3.4 m -131.19 159.79 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.432 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.97 178.1 45.51 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 t -117.84 156.59 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.2 p -84.53 6.26 24.38 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.471 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.91 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.8 m-85 -108.55 -175.01 2.66 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -120.98 126.14 49.19 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -61.58 85.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 0.0 110.422 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.909 HD13 HG21 ' A' ' 72' ' ' VAL . 6.5 tp -59.59 -61.14 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.766 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -121.9 130.1 53.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -68.73 -171.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 116.93 5.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 p -99.26 112.93 24.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -81.96 123.41 28.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 13.1 m-85 -116.61 -46.94 2.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -121.01 -166.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.523 0.678 . . . . 0.0 110.21 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 p -124.0 178.86 1.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.33 18.76 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.307 2.672 . . . . 0.0 111.433 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 m -120.28 -54.88 2.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' CG ' ' HB2' ' A' ' 103' ' ' SER . 0.5 OUTLIER -56.98 -28.01 61.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.478 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 10.9 m -50.09 -25.36 3.39 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.477 -0.764 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -80.95 -87.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.466 -0.771 . . . . 0.0 109.814 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 t -163.44 37.73 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.96 -22.56 38.25 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -170.41 -86.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -1.038 . . . . 0.0 110.647 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.6 34.84 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.16 -23.9 20.74 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.797 2.331 . . . . 0.0 109.994 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -134.46 141.54 46.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 -163.99 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 72.5 t -136.88 154.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.12 150.58 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 108.908 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.2 mtm -129.21 171.93 11.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.292 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.6 m-85 -130.56 169.71 15.23 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.829 0.823 . . . . 0.0 109.566 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.82 -154.05 6.03 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.192 -2.363 . . . . 0.0 107.192 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -74.27 -26.78 12.13 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.527 2.818 . . . . 0.0 110.843 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -53.37 -41.84 66.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.656 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.89 15.88 23.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -121.97 118.99 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -46.5 126.97 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.979 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -64.52 -39.5 93.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.431 -0.793 . . . . 0.0 109.4 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.89 91.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.497 -0.752 . . . . 0.0 110.663 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -88.39 -36.39 16.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.324 -0.86 . . . . 0.0 109.188 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.701 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.07 -42.76 6.4 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.64 -0.663 . . . . 0.0 111.361 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.22 11.43 30.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.981 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -92.25 130.14 38.03 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -66.32 108.81 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -0.756 . . . . 0.0 110.113 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 68.6 m95 -116.47 163.32 16.23 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 4.5 p-10 -140.15 15.1 2.43 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.103 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -147.75 149.84 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.4 p -141.58 144.15 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.974 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.663 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.2 tttt -105.77 134.97 48.03 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HG13 ' A' ' 45' ' ' VAL . 46.9 mm -128.59 107.92 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.475 -0.765 . . . . 0.0 109.236 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.0 t -112.24 109.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.211 -0.93 . . . . 0.0 109.921 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.423 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.63 154.27 28.81 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.4 OUTLIER -157.06 120.94 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 -178.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 5.2 tp60 171.41 135.04 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.5 100.78 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.928 2.419 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 38.0 p90 -147.27 15.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 111.483 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.39 -173.38 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.051 -1.031 . . . . 0.0 110.072 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -177.96 -39.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -116.05 -32.23 5.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.656 -0.653 . . . . 0.0 110.141 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.5 146.05 32.52 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.78 -0.575 . . . . 0.0 109.875 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.2 Cg_endo -87.48 171.81 6.12 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.417 2.745 . . . . 0.0 110.614 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -178.95 -166.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 158.01 -106.75 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.084 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.6 mp -120.12 155.02 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.962 . . . . 0.0 110.849 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 m -88.35 -27.47 21.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.0 p90 -177.1 170.48 2.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.2 m -146.99 142.06 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 21.1 mtm180 -150.56 166.14 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.664 . . . . 0.0 109.534 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.823 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.7 m-85 -141.59 158.19 44.15 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.32 128.54 8.28 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.01 -1.056 . . . . 0.0 110.338 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.424 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -138.67 128.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 168.87 9.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.627 -0.671 . . . . 0.0 110.017 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.691 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.4 mp -103.26 156.29 17.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.706 -0.622 . . . . 0.0 109.755 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' C ' HD11 ' A' ' 25' ' ' LEU . 1.4 tpt180 -109.8 -52.0 2.82 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.93 168.41 24.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -84.01 93.8 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.252 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.7 p -52.99 -59.99 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.243 -0.91 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.524 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.14 153.03 36.78 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -138.59 133.7 32.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.728 . . . . 0.0 109.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.95 42.64 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.702 . . . . 0.0 109.679 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.08 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.926 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.6 pp0? -131.11 132.91 45.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.46 152.51 34.19 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -62.48 -62.16 1.94 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -0.767 . . . . 0.0 109.804 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -61.51 2.43 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 34' ' ' ARG . 43.3 m-70 -93.15 85.06 4.94 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 p -98.28 167.24 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.507 0.67 . . . . 0.0 110.236 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.51 -23.63 66.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.761 -0.587 . . . . 0.0 109.969 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.36 -19.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.239 -0.913 . . . . 0.0 109.774 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -65.5 -17.79 64.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.157 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.12 -25.41 67.76 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.472 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -57.61 -23.09 49.11 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 65.31 0.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.32 -24.95 8.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.783 . . . . 0.0 110.537 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' THR . 6.3 m-20 -120.47 82.81 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 109.758 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -157.02 -85.28 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.501 -0.749 . . . . 0.0 109.398 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -177.48 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.138 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -160.82 142.12 11.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.346 -0.846 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -169.04 1.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.735 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.6 t90 -80.54 136.74 36.33 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.6 mtp180 -142.1 125.69 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.736 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -55.51 169.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.765 0.793 . . . . 0.0 111.018 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -101.57 -22.71 14.42 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.988 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.9 -153.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.14 -174.35 4.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.059 -1.025 . . . . 0.0 109.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 89.75 -13.5 64.14 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 12.6 mt-10 46.08 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.41 -1.053 . . . . 0.0 112.013 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -133.41 -72.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.439 HG22 ' OG ' ' A' ' 133' ' ' SER . 31.1 p -153.91 139.5 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG21 ' HB2' ' A' ' 35' ' ' ALA . 8.9 pt -134.1 149.56 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.597 ' OG ' HG22 ' A' ' 131' ' ' VAL . 30.9 m -126.53 140.42 52.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.398 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -148.41 121.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.681 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.4 t -101.31 120.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.5 mp -98.08 168.63 10.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.631 . . . . 0.0 109.985 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -111.39 142.76 43.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.803 -0.561 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD23 HD12 ' A' ' 6' ' ' LEU . 60.8 mt -97.07 135.26 39.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.63 37.89 0.36 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.48 -0.762 . . . . 0.0 111.262 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 pttt 165.58 127.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.39 108.12 9.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.806 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -178.6 5.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -87.34 -172.63 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.41 122.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.519 -0.738 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.3 t-160 -109.41 -32.09 7.29 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.3 m -146.88 153.53 40.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 149' ' ' PHE . 70.5 t -137.51 158.7 34.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.674 -0.641 . . . . 0.0 109.564 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.517 ' O ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -137.2 138.55 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.706 HG23 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -159.72 139.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -122.99 135.77 10.21 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -91.77 151.56 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.152 -0.617 . . . . 0.0 109.9 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.32 34.47 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.86 -17.14 8.21 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.518 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -60.78 -171.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -1.079 . . . . 0.0 110.449 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.96 -40.88 0.84 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.48 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.05 140.43 39.87 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.509 -0.744 . . . . 0.0 111.322 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 93' ' ' PHE . 61.9 t -143.3 112.44 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.667 -0.645 . . . . 0.0 109.61 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.25 147.3 27.22 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.68 -0.638 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.27 131.55 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.897 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -117.32 167.34 11.32 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.72 HG23 ' HG2' ' A' ' 85' ' ' GLU . 5.6 m -130.61 159.0 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.703 -0.623 . . . . 0.0 109.568 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 176.31 173.8 42.27 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 t -115.62 161.07 19.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.601 0.715 . . . . 0.0 109.58 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -80.34 3.75 20.11 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.803 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.154 -0.966 . . . . 0.0 110.143 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.54 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -109.26 -175.54 2.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.72 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -121.11 127.4 51.57 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.39 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.759 -0.588 . . . . 0.0 110.17 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' CG1' ' A' ' 72' ' ' VAL . 15.3 tp -57.96 -50.65 72.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.67 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -146.6 124.07 11.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -59.01 173.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -56.08 131.32 47.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -103.46 132.9 49.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 99.9 p -90.18 107.4 19.11 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 68' ' ' VAL . 7.2 m-30 -89.29 -51.36 5.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.418 -0.801 . . . . 0.0 109.691 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 mtp -120.89 -178.92 3.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.754 0.788 . . . . 0.0 110.519 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -99.98 179.63 1.0 Allowed Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -86.98 18.45 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.128 2.552 . . . . 0.0 111.445 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -120.31 -53.52 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.49 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -58.11 -18.99 28.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.452 -0.78 . . . . 0.0 110.635 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.4 t -49.04 -26.54 2.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.334 -0.854 . . . . 0.0 110.455 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -85.66 -85.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 t -164.06 37.47 0.08 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.36 -19.84 68.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.06 -83.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.42 -1.047 . . . . 0.0 110.686 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.6 p30 -111.84 82.15 3.88 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.78 -19.23 27.68 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.824 2.349 . . . . 0.0 110.776 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 127.79 40.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 109.567 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -157.73 176.69 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 17.4 m -134.57 -173.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.535 -0.728 . . . . 0.0 109.41 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -160.66 148.91 16.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.646 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtm -126.69 151.93 47.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.836 -0.54 . . . . 0.0 109.731 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' HD13 ' A' ' 88' ' ' LEU . 3.6 m-85 -122.57 165.68 16.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.42 -148.3 5.3 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.6 Cg_endo -75.01 -40.19 0.97 Allowed 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 123.727 2.951 . . . . 0.0 111.152 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.2 -27.76 68.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.742 . . . . 0.0 109.782 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtmm -92.02 3.36 55.41 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.666 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.79 139.37 54.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.037 -1.04 . . . . 0.0 110.45 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.9 p -59.63 129.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -74.29 -32.48 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.558 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.0 -22.44 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 110.189 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.2 -47.07 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 110.152 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.949 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.99 19.39 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.099 -1.001 . . . . 0.0 111.63 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.52 2.23 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.368 -0.832 . . . . 0.0 110.707 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 27.6 mttt -93.51 136.02 34.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.19 113.22 4.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.413 -0.804 . . . . 0.0 110.546 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.8 m95 -116.94 164.53 14.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -139.86 14.82 2.49 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.065 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.401 ' HD3' HG21 ' A' ' 10' ' ' VAL . 6.7 mtt180 -144.38 146.95 32.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.0 p -138.19 140.78 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.036 -1.065 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.681 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -100.33 142.93 31.12 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.667 ' CD1' HG13 ' A' ' 70' ' ' VAL . 37.6 mm -138.24 107.51 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.597 HG22 ' OG ' ' A' ' 44' ' ' SER . 44.0 t -115.46 120.62 65.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 O-C-N 121.293 -0.879 . . . . 0.0 109.874 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 144' ' ' LEU . 2.2 t -94.22 150.71 20.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -155.1 143.02 20.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.09 -1.006 . . . . 0.0 112.206 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.4 tp60 148.53 113.1 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.34 123.32 4.38 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.679 2.253 . . . . 0.0 110.562 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.563 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -146.78 6.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.165 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 -175.19 4.79 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.347 -1.471 . . . . 0.0 111.345 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 58.8 mmtt -137.03 -30.16 0.88 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.828 -0.545 . . . . 0.0 110.912 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.08 -9.01 6.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.798 -1.189 . . . . 0.0 111.924 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.56 148.97 37.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.947 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.11 -161.45 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 123.927 3.085 . . . . 0.0 110.632 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p90 -178.69 -160.32 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 43' ' ' ILE . . . 157.31 -165.37 33.32 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.283 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.706 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -99.27 150.58 21.95 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.063 -0.669 . . . . 0.0 109.569 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 p -76.79 -30.71 56.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 49.6 p90 -175.13 168.9 3.38 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.735 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.9 m -138.65 157.31 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 14.3 mtt180 -160.06 159.74 32.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.627 -0.67 . . . . 0.0 110.269 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.884 ' CE2' HG11 ' A' ' 128' ' ' VAL . 58.2 m-85 -150.38 153.4 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.95 142.91 18.97 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.15 -0.968 . . . . 0.0 110.107 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' OE1' ' A' ' 53' ' ' GLU . 96.0 mt -139.15 130.16 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 167.27 10.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 109.632 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.779 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.2 mp -98.53 160.82 14.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.701 -0.624 . . . . 0.0 109.424 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.717 ' C ' HD11 ' A' ' 25' ' ' LEU . 7.2 tpt180 -116.78 -46.01 2.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -161.19 -171.88 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.706 -0.621 . . . . 0.0 109.422 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -106.48 90.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 109.258 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 11' ' ' SER . 1.4 p -52.25 -62.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.206 -0.934 . . . . 0.0 110.55 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.551 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -118.55 155.1 31.48 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 24.5 p -161.53 126.47 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.748 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -137.61 68.18 1.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.4 p 153.4 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.777 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -122.34 144.0 49.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.978 -1.076 . . . . 0.0 110.765 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -94.12 -168.37 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -68.73 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.444 -0.785 . . . . 0.0 109.825 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.82 65.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.0 71.41 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.4 p -89.81 169.56 11.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.734 . . . . 0.0 109.705 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.777 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -62.6 -25.18 67.95 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.668 -0.645 . . . . 0.0 109.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.4 -19.69 56.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.846 . . . . 0.0 109.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -64.72 -19.94 66.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.102 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 47' ' ' LEU . 8.5 mt -65.83 -25.78 67.37 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.717 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -59.53 -20.82 58.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.43 -0.794 . . . . 0.0 109.014 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.24 73.08 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.26 -47.73 55.07 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.517 -0.739 . . . . 0.0 110.684 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.61 75.96 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.482 -0.761 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -161.57 31.18 0.13 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.632 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.6 p90 47.15 25.57 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.315 0.579 . . . . 0.0 111.658 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -119.89 135.12 55.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.235 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 32.1 mttt -126.96 -178.63 4.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.82 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -94.43 137.25 33.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -139.78 128.12 22.68 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.93 164.72 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.424 -0.797 . . . . 0.0 110.327 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -72.4 -22.42 61.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.793 -0.567 . . . . 0.0 110.531 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.23 176.58 8.57 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.354 -0.841 . . . . 0.0 109.063 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.34 -176.06 5.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.71 -48.84 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 11.9 mp0 40.09 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.021 -0.694 . . . . 0.0 112.367 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 42' ' ' THR . 8.2 ptpt -103.21 -43.35 5.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.676 HG22 ' OG ' ' A' ' 133' ' ' SER . 3.0 p -160.49 106.34 1.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.82 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -107.32 136.66 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.497 -0.752 . . . . 0.0 110.5 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' OG ' ' A' ' 14' ' ' SER . 55.6 p -115.61 134.98 54.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.38 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -142.3 101.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.0 t -90.33 118.16 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 108.965 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -103.02 166.37 10.48 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -107.92 157.49 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.671 -0.643 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.02 124.44 49.63 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.1 -7.31 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.391 -0.818 . . . . 0.0 112.297 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -161.8 140.99 9.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.731 -1.23 . . . . 0.0 109.414 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.27 109.32 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.509 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -143.74 175.9 9.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -84.59 -172.5 4.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.9 121.68 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -110.13 -30.55 7.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.2 m -146.03 154.69 42.15 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.76 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.9 t -137.9 158.67 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.706 ' C ' HD12 ' A' ' 60' ' ' ILE . 12.1 t0 -133.05 134.84 44.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.308 -0.87 . . . . 0.0 110.579 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.946 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -149.7 125.96 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.65 117.04 5.55 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.9 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.849 -0.795 . . . . 0.0 109.881 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -123.15 82.63 2.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.52 80.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 4.9 p -98.4 178.64 4.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -1.123 . . . . 0.0 109.824 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -140.07 -47.56 0.44 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.515 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -109.3 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.172 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 60' ' ' ILE . 42.7 t -132.65 114.05 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.44 150.86 26.29 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.614 HG13 HD13 ' A' ' 130' ' ' ILE . 34.3 t -140.71 127.14 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.586 0.708 . . . . 0.0 110.079 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 3.6 mp -113.85 160.89 18.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 87' ' ' LEU . 2.4 m -125.41 155.55 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.55 -0.719 . . . . 0.0 110.151 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.19 169.69 42.77 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -119.92 165.43 14.64 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.723 0.773 . . . . 0.0 110.014 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -69.91 -9.36 54.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.264 -179.6 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 3.6 m-85 59.24 165.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.554 -0.717 . . . . 0.0 109.282 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -101.69 129.63 47.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.1 86.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.798 -0.563 . . . . 0.0 110.373 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 72' ' ' VAL . 10.3 tp -59.98 -52.59 64.76 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.385 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -57.55 172.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.561 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -58.01 135.01 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.592 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 5.9 p -108.33 130.94 55.18 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.447 0.641 . . . . 0.0 109.64 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -85.91 123.28 31.07 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 25.6 m-85 -123.05 -46.4 2.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 mtp -120.82 -165.7 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.702 -0.624 . . . . 0.0 109.872 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.9 p -126.58 175.77 3.03 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.56 15.42 2.15 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.31 2.674 . . . . 0.0 111.285 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 t -120.17 -42.13 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 109.337 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.09 -20.54 40.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 110.58 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.1 m -50.22 -25.98 4.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.273 -0.892 . . . . 0.0 110.765 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -85.12 -87.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.947 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -163.64 37.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.35 56.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.38 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.476 -1.014 . . . . 0.0 110.722 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.97 92.78 47.01 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 38.6 Cg_endo -73.04 -23.54 18.24 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.615 2.21 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.97 143.54 51.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -148.2 -174.5 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.432 -0.792 . . . . 0.0 110.422 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 70.4 t -148.75 142.44 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -153.26 145.99 24.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.863 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.2 mtm -125.78 152.58 45.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 88' ' ' LEU . 6.7 m-85 -113.02 159.06 19.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -128.19 -149.6 7.06 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.67 -39.27 1.43 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.76 2.973 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.74 -28.31 68.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 42.8 mttt -89.5 3.82 51.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.661 -0.649 . . . . 0.0 110.592 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -124.7 139.81 53.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.098 -1.001 . . . . 0.0 110.442 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.903 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.1 p -60.3 132.35 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -74.86 -34.36 62.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.23 -20.45 65.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.903 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.55 -47.94 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.1 -41.02 25.16 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.217 -0.927 . . . . 0.0 111.617 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -2.18 33.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.4 mttm -90.98 133.63 35.13 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -65.71 113.11 4.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 110.392 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.468 ' CZ2' ' HG3' ' A' ' 85' ' ' GLU . 83.3 m95 -116.17 163.46 15.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.9 7.65 2.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.608 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.24 136.93 35.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.889 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.0 p -127.75 143.93 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.664 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.641 ' HG3' HG22 ' A' ' 46' ' ' VAL . 3.4 tttt -111.6 111.07 21.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.0 109.653 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.614 HD13 HG13 ' A' ' 70' ' ' VAL . 49.4 mm -101.77 128.3 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.09 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.25 117.74 41.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.15 142.39 27.35 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -140.15 127.83 21.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.387 -0.821 . . . . 0.0 111.162 -177.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 150.03 137.95 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.042 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.78 101.48 0.78 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.107 2.538 . . . . 0.0 110.319 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.61 -60.62 2.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.4 -0.812 . . . . 0.0 108.889 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.88 160.59 22.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -106.11 26.61 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.54 -0.725 . . . . 0.0 110.084 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -54.24 2.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 p -116.47 155.33 48.73 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 122.008 -0.433 . . . . 0.0 109.874 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.409 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.1 Cg_endo -83.73 166.18 13.54 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.459 2.772 . . . . 0.0 109.724 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -169.76 -163.02 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 160.89 -106.56 0.29 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -132.45 161.87 32.59 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.212 -1.17 . . . . 0.0 110.189 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 25.3 m -83.43 -17.69 41.26 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.036 -0.415 . . . . 0.0 110.916 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.6 p90 175.88 179.31 0.17 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.232 -0.918 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 144' ' ' LEU . 35.3 m -154.66 128.24 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -140.88 110.79 6.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.277 -0.89 . . . . 0.0 110.562 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.889 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.3 m-85 -88.64 158.57 18.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.412 -0.805 . . . . 0.0 108.859 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.535 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -156.07 139.59 15.89 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.293 -0.88 . . . . 0.0 109.512 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' SER . 40.3 mm -125.3 146.64 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -140.69 134.93 31.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 149' ' ' PHE . 4.3 mm? -85.83 144.63 27.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 109.162 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -94.67 -50.94 4.94 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -160.83 167.78 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -78.67 89.95 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.6 p -50.29 -58.94 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.292 -0.88 . . . . 0.0 110.427 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.52 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.47 158.92 31.69 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.5 p -153.42 136.34 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.675 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -130.01 46.74 2.6 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 154.56 94.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 123.075 0.55 . . . . 0.0 109.624 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.37 146.0 15.05 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.953 -1.092 . . . . 0.0 109.445 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.52 -168.11 1.56 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 -60.21 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 109.522 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -61.15 2.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.801 . . . . 0.0 108.918 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -97.11 77.54 2.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.9 p -90.2 168.26 12.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.576 -0.702 . . . . 0.0 109.937 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.35 -23.72 67.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.65 -17.92 61.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.791 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -65.01 -20.16 66.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.212 -0.93 . . . . 0.0 109.277 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.757 HD21 ' HB2' ' A' ' 33' ' ' TRP . 12.0 mt -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -61.56 -20.16 62.96 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -109.44 64.07 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.6 7.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 0.0 110.563 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 29' ' ' THR . 18.9 t70 -118.65 80.43 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.1 p -155.13 -84.03 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.494 -0.754 . . . . 0.0 109.612 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.7 p90 -179.23 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -79.53 148.85 31.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.391 -0.818 . . . . 0.0 109.772 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 12.4 mttp -127.42 -165.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.639 -0.663 . . . . 0.0 109.541 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.791 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.8 t90 -91.73 141.77 28.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -144.83 126.88 15.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.04 151.71 4.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.76 . . . . 0.0 110.402 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.72 -24.28 67.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.939 -0.475 . . . . 0.0 110.288 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -138.48 -173.22 3.48 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.352 -0.843 . . . . 0.0 109.285 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.15 -163.92 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.785 -0.572 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.07 45.76 95.43 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -47.71 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.582 0.706 . . . . 0.0 111.557 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 42' ' ' THR . 30.3 tttt -93.47 -56.68 2.84 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.673 HG22 ' OG ' ' A' ' 133' ' ' SER . 23.8 p -156.94 113.77 3.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.791 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.9 pt -114.61 132.22 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.573 -0.704 . . . . 0.0 109.874 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -114.57 146.71 40.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.504 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.7 p -147.74 112.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 129' ' ' LYS . 4.6 t -95.54 119.33 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 108.946 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.56 ' C ' HG12 ' A' ' 10' ' ' VAL . 1.5 mp -99.25 160.37 14.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.777 -0.577 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.422 ' N ' HD12 ' A' ' 6' ' ' LEU . 12.6 tm0? -111.85 125.97 54.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.5 -0.75 . . . . 0.0 109.905 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' OE2' ' A' ' 53' ' ' GLU . 14.2 mt -80.15 136.04 36.43 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 41.34 0.61 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.594 -0.691 . . . . 0.0 110.405 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 pttm 164.8 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -75.61 107.45 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.571 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -136.6 179.79 6.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.494 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -94.94 162.96 13.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -117.27 126.41 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.311 -0.868 . . . . 0.0 109.918 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.454 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.2 t60 -116.97 -30.19 5.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.694 -0.629 . . . . 0.0 109.849 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.5 m -148.98 158.73 44.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 0.0 108.876 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.71 HG12 HD12 ' A' ' 60' ' ' ILE . 61.3 t -147.82 161.32 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.804 0.811 . . . . 0.0 110.447 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -136.07 134.68 38.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.71 HD12 HG12 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -153.18 130.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -103.88 125.81 8.55 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -83.68 127.59 33.89 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.247 -0.561 . . . . 0.0 110.281 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 2.4 t0 -96.06 50.4 1.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.75 -24.23 24.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 29.1 t -57.12 161.39 3.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.386 -1.067 . . . . 0.0 109.919 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -121.83 -51.79 2.02 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.813 -0.554 . . . . 0.0 109.601 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -96.25 126.59 41.57 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.176 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.19 111.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.596 -0.69 . . . . 0.0 109.734 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -106.29 146.76 29.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.737 -0.602 . . . . 0.0 109.553 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 130' ' ' ILE . 6.7 t -131.13 125.13 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -111.71 157.03 20.97 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -121.55 154.91 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 109.771 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.77 171.22 41.77 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 t -109.63 161.66 15.17 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 122.037 -0.684 . . . . 0.0 109.242 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.413 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 23.1 p -86.13 6.73 27.88 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.763 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.97 -174.53 2.55 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -121.73 127.88 51.17 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.416 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.0 t -61.16 88.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.652 ' HB2' HG13 ' A' ' 72' ' ' VAL . 18.1 tp -59.65 -60.74 3.36 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 111' ' ' PHE . 2.0 pp -135.85 119.78 17.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.346 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.2 m -51.34 174.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.756 . . . . 0.0 110.278 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.13 133.59 53.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.509 -0.744 . . . . 0.0 109.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.7 p -102.88 122.26 44.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.5 p -87.01 108.31 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 24.2 m-85 -93.48 -51.93 4.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.71 -0.619 . . . . 0.0 109.922 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.45 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 9.3 mtp -122.11 -167.9 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.658 0.742 . . . . 0.0 110.452 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.8 p -109.32 175.64 1.87 Allowed Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.46 10.65 3.63 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.897 2.398 . . . . 0.0 111.332 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -121.44 -35.57 3.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.61 -0.38 53.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 110.671 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 60.1 m -74.19 -30.54 62.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -68.37 -77.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -161.96 38.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.23 -24.74 6.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.54 120.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 109.981 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.2 68.63 2.15 Favored Pre-proline 0 N--CA 1.509 2.499 0 O-C-N 121.975 -0.453 . . . . 0.0 111.551 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -76.83 -30.38 4.73 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.877 2.385 . . . . 0.0 110.233 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 63' ' ' ASP . 1.1 m-20 -128.93 99.23 5.21 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -164.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 109.404 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -148.8 151.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 5.1 mmt180 -144.45 166.15 25.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.3 mtm -139.68 175.02 9.93 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.535 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 88' ' ' LEU . 7.5 m-85 -134.36 169.04 17.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -141.49 -151.48 5.56 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.3 Cg_endo -76.45 -37.12 1.46 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.582 2.855 . . . . 0.0 110.617 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.03 -28.59 68.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 109.429 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -88.09 1.61 53.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.607 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.6 pp -124.02 139.76 53.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.979 -1.076 . . . . 0.0 110.345 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.0 p -59.11 130.37 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -74.7 -31.66 61.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.93 66.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.92 -46.48 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.119 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.66 -38.5 21.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.158 -0.964 . . . . 0.0 111.51 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.68 -0.36 33.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 25.7 mtpt -92.41 135.15 34.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -68.23 111.46 4.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.513 -0.742 . . . . 0.0 110.887 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.5 m95 -113.5 162.36 16.25 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.484 ' CA ' HD12 ' A' ' 49' ' ' LEU . 4.4 p30 -135.36 9.0 3.43 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.681 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.7 mtm180 -140.77 142.39 34.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.768 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.8 p -133.9 142.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.816 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 46' ' ' VAL . 1.5 tttt -106.5 112.48 25.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.844 -0.535 . . . . 0.0 109.647 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.648 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.9 mm -104.83 117.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 44' ' ' SER . 42.6 t -120.14 120.65 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.201 -0.937 . . . . 0.0 110.62 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.405 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -95.6 136.0 36.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.673 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -139.31 123.44 17.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 111.017 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.6 tp60 165.14 128.77 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.159 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.98 90.53 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.875 2.383 . . . . 0.0 109.251 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 7.4 p90 -119.85 -12.45 9.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.738 . . . . 0.0 111.702 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 176.54 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 0.0 110.22 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -153.33 -42.77 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.65 -29.93 6.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.619 -0.675 . . . . 0.0 109.955 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -104.42 145.93 31.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.711 -0.618 . . . . 0.0 109.66 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 45.1 Cg_endo -87.78 -175.74 1.52 Allowed 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.356 2.704 . . . . 0.0 110.626 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 170.26 -166.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.95 -117.57 0.76 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.815 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 5.3 mp -114.83 158.43 21.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.711 -0.876 . . . . 0.0 110.18 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 32.3 m -96.17 -25.8 15.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.979 -0.451 . . . . 0.0 109.982 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -176.98 165.7 2.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.206 -0.934 . . . . 0.0 110.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 159.02 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 0.1 OUTLIER -160.49 101.22 1.35 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.768 ' CE2' HG11 ' A' ' 128' ' ' VAL . 34.5 m-85 -88.99 149.93 23.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 0.0 108.289 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.2 120.12 5.73 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.729 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 151' ' ' SER . 33.6 mt -145.26 119.75 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -96.62 166.17 11.79 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.31 0.576 . . . . 0.0 109.605 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.701 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -103.3 153.05 20.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.71 -0.619 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.494 ' C ' HD11 ' A' ' 25' ' ' LEU . 41.8 ttt85 -102.49 -56.48 2.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -160.97 161.46 31.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.651 -0.655 . . . . 0.0 109.274 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.75 93.51 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.1 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 11' ' ' SER . 2.5 p -54.66 -55.96 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.259 -0.901 . . . . 0.0 110.398 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -121.45 151.57 40.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 0.0 109.058 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.7 112.26 6.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.831 . . . . 0.0 110.274 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -105.95 43.7 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 43' ' ' ILE . 1.7 t 153.05 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.825 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -161.3 135.61 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.45 -163.1 0.64 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -0.796 . . . . 0.0 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.8 m -95.51 -70.37 0.72 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -54.92 25.3 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -93.9 68.57 3.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.6 p -90.92 176.13 6.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.474 -0.766 . . . . 0.0 110.271 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.62 -25.17 68.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.74 -16.4 57.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.446 -0.784 . . . . 0.0 109.918 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.07 -18.19 65.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -0.997 . . . . 0.0 109.204 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' A' ' 33' ' ' TRP . 8.8 mt -66.0 -24.13 66.71 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -58.79 -21.01 55.09 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.459 -0.776 . . . . 0.0 109.06 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -123.62 73.47 1.2 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.71 -22.03 21.55 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.462 -0.774 . . . . 0.0 110.233 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.51 101.41 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -172.71 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 109.117 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' OG1' ' A' ' 29' ' ' THR . 52.0 p90 -166.42 29.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.84 -1.162 . . . . 0.0 109.941 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.21 177.37 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.402 -0.811 . . . . 0.0 109.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -159.57 0.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.2 t90 -77.62 139.27 39.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.125 -0.985 . . . . 0.0 109.731 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -144.07 125.73 15.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.52 151.79 7.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.771 . . . . 0.0 110.246 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -69.55 -29.82 67.48 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.874 -0.516 . . . . 0.0 109.722 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -114.47 -165.8 1.05 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.26 -162.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.66 44.5 97.79 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.4 mm-40 -43.1 91.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.933 0.873 . . . . 0.0 112.002 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.5 ttmt -101.98 -57.61 2.04 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.548 HG22 ' OG ' ' A' ' 133' ' ' SER . 75.2 p -154.51 121.43 5.56 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 7.1 pt -126.73 152.47 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.526 -0.733 . . . . 0.0 110.015 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.76 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -129.97 150.27 51.33 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.491 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.0 p -154.75 108.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 128' ' ' VAL . 19.4 t -92.15 120.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.701 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.4 mp -98.13 161.51 13.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -111.17 129.5 55.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.617 -0.677 . . . . 0.0 109.948 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD13 ' OE2' ' A' ' 53' ' ' GLU . 44.8 mt -84.73 142.64 29.69 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 36.91 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.486 -0.759 . . . . 0.0 111.324 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 pttm 163.22 138.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.205 -0.935 . . . . 0.0 108.797 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 13.4 tt0 -75.55 103.78 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -136.25 172.19 13.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.517 0.675 . . . . 0.0 109.787 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -85.18 179.01 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.6 mp -140.31 124.24 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.437 -0.79 . . . . 0.0 110.047 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 44.5 t60 -112.89 -29.5 7.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.609 -0.682 . . . . 0.0 109.2 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.428 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.4 m -143.07 157.14 44.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 149' ' ' PHE . 61.6 t -143.01 162.72 17.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.331 0.586 . . . . 0.0 109.938 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -142.35 100.77 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.631 HG23 HD23 ' A' ' 144' ' ' LEU . 1.5 mt -122.31 124.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -92.27 128.35 9.35 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' OD1' HG21 ' A' ' 68' ' ' VAL . 4.1 m-80 -84.02 120.69 26.43 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 122.173 -0.604 . . . . 0.0 110.194 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 5.8 t0 -93.64 69.58 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.21 89.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -64.79 -175.1 0.17 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.73 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -148.58 -55.23 0.2 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' ' HG3' ' A' ' 134' ' ' GLN . 28.0 m-85 -105.67 116.46 31.98 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.016 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 ' OD1' ' A' ' 62' ' ' ASN . 48.9 t -120.76 109.86 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.942 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.29 142.45 35.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 HD13 ' A' ' 130' ' ' ILE . 24.1 t -130.73 127.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.603 0.716 . . . . 0.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 86' ' ' VAL . 2.5 mp -112.68 162.23 15.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -122.45 157.58 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.647 -0.658 . . . . 0.0 110.375 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.72 166.85 38.83 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.2 t -109.45 153.26 24.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.843 -0.798 . . . . 0.0 109.867 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.426 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 47.6 t -84.4 8.64 15.59 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 0.0 109.735 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.405 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -102.96 -173.12 2.24 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 135.47 50.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 71' ' ' LEU . 22.4 t -63.16 88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 111.493 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.569 HD13 HG11 ' A' ' 72' ' ' VAL . 10.7 tp -64.5 -42.09 96.05 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.3 pp -150.77 120.51 7.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.459 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.549 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.3 m -54.1 -178.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.697 -0.627 . . . . 0.0 110.293 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.51 133.56 47.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.47 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 p -98.51 117.92 34.02 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.258 0.551 . . . . 0.0 109.594 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.7 p -74.93 68.6 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -59.42 -59.07 6.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.875 -0.516 . . . . 0.0 110.261 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 68.2 mtp -121.23 -176.12 3.21 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.584 0.707 . . . . 0.0 110.713 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 p -114.66 179.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -86.72 11.06 3.39 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.102 2.535 . . . . 0.0 111.322 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.2 p -120.91 -39.37 2.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.955 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -83.43 0.33 46.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 110.768 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.8 t -78.64 -32.55 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -0.983 . . . . 0.0 110.165 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.678 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -161.69 38.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.93 -22.96 7.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 119.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.298 -1.119 . . . . 0.0 110.244 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.98 64.35 4.47 Favored Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.921 -0.487 . . . . 0.0 111.534 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.6 Cg_endo -75.18 -30.66 6.68 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.889 2.393 . . . . 0.0 110.254 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.67 75.52 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.698 -0.627 . . . . 0.0 109.491 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -111.83 -169.56 1.49 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -129.98 165.11 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.197 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 21.5 tpt180 -143.26 134.46 25.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtm -110.72 158.92 18.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.036 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.8 m-85 -133.14 105.63 7.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -83.52 -147.4 7.52 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.4 Cg_endo -74.51 -35.52 3.62 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.517 2.811 . . . . 0.0 110.809 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.62 -27.72 68.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.693 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -92.5 4.32 53.75 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.643 -0.661 . . . . 0.0 110.682 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -128.37 143.87 51.06 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.912 -1.118 . . . . 0.0 110.31 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.892 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -64.25 140.52 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -35.05 44.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.735 . . . . 0.0 109.075 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.02 66.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.579 -0.701 . . . . 0.0 110.291 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.892 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.98 -47.15 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.1 -31.85 8.78 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.186 -0.946 . . . . 0.0 111.12 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -2.03 58.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.458 -0.776 . . . . 0.0 110.557 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 9.3 mtpp -92.02 135.14 34.19 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.85 109.28 3.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.674 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 86.4 m95 -108.63 160.26 16.08 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 12.6 t70 -133.28 2.31 3.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 110.404 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.426 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -140.84 143.0 34.52 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.913 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -133.95 142.49 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.361 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.3 tttp -107.45 114.66 28.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.717 -0.615 . . . . 0.0 109.788 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.66 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 50.0 mm -104.97 122.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 44' ' ' SER . 38.8 t -128.28 125.1 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.15 -0.969 . . . . 0.0 110.654 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 43' ' ' ILE . 18.0 t -97.93 145.92 25.98 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.66 130.03 17.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.0 111.495 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.73 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 149.07 131.3 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.597 0 C-N-CA 123.911 0.884 . . . . 0.0 108.989 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.42 87.1 0.99 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 109.967 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 3.4 p90 -113.86 -1.42 13.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 111.12 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.65 -171.74 2.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.036 . . . . 0.0 109.476 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -164.23 -43.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.84 -32.5 5.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 0.0 109.887 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.34 149.8 36.65 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.885 -0.509 . . . . 0.0 109.702 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_endo -85.25 -169.79 0.67 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.437 2.758 . . . . 0.0 110.639 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 171.2 -162.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.3 -117.05 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.492 -1.337 . . . . 0.0 110.942 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.631 HD23 HG23 ' A' ' 60' ' ' ILE . 6.1 mp -118.0 145.92 44.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.847 -0.796 . . . . 0.0 110.351 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -81.38 -27.21 34.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.509 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 35.3 p90 -175.87 171.69 2.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.453 -0.779 . . . . 0.0 109.804 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.637 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.7 m -150.21 131.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -147.98 105.4 3.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.447 -0.783 . . . . 0.0 110.504 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.913 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.4 m-85 -86.3 157.83 19.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -152.9 136.01 15.63 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.677 ' HB3' HD11 ' A' ' 4' ' ' ILE . 82.3 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.351 0.596 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 151' ' ' SER . 48.6 mt -146.31 123.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -102.04 166.21 10.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.731 -0.606 . . . . 0.0 110.012 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -98.09 138.94 34.65 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.612 ' N ' HD13 ' A' ' 6' ' ' LEU . 9.9 tpt180 -93.06 -56.24 3.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -161.06 160.6 30.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.49 91.18 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.1 p -51.73 -56.24 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.229 -0.919 . . . . 0.0 110.215 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.06 155.25 38.66 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.251 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -146.75 134.4 21.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.799 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -129.32 47.66 2.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.519 -0.738 . . . . 0.0 110.184 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.1 m 151.85 73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.7 pp0? -133.91 143.45 48.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -98.06 152.03 19.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -60.97 -54.43 45.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.013 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -57.11 14.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HD2' ' A' ' 31' ' ' ARG . 35.8 m-70 -107.25 78.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -86.21 163.45 17.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.4 -20.72 65.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.761 -0.587 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.9 tt0 -64.74 -20.42 66.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -65.8 -16.78 64.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.19 -0.943 . . . . 0.0 109.273 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.718 ' HB3' HG22 ' A' ' 147' ' ' VAL . 13.7 mt -64.81 -23.28 67.19 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.2 mm? -57.15 -22.3 39.13 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.418 -0.801 . . . . 0.0 109.19 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.8 66.31 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.76 13.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.488 -0.757 . . . . 0.0 110.318 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.08 74.3 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.823 HG22 ' CD1' ' A' ' 30' ' ' TYR . 86.1 m -156.93 -98.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.823 ' CD1' HG22 ' A' ' 29' ' ' THR . 0.1 OUTLIER 176.25 44.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HD2' ' CE1' ' A' ' 19' ' ' HIS . 3.6 mmm-85 -141.54 100.35 3.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 144' ' ' LEU . 30.9 mtmt -83.62 146.38 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.637 -0.664 . . . . 0.0 109.692 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -62.7 114.9 3.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.203 -0.935 . . . . 0.0 108.583 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -116.88 127.1 53.94 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -49.21 168.81 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.731 0.777 . . . . 0.0 111.696 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -73.74 -32.73 63.99 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -124.85 -175.31 3.25 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 -166.56 1.39 Allowed 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.49 45.81 88.21 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.6 OUTLIER -43.03 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.52 0.676 . . . . 0.0 111.825 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' GLY . 7.3 tttp -93.44 -64.32 1.1 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.664 HG22 ' OG ' ' A' ' 133' ' ' SER . 64.1 p -152.47 113.65 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 24.5 pt -111.29 145.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 110.384 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -123.89 150.49 44.59 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.522 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.787 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.7 p -152.27 107.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.0 t -92.43 122.04 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 147' ' ' VAL . 1.3 mp -101.57 155.76 17.89 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -109.55 120.24 41.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.738 HD13 ' OE2' ' A' ' 53' ' ' GLU . 40.8 mt -71.54 143.35 49.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.36 31.27 0.18 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.637 -0.664 . . . . 0.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.0 pttm 165.01 138.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.92 109.74 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.98 165.66 26.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 151' ' ' SER . 46.3 mt-30 -77.4 -176.73 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -143.22 130.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.432 -0.793 . . . . 0.0 109.36 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.438 ' O ' HD21 ' A' ' 116' ' ' LEU . 45.9 t60 -116.81 -26.24 7.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.621 -0.674 . . . . 0.0 109.731 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -148.48 153.21 38.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.2 t -135.38 160.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.706 -0.621 . . . . 0.0 109.346 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.654 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -138.74 132.51 30.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.544 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -152.4 128.01 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -104.01 114.62 4.81 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 118.882 -1.628 . . . . 0.0 109.91 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.68 138.37 50.59 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.28 0.562 . . . . 0.0 111.206 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -113.44 42.06 2.03 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 -19.4 10.84 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 20.9 p -56.76 -173.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.319 -1.106 . . . . 0.0 109.797 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -147.42 -44.43 0.17 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.3 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -108.35 117.26 33.68 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.746 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' ILE . 45.3 t -120.51 110.62 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -107.21 147.56 30.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG22 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.21 125.87 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -111.52 157.6 20.15 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 87' ' ' LEU . 4.0 m -120.25 156.98 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.795 -0.566 . . . . 0.0 110.292 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.406 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.82 174.52 44.23 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 t -114.64 162.69 16.44 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.646 0.736 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -68.79 -11.11 60.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.239 -179.327 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 t0 . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.4 151.06 41.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.13 147.67 28.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -68.93 86.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 72' ' ' VAL . 19.7 tp -56.68 -54.98 39.81 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.7 pp -138.75 117.26 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.271 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.6 m -50.86 174.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.564 -0.71 . . . . 0.0 110.446 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 132.69 50.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -97.6 118.16 33.48 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.847 -0.533 . . . . 0.0 109.745 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.9 p -75.45 67.96 2.06 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -62.08 -51.61 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.885 -0.509 . . . . 0.0 110.494 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.525 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 20.2 mtp -120.3 -170.25 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 110.455 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 p -121.07 173.74 3.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.99 5.02 5.97 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.272 2.648 . . . . 0.0 111.451 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.8 m -120.74 -39.29 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.097 -1.002 . . . . 0.0 109.827 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.79 -17.19 61.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.527 -0.733 . . . . 0.0 110.266 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -58.16 -20.55 41.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 110.517 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -71.44 -86.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -162.61 38.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 108.578 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.39 -20.27 7.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.93 119.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -1.073 . . . . 0.0 110.198 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.525 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.86 70.31 1.62 Allowed Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.89 -0.506 . . . . 0.0 111.308 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.59 -30.63 3.82 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.906 2.404 . . . . 0.0 110.464 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -146.23 109.75 4.79 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 93' ' ' PHE . 5.6 ptm85 -153.08 -160.79 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.568 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -131.86 172.0 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.773 -1.205 . . . . 0.0 111.388 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 13.9 tpt180 -145.64 147.14 31.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 mtp -126.99 158.12 37.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.688 . . . . 0.0 110.242 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.0 m-85 -126.51 163.95 22.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.99 -148.31 5.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.87 -38.52 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 123.8 3.0 . . . . 0.0 111.042 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.47 -26.7 68.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.502 -0.749 . . . . 0.0 109.701 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.55 2.37 56.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 110.71 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.5 pp -124.16 140.81 52.61 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.974 -1.079 . . . . 0.0 110.351 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.8 p -60.68 137.87 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -40.16 47.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 0.0 109.163 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.73 -20.88 59.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.595 -0.691 . . . . 0.0 110.679 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -114.8 -46.49 2.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.269 -0.894 . . . . 0.0 110.432 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.61 -35.08 12.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.253 -0.904 . . . . 0.0 111.311 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.13 7.08 29.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.356 -0.84 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.1 mttm -98.93 137.61 37.23 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -68.8 113.1 5.95 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.751 0.786 . . . . 0.0 110.973 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.461 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 77.7 m95 -117.21 157.16 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -132.1 10.29 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.275 -0.891 . . . . 0.0 110.057 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.588 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.4 mtt180 -140.08 147.13 39.84 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.6 p -140.6 142.47 30.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.774 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 46' ' ' VAL . 12.7 tttt -112.77 107.31 15.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.679 -0.638 . . . . 0.0 109.718 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.757 ' CD1' HG22 ' A' ' 70' ' ' VAL . 46.4 mm -98.46 122.83 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.7 t -123.99 114.7 42.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -90.83 138.22 31.75 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.664 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -143.11 132.58 23.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.192 -0.943 . . . . 0.0 111.635 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.863 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER 157.02 134.01 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.591 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.92 96.39 0.57 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.081 2.521 . . . . 0.0 109.807 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.4 p90 -128.16 -8.79 5.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.401 -0.812 . . . . 0.0 111.843 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -175.41 3.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.074 -1.016 . . . . 0.0 110.02 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -161.31 -43.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.72 -30.84 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.593 -0.692 . . . . 0.0 110.029 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -104.17 142.95 25.68 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.732 -0.605 . . . . 0.0 109.762 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.9 Cg_endo -88.18 156.69 6.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.353 2.702 . . . . 0.0 110.323 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -161.48 -168.49 2.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 169.41 -101.96 0.18 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.04 163.64 32.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.474 -1.016 . . . . 0.0 109.64 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 50.5 m -85.09 -16.9 39.04 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.646 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 43.3 p90 -179.35 164.56 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 24' ' ' LEU . 25.3 m -139.12 149.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 9.0 mtp180 -154.34 164.26 38.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.76 . . . . 0.0 110.472 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.874 ' CE2' HG11 ' A' ' 128' ' ' VAL . 51.9 m-85 -144.59 152.2 40.17 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.434 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.62 136.18 16.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 109.188 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.1 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.739 -0.601 . . . . 0.0 109.845 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.404 HD13 ' OE1' ' A' ' 53' ' ' GLU . 52.5 mt -126.47 127.65 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -112.52 171.04 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.722 -0.611 . . . . 0.0 109.885 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.756 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.9 mp -101.81 162.51 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.787 -0.571 . . . . 0.0 109.506 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.702 ' C ' HD11 ' A' ' 25' ' ' LEU . 23.1 ttt180 -118.41 -47.64 2.54 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.532 ' CE1' ' CB ' ' A' ' 48' ' ' GLN . 7.2 p80 -160.85 -168.73 2.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.7 p -104.94 96.87 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.705 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.5 p -56.43 -61.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.302 -0.874 . . . . 0.0 110.054 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -121.31 162.89 19.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 20.0 p -158.64 144.96 17.06 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.277 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -151.84 53.85 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.81 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.829 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -127.06 148.82 50.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.939 -1.101 . . . . 0.0 110.096 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -98.97 -165.37 1.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.79 -0.569 . . . . 0.0 109.561 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -66.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.688 . . . . 0.0 109.651 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -34.82 77.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -123.69 74.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -90.71 172.19 8.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.598 0.713 . . . . 0.0 110.256 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.52 -25.89 67.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.799 -0.563 . . . . 0.0 109.619 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.06 -20.02 55.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.365 -0.834 . . . . 0.0 110.17 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.2 -19.47 65.99 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.9 mt -65.91 -25.05 66.97 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.702 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.91 -21.09 60.62 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.482 -0.761 . . . . 0.0 108.977 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 66.12 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.61 -22.75 23.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -0.756 . . . . 0.0 110.391 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' THR . 5.5 m-20 -118.91 77.39 1.18 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -154.28 -85.57 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.404 -0.81 . . . . 0.0 109.576 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.22 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 158.33 29.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.497 -0.752 . . . . 0.0 109.506 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -160.96 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.536 -0.727 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.727 ' CH2' HD12 ' A' ' 43' ' ' ILE . 20.4 t90 -88.36 137.45 32.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 110.817 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -142.5 121.7 13.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.29 158.77 0.24 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.464 -0.773 . . . . 0.0 111.035 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.51 -41.76 99.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.077 0.465 . . . . 0.0 110.28 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.48 -171.4 2.3 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.515 0.674 . . . . 0.0 109.241 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.59 -165.59 1.33 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.98 45.8 94.88 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp0 -51.92 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.461 0.648 . . . . 0.0 111.174 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 42' ' ' THR . 15.5 tttm -91.38 -50.08 5.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.5 p -158.66 124.89 4.59 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.727 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.1 pt -128.34 136.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 131' ' ' VAL . 26.8 m -118.6 138.51 52.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.415 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.636 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.9 p -144.75 111.61 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.4 t -96.96 119.75 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.088 -1.008 . . . . 0.0 108.978 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -100.9 160.67 14.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.539 0.685 . . . . 0.0 110.284 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.532 ' CB ' ' CE1' ' A' ' 8' ' ' HIS . 50.0 tp60 -98.28 148.41 23.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 126' ' ' ASP . 84.8 mt -99.57 123.81 44.18 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -52.59 -7.73 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.37 -0.831 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.2 139.03 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.786 -1.196 . . . . 0.0 108.874 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.69 113.58 12.12 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -147.41 179.77 7.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.16 -178.03 6.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.44 115.2 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -105.22 -30.8 9.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 109.202 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.2 m -144.3 161.09 39.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 149' ' ' PHE . 99.1 t -145.35 159.03 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.28 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 60' ' ' ILE . 35.3 t0 -132.07 138.67 48.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.699 -0.626 . . . . 0.0 110.004 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -153.88 130.38 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -96.69 127.08 9.07 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -83.86 112.09 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.022 -0.693 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.7 56.96 2.12 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.94 58.38 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -53.42 161.72 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.316 -1.108 . . . . 0.0 110.555 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.735 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -123.46 -58.72 1.59 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 23.4 m-85 -101.68 133.19 46.77 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.611 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' ILE . 49.8 t -132.49 111.56 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 109.677 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.14 141.67 37.11 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.741 HG13 HD13 ' A' ' 130' ' ' ILE . 16.2 t -131.07 124.47 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.636 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 86' ' ' VAL . 1.5 mp -109.31 162.48 14.28 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 87' ' ' LEU . 3.1 m -122.71 154.95 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.542 -0.724 . . . . 0.0 110.305 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.55 162.71 34.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 t -116.83 163.91 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.684 0.754 . . . . 0.0 109.872 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 t -77.08 -1.06 27.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.749 -179.518 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.06 -172.31 2.12 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.65 135.11 48.84 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 71' ' ' LEU . 43.7 t -61.76 88.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.671 -0.643 . . . . 0.0 111.263 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.9 tp -61.79 -55.63 28.05 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.705 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.7 pp -137.69 117.47 13.16 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -52.29 178.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.639 -0.663 . . . . 0.0 110.656 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 133.62 52.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.2 p -107.31 126.65 52.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.369 0.605 . . . . 0.0 109.656 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.8 p -86.47 117.87 25.53 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 26.3 m-85 -112.86 -48.18 3.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.437 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 83.3 mtp -121.2 -176.35 3.26 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.549 0.69 . . . . 0.0 110.468 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.7 p -111.84 -178.55 0.54 Allowed Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 43.0 Cg_endo -86.41 19.33 1.41 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 123.155 2.57 . . . . 0.0 111.432 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -120.19 -41.27 2.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.02 -24.9 66.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 34.8 p -45.97 -27.24 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.711 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -92.33 0.11 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -163.36 38.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.863 -1.148 . . . . 0.0 108.569 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.12 -26.55 18.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.93 115.77 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 0.0 110.272 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.27 73.55 0.83 Allowed Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 121.685 -0.634 . . . . 0.0 111.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.7 Cg_endo -74.14 -28.23 11.02 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.557 2.171 . . . . 0.0 110.339 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.86 124.13 34.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.682 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 -170.13 3.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.729 -0.607 . . . . 0.0 109.403 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 40.6 t -132.82 159.99 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 141.22 12.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.762 . . . . 0.0 109.148 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.0 mtp -126.26 156.61 40.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.316 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.705 ' CE2' HD13 ' A' ' 88' ' ' LEU . 11.8 m-85 -110.93 172.28 6.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.33 -150.22 5.3 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.78 -38.04 1.44 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.712 2.941 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.03 -26.73 68.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.935 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -95.08 5.05 52.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.751 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.99 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -125.53 143.0 51.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.921 -1.112 . . . . 0.0 110.712 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.902 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -61.85 141.08 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.75 34.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 108.973 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -67.51 -15.89 63.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.717 . . . . 0.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.902 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -120.23 -45.61 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.99 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.42 -40.27 25.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.302 -0.874 . . . . 0.0 111.305 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.27 4.92 28.76 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 11.8 mttm -97.19 135.71 38.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.92 111.35 4.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.528 -0.732 . . . . 0.0 110.886 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 88.6 m95 -115.38 165.02 13.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 49' ' ' LEU . 3.2 p30 -139.9 14.55 2.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.071 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.705 ' HD3' HG21 ' A' ' 10' ' ' VAL . 11.7 mtt180 -142.06 138.68 31.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.701 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.2 p -130.79 138.95 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.395 -0.816 . . . . 0.0 109.788 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.628 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.7 tttt -110.39 107.55 17.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.848 -0.532 . . . . 0.0 109.654 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 70' ' ' VAL . 50.7 mm -98.43 117.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.733 -0.604 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.8 t -124.07 110.97 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 121.16 -0.963 . . . . 0.0 109.72 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.463 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.5 t -84.94 147.3 26.8 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.68 129.94 22.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.349 -0.844 . . . . 0.0 111.753 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.735 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 148.4 123.28 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 C-N-CA 123.719 0.808 . . . . 0.0 109.057 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.56 89.5 1.34 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.777 2.318 . . . . 0.0 109.1 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 6.7 p90 -114.62 -22.33 9.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.585 -0.697 . . . . 0.0 111.41 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -173.18 2.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.893 . . . . 0.0 109.863 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -168.75 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -114.88 -36.15 4.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.902 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -105.07 145.09 30.07 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.836 -0.54 . . . . 0.0 109.727 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.0 Cg_endo -87.92 167.74 6.91 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.371 2.714 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.35 -169.86 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.84 -109.81 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.872 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.633 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.3 mp -109.69 152.13 26.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.903 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 34.5 m -87.84 -27.56 22.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.464 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 51.7 p90 -179.17 176.52 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.524 HG12 HG13 ' A' ' 60' ' ' ILE . 32.9 m -152.2 131.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 6.5 mtm180 -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.312 -0.867 . . . . 0.0 110.222 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 58' ' ' VAL . 80.7 m-85 -86.08 154.23 21.54 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 131.95 19.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.338 -0.851 . . . . 0.0 109.046 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.873 -0.517 . . . . 0.0 110.486 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.626 ' CG2' HD12 ' A' ' 49' ' ' LEU . 43.9 mm -79.52 143.15 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -123.32 126.05 46.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 HD22 ' A' ' 47' ' ' LEU . 1.1 mp -83.87 147.43 27.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.461 ' C ' HD11 ' A' ' 25' ' ' LEU . 50.2 ttt85 -105.28 -58.71 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.377 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -160.96 178.16 9.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -85.41 89.44 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.704 . . . . 0.0 109.24 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.528 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -51.42 -58.39 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.15 -0.969 . . . . 0.0 110.286 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.522 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -124.9 162.77 23.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.496 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . 21.5 p -160.42 144.04 13.78 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.47 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 m -148.9 58.22 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.608 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.78 58.21 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 123.093 0.557 . . . . 0.0 109.818 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.929 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 3.3 mm-40 -124.54 140.61 52.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.82 -1.175 . . . . 0.0 110.65 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.64 -162.84 0.89 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -99.06 -64.25 1.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 109.374 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -58.53 4.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.692 . . . . 0.0 109.149 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -92.74 68.03 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.8 165.15 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 0.0 109.904 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.81 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -59.89 -23.94 63.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.644 -0.66 . . . . 0.0 110.368 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.46 -21.6 66.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.247 -0.908 . . . . 0.0 109.919 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -66.0 -16.82 64.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.9 mt -65.28 -25.77 67.79 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -60.26 -21.3 61.72 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 65.42 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HB1' ' HE ' ' A' ' 148' ' ' ARG . . . -53.3 -24.32 11.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -116.31 79.95 1.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.434 -0.791 . . . . 0.0 109.746 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' ASP . 2.0 p -157.2 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.483 -0.76 . . . . 0.0 109.196 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -178.06 32.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.003 -1.061 . . . . 0.0 110.379 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -147.25 140.54 25.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.026 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -160.41 0.99 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CH2' HD12 ' A' ' 43' ' ' ILE . 17.6 t90 -97.58 136.19 38.33 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 3.9 tmm_? -142.6 120.54 12.04 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.48 154.76 3.3 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.193 -0.942 . . . . 0.0 110.427 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -78.93 -23.79 44.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.784 -0.572 . . . . 0.0 110.196 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.02 -158.94 0.59 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.423 -0.798 . . . . 0.0 109.368 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 139' ' ' ASP . . . -149.25 172.7 14.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 91.1 -15.62 60.57 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.504 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 2.6 mp0 59.52 117.72 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.618 -0.931 . . . . 0.0 111.418 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 42' ' ' THR . 16.8 ttmt -151.7 -71.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.684 HG22 ' OG ' ' A' ' 133' ' ' SER . 24.6 p -157.88 143.54 17.12 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.775 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -143.57 139.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.522 ' CB ' HG22 ' A' ' 131' ' ' VAL . 69.2 m -126.53 115.06 18.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.234 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.81 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -116.41 126.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.857 HG22 ' CD ' ' A' ' 129' ' ' LYS . 2.8 t -104.76 113.77 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.875 . . . . 0.0 108.897 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 6' ' ' LEU . 1.4 mp -97.61 169.34 9.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.558 0.694 . . . . 0.0 110.66 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.464 ' C ' HD22 ' A' ' 49' ' ' LEU . 11.9 tp60 -114.66 153.71 29.72 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.545 0.688 . . . . 0.0 109.608 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.626 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.0 mm? -104.86 131.98 51.67 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 5.7 tt0 -81.96 43.12 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.25 -0.906 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 4.6 pttt 163.59 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 20.7 tt0 -63.23 104.66 0.62 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CG ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.5 178.46 7.02 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.25 178.12 5.95 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.32 131.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.796 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.572 ' HA ' HD21 ' A' ' 116' ' ' LEU . 6.4 t-160 -122.47 -32.35 3.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -141.97 161.44 37.97 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.681 HG13 ' CD1' ' A' ' 149' ' ' PHE . 58.4 t -146.67 164.1 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.899 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.584 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.4 m-20 -139.28 134.77 33.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.639 -0.663 . . . . 0.0 109.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -146.71 118.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -81.86 99.75 2.03 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.83 125.25 22.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.905 . . . . 0.0 110.361 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 25.0 t70 -107.38 39.07 1.97 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.384 -0.823 . . . . 0.0 109.406 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 136' ' ' TYR . . . 111.98 22.97 5.74 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -101.67 173.1 6.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -1.073 . . . . 0.0 110.382 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -128.8 -47.64 1.25 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 30.0 m-85 -108.41 120.6 42.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.732 -0.605 . . . . 0.0 110.767 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.63 111.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.458 -0.776 . . . . 0.0 109.287 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -107.86 143.62 36.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.696 -0.627 . . . . 0.0 110.197 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 130' ' ' ILE . 38.9 t -132.09 129.57 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.6 mp -117.46 160.17 21.63 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.7 ' CG1' HD22 ' A' ' 87' ' ' LEU . 7.5 m -123.48 172.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 110.159 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.34 170.64 29.55 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -113.21 160.73 17.97 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.822 0.82 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -81.86 8.13 11.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.93 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.131 -0.981 . . . . 0.0 111.224 -179.265 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.428 0.633 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -48.24 160.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.603 0.716 . . . . 0.0 110.079 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -108.69 131.61 54.75 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 42.9 t -61.58 86.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.66 -0.65 . . . . 0.0 110.729 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.7 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -59.0 -61.18 2.83 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 pp -136.14 119.98 17.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.546 -0.721 . . . . 0.0 109.292 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -53.93 179.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.155 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -65.63 133.95 52.23 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.594 -0.691 . . . . 0.0 109.313 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HG ' ' HE2' ' A' ' 111' ' ' PHE . 8.5 p -98.22 119.11 36.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.82 -0.55 . . . . 0.0 109.676 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.2 p -75.53 69.49 2.29 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 28.4 t80 -63.42 -55.49 23.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.803 -0.561 . . . . 0.0 110.587 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 1.6 mtp -117.79 -176.48 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.679 0.752 . . . . 0.0 110.571 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -112.54 176.35 1.52 Allowed Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 41.5 Cg_endo -86.28 14.98 2.3 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.136 2.557 . . . . 0.0 111.518 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -120.09 -46.19 2.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.071 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -19.59 49.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.512 -0.742 . . . . 0.0 110.233 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -49.34 -26.87 3.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -0.863 . . . . 0.0 110.64 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -85.95 -86.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.54 -0.725 . . . . 0.0 109.745 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -164.44 37.53 0.08 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.43 -17.83 67.88 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.18 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.239 -1.154 . . . . 0.0 111.91 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.4 90.33 0.22 Allowed Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.47 ' O ' ' HE1' ' A' ' 94' ' ' MET . 43.1 Cg_endo -81.21 -29.85 1.82 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.686 2.257 . . . . 0.0 110.315 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.41 ' ND2' ' OD1' ' A' ' 63' ' ' ASP . 1.3 m-20 -125.6 129.94 50.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.653 -0.654 . . . . 0.0 109.273 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -160.21 -169.8 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.876 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.618 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 69.2 t -127.06 154.96 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 111' ' ' PHE . 6.6 ttt-85 -143.1 131.94 22.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.1 mtp -111.81 143.34 42.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.72 -0.612 . . . . 0.0 110.054 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.6 m-85 -111.59 165.1 12.3 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.642 0.734 . . . . 0.0 109.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -147.88 -154.6 6.31 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.755 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.8 Cg_endo -74.91 -24.12 13.34 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.644 2.896 . . . . 0.0 110.873 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -50.53 -38.79 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -117.73 15.27 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -117.26 122.57 44.33 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.901 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -49.65 130.33 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.631 -0.668 . . . . 0.0 110.698 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -67.64 -37.69 82.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.738 . . . . 0.0 109.133 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.05 92.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.284 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.901 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -91.96 -36.41 13.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.311 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.98 -35.91 3.13 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.577 -0.702 . . . . 0.0 111.111 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.15 12.29 35.96 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.809 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -91.85 134.47 34.73 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.34 106.61 5.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.913 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 74.5 m95 -111.22 164.0 13.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 12.7 p30 -136.53 8.32 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.521 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 10' ' ' VAL . 12.8 mtt-85 -136.99 144.55 43.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.1 p -137.4 138.67 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.857 ' CD ' HG22 ' A' ' 46' ' ' VAL . 33.9 tptt -104.3 129.57 52.14 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.8 mm -125.24 111.92 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.522 HG22 ' CB ' ' A' ' 44' ' ' SER . 47.9 t -117.92 119.73 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.44 -0.787 . . . . 0.0 110.36 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 152.18 20.11 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.684 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -160.06 132.45 6.4 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.643 -1.286 . . . . 0.0 113.949 -176.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.75 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 10.1 tp60 148.09 125.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.32 114.78 1.87 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.778 2.318 . . . . 0.0 109.23 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -117.18 0.87 12.41 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.694 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.39 -160.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.604 -1.31 . . . . 0.0 110.051 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 ttmm -151.95 23.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 110.011 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.792 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p-10 -149.05 -40.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 111.701 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.7 158.91 33.61 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.687 . . . . 0.0 111.54 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.3 -159.67 0.11 Allowed 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 124.039 3.159 . . . . 0.0 109.601 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 40' ' ' GLU . 21.2 p90 -178.85 -165.01 0.08 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.72 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 145.47 -128.57 3.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -144.91 165.04 29.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.725 -0.868 . . . . 0.0 110.241 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.3 p -79.14 -25.52 42.88 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.558 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 46.3 p90 -175.07 173.64 2.6 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.812 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 24' ' ' LEU . 18.0 m -149.63 130.3 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.463 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 63.2 mtt180 -142.05 116.33 9.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 110.756 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.0 m-85 -88.91 154.0 20.59 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -152.72 120.88 6.23 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.853 -0.53 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.473 HD13 ' OE1' ' A' ' 53' ' ' GLU . 53.6 mt -120.09 126.25 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.33 175.86 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.592 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.6 mp -112.35 158.92 19.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 0.0 109.968 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -55.54 2.31 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -160.74 169.82 22.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -80.61 91.41 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.562 -0.711 . . . . 0.0 109.152 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 1.7 p -52.24 -58.51 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.07 -1.019 . . . . 0.0 110.186 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.3 157.58 36.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -160.44 125.26 3.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.4 OUTLIER -118.53 57.19 0.86 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.659 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 154.33 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 123.012 0.525 . . . . 0.0 109.674 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.24 144.08 14.07 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.87 -1.144 . . . . 0.0 109.494 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.02 -167.54 1.56 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 109.667 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -88.71 -62.77 1.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.685 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -65.04 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -88.59 74.46 8.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -91.08 168.05 11.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.616 -0.678 . . . . 0.0 110.051 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -62.68 -24.09 67.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.881 -0.512 . . . . 0.0 109.62 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.74 -18.42 62.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 109.967 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -64.96 -18.09 64.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.5 mt -65.33 -26.84 68.22 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.6 mm? -61.7 -20.02 63.01 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -116.31 65.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -23.37 18.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.425 -0.797 . . . . 0.0 110.399 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -120.43 78.47 1.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.52 -88.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.483 -0.761 . . . . 0.0 109.408 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.36 36.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -155.1 149.89 26.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 0.0 109.317 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -130.37 -170.41 2.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.574 -0.704 . . . . 0.0 109.959 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.817 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.9 t90 -88.54 139.67 30.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 109.032 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 126.19 17.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.68 152.38 2.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.307 -0.871 . . . . 0.0 110.111 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.1 -23.9 56.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.749 -0.595 . . . . 0.0 110.077 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -139.19 -169.79 2.74 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.421 -0.799 . . . . 0.0 108.965 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 -172.47 2.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.67 -0.644 . . . . 0.0 109.362 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.35 48.67 85.02 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 4.3 mt-10 -62.1 78.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' THR . 15.9 tttt -66.14 -51.07 61.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 133' ' ' SER . 59.3 p -156.94 124.78 5.47 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.786 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.1 pt -118.12 139.35 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.817 . . . . 0.0 110.4 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -115.5 140.36 49.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.135 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.4 p -146.1 107.98 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.9 t -92.35 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 108.894 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.592 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -96.95 168.72 10.3 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.09 129.76 56.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.718 -0.614 . . . . 0.0 110.406 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.623 HD13 ' OE2' ' A' ' 53' ' ' GLU . 46.5 mt -85.4 135.35 33.91 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 1.9 pt-20 -79.89 41.6 0.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.436 -0.79 . . . . 0.0 111.099 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 3.6 pttm 161.98 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.1 tt0 -75.88 100.36 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -131.49 172.38 12.28 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.588 0.709 . . . . 0.0 109.862 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -87.7 170.03 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -128.48 122.81 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.77 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -109.73 -32.97 6.9 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -144.8 155.2 43.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 60' ' ' ILE . 74.8 t -137.38 158.58 35.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.677 0.751 . . . . 0.0 109.98 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.5 m-20 -134.68 137.12 43.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -160.25 132.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -101.91 123.61 7.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 68' ' ' VAL . 2.0 m-80 -83.15 130.73 35.13 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.304 -0.527 . . . . 0.0 110.67 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.34 64.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 99' ' ' SER . . . 85.31 1.4 88.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.9 129.41 34.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 110.295 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 94' ' ' MET . . . -87.3 -57.73 2.85 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.713 -0.617 . . . . 0.0 110.076 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 133' ' ' SER . 16.4 m-85 -90.99 132.97 35.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.274 -0.891 . . . . 0.0 111.195 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 62' ' ' ASN . 82.3 t -139.24 106.84 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -102.32 146.88 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.698 HG13 ' CD1' ' A' ' 130' ' ' ILE . 22.2 t -135.71 121.1 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-O 121.64 0.733 . . . . 0.0 109.544 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -108.78 163.01 13.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.677 HG11 HD13 ' A' ' 87' ' ' LEU . 2.6 m -121.34 161.02 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.646 -0.659 . . . . 0.0 110.553 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.36 167.8 38.05 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 t -108.78 155.12 21.13 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.83 -0.806 . . . . 0.0 109.552 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 60.5 p -89.54 12.69 15.89 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 O-C-N 121.261 -0.899 . . . . 0.0 109.765 -179.745 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.465 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -107.17 -173.68 2.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.83 131.41 47.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.51 88.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.457 -0.777 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.677 HD13 HG11 ' A' ' 72' ' ' VAL . 5.6 tp -64.94 -51.04 63.99 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.5 pp -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.486 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -56.81 172.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.563 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -57.59 130.57 46.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.364 -0.835 . . . . 0.0 110.229 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -97.75 123.99 41.92 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -90.95 81.62 5.66 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 20.7 m-85 -70.86 -55.97 7.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.831 . . . . 0.0 109.922 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.491 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 27.9 mtp -120.78 -163.31 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.685 -0.635 . . . . 0.0 109.638 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -128.85 178.12 1.82 Allowed Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.23 17.59 1.71 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.039 2.493 . . . . 0.0 111.089 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.7 m -120.61 -38.49 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 109.704 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -82.97 -29.55 28.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.469 -0.769 . . . . 0.0 109.337 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 76.1 p -60.49 -18.6 52.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.583 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -71.12 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 t -161.27 38.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.6 -21.88 4.19 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.9 121.55 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.365 -1.079 . . . . 0.0 109.119 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.479 ' O ' ' HE1' ' A' ' 94' ' ' MET . 6.3 p30 43.16 83.92 0.2 Allowed Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.758 -0.589 . . . . 0.0 110.798 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.3 Cg_endo -82.76 -27.55 2.03 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.984 2.456 . . . . 0.0 109.992 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -145.73 86.24 1.72 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -114.71 127.45 55.76 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.6 m -79.76 165.82 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.743 . . . . 0.0 109.517 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.18 169.61 22.02 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.0 mtt -141.89 165.15 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 110.204 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.1 m-85 -120.85 170.35 9.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -144.44 -148.28 4.83 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.1 Cg_endo -74.88 -40.02 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.694 2.929 . . . . 0.0 110.716 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.36 -27.24 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 109.73 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -93.44 3.7 55.15 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.693 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.976 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.3 pp -124.22 152.21 43.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.932 -1.105 . . . . 0.0 109.966 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.768 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 10.3 p -77.54 139.47 18.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -73.43 -29.92 62.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.638 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -68.6 -11.28 59.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.768 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -125.01 -46.04 1.84 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.976 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.95 -29.08 11.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.604 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.48 -5.28 52.18 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.727 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 8.9 mtpt -91.16 133.08 35.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.158 -0.963 . . . . 0.0 108.52 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.81 110.65 3.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.48 -0.762 . . . . 0.0 110.541 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 83.9 m95 -110.72 158.94 18.08 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t70 -130.64 1.19 4.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.115 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.18 144.82 43.11 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.4 p -132.63 142.2 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.547 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.451 ' HG3' HG22 ' A' ' 46' ' ' VAL . 19.8 tttt -110.36 106.12 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.827 -0.546 . . . . 0.0 109.719 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.698 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.3 mm -100.57 131.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.327 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.6 t -134.01 122.54 41.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.424 ' SG ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -99.99 130.24 46.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.77 125.29 28.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.289 -0.882 . . . . 0.0 111.692 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HG2' ' CD2' ' A' ' 136' ' ' TYR . 3.4 pm0 170.44 141.44 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -90.71 95.06 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.71 2.273 . . . . 0.0 110.228 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -120.92 -15.67 8.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.015 -1.053 . . . . 0.0 112.002 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -137.2 178.24 7.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 110.918 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -149.33 -47.34 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.644 -0.66 . . . . 0.0 110.248 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.34 153.15 44.19 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.361 -0.837 . . . . 0.0 110.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.15 -171.76 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.64 2.893 . . . . 0.0 110.9 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.448 ' N ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER 170.03 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 143.19 -121.93 1.8 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.944 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 143' ' ' GLY . 5.6 mp -122.69 162.44 21.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.447 -1.031 . . . . 0.0 110.521 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -92.78 -27.25 17.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 -179.88 166.6 1.3 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.1 m -139.56 145.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.292 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 43.5 mtm180 -149.68 159.09 44.63 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.442 0.639 . . . . 0.0 110.346 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.659 ' CD1' HG13 ' A' ' 58' ' ' VAL . 49.8 m-85 -139.13 156.01 47.46 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.55 127.98 10.68 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.104 -0.998 . . . . 0.0 109.521 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.908 -0.495 . . . . 0.0 110.456 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.213 0.53 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.756 ' CG2' HD12 ' A' ' 49' ' ' LEU . 83.9 mt -142.19 152.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.725 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.08 -173.05 3.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.506 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.3 mm? -119.54 163.17 17.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.55 -0.718 . . . . 0.0 109.64 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -114.43 -47.67 2.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -161.0 163.34 31.78 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -78.96 91.08 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.77 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 11' ' ' SER . 2.4 p -51.27 -54.73 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.176 -0.952 . . . . 0.0 110.361 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.486 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.11 164.07 21.02 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.0 p -159.54 146.31 16.57 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.6 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -145.72 49.71 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 43' ' ' ILE . 2.0 m 152.0 86.12 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.861 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -153.36 133.56 13.41 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.053 -1.029 . . . . 0.0 110.245 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.31 -175.14 4.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.5 t -84.94 -64.13 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.629 -0.67 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -61.48 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -89.13 67.53 8.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.5 p -84.98 168.33 15.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.58 -0.7 . . . . 0.0 109.812 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.46 -22.4 66.95 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.34 -21.01 66.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 109.528 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -65.12 -18.46 65.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 109.014 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 33' ' ' TRP . 11.2 mt -66.02 -26.87 67.73 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.3 mm? -61.96 -19.34 62.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.03 76.15 1.35 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.94 -59.77 2.14 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.33 0.586 . . . . 0.0 110.812 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.64 -119.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p 51.72 -105.78 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.666 -1.271 . . . . 0.0 109.57 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.71 40.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.847 -1.158 . . . . 0.0 110.277 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -154.11 148.51 26.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -132.05 -159.72 0.99 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB2' HD21 ' A' ' 24' ' ' LEU . 14.5 t90 -97.12 140.05 32.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -149.0 126.7 11.74 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.42 142.25 10.74 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.429 -0.794 . . . . 0.0 110.876 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -63.83 -52.18 61.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -152.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -135.78 -179.75 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.7 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 96.34 -24.05 32.12 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 9.8 mt-10 45.17 41.96 6.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.694 -0.886 . . . . 0.0 112.284 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 42' ' ' THR . 25.1 ttmt -59.81 -65.24 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 41' ' ' LYS . 61.0 p -158.76 124.05 4.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.4 pt -112.92 148.63 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.572 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -124.59 146.76 48.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.708 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -154.92 111.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 109.527 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.2 t -95.52 119.82 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 147' ' ' VAL . 1.4 mp -98.27 161.04 13.9 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.453 0.644 . . . . 0.0 109.863 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -107.02 129.3 54.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.731 -0.606 . . . . 0.0 109.796 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.756 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -80.88 133.28 35.54 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.34 37.77 0.4 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.713 . . . . 0.0 110.425 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 pttt 165.67 126.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -76.29 108.86 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 109.225 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.78 -179.33 6.39 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' O ' HD11 ' A' ' 4' ' ' ILE . 52.5 mt-30 -87.94 178.39 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.1 mp -138.04 137.9 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.333 -0.854 . . . . 0.0 109.829 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.697 ' O ' HD21 ' A' ' 116' ' ' LEU . 31.5 t60 -123.97 -34.73 2.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.706 -0.621 . . . . 0.0 109.895 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.6 m -137.1 163.4 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 149' ' ' PHE . 75.4 t -142.62 165.03 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 109.622 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -145.67 115.66 7.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.759 . . . . 0.0 109.949 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.1 mp -133.14 120.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -79.14 89.03 1.19 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 5.3 m120 -71.41 119.12 15.1 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 122.089 -0.653 . . . . 0.0 110.845 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.66 22.99 13.96 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 136' ' ' TYR . 39.3 p -52.91 -175.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.17 0.986 . . . . 0.0 112.022 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 134' ' ' GLN . . . -150.7 -54.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 133' ' ' SER . 44.7 m-85 -117.85 122.17 42.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.769 -0.582 . . . . 0.0 109.597 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 t -118.31 107.63 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.863 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.77 141.2 28.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.793 HG21 HD23 ' A' ' 88' ' ' LEU . 60.0 t -136.55 119.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 0.0 109.668 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD11 HG22 ' A' ' 86' ' ' VAL . 1.4 mp -116.95 163.28 16.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 87' ' ' LEU . 5.5 m -126.74 168.65 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.739 -0.601 . . . . 0.0 110.131 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.412 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 168.97 172.79 36.09 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -110.39 162.36 14.74 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.551 0.691 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 54.8 p -86.27 9.53 17.47 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.116 -0.99 . . . . 0.0 110.436 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.3 m-85 -103.98 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -131.15 135.88 47.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 71' ' ' LEU . 43.0 t -65.19 85.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.462 -0.774 . . . . 0.0 110.563 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HA ' HG12 ' A' ' 117' ' ' VAL . 4.1 tp -68.05 -64.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.793 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -112.47 114.0 26.47 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -62.15 172.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.554 -0.716 . . . . 0.0 109.227 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.554 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -55.05 127.23 28.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.28 -0.887 . . . . 0.0 109.318 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p -95.7 114.7 26.47 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.219 0.533 . . . . 0.0 109.737 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -74.68 68.97 1.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 94' ' ' MET . 15.8 t80 -61.66 -61.66 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.883 -0.511 . . . . 0.0 109.623 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -122.55 -168.9 1.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.524 -0.735 . . . . 0.0 109.877 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -116.41 176.72 1.43 Allowed Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.72 12.67 2.93 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.943 2.429 . . . . 0.0 111.27 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 t -121.68 -37.25 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.156 -0.965 . . . . 0.0 110.248 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.6 -22.04 37.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.804 . . . . 0.0 110.249 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.2 p -58.54 -21.03 51.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 110.718 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -69.28 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -161.95 38.95 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 108.663 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.2 6.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.05 121.91 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -1.161 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 4.6 p-10 41.61 59.35 9.22 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 122.182 -0.324 . . . . 0.0 111.024 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.02 -31.35 5.02 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.117 2.544 . . . . 0.0 111.506 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.91 112.55 5.65 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.86 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -160.89 -157.91 0.56 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -124.59 160.65 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.014 -1.054 . . . . 0.0 109.692 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tpt180 -139.81 131.85 27.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtp -112.42 166.26 11.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.508 -0.745 . . . . 0.0 110.277 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 9.8 m-85 -139.1 166.25 25.0 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.44 -146.66 5.04 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.7 Cg_endo -73.91 -36.7 3.33 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 123.828 3.019 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.5 -27.31 68.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -90.32 1.12 56.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.597 -0.69 . . . . 0.0 110.68 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.1 pp -129.96 147.27 51.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.105 -0.997 . . . . 0.0 109.583 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 87' ' ' LEU . 10.9 p -71.74 139.16 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -71.5 -32.0 67.73 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -64.05 -19.88 65.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.09 -49.42 2.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.96 -28.1 9.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.513 -0.742 . . . . 0.0 110.757 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 19.54 9.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.291 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.8 mtpt -118.34 133.88 55.51 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -67.18 111.61 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.568 -0.708 . . . . 0.0 111.07 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -117.15 164.53 14.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.17 13.49 2.62 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.945 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 75' ' ' SER . 5.6 mtt180 -143.67 144.22 31.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.869 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.8 p -138.64 139.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.399 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.46 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.2 tttt -105.49 124.28 49.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 45' ' ' VAL . 50.2 mm -119.68 112.35 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.621 -0.674 . . . . 0.0 109.689 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 44' ' ' SER . 29.6 t -113.78 118.84 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 O-C-N 121.21 -0.932 . . . . 0.0 109.546 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 93.56 7.32 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -92.48 128.68 38.42 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.639 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER 173.91 69.6 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -174.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.21 92.04 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.881 2.387 . . . . 0.0 108.768 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -120.78 -10.15 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.727 -177.328 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.413 ' CB ' ' OE1' ' A' ' 40' ' ' GLU . 32.6 t -128.77 -175.59 3.58 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.889 -1.132 . . . . 0.0 110.72 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 14.8 tttm -133.54 -33.52 1.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.698 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 1.5 p30 -126.24 -5.03 6.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.017 -1.052 . . . . 0.0 112.247 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -110.93 150.4 41.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.946 -1.096 . . . . 0.0 110.678 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 51.2 Cg_endo -92.08 172.25 2.53 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.083 3.189 . . . . 0.0 110.559 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.47 -160.48 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.059 -1.026 . . . . 0.0 109.513 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.631 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 150.24 -112.02 0.53 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -142.9 161.91 36.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.064 -1.257 . . . . 0.0 111.733 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 5.5 m -83.26 -17.2 43.48 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.708 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.68 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.3 p90 -176.01 166.55 2.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.327 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 24' ' ' LEU . 20.2 m -145.1 137.78 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -149.89 163.27 38.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.997 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.869 ' CE2' HG11 ' A' ' 128' ' ' VAL . 55.9 m-85 -140.72 152.73 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.435 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -151.59 139.16 19.62 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 4' ' ' ILE . 6.1 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.472 ' CG2' HD22 ' A' ' 49' ' ' LEU . 76.9 mt -142.14 127.98 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.05 172.21 7.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.694 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.738 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -100.16 134.88 42.44 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.592 -0.692 . . . . 0.0 109.525 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.655 ' N ' HD13 ' A' ' 6' ' ' LEU . 2.8 tpt85 -88.52 -61.52 1.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 48' ' ' GLN . 3.4 p-80 -160.86 163.54 31.96 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -79.38 89.8 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 11' ' ' SER . 2.0 p -52.49 -55.63 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.177 -0.952 . . . . 0.0 109.973 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.46 161.05 25.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.0 p -154.58 144.15 21.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -141.12 46.72 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.747 -0.596 . . . . 0.0 109.498 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 152.88 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.735 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -155.64 139.95 16.67 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.055 -1.028 . . . . 0.0 109.866 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.45 -161.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.904 . . . . 0.0 109.832 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -68.04 0.82 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.578 -0.701 . . . . 0.0 109.895 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -64.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.451 -0.781 . . . . 0.0 109.16 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.32 58.7 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.4 p -79.71 179.18 7.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.749 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -65.06 -25.7 67.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.84 -15.85 59.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 109.762 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.42 -17.31 64.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.133 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.772 HD22 HG22 ' A' ' 147' ' ' VAL . 12.0 mt -64.76 -24.27 67.51 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 7' ' ' ARG . 4.2 mm? -55.77 -23.99 32.94 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.479 -0.763 . . . . 0.0 109.011 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' HG21 ' A' ' 29' ' ' THR . 31.9 mmtt -108.25 60.81 0.61 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.57 64.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.986 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.05 64.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 26' ' ' LYS . 33.8 p -152.68 -90.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.1 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.075 -1.016 . . . . 0.0 110.082 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -128.47 147.47 50.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.045 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 20.1 mttp -132.5 176.08 8.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.413 -0.805 . . . . 0.0 110.204 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.696 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.0 t90 -88.48 139.49 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -144.67 130.5 19.21 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.97 146.47 8.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.795 . . . . 0.0 110.025 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.12 -22.09 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.738 -0.601 . . . . 0.0 110.436 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 175.58 9.43 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.86 -166.1 1.31 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 68.14 44.3 77.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -48.28 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.513 0.673 . . . . 0.0 111.246 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 42' ' ' THR . 31.6 ttmt -97.8 -58.33 2.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.671 HG22 ' OG ' ' A' ' 133' ' ' SER . 33.5 p -156.29 118.43 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.0 pt -116.01 147.22 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.426 -0.796 . . . . 0.0 110.205 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -126.83 149.52 49.67 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.417 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.749 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.6 p -154.44 107.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.0 t -90.9 120.71 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.738 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.6 mp -100.11 163.29 12.49 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.456 0.646 . . . . 0.0 110.117 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 62.9 tp60 -116.55 117.64 30.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.748 HD13 ' OE2' ' A' ' 53' ' ' GLU . 35.9 mt -71.13 143.58 50.54 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.18 37.15 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.707 -0.621 . . . . 0.0 110.975 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.91 137.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 4.3 tt0 -76.93 108.14 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.748 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -137.6 176.78 8.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -87.25 179.79 6.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -140.5 133.06 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.885 . . . . 0.0 109.941 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HA ' HD21 ' A' ' 116' ' ' LEU . 9.4 t-160 -120.4 -32.81 4.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 0.0 109.692 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.43 163.28 33.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG22 ' HD1' ' A' ' 149' ' ' PHE . 83.3 t -143.37 166.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.614 -0.679 . . . . 0.0 109.215 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.638 ' C ' HD13 ' A' ' 60' ' ' ILE . 5.0 t0 -137.66 102.07 4.65 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.0 110.114 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.638 HD13 ' C ' ' A' ' 59' ' ' ASP . 1.6 mm -115.18 117.98 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.31 114.45 3.97 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.09 127.74 33.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.798 -0.825 . . . . 0.0 110.671 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 67.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.4 -30.1 10.2 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.37 -172.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.967 . . . . 0.0 109.62 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -155.0 -52.81 0.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.695 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.6 m-85 -99.93 123.13 43.84 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.839 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 60' ' ' ILE . 47.3 t -127.75 111.58 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.025 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.78 144.3 31.3 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.711 HG13 ' CD1' ' A' ' 130' ' ' ILE . 20.0 t -133.29 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.6 mp -111.47 158.84 18.67 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.788 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.4 m -120.67 158.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.728 -0.607 . . . . 0.0 110.361 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.44 174.26 44.54 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 t -115.78 159.67 21.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 109.821 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.405 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.3 p -75.51 -5.14 43.72 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.643 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.075 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.533 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.1 m-85 -109.42 -175.12 2.67 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.47 129.91 46.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 71' ' ' LEU . 38.9 t -59.34 87.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.806 -0.559 . . . . 0.0 111.222 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.788 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -59.96 -59.23 5.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD11 HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -137.23 124.06 21.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 109.209 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -54.72 -177.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 0.0 110.114 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.75 133.29 49.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 109.23 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 38.1 p -99.57 120.93 40.45 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -86.15 124.17 32.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 31.0 m-85 -118.67 -47.3 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.633 -0.667 . . . . 0.0 110.237 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 69.8 mtp -122.07 -174.65 2.94 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.603 0.716 . . . . 0.0 110.963 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.2 p -117.14 174.76 2.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.36 12.59 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.19 2.594 . . . . 0.0 111.563 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.4 -39.51 2.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.937 . . . . 0.0 109.754 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -80.2 -20.52 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.8 p -58.06 -22.75 51.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.396 -0.815 . . . . 0.0 110.547 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -68.3 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.216 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 38.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.69 -17.96 7.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.35 117.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.239 . . . . 0.0 110.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 39.76 72.71 0.94 Allowed Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 121.944 -0.473 . . . . 0.0 111.963 178.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.7 -30.33 4.94 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.747 2.298 . . . . 0.0 109.62 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.97 115.21 18.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 -168.78 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.504 -0.747 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.632 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 41.3 t -144.75 131.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HD2' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mmt85 -135.21 131.8 37.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.9 mtt -105.14 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.769 -0.582 . . . . 0.0 109.508 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.511 ' CE1' HG12 ' A' ' 60' ' ' ILE . 14.3 m-85 -140.26 163.98 31.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.74 0.781 . . . . 0.0 109.885 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -144.35 -153.68 5.93 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.6 Cg_endo -74.83 -24.3 13.35 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 123.602 2.868 . . . . 0.0 111.033 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -43.71 41.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.564 -0.71 . . . . 0.0 111.166 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.48 13.12 20.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 110.656 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -114.76 121.0 41.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -48.94 130.57 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.756 -0.59 . . . . 0.0 110.736 -177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.86 -39.24 87.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.443 -0.786 . . . . 0.0 109.224 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.77 89.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.747 -0.596 . . . . 0.0 110.572 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -92.08 -34.9 14.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.41 -0.806 . . . . 0.0 109.373 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.72 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.11 -33.73 3.71 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.595 -0.69 . . . . 0.0 110.993 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.02 10.81 40.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.801 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 2.4 mmtt -92.9 133.13 36.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -72.35 104.57 3.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.312 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 72.0 m95 -110.4 157.54 19.44 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 2.6 p30 -131.27 4.15 4.35 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.271 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.1 mtt180 -132.52 150.61 52.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -144.18 141.59 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.234 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.5 tttm -108.58 110.92 22.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.737 -0.602 . . . . 0.0 109.899 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.711 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.7 mm -104.71 118.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 44' ' ' SER . 39.9 t -122.56 122.1 65.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.26 -0.9 . . . . 0.0 110.03 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.541 ' SG ' HD22 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -95.62 145.72 25.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.671 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.35 126.71 12.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 111.892 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.29 138.94 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 43.8 Cg_endo -90.06 103.26 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 123.189 2.593 . . . . 0.0 110.178 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 65' ' ' SER . 5.4 p90 -137.17 -4.11 1.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.233 -0.917 . . . . 0.0 112.414 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 -173.86 3.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.847 -1.158 . . . . 0.0 110.463 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -173.44 -39.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -105.45 -42.08 5.32 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.647 0.736 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 1.0 OUTLIER -107.97 145.33 31.18 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.5 Cg_endo -87.02 166.89 8.26 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.119 2.546 . . . . 0.0 110.507 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -171.44 -164.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 109.07 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.6 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 164.43 -106.84 0.28 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.642 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -129.23 149.76 50.89 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -71.72 -18.01 62.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 122.097 -0.377 . . . . 0.0 111.021 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.632 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 40.0 p90 179.07 178.11 0.48 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.772 HG22 HD22 ' A' ' 24' ' ' LEU . 15.7 m -155.65 129.79 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -141.82 156.39 45.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 109.474 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 128' ' ' VAL . 39.6 m-85 -127.87 148.44 50.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -146.63 130.44 17.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.458 -0.776 . . . . 0.0 109.273 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 49' ' ' LEU . 71.4 mt -121.57 123.26 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.47 173.06 6.47 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.437 0.637 . . . . 0.0 109.781 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.6 mp -103.07 165.7 10.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.645 . . . . 0.0 109.57 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.611 ' C ' HD11 ' A' ' 25' ' ' LEU . 10.7 tpt180 -120.22 -47.39 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 48' ' ' GLN . 11.0 p-80 -161.0 -173.11 3.74 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -103.14 92.56 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.48 -0.762 . . . . 0.0 109.372 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -54.55 -60.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.544 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.31 163.63 18.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.444 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 19.7 p -160.05 149.37 17.71 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.059 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -152.31 51.91 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.681 -0.637 . . . . 0.0 109.975 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.715 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.63 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.939 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm100 -125.57 133.66 52.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.967 -1.083 . . . . 0.0 110.651 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.09 -175.5 5.67 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -64.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -56.66 12.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -95.32 69.73 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -86.82 166.84 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.6 -24.33 66.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.701 -0.624 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.51 -21.43 65.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.835 . . . . 0.0 109.712 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -65.71 -19.7 66.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.6 mt -65.72 -24.92 67.09 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.611 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -60.62 -20.83 61.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -109.23 62.69 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.86 -24.84 6.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 m-20 -118.31 78.15 1.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 28' ' ' ASP . 3.1 p -157.29 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.526 -0.734 . . . . 0.0 109.342 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -178.27 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -144.24 143.72 31.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -0.838 . . . . 0.0 108.798 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -130.58 -162.67 1.23 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.361 -0.837 . . . . 0.0 109.324 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.783 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.6 t90 -96.87 136.08 37.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -143.1 125.93 16.11 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.73 160.06 1.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 110.753 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -83.24 -45.05 14.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -152.03 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.51 -168.31 2.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.818 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 94.52 -22.62 36.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 12.1 mt-10 53.36 52.56 13.24 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.173 -1.193 . . . . 0.0 110.73 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -107.84 -103.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.38 -0.825 . . . . 0.0 109.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.54 HG22 ' OG ' ' A' ' 133' ' ' SER . 49.0 p -108.03 142.9 37.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.655 -1.278 . . . . 0.0 109.462 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 35' ' ' ALA . 5.6 pt -145.21 147.03 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.673 -0.642 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.676 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.721 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -151.06 106.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.5 t -93.66 116.56 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.99 . . . . 0.0 108.911 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -102.29 152.7 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.923 -178.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.506 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.4 tm0? -91.5 158.94 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.71 -0.619 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -107.22 124.94 50.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -52.29 -8.43 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.428 -0.795 . . . . 0.0 112.188 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -162.59 140.77 8.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.806 -1.184 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -75.87 113.72 13.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -147.52 -176.46 5.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.87 172.34 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' O ' HD22 ' A' ' 116' ' ' LEU . 4.4 mp -128.72 120.04 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 109.509 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.502 ' O ' HD21 ' A' ' 116' ' ' LEU . 23.1 t60 -110.62 -29.37 8.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -147.19 157.22 43.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.707 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.5 t -142.22 163.11 18.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.058 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 60' ' ' ILE . 7.0 m-20 -137.3 141.77 41.9 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.7 OUTLIER -154.87 123.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -87.68 121.7 5.98 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.6 125.59 29.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.971 -0.723 . . . . 0.0 110.162 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' N ' ' A' ' 145' ' ' SER . 2.5 t0 -126.39 62.98 1.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.6 -28.9 13.91 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.454 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 p -56.75 166.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.643 -0.916 . . . . 0.0 110.191 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.32 -57.37 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.16 123.36 45.18 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.56 111.66 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 0.0 110.204 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -105.06 141.43 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 130' ' ' ILE . 35.5 t -130.78 127.23 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.52 -0.737 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 HG22 ' A' ' 86' ' ' VAL . 1.9 mp -110.67 160.92 16.26 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG11 HD13 ' A' ' 87' ' ' LEU . 3.6 m -121.76 161.52 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.634 -0.666 . . . . 0.0 110.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 168.16 37.14 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 t -119.5 158.35 26.46 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.012 -0.699 . . . . 0.0 109.523 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.417 ' HB3' ' NE ' ' A' ' 127' ' ' ARG . 37.9 p -91.65 13.28 18.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 110.36 -179.378 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.17 -175.48 2.69 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.739 ' CD ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -139.52 135.79 33.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG22 HD11 ' A' ' 71' ' ' LEU . 24.3 t -58.08 89.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.636 -0.665 . . . . 0.0 111.952 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.66 HD13 HG11 ' A' ' 72' ' ' VAL . 12.6 tp -65.26 -54.0 35.83 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.631 HD13 ' CD2' ' A' ' 111' ' ' PHE . 2.1 pp -138.64 122.36 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.385 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.524 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -54.76 -177.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.175 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 t -69.64 136.53 51.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.494 -0.754 . . . . 0.0 109.171 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 125.72 52.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.429 0.633 . . . . 0.0 109.961 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -83.79 104.68 14.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 19.2 m-85 -101.89 -47.02 4.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 110.343 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.594 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 2.5 ttp -117.9 -178.5 3.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -114.89 173.76 2.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -88.17 18.88 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.288 2.658 . . . . 0.0 111.292 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.32 -50.0 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -21.43 39.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.395 -0.816 . . . . 0.0 110.307 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 p -45.71 -27.82 0.89 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.0 111.453 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -78.09 0.45 Allowed 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.761 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.8 37.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.45 -27.52 59.28 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 -82.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.542 -0.975 . . . . 0.0 110.489 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 5.8 p-10 -112.03 87.48 8.85 Favored Pre-proline 0 C--N 1.296 -1.735 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.594 ' O ' ' HE1' ' A' ' 94' ' ' MET . 37.5 Cg_endo -69.91 -24.93 28.42 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.651 2.234 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -136.43 148.1 47.59 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -157.68 -168.02 2.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.594 -0.691 . . . . 0.0 109.821 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 96.1 t -137.73 129.77 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 23.5 mmt-85 -137.81 150.48 47.23 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 37.4 mtm -134.43 166.51 22.68 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.596 0.712 . . . . 0.0 110.807 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.1 m-85 -119.76 171.13 8.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.65 -150.71 5.37 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.1 Cg_endo -76.0 -37.43 1.57 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.677 2.918 . . . . 0.0 110.77 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.34 -26.14 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.526 -0.734 . . . . 0.0 109.763 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.96 2.16 56.15 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.652 -0.655 . . . . 0.0 110.74 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.984 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -122.5 141.1 52.01 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.981 -1.074 . . . . 0.0 110.519 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.913 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -61.42 138.71 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -32.87 49.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.356 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.03 -18.12 65.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.503 -0.748 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.19 -45.64 2.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.267 -0.895 . . . . 0.0 110.007 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.05 -39.58 28.05 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.342 -0.849 . . . . 0.0 111.08 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -81.37 1.18 34.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 15.9 mttt -94.04 134.27 36.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -68.58 112.43 5.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.446 -0.784 . . . . 0.0 110.919 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 79.4 m95 -115.14 166.44 11.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.66 12.31 2.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.714 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.73 ' HD3' HG21 ' A' ' 10' ' ' VAL . 7.8 mtt180 -146.92 141.5 26.59 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.93 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.8 p -131.79 143.79 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.579 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HG3' HG22 ' A' ' 46' ' ' VAL . 5.8 tttp -107.64 114.11 27.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.609 . . . . 0.0 109.48 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 44.8 mm -105.5 115.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.648 -0.658 . . . . 0.0 109.599 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.676 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.4 t -122.23 116.27 48.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.2 t -89.34 156.6 18.61 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -151.44 127.81 10.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.361 -0.837 . . . . 0.0 110.988 -178.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.746 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.0 tp60 149.32 136.11 0.0 OUTLIER Pre-proline 0 N--CA 1.519 3.002 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 43.4 Cg_endo -85.89 91.29 0.66 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.906 2.404 . . . . 0.0 110.269 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.47 -0.38 57.45 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.491 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 t -168.3 -162.69 0.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.791 -1.193 . . . . 0.0 110.261 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mtpt -138.89 -39.34 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -117.17 -13.76 10.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -0.984 . . . . 0.0 111.343 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -104.6 142.3 24.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.324 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 46.6 Cg_endo -88.03 177.13 3.56 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.479 2.786 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 173.14 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.594 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 165.37 -112.98 0.53 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.962 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -133.07 160.02 38.4 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.238 -1.154 . . . . 0.0 110.731 -179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 67.3 m -78.64 -21.86 47.77 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.752 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.5 p90 177.08 178.95 0.24 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.249 -0.907 . . . . 0.0 110.459 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 144' ' ' LEU . 33.7 m -154.21 129.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 3.2 mtt85 -139.95 114.4 9.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.766 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.93 ' CE2' HG11 ' A' ' 128' ' ' VAL . 73.0 m-85 -87.94 157.25 18.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.281 -0.887 . . . . 0.0 108.901 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -154.2 136.8 15.14 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.353 -0.842 . . . . 0.0 109.174 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.651 -0.655 . . . . 0.0 110.913 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.749 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -141.04 128.74 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -113.42 151.33 31.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.926 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.2 tp -84.74 149.47 25.75 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.628 ' C ' HD11 ' A' ' 25' ' ' LEU . 11.7 tpt85 -103.87 -50.26 3.44 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -161.03 -178.59 6.88 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -99.96 97.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG13 ' H ' ' A' ' 11' ' ' SER . 2.2 p -54.77 -59.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.329 -0.857 . . . . 0.0 110.442 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.541 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.54 154.25 36.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.147 -0.971 . . . . 0.0 108.75 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . 23.8 p -143.4 125.26 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.0 110.715 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.3 m -127.51 50.1 2.05 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.587 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 154.23 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.87 ' OE1' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.41 146.23 36.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 109.883 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.34 -170.72 2.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.72 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -99.38 -68.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.785 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -37.79 87.24 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -116.56 70.11 0.76 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.9 p -87.5 172.37 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.189 0.995 . . . . 0.0 109.53 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -64.9 -24.98 67.69 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.231 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.78 -20.4 56.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.807 . . . . 0.0 109.509 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.42 -20.5 66.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.3 mt -66.27 -26.94 67.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.628 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.2 mm? -61.65 -18.84 61.14 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.474 -0.766 . . . . 0.0 109.175 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -112.25 66.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.54 -45.4 56.87 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.541 -0.724 . . . . 0.0 110.366 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.86 78.98 7.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.058 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.0 -152.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -130.8 40.3 3.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.069 -1.02 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -149.83 136.55 19.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -160.24 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.493 -0.755 . . . . 0.0 109.738 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.877 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.0 t90 -85.43 140.24 30.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.264 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 129.69 22.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.69 161.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.305 -0.872 . . . . 0.0 110.498 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.57 -30.08 66.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.971 -0.456 . . . . 0.0 110.021 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -174.24 3.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.5 -165.27 1.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.57 45.01 95.69 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -46.12 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 111.812 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 42' ' ' THR . 28.1 tttt -94.77 -56.4 2.79 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.686 HG22 ' OG ' ' A' ' 133' ' ' SER . 17.2 p -158.13 113.05 2.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.877 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.0 pt -111.13 139.65 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.608 -0.683 . . . . 0.0 109.527 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' HG13 ' A' ' 131' ' ' VAL . 50.6 m -126.27 122.65 36.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.523 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.87 HG23 ' OE1' ' A' ' 15' ' ' GLN . 7.2 p -123.23 125.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.864 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.5 t -104.48 113.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.08 171.09 8.25 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.364 0.602 . . . . 0.0 110.281 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.726 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.79 174.49 5.9 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.749 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.5 mm? -124.3 140.43 52.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -76.52 26.55 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.214 -0.929 . . . . 0.0 111.469 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.6 pttt 167.1 132.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.77 111.69 11.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.09 167.82 21.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.642 ' O ' HD13 ' A' ' 55' ' ' ILE . 21.8 mt-30 -72.26 -178.77 2.61 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 54' ' ' GLN . 2.6 mm -126.6 128.8 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.417 ' CE1' ' HG3' ' A' ' 113' ' ' PRO . 77.0 t60 -120.69 -38.97 2.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 m -147.11 162.46 38.8 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.642 HG13 ' CD1' ' A' ' 149' ' ' PHE . 89.4 t -147.37 162.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 58' ' ' VAL . 1.8 m-20 -139.92 127.83 22.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.593 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -143.48 130.46 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.14 128.48 9.53 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.78 115.29 20.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.129 -0.63 . . . . 0.0 109.692 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 9.4 t0 -105.45 61.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.63 -29.08 12.72 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 86.3 p -60.62 173.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.88 -52.71 0.52 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.4 m-85 -95.34 123.99 39.14 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' ILE . 44.0 t -127.77 111.92 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.553 -0.717 . . . . 0.0 110.036 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -103.28 140.13 37.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG13 ' CD1' ' A' ' 130' ' ' ILE . 29.1 t -126.46 122.7 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.14 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -112.13 162.01 15.89 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.879 HG21 HD13 ' A' ' 87' ' ' LEU . 3.2 m -129.14 160.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 110.275 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.15 174.8 46.74 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -112.03 160.27 17.65 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.799 0.809 . . . . 0.0 109.949 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.437 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 56.0 p -86.37 7.27 26.3 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.973 . . . . 0.0 110.103 -179.552 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.66 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -103.12 -174.43 2.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.488 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -119.32 124.77 47.45 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.12 85.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.798 -0.563 . . . . 0.0 110.446 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.879 HD13 HG21 ' A' ' 72' ' ' VAL . 3.4 tp -57.91 -56.29 23.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.195 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -140.41 124.57 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.629 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -55.92 172.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.542 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -59.48 134.37 56.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.4 p -107.57 124.89 50.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.594 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -84.27 125.03 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CD1' ' CD ' ' A' ' 109' ' ' ARG . 28.7 m-85 -121.66 -43.31 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 3.0 mtp -120.4 -165.28 1.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.658 . . . . 0.0 110.086 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.5 p -129.37 175.13 3.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.93 13.64 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 123.178 2.585 . . . . 0.0 111.257 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.6 m -120.36 -46.34 2.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 -22.92 29.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -50.13 -36.32 29.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 110.919 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -74.5 -84.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.853 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -163.59 37.29 0.09 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.66 -25.25 54.13 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.632 -0.922 . . . . 0.0 110.45 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 90.48 30.51 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.513 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.25 -21.54 23.25 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.537 2.158 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.44 ' ND2' ' OD1' ' A' ' 63' ' ' ASP . 0.9 OUTLIER -124.47 156.51 37.1 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -156.41 -175.18 5.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 0.0 110.228 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 42.6 t -155.7 115.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' CD ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.49 165.69 19.37 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.378 -0.826 . . . . 0.0 109.679 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.4 mtt -140.43 175.46 9.58 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.497 0.665 . . . . 0.0 110.153 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.5 m-85 -136.7 159.0 43.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 116' ' ' LEU . . . -125.82 -155.01 8.85 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -75.42 -36.77 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.274 2.65 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.45 -29.12 68.49 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -2.72 44.36 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.551 HD12 ' CB ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -124.99 141.19 52.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.948 -1.095 . . . . 0.0 109.956 179.123 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -51.56 139.98 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -39.2 62.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.157 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.56 -20.91 63.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.51 -43.64 3.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.551 ' CB ' HD12 ' A' ' 116' ' ' LEU . . . -48.3 -32.56 7.52 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.249 -0.907 . . . . 0.0 111.119 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.01 24.23 5.74 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.0 mttm -114.86 137.02 52.46 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -65.34 116.24 6.45 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.78 0.8 . . . . 0.0 110.462 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.487 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 63.2 m95 -122.66 151.05 41.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -133.52 5.19 3.71 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.429 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -132.75 141.39 48.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.774 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.7 p -135.06 141.17 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.655 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.864 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.4 tttt -109.59 121.09 44.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.813 -0.554 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.6 mm -115.5 114.07 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 109.142 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG13 ' OG ' ' A' ' 44' ' ' SER . 61.2 t -114.88 116.83 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.353 -0.842 . . . . 0.0 109.946 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.444 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -92.49 137.38 32.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.686 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -137.94 123.44 19.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.507 -178.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.8 tp60 166.43 133.46 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -87.02 95.05 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.928 2.419 . . . . 0.0 108.952 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.1 p90 -127.79 -7.25 5.59 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.273 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.12 178.65 6.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.0 110.527 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -156.96 -42.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.83 -36.7 5.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.49 -0.756 . . . . 0.0 109.669 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.41 147.67 34.33 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -87.5 178.43 3.38 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.286 2.657 . . . . 0.0 110.777 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER 178.93 -171.9 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.45 -112.1 0.49 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.907 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.593 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.7 mp -111.88 148.79 32.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.68 -0.894 . . . . 0.0 110.412 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -84.89 -27.66 26.5 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.621 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 52.1 p90 -176.03 169.8 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.673 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.8 m -150.15 134.69 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.161 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 17.3 mtt180 -145.63 113.98 6.67 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.531 -0.731 . . . . 0.0 109.855 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 128' ' ' VAL . 64.1 m-85 -93.3 152.56 19.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 133.54 20.81 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.396 -0.815 . . . . 0.0 108.805 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.424 ' CB ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.725 -0.609 . . . . 0.0 109.364 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.356 0.598 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' OE1' ' A' ' 53' ' ' GLU . 47.7 mm -79.67 134.72 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -108.24 113.85 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 109.955 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.942 HD12 HD23 ' A' ' 49' ' ' LEU . 3.3 tp -79.76 140.77 36.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.672 -0.643 . . . . 0.0 109.359 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -91.94 -65.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.531 -0.731 . . . . 0.0 109.519 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -160.39 173.22 15.95 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 22' ' ' GLU . 7.1 p -79.76 90.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.211 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG21 HH11 ' A' ' 127' ' ' ARG . 2.3 p -53.07 -55.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.171 -0.956 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.468 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.19 154.22 37.76 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.989 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.61 125.32 12.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 110.089 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -120.45 45.75 2.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.649 -0.657 . . . . 0.0 109.516 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.606 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.84 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.744 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.83 136.97 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -162.47 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.162 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -93.45 -69.41 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -60.74 2.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.731 . . . . 0.0 109.122 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -88.05 68.43 9.16 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -92.12 170.9 9.46 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.727 0.775 . . . . 0.0 110.219 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.55 -24.26 67.74 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.98 -0.45 . . . . 0.0 109.889 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -61.57 -19.56 62.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.5 -18.48 65.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.843 . . . . 0.0 109.157 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.0 mt -65.13 -25.12 67.62 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.3 mm? -60.08 -20.61 58.96 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.47 -0.769 . . . . 0.0 109.033 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -127.29 73.8 1.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.81 -51.25 30.35 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.651 -0.656 . . . . 0.0 110.845 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.92 79.12 8.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -162.22 31.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 109.618 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.2 p90 46.99 25.18 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.242 0.544 . . . . 0.0 111.765 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -126.62 126.05 42.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 108.972 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -123.48 169.83 11.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.33 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.754 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.5 t90 -74.18 141.07 45.53 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -143.19 130.57 21.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.48 151.73 3.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.463 -0.773 . . . . 0.0 110.239 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.41 -33.79 71.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.61 -0.681 . . . . 0.0 109.702 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.24 -157.66 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.72 167.05 18.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.412 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 138' ' ' LYS . . . 96.03 -34.96 4.59 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 3.9 mp0 51.79 104.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.944 . . . . 0.0 111.782 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 42' ' ' THR . 23.8 ttmt -117.31 -51.02 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.727 HG22 ' OG ' ' A' ' 133' ' ' SER . 4.1 p -158.9 105.01 1.76 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 18.7 pt -105.68 139.88 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.361 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.547 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -121.92 149.26 43.67 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.164 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -153.6 112.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.743 HG22 ' HG2' ' A' ' 129' ' ' LYS . 5.8 t -94.08 119.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -97.27 161.25 13.89 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.416 0.627 . . . . 0.0 109.941 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -107.78 145.28 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.38 0.61 . . . . 0.0 109.355 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 HD12 ' A' ' 6' ' ' LEU . 39.1 mt -104.95 133.67 49.34 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 31.9 tt0 -81.68 45.62 0.9 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.448 -0.783 . . . . 0.0 110.612 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 160.0 126.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -73.79 107.88 6.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.54 178.0 7.38 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.406 0.622 . . . . 0.0 109.588 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.92 177.23 6.54 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.0 mp -130.72 119.04 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.53 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -108.72 -29.0 8.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.63 -0.669 . . . . 0.0 109.435 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 20.8 m -149.26 146.35 27.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.0 t -131.8 162.07 40.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.454 0.645 . . . . 0.0 109.701 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 60' ' ' ILE . 34.7 t0 -141.79 136.07 30.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 HG11 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -156.58 132.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -106.1 131.74 10.79 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.48 128.03 34.36 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 122.185 -0.597 . . . . 0.0 110.244 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.7 71.33 1.7 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.3 7.45 88.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -84.06 -173.47 4.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.762 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -142.88 -51.65 0.37 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -103.09 130.8 50.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.672 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 60' ' ' ILE . 48.0 t -134.53 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.657 . . . . 0.0 109.575 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -105.56 151.36 24.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.761 -0.587 . . . . 0.0 109.486 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.7 t -141.53 122.99 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.855 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.2 mp -110.56 163.71 13.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG1' HD22 ' A' ' 87' ' ' LEU . 2.9 m -127.86 156.73 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.713 -0.617 . . . . 0.0 109.781 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.29 176.25 45.22 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 t -110.32 156.71 20.36 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.2 p -85.77 7.59 23.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.442 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 179.858 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.2 t0 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.4 m-85 -113.16 -177.92 3.25 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.741 0.781 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -123.69 129.04 50.5 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.32 86.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 110.292 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.587 HD22 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tp -59.04 -54.41 47.36 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.66 120.73 10.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -57.42 172.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.559 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -57.31 134.06 55.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.3 p -105.34 126.89 52.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.413 0.625 . . . . 0.0 109.325 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 96.2 p -87.88 119.94 28.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 18.1 m-85 -110.21 -51.51 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.629 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.416 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 19.1 mtp -122.03 -162.71 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.508 0.671 . . . . 0.0 110.084 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.1 p -123.51 177.45 1.7 Allowed Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.79 11.53 3.31 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.929 2.419 . . . . 0.0 111.279 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 -36.72 3.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.314 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -81.65 -16.39 51.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.78 . . . . 0.0 110.226 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 m -59.44 -24.67 63.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -67.45 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 t -162.28 38.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 108.722 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.7 -22.32 6.73 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.96 119.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 109.935 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.416 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.9 OUTLIER 40.87 68.72 2.25 Favored Pre-proline 0 N--CA 1.508 2.449 0 O-C-N 121.949 -0.469 . . . . 0.0 111.233 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.1 -30.71 4.16 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.949 2.433 . . . . 0.0 110.52 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.61 82.58 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.665 -0.647 . . . . 0.0 109.647 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.9 171.99 7.54 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -127.29 172.84 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -155.82 145.9 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 109.144 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.4 mtt -123.71 153.7 40.49 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.45 0.643 . . . . 0.0 110.096 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.601 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.9 m-85 -114.8 161.33 18.34 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -131.3 -149.39 6.44 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 38.7 Cg_endo -74.72 -39.36 1.37 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.614 2.876 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.62 -28.29 69.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -89.99 3.77 52.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.662 -0.649 . . . . 0.0 110.598 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.968 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.61 139.66 53.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.013 -1.054 . . . . 0.0 110.521 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.7 p -59.6 130.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -74.84 -30.81 61.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.475 -0.766 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -20.63 65.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.506 -0.746 . . . . 0.0 110.217 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.98 -46.25 2.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.915 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.968 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.8 -39.55 25.76 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.165 -0.959 . . . . 0.0 111.439 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.13 -0.15 30.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.35 -0.843 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.7 mtpt -92.36 134.42 34.94 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -67.76 113.55 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -0.769 . . . . 0.0 110.766 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -116.31 163.85 15.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.11 7.41 3.41 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.585 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.501 HH11 HG21 ' A' ' 10' ' ' VAL . 19.4 mtm180 -137.39 149.45 46.96 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.3 p -134.77 138.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.956 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HG2' HG22 ' A' ' 46' ' ' VAL . 1.4 tmtm? -106.36 100.81 10.32 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.929 -0.482 . . . . 0.0 109.761 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.8 mm -97.14 118.7 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 44' ' ' SER . 34.2 t -121.95 122.28 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.343 -0.848 . . . . 0.0 109.613 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.5 t -100.57 138.94 36.95 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.727 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -138.25 132.2 31.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.507 -0.746 . . . . 0.0 111.427 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.727 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 151.19 134.79 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.52 103.83 1.12 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.918 2.412 . . . . 0.0 109.587 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -77.14 -62.54 1.62 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.462 0.649 . . . . 0.0 109.612 -179.203 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.62 -161.58 1.37 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.879 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 16.4 mttm -136.29 34.13 2.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 109.389 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -77.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.12 158.19 37.75 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.977 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.6 Cg_endo -80.8 176.56 8.89 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.625 2.883 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -173.55 -166.11 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.78 -111.0 0.46 Allowed Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.771 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.585 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -117.93 149.94 40.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.598 -0.942 . . . . 0.0 110.465 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.7 m -83.67 -26.22 30.04 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -178.65 164.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.502 -0.749 . . . . 0.0 109.023 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 24' ' ' LEU . 26.3 m -140.17 138.37 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.27 149.42 32.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.582 -0.699 . . . . 0.0 109.589 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.645 ' CD1' HG13 ' A' ' 58' ' ' VAL . 58.7 m-85 -127.71 160.95 30.11 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.41 ' CA ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -155.14 120.42 4.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.275 -0.89 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.701 -0.624 . . . . 0.0 110.349 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' NZ ' ' A' ' 51' ' ' LYS . 68.0 mt -135.8 128.7 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.562 -0.711 . . . . 0.0 109.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.597 ' C ' HD22 ' A' ' 6' ' ' LEU . 41.3 mtt180 -120.08 -175.79 3.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.458 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.4 mm? -111.84 160.48 17.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.668 -0.645 . . . . 0.0 109.613 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -108.06 -48.07 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -160.59 162.25 32.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.28 86.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -51.37 -55.92 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.25 155.63 36.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.53 114.8 4.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -0.869 . . . . 0.0 110.336 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -104.67 47.38 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.487 ' HB2' HG22 ' A' ' 43' ' ' ILE . 3.3 t 151.87 111.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.889 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.2 pp0? -161.1 127.63 3.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.064 -1.023 . . . . 0.0 109.834 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.7 150.21 24.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m -61.45 -55.17 34.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.877 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -60.52 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.358 -0.839 . . . . 0.0 108.859 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -102.48 85.45 2.61 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -93.46 163.48 13.56 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.513 0.673 . . . . 0.0 110.096 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.72 -22.01 64.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.838 -0.539 . . . . 0.0 110.007 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.5 tt0 -62.97 -20.73 65.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.819 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -65.45 -18.97 65.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 33' ' ' TRP . 15.5 mt -66.26 -26.06 67.17 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.28 -17.4 62.47 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.562 -0.712 . . . . 0.0 109.25 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HB3' HG21 ' A' ' 29' ' ' THR . 5.3 mmmm -113.12 65.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.22 -26.77 3.14 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.537 -0.727 . . . . 0.0 110.809 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' C ' HG23 ' A' ' 29' ' ' THR . 25.5 t0 -99.75 68.17 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 26' ' ' LYS . 73.9 p -154.97 -161.09 1.14 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -127.56 34.41 4.68 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.365 -0.834 . . . . 0.0 109.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -124.62 105.5 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 35.9 mttt -91.27 162.83 14.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.609 -0.682 . . . . 0.0 109.738 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.729 ' HB2' HD21 ' A' ' 24' ' ' LEU . 23.4 t90 -67.76 139.62 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 127.05 16.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -56.49 164.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 110.616 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -85.16 -30.55 23.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 -156.8 0.53 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.601 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -137.65 172.52 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.83 -25.35 25.56 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mt-10 45.3 51.0 9.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.687 -0.89 . . . . 0.0 112.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 11.7 ttpt -67.06 -59.21 3.66 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.779 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.1 p -160.44 133.79 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -134.54 152.77 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.274 -0.891 . . . . 0.0 110.554 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -129.69 150.37 51.03 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -149.66 106.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' A' ' 129' ' ' LYS . 2.9 t -90.89 118.46 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.729 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.38 158.2 16.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' N ' HD12 ' A' ' 6' ' ' LEU . 17.1 tm0? -104.75 131.21 52.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.554 -0.716 . . . . 0.0 109.683 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 4' ' ' ILE . 4.2 mm? -81.19 121.23 25.88 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -54.06 -6.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.761 ' NZ ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -153.66 150.39 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.877 -1.14 . . . . 0.0 108.033 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.87 111.3 22.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.77 . . . . 0.0 109.013 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.43 -178.59 6.32 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -84.34 -171.02 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.1 115.77 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.507 -0.746 . . . . 0.0 109.313 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.0 t-160 -101.36 -32.01 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.8 m -147.48 153.98 40.22 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.703 HG13 ' CD1' ' A' ' 149' ' ' PHE . 79.7 t -136.72 161.14 36.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.643 -0.661 . . . . 0.0 109.726 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.553 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 27.5 t0 -139.11 139.24 37.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.617 -0.677 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -157.86 132.12 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -106.46 128.74 9.43 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -80.14 123.32 27.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.157 -0.614 . . . . 0.0 110.521 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 24.9 t0 -97.54 72.41 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 12.5 83.24 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 10.8 t -85.8 172.9 10.43 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.304 -1.115 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -134.8 -56.05 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.8 m-85 -102.26 122.89 45.1 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.702 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 60' ' ' ILE . 43.8 t -126.43 112.52 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.705 . . . . 0.0 109.85 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -104.36 142.47 34.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.71 HG13 HD13 ' A' ' 130' ' ' ILE . 22.2 t -131.08 128.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.967 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.6 mp -115.68 161.26 18.95 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -122.89 161.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.734 -0.604 . . . . 0.0 109.996 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 173.35 41.87 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 t -112.22 162.2 15.73 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.728 0.775 . . . . 0.0 109.833 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 13.0 t -86.27 6.19 30.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.055 -179.588 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.577 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.8 m-85 -106.45 -175.01 2.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.71 0.767 . . . . 0.0 109.061 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.644 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -122.66 126.6 47.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.06 87.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.688 -0.633 . . . . 0.0 110.637 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.1 tp -60.15 -51.82 67.95 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.695 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -146.41 122.69 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.25 -177.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.531 -0.731 . . . . 0.0 110.073 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 135.71 55.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.558 -0.714 . . . . 0.0 109.187 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.422 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.4 p -105.74 123.41 47.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.78 -0.575 . . . . 0.0 109.597 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.7 p -85.25 109.81 18.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 26.7 m-85 -104.65 -49.19 3.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 22.0 mtp -121.21 172.67 7.82 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.718 0.77 . . . . 0.0 110.724 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -104.47 179.38 0.95 Allowed Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.261 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.7 Cg_endo -86.66 16.39 1.97 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.964 2.443 . . . . 0.0 111.341 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 t -120.12 -50.94 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.235 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.16 -12.9 61.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 110.111 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t -58.79 -24.37 61.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -91.55 -73.17 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.07 37.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.82 -21.83 54.74 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.76 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -1.021 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.94 95.78 0.61 Allowed Pre-proline 0 C--N 1.292 -1.912 0 O-C-N 121.814 -0.554 . . . . 0.0 109.51 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.21 -25.95 4.54 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.948 2.432 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -127.6 119.41 25.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.738 -0.601 . . . . 0.0 109.786 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -147.08 174.43 11.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.52 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.3 m -135.95 166.68 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -154.73 153.88 31.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.452 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.43 156.99 39.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.48 0.657 . . . . 0.0 110.274 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE2' HD13 ' A' ' 88' ' ' LEU . 4.7 m-85 -118.08 167.45 11.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.65 -149.2 5.52 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.94 -39.84 1.1 Allowed 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 123.692 2.928 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.25 -27.87 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.533 -0.73 . . . . 0.0 109.833 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.0 mptp? -91.98 3.76 54.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.665 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.3 pp -123.46 139.86 53.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.022 -1.049 . . . . 0.0 110.549 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -60.42 130.62 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -74.46 -33.76 62.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.83 -21.17 66.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.271 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.68 -47.33 2.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 110.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.4 17.78 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.16 -0.963 . . . . 0.0 111.626 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.92 3.08 27.68 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.745 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 1.1 mtpm? -95.52 136.22 36.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -67.11 113.38 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.48 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.7 m95 -117.43 163.76 15.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.44 14.98 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -142.3 142.48 32.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.7 p -136.61 143.03 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 110.366 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 46' ' ' VAL . 2.5 tttt -111.62 110.43 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.766 -0.584 . . . . 0.0 109.892 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.71 HD13 HG13 ' A' ' 70' ' ' VAL . 47.4 mm -101.82 129.46 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 44' ' ' SER . 28.0 t -130.98 130.01 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.184 -0.947 . . . . 0.0 110.591 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 43' ' ' ILE . 9.7 t -99.71 149.23 23.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.779 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -150.26 118.77 6.48 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.609 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.5 OUTLIER 160.03 112.24 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.451 ' HD2' ' NE2' ' A' ' 134' ' ' GLN . 39.2 Cg_endo -76.3 97.19 1.11 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.342 2.028 . . . . 0.0 108.725 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.527 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -103.62 -11.42 17.7 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.407 -178.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.76 -167.38 2.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.072 -1.017 . . . . 0.0 110.065 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.78 -47.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.746 -0.597 . . . . 0.0 109.631 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.601 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p30 -108.2 -13.37 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.536 -0.727 . . . . 0.0 110.925 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 35.5 p -99.07 138.46 20.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.265 -0.897 . . . . 0.0 109.861 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.1 Cg_endo -88.2 -177.67 1.91 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.354 2.703 . . . . 0.0 110.502 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 174.52 -164.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 157.44 -115.24 0.65 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.206 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.564 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -120.8 162.29 20.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.685 -0.891 . . . . 0.0 110.84 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 13.7 m -99.14 -27.81 13.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 53.4 p90 -178.05 171.2 1.76 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 147' ' ' VAL . 35.7 m -149.01 123.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -130.26 110.92 11.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 128' ' ' VAL . 85.9 m-85 -90.94 161.97 14.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.238 -0.914 . . . . 0.0 109.105 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -157.33 136.29 11.69 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.666 ' CG2' HD12 ' A' ' 49' ' ' LEU . 61.4 mt -110.43 122.18 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.09 166.32 10.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.68 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.7 mp -103.93 160.19 15.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.697 -0.627 . . . . 0.0 109.557 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -110.23 -54.05 2.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -160.55 164.99 31.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -79.89 93.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.5 -0.75 . . . . 0.0 109.322 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG13 ' H ' ' A' ' 11' ' ' SER . 2.1 p -54.17 -58.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.246 -0.909 . . . . 0.0 110.272 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -121.03 151.67 39.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -143.83 124.3 13.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.995 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -121.5 46.21 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.534 -0.729 . . . . 0.0 109.586 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.09 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.18 143.05 31.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.243 -0.911 . . . . 0.0 109.114 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.25 -161.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 p -98.47 -57.37 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.436 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.67 66.31 4.42 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -82.67 171.94 13.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.53 -0.731 . . . . 0.0 109.893 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.37 -24.05 67.68 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.85 -19.28 63.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -65.78 -17.33 64.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.937 . . . . 0.0 109.322 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 33' ' ' TRP . 19.1 mt -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -62.06 -18.74 61.64 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.528 -0.732 . . . . 0.0 109.252 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 67.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.37 62.49 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.466 -0.771 . . . . 0.0 110.323 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.12 76.51 9.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.469 -0.769 . . . . 0.0 108.984 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 -154.2 0.37 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -130.71 36.48 3.9 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -142.5 121.51 12.86 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -113.19 -165.38 0.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 109.452 -179.164 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.717 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.4 t90 -81.9 139.67 34.53 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 125.19 16.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.64 148.83 6.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.766 . . . . 0.0 110.359 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.91 -20.22 56.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.94 -0.475 . . . . 0.0 110.228 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -138.82 -171.77 3.16 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.354 -0.841 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.32 -161.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.83 43.55 97.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.1 mm-40 -48.47 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.959 0.885 . . . . 0.0 111.328 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -102.78 -50.73 3.46 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.717 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.4 p -158.86 115.39 2.7 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.676 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.3 pt -120.52 148.69 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.4 -0.812 . . . . 0.0 109.617 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.731 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -125.82 146.97 49.57 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.455 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.5 p -152.32 106.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.8 t -92.38 121.03 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -98.72 160.17 14.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.77 53.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.679 -0.638 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -82.03 138.22 34.92 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.14 38.95 0.49 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.537 -0.727 . . . . 0.0 110.503 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 pttm 161.63 132.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -75.94 107.62 8.26 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -138.15 179.36 6.49 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.445 0.641 . . . . 0.0 109.455 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -90.96 174.75 7.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.14 119.06 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.8 . . . . 0.0 109.677 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.436 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.9 t60 -110.01 -29.31 8.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.5 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.1 m -145.53 154.42 42.17 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.8 t -138.99 163.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.616 -0.677 . . . . 0.0 109.76 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -145.06 125.83 14.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.3 mp -147.84 137.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.951 -1.093 . . . . 0.0 108.3 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.87 126.7 8.94 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -83.46 123.04 29.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 122.042 -0.681 . . . . 0.0 110.462 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.9 70.87 3.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.37 7.35 88.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -76.91 166.54 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -1.141 . . . . 0.0 109.603 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -127.91 -55.47 1.29 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -103.87 120.92 42.0 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.904 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.56 103.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 6.2 tt0 -86.88 147.04 25.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.415 0.626 . . . . 0.0 109.92 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HD23 ' A' ' 88' ' ' LEU . 56.7 t -136.92 119.52 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.708 HD11 HG22 ' A' ' 86' ' ' VAL . 1.1 mp -114.72 164.54 13.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.743 HG11 HD13 ' A' ' 87' ' ' LEU . 13.6 m -127.93 163.33 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 110.351 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.56 170.28 37.56 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -114.01 160.27 19.04 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 122.027 -0.69 . . . . 0.0 109.213 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 t -92.25 12.82 21.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.917 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.64 157.59 29.24 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 145.91 42.58 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.708 HG22 HD11 ' A' ' 71' ' ' LEU . 43.6 t -65.8 90.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.763 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.743 HD13 HG11 ' A' ' 72' ' ' VAL . 1.2 tp -72.78 -58.43 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -117.6 117.55 29.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -61.79 171.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.617 -0.677 . . . . 0.0 109.174 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.54 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -64.24 132.67 50.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.84 121.09 39.34 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.1 p -87.19 93.13 9.29 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 25.0 m-85 -84.23 -52.93 5.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 110.403 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 22.2 mtp -121.33 -168.85 1.75 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.543 -0.723 . . . . 0.0 110.428 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.4 p -115.92 176.76 1.4 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.62 14.86 2.33 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.041 2.494 . . . . 0.0 111.32 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.0 p -121.19 -37.69 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.001 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.88 -24.9 32.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -58.53 -20.73 48.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.734 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -69.32 -84.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.23 39.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 108.745 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.65 -18.27 5.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.97 123.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -1.17 . . . . 0.0 110.159 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 6.5 p30 41.59 66.82 3.55 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 122.066 -0.396 . . . . 0.0 111.504 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.61 -29.89 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.746 2.298 . . . . 0.0 110.488 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.3 6.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.687 -0.633 . . . . 0.0 109.601 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.55 174.98 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.752 . . . . 0.0 109.104 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.3 m -140.32 141.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 2.5 mmt-85 -134.35 176.99 8.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 mtt -142.08 178.56 7.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.697 -0.627 . . . . 0.0 109.842 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 88' ' ' LEU . 1.3 m-85 -141.92 171.16 14.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.52 -148.05 5.26 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -75.04 -36.63 2.42 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.595 2.863 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.84 -31.78 73.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -81.95 1.75 33.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.715 -0.615 . . . . 0.0 110.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.967 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -130.59 137.84 49.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.167 -0.958 . . . . 0.0 109.639 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.899 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.3 p -56.96 163.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 117' ' ' VAL . 3.6 mtp180 -97.78 -40.63 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.884 . . . . 0.0 109.142 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.02 -17.63 57.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 110.23 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.899 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.42 -50.81 2.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.35 -39.26 21.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.311 -0.868 . . . . 0.0 111.447 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -78.17 -1.85 34.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 110.656 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 23.2 mtpt -91.77 133.7 35.39 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -68.0 111.27 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.825 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 80.1 m95 -113.27 163.46 14.78 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -135.9 10.18 3.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.267 -0.895 . . . . 0.0 110.312 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 75' ' ' SER . 14.6 mtm180 -142.55 139.53 31.44 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.752 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.0 p -130.14 142.07 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.835 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.7 tttt -109.1 114.19 27.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.668 -0.645 . . . . 0.0 109.843 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 45' ' ' VAL . 47.9 mm -105.78 119.64 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.731 HG22 ' HB3' ' A' ' 44' ' ' SER . 44.1 t -124.92 117.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 O-C-N 121.208 -0.932 . . . . 0.0 110.057 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.461 ' HB3' HG13 ' A' ' 43' ' ' ILE . 7.0 t -89.14 142.72 27.4 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.717 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -141.26 124.81 16.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.717 -0.614 . . . . 0.0 110.6 -178.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.6 tp-100 158.33 131.51 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.446 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.35 93.22 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.021 2.481 . . . . 0.0 109.432 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.2 p90 -127.07 15.31 7.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.595 -0.69 . . . . 0.0 111.034 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.63 -169.57 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -176.06 -40.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.97 -36.41 4.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.547 0.689 . . . . 0.0 109.662 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.85 150.84 38.62 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.89 -0.506 . . . . 0.0 109.657 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.95 -171.42 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.354 2.703 . . . . 0.0 110.623 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.85 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.574 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 152.38 -113.5 0.58 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.366 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.575 HD23 HG23 ' A' ' 60' ' ' ILE . 6.4 mp -124.08 151.51 43.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.732 -0.863 . . . . 0.0 110.992 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 48.9 m -86.45 -26.64 24.57 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.538 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 37.5 p90 -175.54 168.48 3.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.5 m -146.02 142.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.8 mtp85 -150.38 160.41 43.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 109.323 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CE2' HG11 ' A' ' 128' ' ' VAL . 38.7 m-85 -142.19 155.77 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 129.24 10.27 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.76 -0.587 . . . . 0.0 109.947 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 151' ' ' SER . 55.3 mt -143.17 126.74 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.72 . . . . 0.0 109.433 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.705 -0.622 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.798 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.1 mp -107.14 161.07 15.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.635 -0.665 . . . . 0.0 109.858 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' C ' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -109.05 -57.71 2.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.686 -0.634 . . . . 0.0 109.31 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -160.8 164.13 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.83 86.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG21 HH11 ' A' ' 127' ' ' ARG . 2.0 p -50.83 -57.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 110.391 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -125.7 153.51 43.79 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.6 p -149.09 146.04 27.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -135.78 46.58 2.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.764 -0.585 . . . . 0.0 109.644 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 153.19 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.64 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -158.36 142.8 15.97 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.133 -0.979 . . . . 0.0 109.519 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -173.55 3.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.18 -0.95 . . . . 0.0 109.564 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -85.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.383 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -56.08 22.47 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -97.01 76.65 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -92.42 169.04 10.87 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.43 -23.76 67.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.852 -0.53 . . . . 0.0 109.709 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.97 -16.83 60.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.857 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.52 -18.77 65.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.069 -1.019 . . . . 0.0 109.228 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.2 mt -65.59 -24.97 67.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.471 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.19 -21.39 59.36 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -119.14 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.79 7.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 29' ' ' THR . 10.3 m-20 -121.17 87.21 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.829 . . . . 0.0 109.848 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.95 -87.29 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -177.57 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 0.0 109.73 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.73 142.79 12.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 109.273 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.7 mtmt -127.03 -164.9 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.471 -0.768 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.815 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.1 t90 -88.46 140.25 29.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.45 129.49 17.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.05 148.48 6.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.406 -0.809 . . . . 0.0 110.379 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.14 -23.7 56.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.811 -0.555 . . . . 0.0 110.251 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -139.19 -175.88 4.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.96 -166.64 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 64.12 48.0 79.61 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mp0 -55.15 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.378 0.608 . . . . 0.0 111.026 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 39' ' ' GLY . 18.4 tttt -87.82 -53.49 4.73 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 133' ' ' SER . 37.6 p -155.8 114.92 3.54 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.687 HG21 ' HB2' ' A' ' 35' ' ' ALA . 12.5 pt -115.85 146.86 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.475 -0.766 . . . . 0.0 109.401 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -126.18 149.31 49.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.121 178.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.9 p -152.08 105.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.755 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.6 t -89.81 114.06 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.798 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.1 mp -96.35 163.92 12.87 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.587 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.16 136.39 48.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.692 -0.63 . . . . 0.0 109.876 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.8 134.22 34.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -70.91 20.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.381 -0.824 . . . . 0.0 112.284 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttt 176.61 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.714 -1.241 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -59.19 102.12 0.12 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.628 ' OE2' HG23 ' A' ' 4' ' ' ILE . 10.7 pt-20 -137.21 -177.41 4.76 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.483 0.659 . . . . 0.0 110.121 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -96.39 -177.71 4.05 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.49 121.26 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.428 ' O ' HD21 ' A' ' 116' ' ' LEU . 56.3 t60 -111.03 -29.3 7.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.697 -0.627 . . . . 0.0 109.344 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -148.08 146.31 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 149' ' ' PHE . 74.3 t -129.28 160.47 40.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.445 0.64 . . . . 0.0 109.751 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 2.7 m-20 -139.28 133.92 31.9 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -157.73 135.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -110.4 135.23 12.72 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.71 HD21 HG21 ' A' ' 68' ' ' VAL . 1.4 m-80 -88.04 132.66 34.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.138 -0.625 . . . . 0.0 110.739 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' N ' ' A' ' 145' ' ' SER . 7.0 t0 -113.22 58.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.31 -25.33 18.3 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 15.3 t -57.26 165.77 1.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -1.02 . . . . 0.0 109.908 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.72 -57.82 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.1 m-85 -98.94 118.48 35.79 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 62' ' ' ASN . 59.5 t -125.23 114.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.265 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.91 144.43 31.52 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 88' ' ' LEU . 5.0 t -123.13 125.41 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -112.09 161.31 16.65 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -125.43 151.11 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 0.0 109.96 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -173.25 166.81 39.37 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -115.93 157.12 25.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.981 -0.717 . . . . 0.0 109.552 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 t -88.05 10.42 19.17 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -104.83 -173.53 2.32 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -125.19 137.94 54.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.089 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 71' ' ' LEU . 37.1 t -66.22 87.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.573 -0.705 . . . . 0.0 110.727 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.691 HD13 HG11 ' A' ' 72' ' ' VAL . 11.1 tp -58.27 -47.76 82.61 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 70' ' ' VAL . 1.8 pp -143.18 120.76 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.393 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 88' ' ' LEU . 31.5 m -50.42 174.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 110.587 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -63.91 138.09 58.32 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.573 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.8 p -105.89 123.32 47.78 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -87.67 104.26 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 23.7 m-85 -100.38 -46.55 5.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 mtp -120.16 -170.95 2.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.2 p -126.66 -179.62 0.97 Allowed Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.86 9.42 4.15 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.882 2.388 . . . . 0.0 111.328 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.3 p -114.08 -55.08 2.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -63.0 -20.2 65.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.973 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -56.59 -27.26 57.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.239 -0.913 . . . . 0.0 110.141 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -87.73 -74.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 110.009 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.22 37.52 0.1 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.08 -24.06 35.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -1.004 . . . . 0.0 110.368 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 88.95 35.45 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.13 -18.63 16.23 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.959 2.439 . . . . 0.0 110.27 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.39 115.35 11.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.669 -0.644 . . . . 0.0 109.734 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -144.72 160.31 41.42 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 m -120.94 163.85 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.55 159.12 43.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.39 -0.819 . . . . 0.0 109.374 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.4 mtp -130.08 162.57 28.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.626 -0.671 . . . . 0.0 110.113 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -127.32 165.99 18.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -135.52 -150.11 5.93 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -75.68 -37.98 1.5 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.655 2.904 . . . . 0.0 110.731 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -65.4 -28.27 69.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.57 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -89.34 1.51 55.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.649 -0.657 . . . . 0.0 110.589 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.21 139.89 53.49 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.037 -1.039 . . . . 0.0 109.921 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.894 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -59.22 133.4 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -75.8 -29.99 58.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.338 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.32 -23.23 64.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.598 -0.688 . . . . 0.0 109.977 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.894 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.29 -45.55 3.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.67 -40.57 28.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.215 -0.928 . . . . 0.0 111.291 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -77.86 -3.03 39.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 110.547 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 26.5 mtpt -90.31 132.92 35.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -67.62 109.59 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.544 0.688 . . . . 0.0 110.73 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 87.3 m95 -109.09 164.03 12.79 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.5 6.63 3.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.525 HH11 HG21 ' A' ' 10' ' ' VAL . 35.8 mtm180 -145.99 145.9 30.8 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.74 -1.225 . . . . 0.0 107.919 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.88 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.9 p -132.73 142.46 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.348 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.755 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -105.09 116.17 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.754 -0.591 . . . . 0.0 109.797 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 45' ' ' VAL . 51.4 mm -108.07 119.53 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 44' ' ' SER . 30.6 t -124.7 122.89 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.138 -0.976 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.508 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -97.22 142.46 29.09 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.6 123.37 15.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.712 -0.618 . . . . 0.0 110.375 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.833 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 35.1 tp60 156.84 123.24 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.53 104.55 1.74 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.682 2.255 . . . . 0.0 108.884 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 2.0 p90 -132.0 -10.58 3.4 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.568 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.76 126.38 14.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.839 -1.163 . . . . 0.0 109.513 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -110.39 -26.58 9.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.843 -0.536 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.58 -43.66 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 110.262 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.09 145.74 32.38 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.822 -0.549 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.2 Cg_endo -87.03 166.19 8.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.33 2.687 . . . . 0.0 110.409 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -176.85 -165.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.98 -102.63 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 147' ' ' VAL . 5.6 mp -115.26 155.43 27.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.575 -0.956 . . . . 0.0 110.604 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 23.6 m -89.49 -27.51 20.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.531 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 50.1 p90 -178.09 162.31 1.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.6 m -138.64 141.29 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.0 mtp180 -145.79 160.63 41.48 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.478 0.656 . . . . 0.0 110.342 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.88 ' CE2' HG11 ' A' ' 128' ' ' VAL . 54.6 m-85 -142.24 156.88 45.32 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -157.01 136.73 12.37 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.9 p . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' OE1' ' A' ' 53' ' ' GLU . 62.2 mt -125.09 123.76 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -105.2 161.02 14.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.733 -0.604 . . . . 0.0 109.658 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -95.73 151.43 19.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.468 ' C ' HD11 ' A' ' 25' ' ' LEU . 43.3 ttt85 -103.93 -54.32 2.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 109.383 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.407 ' CE1' ' HD3' ' A' ' 7' ' ' ARG . 4.9 p-80 -160.54 166.49 28.97 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -83.69 93.97 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.772 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -53.15 -60.13 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.131 -0.981 . . . . 0.0 110.16 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.512 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.1 155.49 35.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -153.24 105.63 2.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.257 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -105.94 56.46 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 153.46 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.4 pp0? -132.97 139.64 47.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.734 -1.229 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.83 148.57 22.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 109.326 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.6 t -61.14 -52.86 63.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.582 -0.699 . . . . 0.0 110.155 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -58.55 8.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.344 -0.847 . . . . 0.0 109.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -110.16 86.99 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -92.29 166.65 12.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.552 0.692 . . . . 0.0 110.359 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.54 -23.52 67.03 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.3 tt0 -61.96 -18.44 60.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.339 -0.85 . . . . 0.0 109.724 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -65.27 -17.51 64.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.256 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.09 -25.68 67.9 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -58.09 -22.41 50.52 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.491 -0.756 . . . . 0.0 109.002 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -115.36 67.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.51 -25.83 4.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.739 . . . . 0.0 110.6 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' THR . 31.3 m-20 -122.03 88.78 3.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 0.0 109.796 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -157.98 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.583 -0.698 . . . . 0.0 109.236 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 44.2 p90 -178.16 35.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 28.5 mtm180 -157.17 137.53 12.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.2 mtmp? -120.53 -176.87 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.7 t90 -78.51 138.18 38.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -141.66 128.32 20.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.21 168.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.691 0.758 . . . . 0.0 111.21 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -79.16 -30.52 43.57 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.139 0.495 . . . . 0.0 109.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -120.36 -172.16 2.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.2 -165.23 1.1 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.15 45.29 96.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 1.3 mp0 -43.74 89.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.487 0.66 . . . . 0.0 112.075 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 42' ' ' THR . 10.6 pttt -103.02 -44.21 5.29 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.3 p -160.51 132.36 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.761 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -137.73 136.03 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.418 -0.801 . . . . 0.0 110.204 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -112.22 140.84 46.59 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.462 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.754 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -147.41 106.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 128' ' ' VAL . 10.8 t -91.36 121.53 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.673 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -100.42 168.98 9.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.307 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -114.14 148.07 37.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.712 -0.617 . . . . 0.0 109.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.522 HD12 ' CA ' ' A' ' 126' ' ' ASP . 18.1 mt -101.73 137.57 39.87 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.75 40.2 0.51 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.37 -0.831 . . . . 0.0 110.909 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 1.7 pttm 161.32 130.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 14.4 tt0 -75.55 110.6 10.07 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -140.25 -179.49 6.02 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.01 178.14 6.09 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.415 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -127.76 115.71 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -103.4 -30.83 10.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -148.1 159.03 44.34 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.8 t -141.91 158.23 20.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.48 0.657 . . . . 0.0 109.389 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.3 m-20 -140.13 137.89 34.81 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -158.25 130.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.8 132.33 10.96 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -90.7 126.72 36.07 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.301 -0.529 . . . . 0.0 110.366 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -97.7 64.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.93 60.26 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 72.0 m -55.57 158.2 3.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -1.1 . . . . 0.0 110.322 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -119.64 -58.65 1.88 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 133' ' ' SER . 19.5 m-85 -99.61 129.99 45.8 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.946 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 60' ' ' ILE . 53.8 t -130.43 111.84 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.629 . . . . 0.0 109.692 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -105.63 146.28 29.9 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.726 HG22 ' CD1' ' A' ' 130' ' ' ILE . 22.0 t -135.79 126.56 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.57 -0.706 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.59 160.46 18.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.659 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.2 m -121.49 157.82 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.789 -0.569 . . . . 0.0 109.894 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.18 172.45 42.61 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -114.04 158.78 20.76 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 122.041 -0.682 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -73.43 -4.97 36.91 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.797 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 t70 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.4 m-85 -101.36 -173.26 2.32 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.659 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -121.1 130.58 53.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.28 85.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.366 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.626 ' HB2' HG13 ' A' ' 72' ' ' VAL . 15.3 tp -58.03 -59.81 4.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -137.8 120.49 16.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.33 179.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.745 . . . . 0.0 110.325 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 134.4 53.58 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.601 -0.687 . . . . 0.0 109.153 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.1 p -107.87 125.85 51.96 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.441 0.639 . . . . 0.0 109.769 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 84.9 p -83.7 127.83 34.07 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CG ' ' HD3' ' A' ' 109' ' ' ARG . 22.8 m-85 -120.95 -48.21 2.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 81.4 mtp -121.95 -176.83 3.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.933 0.873 . . . . 0.0 111.352 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -120.55 173.93 3.37 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.57 9.48 4.08 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.911 2.407 . . . . 0.0 111.315 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.0 m -120.77 -35.03 3.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.35 -21.67 35.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.316 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.9 p -58.23 -22.13 50.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -0.805 . . . . 0.0 110.425 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -67.96 -83.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.338 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -162.45 39.2 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.74 -22.38 5.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.26 118.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -1.135 . . . . 0.0 110.396 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 41.21 77.44 0.43 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.929 -0.482 . . . . 0.0 111.366 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.12 -28.55 2.39 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.05 2.5 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.41 92.85 2.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -123.89 -176.13 3.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.724 . . . . 0.0 109.332 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.7 m -134.6 158.33 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.713 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' ' CG ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.94 159.78 41.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.8 mtm -135.57 166.23 23.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.0 110.295 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.0 m-85 -129.46 169.63 14.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -140.12 -148.57 5.19 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.7 -39.6 1.31 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.674 2.916 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.37 -28.83 69.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.493 -0.754 . . . . 0.0 109.648 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.59 54.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.658 -0.651 . . . . 0.0 110.598 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -123.51 138.76 54.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.05 -1.031 . . . . 0.0 110.38 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -59.37 130.34 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -33.44 63.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.786 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.95 66.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.334 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.96 -46.68 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.162 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.952 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.73 -38.55 21.92 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.143 -0.973 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.14 0.6 31.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 110.706 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.2 mtpp -92.54 135.81 33.75 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.41 113.2 5.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.744 0.783 . . . . 0.0 110.753 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.3 m95 -115.84 165.97 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.522 ' CA ' HD12 ' A' ' 49' ' ' LEU . 3.8 p30 -140.68 15.5 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.132 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.447 ' HD3' HG11 ' A' ' 10' ' ' VAL . 13.4 mtt180 -145.5 147.58 32.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -137.3 142.14 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.105 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.3 tttt -110.88 108.43 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.668 -0.645 . . . . 0.0 109.729 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.726 ' CD1' HG22 ' A' ' 70' ' ' VAL . 48.4 mm -101.96 127.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 44' ' ' SER . 61.0 t -132.47 115.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.522 ' HB3' HG13 ' A' ' 43' ' ' ILE . 3.1 t -85.55 149.68 25.2 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.726 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.9 122.9 9.41 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.264 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.73 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.45 94.68 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.008 2.472 . . . . 0.0 110.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -121.62 -17.55 7.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.0 111.285 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.48 169.49 8.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.462 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 24.9 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.793 -0.567 . . . . 0.0 109.634 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.79 -46.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.6 146.35 32.44 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.58 169.28 8.19 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.432 2.755 . . . . 0.0 110.898 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 179.49 -164.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.86 -105.93 0.26 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.193 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 60' ' ' ILE . 5.6 mp -115.79 154.67 29.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.937 . . . . 0.0 110.716 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 49.2 m -87.34 -27.99 22.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 52.6 p90 -179.24 167.67 1.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.514 -0.741 . . . . 0.0 109.509 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.5 m -142.46 131.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 14.7 mtt180 -139.07 121.66 16.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.028 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.694 ' CD1' HG13 ' A' ' 58' ' ' VAL . 67.5 m-85 -104.36 156.68 17.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.109 -0.995 . . . . 0.0 109.41 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -150.97 131.28 13.65 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.317 -0.865 . . . . 0.0 109.714 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.704 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG2' HD12 ' A' ' 49' ' ' LEU . 72.1 mt -117.67 124.71 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -104.78 164.8 11.51 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.455 0.645 . . . . 0.0 110.084 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.775 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -97.53 127.63 43.64 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.642 ' N ' HD13 ' A' ' 6' ' ' LEU . 3.7 ttt180 -82.11 -56.89 3.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.379 -0.825 . . . . 0.0 109.584 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.93 165.1 30.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.659 -0.651 . . . . 0.0 109.409 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -81.29 90.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.774 . . . . 0.0 109.307 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.731 HG21 ' NH1' ' A' ' 127' ' ' ARG . 1.8 p -54.37 -58.28 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.487 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -118.04 143.47 46.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.31 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -130.81 124.03 30.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -0.796 . . . . 0.0 109.711 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -124.59 42.24 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.3 m 153.93 76.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.64 141.46 26.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 108.987 -179.361 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -164.49 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.336 -0.853 . . . . 0.0 109.071 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -64.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -49.22 76.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 109.067 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.04 73.7 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -91.71 168.86 11.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.503 -0.748 . . . . 0.0 110.095 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.67 -23.01 67.12 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.616 ' HG3' HG12 ' A' ' 9' ' ' VAL . 1.6 tt0 -63.87 -17.49 63.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.8 -17.8 64.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 109.286 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 33' ' ' TRP . 21.1 mt -65.17 -24.28 67.34 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -58.54 -22.35 55.22 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.526 -0.734 . . . . 0.0 109.055 178.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -107.67 61.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.14 -25.23 4.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.425 -0.797 . . . . 0.0 110.708 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -118.35 76.58 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 28' ' ' ASP . 5.4 p -156.42 -95.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.774 . . . . 0.0 109.075 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -178.4 36.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.391 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -141.75 138.02 32.02 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 11.1 mttm -128.66 -178.69 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.422 -0.799 . . . . 0.0 110.807 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.704 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -80.98 140.46 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.43 129.07 17.13 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.37 150.8 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.496 -0.752 . . . . 0.0 110.909 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.25 -26.56 68.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -169.79 2.09 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.11 178.77 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.73 -30.74 8.78 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 18.4 mm-40 40.67 31.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.969 -0.724 . . . . 0.0 112.526 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 42' ' ' THR . 0.0 OUTLIER -51.57 -52.94 43.17 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.696 -0.627 . . . . 0.0 109.316 179.38 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.9 p -160.32 129.43 4.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.704 HD12 ' CH2' ' A' ' 33' ' ' TRP . 13.1 pt -130.2 141.72 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.86 . . . . 0.0 110.322 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.581 ' OG ' HG13 ' A' ' 131' ' ' VAL . 29.5 m -126.06 141.22 52.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.293 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.703 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.4 p -146.27 110.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 ' HD2' ' A' ' 129' ' ' LYS . 2.7 t -90.42 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.775 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.2 mp -100.09 157.6 16.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -99.89 145.58 27.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 109.834 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -97.96 140.35 32.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.28 33.81 0.24 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.417 -0.802 . . . . 0.0 111.115 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.4 pttm 161.22 138.39 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 10.0 tt0 -75.16 102.48 4.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -131.35 165.74 22.8 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.7 0.762 . . . . 0.0 109.786 -179.163 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 55' ' ' ILE . 15.9 mt-30 -76.15 -176.96 3.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 54' ' ' GLN . 1.9 mm -128.93 174.89 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.403 -0.81 . . . . 0.0 108.891 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.701 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.9 t60 -172.53 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.506 -0.746 . . . . 0.0 109.199 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -145.27 145.76 31.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 60' ' ' ILE . 83.5 t -130.64 163.36 36.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.665 0.745 . . . . 0.0 110.31 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 58' ' ' VAL . 11.8 t0 -133.5 131.97 40.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.692 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.46 129.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -99.36 122.71 7.66 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.92 117.92 17.3 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 122.13 -0.629 . . . . 0.0 110.145 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -102.2 73.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.95 21.91 72.91 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 -177.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 1.8 p -96.98 152.89 18.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.998 . . . . 0.0 109.857 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -114.36 -54.79 2.56 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.6 132.3 52.76 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.52 -0.738 . . . . 0.0 109.969 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.39 112.16 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.832 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -107.54 146.52 31.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.749 -0.595 . . . . 0.0 109.546 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.6 t -133.6 128.85 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.602 -0.686 . . . . 0.0 109.933 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.7 mp -115.03 158.84 21.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.792 ' CG1' HD22 ' A' ' 87' ' ' LEU . 5.4 m -119.6 154.48 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.47 173.36 46.02 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 t -114.71 155.47 26.59 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.98 -0.718 . . . . 0.0 109.831 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.9 p -63.67 -14.0 48.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 O-C-N 121.39 -0.819 . . . . 0.0 109.297 179.886 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.05 154.07 35.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.701 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.21 145.06 32.04 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.73 84.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.581 -0.7 . . . . 0.0 110.751 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -57.57 -59.62 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.8 pp -136.05 121.44 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.312 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.8 m -54.07 -179.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.663 -0.648 . . . . 0.0 110.178 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.14 135.31 51.93 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.241 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -104.62 127.69 52.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -85.33 95.72 9.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 16.6 m-85 -87.3 -52.43 5.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.591 -0.693 . . . . 0.0 109.693 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.3 mtp -120.68 -172.65 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.654 -0.654 . . . . 0.0 110.187 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 p -120.12 179.72 0.85 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.88 13.25 2.8 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.154 2.569 . . . . 0.0 111.47 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -53.26 2.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -63.68 -16.03 59.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 110.153 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -56.72 -21.01 24.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.828 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -87.6 0.13 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.181 -0.95 . . . . 0.0 110.362 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -162.03 38.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.102 -0.999 . . . . 0.0 108.655 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.35 -20.72 24.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.89 -79.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -1.036 . . . . 0.0 110.52 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.36 88.26 25.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.95 -20.54 10.16 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 123.032 2.488 . . . . 0.0 110.622 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.1 128.64 40.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.65 -0.656 . . . . 0.0 109.852 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.85 172.73 17.94 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.2 m -140.16 136.59 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.382 -0.824 . . . . 0.0 109.399 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 mmp_? -133.86 -179.23 5.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 110.282 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 mtm -141.99 178.34 7.59 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.391 0.615 . . . . 0.0 109.675 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.5 m-85 -135.43 166.82 22.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.03 -153.86 5.99 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.79 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.1 Cg_endo -74.3 -27.93 10.99 Favored 'Trans proline' 0 N--CA 1.504 2.136 0 C-N-CA 123.58 2.853 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.87 -42.45 62.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.9 9.54 30.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 111.165 -179.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -116.36 122.19 44.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 108.536 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -50.0 134.49 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.783 -0.573 . . . . 0.0 110.77 -177.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -69.2 -41.09 77.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.557 -0.714 . . . . 0.0 109.357 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.47 78.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 110.508 -179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -93.17 -35.25 13.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.448 -0.783 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.704 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.62 -30.72 2.44 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.518 -0.739 . . . . 0.0 110.789 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 16.75 24.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.485 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' NE1' ' A' ' 125' ' ' TRP . 4.3 mmtm -96.77 132.11 42.81 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -66.06 103.66 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.191 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.443 ' NE1' ' HB2' ' A' ' 123' ' ' LYS . 69.8 m95 -108.09 150.03 27.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t0 -128.84 4.12 5.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.697 -0.627 . . . . 0.0 109.694 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.8 mtt180 -141.76 149.58 40.63 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.8 p -140.36 140.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.187 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD2' HG22 ' A' ' 46' ' ' VAL . 3.5 tttm -106.16 116.74 32.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.703 -0.623 . . . . 0.0 109.747 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.582 ' CD1' HG13 ' A' ' 70' ' ' VAL . 46.5 mm -107.59 111.55 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.581 HG13 ' OG ' ' A' ' 44' ' ' SER . 40.9 t -119.58 120.33 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.414 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.0 t -95.68 149.03 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -142.94 130.66 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.459 -0.775 . . . . 0.0 111.19 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.8 OUTLIER 149.48 129.07 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.751 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.406 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.24 100.38 0.7 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.831 2.354 . . . . 0.0 109.659 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.511 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 1.2 p90 -131.66 40.35 3.4 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.739 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 -168.84 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -106.84 -35.84 6.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.07 142.21 24.55 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.5 Cg_endo -85.93 -176.1 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.174 2.582 . . . . 0.0 110.82 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 178.76 -162.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.616 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.14 -112.89 0.56 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.471 -1.347 . . . . 0.0 111.099 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.6 mp -114.2 158.86 20.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.567 -0.961 . . . . 0.0 110.75 -178.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.422 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 2.4 m -97.62 -28.45 13.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 122.042 -0.411 . . . . 0.0 109.958 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 43.5 p90 -176.38 171.88 2.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.693 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 60' ' ' ILE . 20.7 m -150.17 137.6 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.695 -0.628 . . . . 0.0 109.493 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 11.3 mmm-85 -144.04 108.55 4.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.531 -0.731 . . . . 0.0 109.102 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 128' ' ' VAL . 56.1 m-85 -87.31 155.03 20.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.338 -0.852 . . . . 0.0 109.354 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.46 124.93 6.34 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.495 -0.753 . . . . 0.0 109.363 178.715 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.67 -0.644 . . . . 0.0 110.474 -179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -142.27 146.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 167.04 15.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.933 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.669 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -95.61 136.8 35.54 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.722 -0.611 . . . . 0.0 109.461 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.602 ' N ' HD13 ' A' ' 6' ' ' LEU . 66.8 ttt180 -92.6 -56.42 3.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.805 . . . . 0.0 109.104 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.429 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 4.1 p-80 -161.33 162.99 31.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.3 p -79.14 91.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.534 HG12 ' C ' ' A' ' 47' ' ' LEU . 2.4 p -50.79 -55.99 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.317 -0.864 . . . . 0.0 110.47 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -122.14 153.37 38.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.415 -0.803 . . . . 0.0 109.372 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.74 120.36 17.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.424 -0.798 . . . . 0.0 109.509 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.8 m -123.56 42.02 3.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.806 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER 152.75 72.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.321 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.691 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -136.48 140.95 43.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.336 -0.852 . . . . 0.0 109.431 -179.052 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -165.92 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -101.74 -55.51 2.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -42.78 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -121.34 80.36 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.3 p -91.5 168.78 11.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.594 0.712 . . . . 0.0 110.042 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.12 -24.32 67.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.928 -0.483 . . . . 0.0 109.993 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -62.37 -18.54 61.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 109.835 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -65.37 -17.27 64.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' A' ' 147' ' ' VAL . 11.2 mt -64.91 -24.85 67.65 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.5 mm? -57.97 -22.46 49.29 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.498 -0.751 . . . . 0.0 109.039 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.2 65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.57 -24.41 13.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.394 -0.816 . . . . 0.0 110.406 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.33 81.36 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.634 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.4 p -158.1 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.437 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -177.84 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -158.39 167.7 28.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.553 -0.717 . . . . 0.0 109.446 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -160.32 -157.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.673 -0.642 . . . . 0.0 109.565 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 15.5 t90 -93.69 140.45 29.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.083 -1.01 . . . . 0.0 110.379 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -146.83 123.06 10.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.85 154.6 0.69 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.451 -0.781 . . . . 0.0 111.399 -178.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.66 -30.04 70.21 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -123.45 -172.1 2.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.73 -162.38 0.93 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.75 43.34 94.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 3.8 mm-40 -48.14 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.986 0.898 . . . . 0.0 111.364 -179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 42' ' ' THR . 8.8 pttp -111.62 -44.82 3.44 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.1 p -160.39 119.87 2.76 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.806 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.4 pt -128.02 147.39 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.507 -0.746 . . . . 0.0 109.355 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.584 ' OG ' HG22 ' A' ' 131' ' ' VAL . 31.5 m -128.23 147.6 50.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.661 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.0 p -154.29 117.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 128' ' ' VAL . 5.5 t -95.53 130.14 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.218 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.669 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.3 mt -102.61 167.4 9.94 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 12.2 tm0? -121.6 118.62 29.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.734 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.746 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -71.0 138.46 49.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -81.15 36.53 0.41 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.766 -0.584 . . . . 0.0 110.133 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 pttt 166.73 129.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.44 109.47 9.02 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.42 176.28 9.12 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.621 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -86.35 -174.24 4.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -141.26 130.29 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.741 . . . . 0.0 109.39 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.433 ' O ' HD21 ' A' ' 116' ' ' LEU . 4.6 t60 -119.57 -25.08 6.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -149.87 140.24 22.33 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' CD1' ' A' ' 149' ' ' PHE . 55.2 t -125.04 160.71 30.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.1 m-20 -140.74 135.06 31.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.506 -0.746 . . . . 0.0 109.416 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.4 mp -155.96 131.84 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -107.94 120.83 6.16 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.017 -1.564 . . . . 0.0 110.264 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.75 142.57 53.24 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.458 0.647 . . . . 0.0 111.11 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 23.8 t0 -127.13 56.25 1.53 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.96 12.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t -57.75 170.16 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -1.006 . . . . 0.0 109.73 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.764 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -135.16 -56.83 0.81 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.461 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 24.3 m-85 -100.04 133.41 44.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.281 179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.74 107.51 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.944 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -97.34 129.8 44.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.697 HG13 HD13 ' A' ' 130' ' ' ILE . 37.8 t -122.18 124.4 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.762 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.0 mp -110.61 163.0 14.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.65 HG21 HD13 ' A' ' 87' ' ' LEU . 2.8 m -126.67 160.18 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.15 177.52 46.13 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 t -116.25 158.69 22.95 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.069 -0.665 . . . . 0.0 109.44 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -80.23 3.56 20.43 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.806 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 110.114 -179.905 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.6 m-85 -113.17 -176.26 2.86 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -129.06 132.16 47.41 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.258 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 71' ' ' LEU . 35.5 t -62.31 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.685 -0.634 . . . . 0.0 110.453 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 72' ' ' VAL . 12.0 tp -60.13 -51.68 68.57 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -142.44 123.55 14.57 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.802 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.63 -173.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.886 -0.509 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.74 125.64 25.41 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 86.9 p -99.6 121.95 41.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -88.76 121.45 31.15 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 23.5 m-85 -120.58 -43.67 2.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.422 -0.798 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 33.0 mtp -120.22 -178.1 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.487 -0.758 . . . . 0.0 110.509 -178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -115.29 177.16 1.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.05 11.9 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.201 2.601 . . . . 0.0 111.251 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.48 -54.15 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.337 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 3.6 pt-20 -61.04 -18.42 57.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 20.7 t -54.82 -36.09 64.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.756 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -72.14 -82.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.037 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -162.85 37.49 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.37 -22.41 47.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.48 -77.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.958 . . . . 0.0 110.409 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -117.18 88.82 28.69 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.8 Cg_endo -77.23 -19.87 13.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.976 2.451 . . . . 0.0 110.261 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -141.87 135.06 29.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.754 -0.591 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.02 150.51 18.74 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 13.0 m -106.83 165.13 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 110.2 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -154.12 156.05 36.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.261 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.7 mtp -127.95 166.9 17.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.721 -179.064 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 88' ' ' LEU . 3.1 m-85 -131.61 159.08 39.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -132.64 -149.42 6.22 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.57 -39.76 1.32 Allowed 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 123.738 2.959 . . . . 0.0 110.594 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.72 -27.13 68.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.715 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -91.5 3.1 55.8 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.641 -0.662 . . . . 0.0 110.547 -179.633 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.96 139.35 54.16 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.92 -1.112 . . . . 0.0 110.392 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.908 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.5 p -60.17 130.57 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.12 61.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.708 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -21.39 65.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.908 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.86 -46.58 2.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.95 -38.08 21.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.151 -0.968 . . . . 0.0 111.51 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -82.05 2.78 29.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.338 -0.851 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.5 mttt -93.7 134.9 35.53 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -66.51 113.65 4.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.443 -0.786 . . . . 0.0 110.546 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.498 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 73.6 m95 -117.78 162.85 17.4 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.64 14.15 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.147 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -148.72 151.22 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.912 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.5 p -141.85 145.21 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 110.367 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.57 117.58 34.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.486 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 70' ' ' VAL . 50.0 mm -107.93 119.19 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.599 -0.688 . . . . 0.0 109.534 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.584 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.2 t -128.09 119.94 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.137 -0.977 . . . . 0.0 110.687 -179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.466 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.93 148.15 23.3 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.47 126.65 14.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 111.199 -179.091 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.764 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.4 OUTLIER 150.23 134.58 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.416 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.42 97.85 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.995 2.463 . . . . 0.0 109.965 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.6 p90 -128.77 14.49 6.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.0 110.81 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.03 -166.33 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -176.27 -42.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -113.27 -33.09 6.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.71 -0.619 . . . . 0.0 109.676 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.27 149.84 38.18 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.891 -0.505 . . . . 0.0 109.693 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.413 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.9 Cg_endo -85.52 -178.63 3.1 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.372 2.715 . . . . 0.0 110.285 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 179.88 -164.1 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.541 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 156.03 -112.89 0.54 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -135.47 162.04 33.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.325 -1.103 . . . . 0.0 110.251 178.606 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 2.7 m -82.24 -18.52 42.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.809 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 179.88 163.37 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.32 -0.863 . . . . 0.0 109.92 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.77 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.8 m -140.54 142.25 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 5.0 mtm180 -147.63 165.01 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.744 0.783 . . . . 0.0 110.524 -178.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.912 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.7 m-85 -145.28 154.61 42.54 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -158.63 145.94 17.72 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.087 -1.008 . . . . 0.0 109.283 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 -179.255 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 53' ' ' GLU . 48.4 mm -112.56 154.48 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -134.94 120.69 19.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.571 -0.706 . . . . 0.0 109.638 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 49' ' ' LEU . 1.2 mp -82.55 150.91 26.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.488 ' HD3' ' CD2' ' A' ' 8' ' ' HIS . 22.5 ttt180 -110.86 -53.28 2.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.488 ' CD2' ' HD3' ' A' ' 7' ' ' ARG . 4.1 p80 -160.69 166.24 29.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.655 -0.653 . . . . 0.0 109.511 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.68 89.65 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 11' ' ' SER . 2.6 p -50.32 -55.89 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.258 -0.901 . . . . 0.0 110.777 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -122.29 152.49 40.02 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.12 -179.497 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -144.27 121.82 11.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 109.813 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -118.25 45.52 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.639 -0.663 . . . . 0.0 109.878 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.8 OUTLIER 152.19 73.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.954 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.732 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -138.44 142.33 39.5 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.244 -0.91 . . . . 0.0 109.448 -179.026 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.38 -162.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.469 -0.769 . . . . 0.0 109.333 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -97.55 -57.9 2.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.58 -0.7 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -65.66 0.7 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -88.77 67.7 8.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -86.44 171.32 11.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 -179.512 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.61 -24.7 67.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.9 tt0 -61.02 -19.4 61.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 109.688 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -65.76 -16.68 64.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 109.323 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.9 mt -65.02 -25.66 67.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.5 mm? -58.17 -22.74 52.74 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 65.28 0.67 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.36 -24.69 8.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.352 -0.842 . . . . 0.0 110.528 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 29' ' ' THR . 44.4 m-20 -119.53 81.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.807 . . . . 0.0 109.816 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -155.4 -88.08 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.424 -0.798 . . . . 0.0 109.502 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 42.8 p90 -177.6 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.006 -1.059 . . . . 0.0 110.187 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 4.9 mtm180 -157.47 142.67 17.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.5 -0.75 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -126.72 -159.47 0.93 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.347 -179.393 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.4 t90 -94.32 139.33 31.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.238 -0.913 . . . . 0.0 109.433 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -144.41 129.39 18.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.17 156.08 1.18 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -67.38 -23.99 65.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.845 -0.534 . . . . 0.0 110.202 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -136.45 -173.72 3.49 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.52 -164.27 1.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.45 45.89 88.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.6 mt-10 -54.79 84.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.694 0.759 . . . . 0.0 111.142 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 42' ' ' THR . 42.1 tttm -91.29 -52.28 4.89 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' OG ' ' A' ' 133' ' ' SER . 16.0 p -159.09 121.9 3.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 35' ' ' ALA . 19.0 pt -120.23 151.47 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -129.11 150.36 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.437 178.885 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.851 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -155.16 107.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.5 t -91.39 118.44 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -95.26 153.29 17.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.611 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -104.25 134.09 48.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.673 . . . . 0.0 109.715 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 6' ' ' LEU . 33.0 mt -90.17 134.79 34.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.07 43.85 0.73 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 110.448 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 pttt 166.94 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -74.94 106.37 6.42 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -136.28 -178.33 5.11 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.025 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.48 175.48 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.75 120.34 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 116' ' ' LEU . 74.4 t60 -107.68 -31.33 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 7.4 m -146.15 155.12 42.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 69.6 t -138.39 157.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.666 . . . . 0.0 109.548 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.57 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.7 m-20 -139.44 138.38 36.41 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.57 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.2 mp -159.05 135.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -115.0 134.79 11.85 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 65' ' ' SER . 1.2 m-80 -112.5 151.46 29.92 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 122.149 -0.618 . . . . 0.0 110.707 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -102.12 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.23 24.83 29.65 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 178.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.436 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 59.6 m -77.35 -174.45 3.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.517 -0.99 . . . . 0.0 109.831 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -147.2 -57.53 0.26 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.6 m-85 -99.25 135.28 40.88 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.929 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 93' ' ' PHE . 86.1 t -141.74 109.21 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.479 0.656 . . . . 0.0 109.685 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -99.78 139.23 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 130' ' ' ILE . 18.5 t -124.4 124.28 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.461 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.32 164.06 14.04 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.3 m -128.67 160.69 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.689 -0.632 . . . . 0.0 109.817 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.446 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.23 175.86 43.02 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 t -113.83 158.46 20.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -89.57 11.3 20.0 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.141 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 -179.928 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -108.05 -175.12 2.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -121.37 127.9 51.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.917 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.2 85.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.77 -0.581 . . . . 0.0 110.274 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.644 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -57.79 -53.88 53.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -143.81 122.66 12.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.257 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.35 -179.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 110.528 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 129.76 41.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.297 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 p -98.62 128.72 45.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 8.5 p -90.09 89.71 7.8 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.621 ' HE2' HG21 ' A' ' 68' ' ' VAL . 6.8 m-85 -73.45 -57.81 3.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.341 -0.85 . . . . 0.0 109.607 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.407 ' HE1' ' C ' ' A' ' 105' ' ' PRO . 3.2 mtm -121.3 -164.06 1.1 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.469 0.652 . . . . 0.0 110.187 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 5.8 p -130.64 -176.79 0.58 Allowed Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 41.6 Cg_endo -85.59 18.96 1.47 Allowed 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 123.086 2.524 . . . . 0.0 111.467 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.7 t -120.12 -40.71 2.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.12 -27.02 26.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 3.4 p -56.85 -22.26 35.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.512 -0.743 . . . . 0.0 110.475 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -83.87 -85.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.38 -0.825 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -163.01 38.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.37 -23.31 19.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.25 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.985 . . . . 0.0 110.579 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 3.6 p-10 -119.48 95.26 49.16 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.9 Cg_endo -82.45 -17.99 7.25 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.172 2.582 . . . . 0.0 110.155 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.47 128.93 30.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.787 -0.571 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.26 145.7 15.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 16.0 m -98.71 -179.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 109.983 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.76 148.49 17.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.867 . . . . 0.0 109.407 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.8 mtt -127.15 157.39 39.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.491 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 88' ' ' LEU . 1.8 m-85 -128.82 166.49 18.95 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.22 -150.63 5.79 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.4 Cg_endo -75.51 -37.86 1.62 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.747 2.965 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -65.58 -26.52 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.464 -0.773 . . . . 0.0 109.6 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -91.94 1.97 56.84 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.643 -0.661 . . . . 0.0 110.663 -179.759 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -121.57 138.93 54.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.956 -1.09 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.905 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.2 p -58.25 130.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 -30.98 61.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 109.602 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -21.56 66.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.22 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.905 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.93 -46.24 2.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.304 -0.873 . . . . 0.0 110.104 -179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.97 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.65 -40.49 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.138 -0.976 . . . . 0.0 111.583 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -0.16 31.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.266 -0.896 . . . . 0.0 110.528 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.7 mtpp -91.0 133.93 34.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.95 112.58 4.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.636 0.731 . . . . 0.0 110.804 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.495 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 75.8 m95 -115.43 165.44 12.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.35 10.25 3.22 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.491 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -144.45 149.08 35.42 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -134.47 142.46 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.909 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' A' ' 46' ' ' VAL . 8.6 tttt -109.65 113.33 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.655 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.9 mm -106.93 123.73 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 44' ' ' SER . 41.0 t -128.46 121.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.275 -0.891 . . . . 0.0 110.533 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' CYS . . . . . 0.472 ' HB3' HG13 ' A' ' 43' ' ' ILE . 1.7 t -93.25 144.57 25.18 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.738 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.05 124.29 12.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 111.693 -178.473 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.6 OUTLIER 161.99 113.26 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.035 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.93 102.7 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.563 2.175 . . . . 0.0 110.305 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 134' ' ' GLN . 1.5 p90 -134.16 -9.06 2.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.539 -0.726 . . . . 0.0 112.137 -178.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -172.3 2.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.955 -1.091 . . . . 0.0 110.263 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -170.61 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.95 -31.9 6.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.66 -0.65 . . . . 0.0 109.683 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.67 148.08 37.04 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.845 -0.534 . . . . 0.0 109.719 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.91 -177.43 2.23 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.341 2.694 . . . . 0.0 110.539 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.49 -163.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.474 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 157.06 -128.09 2.08 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -119.59 162.38 19.04 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.354 -1.086 . . . . 0.0 110.17 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 m -84.91 -14.97 46.07 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 50.9 p90 171.65 169.05 0.09 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.204 -0.935 . . . . 0.0 109.936 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.783 HG22 ' HB3' ' A' ' 24' ' ' LEU . 29.5 m -141.1 143.32 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 41.6 mtm180 -149.57 167.31 26.69 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.6 m-85 -149.61 158.69 44.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.454 ' HE2' ' CG ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -155.04 123.18 5.87 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 0.0 109.74 179.386 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.46 70.74 4.12 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.48 2.786 . . . . 0.0 110.401 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.33 -175.15 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.721 ' CG2' HD12 ' A' ' 49' ' ' LEU . 40.2 mm -123.81 133.97 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.39 126.88 50.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.5 mp -79.57 155.14 28.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.141 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.01 -56.14 2.43 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -160.58 165.1 31.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.51 93.22 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.4 p -54.07 -54.61 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.24 -0.912 . . . . 0.0 110.339 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.78 150.99 40.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.484 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 p -137.9 121.19 16.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 m -124.47 41.54 3.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.537 -0.727 . . . . 0.0 109.407 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.672 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 154.4 73.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.81 140.63 29.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 108.744 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.49 -163.06 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 109.084 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -96.47 -63.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -57.57 10.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.52 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 5.6 m-70 -98.16 77.64 2.44 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.433 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -97.11 169.32 9.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.813 0.815 . . . . 0.0 110.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.07 -23.98 67.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.925 -0.484 . . . . 0.0 109.777 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 9' ' ' VAL . 7.5 tt0 -60.38 -19.29 55.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -65.59 -16.47 63.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 0.0 109.28 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.2 mt -64.93 -26.6 68.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -61.2 -19.89 62.14 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.492 -0.755 . . . . 0.0 109.004 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -119.99 73.61 0.98 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . . . -44.86 -60.44 2.05 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.705 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.33 -116.34 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p 50.47 -107.78 0.3 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.818 -1.176 . . . . 0.0 109.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -179.02 37.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 109.92 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 0.4 OUTLIER -148.8 149.67 31.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.532 -0.73 . . . . 0.0 109.461 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 15.4 mttt -131.69 -161.22 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.716 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.9 t90 -90.65 140.53 29.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 109.096 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 132.06 26.18 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.29 155.52 3.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.419 -0.801 . . . . 0.0 110.124 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.69 -21.65 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.798 -0.564 . . . . 0.0 110.182 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -141.67 -174.18 3.99 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.325 -0.86 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.2 -164.56 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.44 46.37 92.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -54.39 83.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.429 0.633 . . . . 0.0 111.529 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -91.9 -44.59 8.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.825 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.7 p -161.39 134.13 6.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.716 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.9 pt -132.34 142.2 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.239 -0.913 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.591 ' OG ' HG22 ' A' ' 131' ' ' VAL . 19.8 m -126.82 147.79 50.0 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.515 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.794 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.6 p -156.05 118.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.789 HG22 ' HG3' ' A' ' 129' ' ' LYS . 14.7 t -97.57 125.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -103.32 150.89 23.34 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -93.19 146.25 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.3 mm? -101.12 123.97 46.1 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.45 -2.6 0.07 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.448 -0.783 . . . . 0.0 112.112 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.99 135.75 3.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 109.132 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -75.57 111.71 11.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CD ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -142.77 -177.98 5.58 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.297 0.57 . . . . 0.0 109.478 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.57 158.98 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.5 mp -113.08 124.07 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -113.83 -30.0 6.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 109.764 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.9 m -148.99 156.79 42.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 109.084 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 t -144.43 154.56 14.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.416 0.627 . . . . 0.0 109.833 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -139.15 101.64 4.32 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.565 HG23 HD23 ' A' ' 144' ' ' LEU . 5.0 mt -126.32 141.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -113.13 137.8 14.49 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -85.27 139.2 31.81 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 122.302 -0.528 . . . . 0.0 110.002 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -111.71 65.83 0.63 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.1 29.4 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 14.9 m -60.5 178.0 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.974 . . . . 0.0 110.152 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -135.94 -50.17 0.7 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -102.32 132.36 48.34 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.6 t -134.84 108.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.503 -0.748 . . . . 0.0 110.083 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -102.51 145.51 29.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG13 HD13 ' A' ' 130' ' ' ILE . 21.4 t -132.02 128.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.097 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 86' ' ' VAL . 3.0 mp -113.08 159.93 18.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 HD13 ' A' ' 87' ' ' LEU . 4.6 m -121.52 155.45 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.66 -0.65 . . . . 0.0 110.213 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.97 170.81 43.82 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 t -115.89 170.45 8.46 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.788 0.804 . . . . 0.0 110.144 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.4 p -76.24 -0.94 24.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.54 149.6 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 110.444 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.13 -62.06 3.73 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.61 -145.3 17.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.25 68.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.61 -0.935 . . . . 0.0 109.297 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.14 -49.4 4.48 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' OE1' HG21 ' A' ' 46' ' ' VAL . 4.1 mm-40 59.29 25.31 13.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -1.002 . . . . 0.0 109.853 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -149.55 21.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 0.0 109.92 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.59 50.76 2.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.631 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -119.66 151.72 38.26 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.73 144.22 40.02 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.352 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 71' ' ' LEU . 23.0 t -62.99 88.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.659 -0.651 . . . . 0.0 111.172 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG11 ' A' ' 72' ' ' VAL . 12.7 tp -61.16 -45.49 94.41 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.6 pp -146.58 124.83 12.21 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.39 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.613 ' O ' HD12 ' A' ' 88' ' ' LEU . 30.6 m -55.46 -175.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.726 -0.609 . . . . 0.0 110.118 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.58 133.31 45.66 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.54 -0.725 . . . . 0.0 109.404 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.1 p -98.26 125.07 43.19 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.2 p -91.48 102.97 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 23.7 m-85 -99.04 -47.02 5.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.375 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.442 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 51.2 mtp -120.08 -157.48 0.71 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.733 -0.604 . . . . 0.0 109.502 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 4.9 p -159.41 -170.86 0.26 Allowed Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 49.6 Cg_endo -81.8 8.48 4.43 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.742 1.628 . . . . 0.0 110.431 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -83.2 -37.55 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.39 -34.61 72.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 t -73.64 -7.27 51.29 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.69 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -109.0 -52.39 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.533 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -120.94 35.86 4.76 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.141 -0.975 . . . . 0.0 111.692 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.07 6.68 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.175 -0.953 . . . . 0.0 111.849 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.93 89.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 p30 48.99 82.03 0.25 Allowed Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.442 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.9 Cg_endo -77.49 -25.9 7.73 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 123.542 2.828 . . . . 0.0 110.977 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.8 109.39 10.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.143 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.1 169.87 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.8 m -138.37 165.73 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 0.0 109.51 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 161.89 33.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.027 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 mtm -123.25 164.47 18.68 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.311 0.577 . . . . 0.0 110.156 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.5 m-85 -132.26 101.78 5.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -80.13 -148.22 5.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.559 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.9 Cg_endo -75.05 -34.18 3.98 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.385 2.724 . . . . 0.0 110.759 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.18 -27.7 68.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.563 -0.711 . . . . 0.0 110.036 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 4.2 mtmt -94.48 4.3 54.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.657 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -126.95 142.71 51.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.953 -1.092 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.9 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -62.65 137.4 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -33.76 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.48 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.72 -22.9 67.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.738 . . . . 0.0 110.191 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.9 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -111.81 -46.99 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.373 -0.829 . . . . 0.0 110.199 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.17 -35.36 16.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.25 -0.906 . . . . 0.0 111.259 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 0.5 47.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 110.602 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.4 mttm -93.43 135.54 34.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -69.33 110.46 4.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 0.0 111.02 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.2 m95 -113.35 162.24 16.3 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.5 12.22 2.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.072 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.547 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.7 mtt180 -142.34 142.25 32.45 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.6 p -139.01 141.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.352 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.789 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.4 tttt -104.08 118.45 36.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.77 -0.581 . . . . 0.0 109.765 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 HG13 ' A' ' 70' ' ' VAL . 47.5 mm -107.33 119.34 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.591 HG22 ' OG ' ' A' ' 44' ' ' SER . 47.0 t -126.2 121.34 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.133 -0.98 . . . . 0.0 110.59 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.415 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -93.56 155.82 17.08 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.825 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -154.06 123.97 6.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.258 -0.901 . . . . 0.0 111.898 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' SER . 1.7 tm0? 162.04 114.88 0.01 OUTLIER Pre-proline 0 N--CA 1.503 2.198 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.05 103.4 1.74 Allowed 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 122.636 2.224 . . . . 0.0 110.361 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 134' ' ' GLN . 2.0 p90 -135.2 -19.39 1.72 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.518 -0.738 . . . . 0.0 112.291 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 -175.27 2.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 0.0 110.379 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -163.18 -43.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.18 -34.73 6.29 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.544 0.688 . . . . 0.0 109.457 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 143.16 26.04 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.69 -172.06 0.78 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.141 2.561 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 176.8 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.77 -121.39 1.02 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.859 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.565 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -114.17 158.39 21.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.752 -0.852 . . . . 0.0 110.1 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 4.1 m -92.49 -26.94 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 39.4 p90 -176.66 167.27 2.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 60' ' ' ILE . 27.2 m -147.02 122.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.691 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 14.6 mmm180 -132.54 110.0 10.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 110.205 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 128' ' ' VAL . 41.1 m-85 -88.8 154.77 20.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 108.787 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 122.72 8.6 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.668 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.65 136.49 4.51 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.373 2.715 . . . . 0.0 110.499 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -160.13 -179.89 8.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.665 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 151' ' ' SER . 78.2 mt -140.63 125.99 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -107.8 154.12 21.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.783 -0.573 . . . . 0.0 109.653 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.657 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.2 mp -89.52 152.53 21.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.748 -0.595 . . . . 0.0 109.508 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -102.02 -56.46 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -160.86 165.24 30.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -79.97 91.05 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 109.098 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -53.95 -57.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.183 -0.948 . . . . 0.0 110.405 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -118.4 147.15 43.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -132.11 133.69 44.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.01 38.76 3.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 109.82 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.573 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.73 74.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -134.87 147.57 49.9 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.5 149.54 24.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.409 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -60.27 -61.02 2.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.465 -0.772 . . . . 0.0 109.967 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.412 ' HB ' ' CD2' ' A' ' 19' ' ' HIS . 0.2 OUTLIER -59.2 -44.51 92.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 29.7 m-70 -118.74 84.67 2.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -95.8 167.26 11.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.595 0.712 . . . . 0.0 110.277 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.729 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.75 -23.34 67.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.32 -18.38 58.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.727 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -64.47 -18.67 64.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 147' ' ' VAL . 9.6 mt -65.29 -26.98 68.31 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -60.12 -20.9 60.53 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.529 -0.732 . . . . 0.0 109.089 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -107.31 62.95 0.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.39 -25.26 5.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.405 -0.809 . . . . 0.0 110.57 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t0 -118.46 81.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 109.831 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -156.54 -82.74 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.421 -0.8 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -177.88 -38.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.926 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -86.5 166.99 15.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.57 -0.706 . . . . 0.0 110.007 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.66 -160.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.724 ' CH2' HD12 ' A' ' 43' ' ' ILE . 18.6 t90 -81.74 139.67 34.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 19' ' ' HIS . 1.2 mtt180 -146.14 127.04 14.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.52 152.98 1.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.654 0.74 . . . . 0.0 111.041 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -61.56 -23.85 66.25 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.008 -0.433 . . . . 0.0 110.127 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 -174.93 3.95 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.992 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.58 -164.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.72 -0.612 . . . . 0.0 109.427 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.8 44.77 91.54 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 2.6 mm-40 -48.04 89.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.756 0.789 . . . . 0.0 111.625 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.1 tttm -97.69 -57.35 2.26 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.618 HG22 ' OG ' ' A' ' 133' ' ' SER . 41.0 p -155.85 122.57 5.26 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 33' ' ' TRP . 12.8 pt -124.03 147.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 131' ' ' VAL . 12.9 m -129.37 144.63 51.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.076 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.729 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.9 p -151.74 116.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.3 t -97.03 121.17 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.657 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 mp -104.03 149.97 24.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.38 156.73 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.644 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.453 HD12 ' CA ' ' A' ' 126' ' ' ASP . 48.6 mt -106.76 125.39 50.94 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -51.73 -9.3 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.381 -0.825 . . . . 0.0 112.253 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -161.11 140.64 10.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 0.0 109.138 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.2 111.48 10.49 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -145.73 178.72 7.94 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -85.51 -172.93 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.41 122.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.412 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -113.32 -28.45 7.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.2 m -149.29 160.69 43.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 63.4 t -146.38 160.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.326 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -131.55 130.74 42.67 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 59' ' ' ASP . 26.2 mm -139.31 118.42 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.41 116.46 4.33 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 24.3 m-80 -82.54 118.32 23.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.974 -0.721 . . . . 0.0 110.517 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 60.58 2.15 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.09 85.76 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.425 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 69.3 m -59.13 162.16 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -123.37 -55.84 1.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.7 m-85 -102.99 118.97 38.0 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.616 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 HG21 ' A' ' 60' ' ' ILE . 50.7 t -122.24 109.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.15 143.66 32.63 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.752 HG13 HD13 ' A' ' 130' ' ' ILE . 11.0 t -133.1 124.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.87 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -111.34 163.23 14.19 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.0 m -127.94 161.79 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.684 -0.635 . . . . 0.0 109.861 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 174.26 176.08 42.36 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -110.9 158.83 18.3 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 t -88.9 11.33 18.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 118.36 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 104.13 0.67 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.76 -32.75 0.23 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 83' ' ' ASP . . . -92.89 -46.28 7.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.65 -0.912 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.91 -172.67 24.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -96.86 25.08 5.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.918 . . . . 0.0 109.761 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -133.29 22.09 4.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.575 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.553 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . 13.1 t70 -131.8 45.11 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.348 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.4 m-85 -88.84 -175.73 4.97 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -123.52 129.74 51.66 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -63.17 86.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.596 -0.69 . . . . 0.0 109.963 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 117' ' ' VAL . 24.6 tp -59.45 -59.59 5.21 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.549 HD11 HG23 ' A' ' 70' ' ' VAL . 1.5 pp -136.36 121.09 18.49 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.308 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.13 -179.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.697 -0.627 . . . . 0.0 110.602 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.69 131.77 46.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 p -99.31 117.52 33.93 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.775 -0.578 . . . . 0.0 109.764 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -75.02 69.43 1.93 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.443 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 36.4 t80 -59.48 -58.46 8.51 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.851 -0.53 . . . . 0.0 110.437 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 82.5 mtp -120.83 -177.19 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.737 0.78 . . . . 0.0 110.925 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.6 p -111.98 -179.43 0.64 Allowed Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.42 ' HB3' ' NE2' ' A' ' 134' ' ' GLN . 46.6 Cg_endo -86.02 12.24 3.09 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.999 2.466 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.8 p -120.77 -48.96 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 109.535 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.9 -7.33 50.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 87.4 p -83.21 -20.73 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.716 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -73.88 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 t -161.99 38.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 108.937 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.41 -24.19 6.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.49 117.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.443 -1.033 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.68 72.61 1.01 Allowed Pre-proline 0 N--CA 1.508 2.446 0 O-C-N 121.801 -0.562 . . . . 0.0 111.393 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 41.3 Cg_endo -79.27 -30.16 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.88 2.387 . . . . 0.0 109.958 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -128.06 112.45 14.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -168.25 2.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 67.1 t -121.29 163.04 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 108' ' ' VAL . 28.3 tpt180 -145.97 124.55 12.48 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtp -109.95 154.01 23.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -0.785 . . . . 0.0 110.5 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.495 ' HE1' ' CG1' ' A' ' 60' ' ' ILE . 7.9 m-85 -126.05 158.1 36.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 -149.95 6.74 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.24 -38.16 1.61 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.798 2.999 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.45 -29.17 69.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -89.08 3.26 52.37 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.672 -0.642 . . . . 0.0 110.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.23 139.76 53.44 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.039 -1.038 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.3 p -60.66 132.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -34.55 62.3 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.406 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.24 65.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 110.437 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.62 -47.29 2.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.014 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.01 -38.58 23.93 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.197 -0.939 . . . . 0.0 111.438 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.15 2.48 27.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.359 -0.838 . . . . 0.0 110.661 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 22.6 mttt -94.61 135.0 36.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -66.59 112.85 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.534 -0.729 . . . . 0.0 110.787 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 76.4 m95 -116.85 164.36 14.79 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' CA ' HD12 ' A' ' 49' ' ' LEU . 5.1 p-10 -137.27 9.66 2.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' HD2' HG11 ' A' ' 10' ' ' VAL . 15.3 mtm180 -143.18 145.33 32.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.4 p -135.41 143.42 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.924 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HG3' HG22 ' A' ' 46' ' ' VAL . 15.2 tttt -107.71 115.57 30.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.721 -0.612 . . . . 0.0 109.7 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.752 HD13 HG13 ' A' ' 70' ' ' VAL . 49.0 mm -105.4 117.6 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 0.0 109.286 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 44' ' ' SER . 46.5 t -125.01 117.8 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.111 -0.993 . . . . 0.0 110.429 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.44 ' HB3' HG13 ' A' ' 43' ' ' ILE . 10.9 t -92.46 148.66 21.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.1 123.97 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.525 -0.734 . . . . 0.0 111.466 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.7 134.11 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.403 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.86 98.2 0.5 Allowed 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.094 2.53 . . . . 0.0 110.207 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -129.77 2.98 4.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.357 -0.839 . . . . 0.0 111.373 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 -170.91 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.942 -1.099 . . . . 0.0 109.701 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -170.38 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.688 -0.632 . . . . 0.0 109.338 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -113.55 -36.25 4.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.694 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -103.04 143.53 26.78 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.39 174.53 5.06 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.236 2.624 . . . . 0.0 110.462 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.74 -164.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.33 -109.91 0.42 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.808 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.25 144.94 40.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.726 -0.867 . . . . 0.0 110.61 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -80.54 -28.72 37.22 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' A' ' 108' ' ' VAL . 48.8 p90 -177.56 174.8 1.49 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.567 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 24' ' ' LEU . 27.7 m -150.63 130.55 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -143.34 107.79 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.506 -0.746 . . . . 0.0 110.157 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 128' ' ' VAL . 83.1 m-85 -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.36 136.67 15.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.386 -0.821 . . . . 0.0 109.388 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.752 -0.593 . . . . 0.0 109.626 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 19.8 ptt? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.64 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.6 Cg_endo -88.86 -11.62 3.79 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.428 2.085 . . . . 0.0 111.207 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.16 -165.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.854 ' CG2' HD11 ' A' ' 49' ' ' LEU . 83.1 mt -128.62 128.21 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -115.39 171.1 7.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -0.856 . . . . 0.0 110.319 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 47' ' ' LEU . 3.1 mp -97.69 163.74 12.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.759 -0.588 . . . . 0.0 109.57 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.634 ' C ' HD11 ' A' ' 25' ' ' LEU . 6.3 ttt85 -121.84 -51.44 2.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -161.09 162.18 31.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.87 96.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.495 -0.753 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -54.37 -60.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.71 159.14 30.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.2 p -158.28 136.63 10.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.26 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 t -141.75 59.77 1.48 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.679 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 157.22 59.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-O 121.443 0.639 . . . . 0.0 109.965 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -139.23 144.14 38.32 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.72 -1.237 . . . . 0.0 110.34 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.84 174.63 6.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.249 -0.907 . . . . 0.0 109.193 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -74.25 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.534 -0.729 . . . . 0.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -58.37 8.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.016 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 9.7 m-70 -97.05 80.44 2.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -93.56 164.5 13.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.572 -0.705 . . . . 0.0 109.839 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.42 -21.08 66.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.869 -0.519 . . . . 0.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.05 -18.82 63.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 31' ' ' ARG . 13.7 m120 -64.79 -18.12 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.868 . . . . 0.0 109.091 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.6 mt -65.13 -26.92 68.4 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.634 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.94 -20.58 58.26 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.493 -0.754 . . . . 0.0 109.003 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -115.18 68.55 0.71 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.3 -24.4 7.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.455 -0.778 . . . . 0.0 110.626 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.46 86.51 2.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.922 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 -83.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 0.0 109.427 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.9 p90 -177.8 -37.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HB3' ' ND2' ' A' ' 23' ' ' ASN . 16.7 tpp85 -86.43 134.6 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.36 -0.837 . . . . 0.0 109.995 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -114.62 -171.86 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.48 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -84.96 142.21 29.8 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.535 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -147.8 130.39 15.89 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.688 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.27 153.02 1.6 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.44 -0.787 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.76 -19.79 52.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.951 -0.468 . . . . 0.0 110.315 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 -171.21 3.16 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.359 -0.838 . . . . 0.0 108.933 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.23 -172.4 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 48.97 77.03 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 35' ' ' ALA . 79.1 mm-40 -34.11 -88.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp 72.02 -60.07 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.531 -0.731 . . . . 0.0 109.109 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.635 HG22 ' OG ' ' A' ' 133' ' ' SER . 40.8 p -155.41 138.84 15.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 ' CH2' ' A' ' 33' ' ' TRP . 1.4 pt -145.73 140.73 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.55 -0.719 . . . . 0.0 109.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 4.2 m -122.08 131.13 53.82 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.594 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.655 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -136.89 116.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.1 t -95.88 116.76 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.232 -0.918 . . . . 0.0 108.974 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.684 HD22 HD21 ' A' ' 6' ' ' LEU . 1.1 mp -101.11 157.02 17.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.641 -0.662 . . . . 0.0 109.76 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -96.3 163.56 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.691 -0.631 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.854 HD11 ' CG2' ' A' ' 4' ' ' ILE . 11.5 tp -108.52 124.78 50.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.84 2.59 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 112.471 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -175.97 134.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.657 -1.277 . . . . 0.0 108.93 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -74.79 111.0 9.55 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.644 0.735 . . . . 0.0 110.108 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -172.85 4.26 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' O ' HD11 ' A' ' 4' ' ' ILE . 14.4 mt-30 -90.61 -178.36 5.27 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -141.92 127.06 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.657 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.472 ' HA ' HD21 ' A' ' 116' ' ' LEU . 13.1 t-160 -115.82 -32.03 5.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.1 m -141.09 159.34 42.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.673 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.3 t -140.21 163.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 m-20 -140.23 127.53 21.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.691 . . . . 0.0 109.519 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 59' ' ' ASP . 1.1 mp -145.21 139.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -98.53 126.88 9.05 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.12 126.19 30.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.066 -0.667 . . . . 0.0 110.231 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.32 63.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 108.839 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.58 -31.47 8.31 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.7 p -62.21 173.39 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.914 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -141.83 -53.45 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -93.61 125.69 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.265 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.87 113.07 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.003 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.0 121.97 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.766 ' CG2' HD12 ' A' ' 88' ' ' LEU . 31.5 t -113.74 127.75 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 110.223 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.1 mp -118.35 162.56 18.09 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 87' ' ' LEU . 3.4 m -131.19 159.79 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.432 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.97 178.1 45.51 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 t -117.84 156.59 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.2 p -84.53 6.26 24.38 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.471 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.29 4.1 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.03 49.69 0.83 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.78 77.54 1.45 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.89 -45.86 9.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.929 . . . . 0.0 109.734 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.83 177.17 17.72 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -85.64 -17.24 36.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.704 -0.88 . . . . 0.0 110.218 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -95.78 35.36 1.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.826 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -116.4 27.84 8.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.8 m-85 -108.55 -175.01 2.66 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -120.98 126.14 49.19 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -61.58 85.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 0.0 110.422 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.909 HD13 HG21 ' A' ' 72' ' ' VAL . 6.5 tp -59.59 -61.14 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.766 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -121.9 130.1 53.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -68.73 -171.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 116.93 5.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 p -99.26 112.93 24.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -81.96 123.41 28.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 13.1 m-85 -116.61 -46.94 2.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -121.01 -166.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.523 0.678 . . . . 0.0 110.21 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 p -124.0 178.86 1.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.33 18.76 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.307 2.672 . . . . 0.0 111.433 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 m -120.28 -54.88 2.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' CG ' ' HB2' ' A' ' 103' ' ' SER . 0.5 OUTLIER -56.98 -28.01 61.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.478 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 10.9 m -50.09 -25.36 3.39 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.477 -0.764 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -80.95 -87.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.466 -0.771 . . . . 0.0 109.814 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 t -163.44 37.73 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.96 -22.56 38.25 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -170.41 -86.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -1.038 . . . . 0.0 110.647 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.6 34.84 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.16 -23.9 20.74 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.797 2.331 . . . . 0.0 109.994 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -134.46 141.54 46.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 -163.99 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 72.5 t -136.88 154.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.12 150.58 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 108.908 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.2 mtm -129.21 171.93 11.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.292 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.6 m-85 -130.56 169.71 15.23 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.829 0.823 . . . . 0.0 109.566 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.82 -154.05 6.03 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.192 -2.363 . . . . 0.0 107.192 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -74.27 -26.78 12.13 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.527 2.818 . . . . 0.0 110.843 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -53.37 -41.84 66.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.656 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.89 15.88 23.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -121.97 118.99 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -46.5 126.97 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.979 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -64.52 -39.5 93.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.431 -0.793 . . . . 0.0 109.4 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.89 91.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.497 -0.752 . . . . 0.0 110.663 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -88.39 -36.39 16.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.324 -0.86 . . . . 0.0 109.188 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.701 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.07 -42.76 6.4 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.64 -0.663 . . . . 0.0 111.361 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.22 11.43 30.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.981 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -92.25 130.14 38.03 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -66.32 108.81 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -0.756 . . . . 0.0 110.113 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 68.6 m95 -116.47 163.32 16.23 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 4.5 p-10 -140.15 15.1 2.43 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.103 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -147.75 149.84 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.4 p -141.58 144.15 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.974 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.663 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.2 tttt -105.77 134.97 48.03 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HG13 ' A' ' 45' ' ' VAL . 46.9 mm -128.59 107.92 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.475 -0.765 . . . . 0.0 109.236 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.0 t -112.24 109.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.211 -0.93 . . . . 0.0 109.921 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.423 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.63 154.27 28.81 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.4 OUTLIER -157.06 120.94 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 -178.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 5.2 tp60 171.41 135.04 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.5 100.78 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.928 2.419 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 38.0 p90 -147.27 15.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 111.483 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.39 -173.38 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.051 -1.031 . . . . 0.0 110.072 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -177.96 -39.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -116.05 -32.23 5.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.656 -0.653 . . . . 0.0 110.141 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.5 146.05 32.52 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.78 -0.575 . . . . 0.0 109.875 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.2 Cg_endo -87.48 171.81 6.12 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.417 2.745 . . . . 0.0 110.614 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -178.95 -166.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 158.01 -106.75 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.084 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.6 mp -120.12 155.02 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.962 . . . . 0.0 110.849 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 m -88.35 -27.47 21.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.0 p90 -177.1 170.48 2.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.2 m -146.99 142.06 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 21.1 mtm180 -150.56 166.14 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.664 . . . . 0.0 109.534 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.823 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.7 m-85 -141.59 158.19 44.15 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.32 128.54 8.28 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.01 -1.056 . . . . 0.0 110.338 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.424 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.8 46.83 1.31 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.573 2.849 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.16 -171.54 3.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -138.67 128.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 168.87 9.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.627 -0.671 . . . . 0.0 110.017 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.691 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.4 mp -103.26 156.29 17.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.706 -0.622 . . . . 0.0 109.755 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' C ' HD11 ' A' ' 25' ' ' LEU . 1.4 tpt180 -109.8 -52.0 2.82 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.93 168.41 24.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -84.01 93.8 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.252 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.7 p -52.99 -59.99 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.243 -0.91 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.524 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.14 153.03 36.78 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -138.59 133.7 32.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.728 . . . . 0.0 109.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.95 42.64 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.702 . . . . 0.0 109.679 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.08 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.926 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.6 pp0? -131.11 132.91 45.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.46 152.51 34.19 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -62.48 -62.16 1.94 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -0.767 . . . . 0.0 109.804 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -61.51 2.43 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 34' ' ' ARG . 43.3 m-70 -93.15 85.06 4.94 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 p -98.28 167.24 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.507 0.67 . . . . 0.0 110.236 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.51 -23.63 66.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.761 -0.587 . . . . 0.0 109.969 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.36 -19.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.239 -0.913 . . . . 0.0 109.774 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -65.5 -17.79 64.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.157 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.12 -25.41 67.76 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.472 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -57.61 -23.09 49.11 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 65.31 0.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.32 -24.95 8.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.783 . . . . 0.0 110.537 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' THR . 6.3 m-20 -120.47 82.81 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 109.758 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -157.02 -85.28 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.501 -0.749 . . . . 0.0 109.398 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -177.48 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.138 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -160.82 142.12 11.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.346 -0.846 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -169.04 1.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.735 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.6 t90 -80.54 136.74 36.33 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.6 mtp180 -142.1 125.69 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.736 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -55.51 169.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.765 0.793 . . . . 0.0 111.018 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -101.57 -22.71 14.42 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.988 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.9 -153.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.14 -174.35 4.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.059 -1.025 . . . . 0.0 109.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 89.75 -13.5 64.14 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 12.6 mt-10 46.08 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.41 -1.053 . . . . 0.0 112.013 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -133.41 -72.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.439 HG22 ' OG ' ' A' ' 133' ' ' SER . 31.1 p -153.91 139.5 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG21 ' HB2' ' A' ' 35' ' ' ALA . 8.9 pt -134.1 149.56 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.597 ' OG ' HG22 ' A' ' 131' ' ' VAL . 30.9 m -126.53 140.42 52.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.398 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -148.41 121.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.681 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.4 t -101.31 120.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.5 mp -98.08 168.63 10.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.631 . . . . 0.0 109.985 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -111.39 142.76 43.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.803 -0.561 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD23 HD12 ' A' ' 6' ' ' LEU . 60.8 mt -97.07 135.26 39.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.63 37.89 0.36 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.48 -0.762 . . . . 0.0 111.262 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 pttt 165.58 127.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.39 108.12 9.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.806 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -178.6 5.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -87.34 -172.63 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.41 122.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.519 -0.738 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.3 t-160 -109.41 -32.09 7.29 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.3 m -146.88 153.53 40.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 149' ' ' PHE . 70.5 t -137.51 158.7 34.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.674 -0.641 . . . . 0.0 109.564 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.517 ' O ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -137.2 138.55 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.706 HG23 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -159.72 139.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -122.99 135.77 10.21 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -91.77 151.56 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.152 -0.617 . . . . 0.0 109.9 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.32 34.47 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.86 -17.14 8.21 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.518 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -60.78 -171.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -1.079 . . . . 0.0 110.449 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.96 -40.88 0.84 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.48 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.05 140.43 39.87 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.509 -0.744 . . . . 0.0 111.322 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 93' ' ' PHE . 61.9 t -143.3 112.44 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.667 -0.645 . . . . 0.0 109.61 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.25 147.3 27.22 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.68 -0.638 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.27 131.55 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.897 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -117.32 167.34 11.32 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.72 HG23 ' HG2' ' A' ' 85' ' ' GLU . 5.6 m -130.61 159.0 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.703 -0.623 . . . . 0.0 109.568 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 176.31 173.8 42.27 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 t -115.62 161.07 19.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.601 0.715 . . . . 0.0 109.58 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -80.34 3.75 20.11 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.803 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -174.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.154 -0.966 . . . . 0.0 110.143 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.64 106.23 0.92 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.59 -72.32 0.04 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.04 43.55 14.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -1.006 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.17 122.55 1.33 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -62.77 -27.51 69.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.931 . . . . 0.0 109.628 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -97.31 28.45 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.468 -0.77 . . . . 0.0 109.618 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.95 25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.543 -0.723 . . . . 0.0 109.62 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.54 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -109.26 -175.54 2.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.72 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -121.11 127.4 51.57 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.39 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.759 -0.588 . . . . 0.0 110.17 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' CG1' ' A' ' 72' ' ' VAL . 15.3 tp -57.96 -50.65 72.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.67 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -146.6 124.07 11.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -59.01 173.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -56.08 131.32 47.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -103.46 132.9 49.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 99.9 p -90.18 107.4 19.11 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 68' ' ' VAL . 7.2 m-30 -89.29 -51.36 5.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.418 -0.801 . . . . 0.0 109.691 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 mtp -120.89 -178.92 3.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.754 0.788 . . . . 0.0 110.519 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -99.98 179.63 1.0 Allowed Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -86.98 18.45 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.128 2.552 . . . . 0.0 111.445 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -120.31 -53.52 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.49 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -58.11 -18.99 28.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.452 -0.78 . . . . 0.0 110.635 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.4 t -49.04 -26.54 2.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.334 -0.854 . . . . 0.0 110.455 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -85.66 -85.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 t -164.06 37.47 0.08 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.36 -19.84 68.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.06 -83.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.42 -1.047 . . . . 0.0 110.686 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.6 p30 -111.84 82.15 3.88 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.78 -19.23 27.68 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.824 2.349 . . . . 0.0 110.776 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 127.79 40.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 109.567 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -157.73 176.69 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 17.4 m -134.57 -173.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.535 -0.728 . . . . 0.0 109.41 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -160.66 148.91 16.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.646 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtm -126.69 151.93 47.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.836 -0.54 . . . . 0.0 109.731 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' HD13 ' A' ' 88' ' ' LEU . 3.6 m-85 -122.57 165.68 16.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.42 -148.3 5.3 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.6 Cg_endo -75.01 -40.19 0.97 Allowed 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 123.727 2.951 . . . . 0.0 111.152 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.2 -27.76 68.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.742 . . . . 0.0 109.782 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtmm -92.02 3.36 55.41 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.666 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.79 139.37 54.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.037 -1.04 . . . . 0.0 110.45 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.9 p -59.63 129.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -74.29 -32.48 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.558 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.0 -22.44 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 110.189 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.2 -47.07 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 110.152 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.949 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.99 19.39 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.099 -1.001 . . . . 0.0 111.63 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.52 2.23 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.368 -0.832 . . . . 0.0 110.707 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 27.6 mttt -93.51 136.02 34.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.19 113.22 4.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.413 -0.804 . . . . 0.0 110.546 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.8 m95 -116.94 164.53 14.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -139.86 14.82 2.49 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.065 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.401 ' HD3' HG21 ' A' ' 10' ' ' VAL . 6.7 mtt180 -144.38 146.95 32.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.0 p -138.19 140.78 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.036 -1.065 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.681 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -100.33 142.93 31.12 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.667 ' CD1' HG13 ' A' ' 70' ' ' VAL . 37.6 mm -138.24 107.51 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.597 HG22 ' OG ' ' A' ' 44' ' ' SER . 44.0 t -115.46 120.62 65.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 O-C-N 121.293 -0.879 . . . . 0.0 109.874 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 144' ' ' LEU . 2.2 t -94.22 150.71 20.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -155.1 143.02 20.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.09 -1.006 . . . . 0.0 112.206 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.4 tp60 148.53 113.1 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.34 123.32 4.38 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.679 2.253 . . . . 0.0 110.562 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.563 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -146.78 6.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.165 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 -175.19 4.79 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.347 -1.471 . . . . 0.0 111.345 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 58.8 mmtt -137.03 -30.16 0.88 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.828 -0.545 . . . . 0.0 110.912 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.08 -9.01 6.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.798 -1.189 . . . . 0.0 111.924 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.56 148.97 37.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.947 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.11 -161.45 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 123.927 3.085 . . . . 0.0 110.632 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p90 -178.69 -160.32 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 43' ' ' ILE . . . 157.31 -165.37 33.32 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.283 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.706 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -99.27 150.58 21.95 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.063 -0.669 . . . . 0.0 109.569 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 p -76.79 -30.71 56.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 49.6 p90 -175.13 168.9 3.38 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.735 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.9 m -138.65 157.31 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 14.3 mtt180 -160.06 159.74 32.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.627 -0.67 . . . . 0.0 110.269 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.884 ' CE2' HG11 ' A' ' 128' ' ' VAL . 58.2 m-85 -150.38 153.4 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.95 142.91 18.97 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.15 -0.968 . . . . 0.0 110.107 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -89.91 20.47 1.04 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.684 2.922 . . . . 0.0 111.097 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -155.78 159.99 39.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' OE1' ' A' ' 53' ' ' GLU . 96.0 mt -139.15 130.16 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 167.27 10.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 109.632 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.779 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.2 mp -98.53 160.82 14.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.701 -0.624 . . . . 0.0 109.424 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.717 ' C ' HD11 ' A' ' 25' ' ' LEU . 7.2 tpt180 -116.78 -46.01 2.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -161.19 -171.88 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.706 -0.621 . . . . 0.0 109.422 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -106.48 90.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 109.258 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 11' ' ' SER . 1.4 p -52.25 -62.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.206 -0.934 . . . . 0.0 110.55 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.551 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -118.55 155.1 31.48 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 24.5 p -161.53 126.47 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.748 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -137.61 68.18 1.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.4 p 153.4 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.777 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -122.34 144.0 49.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.978 -1.076 . . . . 0.0 110.765 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -94.12 -168.37 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -68.73 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.444 -0.785 . . . . 0.0 109.825 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.82 65.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.0 71.41 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.4 p -89.81 169.56 11.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.734 . . . . 0.0 109.705 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.777 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -62.6 -25.18 67.95 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.668 -0.645 . . . . 0.0 109.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.4 -19.69 56.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.846 . . . . 0.0 109.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -64.72 -19.94 66.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.102 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 47' ' ' LEU . 8.5 mt -65.83 -25.78 67.37 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.717 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -59.53 -20.82 58.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.43 -0.794 . . . . 0.0 109.014 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.24 73.08 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.26 -47.73 55.07 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.517 -0.739 . . . . 0.0 110.684 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.61 75.96 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.482 -0.761 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -161.57 31.18 0.13 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.632 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.6 p90 47.15 25.57 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.315 0.579 . . . . 0.0 111.658 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -119.89 135.12 55.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.235 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 32.1 mttt -126.96 -178.63 4.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.82 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -94.43 137.25 33.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -139.78 128.12 22.68 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.93 164.72 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.424 -0.797 . . . . 0.0 110.327 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -72.4 -22.42 61.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.793 -0.567 . . . . 0.0 110.531 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.23 176.58 8.57 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.354 -0.841 . . . . 0.0 109.063 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.34 -176.06 5.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.71 -48.84 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 11.9 mp0 40.09 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.021 -0.694 . . . . 0.0 112.367 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 42' ' ' THR . 8.2 ptpt -103.21 -43.35 5.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.676 HG22 ' OG ' ' A' ' 133' ' ' SER . 3.0 p -160.49 106.34 1.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.82 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -107.32 136.66 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.497 -0.752 . . . . 0.0 110.5 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' OG ' ' A' ' 14' ' ' SER . 55.6 p -115.61 134.98 54.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.38 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -142.3 101.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.0 t -90.33 118.16 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 108.965 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -103.02 166.37 10.48 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -107.92 157.49 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.671 -0.643 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.02 124.44 49.63 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.1 -7.31 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.391 -0.818 . . . . 0.0 112.297 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -161.8 140.99 9.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.731 -1.23 . . . . 0.0 109.414 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.27 109.32 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.509 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -143.74 175.9 9.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -84.59 -172.5 4.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.9 121.68 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -110.13 -30.55 7.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.2 m -146.03 154.69 42.15 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.76 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.9 t -137.9 158.67 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.706 ' C ' HD12 ' A' ' 60' ' ' ILE . 12.1 t0 -133.05 134.84 44.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.308 -0.87 . . . . 0.0 110.579 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.946 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -149.7 125.96 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.65 117.04 5.55 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.9 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.849 -0.795 . . . . 0.0 109.881 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -123.15 82.63 2.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.52 80.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 4.9 p -98.4 178.64 4.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -1.123 . . . . 0.0 109.824 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -140.07 -47.56 0.44 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.515 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -109.3 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.172 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 60' ' ' ILE . 42.7 t -132.65 114.05 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.44 150.86 26.29 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.614 HG13 HD13 ' A' ' 130' ' ' ILE . 34.3 t -140.71 127.14 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.586 0.708 . . . . 0.0 110.079 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 3.6 mp -113.85 160.89 18.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 87' ' ' LEU . 2.4 m -125.41 155.55 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.55 -0.719 . . . . 0.0 110.151 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.19 169.69 42.77 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -119.92 165.43 14.64 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.723 0.773 . . . . 0.0 110.014 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -69.91 -9.36 54.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 145.57 28.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.264 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.02 36.5 4.07 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.38 -102.48 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.8 73.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.961 . . . . 0.0 109.441 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.94 131.85 2.76 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.62 74.74 8.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.943 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -153.81 -46.01 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.23 -47.12 65.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.749 -0.594 . . . . 0.0 109.422 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 3.6 m-85 59.24 165.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.554 -0.717 . . . . 0.0 109.282 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -101.69 129.63 47.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.1 86.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.798 -0.563 . . . . 0.0 110.373 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 72' ' ' VAL . 10.3 tp -59.98 -52.59 64.76 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.385 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -57.55 172.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.561 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -58.01 135.01 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.592 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 5.9 p -108.33 130.94 55.18 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.447 0.641 . . . . 0.0 109.64 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -85.91 123.28 31.07 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 25.6 m-85 -123.05 -46.4 2.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 mtp -120.82 -165.7 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.702 -0.624 . . . . 0.0 109.872 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.9 p -126.58 175.77 3.03 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.56 15.42 2.15 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.31 2.674 . . . . 0.0 111.285 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 t -120.17 -42.13 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 109.337 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.09 -20.54 40.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 110.58 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.1 m -50.22 -25.98 4.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.273 -0.892 . . . . 0.0 110.765 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -85.12 -87.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.947 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -163.64 37.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.35 56.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.38 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.476 -1.014 . . . . 0.0 110.722 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.97 92.78 47.01 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 38.6 Cg_endo -73.04 -23.54 18.24 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.615 2.21 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.97 143.54 51.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -148.2 -174.5 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.432 -0.792 . . . . 0.0 110.422 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 70.4 t -148.75 142.44 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -153.26 145.99 24.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.863 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.2 mtm -125.78 152.58 45.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 88' ' ' LEU . 6.7 m-85 -113.02 159.06 19.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -128.19 -149.6 7.06 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.67 -39.27 1.43 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.76 2.973 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.74 -28.31 68.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 42.8 mttt -89.5 3.82 51.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.661 -0.649 . . . . 0.0 110.592 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -124.7 139.81 53.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.098 -1.001 . . . . 0.0 110.442 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.903 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.1 p -60.3 132.35 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -74.86 -34.36 62.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.23 -20.45 65.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.903 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.55 -47.94 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.1 -41.02 25.16 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.217 -0.927 . . . . 0.0 111.617 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -2.18 33.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.4 mttm -90.98 133.63 35.13 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -65.71 113.11 4.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 110.392 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.468 ' CZ2' ' HG3' ' A' ' 85' ' ' GLU . 83.3 m95 -116.17 163.46 15.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.9 7.65 2.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.608 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.24 136.93 35.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.889 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.0 p -127.75 143.93 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.664 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.641 ' HG3' HG22 ' A' ' 46' ' ' VAL . 3.4 tttt -111.6 111.07 21.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.0 109.653 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.614 HD13 HG13 ' A' ' 70' ' ' VAL . 49.4 mm -101.77 128.3 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.09 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.25 117.74 41.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.15 142.39 27.35 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -140.15 127.83 21.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.387 -0.821 . . . . 0.0 111.162 -177.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 150.03 137.95 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.042 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.78 101.48 0.78 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.107 2.538 . . . . 0.0 110.319 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.61 -60.62 2.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.4 -0.812 . . . . 0.0 108.889 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.88 160.59 22.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -106.11 26.61 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.54 -0.725 . . . . 0.0 110.084 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -54.24 2.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 p -116.47 155.33 48.73 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 122.008 -0.433 . . . . 0.0 109.874 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.409 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.1 Cg_endo -83.73 166.18 13.54 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.459 2.772 . . . . 0.0 109.724 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -169.76 -163.02 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 160.89 -106.56 0.29 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -132.45 161.87 32.59 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.212 -1.17 . . . . 0.0 110.189 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 25.3 m -83.43 -17.69 41.26 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.036 -0.415 . . . . 0.0 110.916 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.6 p90 175.88 179.31 0.17 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.232 -0.918 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 144' ' ' LEU . 35.3 m -154.66 128.24 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -140.88 110.79 6.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.277 -0.89 . . . . 0.0 110.562 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.889 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.3 m-85 -88.64 158.57 18.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.412 -0.805 . . . . 0.0 108.859 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.535 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -156.07 139.59 15.89 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.293 -0.88 . . . . 0.0 109.512 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.3 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.0 Cg_endo -84.0 74.68 4.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.932 2.421 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -133.95 178.66 6.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' SER . 40.3 mm -125.3 146.64 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -140.69 134.93 31.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 149' ' ' PHE . 4.3 mm? -85.83 144.63 27.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 109.162 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -94.67 -50.94 4.94 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -160.83 167.78 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -78.67 89.95 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.6 p -50.29 -58.94 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.292 -0.88 . . . . 0.0 110.427 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.52 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.47 158.92 31.69 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.5 p -153.42 136.34 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.675 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -130.01 46.74 2.6 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 154.56 94.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 123.075 0.55 . . . . 0.0 109.624 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.37 146.0 15.05 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.953 -1.092 . . . . 0.0 109.445 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.52 -168.11 1.56 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 -60.21 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 109.522 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -61.15 2.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.801 . . . . 0.0 108.918 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -97.11 77.54 2.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.9 p -90.2 168.26 12.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.576 -0.702 . . . . 0.0 109.937 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.35 -23.72 67.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.65 -17.92 61.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.791 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -65.01 -20.16 66.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.212 -0.93 . . . . 0.0 109.277 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.757 HD21 ' HB2' ' A' ' 33' ' ' TRP . 12.0 mt -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -61.56 -20.16 62.96 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -109.44 64.07 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.6 7.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 0.0 110.563 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 29' ' ' THR . 18.9 t70 -118.65 80.43 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.1 p -155.13 -84.03 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.494 -0.754 . . . . 0.0 109.612 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.7 p90 -179.23 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -79.53 148.85 31.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.391 -0.818 . . . . 0.0 109.772 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 12.4 mttp -127.42 -165.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.639 -0.663 . . . . 0.0 109.541 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.791 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.8 t90 -91.73 141.77 28.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -144.83 126.88 15.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.04 151.71 4.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.76 . . . . 0.0 110.402 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.72 -24.28 67.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.939 -0.475 . . . . 0.0 110.288 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -138.48 -173.22 3.48 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.352 -0.843 . . . . 0.0 109.285 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.15 -163.92 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.785 -0.572 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.07 45.76 95.43 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -47.71 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.582 0.706 . . . . 0.0 111.557 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 42' ' ' THR . 30.3 tttt -93.47 -56.68 2.84 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.673 HG22 ' OG ' ' A' ' 133' ' ' SER . 23.8 p -156.94 113.77 3.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.791 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.9 pt -114.61 132.22 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.573 -0.704 . . . . 0.0 109.874 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -114.57 146.71 40.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.504 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.7 p -147.74 112.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 129' ' ' LYS . 4.6 t -95.54 119.33 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 108.946 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' C ' HG12 ' A' ' 10' ' ' VAL . 1.5 mp -99.25 160.37 14.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.777 -0.577 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.422 ' N ' HD12 ' A' ' 6' ' ' LEU . 12.6 tm0? -111.85 125.97 54.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.5 -0.75 . . . . 0.0 109.905 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' OE2' ' A' ' 53' ' ' GLU . 14.2 mt -80.15 136.04 36.43 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 41.34 0.61 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.594 -0.691 . . . . 0.0 110.405 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 pttm 164.8 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -75.61 107.45 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.571 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -136.6 179.79 6.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.494 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -94.94 162.96 13.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -117.27 126.41 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.311 -0.868 . . . . 0.0 109.918 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.454 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.2 t60 -116.97 -30.19 5.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.694 -0.629 . . . . 0.0 109.849 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.5 m -148.98 158.73 44.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 0.0 108.876 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.71 HG12 HD12 ' A' ' 60' ' ' ILE . 61.3 t -147.82 161.32 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.804 0.811 . . . . 0.0 110.447 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -136.07 134.68 38.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.71 HD12 HG12 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -153.18 130.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -103.88 125.81 8.55 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -83.68 127.59 33.89 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.247 -0.561 . . . . 0.0 110.281 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 2.4 t0 -96.06 50.4 1.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.75 -24.23 24.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 29.1 t -57.12 161.39 3.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.386 -1.067 . . . . 0.0 109.919 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -121.83 -51.79 2.02 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.813 -0.554 . . . . 0.0 109.601 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -96.25 126.59 41.57 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.176 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.19 111.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.596 -0.69 . . . . 0.0 109.734 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -106.29 146.76 29.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.737 -0.602 . . . . 0.0 109.553 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 130' ' ' ILE . 6.7 t -131.13 125.13 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -111.71 157.03 20.97 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -121.55 154.91 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 109.771 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.77 171.22 41.77 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 t -109.63 161.66 15.17 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 122.037 -0.684 . . . . 0.0 109.242 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.413 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 23.1 p -86.13 6.73 27.88 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.56 114.64 2.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.763 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.66 -69.79 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.46 75.99 0.75 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -177.27 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.617 -0.931 . . . . 0.0 109.459 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.76 115.82 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.67 -28.1 22.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.929 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -97.47 28.53 3.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.628 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -111.84 34.37 4.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.97 -174.53 2.55 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -121.73 127.88 51.17 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.416 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.0 t -61.16 88.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' HB2' HG13 ' A' ' 72' ' ' VAL . 18.1 tp -59.65 -60.74 3.36 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 111' ' ' PHE . 2.0 pp -135.85 119.78 17.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.346 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.2 m -51.34 174.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.756 . . . . 0.0 110.278 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.13 133.59 53.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.509 -0.744 . . . . 0.0 109.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.7 p -102.88 122.26 44.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.5 p -87.01 108.31 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 24.2 m-85 -93.48 -51.93 4.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.71 -0.619 . . . . 0.0 109.922 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.45 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 9.3 mtp -122.11 -167.9 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.658 0.742 . . . . 0.0 110.452 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.8 p -109.32 175.64 1.87 Allowed Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.46 10.65 3.63 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.897 2.398 . . . . 0.0 111.332 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -121.44 -35.57 3.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.61 -0.38 53.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 110.671 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 60.1 m -74.19 -30.54 62.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -68.37 -77.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -161.96 38.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.23 -24.74 6.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.54 120.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 109.981 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.2 68.63 2.15 Favored Pre-proline 0 N--CA 1.509 2.499 0 O-C-N 121.975 -0.453 . . . . 0.0 111.551 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -76.83 -30.38 4.73 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.877 2.385 . . . . 0.0 110.233 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' ND2' ' OD1' ' A' ' 63' ' ' ASP . 1.1 m-20 -128.93 99.23 5.21 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -164.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 109.404 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -148.8 151.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 5.1 mmt180 -144.45 166.15 25.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.3 mtm -139.68 175.02 9.93 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.535 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 88' ' ' LEU . 7.5 m-85 -134.36 169.04 17.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -141.49 -151.48 5.56 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.3 Cg_endo -76.45 -37.12 1.46 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.582 2.855 . . . . 0.0 110.617 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.03 -28.59 68.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 109.429 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -88.09 1.61 53.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.607 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.6 pp -124.02 139.76 53.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.979 -1.076 . . . . 0.0 110.345 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.0 p -59.11 130.37 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -74.7 -31.66 61.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.93 66.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.92 -46.48 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.119 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.66 -38.5 21.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.158 -0.964 . . . . 0.0 111.51 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.68 -0.36 33.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 25.7 mtpt -92.41 135.15 34.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -68.23 111.46 4.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.513 -0.742 . . . . 0.0 110.887 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.5 m95 -113.5 162.36 16.25 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.484 ' CA ' HD12 ' A' ' 49' ' ' LEU . 4.4 p30 -135.36 9.0 3.43 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.681 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.7 mtm180 -140.77 142.39 34.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.768 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.8 p -133.9 142.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.816 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 46' ' ' VAL . 1.5 tttt -106.5 112.48 25.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.844 -0.535 . . . . 0.0 109.647 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.648 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.9 mm -104.83 117.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 44' ' ' SER . 42.6 t -120.14 120.65 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.201 -0.937 . . . . 0.0 110.62 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.405 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -95.6 136.0 36.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.673 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -139.31 123.44 17.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 111.017 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.6 tp60 165.14 128.77 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.159 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.98 90.53 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.875 2.383 . . . . 0.0 109.251 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 7.4 p90 -119.85 -12.45 9.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.738 . . . . 0.0 111.702 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 176.54 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 0.0 110.22 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -153.33 -42.77 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.65 -29.93 6.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.619 -0.675 . . . . 0.0 109.955 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -104.42 145.93 31.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.711 -0.618 . . . . 0.0 109.66 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 45.1 Cg_endo -87.78 -175.74 1.52 Allowed 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.356 2.704 . . . . 0.0 110.626 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 170.26 -166.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.95 -117.57 0.76 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.815 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 5.3 mp -114.83 158.43 21.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.711 -0.876 . . . . 0.0 110.18 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 32.3 m -96.17 -25.8 15.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.979 -0.451 . . . . 0.0 109.982 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -176.98 165.7 2.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.206 -0.934 . . . . 0.0 110.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 159.02 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 0.1 OUTLIER -160.49 101.22 1.35 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.768 ' CE2' HG11 ' A' ' 128' ' ' VAL . 34.5 m-85 -88.99 149.93 23.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 0.0 108.289 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.2 120.12 5.73 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.729 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.02 105.77 0.65 Allowed 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 123.468 2.779 . . . . 0.0 110.514 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -154.77 179.86 8.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.0 109.518 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 151' ' ' SER . 33.6 mt -145.26 119.75 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -96.62 166.17 11.79 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.31 0.576 . . . . 0.0 109.605 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.701 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -103.3 153.05 20.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.71 -0.619 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.494 ' C ' HD11 ' A' ' 25' ' ' LEU . 41.8 ttt85 -102.49 -56.48 2.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -160.97 161.46 31.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.651 -0.655 . . . . 0.0 109.274 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.75 93.51 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.1 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 11' ' ' SER . 2.5 p -54.66 -55.96 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.259 -0.901 . . . . 0.0 110.398 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -121.45 151.57 40.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 0.0 109.058 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.7 112.26 6.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.831 . . . . 0.0 110.274 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -105.95 43.7 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 43' ' ' ILE . 1.7 t 153.05 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.825 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -161.3 135.61 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.45 -163.1 0.64 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -0.796 . . . . 0.0 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.8 m -95.51 -70.37 0.72 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -54.92 25.3 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -93.9 68.57 3.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.6 p -90.92 176.13 6.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.474 -0.766 . . . . 0.0 110.271 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.62 -25.17 68.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.74 -16.4 57.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.446 -0.784 . . . . 0.0 109.918 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.07 -18.19 65.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -0.997 . . . . 0.0 109.204 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' A' ' 33' ' ' TRP . 8.8 mt -66.0 -24.13 66.71 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -58.79 -21.01 55.09 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.459 -0.776 . . . . 0.0 109.06 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -123.62 73.47 1.2 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.71 -22.03 21.55 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.462 -0.774 . . . . 0.0 110.233 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.51 101.41 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -172.71 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 109.117 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' OG1' ' A' ' 29' ' ' THR . 52.0 p90 -166.42 29.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.84 -1.162 . . . . 0.0 109.941 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.21 177.37 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.402 -0.811 . . . . 0.0 109.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -159.57 0.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.2 t90 -77.62 139.27 39.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.125 -0.985 . . . . 0.0 109.731 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -144.07 125.73 15.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.52 151.79 7.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.771 . . . . 0.0 110.246 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -69.55 -29.82 67.48 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.874 -0.516 . . . . 0.0 109.722 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -114.47 -165.8 1.05 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.26 -162.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.66 44.5 97.79 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.4 mm-40 -43.1 91.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.933 0.873 . . . . 0.0 112.002 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.5 ttmt -101.98 -57.61 2.04 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.548 HG22 ' OG ' ' A' ' 133' ' ' SER . 75.2 p -154.51 121.43 5.56 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 7.1 pt -126.73 152.47 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.526 -0.733 . . . . 0.0 110.015 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.76 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -129.97 150.27 51.33 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.491 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.0 p -154.75 108.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 128' ' ' VAL . 19.4 t -92.15 120.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.701 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.4 mp -98.13 161.51 13.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -111.17 129.5 55.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.617 -0.677 . . . . 0.0 109.948 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD13 ' OE2' ' A' ' 53' ' ' GLU . 44.8 mt -84.73 142.64 29.69 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 36.91 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.486 -0.759 . . . . 0.0 111.324 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 pttm 163.22 138.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.205 -0.935 . . . . 0.0 108.797 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 13.4 tt0 -75.55 103.78 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -136.25 172.19 13.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.517 0.675 . . . . 0.0 109.787 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -85.18 179.01 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.6 mp -140.31 124.24 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.437 -0.79 . . . . 0.0 110.047 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 44.5 t60 -112.89 -29.5 7.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.609 -0.682 . . . . 0.0 109.2 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.428 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.4 m -143.07 157.14 44.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 149' ' ' PHE . 61.6 t -143.01 162.72 17.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.331 0.586 . . . . 0.0 109.938 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -142.35 100.77 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.631 HG23 HD23 ' A' ' 144' ' ' LEU . 1.5 mt -122.31 124.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -92.27 128.35 9.35 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' OD1' HG21 ' A' ' 68' ' ' VAL . 4.1 m-80 -84.02 120.69 26.43 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 122.173 -0.604 . . . . 0.0 110.194 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 5.8 t0 -93.64 69.58 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.21 89.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -64.79 -175.1 0.17 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.73 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -148.58 -55.23 0.2 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' ' HG3' ' A' ' 134' ' ' GLN . 28.0 m-85 -105.67 116.46 31.98 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.016 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 ' OD1' ' A' ' 62' ' ' ASN . 48.9 t -120.76 109.86 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.942 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.29 142.45 35.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 HD13 ' A' ' 130' ' ' ILE . 24.1 t -130.73 127.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.603 0.716 . . . . 0.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 86' ' ' VAL . 2.5 mp -112.68 162.23 15.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -122.45 157.58 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.647 -0.658 . . . . 0.0 110.375 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.72 166.85 38.83 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.2 t -109.45 153.26 24.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.843 -0.798 . . . . 0.0 109.867 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.426 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 47.6 t -84.4 8.64 15.59 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.32 119.57 9.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 0.0 109.735 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.45 -82.31 0.1 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 117.41 73.4 0.48 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.12 87.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.933 . . . . 0.0 109.459 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.27 -163.72 34.59 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -105.33 -20.88 13.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.581 -0.953 . . . . 0.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.49 27.96 3.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 109.923 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -118.09 40.25 3.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.043 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.405 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -102.96 -173.12 2.24 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 135.47 50.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 71' ' ' LEU . 22.4 t -63.16 88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 111.493 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.569 HD13 HG11 ' A' ' 72' ' ' VAL . 10.7 tp -64.5 -42.09 96.05 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.3 pp -150.77 120.51 7.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.459 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.549 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.3 m -54.1 -178.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.697 -0.627 . . . . 0.0 110.293 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.51 133.56 47.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.47 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 p -98.51 117.92 34.02 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.258 0.551 . . . . 0.0 109.594 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.7 p -74.93 68.6 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -59.42 -59.07 6.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.875 -0.516 . . . . 0.0 110.261 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 68.2 mtp -121.23 -176.12 3.21 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.584 0.707 . . . . 0.0 110.713 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 p -114.66 179.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -86.72 11.06 3.39 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.102 2.535 . . . . 0.0 111.322 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.2 p -120.91 -39.37 2.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.955 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -83.43 0.33 46.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 110.768 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.8 t -78.64 -32.55 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -0.983 . . . . 0.0 110.165 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.678 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -161.69 38.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.93 -22.96 7.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 119.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.298 -1.119 . . . . 0.0 110.244 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.98 64.35 4.47 Favored Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.921 -0.487 . . . . 0.0 111.534 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.6 Cg_endo -75.18 -30.66 6.68 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.889 2.393 . . . . 0.0 110.254 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.67 75.52 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.698 -0.627 . . . . 0.0 109.491 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -111.83 -169.56 1.49 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -129.98 165.11 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.197 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 21.5 tpt180 -143.26 134.46 25.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtm -110.72 158.92 18.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.036 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.8 m-85 -133.14 105.63 7.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -83.52 -147.4 7.52 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.4 Cg_endo -74.51 -35.52 3.62 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.517 2.811 . . . . 0.0 110.809 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.62 -27.72 68.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.693 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -92.5 4.32 53.75 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.643 -0.661 . . . . 0.0 110.682 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -128.37 143.87 51.06 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.912 -1.118 . . . . 0.0 110.31 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.892 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -64.25 140.52 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -35.05 44.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.735 . . . . 0.0 109.075 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.02 66.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.579 -0.701 . . . . 0.0 110.291 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.892 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.98 -47.15 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.1 -31.85 8.78 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.186 -0.946 . . . . 0.0 111.12 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -2.03 58.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.458 -0.776 . . . . 0.0 110.557 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 9.3 mtpp -92.02 135.14 34.19 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.85 109.28 3.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.674 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 86.4 m95 -108.63 160.26 16.08 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 12.6 t70 -133.28 2.31 3.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 110.404 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.426 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -140.84 143.0 34.52 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.913 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -133.95 142.49 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.361 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.3 tttp -107.45 114.66 28.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.717 -0.615 . . . . 0.0 109.788 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.66 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 50.0 mm -104.97 122.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 44' ' ' SER . 38.8 t -128.28 125.1 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.15 -0.969 . . . . 0.0 110.654 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 43' ' ' ILE . 18.0 t -97.93 145.92 25.98 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.66 130.03 17.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.0 111.495 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.73 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 149.07 131.3 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.597 0 C-N-CA 123.911 0.884 . . . . 0.0 108.989 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.42 87.1 0.99 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 109.967 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 3.4 p90 -113.86 -1.42 13.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 111.12 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.65 -171.74 2.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.036 . . . . 0.0 109.476 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -164.23 -43.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.84 -32.5 5.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 0.0 109.887 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.34 149.8 36.65 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.885 -0.509 . . . . 0.0 109.702 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_endo -85.25 -169.79 0.67 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.437 2.758 . . . . 0.0 110.639 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 171.2 -162.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.3 -117.05 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.492 -1.337 . . . . 0.0 110.942 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.631 HD23 HG23 ' A' ' 60' ' ' ILE . 6.1 mp -118.0 145.92 44.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.847 -0.796 . . . . 0.0 110.351 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -81.38 -27.21 34.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.509 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 35.3 p90 -175.87 171.69 2.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.453 -0.779 . . . . 0.0 109.804 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.637 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.7 m -150.21 131.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -147.98 105.4 3.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.447 -0.783 . . . . 0.0 110.504 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.913 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.4 m-85 -86.3 157.83 19.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -152.9 136.01 15.63 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.677 ' HB3' HD11 ' A' ' 4' ' ' ILE . 82.3 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.41 94.43 0.54 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.517 2.812 . . . . 0.0 110.391 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.66 171.75 18.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.771 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 151' ' ' SER . 48.6 mt -146.31 123.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -102.04 166.21 10.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.731 -0.606 . . . . 0.0 110.012 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -98.09 138.94 34.65 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.612 ' N ' HD13 ' A' ' 6' ' ' LEU . 9.9 tpt180 -93.06 -56.24 3.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -161.06 160.6 30.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.49 91.18 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.1 p -51.73 -56.24 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.229 -0.919 . . . . 0.0 110.215 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.06 155.25 38.66 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.251 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -146.75 134.4 21.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.799 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -129.32 47.66 2.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.519 -0.738 . . . . 0.0 110.184 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.1 m 151.85 73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.7 pp0? -133.91 143.45 48.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -98.06 152.03 19.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -60.97 -54.43 45.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.013 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -57.11 14.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HD2' ' A' ' 31' ' ' ARG . 35.8 m-70 -107.25 78.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -86.21 163.45 17.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.4 -20.72 65.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.761 -0.587 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.9 tt0 -64.74 -20.42 66.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -65.8 -16.78 64.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.19 -0.943 . . . . 0.0 109.273 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.718 ' HB3' HG22 ' A' ' 147' ' ' VAL . 13.7 mt -64.81 -23.28 67.19 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.2 mm? -57.15 -22.3 39.13 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.418 -0.801 . . . . 0.0 109.19 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.8 66.31 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.76 13.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.488 -0.757 . . . . 0.0 110.318 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.08 74.3 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.823 HG22 ' CD1' ' A' ' 30' ' ' TYR . 86.1 m -156.93 -98.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.823 ' CD1' HG22 ' A' ' 29' ' ' THR . 0.1 OUTLIER 176.25 44.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HD2' ' CE1' ' A' ' 19' ' ' HIS . 3.6 mmm-85 -141.54 100.35 3.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 144' ' ' LEU . 30.9 mtmt -83.62 146.38 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.637 -0.664 . . . . 0.0 109.692 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -62.7 114.9 3.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.203 -0.935 . . . . 0.0 108.583 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -116.88 127.1 53.94 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -49.21 168.81 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.731 0.777 . . . . 0.0 111.696 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -73.74 -32.73 63.99 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -124.85 -175.31 3.25 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 -166.56 1.39 Allowed 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.49 45.81 88.21 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.6 OUTLIER -43.03 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.52 0.676 . . . . 0.0 111.825 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' GLY . 7.3 tttp -93.44 -64.32 1.1 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.664 HG22 ' OG ' ' A' ' 133' ' ' SER . 64.1 p -152.47 113.65 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 24.5 pt -111.29 145.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 110.384 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -123.89 150.49 44.59 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.522 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.787 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.7 p -152.27 107.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.0 t -92.43 122.04 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 147' ' ' VAL . 1.3 mp -101.57 155.76 17.89 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -109.55 120.24 41.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.738 HD13 ' OE2' ' A' ' 53' ' ' GLU . 40.8 mt -71.54 143.35 49.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.36 31.27 0.18 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.637 -0.664 . . . . 0.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.0 pttm 165.01 138.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.92 109.74 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.98 165.66 26.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 151' ' ' SER . 46.3 mt-30 -77.4 -176.73 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -143.22 130.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.432 -0.793 . . . . 0.0 109.36 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.438 ' O ' HD21 ' A' ' 116' ' ' LEU . 45.9 t60 -116.81 -26.24 7.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.621 -0.674 . . . . 0.0 109.731 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -148.48 153.21 38.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.2 t -135.38 160.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.706 -0.621 . . . . 0.0 109.346 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.654 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -138.74 132.51 30.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.544 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -152.4 128.01 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -104.01 114.62 4.81 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 118.882 -1.628 . . . . 0.0 109.91 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.68 138.37 50.59 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.28 0.562 . . . . 0.0 111.206 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -113.44 42.06 2.03 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 -19.4 10.84 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 20.9 p -56.76 -173.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.319 -1.106 . . . . 0.0 109.797 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -147.42 -44.43 0.17 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.3 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -108.35 117.26 33.68 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.746 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' ILE . 45.3 t -120.51 110.62 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -107.21 147.56 30.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG22 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.21 125.87 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -111.52 157.6 20.15 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 87' ' ' LEU . 4.0 m -120.25 156.98 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.795 -0.566 . . . . 0.0 110.292 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.406 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.82 174.52 44.23 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 t -114.64 162.69 16.44 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.646 0.736 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -68.79 -11.11 60.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 175.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.239 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.16 -109.41 3.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.98 -51.52 0.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.24 -49.08 7.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.91 . . . . 0.0 109.312 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.2 -32.3 7.06 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.55 143.88 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -1.007 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 59.84 28.05 17.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 109.906 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.76 19.39 4.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.754 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.4 151.06 41.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.13 147.67 28.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -68.93 86.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 72' ' ' VAL . 19.7 tp -56.68 -54.98 39.81 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.7 pp -138.75 117.26 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.271 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.6 m -50.86 174.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.564 -0.71 . . . . 0.0 110.446 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 132.69 50.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -97.6 118.16 33.48 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.847 -0.533 . . . . 0.0 109.745 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.9 p -75.45 67.96 2.06 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -62.08 -51.61 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.885 -0.509 . . . . 0.0 110.494 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.525 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 20.2 mtp -120.3 -170.25 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 110.455 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 p -121.07 173.74 3.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.99 5.02 5.97 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.272 2.648 . . . . 0.0 111.451 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.8 m -120.74 -39.29 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.097 -1.002 . . . . 0.0 109.827 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.79 -17.19 61.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.527 -0.733 . . . . 0.0 110.266 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -58.16 -20.55 41.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 110.517 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -71.44 -86.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -162.61 38.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 108.578 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.39 -20.27 7.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.93 119.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -1.073 . . . . 0.0 110.198 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.525 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.86 70.31 1.62 Allowed Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.89 -0.506 . . . . 0.0 111.308 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.59 -30.63 3.82 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.906 2.404 . . . . 0.0 110.464 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -146.23 109.75 4.79 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 93' ' ' PHE . 5.6 ptm85 -153.08 -160.79 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.568 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -131.86 172.0 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.773 -1.205 . . . . 0.0 111.388 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 13.9 tpt180 -145.64 147.14 31.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 mtp -126.99 158.12 37.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.688 . . . . 0.0 110.242 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.0 m-85 -126.51 163.95 22.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.99 -148.31 5.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.87 -38.52 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 123.8 3.0 . . . . 0.0 111.042 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.47 -26.7 68.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.502 -0.749 . . . . 0.0 109.701 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.55 2.37 56.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 110.71 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.5 pp -124.16 140.81 52.61 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.974 -1.079 . . . . 0.0 110.351 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.8 p -60.68 137.87 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -40.16 47.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 0.0 109.163 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.73 -20.88 59.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.595 -0.691 . . . . 0.0 110.679 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -114.8 -46.49 2.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.269 -0.894 . . . . 0.0 110.432 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.61 -35.08 12.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.253 -0.904 . . . . 0.0 111.311 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.13 7.08 29.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.356 -0.84 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.1 mttm -98.93 137.61 37.23 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -68.8 113.1 5.95 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.751 0.786 . . . . 0.0 110.973 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.461 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 77.7 m95 -117.21 157.16 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -132.1 10.29 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.275 -0.891 . . . . 0.0 110.057 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.588 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.4 mtt180 -140.08 147.13 39.84 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.6 p -140.6 142.47 30.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.774 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 46' ' ' VAL . 12.7 tttt -112.77 107.31 15.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.679 -0.638 . . . . 0.0 109.718 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.757 ' CD1' HG22 ' A' ' 70' ' ' VAL . 46.4 mm -98.46 122.83 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.7 t -123.99 114.7 42.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -90.83 138.22 31.75 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.664 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -143.11 132.58 23.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.192 -0.943 . . . . 0.0 111.635 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.863 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER 157.02 134.01 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.591 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.92 96.39 0.57 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.081 2.521 . . . . 0.0 109.807 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.4 p90 -128.16 -8.79 5.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.401 -0.812 . . . . 0.0 111.843 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -175.41 3.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.074 -1.016 . . . . 0.0 110.02 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -161.31 -43.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.72 -30.84 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.593 -0.692 . . . . 0.0 110.029 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -104.17 142.95 25.68 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.732 -0.605 . . . . 0.0 109.762 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.9 Cg_endo -88.18 156.69 6.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.353 2.702 . . . . 0.0 110.323 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -161.48 -168.49 2.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 169.41 -101.96 0.18 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.04 163.64 32.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.474 -1.016 . . . . 0.0 109.64 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 50.5 m -85.09 -16.9 39.04 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.646 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 43.3 p90 -179.35 164.56 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 24' ' ' LEU . 25.3 m -139.12 149.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 9.0 mtp180 -154.34 164.26 38.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.76 . . . . 0.0 110.472 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.874 ' CE2' HG11 ' A' ' 128' ' ' VAL . 51.9 m-85 -144.59 152.2 40.17 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.434 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.62 136.18 16.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 109.188 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.1 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.739 -0.601 . . . . 0.0 109.845 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.62 -165.26 0.22 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.513 2.809 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.39 -160.91 0.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.582 -0.699 . . . . 0.0 109.149 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.404 HD13 ' OE1' ' A' ' 53' ' ' GLU . 52.5 mt -126.47 127.65 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -112.52 171.04 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.722 -0.611 . . . . 0.0 109.885 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.756 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.9 mp -101.81 162.51 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.787 -0.571 . . . . 0.0 109.506 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.702 ' C ' HD11 ' A' ' 25' ' ' LEU . 23.1 ttt180 -118.41 -47.64 2.54 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.532 ' CE1' ' CB ' ' A' ' 48' ' ' GLN . 7.2 p80 -160.85 -168.73 2.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.7 p -104.94 96.87 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.705 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.5 p -56.43 -61.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.302 -0.874 . . . . 0.0 110.054 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -121.31 162.89 19.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 20.0 p -158.64 144.96 17.06 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.277 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -151.84 53.85 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.81 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.829 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -127.06 148.82 50.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.939 -1.101 . . . . 0.0 110.096 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -98.97 -165.37 1.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.79 -0.569 . . . . 0.0 109.561 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -66.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.688 . . . . 0.0 109.651 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -34.82 77.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -123.69 74.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -90.71 172.19 8.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.598 0.713 . . . . 0.0 110.256 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.52 -25.89 67.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.799 -0.563 . . . . 0.0 109.619 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.06 -20.02 55.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.365 -0.834 . . . . 0.0 110.17 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.2 -19.47 65.99 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.9 mt -65.91 -25.05 66.97 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.702 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.91 -21.09 60.62 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.482 -0.761 . . . . 0.0 108.977 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 66.12 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.61 -22.75 23.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -0.756 . . . . 0.0 110.391 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' THR . 5.5 m-20 -118.91 77.39 1.18 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -154.28 -85.57 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.404 -0.81 . . . . 0.0 109.576 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.22 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 158.33 29.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.497 -0.752 . . . . 0.0 109.506 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -160.96 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.536 -0.727 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.727 ' CH2' HD12 ' A' ' 43' ' ' ILE . 20.4 t90 -88.36 137.45 32.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 110.817 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -142.5 121.7 13.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.29 158.77 0.24 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.464 -0.773 . . . . 0.0 111.035 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.51 -41.76 99.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.077 0.465 . . . . 0.0 110.28 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.48 -171.4 2.3 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.515 0.674 . . . . 0.0 109.241 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.59 -165.59 1.33 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.98 45.8 94.88 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp0 -51.92 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.461 0.648 . . . . 0.0 111.174 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 42' ' ' THR . 15.5 tttm -91.38 -50.08 5.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.5 p -158.66 124.89 4.59 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.727 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.1 pt -128.34 136.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 131' ' ' VAL . 26.8 m -118.6 138.51 52.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.415 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.636 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.9 p -144.75 111.61 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.4 t -96.96 119.75 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.088 -1.008 . . . . 0.0 108.978 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -100.9 160.67 14.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.539 0.685 . . . . 0.0 110.284 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.532 ' CB ' ' CE1' ' A' ' 8' ' ' HIS . 50.0 tp60 -98.28 148.41 23.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 126' ' ' ASP . 84.8 mt -99.57 123.81 44.18 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -52.59 -7.73 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.37 -0.831 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.2 139.03 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.786 -1.196 . . . . 0.0 108.874 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.69 113.58 12.12 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -147.41 179.77 7.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.16 -178.03 6.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.44 115.2 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -105.22 -30.8 9.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 109.202 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.2 m -144.3 161.09 39.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 149' ' ' PHE . 99.1 t -145.35 159.03 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.28 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 60' ' ' ILE . 35.3 t0 -132.07 138.67 48.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.699 -0.626 . . . . 0.0 110.004 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -153.88 130.38 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -96.69 127.08 9.07 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -83.86 112.09 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.022 -0.693 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.7 56.96 2.12 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.94 58.38 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -53.42 161.72 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.316 -1.108 . . . . 0.0 110.555 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.735 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -123.46 -58.72 1.59 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 23.4 m-85 -101.68 133.19 46.77 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.611 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' ILE . 49.8 t -132.49 111.56 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 109.677 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.14 141.67 37.11 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.741 HG13 HD13 ' A' ' 130' ' ' ILE . 16.2 t -131.07 124.47 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.636 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 86' ' ' VAL . 1.5 mp -109.31 162.48 14.28 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 87' ' ' LEU . 3.1 m -122.71 154.95 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.542 -0.724 . . . . 0.0 110.305 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.55 162.71 34.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 t -116.83 163.91 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.684 0.754 . . . . 0.0 109.872 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 t -77.08 -1.06 27.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -25.22 7.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.11 -27.48 9.35 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.38 21.47 59.97 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.42 39.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -1.105 . . . . 0.0 108.868 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.2 -75.03 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 63.94 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.7 -0.882 . . . . 0.0 109.104 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.16 28.66 4.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.179 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -126.62 37.7 4.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.228 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.06 -172.31 2.12 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.65 135.11 48.84 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 71' ' ' LEU . 43.7 t -61.76 88.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.671 -0.643 . . . . 0.0 111.263 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.9 tp -61.79 -55.63 28.05 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.705 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.7 pp -137.69 117.47 13.16 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -52.29 178.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.639 -0.663 . . . . 0.0 110.656 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 133.62 52.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.2 p -107.31 126.65 52.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.369 0.605 . . . . 0.0 109.656 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.8 p -86.47 117.87 25.53 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 26.3 m-85 -112.86 -48.18 3.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.437 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 83.3 mtp -121.2 -176.35 3.26 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.549 0.69 . . . . 0.0 110.468 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.7 p -111.84 -178.55 0.54 Allowed Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 43.0 Cg_endo -86.41 19.33 1.41 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 123.155 2.57 . . . . 0.0 111.432 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -120.19 -41.27 2.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.02 -24.9 66.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 34.8 p -45.97 -27.24 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.711 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -92.33 0.11 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -163.36 38.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.863 -1.148 . . . . 0.0 108.569 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.12 -26.55 18.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.93 115.77 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 0.0 110.272 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.27 73.55 0.83 Allowed Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 121.685 -0.634 . . . . 0.0 111.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.7 Cg_endo -74.14 -28.23 11.02 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.557 2.171 . . . . 0.0 110.339 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -128.86 124.13 34.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.682 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 -170.13 3.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.729 -0.607 . . . . 0.0 109.403 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 40.6 t -132.82 159.99 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 141.22 12.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.762 . . . . 0.0 109.148 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.0 mtp -126.26 156.61 40.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.316 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.705 ' CE2' HD13 ' A' ' 88' ' ' LEU . 11.8 m-85 -110.93 172.28 6.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.33 -150.22 5.3 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.78 -38.04 1.44 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.712 2.941 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.03 -26.73 68.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.935 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -95.08 5.05 52.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.751 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.99 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -125.53 143.0 51.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.921 -1.112 . . . . 0.0 110.712 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.902 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -61.85 141.08 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.75 34.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 108.973 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -67.51 -15.89 63.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.717 . . . . 0.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.902 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -120.23 -45.61 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.99 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.42 -40.27 25.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.302 -0.874 . . . . 0.0 111.305 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.27 4.92 28.76 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 11.8 mttm -97.19 135.71 38.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.92 111.35 4.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.528 -0.732 . . . . 0.0 110.886 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 88.6 m95 -115.38 165.02 13.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 49' ' ' LEU . 3.2 p30 -139.9 14.55 2.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.071 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.705 ' HD3' HG21 ' A' ' 10' ' ' VAL . 11.7 mtt180 -142.06 138.68 31.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.701 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.2 p -130.79 138.95 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.395 -0.816 . . . . 0.0 109.788 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.628 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.7 tttt -110.39 107.55 17.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.848 -0.532 . . . . 0.0 109.654 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 70' ' ' VAL . 50.7 mm -98.43 117.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.733 -0.604 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.8 t -124.07 110.97 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 121.16 -0.963 . . . . 0.0 109.72 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.463 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.5 t -84.94 147.3 26.8 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.68 129.94 22.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.349 -0.844 . . . . 0.0 111.753 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.735 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 148.4 123.28 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 C-N-CA 123.719 0.808 . . . . 0.0 109.057 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.56 89.5 1.34 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.777 2.318 . . . . 0.0 109.1 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 6.7 p90 -114.62 -22.33 9.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.585 -0.697 . . . . 0.0 111.41 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -173.18 2.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.893 . . . . 0.0 109.863 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -168.75 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -114.88 -36.15 4.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.902 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -105.07 145.09 30.07 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.836 -0.54 . . . . 0.0 109.727 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.0 Cg_endo -87.92 167.74 6.91 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.371 2.714 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.35 -169.86 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.84 -109.81 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.872 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.633 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.3 mp -109.69 152.13 26.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.903 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 34.5 m -87.84 -27.56 22.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.464 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 51.7 p90 -179.17 176.52 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.524 HG12 HG13 ' A' ' 60' ' ' ILE . 32.9 m -152.2 131.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 6.5 mtm180 -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.312 -0.867 . . . . 0.0 110.222 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 58' ' ' VAL . 80.7 m-85 -86.08 154.23 21.54 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 131.95 19.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.338 -0.851 . . . . 0.0 109.046 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.873 -0.517 . . . . 0.0 110.486 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.86 13.75 2.53 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.556 2.837 . . . . 0.0 111.327 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -78.47 165.92 23.2 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.228 -0.92 . . . . 0.0 109.214 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.626 ' CG2' HD12 ' A' ' 49' ' ' LEU . 43.9 mm -79.52 143.15 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -123.32 126.05 46.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 HD22 ' A' ' 47' ' ' LEU . 1.1 mp -83.87 147.43 27.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' C ' HD11 ' A' ' 25' ' ' LEU . 50.2 ttt85 -105.28 -58.71 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.377 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -160.96 178.16 9.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -85.41 89.44 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.704 . . . . 0.0 109.24 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.528 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -51.42 -58.39 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.15 -0.969 . . . . 0.0 110.286 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.522 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -124.9 162.77 23.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.496 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . 21.5 p -160.42 144.04 13.78 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.47 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 m -148.9 58.22 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.608 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.78 58.21 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 123.093 0.557 . . . . 0.0 109.818 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.929 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 3.3 mm-40 -124.54 140.61 52.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.82 -1.175 . . . . 0.0 110.65 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.64 -162.84 0.89 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -99.06 -64.25 1.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 109.374 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -58.53 4.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.692 . . . . 0.0 109.149 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -92.74 68.03 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.8 165.15 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 0.0 109.904 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.81 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -59.89 -23.94 63.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.644 -0.66 . . . . 0.0 110.368 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.46 -21.6 66.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.247 -0.908 . . . . 0.0 109.919 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -66.0 -16.82 64.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.9 mt -65.28 -25.77 67.79 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -60.26 -21.3 61.72 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 65.42 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HB1' ' HE ' ' A' ' 148' ' ' ARG . . . -53.3 -24.32 11.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -116.31 79.95 1.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.434 -0.791 . . . . 0.0 109.746 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' ASP . 2.0 p -157.2 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.483 -0.76 . . . . 0.0 109.196 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -178.06 32.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.003 -1.061 . . . . 0.0 110.379 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -147.25 140.54 25.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.026 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -160.41 0.99 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CH2' HD12 ' A' ' 43' ' ' ILE . 17.6 t90 -97.58 136.19 38.33 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 3.9 tmm_? -142.6 120.54 12.04 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.48 154.76 3.3 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.193 -0.942 . . . . 0.0 110.427 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -78.93 -23.79 44.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.784 -0.572 . . . . 0.0 110.196 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.02 -158.94 0.59 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.423 -0.798 . . . . 0.0 109.368 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 139' ' ' ASP . . . -149.25 172.7 14.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 91.1 -15.62 60.57 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.504 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 2.6 mp0 59.52 117.72 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.618 -0.931 . . . . 0.0 111.418 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 42' ' ' THR . 16.8 ttmt -151.7 -71.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.684 HG22 ' OG ' ' A' ' 133' ' ' SER . 24.6 p -157.88 143.54 17.12 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.775 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -143.57 139.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.522 ' CB ' HG22 ' A' ' 131' ' ' VAL . 69.2 m -126.53 115.06 18.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.234 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.81 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -116.41 126.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.857 HG22 ' CD ' ' A' ' 129' ' ' LYS . 2.8 t -104.76 113.77 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.875 . . . . 0.0 108.897 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 6' ' ' LEU . 1.4 mp -97.61 169.34 9.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.558 0.694 . . . . 0.0 110.66 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.464 ' C ' HD22 ' A' ' 49' ' ' LEU . 11.9 tp60 -114.66 153.71 29.72 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.545 0.688 . . . . 0.0 109.608 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.626 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.0 mm? -104.86 131.98 51.67 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 5.7 tt0 -81.96 43.12 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.25 -0.906 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 4.6 pttt 163.59 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 20.7 tt0 -63.23 104.66 0.62 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CG ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.5 178.46 7.02 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.25 178.12 5.95 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.32 131.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.796 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.572 ' HA ' HD21 ' A' ' 116' ' ' LEU . 6.4 t-160 -122.47 -32.35 3.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -141.97 161.44 37.97 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.681 HG13 ' CD1' ' A' ' 149' ' ' PHE . 58.4 t -146.67 164.1 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.899 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.584 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.4 m-20 -139.28 134.77 33.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.639 -0.663 . . . . 0.0 109.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -146.71 118.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -81.86 99.75 2.03 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.83 125.25 22.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.905 . . . . 0.0 110.361 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 25.0 t70 -107.38 39.07 1.97 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.384 -0.823 . . . . 0.0 109.406 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 136' ' ' TYR . . . 111.98 22.97 5.74 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -101.67 173.1 6.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -1.073 . . . . 0.0 110.382 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -128.8 -47.64 1.25 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 30.0 m-85 -108.41 120.6 42.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.732 -0.605 . . . . 0.0 110.767 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.63 111.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.458 -0.776 . . . . 0.0 109.287 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -107.86 143.62 36.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.696 -0.627 . . . . 0.0 110.197 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 130' ' ' ILE . 38.9 t -132.09 129.57 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.6 mp -117.46 160.17 21.63 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.7 ' CG1' HD22 ' A' ' 87' ' ' LEU . 7.5 m -123.48 172.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 110.159 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.34 170.64 29.55 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -113.21 160.73 17.97 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.822 0.82 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -81.86 8.13 11.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.93 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.02 -26.48 2.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.131 -0.981 . . . . 0.0 111.224 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.39 70.47 0.11 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.51 64.43 2.16 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.25 -63.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.538 -0.978 . . . . 0.0 109.132 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.28 79.13 0.29 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 4.8 mp0 61.48 17.84 8.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.584 -0.951 . . . . 0.0 110.154 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 38.42 29.49 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.4 t0 42.15 48.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.428 0.633 . . . . 0.0 111.39 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 3.5 m-30 -48.24 160.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.603 0.716 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -108.69 131.61 54.75 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 42.9 t -61.58 86.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.66 -0.65 . . . . 0.0 110.729 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.7 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -59.0 -61.18 2.83 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 pp -136.14 119.98 17.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.546 -0.721 . . . . 0.0 109.292 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -53.93 179.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.155 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -65.63 133.95 52.23 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.594 -0.691 . . . . 0.0 109.313 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HG ' ' HE2' ' A' ' 111' ' ' PHE . 8.5 p -98.22 119.11 36.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.82 -0.55 . . . . 0.0 109.676 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.2 p -75.53 69.49 2.29 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 28.4 t80 -63.42 -55.49 23.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.803 -0.561 . . . . 0.0 110.587 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 1.6 mtp -117.79 -176.48 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.679 0.752 . . . . 0.0 110.571 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -112.54 176.35 1.52 Allowed Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 41.5 Cg_endo -86.28 14.98 2.3 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.136 2.557 . . . . 0.0 111.518 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -120.09 -46.19 2.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.071 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -19.59 49.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.512 -0.742 . . . . 0.0 110.233 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -49.34 -26.87 3.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -0.863 . . . . 0.0 110.64 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -85.95 -86.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.54 -0.725 . . . . 0.0 109.745 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -164.44 37.53 0.08 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.43 -17.83 67.88 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.18 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.239 -1.154 . . . . 0.0 111.91 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.4 90.33 0.22 Allowed Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.47 ' O ' ' HE1' ' A' ' 94' ' ' MET . 43.1 Cg_endo -81.21 -29.85 1.82 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.686 2.257 . . . . 0.0 110.315 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.41 ' ND2' ' OD1' ' A' ' 63' ' ' ASP . 1.3 m-20 -125.6 129.94 50.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.653 -0.654 . . . . 0.0 109.273 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -160.21 -169.8 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.876 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.618 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 69.2 t -127.06 154.96 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 111' ' ' PHE . 6.6 ttt-85 -143.1 131.94 22.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.1 mtp -111.81 143.34 42.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.72 -0.612 . . . . 0.0 110.054 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.6 m-85 -111.59 165.1 12.3 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.642 0.734 . . . . 0.0 109.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -147.88 -154.6 6.31 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.755 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.8 Cg_endo -74.91 -24.12 13.34 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.644 2.896 . . . . 0.0 110.873 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -50.53 -38.79 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -117.73 15.27 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -117.26 122.57 44.33 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.901 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -49.65 130.33 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.631 -0.668 . . . . 0.0 110.698 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -67.64 -37.69 82.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.738 . . . . 0.0 109.133 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.05 92.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.284 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.901 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -91.96 -36.41 13.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.311 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.98 -35.91 3.13 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.577 -0.702 . . . . 0.0 111.111 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.15 12.29 35.96 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.809 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -91.85 134.47 34.73 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.34 106.61 5.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.913 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 74.5 m95 -111.22 164.0 13.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 12.7 p30 -136.53 8.32 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.521 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 10' ' ' VAL . 12.8 mtt-85 -136.99 144.55 43.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.1 p -137.4 138.67 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.857 ' CD ' HG22 ' A' ' 46' ' ' VAL . 33.9 tptt -104.3 129.57 52.14 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.8 mm -125.24 111.92 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.522 HG22 ' CB ' ' A' ' 44' ' ' SER . 47.9 t -117.92 119.73 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.44 -0.787 . . . . 0.0 110.36 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 152.18 20.11 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.684 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -160.06 132.45 6.4 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.643 -1.286 . . . . 0.0 113.949 -176.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.75 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 10.1 tp60 148.09 125.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.32 114.78 1.87 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.778 2.318 . . . . 0.0 109.23 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -117.18 0.87 12.41 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.694 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.39 -160.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.604 -1.31 . . . . 0.0 110.051 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 ttmm -151.95 23.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 110.011 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.792 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p-10 -149.05 -40.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 111.701 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.7 158.91 33.61 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.687 . . . . 0.0 111.54 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.3 -159.67 0.11 Allowed 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 124.039 3.159 . . . . 0.0 109.601 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 40' ' ' GLU . 21.2 p90 -178.85 -165.01 0.08 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.72 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 145.47 -128.57 3.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -144.91 165.04 29.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.725 -0.868 . . . . 0.0 110.241 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.3 p -79.14 -25.52 42.88 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.558 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 46.3 p90 -175.07 173.64 2.6 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.812 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 24' ' ' LEU . 18.0 m -149.63 130.3 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.463 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 63.2 mtt180 -142.05 116.33 9.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 110.756 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.0 m-85 -88.91 154.0 20.59 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -152.72 120.88 6.23 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.853 -0.53 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -87.85 -165.16 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.479 2.786 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -79.02 -168.79 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.183 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.473 HD13 ' OE1' ' A' ' 53' ' ' GLU . 53.6 mt -120.09 126.25 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.33 175.86 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.592 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.6 mp -112.35 158.92 19.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 0.0 109.968 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -55.54 2.31 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -160.74 169.82 22.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -80.61 91.41 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.562 -0.711 . . . . 0.0 109.152 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 1.7 p -52.24 -58.51 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.07 -1.019 . . . . 0.0 110.186 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.3 157.58 36.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -160.44 125.26 3.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.4 OUTLIER -118.53 57.19 0.86 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.659 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 154.33 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 123.012 0.525 . . . . 0.0 109.674 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.24 144.08 14.07 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.87 -1.144 . . . . 0.0 109.494 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.02 -167.54 1.56 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 109.667 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -88.71 -62.77 1.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.685 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -65.04 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -88.59 74.46 8.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -91.08 168.05 11.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.616 -0.678 . . . . 0.0 110.051 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -62.68 -24.09 67.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.881 -0.512 . . . . 0.0 109.62 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.74 -18.42 62.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 109.967 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -64.96 -18.09 64.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.5 mt -65.33 -26.84 68.22 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.6 mm? -61.7 -20.02 63.01 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -116.31 65.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -23.37 18.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.425 -0.797 . . . . 0.0 110.399 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -120.43 78.47 1.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.52 -88.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.483 -0.761 . . . . 0.0 109.408 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.36 36.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -155.1 149.89 26.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 0.0 109.317 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -130.37 -170.41 2.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.574 -0.704 . . . . 0.0 109.959 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.817 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.9 t90 -88.54 139.67 30.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 109.032 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 126.19 17.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.68 152.38 2.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.307 -0.871 . . . . 0.0 110.111 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.1 -23.9 56.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.749 -0.595 . . . . 0.0 110.077 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -139.19 -169.79 2.74 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.421 -0.799 . . . . 0.0 108.965 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 -172.47 2.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.67 -0.644 . . . . 0.0 109.362 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.35 48.67 85.02 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 4.3 mt-10 -62.1 78.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' THR . 15.9 tttt -66.14 -51.07 61.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 133' ' ' SER . 59.3 p -156.94 124.78 5.47 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.786 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.1 pt -118.12 139.35 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.817 . . . . 0.0 110.4 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -115.5 140.36 49.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.135 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.4 p -146.1 107.98 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.9 t -92.35 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 108.894 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.592 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -96.95 168.72 10.3 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.09 129.76 56.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.718 -0.614 . . . . 0.0 110.406 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.623 HD13 ' OE2' ' A' ' 53' ' ' GLU . 46.5 mt -85.4 135.35 33.91 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 1.9 pt-20 -79.89 41.6 0.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.436 -0.79 . . . . 0.0 111.099 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 3.6 pttm 161.98 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.1 tt0 -75.88 100.36 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -131.49 172.38 12.28 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.588 0.709 . . . . 0.0 109.862 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -87.7 170.03 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -128.48 122.81 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.77 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -109.73 -32.97 6.9 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -144.8 155.2 43.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 60' ' ' ILE . 74.8 t -137.38 158.58 35.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.677 0.751 . . . . 0.0 109.98 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.5 m-20 -134.68 137.12 43.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -160.25 132.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -101.91 123.61 7.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 68' ' ' VAL . 2.0 m-80 -83.15 130.73 35.13 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.304 -0.527 . . . . 0.0 110.67 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.34 64.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 99' ' ' SER . . . 85.31 1.4 88.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.9 129.41 34.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 110.295 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 94' ' ' MET . . . -87.3 -57.73 2.85 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.713 -0.617 . . . . 0.0 110.076 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 133' ' ' SER . 16.4 m-85 -90.99 132.97 35.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.274 -0.891 . . . . 0.0 111.195 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 62' ' ' ASN . 82.3 t -139.24 106.84 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -102.32 146.88 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.698 HG13 ' CD1' ' A' ' 130' ' ' ILE . 22.2 t -135.71 121.1 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-O 121.64 0.733 . . . . 0.0 109.544 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -108.78 163.01 13.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.677 HG11 HD13 ' A' ' 87' ' ' LEU . 2.6 m -121.34 161.02 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.646 -0.659 . . . . 0.0 110.553 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.36 167.8 38.05 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 t -108.78 155.12 21.13 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.83 -0.806 . . . . 0.0 109.552 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 60.5 p -89.54 12.69 15.89 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.69 -76.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.261 -0.899 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -116.24 90.66 0.52 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.84 159.01 28.81 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.22 -47.07 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.524 -0.986 . . . . 0.0 109.392 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.04 -135.92 1.91 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -107.21 -22.29 12.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.639 -0.918 . . . . 0.0 109.974 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -95.91 26.83 3.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -104.99 24.66 11.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -107.17 -173.68 2.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.83 131.41 47.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.51 88.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.457 -0.777 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.677 HD13 HG11 ' A' ' 72' ' ' VAL . 5.6 tp -64.94 -51.04 63.99 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.5 pp -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.486 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -56.81 172.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.563 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -57.59 130.57 46.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.364 -0.835 . . . . 0.0 110.229 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -97.75 123.99 41.92 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -90.95 81.62 5.66 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 20.7 m-85 -70.86 -55.97 7.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.831 . . . . 0.0 109.922 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.491 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 27.9 mtp -120.78 -163.31 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.685 -0.635 . . . . 0.0 109.638 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -128.85 178.12 1.82 Allowed Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.23 17.59 1.71 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.039 2.493 . . . . 0.0 111.089 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.7 m -120.61 -38.49 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 109.704 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -82.97 -29.55 28.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.469 -0.769 . . . . 0.0 109.337 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 76.1 p -60.49 -18.6 52.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.583 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -71.12 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 t -161.27 38.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.6 -21.88 4.19 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.9 121.55 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.365 -1.079 . . . . 0.0 109.119 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.479 ' O ' ' HE1' ' A' ' 94' ' ' MET . 6.3 p30 43.16 83.92 0.2 Allowed Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.758 -0.589 . . . . 0.0 110.798 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.3 Cg_endo -82.76 -27.55 2.03 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.984 2.456 . . . . 0.0 109.992 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -145.73 86.24 1.72 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -114.71 127.45 55.76 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.6 m -79.76 165.82 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.743 . . . . 0.0 109.517 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.18 169.61 22.02 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.0 mtt -141.89 165.15 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 110.204 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.1 m-85 -120.85 170.35 9.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -144.44 -148.28 4.83 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.1 Cg_endo -74.88 -40.02 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.694 2.929 . . . . 0.0 110.716 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.36 -27.24 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 109.73 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -93.44 3.7 55.15 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.693 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.976 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.3 pp -124.22 152.21 43.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.932 -1.105 . . . . 0.0 109.966 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.768 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 10.3 p -77.54 139.47 18.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -73.43 -29.92 62.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.638 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -68.6 -11.28 59.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.768 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -125.01 -46.04 1.84 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.976 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.95 -29.08 11.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.604 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.48 -5.28 52.18 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.727 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 8.9 mtpt -91.16 133.08 35.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.158 -0.963 . . . . 0.0 108.52 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.81 110.65 3.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.48 -0.762 . . . . 0.0 110.541 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 83.9 m95 -110.72 158.94 18.08 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t70 -130.64 1.19 4.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.115 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.18 144.82 43.11 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.4 p -132.63 142.2 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.547 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.451 ' HG3' HG22 ' A' ' 46' ' ' VAL . 19.8 tttt -110.36 106.12 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.827 -0.546 . . . . 0.0 109.719 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.698 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.3 mm -100.57 131.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.327 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.6 t -134.01 122.54 41.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.424 ' SG ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -99.99 130.24 46.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.77 125.29 28.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.289 -0.882 . . . . 0.0 111.692 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HG2' ' CD2' ' A' ' 136' ' ' TYR . 3.4 pm0 170.44 141.44 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -90.71 95.06 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.71 2.273 . . . . 0.0 110.228 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -120.92 -15.67 8.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.015 -1.053 . . . . 0.0 112.002 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -137.2 178.24 7.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 110.918 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -149.33 -47.34 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.644 -0.66 . . . . 0.0 110.248 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.34 153.15 44.19 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.361 -0.837 . . . . 0.0 110.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.15 -171.76 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.64 2.893 . . . . 0.0 110.9 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.448 ' N ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER 170.03 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 143.19 -121.93 1.8 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.944 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 143' ' ' GLY . 5.6 mp -122.69 162.44 21.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.447 -1.031 . . . . 0.0 110.521 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -92.78 -27.25 17.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 -179.88 166.6 1.3 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.1 m -139.56 145.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.292 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 43.5 mtm180 -149.68 159.09 44.63 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.442 0.639 . . . . 0.0 110.346 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.659 ' CD1' HG13 ' A' ' 58' ' ' VAL . 49.8 m-85 -139.13 156.01 47.46 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.55 127.98 10.68 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.104 -0.998 . . . . 0.0 109.521 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.908 -0.495 . . . . 0.0 110.456 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.59 96.82 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.434 2.756 . . . . 0.0 110.523 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -146.96 176.58 9.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.559 -0.713 . . . . 0.0 109.684 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.756 ' CG2' HD12 ' A' ' 49' ' ' LEU . 83.9 mt -142.19 152.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.725 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.08 -173.05 3.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.506 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.3 mm? -119.54 163.17 17.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.55 -0.718 . . . . 0.0 109.64 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -114.43 -47.67 2.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -161.0 163.34 31.78 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -78.96 91.08 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.77 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 11' ' ' SER . 2.4 p -51.27 -54.73 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.176 -0.952 . . . . 0.0 110.361 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.486 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.11 164.07 21.02 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.0 p -159.54 146.31 16.57 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.6 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -145.72 49.71 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 43' ' ' ILE . 2.0 m 152.0 86.12 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.861 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -153.36 133.56 13.41 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.053 -1.029 . . . . 0.0 110.245 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.31 -175.14 4.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.5 t -84.94 -64.13 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.629 -0.67 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -61.48 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -89.13 67.53 8.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.5 p -84.98 168.33 15.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.58 -0.7 . . . . 0.0 109.812 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.46 -22.4 66.95 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.34 -21.01 66.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 109.528 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -65.12 -18.46 65.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 109.014 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 33' ' ' TRP . 11.2 mt -66.02 -26.87 67.73 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.3 mm? -61.96 -19.34 62.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.03 76.15 1.35 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.94 -59.77 2.14 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.33 0.586 . . . . 0.0 110.812 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.64 -119.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p 51.72 -105.78 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.666 -1.271 . . . . 0.0 109.57 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.71 40.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.847 -1.158 . . . . 0.0 110.277 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -154.11 148.51 26.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -132.05 -159.72 0.99 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB2' HD21 ' A' ' 24' ' ' LEU . 14.5 t90 -97.12 140.05 32.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -149.0 126.7 11.74 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.42 142.25 10.74 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.429 -0.794 . . . . 0.0 110.876 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -63.83 -52.18 61.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -152.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -135.78 -179.75 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.7 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 96.34 -24.05 32.12 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 9.8 mt-10 45.17 41.96 6.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.694 -0.886 . . . . 0.0 112.284 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 42' ' ' THR . 25.1 ttmt -59.81 -65.24 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 41' ' ' LYS . 61.0 p -158.76 124.05 4.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.4 pt -112.92 148.63 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.572 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -124.59 146.76 48.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.708 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -154.92 111.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 109.527 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.2 t -95.52 119.82 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 147' ' ' VAL . 1.4 mp -98.27 161.04 13.9 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.453 0.644 . . . . 0.0 109.863 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -107.02 129.3 54.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.731 -0.606 . . . . 0.0 109.796 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.756 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -80.88 133.28 35.54 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.34 37.77 0.4 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.713 . . . . 0.0 110.425 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 pttt 165.67 126.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -76.29 108.86 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 109.225 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.78 -179.33 6.39 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' O ' HD11 ' A' ' 4' ' ' ILE . 52.5 mt-30 -87.94 178.39 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.1 mp -138.04 137.9 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.333 -0.854 . . . . 0.0 109.829 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.697 ' O ' HD21 ' A' ' 116' ' ' LEU . 31.5 t60 -123.97 -34.73 2.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.706 -0.621 . . . . 0.0 109.895 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.6 m -137.1 163.4 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 149' ' ' PHE . 75.4 t -142.62 165.03 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 109.622 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -145.67 115.66 7.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.759 . . . . 0.0 109.949 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.1 mp -133.14 120.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -79.14 89.03 1.19 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 5.3 m120 -71.41 119.12 15.1 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 122.089 -0.653 . . . . 0.0 110.845 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.66 22.99 13.96 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 136' ' ' TYR . 39.3 p -52.91 -175.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.17 0.986 . . . . 0.0 112.022 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 134' ' ' GLN . . . -150.7 -54.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 133' ' ' SER . 44.7 m-85 -117.85 122.17 42.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.769 -0.582 . . . . 0.0 109.597 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 t -118.31 107.63 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.863 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.77 141.2 28.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.793 HG21 HD23 ' A' ' 88' ' ' LEU . 60.0 t -136.55 119.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 0.0 109.668 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD11 HG22 ' A' ' 86' ' ' VAL . 1.4 mp -116.95 163.28 16.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 87' ' ' LEU . 5.5 m -126.74 168.65 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.739 -0.601 . . . . 0.0 110.131 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 168.97 172.79 36.09 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -110.39 162.36 14.74 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.551 0.691 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 54.8 p -86.27 9.53 17.47 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.38 124.88 12.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.116 -0.99 . . . . 0.0 110.436 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.09 104.12 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.54 73.07 0.05 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.935 ' HB1' ' HB3' ' A' ' 83' ' ' ASP . . . -177.1 -48.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 109.262 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.94 -140.94 15.3 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -110.35 -23.11 11.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.926 . . . . 0.0 109.988 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -96.65 29.45 2.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 109.746 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.935 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . 2.5 t0 -115.93 35.77 4.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.3 m-85 -103.98 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -131.15 135.88 47.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 71' ' ' LEU . 43.0 t -65.19 85.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.462 -0.774 . . . . 0.0 110.563 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HA ' HG12 ' A' ' 117' ' ' VAL . 4.1 tp -68.05 -64.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.793 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -112.47 114.0 26.47 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -62.15 172.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.554 -0.716 . . . . 0.0 109.227 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.554 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -55.05 127.23 28.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.28 -0.887 . . . . 0.0 109.318 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p -95.7 114.7 26.47 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.219 0.533 . . . . 0.0 109.737 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -74.68 68.97 1.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 94' ' ' MET . 15.8 t80 -61.66 -61.66 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.883 -0.511 . . . . 0.0 109.623 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -122.55 -168.9 1.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.524 -0.735 . . . . 0.0 109.877 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -116.41 176.72 1.43 Allowed Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.72 12.67 2.93 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.943 2.429 . . . . 0.0 111.27 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 t -121.68 -37.25 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.156 -0.965 . . . . 0.0 110.248 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.6 -22.04 37.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.804 . . . . 0.0 110.249 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.2 p -58.54 -21.03 51.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 110.718 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -69.28 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -161.95 38.95 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 108.663 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.2 6.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.05 121.91 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -1.161 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 4.6 p-10 41.61 59.35 9.22 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 122.182 -0.324 . . . . 0.0 111.024 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.02 -31.35 5.02 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.117 2.544 . . . . 0.0 111.506 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.91 112.55 5.65 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.86 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -160.89 -157.91 0.56 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -124.59 160.65 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.014 -1.054 . . . . 0.0 109.692 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tpt180 -139.81 131.85 27.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtp -112.42 166.26 11.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.508 -0.745 . . . . 0.0 110.277 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 9.8 m-85 -139.1 166.25 25.0 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.44 -146.66 5.04 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.7 Cg_endo -73.91 -36.7 3.33 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 123.828 3.019 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.5 -27.31 68.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -90.32 1.12 56.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.597 -0.69 . . . . 0.0 110.68 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.1 pp -129.96 147.27 51.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.105 -0.997 . . . . 0.0 109.583 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 87' ' ' LEU . 10.9 p -71.74 139.16 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -71.5 -32.0 67.73 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -64.05 -19.88 65.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.09 -49.42 2.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.96 -28.1 9.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.513 -0.742 . . . . 0.0 110.757 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 19.54 9.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.291 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.8 mtpt -118.34 133.88 55.51 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -67.18 111.61 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.568 -0.708 . . . . 0.0 111.07 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -117.15 164.53 14.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.17 13.49 2.62 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.945 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 75' ' ' SER . 5.6 mtt180 -143.67 144.22 31.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.869 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.8 p -138.64 139.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.399 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.46 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.2 tttt -105.49 124.28 49.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 45' ' ' VAL . 50.2 mm -119.68 112.35 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.621 -0.674 . . . . 0.0 109.689 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 44' ' ' SER . 29.6 t -113.78 118.84 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 O-C-N 121.21 -0.932 . . . . 0.0 109.546 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 93.56 7.32 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -92.48 128.68 38.42 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.639 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER 173.91 69.6 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -174.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.21 92.04 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.881 2.387 . . . . 0.0 108.768 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -120.78 -10.15 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.727 -177.328 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.413 ' CB ' ' OE1' ' A' ' 40' ' ' GLU . 32.6 t -128.77 -175.59 3.58 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.889 -1.132 . . . . 0.0 110.72 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 14.8 tttm -133.54 -33.52 1.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.698 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 1.5 p30 -126.24 -5.03 6.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.017 -1.052 . . . . 0.0 112.247 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -110.93 150.4 41.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.946 -1.096 . . . . 0.0 110.678 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 51.2 Cg_endo -92.08 172.25 2.53 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.083 3.189 . . . . 0.0 110.559 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.47 -160.48 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.059 -1.026 . . . . 0.0 109.513 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.631 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 150.24 -112.02 0.53 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -142.9 161.91 36.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.064 -1.257 . . . . 0.0 111.733 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 5.5 m -83.26 -17.2 43.48 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.708 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.68 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.3 p90 -176.01 166.55 2.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.327 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 24' ' ' LEU . 20.2 m -145.1 137.78 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -149.89 163.27 38.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.997 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.869 ' CE2' HG11 ' A' ' 128' ' ' VAL . 55.9 m-85 -140.72 152.73 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.435 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -151.59 139.16 19.62 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 4' ' ' ILE . 6.1 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_endo -83.41 -25.7 2.48 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.883 2.388 . . . . 0.0 110.603 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.31 172.31 6.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.472 ' CG2' HD22 ' A' ' 49' ' ' LEU . 76.9 mt -142.14 127.98 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.05 172.21 7.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.694 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.738 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -100.16 134.88 42.44 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.592 -0.692 . . . . 0.0 109.525 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.655 ' N ' HD13 ' A' ' 6' ' ' LEU . 2.8 tpt85 -88.52 -61.52 1.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 48' ' ' GLN . 3.4 p-80 -160.86 163.54 31.96 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -79.38 89.8 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 11' ' ' SER . 2.0 p -52.49 -55.63 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.177 -0.952 . . . . 0.0 109.973 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.46 161.05 25.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.0 p -154.58 144.15 21.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -141.12 46.72 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.747 -0.596 . . . . 0.0 109.498 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 152.88 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.735 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -155.64 139.95 16.67 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.055 -1.028 . . . . 0.0 109.866 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.45 -161.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.904 . . . . 0.0 109.832 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -68.04 0.82 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.578 -0.701 . . . . 0.0 109.895 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -64.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.451 -0.781 . . . . 0.0 109.16 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.32 58.7 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.4 p -79.71 179.18 7.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.749 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -65.06 -25.7 67.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.84 -15.85 59.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 109.762 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.42 -17.31 64.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.133 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.772 HD22 HG22 ' A' ' 147' ' ' VAL . 12.0 mt -64.76 -24.27 67.51 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 7' ' ' ARG . 4.2 mm? -55.77 -23.99 32.94 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.479 -0.763 . . . . 0.0 109.011 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' HG21 ' A' ' 29' ' ' THR . 31.9 mmtt -108.25 60.81 0.61 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.57 64.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.986 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.05 64.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 26' ' ' LYS . 33.8 p -152.68 -90.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.1 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.075 -1.016 . . . . 0.0 110.082 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -128.47 147.47 50.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.045 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 20.1 mttp -132.5 176.08 8.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.413 -0.805 . . . . 0.0 110.204 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.696 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.0 t90 -88.48 139.49 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -144.67 130.5 19.21 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.97 146.47 8.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.795 . . . . 0.0 110.025 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.12 -22.09 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.738 -0.601 . . . . 0.0 110.436 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 175.58 9.43 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.86 -166.1 1.31 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 68.14 44.3 77.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -48.28 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.513 0.673 . . . . 0.0 111.246 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 42' ' ' THR . 31.6 ttmt -97.8 -58.33 2.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.671 HG22 ' OG ' ' A' ' 133' ' ' SER . 33.5 p -156.29 118.43 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.0 pt -116.01 147.22 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.426 -0.796 . . . . 0.0 110.205 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -126.83 149.52 49.67 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.417 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.749 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.6 p -154.44 107.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.0 t -90.9 120.71 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.738 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.6 mp -100.11 163.29 12.49 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.456 0.646 . . . . 0.0 110.117 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 62.9 tp60 -116.55 117.64 30.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.748 HD13 ' OE2' ' A' ' 53' ' ' GLU . 35.9 mt -71.13 143.58 50.54 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.18 37.15 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.707 -0.621 . . . . 0.0 110.975 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.91 137.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 4.3 tt0 -76.93 108.14 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.748 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -137.6 176.78 8.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -87.25 179.79 6.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -140.5 133.06 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.885 . . . . 0.0 109.941 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HA ' HD21 ' A' ' 116' ' ' LEU . 9.4 t-160 -120.4 -32.81 4.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 0.0 109.692 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.43 163.28 33.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG22 ' HD1' ' A' ' 149' ' ' PHE . 83.3 t -143.37 166.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.614 -0.679 . . . . 0.0 109.215 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.638 ' C ' HD13 ' A' ' 60' ' ' ILE . 5.0 t0 -137.66 102.07 4.65 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.0 110.114 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.638 HD13 ' C ' ' A' ' 59' ' ' ASP . 1.6 mm -115.18 117.98 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.31 114.45 3.97 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.09 127.74 33.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.798 -0.825 . . . . 0.0 110.671 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 67.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.4 -30.1 10.2 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.37 -172.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.967 . . . . 0.0 109.62 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -155.0 -52.81 0.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.695 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.6 m-85 -99.93 123.13 43.84 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.839 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 60' ' ' ILE . 47.3 t -127.75 111.58 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.025 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.78 144.3 31.3 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.711 HG13 ' CD1' ' A' ' 130' ' ' ILE . 20.0 t -133.29 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.6 mp -111.47 158.84 18.67 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.788 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.4 m -120.67 158.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.728 -0.607 . . . . 0.0 110.361 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.44 174.26 44.54 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 t -115.78 159.67 21.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 109.821 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.405 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.3 p -75.51 -5.14 43.72 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.643 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.69 -72.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.075 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.23 -70.28 1.03 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.63 29.23 66.56 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.46 75.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.52 -0.988 . . . . 0.0 109.69 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.78 -150.99 15.95 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.13 28.79 3.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.687 -0.89 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -136.72 16.48 3.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -112.62 28.97 8.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.533 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.1 m-85 -109.42 -175.12 2.67 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.47 129.91 46.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 71' ' ' LEU . 38.9 t -59.34 87.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.806 -0.559 . . . . 0.0 111.222 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.788 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -59.96 -59.23 5.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD11 HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -137.23 124.06 21.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 109.209 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -54.72 -177.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 0.0 110.114 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.75 133.29 49.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 109.23 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 38.1 p -99.57 120.93 40.45 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -86.15 124.17 32.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 31.0 m-85 -118.67 -47.3 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.633 -0.667 . . . . 0.0 110.237 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 69.8 mtp -122.07 -174.65 2.94 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.603 0.716 . . . . 0.0 110.963 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.2 p -117.14 174.76 2.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.36 12.59 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.19 2.594 . . . . 0.0 111.563 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.4 -39.51 2.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.937 . . . . 0.0 109.754 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -80.2 -20.52 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.8 p -58.06 -22.75 51.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.396 -0.815 . . . . 0.0 110.547 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -68.3 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.216 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 38.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.69 -17.96 7.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.35 117.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.239 . . . . 0.0 110.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 39.76 72.71 0.94 Allowed Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 121.944 -0.473 . . . . 0.0 111.963 178.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.7 -30.33 4.94 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.747 2.298 . . . . 0.0 109.62 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.97 115.21 18.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 -168.78 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.504 -0.747 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.632 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 41.3 t -144.75 131.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HD2' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mmt85 -135.21 131.8 37.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.9 mtt -105.14 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.769 -0.582 . . . . 0.0 109.508 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.511 ' CE1' HG12 ' A' ' 60' ' ' ILE . 14.3 m-85 -140.26 163.98 31.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.74 0.781 . . . . 0.0 109.885 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -144.35 -153.68 5.93 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.6 Cg_endo -74.83 -24.3 13.35 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 123.602 2.868 . . . . 0.0 111.033 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -43.71 41.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.564 -0.71 . . . . 0.0 111.166 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.48 13.12 20.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 110.656 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -114.76 121.0 41.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -48.94 130.57 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.756 -0.59 . . . . 0.0 110.736 -177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.86 -39.24 87.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.443 -0.786 . . . . 0.0 109.224 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.77 89.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.747 -0.596 . . . . 0.0 110.572 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -92.08 -34.9 14.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.41 -0.806 . . . . 0.0 109.373 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.72 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.11 -33.73 3.71 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.595 -0.69 . . . . 0.0 110.993 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.02 10.81 40.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.801 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 2.4 mmtt -92.9 133.13 36.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -72.35 104.57 3.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.312 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 72.0 m95 -110.4 157.54 19.44 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 2.6 p30 -131.27 4.15 4.35 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.271 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.1 mtt180 -132.52 150.61 52.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -144.18 141.59 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.234 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.5 tttm -108.58 110.92 22.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.737 -0.602 . . . . 0.0 109.899 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.711 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.7 mm -104.71 118.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 44' ' ' SER . 39.9 t -122.56 122.1 65.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.26 -0.9 . . . . 0.0 110.03 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.541 ' SG ' HD22 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -95.62 145.72 25.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.671 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.35 126.71 12.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 111.892 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.29 138.94 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 43.8 Cg_endo -90.06 103.26 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 123.189 2.593 . . . . 0.0 110.178 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 65' ' ' SER . 5.4 p90 -137.17 -4.11 1.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.233 -0.917 . . . . 0.0 112.414 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 -173.86 3.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.847 -1.158 . . . . 0.0 110.463 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -173.44 -39.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -105.45 -42.08 5.32 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.647 0.736 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 1.0 OUTLIER -107.97 145.33 31.18 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.5 Cg_endo -87.02 166.89 8.26 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.119 2.546 . . . . 0.0 110.507 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -171.44 -164.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 109.07 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.6 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 164.43 -106.84 0.28 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.642 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -129.23 149.76 50.89 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -71.72 -18.01 62.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 122.097 -0.377 . . . . 0.0 111.021 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.632 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 40.0 p90 179.07 178.11 0.48 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.772 HG22 HD22 ' A' ' 24' ' ' LEU . 15.7 m -155.65 129.79 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -141.82 156.39 45.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 109.474 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 128' ' ' VAL . 39.6 m-85 -127.87 148.44 50.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -146.63 130.44 17.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.458 -0.776 . . . . 0.0 109.273 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.55 13.42 2.65 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.53 2.82 . . . . 0.0 111.277 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -160.86 176.55 11.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 49' ' ' LEU . 71.4 mt -121.57 123.26 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.47 173.06 6.47 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.437 0.637 . . . . 0.0 109.781 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.6 mp -103.07 165.7 10.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.645 . . . . 0.0 109.57 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.611 ' C ' HD11 ' A' ' 25' ' ' LEU . 10.7 tpt180 -120.22 -47.39 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 48' ' ' GLN . 11.0 p-80 -161.0 -173.11 3.74 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -103.14 92.56 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.48 -0.762 . . . . 0.0 109.372 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -54.55 -60.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.544 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.31 163.63 18.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.444 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 19.7 p -160.05 149.37 17.71 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.059 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -152.31 51.91 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.681 -0.637 . . . . 0.0 109.975 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.715 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.63 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.939 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm100 -125.57 133.66 52.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.967 -1.083 . . . . 0.0 110.651 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.09 -175.5 5.67 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -64.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -56.66 12.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -95.32 69.73 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -86.82 166.84 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.6 -24.33 66.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.701 -0.624 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.51 -21.43 65.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.835 . . . . 0.0 109.712 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -65.71 -19.7 66.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.6 mt -65.72 -24.92 67.09 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.611 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -60.62 -20.83 61.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -109.23 62.69 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.86 -24.84 6.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 m-20 -118.31 78.15 1.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 28' ' ' ASP . 3.1 p -157.29 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.526 -0.734 . . . . 0.0 109.342 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -178.27 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -144.24 143.72 31.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -0.838 . . . . 0.0 108.798 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -130.58 -162.67 1.23 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.361 -0.837 . . . . 0.0 109.324 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.783 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.6 t90 -96.87 136.08 37.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -143.1 125.93 16.11 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.73 160.06 1.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 110.753 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -83.24 -45.05 14.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -152.03 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.51 -168.31 2.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.818 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 94.52 -22.62 36.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 12.1 mt-10 53.36 52.56 13.24 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.173 -1.193 . . . . 0.0 110.73 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -107.84 -103.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.38 -0.825 . . . . 0.0 109.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.54 HG22 ' OG ' ' A' ' 133' ' ' SER . 49.0 p -108.03 142.9 37.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.655 -1.278 . . . . 0.0 109.462 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 35' ' ' ALA . 5.6 pt -145.21 147.03 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.673 -0.642 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.676 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.721 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -151.06 106.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.5 t -93.66 116.56 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.99 . . . . 0.0 108.911 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -102.29 152.7 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.923 -178.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.506 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.4 tm0? -91.5 158.94 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.71 -0.619 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -107.22 124.94 50.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -52.29 -8.43 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.428 -0.795 . . . . 0.0 112.188 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -162.59 140.77 8.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.806 -1.184 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -75.87 113.72 13.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -147.52 -176.46 5.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.87 172.34 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' O ' HD22 ' A' ' 116' ' ' LEU . 4.4 mp -128.72 120.04 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 109.509 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.502 ' O ' HD21 ' A' ' 116' ' ' LEU . 23.1 t60 -110.62 -29.37 8.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -147.19 157.22 43.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.707 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.5 t -142.22 163.11 18.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.058 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 60' ' ' ILE . 7.0 m-20 -137.3 141.77 41.9 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.7 OUTLIER -154.87 123.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -87.68 121.7 5.98 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.6 125.59 29.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.971 -0.723 . . . . 0.0 110.162 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' N ' ' A' ' 145' ' ' SER . 2.5 t0 -126.39 62.98 1.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.6 -28.9 13.91 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.454 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 p -56.75 166.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.643 -0.916 . . . . 0.0 110.191 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.32 -57.37 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.16 123.36 45.18 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.56 111.66 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 0.0 110.204 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -105.06 141.43 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 130' ' ' ILE . 35.5 t -130.78 127.23 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.52 -0.737 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 HG22 ' A' ' 86' ' ' VAL . 1.9 mp -110.67 160.92 16.26 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG11 HD13 ' A' ' 87' ' ' LEU . 3.6 m -121.76 161.52 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.634 -0.666 . . . . 0.0 110.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 168.16 37.14 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 t -119.5 158.35 26.46 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.012 -0.699 . . . . 0.0 109.523 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.417 ' HB3' ' NE ' ' A' ' 127' ' ' ARG . 37.9 p -91.65 13.28 18.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.55 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 110.36 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -111.69 -37.36 1.58 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.19 112.13 4.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.93 70.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.926 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.5 159.9 8.24 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 64.5 128.06 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.623 -0.928 . . . . 0.0 109.906 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.77 21.88 10.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.521 -0.737 . . . . 0.0 110.288 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -137.04 22.46 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.65 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.17 -175.48 2.69 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.739 ' CD ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -139.52 135.79 33.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG22 HD11 ' A' ' 71' ' ' LEU . 24.3 t -58.08 89.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.636 -0.665 . . . . 0.0 111.952 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.66 HD13 HG11 ' A' ' 72' ' ' VAL . 12.6 tp -65.26 -54.0 35.83 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.631 HD13 ' CD2' ' A' ' 111' ' ' PHE . 2.1 pp -138.64 122.36 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.385 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.524 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -54.76 -177.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.175 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 t -69.64 136.53 51.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.494 -0.754 . . . . 0.0 109.171 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 125.72 52.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.429 0.633 . . . . 0.0 109.961 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -83.79 104.68 14.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 19.2 m-85 -101.89 -47.02 4.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 110.343 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.594 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 2.5 ttp -117.9 -178.5 3.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -114.89 173.76 2.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -88.17 18.88 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.288 2.658 . . . . 0.0 111.292 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.32 -50.0 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.65 -21.43 39.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.395 -0.816 . . . . 0.0 110.307 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 p -45.71 -27.82 0.89 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.0 111.453 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -78.09 0.45 Allowed 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.761 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.8 37.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.45 -27.52 59.28 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 -82.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.542 -0.975 . . . . 0.0 110.489 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 5.8 p-10 -112.03 87.48 8.85 Favored Pre-proline 0 C--N 1.296 -1.735 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.594 ' O ' ' HE1' ' A' ' 94' ' ' MET . 37.5 Cg_endo -69.91 -24.93 28.42 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.651 2.234 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -136.43 148.1 47.59 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -157.68 -168.02 2.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.594 -0.691 . . . . 0.0 109.821 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 96.1 t -137.73 129.77 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 23.5 mmt-85 -137.81 150.48 47.23 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 37.4 mtm -134.43 166.51 22.68 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.596 0.712 . . . . 0.0 110.807 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.1 m-85 -119.76 171.13 8.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.65 -150.71 5.37 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.1 Cg_endo -76.0 -37.43 1.57 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.677 2.918 . . . . 0.0 110.77 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.34 -26.14 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.526 -0.734 . . . . 0.0 109.763 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.96 2.16 56.15 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.652 -0.655 . . . . 0.0 110.74 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.984 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -122.5 141.1 52.01 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.981 -1.074 . . . . 0.0 110.519 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.913 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -61.42 138.71 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -32.87 49.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.356 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.03 -18.12 65.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.503 -0.748 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.19 -45.64 2.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.267 -0.895 . . . . 0.0 110.007 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.05 -39.58 28.05 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.342 -0.849 . . . . 0.0 111.08 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -81.37 1.18 34.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 15.9 mttt -94.04 134.27 36.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -68.58 112.43 5.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.446 -0.784 . . . . 0.0 110.919 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 79.4 m95 -115.14 166.44 11.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.66 12.31 2.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.714 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.73 ' HD3' HG21 ' A' ' 10' ' ' VAL . 7.8 mtt180 -146.92 141.5 26.59 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.93 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.8 p -131.79 143.79 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.579 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HG3' HG22 ' A' ' 46' ' ' VAL . 5.8 tttp -107.64 114.11 27.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.609 . . . . 0.0 109.48 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 44.8 mm -105.5 115.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.648 -0.658 . . . . 0.0 109.599 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.676 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.4 t -122.23 116.27 48.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.2 t -89.34 156.6 18.61 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -151.44 127.81 10.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.361 -0.837 . . . . 0.0 110.988 -178.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.746 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.0 tp60 149.32 136.11 0.0 OUTLIER Pre-proline 0 N--CA 1.519 3.002 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 43.4 Cg_endo -85.89 91.29 0.66 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.906 2.404 . . . . 0.0 110.269 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.47 -0.38 57.45 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.491 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 t -168.3 -162.69 0.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.791 -1.193 . . . . 0.0 110.261 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mtpt -138.89 -39.34 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -117.17 -13.76 10.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -0.984 . . . . 0.0 111.343 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -104.6 142.3 24.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.324 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 46.6 Cg_endo -88.03 177.13 3.56 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.479 2.786 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 173.14 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.594 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 165.37 -112.98 0.53 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.962 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -133.07 160.02 38.4 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.238 -1.154 . . . . 0.0 110.731 -179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 67.3 m -78.64 -21.86 47.77 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.752 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.5 p90 177.08 178.95 0.24 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.249 -0.907 . . . . 0.0 110.459 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 144' ' ' LEU . 33.7 m -154.21 129.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 3.2 mtt85 -139.95 114.4 9.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.766 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.93 ' CE2' HG11 ' A' ' 128' ' ' VAL . 73.0 m-85 -87.94 157.25 18.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.281 -0.887 . . . . 0.0 108.901 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -154.2 136.8 15.14 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.353 -0.842 . . . . 0.0 109.174 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.651 -0.655 . . . . 0.0 110.913 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.15 -51.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.438 2.758 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.03 -173.16 4.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.75 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.749 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -141.04 128.74 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -113.42 151.33 31.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.926 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.2 tp -84.74 149.47 25.75 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.628 ' C ' HD11 ' A' ' 25' ' ' LEU . 11.7 tpt85 -103.87 -50.26 3.44 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -161.03 -178.59 6.88 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -99.96 97.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG13 ' H ' ' A' ' 11' ' ' SER . 2.2 p -54.77 -59.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.329 -0.857 . . . . 0.0 110.442 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.541 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.54 154.25 36.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.147 -0.971 . . . . 0.0 108.75 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . 23.8 p -143.4 125.26 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.0 110.715 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.3 m -127.51 50.1 2.05 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.587 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 154.23 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.87 ' OE1' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.41 146.23 36.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 109.883 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.34 -170.72 2.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.72 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -99.38 -68.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.785 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -37.79 87.24 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -116.56 70.11 0.76 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.9 p -87.5 172.37 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.189 0.995 . . . . 0.0 109.53 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -64.9 -24.98 67.69 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.231 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.78 -20.4 56.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.807 . . . . 0.0 109.509 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.42 -20.5 66.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.3 mt -66.27 -26.94 67.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.628 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.2 mm? -61.65 -18.84 61.14 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.474 -0.766 . . . . 0.0 109.175 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -112.25 66.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.54 -45.4 56.87 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.541 -0.724 . . . . 0.0 110.366 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.86 78.98 7.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.058 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.0 -152.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -130.8 40.3 3.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.069 -1.02 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -149.83 136.55 19.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -160.24 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.493 -0.755 . . . . 0.0 109.738 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.877 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.0 t90 -85.43 140.24 30.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.264 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 129.69 22.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.69 161.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.305 -0.872 . . . . 0.0 110.498 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.57 -30.08 66.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.971 -0.456 . . . . 0.0 110.021 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -174.24 3.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.5 -165.27 1.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.57 45.01 95.69 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -46.12 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 111.812 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 42' ' ' THR . 28.1 tttt -94.77 -56.4 2.79 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.686 HG22 ' OG ' ' A' ' 133' ' ' SER . 17.2 p -158.13 113.05 2.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.877 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.0 pt -111.13 139.65 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.608 -0.683 . . . . 0.0 109.527 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' HG13 ' A' ' 131' ' ' VAL . 50.6 m -126.27 122.65 36.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.523 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.87 HG23 ' OE1' ' A' ' 15' ' ' GLN . 7.2 p -123.23 125.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.864 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.5 t -104.48 113.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.08 171.09 8.25 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.364 0.602 . . . . 0.0 110.281 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.726 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.79 174.49 5.9 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.749 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.5 mm? -124.3 140.43 52.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -76.52 26.55 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.214 -0.929 . . . . 0.0 111.469 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.6 pttt 167.1 132.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.77 111.69 11.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.09 167.82 21.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.642 ' O ' HD13 ' A' ' 55' ' ' ILE . 21.8 mt-30 -72.26 -178.77 2.61 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 54' ' ' GLN . 2.6 mm -126.6 128.8 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.417 ' CE1' ' HG3' ' A' ' 113' ' ' PRO . 77.0 t60 -120.69 -38.97 2.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 m -147.11 162.46 38.8 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.642 HG13 ' CD1' ' A' ' 149' ' ' PHE . 89.4 t -147.37 162.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 58' ' ' VAL . 1.8 m-20 -139.92 127.83 22.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -143.48 130.46 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.14 128.48 9.53 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.78 115.29 20.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.129 -0.63 . . . . 0.0 109.692 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 9.4 t0 -105.45 61.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.63 -29.08 12.72 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 86.3 p -60.62 173.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.88 -52.71 0.52 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.4 m-85 -95.34 123.99 39.14 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' ILE . 44.0 t -127.77 111.92 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.553 -0.717 . . . . 0.0 110.036 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -103.28 140.13 37.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG13 ' CD1' ' A' ' 130' ' ' ILE . 29.1 t -126.46 122.7 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.14 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -112.13 162.01 15.89 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.879 HG21 HD13 ' A' ' 87' ' ' LEU . 3.2 m -129.14 160.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 110.275 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.15 174.8 46.74 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -112.03 160.27 17.65 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.799 0.809 . . . . 0.0 109.949 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.437 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 56.0 p -86.37 7.27 26.3 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.01 112.03 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.973 . . . . 0.0 110.103 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.9 -102.51 0.52 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.79 115.36 0.66 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 83' ' ' ASP . . . -63.24 -57.37 10.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.947 . . . . 0.0 109.339 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.03 26.29 3.31 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 69.84 -63.04 0.4 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.366 -1.079 . . . . 0.0 109.975 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -93.7 39.29 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.951 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.686 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . 9.9 t70 -125.51 30.88 5.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.433 -0.792 . . . . 0.0 108.986 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.66 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -103.12 -174.43 2.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.488 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -119.32 124.77 47.45 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.12 85.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.798 -0.563 . . . . 0.0 110.446 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.879 HD13 HG21 ' A' ' 72' ' ' VAL . 3.4 tp -57.91 -56.29 23.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.195 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -140.41 124.57 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.629 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -55.92 172.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.542 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -59.48 134.37 56.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.4 p -107.57 124.89 50.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.594 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -84.27 125.03 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CD1' ' CD ' ' A' ' 109' ' ' ARG . 28.7 m-85 -121.66 -43.31 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 3.0 mtp -120.4 -165.28 1.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.658 . . . . 0.0 110.086 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.5 p -129.37 175.13 3.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.93 13.64 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 123.178 2.585 . . . . 0.0 111.257 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.6 m -120.36 -46.34 2.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 -22.92 29.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -50.13 -36.32 29.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 110.919 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -74.5 -84.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.853 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -163.59 37.29 0.09 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.66 -25.25 54.13 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.632 -0.922 . . . . 0.0 110.45 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 90.48 30.51 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.513 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.25 -21.54 23.25 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.537 2.158 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' ND2' ' OD1' ' A' ' 63' ' ' ASP . 0.9 OUTLIER -124.47 156.51 37.1 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -156.41 -175.18 5.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 0.0 110.228 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 42.6 t -155.7 115.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' CD ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.49 165.69 19.37 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.378 -0.826 . . . . 0.0 109.679 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.4 mtt -140.43 175.46 9.58 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.497 0.665 . . . . 0.0 110.153 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.5 m-85 -136.7 159.0 43.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 116' ' ' LEU . . . -125.82 -155.01 8.85 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -75.42 -36.77 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.274 2.65 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.45 -29.12 68.49 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -2.72 44.36 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.551 HD12 ' CB ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -124.99 141.19 52.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.948 -1.095 . . . . 0.0 109.956 179.123 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -51.56 139.98 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -39.2 62.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.157 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.56 -20.91 63.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.51 -43.64 3.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.551 ' CB ' HD12 ' A' ' 116' ' ' LEU . . . -48.3 -32.56 7.52 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.249 -0.907 . . . . 0.0 111.119 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.01 24.23 5.74 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.0 mttm -114.86 137.02 52.46 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -65.34 116.24 6.45 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.78 0.8 . . . . 0.0 110.462 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.487 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 63.2 m95 -122.66 151.05 41.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -133.52 5.19 3.71 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.429 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -132.75 141.39 48.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.774 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.7 p -135.06 141.17 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.655 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.864 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.4 tttt -109.59 121.09 44.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.813 -0.554 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.6 mm -115.5 114.07 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 109.142 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG13 ' OG ' ' A' ' 44' ' ' SER . 61.2 t -114.88 116.83 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.353 -0.842 . . . . 0.0 109.946 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.444 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -92.49 137.38 32.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.686 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -137.94 123.44 19.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.507 -178.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.8 tp60 166.43 133.46 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -87.02 95.05 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.928 2.419 . . . . 0.0 108.952 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.1 p90 -127.79 -7.25 5.59 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.273 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.12 178.65 6.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.0 110.527 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -156.96 -42.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.83 -36.7 5.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.49 -0.756 . . . . 0.0 109.669 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.41 147.67 34.33 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -87.5 178.43 3.38 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.286 2.657 . . . . 0.0 110.777 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER 178.93 -171.9 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.45 -112.1 0.49 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.907 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.593 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.7 mp -111.88 148.79 32.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.68 -0.894 . . . . 0.0 110.412 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -84.89 -27.66 26.5 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.621 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 52.1 p90 -176.03 169.8 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.673 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.8 m -150.15 134.69 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.161 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 17.3 mtt180 -145.63 113.98 6.67 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.531 -0.731 . . . . 0.0 109.855 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 128' ' ' VAL . 64.1 m-85 -93.3 152.56 19.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 133.54 20.81 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.396 -0.815 . . . . 0.0 108.805 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.424 ' CB ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.725 -0.609 . . . . 0.0 109.364 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.18 50.61 2.14 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 123.528 2.819 . . . . 0.0 110.648 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.92 158.37 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.552 -0.717 . . . . 0.0 109.454 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' OE1' ' A' ' 53' ' ' GLU . 47.7 mm -79.67 134.72 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -108.24 113.85 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 109.955 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.942 HD12 HD23 ' A' ' 49' ' ' LEU . 3.3 tp -79.76 140.77 36.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.672 -0.643 . . . . 0.0 109.359 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -91.94 -65.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.531 -0.731 . . . . 0.0 109.519 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -160.39 173.22 15.95 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 22' ' ' GLU . 7.1 p -79.76 90.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.211 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG21 HH11 ' A' ' 127' ' ' ARG . 2.3 p -53.07 -55.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.171 -0.956 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.468 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.19 154.22 37.76 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.989 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.61 125.32 12.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 110.089 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -120.45 45.75 2.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.649 -0.657 . . . . 0.0 109.516 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.606 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.84 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.744 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.83 136.97 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -162.47 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.162 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -93.45 -69.41 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -60.74 2.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.731 . . . . 0.0 109.122 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -88.05 68.43 9.16 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -92.12 170.9 9.46 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.727 0.775 . . . . 0.0 110.219 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.55 -24.26 67.74 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.98 -0.45 . . . . 0.0 109.889 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -61.57 -19.56 62.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.5 -18.48 65.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.843 . . . . 0.0 109.157 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.0 mt -65.13 -25.12 67.62 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.3 mm? -60.08 -20.61 58.96 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.47 -0.769 . . . . 0.0 109.033 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -127.29 73.8 1.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.81 -51.25 30.35 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.651 -0.656 . . . . 0.0 110.845 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.92 79.12 8.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -162.22 31.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 109.618 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.2 p90 46.99 25.18 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.242 0.544 . . . . 0.0 111.765 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -126.62 126.05 42.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 108.972 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -123.48 169.83 11.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.33 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.754 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.5 t90 -74.18 141.07 45.53 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -143.19 130.57 21.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.48 151.73 3.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.463 -0.773 . . . . 0.0 110.239 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.41 -33.79 71.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.61 -0.681 . . . . 0.0 109.702 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.24 -157.66 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.72 167.05 18.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.412 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 138' ' ' LYS . . . 96.03 -34.96 4.59 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 3.9 mp0 51.79 104.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.944 . . . . 0.0 111.782 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 42' ' ' THR . 23.8 ttmt -117.31 -51.02 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.727 HG22 ' OG ' ' A' ' 133' ' ' SER . 4.1 p -158.9 105.01 1.76 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 18.7 pt -105.68 139.88 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.361 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.547 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -121.92 149.26 43.67 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.164 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -153.6 112.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.743 HG22 ' HG2' ' A' ' 129' ' ' LYS . 5.8 t -94.08 119.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -97.27 161.25 13.89 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.416 0.627 . . . . 0.0 109.941 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -107.78 145.28 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.38 0.61 . . . . 0.0 109.355 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 HD12 ' A' ' 6' ' ' LEU . 39.1 mt -104.95 133.67 49.34 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 31.9 tt0 -81.68 45.62 0.9 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.448 -0.783 . . . . 0.0 110.612 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 160.0 126.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -73.79 107.88 6.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.54 178.0 7.38 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.406 0.622 . . . . 0.0 109.588 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -89.92 177.23 6.54 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.0 mp -130.72 119.04 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.53 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -108.72 -29.0 8.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.63 -0.669 . . . . 0.0 109.435 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 20.8 m -149.26 146.35 27.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.0 t -131.8 162.07 40.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.454 0.645 . . . . 0.0 109.701 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 60' ' ' ILE . 34.7 t0 -141.79 136.07 30.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 HG11 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -156.58 132.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -106.1 131.74 10.79 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.48 128.03 34.36 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 122.185 -0.597 . . . . 0.0 110.244 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.7 71.33 1.7 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.3 7.45 88.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -84.06 -173.47 4.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.762 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -142.88 -51.65 0.37 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -103.09 130.8 50.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.672 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 60' ' ' ILE . 48.0 t -134.53 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.657 . . . . 0.0 109.575 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -105.56 151.36 24.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.761 -0.587 . . . . 0.0 109.486 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.7 t -141.53 122.99 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.855 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.2 mp -110.56 163.71 13.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG1' HD22 ' A' ' 87' ' ' LEU . 2.9 m -127.86 156.73 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.713 -0.617 . . . . 0.0 109.781 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.29 176.25 45.22 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 t -110.32 156.71 20.36 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.2 p -85.77 7.59 23.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.442 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.99 171.61 2.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.88 -102.75 1.26 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.4 -139.93 3.12 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.68 80.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.954 . . . . 0.0 109.558 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.73 149.41 18.12 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -110.26 -27.27 9.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.623 -0.928 . . . . 0.0 109.705 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -101.35 37.47 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.366 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -126.9 34.37 4.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.547 -0.721 . . . . 0.0 109.647 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.4 m-85 -113.16 -177.92 3.25 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.741 0.781 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -123.69 129.04 50.5 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.32 86.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 110.292 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.587 HD22 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tp -59.04 -54.41 47.36 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.66 120.73 10.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -57.42 172.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.559 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -57.31 134.06 55.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.3 p -105.34 126.89 52.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.413 0.625 . . . . 0.0 109.325 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 96.2 p -87.88 119.94 28.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 18.1 m-85 -110.21 -51.51 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.629 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.416 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 19.1 mtp -122.03 -162.71 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.508 0.671 . . . . 0.0 110.084 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.1 p -123.51 177.45 1.7 Allowed Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.79 11.53 3.31 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.929 2.419 . . . . 0.0 111.279 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 -36.72 3.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.314 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -81.65 -16.39 51.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.78 . . . . 0.0 110.226 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 m -59.44 -24.67 63.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -67.45 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 t -162.28 38.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 108.722 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.7 -22.32 6.73 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.96 119.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 109.935 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.416 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.9 OUTLIER 40.87 68.72 2.25 Favored Pre-proline 0 N--CA 1.508 2.449 0 O-C-N 121.949 -0.469 . . . . 0.0 111.233 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.1 -30.71 4.16 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.949 2.433 . . . . 0.0 110.52 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -131.61 82.58 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.665 -0.647 . . . . 0.0 109.647 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.9 171.99 7.54 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -127.29 172.84 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -155.82 145.9 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 109.144 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.4 mtt -123.71 153.7 40.49 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.45 0.643 . . . . 0.0 110.096 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.601 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.9 m-85 -114.8 161.33 18.34 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -131.3 -149.39 6.44 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 38.7 Cg_endo -74.72 -39.36 1.37 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.614 2.876 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.62 -28.29 69.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -89.99 3.77 52.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.662 -0.649 . . . . 0.0 110.598 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.968 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.61 139.66 53.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.013 -1.054 . . . . 0.0 110.521 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.7 p -59.6 130.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -74.84 -30.81 61.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.475 -0.766 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -20.63 65.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.506 -0.746 . . . . 0.0 110.217 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.98 -46.25 2.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.915 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.968 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.8 -39.55 25.76 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.165 -0.959 . . . . 0.0 111.439 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.13 -0.15 30.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.35 -0.843 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.7 mtpt -92.36 134.42 34.94 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -67.76 113.55 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -0.769 . . . . 0.0 110.766 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -116.31 163.85 15.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.11 7.41 3.41 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.585 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.501 HH11 HG21 ' A' ' 10' ' ' VAL . 19.4 mtm180 -137.39 149.45 46.96 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.3 p -134.77 138.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.956 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HG2' HG22 ' A' ' 46' ' ' VAL . 1.4 tmtm? -106.36 100.81 10.32 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.929 -0.482 . . . . 0.0 109.761 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.8 mm -97.14 118.7 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 44' ' ' SER . 34.2 t -121.95 122.28 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.343 -0.848 . . . . 0.0 109.613 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.5 t -100.57 138.94 36.95 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.727 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -138.25 132.2 31.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.507 -0.746 . . . . 0.0 111.427 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.727 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 151.19 134.79 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.52 103.83 1.12 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.918 2.412 . . . . 0.0 109.587 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -77.14 -62.54 1.62 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.462 0.649 . . . . 0.0 109.612 -179.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.62 -161.58 1.37 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.879 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 16.4 mttm -136.29 34.13 2.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 109.389 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -77.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.12 158.19 37.75 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.977 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.6 Cg_endo -80.8 176.56 8.89 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.625 2.883 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -173.55 -166.11 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.78 -111.0 0.46 Allowed Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.771 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.585 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -117.93 149.94 40.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.598 -0.942 . . . . 0.0 110.465 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.7 m -83.67 -26.22 30.04 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -178.65 164.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.502 -0.749 . . . . 0.0 109.023 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 24' ' ' LEU . 26.3 m -140.17 138.37 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.27 149.42 32.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.582 -0.699 . . . . 0.0 109.589 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.645 ' CD1' HG13 ' A' ' 58' ' ' VAL . 58.7 m-85 -127.71 160.95 30.11 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.41 ' CA ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -155.14 120.42 4.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.275 -0.89 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.701 -0.624 . . . . 0.0 110.349 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.33 120.75 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.482 2.788 . . . . 0.0 110.454 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -137.89 178.49 7.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.683 . . . . 0.0 109.545 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' NZ ' ' A' ' 51' ' ' LYS . 68.0 mt -135.8 128.7 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.562 -0.711 . . . . 0.0 109.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.597 ' C ' HD22 ' A' ' 6' ' ' LEU . 41.3 mtt180 -120.08 -175.79 3.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.458 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.4 mm? -111.84 160.48 17.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.668 -0.645 . . . . 0.0 109.613 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -108.06 -48.07 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -160.59 162.25 32.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.28 86.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -51.37 -55.92 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.25 155.63 36.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.53 114.8 4.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -0.869 . . . . 0.0 110.336 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -104.67 47.38 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.487 ' HB2' HG22 ' A' ' 43' ' ' ILE . 3.3 t 151.87 111.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.889 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.2 pp0? -161.1 127.63 3.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.064 -1.023 . . . . 0.0 109.834 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.7 150.21 24.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m -61.45 -55.17 34.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.877 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -60.52 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.358 -0.839 . . . . 0.0 108.859 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -102.48 85.45 2.61 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -93.46 163.48 13.56 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.513 0.673 . . . . 0.0 110.096 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.72 -22.01 64.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.838 -0.539 . . . . 0.0 110.007 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.5 tt0 -62.97 -20.73 65.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.819 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -65.45 -18.97 65.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 33' ' ' TRP . 15.5 mt -66.26 -26.06 67.17 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.28 -17.4 62.47 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.562 -0.712 . . . . 0.0 109.25 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HB3' HG21 ' A' ' 29' ' ' THR . 5.3 mmmm -113.12 65.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.22 -26.77 3.14 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.537 -0.727 . . . . 0.0 110.809 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' C ' HG23 ' A' ' 29' ' ' THR . 25.5 t0 -99.75 68.17 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 26' ' ' LYS . 73.9 p -154.97 -161.09 1.14 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -127.56 34.41 4.68 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.365 -0.834 . . . . 0.0 109.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -124.62 105.5 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 35.9 mttt -91.27 162.83 14.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.609 -0.682 . . . . 0.0 109.738 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.729 ' HB2' HD21 ' A' ' 24' ' ' LEU . 23.4 t90 -67.76 139.62 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 127.05 16.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -56.49 164.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 110.616 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -85.16 -30.55 23.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 -156.8 0.53 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.601 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -137.65 172.52 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.83 -25.35 25.56 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mt-10 45.3 51.0 9.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.687 -0.89 . . . . 0.0 112.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 11.7 ttpt -67.06 -59.21 3.66 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.779 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.1 p -160.44 133.79 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -134.54 152.77 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.274 -0.891 . . . . 0.0 110.554 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -129.69 150.37 51.03 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -149.66 106.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' A' ' 129' ' ' LYS . 2.9 t -90.89 118.46 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.729 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.38 158.2 16.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' N ' HD12 ' A' ' 6' ' ' LEU . 17.1 tm0? -104.75 131.21 52.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.554 -0.716 . . . . 0.0 109.683 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 4' ' ' ILE . 4.2 mm? -81.19 121.23 25.88 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -54.06 -6.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.761 ' NZ ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -153.66 150.39 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.877 -1.14 . . . . 0.0 108.033 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.87 111.3 22.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.77 . . . . 0.0 109.013 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.43 -178.59 6.32 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -84.34 -171.02 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.1 115.77 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.507 -0.746 . . . . 0.0 109.313 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.0 t-160 -101.36 -32.01 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.8 m -147.48 153.98 40.22 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG13 ' CD1' ' A' ' 149' ' ' PHE . 79.7 t -136.72 161.14 36.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.643 -0.661 . . . . 0.0 109.726 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.553 ' HB2' ' CE1' ' A' ' 150' ' ' HIS . 27.5 t0 -139.11 139.24 37.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.617 -0.677 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -157.86 132.12 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -106.46 128.74 9.43 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -80.14 123.32 27.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.157 -0.614 . . . . 0.0 110.521 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 24.9 t0 -97.54 72.41 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 12.5 83.24 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 10.8 t -85.8 172.9 10.43 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.304 -1.115 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -134.8 -56.05 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.8 m-85 -102.26 122.89 45.1 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.702 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 60' ' ' ILE . 43.8 t -126.43 112.52 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.705 . . . . 0.0 109.85 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -104.36 142.47 34.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.71 HG13 HD13 ' A' ' 130' ' ' ILE . 22.2 t -131.08 128.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.967 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.6 mp -115.68 161.26 18.95 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -122.89 161.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.734 -0.604 . . . . 0.0 109.996 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 173.35 41.87 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 t -112.22 162.2 15.73 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.728 0.775 . . . . 0.0 109.833 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 13.0 t -86.27 6.19 30.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.1 -77.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.055 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -126.96 80.35 0.36 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.14 -65.84 1.96 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 59.73 29.37 18.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.574 -0.957 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 172.25 12.95 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -107.37 33.97 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.998 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -122.98 -0.75 8.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.575 -0.703 . . . . 0.0 110.505 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -100.13 43.09 1.07 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.141 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.577 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.8 m-85 -106.45 -175.01 2.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.71 0.767 . . . . 0.0 109.061 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.644 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -122.66 126.6 47.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.06 87.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.688 -0.633 . . . . 0.0 110.637 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.1 tp -60.15 -51.82 67.95 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.695 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -146.41 122.69 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.25 -177.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.531 -0.731 . . . . 0.0 110.073 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 135.71 55.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.558 -0.714 . . . . 0.0 109.187 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.422 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.4 p -105.74 123.41 47.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.78 -0.575 . . . . 0.0 109.597 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.7 p -85.25 109.81 18.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 26.7 m-85 -104.65 -49.19 3.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 22.0 mtp -121.21 172.67 7.82 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.718 0.77 . . . . 0.0 110.724 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -104.47 179.38 0.95 Allowed Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.261 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.7 Cg_endo -86.66 16.39 1.97 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.964 2.443 . . . . 0.0 111.341 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 t -120.12 -50.94 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.235 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.16 -12.9 61.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 110.111 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t -58.79 -24.37 61.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -91.55 -73.17 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.07 37.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.82 -21.83 54.74 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.76 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -1.021 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.94 95.78 0.61 Allowed Pre-proline 0 C--N 1.292 -1.912 0 O-C-N 121.814 -0.554 . . . . 0.0 109.51 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.21 -25.95 4.54 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.948 2.432 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -127.6 119.41 25.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.738 -0.601 . . . . 0.0 109.786 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -147.08 174.43 11.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.3 m -135.95 166.68 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -154.73 153.88 31.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.452 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.43 156.99 39.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.48 0.657 . . . . 0.0 110.274 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE2' HD13 ' A' ' 88' ' ' LEU . 4.7 m-85 -118.08 167.45 11.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.65 -149.2 5.52 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.94 -39.84 1.1 Allowed 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 123.692 2.928 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.25 -27.87 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.533 -0.73 . . . . 0.0 109.833 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.0 mptp? -91.98 3.76 54.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.665 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.3 pp -123.46 139.86 53.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.022 -1.049 . . . . 0.0 110.549 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -60.42 130.62 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -74.46 -33.76 62.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.83 -21.17 66.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.271 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.68 -47.33 2.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 110.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.4 17.78 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.16 -0.963 . . . . 0.0 111.626 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.92 3.08 27.68 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.745 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 1.1 mtpm? -95.52 136.22 36.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -67.11 113.38 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.48 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.7 m95 -117.43 163.76 15.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.44 14.98 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -142.3 142.48 32.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.7 p -136.61 143.03 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 110.366 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 46' ' ' VAL . 2.5 tttt -111.62 110.43 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.766 -0.584 . . . . 0.0 109.892 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.71 HD13 HG13 ' A' ' 70' ' ' VAL . 47.4 mm -101.82 129.46 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 44' ' ' SER . 28.0 t -130.98 130.01 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.184 -0.947 . . . . 0.0 110.591 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 43' ' ' ILE . 9.7 t -99.71 149.23 23.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.779 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -150.26 118.77 6.48 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.609 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.5 OUTLIER 160.03 112.24 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.451 ' HD2' ' NE2' ' A' ' 134' ' ' GLN . 39.2 Cg_endo -76.3 97.19 1.11 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.342 2.028 . . . . 0.0 108.725 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.527 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -103.62 -11.42 17.7 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.407 -178.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.76 -167.38 2.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.072 -1.017 . . . . 0.0 110.065 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.78 -47.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.746 -0.597 . . . . 0.0 109.631 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.601 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p30 -108.2 -13.37 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.536 -0.727 . . . . 0.0 110.925 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 35.5 p -99.07 138.46 20.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.265 -0.897 . . . . 0.0 109.861 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.1 Cg_endo -88.2 -177.67 1.91 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.354 2.703 . . . . 0.0 110.502 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 174.52 -164.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 157.44 -115.24 0.65 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.206 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.564 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -120.8 162.29 20.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.685 -0.891 . . . . 0.0 110.84 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 13.7 m -99.14 -27.81 13.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 53.4 p90 -178.05 171.2 1.76 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 147' ' ' VAL . 35.7 m -149.01 123.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -130.26 110.92 11.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 128' ' ' VAL . 85.9 m-85 -90.94 161.97 14.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.238 -0.914 . . . . 0.0 109.105 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -157.33 136.29 11.69 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -90.33 36.63 0.33 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.77 2.98 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -160.37 165.77 30.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.35 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.666 ' CG2' HD12 ' A' ' 49' ' ' LEU . 61.4 mt -110.43 122.18 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.09 166.32 10.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.68 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.7 mp -103.93 160.19 15.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.697 -0.627 . . . . 0.0 109.557 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -110.23 -54.05 2.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -160.55 164.99 31.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -79.89 93.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.5 -0.75 . . . . 0.0 109.322 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG13 ' H ' ' A' ' 11' ' ' SER . 2.1 p -54.17 -58.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.246 -0.909 . . . . 0.0 110.272 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -121.03 151.67 39.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -143.83 124.3 13.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.995 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -121.5 46.21 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.534 -0.729 . . . . 0.0 109.586 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.09 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.18 143.05 31.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.243 -0.911 . . . . 0.0 109.114 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.25 -161.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 p -98.47 -57.37 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.436 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.67 66.31 4.42 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -82.67 171.94 13.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.53 -0.731 . . . . 0.0 109.893 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.37 -24.05 67.68 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.85 -19.28 63.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -65.78 -17.33 64.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.937 . . . . 0.0 109.322 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 33' ' ' TRP . 19.1 mt -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -62.06 -18.74 61.64 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.528 -0.732 . . . . 0.0 109.252 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 67.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.37 62.49 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.466 -0.771 . . . . 0.0 110.323 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.12 76.51 9.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.469 -0.769 . . . . 0.0 108.984 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 -154.2 0.37 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -130.71 36.48 3.9 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -142.5 121.51 12.86 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -113.19 -165.38 0.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 109.452 -179.164 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.717 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.4 t90 -81.9 139.67 34.53 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 125.19 16.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.64 148.83 6.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.766 . . . . 0.0 110.359 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.91 -20.22 56.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.94 -0.475 . . . . 0.0 110.228 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -138.82 -171.77 3.16 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.354 -0.841 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.32 -161.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.83 43.55 97.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.1 mm-40 -48.47 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.959 0.885 . . . . 0.0 111.328 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -102.78 -50.73 3.46 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.717 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.4 p -158.86 115.39 2.7 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.676 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.3 pt -120.52 148.69 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.4 -0.812 . . . . 0.0 109.617 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.731 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -125.82 146.97 49.57 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.455 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.5 p -152.32 106.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.8 t -92.38 121.03 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -98.72 160.17 14.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.77 53.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.679 -0.638 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -82.03 138.22 34.92 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.14 38.95 0.49 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.537 -0.727 . . . . 0.0 110.503 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 pttm 161.63 132.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -75.94 107.62 8.26 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -138.15 179.36 6.49 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.445 0.641 . . . . 0.0 109.455 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -90.96 174.75 7.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.14 119.06 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.8 . . . . 0.0 109.677 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.436 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.9 t60 -110.01 -29.31 8.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.5 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.1 m -145.53 154.42 42.17 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.8 t -138.99 163.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.616 -0.677 . . . . 0.0 109.76 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -145.06 125.83 14.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.3 mp -147.84 137.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.951 -1.093 . . . . 0.0 108.3 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.87 126.7 8.94 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -83.46 123.04 29.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 122.042 -0.681 . . . . 0.0 110.462 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.9 70.87 3.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.37 7.35 88.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -76.91 166.54 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -1.141 . . . . 0.0 109.603 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -127.91 -55.47 1.29 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -103.87 120.92 42.0 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.904 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.56 103.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 6.2 tt0 -86.88 147.04 25.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.415 0.626 . . . . 0.0 109.92 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HD23 ' A' ' 88' ' ' LEU . 56.7 t -136.92 119.52 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.708 HD11 HG22 ' A' ' 86' ' ' VAL . 1.1 mp -114.72 164.54 13.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.743 HG11 HD13 ' A' ' 87' ' ' LEU . 13.6 m -127.93 163.33 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 110.351 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.56 170.28 37.56 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -114.01 160.27 19.04 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 122.027 -0.69 . . . . 0.0 109.213 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 t -92.25 12.82 21.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.8 -66.83 0.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.917 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.7 55.82 0.56 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.55 88.23 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.78 84.48 7.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.932 . . . . 0.0 109.411 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.74 168.36 26.35 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.36 -2.08 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.655 -0.909 . . . . 0.0 110.488 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -97.13 25.47 5.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.968 . . . . 0.0 109.964 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.65 21.57 12.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -0.812 . . . . 0.0 109.745 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.64 157.59 29.24 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 145.91 42.58 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.708 HG22 HD11 ' A' ' 71' ' ' LEU . 43.6 t -65.8 90.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.763 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.743 HD13 HG11 ' A' ' 72' ' ' VAL . 1.2 tp -72.78 -58.43 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -117.6 117.55 29.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -61.79 171.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.617 -0.677 . . . . 0.0 109.174 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.54 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -64.24 132.67 50.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.84 121.09 39.34 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.1 p -87.19 93.13 9.29 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 25.0 m-85 -84.23 -52.93 5.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 110.403 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 22.2 mtp -121.33 -168.85 1.75 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.543 -0.723 . . . . 0.0 110.428 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.4 p -115.92 176.76 1.4 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.62 14.86 2.33 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.041 2.494 . . . . 0.0 111.32 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.0 p -121.19 -37.69 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.001 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.88 -24.9 32.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -58.53 -20.73 48.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.734 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -69.32 -84.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.23 39.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 108.745 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.65 -18.27 5.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.97 123.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -1.17 . . . . 0.0 110.159 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 6.5 p30 41.59 66.82 3.55 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 122.066 -0.396 . . . . 0.0 111.504 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.61 -29.89 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.746 2.298 . . . . 0.0 110.488 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.44 103.3 6.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.687 -0.633 . . . . 0.0 109.601 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.55 174.98 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.752 . . . . 0.0 109.104 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.3 m -140.32 141.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 2.5 mmt-85 -134.35 176.99 8.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 mtt -142.08 178.56 7.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.697 -0.627 . . . . 0.0 109.842 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 88' ' ' LEU . 1.3 m-85 -141.92 171.16 14.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.52 -148.05 5.26 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -75.04 -36.63 2.42 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.595 2.863 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.84 -31.78 73.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -81.95 1.75 33.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.715 -0.615 . . . . 0.0 110.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.967 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -130.59 137.84 49.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.167 -0.958 . . . . 0.0 109.639 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.899 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.3 p -56.96 163.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 117' ' ' VAL . 3.6 mtp180 -97.78 -40.63 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.884 . . . . 0.0 109.142 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.02 -17.63 57.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 110.23 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.899 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.42 -50.81 2.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.35 -39.26 21.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.311 -0.868 . . . . 0.0 111.447 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -78.17 -1.85 34.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 110.656 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 23.2 mtpt -91.77 133.7 35.39 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -68.0 111.27 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.825 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 80.1 m95 -113.27 163.46 14.78 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -135.9 10.18 3.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.267 -0.895 . . . . 0.0 110.312 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 75' ' ' SER . 14.6 mtm180 -142.55 139.53 31.44 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.752 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.0 p -130.14 142.07 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.835 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.7 tttt -109.1 114.19 27.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.668 -0.645 . . . . 0.0 109.843 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 45' ' ' VAL . 47.9 mm -105.78 119.64 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.731 HG22 ' HB3' ' A' ' 44' ' ' SER . 44.1 t -124.92 117.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 O-C-N 121.208 -0.932 . . . . 0.0 110.057 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.461 ' HB3' HG13 ' A' ' 43' ' ' ILE . 7.0 t -89.14 142.72 27.4 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.717 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -141.26 124.81 16.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.717 -0.614 . . . . 0.0 110.6 -178.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.6 tp-100 158.33 131.51 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.446 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.35 93.22 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.021 2.481 . . . . 0.0 109.432 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.2 p90 -127.07 15.31 7.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.595 -0.69 . . . . 0.0 111.034 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.63 -169.57 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -176.06 -40.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.97 -36.41 4.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.547 0.689 . . . . 0.0 109.662 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.85 150.84 38.62 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.89 -0.506 . . . . 0.0 109.657 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.95 -171.42 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.354 2.703 . . . . 0.0 110.623 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.85 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.574 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 152.38 -113.5 0.58 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.366 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.575 HD23 HG23 ' A' ' 60' ' ' ILE . 6.4 mp -124.08 151.51 43.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.732 -0.863 . . . . 0.0 110.992 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 48.9 m -86.45 -26.64 24.57 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.538 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 37.5 p90 -175.54 168.48 3.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.5 m -146.02 142.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.8 mtp85 -150.38 160.41 43.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 109.323 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CE2' HG11 ' A' ' 128' ' ' VAL . 38.7 m-85 -142.19 155.77 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 129.24 10.27 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.76 -0.587 . . . . 0.0 109.947 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.5 mmm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.2 Cg_endo -81.92 84.46 1.88 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.956 2.437 . . . . 0.0 110.372 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -133.79 171.05 14.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.422 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 151' ' ' SER . 55.3 mt -143.17 126.74 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.72 . . . . 0.0 109.433 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.705 -0.622 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.798 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.1 mp -107.14 161.07 15.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.635 -0.665 . . . . 0.0 109.858 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' C ' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -109.05 -57.71 2.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.686 -0.634 . . . . 0.0 109.31 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -160.8 164.13 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.83 86.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG21 HH11 ' A' ' 127' ' ' ARG . 2.0 p -50.83 -57.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 110.391 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -125.7 153.51 43.79 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.6 p -149.09 146.04 27.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -135.78 46.58 2.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.764 -0.585 . . . . 0.0 109.644 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 153.19 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.64 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -158.36 142.8 15.97 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.133 -0.979 . . . . 0.0 109.519 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -173.55 3.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.18 -0.95 . . . . 0.0 109.564 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -85.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.383 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -56.08 22.47 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -97.01 76.65 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -92.42 169.04 10.87 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.43 -23.76 67.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.852 -0.53 . . . . 0.0 109.709 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.97 -16.83 60.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.857 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.52 -18.77 65.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.069 -1.019 . . . . 0.0 109.228 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.2 mt -65.59 -24.97 67.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.471 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.19 -21.39 59.36 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -119.14 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.79 7.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 29' ' ' THR . 10.3 m-20 -121.17 87.21 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.829 . . . . 0.0 109.848 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.95 -87.29 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -177.57 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 0.0 109.73 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.73 142.79 12.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 109.273 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.7 mtmt -127.03 -164.9 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.471 -0.768 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.815 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.1 t90 -88.46 140.25 29.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.45 129.49 17.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.05 148.48 6.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.406 -0.809 . . . . 0.0 110.379 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.14 -23.7 56.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.811 -0.555 . . . . 0.0 110.251 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -139.19 -175.88 4.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.96 -166.64 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 64.12 48.0 79.61 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mp0 -55.15 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.378 0.608 . . . . 0.0 111.026 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 39' ' ' GLY . 18.4 tttt -87.82 -53.49 4.73 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 133' ' ' SER . 37.6 p -155.8 114.92 3.54 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.687 HG21 ' HB2' ' A' ' 35' ' ' ALA . 12.5 pt -115.85 146.86 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.475 -0.766 . . . . 0.0 109.401 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -126.18 149.31 49.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.121 178.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.9 p -152.08 105.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.755 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.6 t -89.81 114.06 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.798 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.1 mp -96.35 163.92 12.87 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.587 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.16 136.39 48.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.692 -0.63 . . . . 0.0 109.876 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.8 134.22 34.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -70.91 20.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.381 -0.824 . . . . 0.0 112.284 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttt 176.61 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.714 -1.241 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -59.19 102.12 0.12 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.628 ' OE2' HG23 ' A' ' 4' ' ' ILE . 10.7 pt-20 -137.21 -177.41 4.76 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.483 0.659 . . . . 0.0 110.121 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -96.39 -177.71 4.05 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.49 121.26 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.428 ' O ' HD21 ' A' ' 116' ' ' LEU . 56.3 t60 -111.03 -29.3 7.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.697 -0.627 . . . . 0.0 109.344 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -148.08 146.31 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 149' ' ' PHE . 74.3 t -129.28 160.47 40.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.445 0.64 . . . . 0.0 109.751 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 2.7 m-20 -139.28 133.92 31.9 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -157.73 135.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -110.4 135.23 12.72 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.71 HD21 HG21 ' A' ' 68' ' ' VAL . 1.4 m-80 -88.04 132.66 34.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.138 -0.625 . . . . 0.0 110.739 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' N ' ' A' ' 145' ' ' SER . 7.0 t0 -113.22 58.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.31 -25.33 18.3 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 15.3 t -57.26 165.77 1.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -1.02 . . . . 0.0 109.908 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.72 -57.82 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.1 m-85 -98.94 118.48 35.79 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 62' ' ' ASN . 59.5 t -125.23 114.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.265 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.91 144.43 31.52 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 88' ' ' LEU . 5.0 t -123.13 125.41 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -112.09 161.31 16.65 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -125.43 151.11 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 0.0 109.96 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -173.25 166.81 39.37 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -115.93 157.12 25.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.981 -0.717 . . . . 0.0 109.552 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 t -88.05 10.42 19.17 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.46 107.56 0.81 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.9 -74.44 0.48 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.4 166.17 12.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.64 -45.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.901 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.08 161.08 11.55 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.55 -26.51 68.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.517 -0.99 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.67 29.43 3.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 0.0 109.707 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.46 28.4 8.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.481 -0.762 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -104.83 -173.53 2.32 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -125.19 137.94 54.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.089 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 71' ' ' LEU . 37.1 t -66.22 87.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.573 -0.705 . . . . 0.0 110.727 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.691 HD13 HG11 ' A' ' 72' ' ' VAL . 11.1 tp -58.27 -47.76 82.61 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 70' ' ' VAL . 1.8 pp -143.18 120.76 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.393 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 88' ' ' LEU . 31.5 m -50.42 174.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 110.587 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -63.91 138.09 58.32 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.573 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.8 p -105.89 123.32 47.78 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -87.67 104.26 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 23.7 m-85 -100.38 -46.55 5.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 mtp -120.16 -170.95 2.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.2 p -126.66 -179.62 0.97 Allowed Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.86 9.42 4.15 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.882 2.388 . . . . 0.0 111.328 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.3 p -114.08 -55.08 2.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -63.0 -20.2 65.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.973 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -56.59 -27.26 57.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.239 -0.913 . . . . 0.0 110.141 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -87.73 -74.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 110.009 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.22 37.52 0.1 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.08 -24.06 35.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -1.004 . . . . 0.0 110.368 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 88.95 35.45 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.13 -18.63 16.23 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.959 2.439 . . . . 0.0 110.27 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.39 115.35 11.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.669 -0.644 . . . . 0.0 109.734 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -144.72 160.31 41.42 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 m -120.94 163.85 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.55 159.12 43.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.39 -0.819 . . . . 0.0 109.374 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.4 mtp -130.08 162.57 28.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.626 -0.671 . . . . 0.0 110.113 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -127.32 165.99 18.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -135.52 -150.11 5.93 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -75.68 -37.98 1.5 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.655 2.904 . . . . 0.0 110.731 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -65.4 -28.27 69.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.57 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -89.34 1.51 55.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.649 -0.657 . . . . 0.0 110.589 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.21 139.89 53.49 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.037 -1.039 . . . . 0.0 109.921 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.894 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -59.22 133.4 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -75.8 -29.99 58.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.338 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.32 -23.23 64.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.598 -0.688 . . . . 0.0 109.977 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.894 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.29 -45.55 3.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.67 -40.57 28.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.215 -0.928 . . . . 0.0 111.291 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -77.86 -3.03 39.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 110.547 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 26.5 mtpt -90.31 132.92 35.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -67.62 109.59 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.544 0.688 . . . . 0.0 110.73 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 87.3 m95 -109.09 164.03 12.79 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.5 6.63 3.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.525 HH11 HG21 ' A' ' 10' ' ' VAL . 35.8 mtm180 -145.99 145.9 30.8 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.74 -1.225 . . . . 0.0 107.919 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.88 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.9 p -132.73 142.46 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.348 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.755 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -105.09 116.17 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.754 -0.591 . . . . 0.0 109.797 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 45' ' ' VAL . 51.4 mm -108.07 119.53 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 44' ' ' SER . 30.6 t -124.7 122.89 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.138 -0.976 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.508 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -97.22 142.46 29.09 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.6 123.37 15.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.712 -0.618 . . . . 0.0 110.375 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.833 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 35.1 tp60 156.84 123.24 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.53 104.55 1.74 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.682 2.255 . . . . 0.0 108.884 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 2.0 p90 -132.0 -10.58 3.4 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.568 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.76 126.38 14.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.839 -1.163 . . . . 0.0 109.513 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -110.39 -26.58 9.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.843 -0.536 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.58 -43.66 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 110.262 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.09 145.74 32.38 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.822 -0.549 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.2 Cg_endo -87.03 166.19 8.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.33 2.687 . . . . 0.0 110.409 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -176.85 -165.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.98 -102.63 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 147' ' ' VAL . 5.6 mp -115.26 155.43 27.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.575 -0.956 . . . . 0.0 110.604 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 23.6 m -89.49 -27.51 20.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.531 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 50.1 p90 -178.09 162.31 1.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.6 m -138.64 141.29 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.0 mtp180 -145.79 160.63 41.48 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.478 0.656 . . . . 0.0 110.342 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.88 ' CE2' HG11 ' A' ' 128' ' ' VAL . 54.6 m-85 -142.24 156.88 45.32 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -157.01 136.73 12.37 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.9 p . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.95 144.85 7.41 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.599 2.866 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.1 169.09 24.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.522 -0.737 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' OE1' ' A' ' 53' ' ' GLU . 62.2 mt -125.09 123.76 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -105.2 161.02 14.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.733 -0.604 . . . . 0.0 109.658 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -95.73 151.43 19.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.468 ' C ' HD11 ' A' ' 25' ' ' LEU . 43.3 ttt85 -103.93 -54.32 2.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 109.383 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' CE1' ' HD3' ' A' ' 7' ' ' ARG . 4.9 p-80 -160.54 166.49 28.97 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -83.69 93.97 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.772 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -53.15 -60.13 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.131 -0.981 . . . . 0.0 110.16 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.512 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.1 155.49 35.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -153.24 105.63 2.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.257 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -105.94 56.46 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 153.46 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.4 pp0? -132.97 139.64 47.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.734 -1.229 . . . . 0.0 110.145 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.83 148.57 22.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 109.326 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.6 t -61.14 -52.86 63.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.582 -0.699 . . . . 0.0 110.155 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -58.55 8.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.344 -0.847 . . . . 0.0 109.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -110.16 86.99 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -92.29 166.65 12.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.552 0.692 . . . . 0.0 110.359 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.54 -23.52 67.03 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.3 tt0 -61.96 -18.44 60.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.339 -0.85 . . . . 0.0 109.724 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -65.27 -17.51 64.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.256 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.09 -25.68 67.9 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -58.09 -22.41 50.52 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.491 -0.756 . . . . 0.0 109.002 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -115.36 67.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.51 -25.83 4.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.739 . . . . 0.0 110.6 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' THR . 31.3 m-20 -122.03 88.78 3.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 0.0 109.796 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -157.98 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.583 -0.698 . . . . 0.0 109.236 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 44.2 p90 -178.16 35.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 28.5 mtm180 -157.17 137.53 12.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.2 mtmp? -120.53 -176.87 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.7 t90 -78.51 138.18 38.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -141.66 128.32 20.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.21 168.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.691 0.758 . . . . 0.0 111.21 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -79.16 -30.52 43.57 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.139 0.495 . . . . 0.0 109.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -120.36 -172.16 2.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.2 -165.23 1.1 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.15 45.29 96.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 1.3 mp0 -43.74 89.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.487 0.66 . . . . 0.0 112.075 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 42' ' ' THR . 10.6 pttt -103.02 -44.21 5.29 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.3 p -160.51 132.36 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.761 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -137.73 136.03 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.418 -0.801 . . . . 0.0 110.204 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -112.22 140.84 46.59 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.462 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.754 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -147.41 106.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 128' ' ' VAL . 10.8 t -91.36 121.53 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.673 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -100.42 168.98 9.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.307 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -114.14 148.07 37.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.712 -0.617 . . . . 0.0 109.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.522 HD12 ' CA ' ' A' ' 126' ' ' ASP . 18.1 mt -101.73 137.57 39.87 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.75 40.2 0.51 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.37 -0.831 . . . . 0.0 110.909 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 1.7 pttm 161.32 130.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 14.4 tt0 -75.55 110.6 10.07 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -140.25 -179.49 6.02 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.01 178.14 6.09 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.415 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -127.76 115.71 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -103.4 -30.83 10.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -148.1 159.03 44.34 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.8 t -141.91 158.23 20.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.48 0.657 . . . . 0.0 109.389 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.3 m-20 -140.13 137.89 34.81 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -158.25 130.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.8 132.33 10.96 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -90.7 126.72 36.07 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.301 -0.529 . . . . 0.0 110.366 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -97.7 64.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.93 60.26 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 72.0 m -55.57 158.2 3.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -1.1 . . . . 0.0 110.322 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -119.64 -58.65 1.88 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 133' ' ' SER . 19.5 m-85 -99.61 129.99 45.8 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.946 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 60' ' ' ILE . 53.8 t -130.43 111.84 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.629 . . . . 0.0 109.692 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -105.63 146.28 29.9 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.726 HG22 ' CD1' ' A' ' 130' ' ' ILE . 22.0 t -135.79 126.56 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.57 -0.706 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.59 160.46 18.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.659 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.2 m -121.49 157.82 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.789 -0.569 . . . . 0.0 109.894 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.18 172.45 42.61 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -114.04 158.78 20.76 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 122.041 -0.682 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -73.43 -4.97 36.91 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.797 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.95 153.98 16.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.1 87.98 0.04 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.2 160.55 16.32 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.31 37.28 20.37 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.538 -0.978 . . . . 0.0 109.517 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.06 -100.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 64.56 140.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.67 -0.9 . . . . 0.0 109.328 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 58.4 21.8 8.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.454 -0.778 . . . . 0.0 109.965 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.09 34.1 3.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.197 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.4 m-85 -101.36 -173.26 2.32 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.659 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -121.1 130.58 53.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.28 85.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.366 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.626 ' HB2' HG13 ' A' ' 72' ' ' VAL . 15.3 tp -58.03 -59.81 4.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -137.8 120.49 16.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.33 179.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.745 . . . . 0.0 110.325 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 134.4 53.58 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.601 -0.687 . . . . 0.0 109.153 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.1 p -107.87 125.85 51.96 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.441 0.639 . . . . 0.0 109.769 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 84.9 p -83.7 127.83 34.07 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CG ' ' HD3' ' A' ' 109' ' ' ARG . 22.8 m-85 -120.95 -48.21 2.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 81.4 mtp -121.95 -176.83 3.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.933 0.873 . . . . 0.0 111.352 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -120.55 173.93 3.37 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.57 9.48 4.08 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.911 2.407 . . . . 0.0 111.315 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.0 m -120.77 -35.03 3.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.35 -21.67 35.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.316 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.9 p -58.23 -22.13 50.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -0.805 . . . . 0.0 110.425 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -67.96 -83.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.338 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -162.45 39.2 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.74 -22.38 5.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.26 118.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -1.135 . . . . 0.0 110.396 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 41.21 77.44 0.43 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.929 -0.482 . . . . 0.0 111.366 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.12 -28.55 2.39 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.05 2.5 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.41 92.85 2.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -123.89 -176.13 3.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.724 . . . . 0.0 109.332 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.7 m -134.6 158.33 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.713 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' ' CG ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.94 159.78 41.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.8 mtm -135.57 166.23 23.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.0 110.295 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.0 m-85 -129.46 169.63 14.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -140.12 -148.57 5.19 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.7 -39.6 1.31 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.674 2.916 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.37 -28.83 69.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.493 -0.754 . . . . 0.0 109.648 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.59 54.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.658 -0.651 . . . . 0.0 110.598 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -123.51 138.76 54.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.05 -1.031 . . . . 0.0 110.38 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -59.37 130.34 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -33.44 63.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.786 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.95 66.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.334 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.96 -46.68 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.162 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.952 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.73 -38.55 21.92 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.143 -0.973 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.14 0.6 31.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 110.706 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.2 mtpp -92.54 135.81 33.75 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.41 113.2 5.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.744 0.783 . . . . 0.0 110.753 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.3 m95 -115.84 165.97 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.522 ' CA ' HD12 ' A' ' 49' ' ' LEU . 3.8 p30 -140.68 15.5 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.132 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.447 ' HD3' HG11 ' A' ' 10' ' ' VAL . 13.4 mtt180 -145.5 147.58 32.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -137.3 142.14 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.105 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.3 tttt -110.88 108.43 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.668 -0.645 . . . . 0.0 109.729 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.726 ' CD1' HG22 ' A' ' 70' ' ' VAL . 48.4 mm -101.96 127.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 44' ' ' SER . 61.0 t -132.47 115.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.522 ' HB3' HG13 ' A' ' 43' ' ' ILE . 3.1 t -85.55 149.68 25.2 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.726 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.9 122.9 9.41 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.264 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.73 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.45 94.68 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.008 2.472 . . . . 0.0 110.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -121.62 -17.55 7.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.0 111.285 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.48 169.49 8.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.462 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 24.9 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.793 -0.567 . . . . 0.0 109.634 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.79 -46.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.6 146.35 32.44 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.58 169.28 8.19 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.432 2.755 . . . . 0.0 110.898 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 179.49 -164.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.86 -105.93 0.26 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.193 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 60' ' ' ILE . 5.6 mp -115.79 154.67 29.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.937 . . . . 0.0 110.716 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 49.2 m -87.34 -27.99 22.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 52.6 p90 -179.24 167.67 1.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.514 -0.741 . . . . 0.0 109.509 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.5 m -142.46 131.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 14.7 mtt180 -139.07 121.66 16.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.028 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.694 ' CD1' HG13 ' A' ' 58' ' ' VAL . 67.5 m-85 -104.36 156.68 17.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.109 -0.995 . . . . 0.0 109.41 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -150.97 131.28 13.65 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.317 -0.865 . . . . 0.0 109.714 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.704 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.56 58.56 3.99 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.457 2.772 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.6 177.5 10.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 109.309 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG2' HD12 ' A' ' 49' ' ' LEU . 72.1 mt -117.67 124.71 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -104.78 164.8 11.51 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.455 0.645 . . . . 0.0 110.084 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.775 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -97.53 127.63 43.64 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.642 ' N ' HD13 ' A' ' 6' ' ' LEU . 3.7 ttt180 -82.11 -56.89 3.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.379 -0.825 . . . . 0.0 109.584 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.93 165.1 30.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.659 -0.651 . . . . 0.0 109.409 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -81.29 90.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.774 . . . . 0.0 109.307 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.731 HG21 ' NH1' ' A' ' 127' ' ' ARG . 1.8 p -54.37 -58.28 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.487 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -118.04 143.47 46.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.31 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -130.81 124.03 30.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -0.796 . . . . 0.0 109.711 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -124.59 42.24 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.3 m 153.93 76.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.64 141.46 26.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 108.987 -179.361 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -164.49 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.336 -0.853 . . . . 0.0 109.071 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -64.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -49.22 76.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 109.067 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.04 73.7 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -91.71 168.86 11.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.503 -0.748 . . . . 0.0 110.095 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.67 -23.01 67.12 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.616 ' HG3' HG12 ' A' ' 9' ' ' VAL . 1.6 tt0 -63.87 -17.49 63.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.8 -17.8 64.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 109.286 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 33' ' ' TRP . 21.1 mt -65.17 -24.28 67.34 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -58.54 -22.35 55.22 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.526 -0.734 . . . . 0.0 109.055 178.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -107.67 61.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.14 -25.23 4.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.425 -0.797 . . . . 0.0 110.708 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -118.35 76.58 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 28' ' ' ASP . 5.4 p -156.42 -95.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.774 . . . . 0.0 109.075 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -178.4 36.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.391 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -141.75 138.02 32.02 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 11.1 mttm -128.66 -178.69 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.422 -0.799 . . . . 0.0 110.807 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.704 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -80.98 140.46 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.43 129.07 17.13 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.37 150.8 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.496 -0.752 . . . . 0.0 110.909 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.25 -26.56 68.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -169.79 2.09 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.11 178.77 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.73 -30.74 8.78 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 18.4 mm-40 40.67 31.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.969 -0.724 . . . . 0.0 112.526 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 42' ' ' THR . 0.0 OUTLIER -51.57 -52.94 43.17 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.696 -0.627 . . . . 0.0 109.316 179.38 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.9 p -160.32 129.43 4.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.704 HD12 ' CH2' ' A' ' 33' ' ' TRP . 13.1 pt -130.2 141.72 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.86 . . . . 0.0 110.322 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.581 ' OG ' HG13 ' A' ' 131' ' ' VAL . 29.5 m -126.06 141.22 52.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.293 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.703 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.4 p -146.27 110.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 ' HD2' ' A' ' 129' ' ' LYS . 2.7 t -90.42 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.775 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.2 mp -100.09 157.6 16.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -99.89 145.58 27.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 109.834 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -97.96 140.35 32.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.28 33.81 0.24 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.417 -0.802 . . . . 0.0 111.115 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.4 pttm 161.22 138.39 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 10.0 tt0 -75.16 102.48 4.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -131.35 165.74 22.8 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.7 0.762 . . . . 0.0 109.786 -179.163 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 55' ' ' ILE . 15.9 mt-30 -76.15 -176.96 3.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 54' ' ' GLN . 1.9 mm -128.93 174.89 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.403 -0.81 . . . . 0.0 108.891 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.701 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.9 t60 -172.53 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.506 -0.746 . . . . 0.0 109.199 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -145.27 145.76 31.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 60' ' ' ILE . 83.5 t -130.64 163.36 36.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.665 0.745 . . . . 0.0 110.31 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 58' ' ' VAL . 11.8 t0 -133.5 131.97 40.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.692 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.46 129.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -99.36 122.71 7.66 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.92 117.92 17.3 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 122.13 -0.629 . . . . 0.0 110.145 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -102.2 73.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.95 21.91 72.91 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 -177.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 1.8 p -96.98 152.89 18.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.998 . . . . 0.0 109.857 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -114.36 -54.79 2.56 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.6 132.3 52.76 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.52 -0.738 . . . . 0.0 109.969 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.39 112.16 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.832 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -107.54 146.52 31.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.749 -0.595 . . . . 0.0 109.546 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.6 t -133.6 128.85 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.602 -0.686 . . . . 0.0 109.933 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.7 mp -115.03 158.84 21.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.792 ' CG1' HD22 ' A' ' 87' ' ' LEU . 5.4 m -119.6 154.48 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.47 173.36 46.02 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 t -114.71 155.47 26.59 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.98 -0.718 . . . . 0.0 109.831 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.9 p -63.67 -14.0 48.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.36 150.08 46.99 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.39 -0.819 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.95 -96.18 0.75 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.25 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.57 -55.12 16.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.569 -0.96 . . . . 0.0 109.554 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.75 51.67 3.96 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -110.72 -62.88 1.47 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.62 -0.93 . . . . 0.0 109.358 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -100.99 30.66 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -116.16 30.3 7.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.702 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.05 154.07 35.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.701 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.21 145.06 32.04 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.73 84.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.581 -0.7 . . . . 0.0 110.751 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.792 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -57.57 -59.62 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.8 pp -136.05 121.44 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.312 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.8 m -54.07 -179.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.663 -0.648 . . . . 0.0 110.178 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.14 135.31 51.93 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.241 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -104.62 127.69 52.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -85.33 95.72 9.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 16.6 m-85 -87.3 -52.43 5.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.591 -0.693 . . . . 0.0 109.693 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.3 mtp -120.68 -172.65 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.654 -0.654 . . . . 0.0 110.187 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 p -120.12 179.72 0.85 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.88 13.25 2.8 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.154 2.569 . . . . 0.0 111.47 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -53.26 2.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -63.68 -16.03 59.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 110.153 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -56.72 -21.01 24.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.828 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -87.6 0.13 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.181 -0.95 . . . . 0.0 110.362 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -162.03 38.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.102 -0.999 . . . . 0.0 108.655 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.35 -20.72 24.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.89 -79.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -1.036 . . . . 0.0 110.52 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.36 88.26 25.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.95 -20.54 10.16 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 123.032 2.488 . . . . 0.0 110.622 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.1 128.64 40.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.65 -0.656 . . . . 0.0 109.852 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.85 172.73 17.94 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.2 m -140.16 136.59 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.382 -0.824 . . . . 0.0 109.399 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 mmp_? -133.86 -179.23 5.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 110.282 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 mtm -141.99 178.34 7.59 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.391 0.615 . . . . 0.0 109.675 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.5 m-85 -135.43 166.82 22.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.03 -153.86 5.99 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.79 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.1 Cg_endo -74.3 -27.93 10.99 Favored 'Trans proline' 0 N--CA 1.504 2.136 0 C-N-CA 123.58 2.853 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.87 -42.45 62.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.9 9.54 30.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 111.165 -179.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -116.36 122.19 44.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 108.536 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -50.0 134.49 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.783 -0.573 . . . . 0.0 110.77 -177.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -69.2 -41.09 77.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.557 -0.714 . . . . 0.0 109.357 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.47 78.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 110.508 -179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -93.17 -35.25 13.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.448 -0.783 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.704 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.62 -30.72 2.44 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.518 -0.739 . . . . 0.0 110.789 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 16.75 24.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.485 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' NE1' ' A' ' 125' ' ' TRP . 4.3 mmtm -96.77 132.11 42.81 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -66.06 103.66 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.191 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.443 ' NE1' ' HB2' ' A' ' 123' ' ' LYS . 69.8 m95 -108.09 150.03 27.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t0 -128.84 4.12 5.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.697 -0.627 . . . . 0.0 109.694 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.8 mtt180 -141.76 149.58 40.63 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.8 p -140.36 140.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.187 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD2' HG22 ' A' ' 46' ' ' VAL . 3.5 tttm -106.16 116.74 32.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.703 -0.623 . . . . 0.0 109.747 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.582 ' CD1' HG13 ' A' ' 70' ' ' VAL . 46.5 mm -107.59 111.55 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.581 HG13 ' OG ' ' A' ' 44' ' ' SER . 40.9 t -119.58 120.33 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.414 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.0 t -95.68 149.03 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -142.94 130.66 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.459 -0.775 . . . . 0.0 111.19 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.8 OUTLIER 149.48 129.07 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.751 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.406 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.24 100.38 0.7 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.831 2.354 . . . . 0.0 109.659 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.511 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 1.2 p90 -131.66 40.35 3.4 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.739 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 -168.84 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -106.84 -35.84 6.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.07 142.21 24.55 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.5 Cg_endo -85.93 -176.1 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.174 2.582 . . . . 0.0 110.82 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 178.76 -162.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.616 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.14 -112.89 0.56 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.471 -1.347 . . . . 0.0 111.099 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.6 mp -114.2 158.86 20.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.567 -0.961 . . . . 0.0 110.75 -178.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.422 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 2.4 m -97.62 -28.45 13.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 122.042 -0.411 . . . . 0.0 109.958 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 43.5 p90 -176.38 171.88 2.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.693 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 60' ' ' ILE . 20.7 m -150.17 137.6 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.695 -0.628 . . . . 0.0 109.493 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 11.3 mmm-85 -144.04 108.55 4.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.531 -0.731 . . . . 0.0 109.102 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 128' ' ' VAL . 56.1 m-85 -87.31 155.03 20.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.338 -0.852 . . . . 0.0 109.354 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.46 124.93 6.34 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.495 -0.753 . . . . 0.0 109.363 178.715 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.67 -0.644 . . . . 0.0 110.474 -179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 4.9 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.1 Cg_endo -82.15 -27.68 2.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.913 2.409 . . . . 0.0 110.473 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.36 168.47 11.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -142.27 146.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 167.04 15.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.933 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.669 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -95.61 136.8 35.54 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.722 -0.611 . . . . 0.0 109.461 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.602 ' N ' HD13 ' A' ' 6' ' ' LEU . 66.8 ttt180 -92.6 -56.42 3.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.805 . . . . 0.0 109.104 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.429 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 4.1 p-80 -161.33 162.99 31.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.3 p -79.14 91.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.534 HG12 ' C ' ' A' ' 47' ' ' LEU . 2.4 p -50.79 -55.99 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.317 -0.864 . . . . 0.0 110.47 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -122.14 153.37 38.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.415 -0.803 . . . . 0.0 109.372 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.74 120.36 17.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.424 -0.798 . . . . 0.0 109.509 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.8 m -123.56 42.02 3.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.806 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER 152.75 72.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.321 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.691 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -136.48 140.95 43.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.336 -0.852 . . . . 0.0 109.431 -179.052 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -165.92 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -101.74 -55.51 2.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -42.78 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -121.34 80.36 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.3 p -91.5 168.78 11.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.594 0.712 . . . . 0.0 110.042 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.12 -24.32 67.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.928 -0.483 . . . . 0.0 109.993 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -62.37 -18.54 61.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 109.835 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -65.37 -17.27 64.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' A' ' 147' ' ' VAL . 11.2 mt -64.91 -24.85 67.65 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.5 mm? -57.97 -22.46 49.29 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.498 -0.751 . . . . 0.0 109.039 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.2 65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.57 -24.41 13.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.394 -0.816 . . . . 0.0 110.406 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.33 81.36 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.634 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.4 p -158.1 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.437 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -177.84 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -158.39 167.7 28.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.553 -0.717 . . . . 0.0 109.446 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -160.32 -157.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.673 -0.642 . . . . 0.0 109.565 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 15.5 t90 -93.69 140.45 29.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.083 -1.01 . . . . 0.0 110.379 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -146.83 123.06 10.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.85 154.6 0.69 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.451 -0.781 . . . . 0.0 111.399 -178.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.66 -30.04 70.21 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -123.45 -172.1 2.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.73 -162.38 0.93 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.75 43.34 94.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 3.8 mm-40 -48.14 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.986 0.898 . . . . 0.0 111.364 -179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 42' ' ' THR . 8.8 pttp -111.62 -44.82 3.44 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.1 p -160.39 119.87 2.76 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.806 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.4 pt -128.02 147.39 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.507 -0.746 . . . . 0.0 109.355 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.584 ' OG ' HG22 ' A' ' 131' ' ' VAL . 31.5 m -128.23 147.6 50.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.661 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.0 p -154.29 117.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 128' ' ' VAL . 5.5 t -95.53 130.14 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.218 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.669 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.3 mt -102.61 167.4 9.94 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 12.2 tm0? -121.6 118.62 29.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.734 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.746 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -71.0 138.46 49.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -81.15 36.53 0.41 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.766 -0.584 . . . . 0.0 110.133 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 pttt 166.73 129.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.44 109.47 9.02 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.42 176.28 9.12 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.621 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -86.35 -174.24 4.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -141.26 130.29 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.741 . . . . 0.0 109.39 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.433 ' O ' HD21 ' A' ' 116' ' ' LEU . 4.6 t60 -119.57 -25.08 6.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -149.87 140.24 22.33 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' CD1' ' A' ' 149' ' ' PHE . 55.2 t -125.04 160.71 30.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.1 m-20 -140.74 135.06 31.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.506 -0.746 . . . . 0.0 109.416 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.4 mp -155.96 131.84 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -107.94 120.83 6.16 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.017 -1.564 . . . . 0.0 110.264 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.75 142.57 53.24 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.458 0.647 . . . . 0.0 111.11 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 23.8 t0 -127.13 56.25 1.53 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.96 12.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t -57.75 170.16 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -1.006 . . . . 0.0 109.73 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.764 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -135.16 -56.83 0.81 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.461 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 24.3 m-85 -100.04 133.41 44.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.281 179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.74 107.51 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.944 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -97.34 129.8 44.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.697 HG13 HD13 ' A' ' 130' ' ' ILE . 37.8 t -122.18 124.4 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.762 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.0 mp -110.61 163.0 14.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG21 HD13 ' A' ' 87' ' ' LEU . 2.8 m -126.67 160.18 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.15 177.52 46.13 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 t -116.25 158.69 22.95 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.069 -0.665 . . . . 0.0 109.44 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -80.23 3.56 20.43 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.806 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.37 157.04 3.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 110.114 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.02 104.12 0.69 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.08 -152.76 5.81 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 83' ' ' ASP . . . -67.54 -43.39 80.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.985 . . . . 0.0 109.481 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.4 -118.61 3.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -69.5 -25.07 63.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.947 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -97.27 35.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 109.64 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 11.6 t70 -133.48 36.99 3.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.71 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.6 m-85 -113.17 -176.26 2.86 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -129.06 132.16 47.41 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.258 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 71' ' ' LEU . 35.5 t -62.31 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.685 -0.634 . . . . 0.0 110.453 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 72' ' ' VAL . 12.0 tp -60.13 -51.68 68.57 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -142.44 123.55 14.57 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.802 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.63 -173.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.886 -0.509 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.74 125.64 25.41 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 86.9 p -99.6 121.95 41.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -88.76 121.45 31.15 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 23.5 m-85 -120.58 -43.67 2.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.422 -0.798 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 33.0 mtp -120.22 -178.1 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.487 -0.758 . . . . 0.0 110.509 -178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -115.29 177.16 1.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.05 11.9 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.201 2.601 . . . . 0.0 111.251 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.48 -54.15 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.337 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 3.6 pt-20 -61.04 -18.42 57.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 20.7 t -54.82 -36.09 64.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.756 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -72.14 -82.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.037 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -162.85 37.49 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.37 -22.41 47.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.48 -77.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.958 . . . . 0.0 110.409 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -117.18 88.82 28.69 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.8 Cg_endo -77.23 -19.87 13.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.976 2.451 . . . . 0.0 110.261 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -141.87 135.06 29.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.754 -0.591 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.02 150.51 18.74 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 13.0 m -106.83 165.13 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 110.2 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -154.12 156.05 36.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.261 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.7 mtp -127.95 166.9 17.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.721 -179.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 88' ' ' LEU . 3.1 m-85 -131.61 159.08 39.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -132.64 -149.42 6.22 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.57 -39.76 1.32 Allowed 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 123.738 2.959 . . . . 0.0 110.594 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.72 -27.13 68.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.715 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -91.5 3.1 55.8 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.641 -0.662 . . . . 0.0 110.547 -179.633 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.96 139.35 54.16 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.92 -1.112 . . . . 0.0 110.392 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.908 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.5 p -60.17 130.57 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.12 61.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.708 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -21.39 65.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.908 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.86 -46.58 2.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.95 -38.08 21.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.151 -0.968 . . . . 0.0 111.51 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -82.05 2.78 29.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.338 -0.851 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.5 mttt -93.7 134.9 35.53 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -66.51 113.65 4.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.443 -0.786 . . . . 0.0 110.546 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.498 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 73.6 m95 -117.78 162.85 17.4 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.64 14.15 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.147 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -148.72 151.22 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.912 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.5 p -141.85 145.21 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 110.367 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.57 117.58 34.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.486 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 70' ' ' VAL . 50.0 mm -107.93 119.19 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.599 -0.688 . . . . 0.0 109.534 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.584 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.2 t -128.09 119.94 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.137 -0.977 . . . . 0.0 110.687 -179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.466 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.93 148.15 23.3 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.47 126.65 14.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 111.199 -179.091 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.764 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.4 OUTLIER 150.23 134.58 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.416 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.42 97.85 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.995 2.463 . . . . 0.0 109.965 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.6 p90 -128.77 14.49 6.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.0 110.81 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.03 -166.33 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -176.27 -42.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -113.27 -33.09 6.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.71 -0.619 . . . . 0.0 109.676 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.27 149.84 38.18 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.891 -0.505 . . . . 0.0 109.693 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.413 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.9 Cg_endo -85.52 -178.63 3.1 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.372 2.715 . . . . 0.0 110.285 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 179.88 -164.1 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.541 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 156.03 -112.89 0.54 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -135.47 162.04 33.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.325 -1.103 . . . . 0.0 110.251 178.606 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 2.7 m -82.24 -18.52 42.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.809 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 179.88 163.37 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.32 -0.863 . . . . 0.0 109.92 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.77 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.8 m -140.54 142.25 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 5.0 mtm180 -147.63 165.01 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.744 0.783 . . . . 0.0 110.524 -178.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.912 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.7 m-85 -145.28 154.61 42.54 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -158.63 145.94 17.72 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.087 -1.008 . . . . 0.0 109.283 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 -179.255 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -89.64 20.96 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.661 2.908 . . . . 0.0 111.234 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -153.96 -170.83 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.904 . . . . 0.0 109.253 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 53' ' ' GLU . 48.4 mm -112.56 154.48 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -134.94 120.69 19.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.571 -0.706 . . . . 0.0 109.638 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 49' ' ' LEU . 1.2 mp -82.55 150.91 26.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.488 ' HD3' ' CD2' ' A' ' 8' ' ' HIS . 22.5 ttt180 -110.86 -53.28 2.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.488 ' CD2' ' HD3' ' A' ' 7' ' ' ARG . 4.1 p80 -160.69 166.24 29.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.655 -0.653 . . . . 0.0 109.511 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.68 89.65 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 11' ' ' SER . 2.6 p -50.32 -55.89 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.258 -0.901 . . . . 0.0 110.777 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -122.29 152.49 40.02 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.12 -179.497 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -144.27 121.82 11.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 109.813 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -118.25 45.52 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.639 -0.663 . . . . 0.0 109.878 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.8 OUTLIER 152.19 73.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.954 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.732 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -138.44 142.33 39.5 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.244 -0.91 . . . . 0.0 109.448 -179.026 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.38 -162.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.469 -0.769 . . . . 0.0 109.333 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -97.55 -57.9 2.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.58 -0.7 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -65.66 0.7 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -88.77 67.7 8.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -86.44 171.32 11.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 -179.512 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.61 -24.7 67.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.9 tt0 -61.02 -19.4 61.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 109.688 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -65.76 -16.68 64.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 109.323 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.9 mt -65.02 -25.66 67.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.5 mm? -58.17 -22.74 52.74 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 65.28 0.67 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.36 -24.69 8.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.352 -0.842 . . . . 0.0 110.528 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 29' ' ' THR . 44.4 m-20 -119.53 81.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.807 . . . . 0.0 109.816 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -155.4 -88.08 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.424 -0.798 . . . . 0.0 109.502 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 42.8 p90 -177.6 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.006 -1.059 . . . . 0.0 110.187 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 4.9 mtm180 -157.47 142.67 17.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.5 -0.75 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -126.72 -159.47 0.93 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.347 -179.393 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.4 t90 -94.32 139.33 31.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.238 -0.913 . . . . 0.0 109.433 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -144.41 129.39 18.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.17 156.08 1.18 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -67.38 -23.99 65.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.845 -0.534 . . . . 0.0 110.202 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -136.45 -173.72 3.49 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.52 -164.27 1.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.45 45.89 88.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.6 mt-10 -54.79 84.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.694 0.759 . . . . 0.0 111.142 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 42' ' ' THR . 42.1 tttm -91.29 -52.28 4.89 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' OG ' ' A' ' 133' ' ' SER . 16.0 p -159.09 121.9 3.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 35' ' ' ALA . 19.0 pt -120.23 151.47 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -129.11 150.36 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.437 178.885 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.851 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -155.16 107.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.5 t -91.39 118.44 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -95.26 153.29 17.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.611 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -104.25 134.09 48.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.673 . . . . 0.0 109.715 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 6' ' ' LEU . 33.0 mt -90.17 134.79 34.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.07 43.85 0.73 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 110.448 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 pttt 166.94 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -74.94 106.37 6.42 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -136.28 -178.33 5.11 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.025 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -96.48 175.48 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.75 120.34 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 116' ' ' LEU . 74.4 t60 -107.68 -31.33 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 7.4 m -146.15 155.12 42.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 69.6 t -138.39 157.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.666 . . . . 0.0 109.548 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.57 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.7 m-20 -139.44 138.38 36.41 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.57 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.2 mp -159.05 135.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -115.0 134.79 11.85 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 65' ' ' SER . 1.2 m-80 -112.5 151.46 29.92 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 122.149 -0.618 . . . . 0.0 110.707 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -102.12 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.23 24.83 29.65 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 178.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.436 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 59.6 m -77.35 -174.45 3.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.517 -0.99 . . . . 0.0 109.831 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -147.2 -57.53 0.26 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.6 m-85 -99.25 135.28 40.88 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.929 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 93' ' ' PHE . 86.1 t -141.74 109.21 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.479 0.656 . . . . 0.0 109.685 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -99.78 139.23 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 130' ' ' ILE . 18.5 t -124.4 124.28 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.461 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.32 164.06 14.04 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.3 m -128.67 160.69 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.689 -0.632 . . . . 0.0 109.817 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.446 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.23 175.86 43.02 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 t -113.83 158.46 20.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -89.57 11.3 20.0 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 107.92 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.26 -86.12 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.6 163.19 9.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 59.99 35.83 21.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.993 . . . . 0.0 109.67 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 98.94 2.5 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -115.89 -58.76 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.927 . . . . 0.0 109.412 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -98.92 32.14 2.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.661 -0.649 . . . . 0.0 109.401 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -124.49 38.05 4.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.482 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -108.05 -175.12 2.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -121.37 127.9 51.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.917 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.2 85.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.77 -0.581 . . . . 0.0 110.274 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.644 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -57.79 -53.88 53.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -143.81 122.66 12.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.257 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.35 -179.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 110.528 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 129.76 41.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.297 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 p -98.62 128.72 45.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 8.5 p -90.09 89.71 7.8 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.621 ' HE2' HG21 ' A' ' 68' ' ' VAL . 6.8 m-85 -73.45 -57.81 3.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.341 -0.85 . . . . 0.0 109.607 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.407 ' HE1' ' C ' ' A' ' 105' ' ' PRO . 3.2 mtm -121.3 -164.06 1.1 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.469 0.652 . . . . 0.0 110.187 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 5.8 p -130.64 -176.79 0.58 Allowed Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 41.6 Cg_endo -85.59 18.96 1.47 Allowed 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 123.086 2.524 . . . . 0.0 111.467 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.7 t -120.12 -40.71 2.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.12 -27.02 26.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 3.4 p -56.85 -22.26 35.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.512 -0.743 . . . . 0.0 110.475 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -83.87 -85.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.38 -0.825 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -163.01 38.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.37 -23.31 19.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.25 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.985 . . . . 0.0 110.579 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 3.6 p-10 -119.48 95.26 49.16 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.9 Cg_endo -82.45 -17.99 7.25 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.172 2.582 . . . . 0.0 110.155 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.47 128.93 30.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.787 -0.571 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.26 145.7 15.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 16.0 m -98.71 -179.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 109.983 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.76 148.49 17.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.867 . . . . 0.0 109.407 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.8 mtt -127.15 157.39 39.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.491 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 88' ' ' LEU . 1.8 m-85 -128.82 166.49 18.95 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.22 -150.63 5.79 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.4 Cg_endo -75.51 -37.86 1.62 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.747 2.965 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -65.58 -26.52 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.464 -0.773 . . . . 0.0 109.6 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -91.94 1.97 56.84 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.643 -0.661 . . . . 0.0 110.663 -179.759 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -121.57 138.93 54.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.956 -1.09 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.905 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.2 p -58.25 130.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 -30.98 61.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 109.602 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -21.56 66.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.22 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.905 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.93 -46.24 2.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.304 -0.873 . . . . 0.0 110.104 -179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.97 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.65 -40.49 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.138 -0.976 . . . . 0.0 111.583 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -0.16 31.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.266 -0.896 . . . . 0.0 110.528 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.7 mtpp -91.0 133.93 34.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.95 112.58 4.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.636 0.731 . . . . 0.0 110.804 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.495 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 75.8 m95 -115.43 165.44 12.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.35 10.25 3.22 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.491 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -144.45 149.08 35.42 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -134.47 142.46 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.909 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' A' ' 46' ' ' VAL . 8.6 tttt -109.65 113.33 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.655 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.9 mm -106.93 123.73 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 44' ' ' SER . 41.0 t -128.46 121.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.275 -0.891 . . . . 0.0 110.533 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.472 ' HB3' HG13 ' A' ' 43' ' ' ILE . 1.7 t -93.25 144.57 25.18 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.738 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.05 124.29 12.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 111.693 -178.473 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.6 OUTLIER 161.99 113.26 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.035 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.93 102.7 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.563 2.175 . . . . 0.0 110.305 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 134' ' ' GLN . 1.5 p90 -134.16 -9.06 2.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.539 -0.726 . . . . 0.0 112.137 -178.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -172.3 2.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.955 -1.091 . . . . 0.0 110.263 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -170.61 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.95 -31.9 6.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.66 -0.65 . . . . 0.0 109.683 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.67 148.08 37.04 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.845 -0.534 . . . . 0.0 109.719 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.91 -177.43 2.23 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.341 2.694 . . . . 0.0 110.539 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.49 -163.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.474 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 157.06 -128.09 2.08 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -119.59 162.38 19.04 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.354 -1.086 . . . . 0.0 110.17 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 m -84.91 -14.97 46.07 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 50.9 p90 171.65 169.05 0.09 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.204 -0.935 . . . . 0.0 109.936 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.783 HG22 ' HB3' ' A' ' 24' ' ' LEU . 29.5 m -141.1 143.32 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 41.6 mtm180 -149.57 167.31 26.69 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.6 m-85 -149.61 158.69 44.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.454 ' HE2' ' CG ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -155.04 123.18 5.87 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 0.0 109.74 179.386 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.721 ' CG2' HD12 ' A' ' 49' ' ' LEU . 40.2 mm -123.81 133.97 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.39 126.88 50.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.5 mp -79.57 155.14 28.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.141 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.01 -56.14 2.43 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -160.58 165.1 31.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.51 93.22 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.4 p -54.07 -54.61 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.24 -0.912 . . . . 0.0 110.339 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.78 150.99 40.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.484 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 p -137.9 121.19 16.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 m -124.47 41.54 3.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.537 -0.727 . . . . 0.0 109.407 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.672 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 154.4 73.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.81 140.63 29.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 108.744 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.49 -163.06 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 109.084 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -96.47 -63.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -57.57 10.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 18.5 m170 -98.16 77.64 2.44 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -97.11 169.32 9.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.813 0.815 . . . . 0.0 110.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.07 -23.98 67.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.925 -0.484 . . . . 0.0 109.777 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 9' ' ' VAL . 7.5 tt0 -60.38 -19.29 55.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -65.59 -16.47 63.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 0.0 109.28 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.2 mt -64.93 -26.6 68.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -61.2 -19.89 62.14 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.492 -0.755 . . . . 0.0 109.004 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -119.99 73.61 0.98 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . . . -44.86 -60.44 2.05 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.705 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.33 -116.34 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p 50.47 -107.78 0.3 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.818 -1.176 . . . . 0.0 109.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -179.02 37.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 109.92 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 0.4 OUTLIER -148.8 149.67 31.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.532 -0.73 . . . . 0.0 109.461 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 15.4 mttt -131.69 -161.22 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.716 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.9 t90 -90.65 140.53 29.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 109.096 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 132.06 26.18 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.29 155.52 3.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.419 -0.801 . . . . 0.0 110.124 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.69 -21.65 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.798 -0.564 . . . . 0.0 110.182 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -141.67 -174.18 3.99 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.325 -0.86 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.2 -164.56 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.44 46.37 92.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.467 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -54.39 83.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.429 0.633 . . . . 0.0 111.529 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -91.9 -44.59 8.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.825 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.7 p -161.39 134.13 6.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.716 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.9 pt -132.34 142.2 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.239 -0.913 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.591 ' OG ' HG22 ' A' ' 131' ' ' VAL . 19.8 m -126.82 147.79 50.0 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.515 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.794 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.6 p -156.05 118.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.789 HG22 ' HG3' ' A' ' 129' ' ' LYS . 14.7 t -97.57 125.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -103.32 150.89 23.34 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -93.19 146.25 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.3 mm? -101.12 123.97 46.1 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.45 -2.6 0.07 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.448 -0.783 . . . . 0.0 112.112 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.99 135.75 3.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 109.132 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -75.57 111.71 11.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CD ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -142.77 -177.98 5.58 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.297 0.57 . . . . 0.0 109.478 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.57 158.98 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.5 mp -113.08 124.07 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -113.83 -30.0 6.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 109.764 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.9 m -148.99 156.79 42.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 109.084 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 t -144.43 154.56 14.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.416 0.627 . . . . 0.0 109.833 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -139.15 101.64 4.32 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.565 HG23 HD23 ' A' ' 144' ' ' LEU . 5.0 mt -126.32 141.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -113.13 137.8 14.49 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -85.27 139.2 31.81 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 122.302 -0.528 . . . . 0.0 110.002 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -111.71 65.83 0.63 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.1 29.4 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 14.9 m -60.5 178.0 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.974 . . . . 0.0 110.152 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -135.94 -50.17 0.7 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -102.32 132.36 48.34 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.6 t -134.84 108.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.503 -0.748 . . . . 0.0 110.083 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -102.51 145.51 29.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG13 HD13 ' A' ' 130' ' ' ILE . 21.4 t -132.02 128.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.097 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 86' ' ' VAL . 3.0 mp -113.08 159.93 18.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 HD13 ' A' ' 87' ' ' LEU . 4.6 m -121.52 155.45 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.66 -0.65 . . . . 0.0 110.213 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.97 170.81 43.82 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 t -115.89 170.45 8.46 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.788 0.804 . . . . 0.0 110.144 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.4 p -76.24 -0.94 24.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 110.444 -179.67 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.255 0.55 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -119.66 151.72 38.26 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.73 144.22 40.02 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.352 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 71' ' ' LEU . 23.0 t -62.99 88.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.659 -0.651 . . . . 0.0 111.172 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG11 ' A' ' 72' ' ' VAL . 12.7 tp -61.16 -45.49 94.41 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.6 pp -146.58 124.83 12.21 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.39 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.613 ' O ' HD12 ' A' ' 88' ' ' LEU . 30.6 m -55.46 -175.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.726 -0.609 . . . . 0.0 110.118 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.58 133.31 45.66 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.54 -0.725 . . . . 0.0 109.404 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.1 p -98.26 125.07 43.19 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.2 p -91.48 102.97 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 23.7 m-85 -99.04 -47.02 5.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.375 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.442 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 51.2 mtp -120.08 -157.48 0.71 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.733 -0.604 . . . . 0.0 109.502 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 4.9 p -159.41 -170.86 0.26 Allowed Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 49.6 Cg_endo -81.8 8.48 4.43 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.742 1.628 . . . . 0.0 110.431 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -83.2 -37.55 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.39 -34.61 72.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 t -73.64 -7.27 51.29 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.69 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -109.0 -52.39 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.533 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -120.94 35.86 4.76 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.141 -0.975 . . . . 0.0 111.692 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.07 6.68 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.175 -0.953 . . . . 0.0 111.849 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.93 89.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 p30 48.99 82.03 0.25 Allowed Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.442 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.9 Cg_endo -77.49 -25.9 7.73 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 123.542 2.828 . . . . 0.0 110.977 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.8 109.39 10.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.143 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.1 169.87 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.8 m -138.37 165.73 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 0.0 109.51 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 161.89 33.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.027 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 mtm -123.25 164.47 18.68 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.311 0.577 . . . . 0.0 110.156 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.5 m-85 -132.26 101.78 5.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -80.13 -148.22 5.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.559 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.9 Cg_endo -75.05 -34.18 3.98 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.385 2.724 . . . . 0.0 110.759 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.18 -27.7 68.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.563 -0.711 . . . . 0.0 110.036 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 4.2 mtmt -94.48 4.3 54.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.657 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -126.95 142.71 51.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.953 -1.092 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.9 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -62.65 137.4 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -33.76 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.48 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.72 -22.9 67.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.738 . . . . 0.0 110.191 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.9 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -111.81 -46.99 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.373 -0.829 . . . . 0.0 110.199 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.17 -35.36 16.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.25 -0.906 . . . . 0.0 111.259 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 0.5 47.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 110.602 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.4 mttm -93.43 135.54 34.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -69.33 110.46 4.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 0.0 111.02 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.2 m95 -113.35 162.24 16.3 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.5 12.22 2.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.072 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.547 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.7 mtt180 -142.34 142.25 32.45 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.6 p -139.01 141.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.352 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.789 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.4 tttt -104.08 118.45 36.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.77 -0.581 . . . . 0.0 109.765 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 HG13 ' A' ' 70' ' ' VAL . 47.5 mm -107.33 119.34 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.591 HG22 ' OG ' ' A' ' 44' ' ' SER . 47.0 t -126.2 121.34 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.133 -0.98 . . . . 0.0 110.59 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.415 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -93.56 155.82 17.08 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.825 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -154.06 123.97 6.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.258 -0.901 . . . . 0.0 111.898 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' SER . 1.7 tm0? 162.04 114.88 0.01 OUTLIER Pre-proline 0 N--CA 1.503 2.198 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.05 103.4 1.74 Allowed 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 122.636 2.224 . . . . 0.0 110.361 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 134' ' ' GLN . 2.0 p90 -135.2 -19.39 1.72 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.518 -0.738 . . . . 0.0 112.291 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 -175.27 2.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 0.0 110.379 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -163.18 -43.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.18 -34.73 6.29 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.544 0.688 . . . . 0.0 109.457 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 143.16 26.04 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.69 -172.06 0.78 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.141 2.561 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 176.8 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.77 -121.39 1.02 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.859 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.565 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -114.17 158.39 21.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.752 -0.852 . . . . 0.0 110.1 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 4.1 m -92.49 -26.94 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 39.4 p90 -176.66 167.27 2.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 60' ' ' ILE . 27.2 m -147.02 122.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.691 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 14.6 mmm180 -132.54 110.0 10.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 110.205 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 128' ' ' VAL . 41.1 m-85 -88.8 154.77 20.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 108.787 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 122.72 8.6 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.668 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 151' ' ' SER . 78.2 mt -140.63 125.99 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -107.8 154.12 21.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.783 -0.573 . . . . 0.0 109.653 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.657 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.2 mp -89.52 152.53 21.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.748 -0.595 . . . . 0.0 109.508 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -102.02 -56.46 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -160.86 165.24 30.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -79.97 91.05 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 109.098 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -53.95 -57.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.183 -0.948 . . . . 0.0 110.405 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -118.4 147.15 43.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -132.11 133.69 44.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.01 38.76 3.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 109.82 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.573 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.73 74.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -134.87 147.57 49.9 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.5 149.54 24.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.409 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -60.27 -61.02 2.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.465 -0.772 . . . . 0.0 109.967 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.412 ' HB ' ' CD2' ' A' ' 19' ' ' HIS . 0.2 OUTLIER -59.2 -44.51 92.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 29.7 m-70 -118.74 84.67 2.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -95.8 167.26 11.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.595 0.712 . . . . 0.0 110.277 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.729 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.75 -23.34 67.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.32 -18.38 58.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.727 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -64.47 -18.67 64.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 147' ' ' VAL . 9.6 mt -65.29 -26.98 68.31 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -60.12 -20.9 60.53 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.529 -0.732 . . . . 0.0 109.089 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -107.31 62.95 0.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.39 -25.26 5.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.405 -0.809 . . . . 0.0 110.57 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t0 -118.46 81.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 109.831 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -156.54 -82.74 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.421 -0.8 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -177.88 -38.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.926 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -86.5 166.99 15.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.57 -0.706 . . . . 0.0 110.007 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.66 -160.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.724 ' CH2' HD12 ' A' ' 43' ' ' ILE . 18.6 t90 -81.74 139.67 34.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 19' ' ' HIS . 1.2 mtt180 -146.14 127.04 14.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.52 152.98 1.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.654 0.74 . . . . 0.0 111.041 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -61.56 -23.85 66.25 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.008 -0.433 . . . . 0.0 110.127 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 -174.93 3.95 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.992 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.58 -164.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.72 -0.612 . . . . 0.0 109.427 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.8 44.77 91.54 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 2.6 mm-40 -48.04 89.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.756 0.789 . . . . 0.0 111.625 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.1 tttm -97.69 -57.35 2.26 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.618 HG22 ' OG ' ' A' ' 133' ' ' SER . 41.0 p -155.85 122.57 5.26 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 33' ' ' TRP . 12.8 pt -124.03 147.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 131' ' ' VAL . 12.9 m -129.37 144.63 51.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.076 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.729 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.9 p -151.74 116.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.3 t -97.03 121.17 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.657 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 mp -104.03 149.97 24.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.38 156.73 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.644 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.453 HD12 ' CA ' ' A' ' 126' ' ' ASP . 48.6 mt -106.76 125.39 50.94 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -51.73 -9.3 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.381 -0.825 . . . . 0.0 112.253 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -161.11 140.64 10.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 0.0 109.138 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.2 111.48 10.49 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -145.73 178.72 7.94 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -85.51 -172.93 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.41 122.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.412 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -113.32 -28.45 7.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.2 m -149.29 160.69 43.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 63.4 t -146.38 160.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.326 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -131.55 130.74 42.67 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 59' ' ' ASP . 26.2 mm -139.31 118.42 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.41 116.46 4.33 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 24.3 m-80 -82.54 118.32 23.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.974 -0.721 . . . . 0.0 110.517 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 60.58 2.15 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.09 85.76 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.425 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 69.3 m -59.13 162.16 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -123.37 -55.84 1.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.7 m-85 -102.99 118.97 38.0 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.616 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 HG21 ' A' ' 60' ' ' ILE . 50.7 t -122.24 109.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.15 143.66 32.63 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.752 HG13 HD13 ' A' ' 130' ' ' ILE . 11.0 t -133.1 124.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.87 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -111.34 163.23 14.19 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.0 m -127.94 161.79 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.684 -0.635 . . . . 0.0 109.861 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 174.26 176.08 42.36 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -110.9 158.83 18.3 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 t -88.9 11.33 18.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.4 m-85 -88.84 -175.73 4.97 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -123.52 129.74 51.66 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -63.17 86.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.596 -0.69 . . . . 0.0 109.963 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 117' ' ' VAL . 24.6 tp -59.45 -59.59 5.21 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.549 HD11 HG23 ' A' ' 70' ' ' VAL . 1.5 pp -136.36 121.09 18.49 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.308 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.13 -179.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.697 -0.627 . . . . 0.0 110.602 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.69 131.77 46.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 p -99.31 117.52 33.93 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.775 -0.578 . . . . 0.0 109.764 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -75.02 69.43 1.93 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.443 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 36.4 t80 -59.48 -58.46 8.51 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.851 -0.53 . . . . 0.0 110.437 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 82.5 mtp -120.83 -177.19 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.737 0.78 . . . . 0.0 110.925 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.6 p -111.98 -179.43 0.64 Allowed Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.42 ' HB3' ' NE2' ' A' ' 134' ' ' GLN . 46.6 Cg_endo -86.02 12.24 3.09 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.999 2.466 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.8 p -120.77 -48.96 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 109.535 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.9 -7.33 50.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 87.4 p -83.21 -20.73 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.716 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -73.88 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 t -161.99 38.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 108.937 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.41 -24.19 6.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.49 117.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.443 -1.033 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.68 72.61 1.01 Allowed Pre-proline 0 N--CA 1.508 2.446 0 O-C-N 121.801 -0.562 . . . . 0.0 111.393 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 41.3 Cg_endo -79.27 -30.16 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.88 2.387 . . . . 0.0 109.958 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -128.06 112.45 14.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -168.25 2.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 67.1 t -121.29 163.04 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 108' ' ' VAL . 28.3 tpt180 -145.97 124.55 12.48 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtp -109.95 154.01 23.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -0.785 . . . . 0.0 110.5 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.495 ' HE1' ' CG1' ' A' ' 60' ' ' ILE . 7.9 m-85 -126.05 158.1 36.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 -149.95 6.74 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.24 -38.16 1.61 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.798 2.999 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.45 -29.17 69.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -89.08 3.26 52.37 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.672 -0.642 . . . . 0.0 110.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.23 139.76 53.44 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.039 -1.038 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.3 p -60.66 132.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -34.55 62.3 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.406 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.24 65.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 110.437 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.62 -47.29 2.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.014 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.01 -38.58 23.93 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.197 -0.939 . . . . 0.0 111.438 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.15 2.48 27.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.359 -0.838 . . . . 0.0 110.661 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 22.6 mttt -94.61 135.0 36.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -66.59 112.85 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.534 -0.729 . . . . 0.0 110.787 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 76.4 m95 -116.85 164.36 14.79 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' CA ' HD12 ' A' ' 49' ' ' LEU . 5.1 p-10 -137.27 9.66 2.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' HD2' HG11 ' A' ' 10' ' ' VAL . 15.3 mtm180 -143.18 145.33 32.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.4 p -135.41 143.42 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.924 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HG3' HG22 ' A' ' 46' ' ' VAL . 15.2 tttt -107.71 115.57 30.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.721 -0.612 . . . . 0.0 109.7 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.752 HD13 HG13 ' A' ' 70' ' ' VAL . 49.0 mm -105.4 117.6 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 0.0 109.286 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 44' ' ' SER . 46.5 t -125.01 117.8 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.111 -0.993 . . . . 0.0 110.429 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.44 ' HB3' HG13 ' A' ' 43' ' ' ILE . 10.9 t -92.46 148.66 21.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.1 123.97 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.525 -0.734 . . . . 0.0 111.466 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.7 134.11 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.403 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.86 98.2 0.5 Allowed 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.094 2.53 . . . . 0.0 110.207 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -129.77 2.98 4.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.357 -0.839 . . . . 0.0 111.373 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 -170.91 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.942 -1.099 . . . . 0.0 109.701 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -170.38 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.688 -0.632 . . . . 0.0 109.338 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -113.55 -36.25 4.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.694 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -103.04 143.53 26.78 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.39 174.53 5.06 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.236 2.624 . . . . 0.0 110.462 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.74 -164.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.33 -109.91 0.42 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.808 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.25 144.94 40.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.726 -0.867 . . . . 0.0 110.61 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -80.54 -28.72 37.22 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' A' ' 108' ' ' VAL . 48.8 p90 -177.56 174.8 1.49 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.567 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 24' ' ' LEU . 27.7 m -150.63 130.55 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -143.34 107.79 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.506 -0.746 . . . . 0.0 110.157 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 128' ' ' VAL . 83.1 m-85 -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.36 136.67 15.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.386 -0.821 . . . . 0.0 109.388 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.752 -0.593 . . . . 0.0 109.626 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.854 ' CG2' HD11 ' A' ' 49' ' ' LEU . 83.1 mt -128.62 128.21 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -115.39 171.1 7.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -0.856 . . . . 0.0 110.319 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 47' ' ' LEU . 3.1 mp -97.69 163.74 12.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.759 -0.588 . . . . 0.0 109.57 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.634 ' C ' HD11 ' A' ' 25' ' ' LEU . 6.3 ttt85 -121.84 -51.44 2.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -161.09 162.18 31.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.87 96.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.495 -0.753 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -54.37 -60.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.71 159.14 30.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.2 p -158.28 136.63 10.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.26 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 t -141.75 59.77 1.48 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.679 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 157.22 59.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-O 121.443 0.639 . . . . 0.0 109.965 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -139.23 144.14 38.32 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.72 -1.237 . . . . 0.0 110.34 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.84 174.63 6.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.249 -0.907 . . . . 0.0 109.193 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -74.25 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.534 -0.729 . . . . 0.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -58.37 8.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.016 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 9.7 m-70 -97.05 80.44 2.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -93.56 164.5 13.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.572 -0.705 . . . . 0.0 109.839 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.42 -21.08 66.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.869 -0.519 . . . . 0.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.05 -18.82 63.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.79 -18.12 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.868 . . . . 0.0 109.091 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.6 mt -65.13 -26.92 68.4 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.634 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.94 -20.58 58.26 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.493 -0.754 . . . . 0.0 109.003 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -115.18 68.55 0.71 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.3 -24.4 7.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.455 -0.778 . . . . 0.0 110.626 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.46 86.51 2.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.922 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 -83.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 0.0 109.427 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.9 p90 -177.8 -37.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 16.7 tpp85 -86.43 134.6 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.36 -0.837 . . . . 0.0 109.995 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -114.62 -171.86 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.48 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -84.96 142.21 29.8 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.535 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -147.8 130.39 15.89 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.688 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.27 153.02 1.6 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.44 -0.787 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.76 -19.79 52.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.951 -0.468 . . . . 0.0 110.315 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 -171.21 3.16 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.359 -0.838 . . . . 0.0 108.933 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.23 -172.4 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 48.97 77.03 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 35' ' ' ALA . 79.1 mm-40 -34.11 -88.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp 72.02 -60.07 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.531 -0.731 . . . . 0.0 109.109 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.635 HG22 ' OG ' ' A' ' 133' ' ' SER . 40.8 p -155.41 138.84 15.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 ' CH2' ' A' ' 33' ' ' TRP . 1.4 pt -145.73 140.73 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.55 -0.719 . . . . 0.0 109.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 4.2 m -122.08 131.13 53.82 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.594 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.655 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -136.89 116.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.1 t -95.88 116.76 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.232 -0.918 . . . . 0.0 108.974 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.684 HD22 HD21 ' A' ' 6' ' ' LEU . 1.1 mp -101.11 157.02 17.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.641 -0.662 . . . . 0.0 109.76 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -96.3 163.56 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.691 -0.631 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.854 HD11 ' CG2' ' A' ' 4' ' ' ILE . 11.5 tp -108.52 124.78 50.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.84 2.59 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 112.471 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -175.97 134.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.657 -1.277 . . . . 0.0 108.93 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -74.79 111.0 9.55 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.644 0.735 . . . . 0.0 110.108 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -172.85 4.26 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' O ' HD11 ' A' ' 4' ' ' ILE . 14.4 mt-30 -90.61 -178.36 5.27 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -141.92 127.06 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.657 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.472 ' HA ' HD21 ' A' ' 116' ' ' LEU . 13.1 t-160 -115.82 -32.03 5.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.1 m -141.09 159.34 42.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.673 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.3 t -140.21 163.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 m-20 -140.23 127.53 21.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.691 . . . . 0.0 109.519 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 59' ' ' ASP . 1.1 mp -145.21 139.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -98.53 126.88 9.05 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.12 126.19 30.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.066 -0.667 . . . . 0.0 110.231 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.32 63.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 108.839 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.58 -31.47 8.31 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.7 p -62.21 173.39 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.914 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -141.83 -53.45 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -93.61 125.69 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.265 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.87 113.07 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.003 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.0 121.97 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.766 ' CG2' HD12 ' A' ' 88' ' ' LEU . 31.5 t -113.74 127.75 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 110.223 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.1 mp -118.35 162.56 18.09 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 87' ' ' LEU . 3.4 m -131.19 159.79 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.432 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.97 178.1 45.51 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 t -117.84 156.59 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.2 p -84.53 6.26 24.38 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.471 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.91 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.8 m-85 -108.55 -175.01 2.66 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -120.98 126.14 49.19 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -61.58 85.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 0.0 110.422 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.909 HD13 HG21 ' A' ' 72' ' ' VAL . 6.5 tp -59.59 -61.14 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.766 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -121.9 130.1 53.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -68.73 -171.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 116.93 5.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 p -99.26 112.93 24.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -81.96 123.41 28.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 13.1 m-85 -116.61 -46.94 2.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -121.01 -166.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.523 0.678 . . . . 0.0 110.21 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 p -124.0 178.86 1.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.33 18.76 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.307 2.672 . . . . 0.0 111.433 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 m -120.28 -54.88 2.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' CG ' ' HB2' ' A' ' 103' ' ' SER . 0.5 OUTLIER -56.98 -28.01 61.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.478 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 10.9 m -50.09 -25.36 3.39 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.477 -0.764 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -80.95 -87.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.466 -0.771 . . . . 0.0 109.814 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 t -163.44 37.73 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.96 -22.56 38.25 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -170.41 -86.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -1.038 . . . . 0.0 110.647 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.6 34.84 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.16 -23.9 20.74 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.797 2.331 . . . . 0.0 109.994 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -134.46 141.54 46.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 -163.99 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 72.5 t -136.88 154.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.12 150.58 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 108.908 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.2 mtm -129.21 171.93 11.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.292 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.6 m-85 -130.56 169.71 15.23 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.829 0.823 . . . . 0.0 109.566 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.82 -154.05 6.03 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.192 -2.363 . . . . 0.0 107.192 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -74.27 -26.78 12.13 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.527 2.818 . . . . 0.0 110.843 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -53.37 -41.84 66.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.656 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.89 15.88 23.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -121.97 118.99 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -46.5 126.97 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.979 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -64.52 -39.5 93.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.431 -0.793 . . . . 0.0 109.4 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.89 91.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.497 -0.752 . . . . 0.0 110.663 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -88.39 -36.39 16.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.324 -0.86 . . . . 0.0 109.188 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.701 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.07 -42.76 6.4 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.64 -0.663 . . . . 0.0 111.361 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.22 11.43 30.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.981 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -92.25 130.14 38.03 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -66.32 108.81 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -0.756 . . . . 0.0 110.113 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 68.6 m95 -116.47 163.32 16.23 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 4.5 p-10 -140.15 15.1 2.43 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.103 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -147.75 149.84 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.4 p -141.58 144.15 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.974 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.663 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.2 tttt -105.77 134.97 48.03 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HG13 ' A' ' 45' ' ' VAL . 46.9 mm -128.59 107.92 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.475 -0.765 . . . . 0.0 109.236 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.0 t -112.24 109.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.211 -0.93 . . . . 0.0 109.921 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.423 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.63 154.27 28.81 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.4 OUTLIER -157.06 120.94 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 -178.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 5.2 tp60 171.41 135.04 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.5 100.78 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.928 2.419 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 38.0 p90 -147.27 15.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 111.483 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.39 -173.38 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.051 -1.031 . . . . 0.0 110.072 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -177.96 -39.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -116.05 -32.23 5.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.656 -0.653 . . . . 0.0 110.141 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.5 146.05 32.52 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.78 -0.575 . . . . 0.0 109.875 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.2 Cg_endo -87.48 171.81 6.12 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.417 2.745 . . . . 0.0 110.614 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -178.95 -166.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 158.01 -106.75 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.084 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.6 mp -120.12 155.02 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.962 . . . . 0.0 110.849 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 m -88.35 -27.47 21.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.0 p90 -177.1 170.48 2.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.2 m -146.99 142.06 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 21.1 mtm180 -150.56 166.14 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.664 . . . . 0.0 109.534 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.823 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.7 m-85 -141.59 158.19 44.15 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.32 128.54 8.28 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.01 -1.056 . . . . 0.0 110.338 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.424 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -138.67 128.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 168.87 9.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.627 -0.671 . . . . 0.0 110.017 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.691 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.4 mp -103.26 156.29 17.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.706 -0.622 . . . . 0.0 109.755 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' C ' HD11 ' A' ' 25' ' ' LEU . 1.4 tpt180 -109.8 -52.0 2.82 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.93 168.41 24.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -84.01 93.8 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.252 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.7 p -52.99 -59.99 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.243 -0.91 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.524 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.14 153.03 36.78 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -138.59 133.7 32.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.728 . . . . 0.0 109.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.95 42.64 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.702 . . . . 0.0 109.679 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.08 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.926 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -131.11 132.91 45.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.46 152.51 34.19 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -62.48 -62.16 1.94 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -0.767 . . . . 0.0 109.804 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -61.51 2.43 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 34' ' ' ARG . 43.3 m-70 -93.15 85.06 4.94 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 p -98.28 167.24 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.507 0.67 . . . . 0.0 110.236 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.51 -23.63 66.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.761 -0.587 . . . . 0.0 109.969 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.36 -19.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.239 -0.913 . . . . 0.0 109.774 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -65.5 -17.79 64.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.157 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.12 -25.41 67.76 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.472 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -57.61 -23.09 49.11 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 65.31 0.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.32 -24.95 8.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.783 . . . . 0.0 110.537 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' THR . 6.3 m-20 -120.47 82.81 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 109.758 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -157.02 -85.28 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.501 -0.749 . . . . 0.0 109.398 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -177.48 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.138 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -160.82 142.12 11.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.346 -0.846 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -169.04 1.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.735 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.6 t90 -80.54 136.74 36.33 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.6 mtp180 -142.1 125.69 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.736 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -55.51 169.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.765 0.793 . . . . 0.0 111.018 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -101.57 -22.71 14.42 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.988 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.9 -153.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.14 -174.35 4.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.059 -1.025 . . . . 0.0 109.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 89.75 -13.5 64.14 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 12.6 mt-10 46.08 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.41 -1.053 . . . . 0.0 112.013 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -133.41 -72.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.439 HG22 ' OG ' ' A' ' 133' ' ' SER . 31.1 p -153.91 139.5 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.736 HG21 ' HB2' ' A' ' 35' ' ' ALA . 8.9 pt -134.1 149.56 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.597 ' OG ' HG22 ' A' ' 131' ' ' VAL . 30.9 m -126.53 140.42 52.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.398 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -148.41 121.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.681 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.4 t -101.31 120.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.5 mp -98.08 168.63 10.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.631 . . . . 0.0 109.985 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -111.39 142.76 43.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.803 -0.561 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD23 HD12 ' A' ' 6' ' ' LEU . 60.8 mt -97.07 135.26 39.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.63 37.89 0.36 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.48 -0.762 . . . . 0.0 111.262 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 pttt 165.58 127.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.39 108.12 9.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.806 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -178.6 5.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -87.34 -172.63 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.41 122.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.519 -0.738 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.3 t-160 -109.41 -32.09 7.29 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.3 m -146.88 153.53 40.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 149' ' ' PHE . 70.5 t -137.51 158.7 34.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.674 -0.641 . . . . 0.0 109.564 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.517 ' O ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -137.2 138.55 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.706 HG23 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -159.72 139.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -122.99 135.77 10.21 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -91.77 151.56 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.152 -0.617 . . . . 0.0 109.9 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.32 34.47 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.86 -17.14 8.21 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.518 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -60.78 -171.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -1.079 . . . . 0.0 110.449 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.96 -40.88 0.84 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.48 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.05 140.43 39.87 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.509 -0.744 . . . . 0.0 111.322 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 93' ' ' PHE . 61.9 t -143.3 112.44 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.667 -0.645 . . . . 0.0 109.61 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.25 147.3 27.22 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.68 -0.638 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.27 131.55 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.897 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -117.32 167.34 11.32 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.72 HG23 ' HG2' ' A' ' 85' ' ' GLU . 5.6 m -130.61 159.0 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.703 -0.623 . . . . 0.0 109.568 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 176.31 173.8 42.27 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 t -115.62 161.07 19.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.601 0.715 . . . . 0.0 109.58 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -80.34 3.75 20.11 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.803 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.154 -0.966 . . . . 0.0 110.143 -179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.54 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -109.26 -175.54 2.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.72 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -121.11 127.4 51.57 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.39 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.759 -0.588 . . . . 0.0 110.17 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' CG1' ' A' ' 72' ' ' VAL . 15.3 tp -57.96 -50.65 72.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.67 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -146.6 124.07 11.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -59.01 173.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -56.08 131.32 47.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -103.46 132.9 49.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 99.9 p -90.18 107.4 19.11 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 68' ' ' VAL . 7.2 m-30 -89.29 -51.36 5.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.418 -0.801 . . . . 0.0 109.691 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 mtp -120.89 -178.92 3.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.754 0.788 . . . . 0.0 110.519 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -99.98 179.63 1.0 Allowed Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -86.98 18.45 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.128 2.552 . . . . 0.0 111.445 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -120.31 -53.52 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.49 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -58.11 -18.99 28.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.452 -0.78 . . . . 0.0 110.635 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.4 t -49.04 -26.54 2.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.334 -0.854 . . . . 0.0 110.455 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -85.66 -85.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 t -164.06 37.47 0.08 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.36 -19.84 68.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.06 -83.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.42 -1.047 . . . . 0.0 110.686 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.6 p30 -111.84 82.15 3.88 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.78 -19.23 27.68 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.824 2.349 . . . . 0.0 110.776 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 127.79 40.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 109.567 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -157.73 176.69 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 17.4 m -134.57 -173.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.535 -0.728 . . . . 0.0 109.41 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -160.66 148.91 16.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.646 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtm -126.69 151.93 47.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.836 -0.54 . . . . 0.0 109.731 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' HD13 ' A' ' 88' ' ' LEU . 3.6 m-85 -122.57 165.68 16.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.42 -148.3 5.3 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.6 Cg_endo -75.01 -40.19 0.97 Allowed 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 123.727 2.951 . . . . 0.0 111.152 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.2 -27.76 68.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.742 . . . . 0.0 109.782 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtmm -92.02 3.36 55.41 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.666 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.79 139.37 54.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.037 -1.04 . . . . 0.0 110.45 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.9 p -59.63 129.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -74.29 -32.48 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.558 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.0 -22.44 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 110.189 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.2 -47.07 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 110.152 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.949 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.99 19.39 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.099 -1.001 . . . . 0.0 111.63 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.52 2.23 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.368 -0.832 . . . . 0.0 110.707 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 27.6 mttt -93.51 136.02 34.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.19 113.22 4.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.413 -0.804 . . . . 0.0 110.546 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.8 m95 -116.94 164.53 14.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -139.86 14.82 2.49 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.065 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.401 ' HD3' HG21 ' A' ' 10' ' ' VAL . 6.7 mtt180 -144.38 146.95 32.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.0 p -138.19 140.78 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.036 -1.065 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.681 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -100.33 142.93 31.12 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.667 ' CD1' HG13 ' A' ' 70' ' ' VAL . 37.6 mm -138.24 107.51 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.597 HG22 ' OG ' ' A' ' 44' ' ' SER . 44.0 t -115.46 120.62 65.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 O-C-N 121.293 -0.879 . . . . 0.0 109.874 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 144' ' ' LEU . 2.2 t -94.22 150.71 20.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -155.1 143.02 20.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.09 -1.006 . . . . 0.0 112.206 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.4 tp60 148.53 113.1 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.34 123.32 4.38 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.679 2.253 . . . . 0.0 110.562 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.563 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -146.78 6.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.165 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 -175.19 4.79 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.347 -1.471 . . . . 0.0 111.345 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 58.8 mmtt -137.03 -30.16 0.88 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.828 -0.545 . . . . 0.0 110.912 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.08 -9.01 6.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.798 -1.189 . . . . 0.0 111.924 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.56 148.97 37.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.947 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.11 -161.45 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 123.927 3.085 . . . . 0.0 110.632 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p90 -178.69 -160.32 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 43' ' ' ILE . . . 157.31 -165.37 33.32 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.283 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.706 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -99.27 150.58 21.95 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.063 -0.669 . . . . 0.0 109.569 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 p -76.79 -30.71 56.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 49.6 p90 -175.13 168.9 3.38 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.735 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.9 m -138.65 157.31 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 14.3 mtt180 -160.06 159.74 32.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.627 -0.67 . . . . 0.0 110.269 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.884 ' CE2' HG11 ' A' ' 128' ' ' VAL . 58.2 m-85 -150.38 153.4 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.95 142.91 18.97 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.15 -0.968 . . . . 0.0 110.107 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' OE1' ' A' ' 53' ' ' GLU . 96.0 mt -139.15 130.16 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 167.27 10.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 109.632 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.779 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.2 mp -98.53 160.82 14.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.701 -0.624 . . . . 0.0 109.424 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.717 ' C ' HD11 ' A' ' 25' ' ' LEU . 7.2 tpt180 -116.78 -46.01 2.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -161.19 -171.88 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.706 -0.621 . . . . 0.0 109.422 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -106.48 90.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 109.258 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 11' ' ' SER . 1.4 p -52.25 -62.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.206 -0.934 . . . . 0.0 110.55 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.551 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -118.55 155.1 31.48 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 24.5 p -161.53 126.47 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.748 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -137.61 68.18 1.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.4 p 153.4 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.777 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -122.34 144.0 49.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.978 -1.076 . . . . 0.0 110.765 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -94.12 -168.37 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -68.73 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.444 -0.785 . . . . 0.0 109.825 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.82 65.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.0 71.41 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.4 p -89.81 169.56 11.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.734 . . . . 0.0 109.705 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.777 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -62.6 -25.18 67.95 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.668 -0.645 . . . . 0.0 109.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.4 -19.69 56.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.846 . . . . 0.0 109.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -64.72 -19.94 66.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.102 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 47' ' ' LEU . 8.5 mt -65.83 -25.78 67.37 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.717 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -59.53 -20.82 58.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.43 -0.794 . . . . 0.0 109.014 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.24 73.08 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.26 -47.73 55.07 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.517 -0.739 . . . . 0.0 110.684 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.61 75.96 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.482 -0.761 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -161.57 31.18 0.13 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.632 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.6 p90 47.15 25.57 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.315 0.579 . . . . 0.0 111.658 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -119.89 135.12 55.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.235 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 32.1 mttt -126.96 -178.63 4.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.82 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -94.43 137.25 33.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -139.78 128.12 22.68 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.93 164.72 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.424 -0.797 . . . . 0.0 110.327 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -72.4 -22.42 61.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.793 -0.567 . . . . 0.0 110.531 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.23 176.58 8.57 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.354 -0.841 . . . . 0.0 109.063 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.34 -176.06 5.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.71 -48.84 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 11.9 mp0 40.09 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.021 -0.694 . . . . 0.0 112.367 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 42' ' ' THR . 8.2 ptpt -103.21 -43.35 5.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.676 HG22 ' OG ' ' A' ' 133' ' ' SER . 3.0 p -160.49 106.34 1.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.82 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -107.32 136.66 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.497 -0.752 . . . . 0.0 110.5 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' OG ' ' A' ' 14' ' ' SER . 55.6 p -115.61 134.98 54.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.38 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -142.3 101.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.0 t -90.33 118.16 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 108.965 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -103.02 166.37 10.48 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -107.92 157.49 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.671 -0.643 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.02 124.44 49.63 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.1 -7.31 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.391 -0.818 . . . . 0.0 112.297 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -161.8 140.99 9.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.731 -1.23 . . . . 0.0 109.414 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.27 109.32 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.509 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -143.74 175.9 9.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.59 -172.5 4.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.9 121.68 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -110.13 -30.55 7.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.2 m -146.03 154.69 42.15 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.76 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.9 t -137.9 158.67 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.706 ' C ' HD12 ' A' ' 60' ' ' ILE . 12.1 t0 -133.05 134.84 44.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.308 -0.87 . . . . 0.0 110.579 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.946 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -149.7 125.96 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.65 117.04 5.55 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.9 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.849 -0.795 . . . . 0.0 109.881 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -123.15 82.63 2.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.52 80.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 4.9 p -98.4 178.64 4.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -1.123 . . . . 0.0 109.824 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -140.07 -47.56 0.44 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.515 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -109.3 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.172 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 60' ' ' ILE . 42.7 t -132.65 114.05 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.44 150.86 26.29 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.614 HG13 HD13 ' A' ' 130' ' ' ILE . 34.3 t -140.71 127.14 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.586 0.708 . . . . 0.0 110.079 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 3.6 mp -113.85 160.89 18.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 87' ' ' LEU . 2.4 m -125.41 155.55 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.55 -0.719 . . . . 0.0 110.151 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.19 169.69 42.77 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -119.92 165.43 14.64 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.723 0.773 . . . . 0.0 110.014 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -69.91 -9.36 54.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.264 -179.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 3.6 m-85 59.24 165.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.554 -0.717 . . . . 0.0 109.282 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -101.69 129.63 47.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.1 86.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.798 -0.563 . . . . 0.0 110.373 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 72' ' ' VAL . 10.3 tp -59.98 -52.59 64.76 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.385 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -57.55 172.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.561 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -58.01 135.01 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.592 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 5.9 p -108.33 130.94 55.18 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.447 0.641 . . . . 0.0 109.64 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -85.91 123.28 31.07 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 25.6 m-85 -123.05 -46.4 2.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 mtp -120.82 -165.7 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.702 -0.624 . . . . 0.0 109.872 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.9 p -126.58 175.77 3.03 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.56 15.42 2.15 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.31 2.674 . . . . 0.0 111.285 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 t -120.17 -42.13 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 109.337 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.09 -20.54 40.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 110.58 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.1 m -50.22 -25.98 4.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.273 -0.892 . . . . 0.0 110.765 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -85.12 -87.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.947 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -163.64 37.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.35 56.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.38 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.476 -1.014 . . . . 0.0 110.722 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.97 92.78 47.01 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 38.6 Cg_endo -73.04 -23.54 18.24 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.615 2.21 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.97 143.54 51.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -148.2 -174.5 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.432 -0.792 . . . . 0.0 110.422 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 70.4 t -148.75 142.44 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -153.26 145.99 24.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.863 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.2 mtm -125.78 152.58 45.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 88' ' ' LEU . 6.7 m-85 -113.02 159.06 19.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -128.19 -149.6 7.06 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.67 -39.27 1.43 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.76 2.973 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.74 -28.31 68.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 42.8 mttt -89.5 3.82 51.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.661 -0.649 . . . . 0.0 110.592 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -124.7 139.81 53.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.098 -1.001 . . . . 0.0 110.442 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.903 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.1 p -60.3 132.35 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -74.86 -34.36 62.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.23 -20.45 65.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.903 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.55 -47.94 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.1 -41.02 25.16 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.217 -0.927 . . . . 0.0 111.617 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -2.18 33.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.4 mttm -90.98 133.63 35.13 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -65.71 113.11 4.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 110.392 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.468 ' CZ2' ' HG3' ' A' ' 85' ' ' GLU . 83.3 m95 -116.17 163.46 15.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.9 7.65 2.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.608 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.24 136.93 35.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.889 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.0 p -127.75 143.93 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.664 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.641 ' HG3' HG22 ' A' ' 46' ' ' VAL . 3.4 tttt -111.6 111.07 21.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.0 109.653 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.614 HD13 HG13 ' A' ' 70' ' ' VAL . 49.4 mm -101.77 128.3 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.09 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.25 117.74 41.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.15 142.39 27.35 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -140.15 127.83 21.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.387 -0.821 . . . . 0.0 111.162 -177.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 150.03 137.95 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.042 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.78 101.48 0.78 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.107 2.538 . . . . 0.0 110.319 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.61 -60.62 2.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.4 -0.812 . . . . 0.0 108.889 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.88 160.59 22.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -106.11 26.61 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.54 -0.725 . . . . 0.0 110.084 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -54.24 2.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 p -116.47 155.33 48.73 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 122.008 -0.433 . . . . 0.0 109.874 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.409 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.1 Cg_endo -83.73 166.18 13.54 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.459 2.772 . . . . 0.0 109.724 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -169.76 -163.02 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 160.89 -106.56 0.29 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -132.45 161.87 32.59 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.212 -1.17 . . . . 0.0 110.189 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 25.3 m -83.43 -17.69 41.26 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.036 -0.415 . . . . 0.0 110.916 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.6 p90 175.88 179.31 0.17 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.232 -0.918 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 144' ' ' LEU . 35.3 m -154.66 128.24 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 150' ' ' HIS . 11.8 mtm180 -140.88 110.79 6.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.277 -0.89 . . . . 0.0 110.562 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.889 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.3 m-85 -88.64 158.57 18.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.412 -0.805 . . . . 0.0 108.859 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -156.07 139.59 15.89 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.293 -0.88 . . . . 0.0 109.512 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' SER . 40.3 mm -125.3 146.64 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -140.69 134.93 31.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 149' ' ' PHE . 4.3 mm? -85.83 144.63 27.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 109.162 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -94.67 -50.94 4.94 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -160.83 167.78 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -78.67 89.95 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.6 p -50.29 -58.94 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.292 -0.88 . . . . 0.0 110.427 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.52 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.47 158.92 31.69 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.5 p -153.42 136.34 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.675 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -130.01 46.74 2.6 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 154.56 94.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 123.075 0.55 . . . . 0.0 109.624 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.37 146.0 15.05 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.953 -1.092 . . . . 0.0 109.445 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.52 -168.11 1.56 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 -60.21 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 109.522 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -61.15 2.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.801 . . . . 0.0 108.918 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -97.11 77.54 2.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.9 p -90.2 168.26 12.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.576 -0.702 . . . . 0.0 109.937 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.35 -23.72 67.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.65 -17.92 61.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.791 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -65.01 -20.16 66.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.212 -0.93 . . . . 0.0 109.277 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.757 HD21 ' HB2' ' A' ' 33' ' ' TRP . 12.0 mt -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -61.56 -20.16 62.96 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -109.44 64.07 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.6 7.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 0.0 110.563 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 29' ' ' THR . 18.9 t70 -118.65 80.43 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.1 p -155.13 -84.03 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.494 -0.754 . . . . 0.0 109.612 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.7 p90 -179.23 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -79.53 148.85 31.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.391 -0.818 . . . . 0.0 109.772 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 12.4 mttp -127.42 -165.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.639 -0.663 . . . . 0.0 109.541 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.791 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.8 t90 -91.73 141.77 28.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -144.83 126.88 15.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.04 151.71 4.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.76 . . . . 0.0 110.402 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.72 -24.28 67.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.939 -0.475 . . . . 0.0 110.288 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -138.48 -173.22 3.48 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.352 -0.843 . . . . 0.0 109.285 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.15 -163.92 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.785 -0.572 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.07 45.76 95.43 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -47.71 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.582 0.706 . . . . 0.0 111.557 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 42' ' ' THR . 30.3 tttt -93.47 -56.68 2.84 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.673 HG22 ' OG ' ' A' ' 133' ' ' SER . 23.8 p -156.94 113.77 3.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.791 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.9 pt -114.61 132.22 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.573 -0.704 . . . . 0.0 109.874 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -114.57 146.71 40.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.504 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.7 p -147.74 112.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 129' ' ' LYS . 4.6 t -95.54 119.33 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 108.946 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.56 ' C ' HG12 ' A' ' 10' ' ' VAL . 1.5 mp -99.25 160.37 14.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.777 -0.577 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.422 ' N ' HD12 ' A' ' 6' ' ' LEU . 12.6 tm0? -111.85 125.97 54.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.5 -0.75 . . . . 0.0 109.905 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' OE2' ' A' ' 53' ' ' GLU . 14.2 mt -80.15 136.04 36.43 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 41.34 0.61 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.594 -0.691 . . . . 0.0 110.405 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 pttm 164.8 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -75.61 107.45 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.571 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -136.6 179.79 6.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.494 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -94.94 162.96 13.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -117.27 126.41 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.311 -0.868 . . . . 0.0 109.918 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.454 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.2 t60 -116.97 -30.19 5.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.694 -0.629 . . . . 0.0 109.849 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.5 m -148.98 158.73 44.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 0.0 108.876 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.71 HG12 HD12 ' A' ' 60' ' ' ILE . 61.3 t -147.82 161.32 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.804 0.811 . . . . 0.0 110.447 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -136.07 134.68 38.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.71 HD12 HG12 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -153.18 130.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -103.88 125.81 8.55 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -83.68 127.59 33.89 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.247 -0.561 . . . . 0.0 110.281 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.06 50.4 1.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.75 -24.23 24.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 29.1 t -57.12 161.39 3.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.386 -1.067 . . . . 0.0 109.919 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -121.83 -51.79 2.02 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.813 -0.554 . . . . 0.0 109.601 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -96.25 126.59 41.57 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.176 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.19 111.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.596 -0.69 . . . . 0.0 109.734 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -106.29 146.76 29.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.737 -0.602 . . . . 0.0 109.553 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 130' ' ' ILE . 6.7 t -131.13 125.13 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -111.71 157.03 20.97 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -121.55 154.91 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 109.771 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.77 171.22 41.77 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 t -109.63 161.66 15.17 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 122.037 -0.684 . . . . 0.0 109.242 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.413 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 23.1 p -86.13 6.73 27.88 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.763 -179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.97 -174.53 2.55 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -121.73 127.88 51.17 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.416 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.0 t -61.16 88.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.652 ' HB2' HG13 ' A' ' 72' ' ' VAL . 18.1 tp -59.65 -60.74 3.36 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 111' ' ' PHE . 2.0 pp -135.85 119.78 17.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.346 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.2 m -51.34 174.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.756 . . . . 0.0 110.278 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.13 133.59 53.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.509 -0.744 . . . . 0.0 109.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.7 p -102.88 122.26 44.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.5 p -87.01 108.31 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 24.2 m-85 -93.48 -51.93 4.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.71 -0.619 . . . . 0.0 109.922 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.45 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 9.3 mtp -122.11 -167.9 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.658 0.742 . . . . 0.0 110.452 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.8 p -109.32 175.64 1.87 Allowed Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.46 10.65 3.63 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.897 2.398 . . . . 0.0 111.332 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -121.44 -35.57 3.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.61 -0.38 53.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 110.671 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 60.1 m -74.19 -30.54 62.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -68.37 -77.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -161.96 38.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.23 -24.74 6.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.54 120.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 109.981 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.2 68.63 2.15 Favored Pre-proline 0 N--CA 1.509 2.499 0 O-C-N 121.975 -0.453 . . . . 0.0 111.551 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -76.83 -30.38 4.73 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.877 2.385 . . . . 0.0 110.233 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.93 99.23 5.21 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -164.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 109.404 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -148.8 151.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 5.1 mmt180 -144.45 166.15 25.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.3 mtm -139.68 175.02 9.93 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.535 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 88' ' ' LEU . 7.5 m-85 -134.36 169.04 17.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -141.49 -151.48 5.56 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.3 Cg_endo -76.45 -37.12 1.46 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.582 2.855 . . . . 0.0 110.617 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.03 -28.59 68.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 109.429 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -88.09 1.61 53.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.607 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.6 pp -124.02 139.76 53.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.979 -1.076 . . . . 0.0 110.345 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.0 p -59.11 130.37 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -74.7 -31.66 61.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.93 66.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.92 -46.48 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.119 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.66 -38.5 21.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.158 -0.964 . . . . 0.0 111.51 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.68 -0.36 33.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 25.7 mtpt -92.41 135.15 34.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -68.23 111.46 4.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.513 -0.742 . . . . 0.0 110.887 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.5 m95 -113.5 162.36 16.25 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.484 ' CA ' HD12 ' A' ' 49' ' ' LEU . 4.4 p30 -135.36 9.0 3.43 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.681 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.7 mtm180 -140.77 142.39 34.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.768 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.8 p -133.9 142.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.816 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 46' ' ' VAL . 1.5 tttt -106.5 112.48 25.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.844 -0.535 . . . . 0.0 109.647 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.648 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.9 mm -104.83 117.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 44' ' ' SER . 42.6 t -120.14 120.65 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.201 -0.937 . . . . 0.0 110.62 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.405 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -95.6 136.0 36.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.673 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -139.31 123.44 17.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 111.017 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.6 tp60 165.14 128.77 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.159 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.98 90.53 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.875 2.383 . . . . 0.0 109.251 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 7.4 p90 -119.85 -12.45 9.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.738 . . . . 0.0 111.702 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 176.54 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 0.0 110.22 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -153.33 -42.77 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.65 -29.93 6.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.619 -0.675 . . . . 0.0 109.955 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -104.42 145.93 31.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.711 -0.618 . . . . 0.0 109.66 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 45.1 Cg_endo -87.78 -175.74 1.52 Allowed 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.356 2.704 . . . . 0.0 110.626 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 170.26 -166.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.95 -117.57 0.76 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.815 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 5.3 mp -114.83 158.43 21.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.711 -0.876 . . . . 0.0 110.18 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 32.3 m -96.17 -25.8 15.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.979 -0.451 . . . . 0.0 109.982 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -176.98 165.7 2.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.206 -0.934 . . . . 0.0 110.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 159.02 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 0.1 OUTLIER -160.49 101.22 1.35 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.768 ' CE2' HG11 ' A' ' 128' ' ' VAL . 34.5 m-85 -88.99 149.93 23.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 0.0 108.289 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.2 120.12 5.73 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.729 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 151' ' ' SER . 33.6 mt -145.26 119.75 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -96.62 166.17 11.79 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.31 0.576 . . . . 0.0 109.605 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.701 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -103.3 153.05 20.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.71 -0.619 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.494 ' C ' HD11 ' A' ' 25' ' ' LEU . 41.8 ttt85 -102.49 -56.48 2.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -160.97 161.46 31.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.651 -0.655 . . . . 0.0 109.274 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.75 93.51 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.1 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 11' ' ' SER . 2.5 p -54.66 -55.96 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.259 -0.901 . . . . 0.0 110.398 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -121.45 151.57 40.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 0.0 109.058 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.7 112.26 6.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.831 . . . . 0.0 110.274 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -105.95 43.7 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 43' ' ' ILE . 1.7 t 153.05 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.825 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -161.3 135.61 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.45 -163.1 0.64 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -0.796 . . . . 0.0 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.8 m -95.51 -70.37 0.72 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -54.92 25.3 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -93.9 68.57 3.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.6 p -90.92 176.13 6.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.474 -0.766 . . . . 0.0 110.271 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.62 -25.17 68.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.74 -16.4 57.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.446 -0.784 . . . . 0.0 109.918 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.07 -18.19 65.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -0.997 . . . . 0.0 109.204 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' A' ' 33' ' ' TRP . 8.8 mt -66.0 -24.13 66.71 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -58.79 -21.01 55.09 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.459 -0.776 . . . . 0.0 109.06 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -123.62 73.47 1.2 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.71 -22.03 21.55 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.462 -0.774 . . . . 0.0 110.233 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.51 101.41 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -172.71 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 109.117 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' OG1' ' A' ' 29' ' ' THR . 52.0 p90 -166.42 29.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.84 -1.162 . . . . 0.0 109.941 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.21 177.37 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.402 -0.811 . . . . 0.0 109.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -159.57 0.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.2 t90 -77.62 139.27 39.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.125 -0.985 . . . . 0.0 109.731 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -144.07 125.73 15.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.52 151.79 7.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.771 . . . . 0.0 110.246 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -69.55 -29.82 67.48 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.874 -0.516 . . . . 0.0 109.722 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -114.47 -165.8 1.05 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.26 -162.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.66 44.5 97.79 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.4 mm-40 -43.1 91.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.933 0.873 . . . . 0.0 112.002 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.5 ttmt -101.98 -57.61 2.04 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.548 HG22 ' OG ' ' A' ' 133' ' ' SER . 75.2 p -154.51 121.43 5.56 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 7.1 pt -126.73 152.47 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.526 -0.733 . . . . 0.0 110.015 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.76 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -129.97 150.27 51.33 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.491 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.0 p -154.75 108.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 128' ' ' VAL . 19.4 t -92.15 120.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.701 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.4 mp -98.13 161.51 13.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -111.17 129.5 55.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.617 -0.677 . . . . 0.0 109.948 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD13 ' OE2' ' A' ' 53' ' ' GLU . 44.8 mt -84.73 142.64 29.69 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 36.91 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.486 -0.759 . . . . 0.0 111.324 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 pttm 163.22 138.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.205 -0.935 . . . . 0.0 108.797 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 13.4 tt0 -75.55 103.78 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -136.25 172.19 13.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.517 0.675 . . . . 0.0 109.787 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -85.18 179.01 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.6 mp -140.31 124.24 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.437 -0.79 . . . . 0.0 110.047 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 44.5 t60 -112.89 -29.5 7.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.609 -0.682 . . . . 0.0 109.2 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.428 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.4 m -143.07 157.14 44.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 149' ' ' PHE . 61.6 t -143.01 162.72 17.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.331 0.586 . . . . 0.0 109.938 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -142.35 100.77 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.631 HG23 HD23 ' A' ' 144' ' ' LEU . 1.5 mt -122.31 124.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -92.27 128.35 9.35 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' OD1' HG21 ' A' ' 68' ' ' VAL . 4.1 m-80 -84.02 120.69 26.43 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 122.173 -0.604 . . . . 0.0 110.194 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 5.8 t0 -93.64 69.58 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.21 89.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -64.79 -175.1 0.17 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.73 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -148.58 -55.23 0.2 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' ' HG3' ' A' ' 134' ' ' GLN . 28.0 m-85 -105.67 116.46 31.98 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.016 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 ' OD1' ' A' ' 62' ' ' ASN . 48.9 t -120.76 109.86 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.942 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.29 142.45 35.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 HD13 ' A' ' 130' ' ' ILE . 24.1 t -130.73 127.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.603 0.716 . . . . 0.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 86' ' ' VAL . 2.5 mp -112.68 162.23 15.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -122.45 157.58 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.647 -0.658 . . . . 0.0 110.375 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.72 166.85 38.83 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.2 t -109.45 153.26 24.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.843 -0.798 . . . . 0.0 109.867 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.426 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 47.6 t -84.4 8.64 15.59 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 0.0 109.735 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.405 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -102.96 -173.12 2.24 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 135.47 50.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 71' ' ' LEU . 22.4 t -63.16 88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 111.493 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.569 HD13 HG11 ' A' ' 72' ' ' VAL . 10.7 tp -64.5 -42.09 96.05 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.3 pp -150.77 120.51 7.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.459 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.549 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.3 m -54.1 -178.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.697 -0.627 . . . . 0.0 110.293 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.51 133.56 47.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.47 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 p -98.51 117.92 34.02 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.258 0.551 . . . . 0.0 109.594 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.7 p -74.93 68.6 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -59.42 -59.07 6.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.875 -0.516 . . . . 0.0 110.261 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 68.2 mtp -121.23 -176.12 3.21 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.584 0.707 . . . . 0.0 110.713 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 p -114.66 179.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -86.72 11.06 3.39 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.102 2.535 . . . . 0.0 111.322 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.2 p -120.91 -39.37 2.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.955 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -83.43 0.33 46.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 110.768 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.8 t -78.64 -32.55 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -0.983 . . . . 0.0 110.165 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.678 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -161.69 38.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.93 -22.96 7.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 119.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.298 -1.119 . . . . 0.0 110.244 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.98 64.35 4.47 Favored Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.921 -0.487 . . . . 0.0 111.534 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.6 Cg_endo -75.18 -30.66 6.68 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.889 2.393 . . . . 0.0 110.254 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.67 75.52 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.698 -0.627 . . . . 0.0 109.491 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -111.83 -169.56 1.49 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -129.98 165.11 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.197 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 21.5 tpt180 -143.26 134.46 25.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtm -110.72 158.92 18.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.036 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.8 m-85 -133.14 105.63 7.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -83.52 -147.4 7.52 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.4 Cg_endo -74.51 -35.52 3.62 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.517 2.811 . . . . 0.0 110.809 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.62 -27.72 68.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.693 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -92.5 4.32 53.75 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.643 -0.661 . . . . 0.0 110.682 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -128.37 143.87 51.06 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.912 -1.118 . . . . 0.0 110.31 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.892 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -64.25 140.52 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -35.05 44.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.735 . . . . 0.0 109.075 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.02 66.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.579 -0.701 . . . . 0.0 110.291 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.892 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.98 -47.15 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.1 -31.85 8.78 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.186 -0.946 . . . . 0.0 111.12 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -2.03 58.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.458 -0.776 . . . . 0.0 110.557 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 9.3 mtpp -92.02 135.14 34.19 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.85 109.28 3.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.674 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 86.4 m95 -108.63 160.26 16.08 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 12.6 t70 -133.28 2.31 3.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 110.404 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.426 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -140.84 143.0 34.52 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.913 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -133.95 142.49 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.361 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.3 tttp -107.45 114.66 28.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.717 -0.615 . . . . 0.0 109.788 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.66 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 50.0 mm -104.97 122.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 44' ' ' SER . 38.8 t -128.28 125.1 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.15 -0.969 . . . . 0.0 110.654 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 43' ' ' ILE . 18.0 t -97.93 145.92 25.98 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.66 130.03 17.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.0 111.495 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.73 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 149.07 131.3 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.597 0 C-N-CA 123.911 0.884 . . . . 0.0 108.989 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.42 87.1 0.99 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 109.967 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 3.4 p90 -113.86 -1.42 13.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 111.12 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.65 -171.74 2.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.036 . . . . 0.0 109.476 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -164.23 -43.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.84 -32.5 5.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 0.0 109.887 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.34 149.8 36.65 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.885 -0.509 . . . . 0.0 109.702 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_endo -85.25 -169.79 0.67 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.437 2.758 . . . . 0.0 110.639 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 171.2 -162.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.3 -117.05 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.492 -1.337 . . . . 0.0 110.942 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.631 HD23 HG23 ' A' ' 60' ' ' ILE . 6.1 mp -118.0 145.92 44.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.847 -0.796 . . . . 0.0 110.351 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -81.38 -27.21 34.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.509 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 35.3 p90 -175.87 171.69 2.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.453 -0.779 . . . . 0.0 109.804 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.637 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.7 m -150.21 131.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -147.98 105.4 3.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.447 -0.783 . . . . 0.0 110.504 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.913 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.4 m-85 -86.3 157.83 19.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -152.9 136.01 15.63 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.677 ' HB3' HD11 ' A' ' 4' ' ' ILE . 82.3 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.351 0.596 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 151' ' ' SER . 48.6 mt -146.31 123.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -102.04 166.21 10.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.731 -0.606 . . . . 0.0 110.012 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -98.09 138.94 34.65 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.612 ' N ' HD13 ' A' ' 6' ' ' LEU . 9.9 tpt180 -93.06 -56.24 3.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -161.06 160.6 30.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.49 91.18 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.1 p -51.73 -56.24 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.229 -0.919 . . . . 0.0 110.215 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.06 155.25 38.66 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.251 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -146.75 134.4 21.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.799 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -129.32 47.66 2.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.519 -0.738 . . . . 0.0 110.184 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.1 m 151.85 73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -133.91 143.45 48.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -98.06 152.03 19.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -60.97 -54.43 45.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.013 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -57.11 14.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HD2' ' A' ' 31' ' ' ARG . 35.8 m-70 -107.25 78.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -86.21 163.45 17.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.4 -20.72 65.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.761 -0.587 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.9 tt0 -64.74 -20.42 66.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -65.8 -16.78 64.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.19 -0.943 . . . . 0.0 109.273 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.718 ' HB3' HG22 ' A' ' 147' ' ' VAL . 13.7 mt -64.81 -23.28 67.19 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.2 mm? -57.15 -22.3 39.13 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.418 -0.801 . . . . 0.0 109.19 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.8 66.31 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.76 13.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.488 -0.757 . . . . 0.0 110.318 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.08 74.3 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.823 HG22 ' CD1' ' A' ' 30' ' ' TYR . 86.1 m -156.93 -98.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.823 ' CD1' HG22 ' A' ' 29' ' ' THR . 0.1 OUTLIER 176.25 44.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HD2' ' CE1' ' A' ' 19' ' ' HIS . 3.6 mmm-85 -141.54 100.35 3.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 144' ' ' LEU . 30.9 mtmt -83.62 146.38 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.637 -0.664 . . . . 0.0 109.692 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -62.7 114.9 3.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.203 -0.935 . . . . 0.0 108.583 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -116.88 127.1 53.94 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -49.21 168.81 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.731 0.777 . . . . 0.0 111.696 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -73.74 -32.73 63.99 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -124.85 -175.31 3.25 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 -166.56 1.39 Allowed 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.49 45.81 88.21 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.6 OUTLIER -43.03 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.52 0.676 . . . . 0.0 111.825 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' GLY . 7.3 tttp -93.44 -64.32 1.1 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.664 HG22 ' OG ' ' A' ' 133' ' ' SER . 64.1 p -152.47 113.65 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 24.5 pt -111.29 145.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 110.384 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -123.89 150.49 44.59 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.522 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.787 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.7 p -152.27 107.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.0 t -92.43 122.04 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 147' ' ' VAL . 1.3 mp -101.57 155.76 17.89 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -109.55 120.24 41.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.738 HD13 ' OE2' ' A' ' 53' ' ' GLU . 40.8 mt -71.54 143.35 49.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.36 31.27 0.18 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.637 -0.664 . . . . 0.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.0 pttm 165.01 138.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.92 109.74 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.738 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.98 165.66 26.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 151' ' ' SER . 18.9 mt-30 -77.4 -176.73 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -143.22 130.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.432 -0.793 . . . . 0.0 109.36 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.438 ' O ' HD21 ' A' ' 116' ' ' LEU . 45.9 t60 -116.81 -26.24 7.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.621 -0.674 . . . . 0.0 109.731 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -148.48 153.21 38.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.2 t -135.38 160.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.706 -0.621 . . . . 0.0 109.346 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.654 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -138.74 132.51 30.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.544 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -152.4 128.01 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -104.01 114.62 4.81 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 118.882 -1.628 . . . . 0.0 109.91 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.68 138.37 50.59 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.28 0.562 . . . . 0.0 111.206 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -113.44 42.06 2.03 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 -19.4 10.84 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 20.9 p -56.76 -173.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.319 -1.106 . . . . 0.0 109.797 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -147.42 -44.43 0.17 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.3 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -108.35 117.26 33.68 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.746 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' ILE . 45.3 t -120.51 110.62 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -107.21 147.56 30.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG22 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.21 125.87 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -111.52 157.6 20.15 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 87' ' ' LEU . 4.0 m -120.25 156.98 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.795 -0.566 . . . . 0.0 110.292 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.406 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.82 174.52 44.23 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 t -114.64 162.69 16.44 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.646 0.736 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -68.79 -11.11 60.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.239 -179.327 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 t0 . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.4 151.06 41.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.13 147.67 28.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -68.93 86.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 72' ' ' VAL . 19.7 tp -56.68 -54.98 39.81 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.7 pp -138.75 117.26 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.271 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.6 m -50.86 174.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.564 -0.71 . . . . 0.0 110.446 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 132.69 50.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -97.6 118.16 33.48 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.847 -0.533 . . . . 0.0 109.745 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.9 p -75.45 67.96 2.06 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -62.08 -51.61 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.885 -0.509 . . . . 0.0 110.494 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.525 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 20.2 mtp -120.3 -170.25 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 110.455 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 p -121.07 173.74 3.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.99 5.02 5.97 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.272 2.648 . . . . 0.0 111.451 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.8 m -120.74 -39.29 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.097 -1.002 . . . . 0.0 109.827 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.79 -17.19 61.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.527 -0.733 . . . . 0.0 110.266 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -58.16 -20.55 41.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 110.517 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -71.44 -86.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -162.61 38.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 108.578 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.39 -20.27 7.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.93 119.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -1.073 . . . . 0.0 110.198 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.525 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.86 70.31 1.62 Allowed Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.89 -0.506 . . . . 0.0 111.308 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.59 -30.63 3.82 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.906 2.404 . . . . 0.0 110.464 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -146.23 109.75 4.79 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 93' ' ' PHE . 5.6 ptm85 -153.08 -160.79 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.568 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -131.86 172.0 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.773 -1.205 . . . . 0.0 111.388 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 13.9 tpt180 -145.64 147.14 31.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 mtp -126.99 158.12 37.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.688 . . . . 0.0 110.242 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.0 m-85 -126.51 163.95 22.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.99 -148.31 5.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.87 -38.52 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 123.8 3.0 . . . . 0.0 111.042 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.47 -26.7 68.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.502 -0.749 . . . . 0.0 109.701 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.55 2.37 56.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 110.71 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.5 pp -124.16 140.81 52.61 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.974 -1.079 . . . . 0.0 110.351 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.8 p -60.68 137.87 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -40.16 47.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 0.0 109.163 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.73 -20.88 59.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.595 -0.691 . . . . 0.0 110.679 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -114.8 -46.49 2.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.269 -0.894 . . . . 0.0 110.432 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.61 -35.08 12.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.253 -0.904 . . . . 0.0 111.311 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.13 7.08 29.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.356 -0.84 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.1 mttm -98.93 137.61 37.23 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -68.8 113.1 5.95 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.751 0.786 . . . . 0.0 110.973 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.461 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 77.7 m95 -117.21 157.16 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -132.1 10.29 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.275 -0.891 . . . . 0.0 110.057 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.588 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.4 mtt180 -140.08 147.13 39.84 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.6 p -140.6 142.47 30.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.774 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 46' ' ' VAL . 12.7 tttt -112.77 107.31 15.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.679 -0.638 . . . . 0.0 109.718 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.757 ' CD1' HG22 ' A' ' 70' ' ' VAL . 46.4 mm -98.46 122.83 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.7 t -123.99 114.7 42.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -90.83 138.22 31.75 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.664 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -143.11 132.58 23.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.192 -0.943 . . . . 0.0 111.635 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.863 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER 157.02 134.01 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.591 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.92 96.39 0.57 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.081 2.521 . . . . 0.0 109.807 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.4 p90 -128.16 -8.79 5.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.401 -0.812 . . . . 0.0 111.843 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -175.41 3.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.074 -1.016 . . . . 0.0 110.02 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -161.31 -43.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.72 -30.84 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.593 -0.692 . . . . 0.0 110.029 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -104.17 142.95 25.68 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.732 -0.605 . . . . 0.0 109.762 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.9 Cg_endo -88.18 156.69 6.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.353 2.702 . . . . 0.0 110.323 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -161.48 -168.49 2.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 169.41 -101.96 0.18 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.04 163.64 32.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.474 -1.016 . . . . 0.0 109.64 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 50.5 m -85.09 -16.9 39.04 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.646 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 43.3 p90 -179.35 164.56 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 24' ' ' LEU . 25.3 m -139.12 149.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 9.0 mtp180 -154.34 164.26 38.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.76 . . . . 0.0 110.472 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.874 ' CE2' HG11 ' A' ' 128' ' ' VAL . 51.9 m-85 -144.59 152.2 40.17 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.434 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.62 136.18 16.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 109.188 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.1 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.739 -0.601 . . . . 0.0 109.845 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.404 HD13 ' OE1' ' A' ' 53' ' ' GLU . 52.5 mt -126.47 127.65 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -112.52 171.04 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.722 -0.611 . . . . 0.0 109.885 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.756 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.9 mp -101.81 162.51 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.787 -0.571 . . . . 0.0 109.506 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.702 ' C ' HD11 ' A' ' 25' ' ' LEU . 23.1 ttt180 -118.41 -47.64 2.54 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.444 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 3.1 p-80 -160.85 -168.73 2.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.7 p -104.94 96.87 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.705 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.5 p -56.43 -61.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.302 -0.874 . . . . 0.0 110.054 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -121.31 162.89 19.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 20.0 p -158.64 144.96 17.06 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.277 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -151.84 53.85 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.81 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.829 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -127.06 148.82 50.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.939 -1.101 . . . . 0.0 110.096 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -98.97 -165.37 1.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.79 -0.569 . . . . 0.0 109.561 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -66.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.688 . . . . 0.0 109.651 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -34.82 77.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -123.69 74.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -90.71 172.19 8.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.598 0.713 . . . . 0.0 110.256 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.52 -25.89 67.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.799 -0.563 . . . . 0.0 109.619 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.06 -20.02 55.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.365 -0.834 . . . . 0.0 110.17 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.2 -19.47 65.99 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.9 mt -65.91 -25.05 66.97 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.702 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.91 -21.09 60.62 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.482 -0.761 . . . . 0.0 108.977 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 66.12 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.61 -22.75 23.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -0.756 . . . . 0.0 110.391 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' THR . 5.5 m-20 -118.91 77.39 1.18 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -154.28 -85.57 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.404 -0.81 . . . . 0.0 109.576 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.22 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 158.33 29.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.497 -0.752 . . . . 0.0 109.506 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -160.96 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.536 -0.727 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.727 ' CH2' HD12 ' A' ' 43' ' ' ILE . 20.4 t90 -88.36 137.45 32.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 110.817 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -142.5 121.7 13.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.29 158.77 0.24 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.464 -0.773 . . . . 0.0 111.035 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.51 -41.76 99.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.077 0.465 . . . . 0.0 110.28 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.48 -171.4 2.3 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.515 0.674 . . . . 0.0 109.241 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.59 -165.59 1.33 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.98 45.8 94.88 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp0 -51.92 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.461 0.648 . . . . 0.0 111.174 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 42' ' ' THR . 15.5 tttm -91.38 -50.08 5.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.5 p -158.66 124.89 4.59 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.727 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.1 pt -128.34 136.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 131' ' ' VAL . 26.8 m -118.6 138.51 52.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.415 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.636 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.9 p -144.75 111.61 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.4 t -96.96 119.75 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.088 -1.008 . . . . 0.0 108.978 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -100.9 160.67 14.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.539 0.685 . . . . 0.0 110.284 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 7.1 tp-100 -98.28 148.41 23.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 126' ' ' ASP . 84.8 mt -99.57 123.81 44.18 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -52.59 -7.73 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.37 -0.831 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.2 139.03 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.786 -1.196 . . . . 0.0 108.874 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.69 113.58 12.12 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -147.41 179.77 7.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.16 -178.03 6.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.44 115.2 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -105.22 -30.8 9.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 109.202 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.2 m -144.3 161.09 39.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 149' ' ' PHE . 99.1 t -145.35 159.03 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.28 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 60' ' ' ILE . 35.3 t0 -132.07 138.67 48.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.699 -0.626 . . . . 0.0 110.004 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -153.88 130.38 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -96.69 127.08 9.07 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -83.86 112.09 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.022 -0.693 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.7 56.96 2.12 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.94 58.38 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -53.42 161.72 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.316 -1.108 . . . . 0.0 110.555 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.735 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -123.46 -58.72 1.59 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 23.4 m-85 -101.68 133.19 46.77 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.611 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' ILE . 49.8 t -132.49 111.56 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 109.677 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.14 141.67 37.11 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.741 HG13 HD13 ' A' ' 130' ' ' ILE . 16.2 t -131.07 124.47 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.636 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 86' ' ' VAL . 1.5 mp -109.31 162.48 14.28 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 87' ' ' LEU . 3.1 m -122.71 154.95 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.542 -0.724 . . . . 0.0 110.305 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.55 162.71 34.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 t -116.83 163.91 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.684 0.754 . . . . 0.0 109.872 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 t -77.08 -1.06 27.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.749 -179.518 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.06 -172.31 2.12 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.65 135.11 48.84 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 71' ' ' LEU . 43.7 t -61.76 88.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.671 -0.643 . . . . 0.0 111.263 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.9 tp -61.79 -55.63 28.05 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.705 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.7 pp -137.69 117.47 13.16 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -52.29 178.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.639 -0.663 . . . . 0.0 110.656 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 133.62 52.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.2 p -107.31 126.65 52.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.369 0.605 . . . . 0.0 109.656 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.8 p -86.47 117.87 25.53 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 26.3 m-85 -112.86 -48.18 3.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.437 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 83.3 mtp -121.2 -176.35 3.26 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.549 0.69 . . . . 0.0 110.468 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.7 p -111.84 -178.55 0.54 Allowed Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 43.0 Cg_endo -86.41 19.33 1.41 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 123.155 2.57 . . . . 0.0 111.432 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -120.19 -41.27 2.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.02 -24.9 66.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 34.8 p -45.97 -27.24 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.711 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -92.33 0.11 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -163.36 38.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.863 -1.148 . . . . 0.0 108.569 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.12 -26.55 18.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.93 115.77 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 0.0 110.272 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.27 73.55 0.83 Allowed Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 121.685 -0.634 . . . . 0.0 111.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.7 Cg_endo -74.14 -28.23 11.02 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.557 2.171 . . . . 0.0 110.339 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -128.86 124.13 34.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.682 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 -170.13 3.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.729 -0.607 . . . . 0.0 109.403 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 40.6 t -132.82 159.99 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 141.22 12.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.762 . . . . 0.0 109.148 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.0 mtp -126.26 156.61 40.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.316 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.705 ' CE2' HD13 ' A' ' 88' ' ' LEU . 11.8 m-85 -110.93 172.28 6.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.33 -150.22 5.3 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.78 -38.04 1.44 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.712 2.941 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.03 -26.73 68.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.935 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -95.08 5.05 52.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.751 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.99 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -125.53 143.0 51.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.921 -1.112 . . . . 0.0 110.712 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.902 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -61.85 141.08 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.75 34.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 108.973 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -67.51 -15.89 63.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.717 . . . . 0.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.902 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -120.23 -45.61 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.99 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.42 -40.27 25.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.302 -0.874 . . . . 0.0 111.305 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.27 4.92 28.76 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 11.8 mttm -97.19 135.71 38.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.92 111.35 4.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.528 -0.732 . . . . 0.0 110.886 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 88.6 m95 -115.38 165.02 13.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 49' ' ' LEU . 3.2 p30 -139.9 14.55 2.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.071 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.705 ' HD3' HG21 ' A' ' 10' ' ' VAL . 11.7 mtt180 -142.06 138.68 31.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.701 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.2 p -130.79 138.95 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.395 -0.816 . . . . 0.0 109.788 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.628 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.7 tttt -110.39 107.55 17.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.848 -0.532 . . . . 0.0 109.654 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 70' ' ' VAL . 50.7 mm -98.43 117.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.733 -0.604 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.8 t -124.07 110.97 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 121.16 -0.963 . . . . 0.0 109.72 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.463 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.5 t -84.94 147.3 26.8 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.68 129.94 22.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.349 -0.844 . . . . 0.0 111.753 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.735 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 148.4 123.28 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 C-N-CA 123.719 0.808 . . . . 0.0 109.057 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.56 89.5 1.34 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.777 2.318 . . . . 0.0 109.1 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 6.7 p90 -114.62 -22.33 9.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.585 -0.697 . . . . 0.0 111.41 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -173.18 2.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.893 . . . . 0.0 109.863 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -168.75 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -114.88 -36.15 4.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.902 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -105.07 145.09 30.07 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.836 -0.54 . . . . 0.0 109.727 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.0 Cg_endo -87.92 167.74 6.91 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.371 2.714 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.35 -169.86 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.84 -109.81 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.872 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.633 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.3 mp -109.69 152.13 26.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.903 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 34.5 m -87.84 -27.56 22.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.464 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 51.7 p90 -179.17 176.52 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.524 HG12 HG13 ' A' ' 60' ' ' ILE . 32.9 m -152.2 131.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 6.5 mtm180 -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.312 -0.867 . . . . 0.0 110.222 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 58' ' ' VAL . 80.7 m-85 -86.08 154.23 21.54 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 131.95 19.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.338 -0.851 . . . . 0.0 109.046 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.873 -0.517 . . . . 0.0 110.486 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.617 0.722 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.626 ' CG2' HD12 ' A' ' 49' ' ' LEU . 43.9 mm -79.52 143.15 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -123.32 126.05 46.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 HD22 ' A' ' 47' ' ' LEU . 1.1 mp -83.87 147.43 27.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.461 ' C ' HD11 ' A' ' 25' ' ' LEU . 50.2 ttt85 -105.28 -58.71 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.377 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.96 178.16 9.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -85.41 89.44 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.704 . . . . 0.0 109.24 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.528 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -51.42 -58.39 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.15 -0.969 . . . . 0.0 110.286 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.522 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -124.9 162.77 23.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.495 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 21.5 p -160.42 144.04 13.78 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.47 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 m -148.9 58.22 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.608 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.78 58.21 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 123.093 0.557 . . . . 0.0 109.818 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.929 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -124.54 140.61 52.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.82 -1.175 . . . . 0.0 110.65 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.64 -162.84 0.89 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -99.06 -64.25 1.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 109.374 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -58.53 4.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.692 . . . . 0.0 109.149 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -92.74 68.03 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.8 165.15 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 0.0 109.904 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.81 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -59.89 -23.94 63.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.644 -0.66 . . . . 0.0 110.368 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.46 -21.6 66.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.247 -0.908 . . . . 0.0 109.919 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -66.0 -16.82 64.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.9 mt -65.28 -25.77 67.79 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -60.26 -21.3 61.72 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 65.42 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HB1' ' HE ' ' A' ' 148' ' ' ARG . . . -53.3 -24.32 11.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -116.31 79.95 1.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.434 -0.791 . . . . 0.0 109.746 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' ASP . 2.0 p -157.2 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.483 -0.76 . . . . 0.0 109.196 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -178.06 32.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.003 -1.061 . . . . 0.0 110.379 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -147.25 140.54 25.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.026 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -160.41 0.99 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CH2' HD12 ' A' ' 43' ' ' ILE . 17.6 t90 -97.58 136.19 38.33 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 3.9 tmm_? -142.6 120.54 12.04 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.48 154.76 3.3 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.193 -0.942 . . . . 0.0 110.427 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -78.93 -23.79 44.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.784 -0.572 . . . . 0.0 110.196 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.02 -158.94 0.59 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.423 -0.798 . . . . 0.0 109.368 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 139' ' ' ASP . . . -149.25 172.7 14.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 91.1 -15.62 60.57 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.504 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 2.6 mp0 59.52 117.72 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.618 -0.931 . . . . 0.0 111.418 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 42' ' ' THR . 16.8 ttmt -151.7 -71.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.684 HG22 ' OG ' ' A' ' 133' ' ' SER . 24.6 p -157.88 143.54 17.12 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.775 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -143.57 139.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.522 ' CB ' HG22 ' A' ' 131' ' ' VAL . 69.2 m -126.53 115.06 18.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.234 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.81 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -116.41 126.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.857 HG22 ' CD ' ' A' ' 129' ' ' LYS . 2.8 t -104.76 113.77 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.875 . . . . 0.0 108.897 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 6' ' ' LEU . 1.4 mp -97.61 169.34 9.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.558 0.694 . . . . 0.0 110.66 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.464 ' C ' HD22 ' A' ' 49' ' ' LEU . 11.9 tp60 -114.66 153.71 29.72 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.545 0.688 . . . . 0.0 109.608 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.626 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.0 mm? -104.86 131.98 51.67 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 5.7 tt0 -81.96 43.12 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.25 -0.906 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 4.6 pttt 163.59 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 20.7 tt0 -63.23 104.66 0.62 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CG ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.5 178.46 7.02 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.25 178.12 5.95 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.32 131.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.796 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.572 ' HA ' HD21 ' A' ' 116' ' ' LEU . 6.4 t-160 -122.47 -32.35 3.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -141.97 161.44 37.97 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.681 HG13 ' CD1' ' A' ' 149' ' ' PHE . 58.4 t -146.67 164.1 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.899 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.584 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.4 m-20 -139.28 134.77 33.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.639 -0.663 . . . . 0.0 109.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -146.71 118.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -81.86 99.75 2.03 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.83 125.25 22.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.905 . . . . 0.0 110.361 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -107.38 39.07 1.97 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.384 -0.823 . . . . 0.0 109.406 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 136' ' ' TYR . . . 111.98 22.97 5.74 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -101.67 173.1 6.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -1.073 . . . . 0.0 110.382 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -128.8 -47.64 1.25 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 30.0 m-85 -108.41 120.6 42.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.732 -0.605 . . . . 0.0 110.767 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.63 111.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.458 -0.776 . . . . 0.0 109.287 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -107.86 143.62 36.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.696 -0.627 . . . . 0.0 110.197 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 130' ' ' ILE . 38.9 t -132.09 129.57 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.6 mp -117.46 160.17 21.63 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.7 ' CG1' HD22 ' A' ' 87' ' ' LEU . 7.5 m -123.48 172.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 110.159 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.34 170.64 29.55 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -113.21 160.73 17.97 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.822 0.82 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -81.86 8.13 11.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.93 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.131 -0.981 . . . . 0.0 111.224 -179.265 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.428 0.633 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -48.24 160.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.603 0.716 . . . . 0.0 110.079 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -108.69 131.61 54.75 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 42.9 t -61.58 86.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.66 -0.65 . . . . 0.0 110.729 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.7 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -59.0 -61.18 2.83 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 pp -136.14 119.98 17.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.546 -0.721 . . . . 0.0 109.292 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -53.93 179.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.155 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -65.63 133.95 52.23 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.594 -0.691 . . . . 0.0 109.313 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HG ' ' HE2' ' A' ' 111' ' ' PHE . 8.5 p -98.22 119.11 36.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.82 -0.55 . . . . 0.0 109.676 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.2 p -75.53 69.49 2.29 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 28.4 t80 -63.42 -55.49 23.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.803 -0.561 . . . . 0.0 110.587 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 1.6 mtp -117.79 -176.48 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.679 0.752 . . . . 0.0 110.571 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -112.54 176.35 1.52 Allowed Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 41.5 Cg_endo -86.28 14.98 2.3 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.136 2.557 . . . . 0.0 111.518 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -120.09 -46.19 2.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.071 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -19.59 49.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.512 -0.742 . . . . 0.0 110.233 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -49.34 -26.87 3.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -0.863 . . . . 0.0 110.64 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -85.95 -86.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.54 -0.725 . . . . 0.0 109.745 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -164.44 37.53 0.08 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.43 -17.83 67.88 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.18 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.239 -1.154 . . . . 0.0 111.91 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.4 90.33 0.22 Allowed Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.47 ' O ' ' HE1' ' A' ' 94' ' ' MET . 43.1 Cg_endo -81.21 -29.85 1.82 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.686 2.257 . . . . 0.0 110.315 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.6 129.94 50.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.653 -0.654 . . . . 0.0 109.273 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -160.21 -169.8 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.876 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.618 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 69.2 t -127.06 154.96 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 111' ' ' PHE . 6.6 ttt-85 -143.1 131.94 22.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.1 mtp -111.81 143.34 42.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.72 -0.612 . . . . 0.0 110.054 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.6 m-85 -111.59 165.1 12.3 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.642 0.734 . . . . 0.0 109.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -147.88 -154.6 6.31 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.755 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.8 Cg_endo -74.91 -24.12 13.34 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.644 2.896 . . . . 0.0 110.873 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -50.53 -38.79 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -117.73 15.27 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -117.26 122.57 44.33 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.901 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -49.65 130.33 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.631 -0.668 . . . . 0.0 110.698 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -67.64 -37.69 82.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.738 . . . . 0.0 109.133 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.05 92.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.284 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.901 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -91.96 -36.41 13.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.311 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.98 -35.91 3.13 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.577 -0.702 . . . . 0.0 111.111 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.15 12.29 35.96 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.809 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -91.85 134.47 34.73 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.34 106.61 5.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.913 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 74.5 m95 -111.22 164.0 13.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 12.7 p30 -136.53 8.32 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.521 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 10' ' ' VAL . 12.8 mtt-85 -136.99 144.55 43.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.1 p -137.4 138.67 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.857 ' CD ' HG22 ' A' ' 46' ' ' VAL . 33.9 tptt -104.3 129.57 52.14 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.8 mm -125.24 111.92 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.522 HG22 ' CB ' ' A' ' 44' ' ' SER . 47.9 t -117.92 119.73 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.44 -0.787 . . . . 0.0 110.36 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 152.18 20.11 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.684 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -160.06 132.45 6.4 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.643 -1.286 . . . . 0.0 113.949 -176.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.75 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 10.1 tp60 148.09 125.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.32 114.78 1.87 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.778 2.318 . . . . 0.0 109.23 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -117.18 0.87 12.41 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.694 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.39 -160.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.604 -1.31 . . . . 0.0 110.051 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 ttmm -151.95 23.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 110.011 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.792 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p-10 -149.05 -40.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 111.701 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.7 158.91 33.61 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.687 . . . . 0.0 111.54 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.3 -159.67 0.11 Allowed 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 124.039 3.159 . . . . 0.0 109.601 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 40' ' ' GLU . 21.2 p90 -178.85 -165.01 0.08 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.72 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 145.47 -128.57 3.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -144.91 165.04 29.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.725 -0.868 . . . . 0.0 110.241 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.3 p -79.14 -25.52 42.88 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.558 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 46.3 p90 -175.07 173.64 2.6 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.812 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 24' ' ' LEU . 18.0 m -149.63 130.3 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.463 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 63.2 mtt180 -142.05 116.33 9.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 110.756 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.0 m-85 -88.91 154.0 20.59 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -152.72 120.88 6.23 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.853 -0.53 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.492 1.675 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.473 HD13 ' OE1' ' A' ' 53' ' ' GLU . 53.6 mt -120.09 126.25 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.33 175.86 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.592 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.6 mp -112.35 158.92 19.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 0.0 109.968 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -55.54 2.31 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -160.74 169.82 22.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -80.61 91.41 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.562 -0.711 . . . . 0.0 109.152 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 1.7 p -52.24 -58.51 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.07 -1.019 . . . . 0.0 110.186 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.3 157.58 36.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -160.44 125.26 3.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.4 OUTLIER -118.53 57.19 0.86 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.659 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 154.33 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 123.012 0.525 . . . . 0.0 109.674 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.24 144.08 14.07 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.87 -1.144 . . . . 0.0 109.494 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.02 -167.54 1.56 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 109.667 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -88.71 -62.77 1.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.685 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -65.04 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -88.59 74.46 8.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -91.08 168.05 11.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.616 -0.678 . . . . 0.0 110.051 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -62.68 -24.09 67.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.881 -0.512 . . . . 0.0 109.62 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.74 -18.42 62.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 109.967 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -64.96 -18.09 64.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.5 mt -65.33 -26.84 68.22 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.6 mm? -61.7 -20.02 63.01 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -116.31 65.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -23.37 18.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.425 -0.797 . . . . 0.0 110.399 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -120.43 78.47 1.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.52 -88.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.483 -0.761 . . . . 0.0 109.408 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.36 36.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -155.1 149.89 26.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 0.0 109.317 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -130.37 -170.41 2.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.574 -0.704 . . . . 0.0 109.959 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.817 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.9 t90 -88.54 139.67 30.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 109.032 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 126.19 17.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.68 152.38 2.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.307 -0.871 . . . . 0.0 110.111 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.1 -23.9 56.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.749 -0.595 . . . . 0.0 110.077 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -139.19 -169.79 2.74 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.421 -0.799 . . . . 0.0 108.965 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 -172.47 2.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.67 -0.644 . . . . 0.0 109.362 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.35 48.67 85.02 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 4.3 mt-10 -62.1 78.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' THR . 15.9 tttt -66.14 -51.07 61.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 133' ' ' SER . 59.3 p -156.94 124.78 5.47 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.786 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.1 pt -118.12 139.35 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.817 . . . . 0.0 110.4 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -115.5 140.36 49.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.135 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.4 p -146.1 107.98 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.9 t -92.35 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 108.894 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.592 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -96.95 168.72 10.3 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.09 129.76 56.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.718 -0.614 . . . . 0.0 110.406 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.623 HD13 ' OE2' ' A' ' 53' ' ' GLU . 46.5 mt -85.4 135.35 33.91 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 1.9 pt-20 -79.89 41.6 0.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.436 -0.79 . . . . 0.0 111.099 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 3.6 pttm 161.98 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.1 tt0 -75.88 100.36 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -131.49 172.38 12.28 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.588 0.709 . . . . 0.0 109.862 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -87.7 170.03 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -128.48 122.81 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.77 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -109.73 -32.97 6.9 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -144.8 155.2 43.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 60' ' ' ILE . 74.8 t -137.38 158.58 35.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.677 0.751 . . . . 0.0 109.98 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.5 m-20 -134.68 137.12 43.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -160.25 132.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -101.91 123.61 7.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 68' ' ' VAL . 2.0 m-80 -83.15 130.73 35.13 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.304 -0.527 . . . . 0.0 110.67 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.34 64.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 99' ' ' SER . . . 85.31 1.4 88.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.9 129.41 34.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 110.295 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 94' ' ' MET . . . -87.3 -57.73 2.85 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.713 -0.617 . . . . 0.0 110.076 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 133' ' ' SER . 16.4 m-85 -90.99 132.97 35.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.274 -0.891 . . . . 0.0 111.195 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 62' ' ' ASN . 82.3 t -139.24 106.84 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -102.32 146.88 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.698 HG13 ' CD1' ' A' ' 130' ' ' ILE . 22.2 t -135.71 121.1 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-O 121.64 0.733 . . . . 0.0 109.544 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -108.78 163.01 13.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.677 HG11 HD13 ' A' ' 87' ' ' LEU . 2.6 m -121.34 161.02 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.646 -0.659 . . . . 0.0 110.553 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.36 167.8 38.05 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 t -108.78 155.12 21.13 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.83 -0.806 . . . . 0.0 109.552 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 60.5 p -89.54 12.69 15.89 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 O-C-N 121.261 -0.899 . . . . 0.0 109.765 -179.745 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.465 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -107.17 -173.68 2.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.83 131.41 47.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.51 88.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.457 -0.777 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.677 HD13 HG11 ' A' ' 72' ' ' VAL . 5.6 tp -64.94 -51.04 63.99 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.5 pp -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.486 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -56.81 172.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.563 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -57.59 130.57 46.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.364 -0.835 . . . . 0.0 110.229 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -97.75 123.99 41.92 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -90.95 81.62 5.66 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 20.7 m-85 -70.86 -55.97 7.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.831 . . . . 0.0 109.922 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.491 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 27.9 mtp -120.78 -163.31 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.685 -0.635 . . . . 0.0 109.638 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -128.85 178.12 1.82 Allowed Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.23 17.59 1.71 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.039 2.493 . . . . 0.0 111.089 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.7 m -120.61 -38.49 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 109.704 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -82.97 -29.55 28.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.469 -0.769 . . . . 0.0 109.337 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 76.1 p -60.49 -18.6 52.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.583 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -71.12 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 t -161.27 38.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.6 -21.88 4.19 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.9 121.55 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.365 -1.079 . . . . 0.0 109.119 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.479 ' O ' ' HE1' ' A' ' 94' ' ' MET . 6.3 p30 43.16 83.92 0.2 Allowed Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.758 -0.589 . . . . 0.0 110.798 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.3 Cg_endo -82.76 -27.55 2.03 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.984 2.456 . . . . 0.0 109.992 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -145.73 86.24 1.72 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -114.71 127.45 55.76 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.6 m -79.76 165.82 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.743 . . . . 0.0 109.517 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.18 169.61 22.02 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.0 mtt -141.89 165.15 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 110.204 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.1 m-85 -120.85 170.35 9.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -144.44 -148.28 4.83 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.1 Cg_endo -74.88 -40.02 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.694 2.929 . . . . 0.0 110.716 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.36 -27.24 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 109.73 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -93.44 3.7 55.15 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.693 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.976 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.3 pp -124.22 152.21 43.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.932 -1.105 . . . . 0.0 109.966 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.768 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 10.3 p -77.54 139.47 18.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -73.43 -29.92 62.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.638 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -68.6 -11.28 59.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.768 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -125.01 -46.04 1.84 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.976 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.95 -29.08 11.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.604 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.48 -5.28 52.18 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.727 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 8.9 mtpt -91.16 133.08 35.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.158 -0.963 . . . . 0.0 108.52 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.81 110.65 3.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.48 -0.762 . . . . 0.0 110.541 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 83.9 m95 -110.72 158.94 18.08 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t70 -130.64 1.19 4.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.115 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.18 144.82 43.11 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.4 p -132.63 142.2 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.547 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.451 ' HG3' HG22 ' A' ' 46' ' ' VAL . 19.8 tttt -110.36 106.12 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.827 -0.546 . . . . 0.0 109.719 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.698 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.3 mm -100.57 131.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.327 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.6 t -134.01 122.54 41.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 130.24 46.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.77 125.29 28.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.289 -0.882 . . . . 0.0 111.692 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HG2' ' CD2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER 170.44 141.44 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -90.71 95.06 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.71 2.273 . . . . 0.0 110.228 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -120.92 -15.67 8.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.015 -1.053 . . . . 0.0 112.002 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -137.2 178.24 7.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 110.918 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -149.33 -47.34 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.644 -0.66 . . . . 0.0 110.248 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.34 153.15 44.19 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.361 -0.837 . . . . 0.0 110.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.15 -171.76 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.64 2.893 . . . . 0.0 110.9 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.448 ' N ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER 170.03 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 143.19 -121.93 1.8 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.944 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 143' ' ' GLY . 5.6 mp -122.69 162.44 21.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.447 -1.031 . . . . 0.0 110.521 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -92.78 -27.25 17.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 -179.88 166.6 1.3 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.1 m -139.56 145.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.292 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 43.5 mtm180 -149.68 159.09 44.63 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.442 0.639 . . . . 0.0 110.346 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.659 ' CD1' HG13 ' A' ' 58' ' ' VAL . 49.8 m-85 -139.13 156.01 47.46 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.55 127.98 10.68 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.104 -0.998 . . . . 0.0 109.521 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.908 -0.495 . . . . 0.0 110.456 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.213 0.53 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.756 ' CG2' HD12 ' A' ' 49' ' ' LEU . 83.9 mt -142.19 152.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.725 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.08 -173.05 3.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.506 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.3 mm? -119.54 163.17 17.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.55 -0.718 . . . . 0.0 109.64 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -114.43 -47.67 2.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -161.0 163.34 31.78 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -78.96 91.08 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.77 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 11' ' ' SER . 2.4 p -51.27 -54.73 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.176 -0.952 . . . . 0.0 110.361 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.486 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.11 164.07 21.02 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.0 p -159.54 146.31 16.57 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.6 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -145.72 49.71 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 43' ' ' ILE . 2.0 m 152.0 86.12 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.861 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -153.36 133.56 13.41 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.053 -1.029 . . . . 0.0 110.245 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.31 -175.14 4.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.5 t -84.94 -64.13 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.629 -0.67 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -61.48 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -89.13 67.53 8.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.5 p -84.98 168.33 15.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.58 -0.7 . . . . 0.0 109.812 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.46 -22.4 66.95 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.34 -21.01 66.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 109.528 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -65.12 -18.46 65.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 109.014 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 33' ' ' TRP . 11.2 mt -66.02 -26.87 67.73 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.3 mm? -61.96 -19.34 62.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.03 76.15 1.35 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.94 -59.77 2.14 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.33 0.586 . . . . 0.0 110.812 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.64 -119.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p 51.72 -105.78 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.666 -1.271 . . . . 0.0 109.57 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.71 40.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.847 -1.158 . . . . 0.0 110.277 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -154.11 148.51 26.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -132.05 -159.72 0.99 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB2' HD21 ' A' ' 24' ' ' LEU . 14.5 t90 -97.12 140.05 32.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -149.0 126.7 11.74 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.42 142.25 10.74 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.429 -0.794 . . . . 0.0 110.876 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -63.83 -52.18 61.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -152.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -135.78 -179.75 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.7 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 96.34 -24.05 32.12 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 9.8 mt-10 45.17 41.96 6.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.694 -0.886 . . . . 0.0 112.284 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 42' ' ' THR . 25.1 ttmt -59.81 -65.24 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 41' ' ' LYS . 61.0 p -158.76 124.05 4.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.4 pt -112.92 148.63 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.572 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -124.59 146.76 48.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.708 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -154.92 111.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 109.527 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.2 t -95.52 119.82 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 147' ' ' VAL . 1.4 mp -98.27 161.04 13.9 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.453 0.644 . . . . 0.0 109.863 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -107.02 129.3 54.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.731 -0.606 . . . . 0.0 109.796 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.756 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -80.88 133.28 35.54 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.34 37.77 0.4 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.713 . . . . 0.0 110.425 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 pttt 165.67 126.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -76.29 108.86 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 109.225 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.78 -179.33 6.39 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' O ' HD11 ' A' ' 4' ' ' ILE . 27.3 mt-30 -87.94 178.39 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.1 mp -138.04 137.9 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.333 -0.854 . . . . 0.0 109.829 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.697 ' O ' HD21 ' A' ' 116' ' ' LEU . 31.5 t60 -123.97 -34.73 2.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.706 -0.621 . . . . 0.0 109.895 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.6 m -137.1 163.4 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 149' ' ' PHE . 75.4 t -142.62 165.03 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 109.622 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -145.67 115.66 7.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.759 . . . . 0.0 109.949 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.1 mp -133.14 120.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -79.14 89.03 1.19 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 5.3 m120 -71.41 119.12 15.1 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 122.089 -0.653 . . . . 0.0 110.845 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.66 22.99 13.96 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 136' ' ' TYR . 39.3 p -52.91 -175.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.17 0.986 . . . . 0.0 112.022 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 134' ' ' GLN . . . -150.7 -54.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 133' ' ' SER . 44.7 m-85 -117.85 122.17 42.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.769 -0.582 . . . . 0.0 109.597 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 t -118.31 107.63 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.863 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.77 141.2 28.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.793 HG21 HD23 ' A' ' 88' ' ' LEU . 60.0 t -136.55 119.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 0.0 109.668 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD11 HG22 ' A' ' 86' ' ' VAL . 1.4 mp -116.95 163.28 16.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 87' ' ' LEU . 5.5 m -126.74 168.65 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.739 -0.601 . . . . 0.0 110.131 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.412 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 168.97 172.79 36.09 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -110.39 162.36 14.74 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.551 0.691 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 54.8 p -86.27 9.53 17.47 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.116 -0.99 . . . . 0.0 110.436 -179.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.3 m-85 -103.98 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -131.15 135.88 47.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 71' ' ' LEU . 43.0 t -65.19 85.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.462 -0.774 . . . . 0.0 110.563 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HA ' HG12 ' A' ' 117' ' ' VAL . 4.1 tp -68.05 -64.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.793 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -112.47 114.0 26.47 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -62.15 172.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.554 -0.716 . . . . 0.0 109.227 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.554 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -55.05 127.23 28.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.28 -0.887 . . . . 0.0 109.318 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p -95.7 114.7 26.47 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.219 0.533 . . . . 0.0 109.737 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -74.68 68.97 1.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 94' ' ' MET . 15.8 t80 -61.66 -61.66 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.883 -0.511 . . . . 0.0 109.623 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -122.55 -168.9 1.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.524 -0.735 . . . . 0.0 109.877 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -116.41 176.72 1.43 Allowed Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.72 12.67 2.93 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.943 2.429 . . . . 0.0 111.27 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 t -121.68 -37.25 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.156 -0.965 . . . . 0.0 110.248 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.6 -22.04 37.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.804 . . . . 0.0 110.249 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.2 p -58.54 -21.03 51.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 110.718 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -69.28 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -161.95 38.95 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 108.663 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.2 6.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.05 121.91 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -1.161 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.431 ' O ' ' CE ' ' A' ' 94' ' ' MET . 7.4 p30 41.61 59.35 9.22 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 122.182 -0.324 . . . . 0.0 111.024 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.02 -31.35 5.02 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.117 2.544 . . . . 0.0 111.506 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.91 112.55 5.65 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.86 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -160.89 -157.91 0.56 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -124.59 160.65 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.014 -1.054 . . . . 0.0 109.692 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tpt180 -139.81 131.85 27.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtp -112.42 166.26 11.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.508 -0.745 . . . . 0.0 110.277 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 9.8 m-85 -139.1 166.25 25.0 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.44 -146.66 5.04 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.7 Cg_endo -73.91 -36.7 3.33 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 123.828 3.019 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.5 -27.31 68.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -90.32 1.12 56.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.597 -0.69 . . . . 0.0 110.68 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.1 pp -129.96 147.27 51.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.105 -0.997 . . . . 0.0 109.583 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 87' ' ' LEU . 10.9 p -71.74 139.16 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -71.5 -32.0 67.73 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -64.05 -19.88 65.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.09 -49.42 2.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.96 -28.1 9.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.513 -0.742 . . . . 0.0 110.757 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 19.54 9.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.291 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.8 mtpt -118.34 133.88 55.51 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -67.18 111.61 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.568 -0.708 . . . . 0.0 111.07 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -117.15 164.53 14.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.17 13.49 2.62 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.945 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 75' ' ' SER . 5.6 mtt180 -143.67 144.22 31.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.869 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.8 p -138.64 139.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.399 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.46 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.2 tttt -105.49 124.28 49.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 45' ' ' VAL . 50.2 mm -119.68 112.35 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.621 -0.674 . . . . 0.0 109.689 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 44' ' ' SER . 29.6 t -113.78 118.84 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 O-C-N 121.21 -0.932 . . . . 0.0 109.546 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 93.56 7.32 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -92.48 128.68 38.42 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.639 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER 173.91 69.6 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -174.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.21 92.04 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.881 2.387 . . . . 0.0 108.768 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -120.78 -10.15 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.727 -177.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.413 ' CB ' ' OE1' ' A' ' 40' ' ' GLU . 32.6 t -128.77 -175.59 3.58 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.889 -1.132 . . . . 0.0 110.72 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 14.8 tttm -133.54 -33.52 1.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.698 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 1.5 p30 -126.24 -5.03 6.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.017 -1.052 . . . . 0.0 112.247 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -110.93 150.4 41.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.946 -1.096 . . . . 0.0 110.678 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 51.2 Cg_endo -92.08 172.25 2.53 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.083 3.189 . . . . 0.0 110.559 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.47 -160.48 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.059 -1.026 . . . . 0.0 109.513 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.631 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 150.24 -112.02 0.53 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -142.9 161.91 36.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.064 -1.257 . . . . 0.0 111.733 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 5.5 m -83.26 -17.2 43.48 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.708 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.68 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.3 p90 -176.01 166.55 2.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.327 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 24' ' ' LEU . 20.2 m -145.1 137.78 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -149.89 163.27 38.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.997 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.869 ' CE2' HG11 ' A' ' 128' ' ' VAL . 55.9 m-85 -140.72 152.73 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.435 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -151.59 139.16 19.62 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 4' ' ' ILE . 6.1 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.472 ' CG2' HD22 ' A' ' 49' ' ' LEU . 76.9 mt -142.14 127.98 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.05 172.21 7.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.694 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.738 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -100.16 134.88 42.44 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.592 -0.692 . . . . 0.0 109.525 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.655 ' N ' HD13 ' A' ' 6' ' ' LEU . 2.8 tpt85 -88.52 -61.52 1.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 48' ' ' GLN . 3.4 p-80 -160.86 163.54 31.96 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -79.38 89.8 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 11' ' ' SER . 2.0 p -52.49 -55.63 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.177 -0.952 . . . . 0.0 109.973 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.46 161.05 25.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.0 p -154.58 144.15 21.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -141.12 46.72 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.747 -0.596 . . . . 0.0 109.498 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 152.88 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.735 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -155.64 139.95 16.67 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.055 -1.028 . . . . 0.0 109.866 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.45 -161.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.904 . . . . 0.0 109.832 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -68.04 0.82 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.578 -0.701 . . . . 0.0 109.895 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -64.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.451 -0.781 . . . . 0.0 109.16 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.32 58.7 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.4 p -79.71 179.18 7.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.749 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -65.06 -25.7 67.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.84 -15.85 59.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 109.762 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.42 -17.31 64.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.133 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.772 HD22 HG22 ' A' ' 147' ' ' VAL . 12.0 mt -64.76 -24.27 67.51 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 7' ' ' ARG . 4.2 mm? -55.77 -23.99 32.94 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.479 -0.763 . . . . 0.0 109.011 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' HG21 ' A' ' 29' ' ' THR . 31.9 mmtt -108.25 60.81 0.61 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.57 64.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.986 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.05 64.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 26' ' ' LYS . 33.8 p -152.68 -90.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.1 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.075 -1.016 . . . . 0.0 110.082 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -128.47 147.47 50.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.045 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 20.1 mttp -132.5 176.08 8.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.413 -0.805 . . . . 0.0 110.204 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.696 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.0 t90 -88.48 139.49 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -144.67 130.5 19.21 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.97 146.47 8.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.795 . . . . 0.0 110.025 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.12 -22.09 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.738 -0.601 . . . . 0.0 110.436 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 175.58 9.43 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.86 -166.1 1.31 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 68.14 44.3 77.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -48.28 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.513 0.673 . . . . 0.0 111.246 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 42' ' ' THR . 31.6 ttmt -97.8 -58.33 2.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.671 HG22 ' OG ' ' A' ' 133' ' ' SER . 33.5 p -156.29 118.43 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.0 pt -116.01 147.22 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.426 -0.796 . . . . 0.0 110.205 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -126.83 149.52 49.67 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.417 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.749 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.6 p -154.44 107.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.0 t -90.9 120.71 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.738 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.6 mp -100.11 163.29 12.49 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.456 0.646 . . . . 0.0 110.117 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 62.9 tp60 -116.55 117.64 30.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.748 HD13 ' OE2' ' A' ' 53' ' ' GLU . 35.9 mt -71.13 143.58 50.54 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.18 37.15 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.707 -0.621 . . . . 0.0 110.975 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.91 137.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 4.3 tt0 -76.93 108.14 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.748 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -137.6 176.78 8.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -87.25 179.79 6.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -140.5 133.06 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.885 . . . . 0.0 109.941 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HA ' HD21 ' A' ' 116' ' ' LEU . 9.4 t-160 -120.4 -32.81 4.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 0.0 109.692 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.43 163.28 33.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG22 ' HD1' ' A' ' 149' ' ' PHE . 83.3 t -143.37 166.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.614 -0.679 . . . . 0.0 109.215 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.638 ' C ' HD13 ' A' ' 60' ' ' ILE . 5.0 t0 -137.66 102.07 4.65 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.0 110.114 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.638 HD13 ' C ' ' A' ' 59' ' ' ASP . 1.6 mm -115.18 117.98 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.31 114.45 3.97 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.09 127.74 33.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.798 -0.825 . . . . 0.0 110.671 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 67.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.4 -30.1 10.2 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.37 -172.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.967 . . . . 0.0 109.62 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -155.0 -52.81 0.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.695 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.6 m-85 -99.93 123.13 43.84 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.839 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 60' ' ' ILE . 47.3 t -127.75 111.58 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.025 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.78 144.3 31.3 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.711 HG13 ' CD1' ' A' ' 130' ' ' ILE . 20.0 t -133.29 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.6 mp -111.47 158.84 18.67 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.788 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.4 m -120.67 158.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.728 -0.607 . . . . 0.0 110.361 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.44 174.26 44.54 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 t -115.78 159.67 21.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 109.821 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.405 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.3 p -75.51 -5.14 43.72 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.643 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.075 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.533 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.1 m-85 -109.42 -175.12 2.67 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.47 129.91 46.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 71' ' ' LEU . 38.9 t -59.34 87.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.806 -0.559 . . . . 0.0 111.222 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.788 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -59.96 -59.23 5.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.488 HD11 HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -137.23 124.06 21.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 109.209 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -54.72 -177.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 0.0 110.114 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.75 133.29 49.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 109.23 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 38.1 p -99.57 120.93 40.45 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -86.15 124.17 32.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 31.0 m-85 -118.67 -47.3 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.633 -0.667 . . . . 0.0 110.237 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 69.8 mtp -122.07 -174.65 2.94 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.603 0.716 . . . . 0.0 110.963 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.2 p -117.14 174.76 2.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.36 12.59 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.19 2.594 . . . . 0.0 111.563 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.4 -39.51 2.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.937 . . . . 0.0 109.754 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -80.2 -20.52 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.8 p -58.06 -22.75 51.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.396 -0.815 . . . . 0.0 110.547 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -68.3 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.216 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 38.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.69 -17.96 7.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.35 117.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.239 . . . . 0.0 110.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 39.76 72.71 0.94 Allowed Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 121.944 -0.473 . . . . 0.0 111.963 178.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.7 -30.33 4.94 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.747 2.298 . . . . 0.0 109.62 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.97 115.21 18.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 -168.78 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.504 -0.747 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.632 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 41.3 t -144.75 131.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HD2' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mmt85 -135.21 131.8 37.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.9 mtt -105.14 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.769 -0.582 . . . . 0.0 109.508 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.511 ' CE1' HG12 ' A' ' 60' ' ' ILE . 14.3 m-85 -140.26 163.98 31.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.74 0.781 . . . . 0.0 109.885 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -144.35 -153.68 5.93 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.6 Cg_endo -74.83 -24.3 13.35 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 123.602 2.868 . . . . 0.0 111.033 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -43.71 41.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.564 -0.71 . . . . 0.0 111.166 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.48 13.12 20.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 110.656 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -114.76 121.0 41.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -48.94 130.57 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.756 -0.59 . . . . 0.0 110.736 -177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.86 -39.24 87.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.443 -0.786 . . . . 0.0 109.224 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.77 89.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.747 -0.596 . . . . 0.0 110.572 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -92.08 -34.9 14.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.41 -0.806 . . . . 0.0 109.373 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.72 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.11 -33.73 3.71 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.595 -0.69 . . . . 0.0 110.993 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.02 10.81 40.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.801 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 2.4 mmtt -92.9 133.13 36.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -72.35 104.57 3.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.312 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 72.0 m95 -110.4 157.54 19.44 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 2.6 p30 -131.27 4.15 4.35 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.271 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.1 mtt180 -132.52 150.61 52.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -144.18 141.59 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.234 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.5 tttm -108.58 110.92 22.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.737 -0.602 . . . . 0.0 109.899 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.711 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.7 mm -104.71 118.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 44' ' ' SER . 39.9 t -122.56 122.1 65.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.26 -0.9 . . . . 0.0 110.03 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.541 ' SG ' HD22 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -95.62 145.72 25.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.671 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.35 126.71 12.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 111.892 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.29 138.94 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 43.8 Cg_endo -90.06 103.26 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 123.189 2.593 . . . . 0.0 110.178 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 65' ' ' SER . 5.4 p90 -137.17 -4.11 1.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.233 -0.917 . . . . 0.0 112.414 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 -173.86 3.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.847 -1.158 . . . . 0.0 110.463 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -173.44 -39.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -105.45 -42.08 5.32 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.647 0.736 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 1.0 OUTLIER -107.97 145.33 31.18 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.5 Cg_endo -87.02 166.89 8.26 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.119 2.546 . . . . 0.0 110.507 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -171.44 -164.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 109.07 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.6 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 164.43 -106.84 0.28 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.642 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -129.23 149.76 50.89 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -71.72 -18.01 62.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 122.097 -0.377 . . . . 0.0 111.021 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.632 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 40.0 p90 179.07 178.11 0.48 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.772 HG22 HD22 ' A' ' 24' ' ' LEU . 15.7 m -155.65 129.79 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -141.82 156.39 45.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 109.474 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 128' ' ' VAL . 39.6 m-85 -127.87 148.44 50.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -146.63 130.44 17.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.458 -0.776 . . . . 0.0 109.273 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 49' ' ' LEU . 71.4 mt -121.57 123.26 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.47 173.06 6.47 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.437 0.637 . . . . 0.0 109.781 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.6 mp -103.07 165.7 10.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.645 . . . . 0.0 109.57 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.611 ' C ' HD11 ' A' ' 25' ' ' LEU . 10.7 tpt180 -120.22 -47.39 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 48' ' ' GLN . 11.0 p-80 -161.0 -173.11 3.74 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -103.14 92.56 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.48 -0.762 . . . . 0.0 109.372 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -54.55 -60.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.544 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.31 163.63 18.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.444 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 19.7 p -160.05 149.37 17.71 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.059 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -152.31 51.91 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.681 -0.637 . . . . 0.0 109.975 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.715 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.63 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.939 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm100 -125.57 133.66 52.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.967 -1.083 . . . . 0.0 110.651 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.09 -175.5 5.67 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -64.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -56.66 12.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 88.8 m-70 -95.32 69.73 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -86.82 166.84 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.6 -24.33 66.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.701 -0.624 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.51 -21.43 65.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.835 . . . . 0.0 109.712 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -65.71 -19.7 66.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.6 mt -65.72 -24.92 67.09 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.611 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -60.62 -20.83 61.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -109.23 62.69 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.86 -24.84 6.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 m-20 -118.31 78.15 1.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 28' ' ' ASP . 3.1 p -157.29 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.526 -0.734 . . . . 0.0 109.342 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -178.27 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 6.0 mmm180 -144.24 143.72 31.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -0.838 . . . . 0.0 108.798 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -130.58 -162.67 1.23 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.361 -0.837 . . . . 0.0 109.324 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.783 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.6 t90 -96.87 136.08 37.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -143.1 125.93 16.11 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.73 160.06 1.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 110.753 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -83.24 -45.05 14.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -152.03 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.51 -168.31 2.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.818 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 94.52 -22.62 36.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 12.1 mt-10 53.36 52.56 13.24 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.173 -1.193 . . . . 0.0 110.73 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -107.84 -103.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.38 -0.825 . . . . 0.0 109.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.54 HG22 ' OG ' ' A' ' 133' ' ' SER . 49.0 p -108.03 142.9 37.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.655 -1.278 . . . . 0.0 109.462 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 35' ' ' ALA . 5.6 pt -145.21 147.03 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.673 -0.642 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.676 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.721 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -151.06 106.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.5 t -93.66 116.56 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.99 . . . . 0.0 108.911 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -102.29 152.7 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.923 -178.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.506 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.4 tm0? -91.5 158.94 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.71 -0.619 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -107.22 124.94 50.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -52.29 -8.43 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.428 -0.795 . . . . 0.0 112.188 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -162.59 140.77 8.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.806 -1.184 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -75.87 113.72 13.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -147.52 -176.46 5.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.87 172.34 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' O ' HD22 ' A' ' 116' ' ' LEU . 4.4 mp -128.72 120.04 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 109.509 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.502 ' O ' HD21 ' A' ' 116' ' ' LEU . 23.1 t60 -110.62 -29.37 8.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -147.19 157.22 43.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.707 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.5 t -142.22 163.11 18.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.058 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 60' ' ' ILE . 7.0 m-20 -137.3 141.77 41.9 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.7 OUTLIER -154.87 123.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -87.68 121.7 5.98 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.6 125.59 29.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.971 -0.723 . . . . 0.0 110.162 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' N ' ' A' ' 145' ' ' SER . 2.5 t0 -126.39 62.98 1.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.6 -28.9 13.91 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.454 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 p -56.75 166.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.643 -0.916 . . . . 0.0 110.191 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.32 -57.37 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.16 123.36 45.18 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.56 111.66 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 0.0 110.204 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -105.06 141.43 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 130' ' ' ILE . 35.5 t -130.78 127.23 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.52 -0.737 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 HG22 ' A' ' 86' ' ' VAL . 1.9 mp -110.67 160.92 16.26 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.66 HG11 HD13 ' A' ' 87' ' ' LEU . 3.6 m -121.76 161.52 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.634 -0.666 . . . . 0.0 110.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 168.16 37.14 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 t -119.5 158.35 26.46 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.012 -0.699 . . . . 0.0 109.523 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.417 ' HB3' ' NE ' ' A' ' 127' ' ' ARG . 37.9 p -91.65 13.28 18.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 110.36 -179.378 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.17 -175.48 2.69 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.739 ' CD ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -139.52 135.79 33.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG22 HD11 ' A' ' 71' ' ' LEU . 24.3 t -58.08 89.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.636 -0.665 . . . . 0.0 111.952 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.66 HD13 HG11 ' A' ' 72' ' ' VAL . 12.6 tp -65.26 -54.0 35.83 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.631 HD13 ' CD2' ' A' ' 111' ' ' PHE . 2.1 pp -138.64 122.36 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.385 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.524 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -54.76 -177.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.175 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 t -69.64 136.53 51.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.494 -0.754 . . . . 0.0 109.171 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 125.72 52.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.429 0.633 . . . . 0.0 109.961 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -83.79 104.68 14.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 19.2 m-85 -101.89 -47.02 4.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 110.343 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.594 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 2.5 ttp -117.9 -178.5 3.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -114.89 173.76 2.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -88.17 18.88 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.288 2.658 . . . . 0.0 111.292 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.32 -50.0 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -57.65 -21.43 39.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.395 -0.816 . . . . 0.0 110.307 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 p -45.71 -27.82 0.89 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.0 111.453 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -78.09 0.45 Allowed 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.761 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.8 37.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.45 -27.52 59.28 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 -82.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.542 -0.975 . . . . 0.0 110.489 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.426 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.7 p30 -112.03 87.48 8.85 Favored Pre-proline 0 C--N 1.296 -1.735 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.594 ' O ' ' HE1' ' A' ' 94' ' ' MET . 37.5 Cg_endo -69.91 -24.93 28.42 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.651 2.234 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -136.43 148.1 47.59 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -157.68 -168.02 2.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.594 -0.691 . . . . 0.0 109.821 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 96.1 t -137.73 129.77 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 23.5 mmt-85 -137.81 150.48 47.23 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 37.4 mtm -134.43 166.51 22.68 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.596 0.712 . . . . 0.0 110.807 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.1 m-85 -119.76 171.13 8.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.65 -150.71 5.37 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.1 Cg_endo -76.0 -37.43 1.57 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.677 2.918 . . . . 0.0 110.77 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.34 -26.14 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.526 -0.734 . . . . 0.0 109.763 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.96 2.16 56.15 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.652 -0.655 . . . . 0.0 110.74 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.984 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -122.5 141.1 52.01 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.981 -1.074 . . . . 0.0 110.519 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.913 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -61.42 138.71 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -32.87 49.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.356 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.03 -18.12 65.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.503 -0.748 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.19 -45.64 2.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.267 -0.895 . . . . 0.0 110.007 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.05 -39.58 28.05 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.342 -0.849 . . . . 0.0 111.08 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -81.37 1.18 34.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 15.9 mttt -94.04 134.27 36.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -68.58 112.43 5.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.446 -0.784 . . . . 0.0 110.919 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 79.4 m95 -115.14 166.44 11.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.66 12.31 2.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.714 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.73 ' HD3' HG21 ' A' ' 10' ' ' VAL . 7.8 mtt180 -146.92 141.5 26.59 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.93 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.8 p -131.79 143.79 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.579 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HG3' HG22 ' A' ' 46' ' ' VAL . 5.8 tttp -107.64 114.11 27.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.609 . . . . 0.0 109.48 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 44.8 mm -105.5 115.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.648 -0.658 . . . . 0.0 109.599 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.676 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.4 t -122.23 116.27 48.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.2 t -89.34 156.6 18.61 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -151.44 127.81 10.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.361 -0.837 . . . . 0.0 110.988 -178.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.746 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.0 tp60 149.32 136.11 0.0 OUTLIER Pre-proline 0 N--CA 1.519 3.002 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 43.4 Cg_endo -85.89 91.29 0.66 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.906 2.404 . . . . 0.0 110.269 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.47 -0.38 57.45 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.491 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 t -168.3 -162.69 0.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.791 -1.193 . . . . 0.0 110.261 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mtpt -138.89 -39.34 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -117.17 -13.76 10.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -0.984 . . . . 0.0 111.343 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -104.6 142.3 24.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.324 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 46.6 Cg_endo -88.03 177.13 3.56 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.479 2.786 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 173.14 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.594 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 165.37 -112.98 0.53 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.962 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -133.07 160.02 38.4 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.238 -1.154 . . . . 0.0 110.731 -179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 67.3 m -78.64 -21.86 47.77 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.752 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.5 p90 177.08 178.95 0.24 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.249 -0.907 . . . . 0.0 110.459 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 144' ' ' LEU . 33.7 m -154.21 129.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 3.2 mtt85 -139.95 114.4 9.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.766 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.93 ' CE2' HG11 ' A' ' 128' ' ' VAL . 73.0 m-85 -87.94 157.25 18.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.281 -0.887 . . . . 0.0 108.901 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -154.2 136.8 15.14 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.353 -0.842 . . . . 0.0 109.174 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.651 -0.655 . . . . 0.0 110.913 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.749 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -141.04 128.74 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -113.42 151.33 31.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.926 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.2 tp -84.74 149.47 25.75 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.628 ' C ' HD11 ' A' ' 25' ' ' LEU . 11.7 tpt85 -103.87 -50.26 3.44 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -161.03 -178.59 6.88 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -99.96 97.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG13 ' H ' ' A' ' 11' ' ' SER . 2.2 p -54.77 -59.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.329 -0.857 . . . . 0.0 110.442 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.541 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.54 154.25 36.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.147 -0.971 . . . . 0.0 108.75 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . 23.8 p -143.4 125.26 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.0 110.715 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.3 m -127.51 50.1 2.05 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.587 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 154.23 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.87 ' OE1' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.41 146.23 36.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 109.883 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.34 -170.72 2.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.72 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -99.38 -68.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.785 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -37.79 87.24 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -116.56 70.11 0.76 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.9 p -87.5 172.37 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.189 0.995 . . . . 0.0 109.53 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -64.9 -24.98 67.69 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.231 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.78 -20.4 56.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.807 . . . . 0.0 109.509 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.42 -20.5 66.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.3 mt -66.27 -26.94 67.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.628 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.2 mm? -61.65 -18.84 61.14 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.474 -0.766 . . . . 0.0 109.175 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -112.25 66.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.54 -45.4 56.87 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.541 -0.724 . . . . 0.0 110.366 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.86 78.98 7.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.058 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.0 -152.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -130.8 40.3 3.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.069 -1.02 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -149.83 136.55 19.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -160.24 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.493 -0.755 . . . . 0.0 109.738 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.877 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.0 t90 -85.43 140.24 30.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.264 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 129.69 22.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.69 161.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.305 -0.872 . . . . 0.0 110.498 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.57 -30.08 66.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.971 -0.456 . . . . 0.0 110.021 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -174.24 3.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.5 -165.27 1.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.57 45.01 95.69 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -46.12 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 111.812 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 42' ' ' THR . 28.1 tttt -94.77 -56.4 2.79 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.686 HG22 ' OG ' ' A' ' 133' ' ' SER . 17.2 p -158.13 113.05 2.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.877 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.0 pt -111.13 139.65 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.608 -0.683 . . . . 0.0 109.527 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' HG13 ' A' ' 131' ' ' VAL . 50.6 m -126.27 122.65 36.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.523 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.87 HG23 ' OE1' ' A' ' 15' ' ' GLN . 7.2 p -123.23 125.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.864 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.5 t -104.48 113.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.08 171.09 8.25 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.364 0.602 . . . . 0.0 110.281 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.726 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.79 174.49 5.9 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.749 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.5 mm? -124.3 140.43 52.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -76.52 26.55 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.214 -0.929 . . . . 0.0 111.469 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.6 pttt 167.1 132.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.77 111.69 11.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.09 167.82 21.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.642 ' O ' HD13 ' A' ' 55' ' ' ILE . 21.8 mt-30 -72.26 -178.77 2.61 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 54' ' ' GLN . 2.6 mm -126.6 128.8 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.417 ' CE1' ' HG3' ' A' ' 113' ' ' PRO . 77.0 t60 -120.69 -38.97 2.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 m -147.11 162.46 38.8 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.642 HG13 ' CD1' ' A' ' 149' ' ' PHE . 89.4 t -147.37 162.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 58' ' ' VAL . 1.8 m-20 -139.92 127.83 22.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.593 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -143.48 130.46 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.14 128.48 9.53 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.78 115.29 20.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.129 -0.63 . . . . 0.0 109.692 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -105.45 61.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.63 -29.08 12.72 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 86.3 p -60.62 173.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.88 -52.71 0.52 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.4 m-85 -95.34 123.99 39.14 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' ILE . 44.0 t -127.77 111.92 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.553 -0.717 . . . . 0.0 110.036 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -103.28 140.13 37.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG13 ' CD1' ' A' ' 130' ' ' ILE . 29.1 t -126.46 122.7 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.14 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -112.13 162.01 15.89 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.879 HG21 HD13 ' A' ' 87' ' ' LEU . 3.2 m -129.14 160.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 110.275 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.15 174.8 46.74 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -112.03 160.27 17.65 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.799 0.809 . . . . 0.0 109.949 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.437 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 56.0 p -86.37 7.27 26.3 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.973 . . . . 0.0 110.103 -179.552 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.66 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -103.12 -174.43 2.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.488 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -119.32 124.77 47.45 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.12 85.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.798 -0.563 . . . . 0.0 110.446 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.879 HD13 HG21 ' A' ' 72' ' ' VAL . 3.4 tp -57.91 -56.29 23.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.195 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -140.41 124.57 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.629 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -55.92 172.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.542 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -59.48 134.37 56.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.4 p -107.57 124.89 50.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.594 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -84.27 125.03 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CD1' ' CD ' ' A' ' 109' ' ' ARG . 28.7 m-85 -121.66 -43.31 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 3.0 mtp -120.4 -165.28 1.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.658 . . . . 0.0 110.086 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.5 p -129.37 175.13 3.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.93 13.64 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 123.178 2.585 . . . . 0.0 111.257 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.6 m -120.36 -46.34 2.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 -22.92 29.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -50.13 -36.32 29.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 110.919 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -74.5 -84.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.853 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -163.59 37.29 0.09 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.66 -25.25 54.13 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.632 -0.922 . . . . 0.0 110.45 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 90.48 30.51 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.513 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.25 -21.54 23.25 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.537 2.158 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.47 156.51 37.1 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -156.41 -175.18 5.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 0.0 110.228 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.621 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 42.6 t -155.7 115.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' CD ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.49 165.69 19.37 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.378 -0.826 . . . . 0.0 109.679 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.4 mtt -140.43 175.46 9.58 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.497 0.665 . . . . 0.0 110.153 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.5 m-85 -136.7 159.0 43.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 116' ' ' LEU . . . -125.82 -155.01 8.85 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -75.42 -36.77 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.274 2.65 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.45 -29.12 68.49 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -2.72 44.36 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.551 HD12 ' CB ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -124.99 141.19 52.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.948 -1.095 . . . . 0.0 109.956 179.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -51.56 139.98 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -39.2 62.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.157 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.56 -20.91 63.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.51 -43.64 3.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.551 ' CB ' HD12 ' A' ' 116' ' ' LEU . . . -48.3 -32.56 7.52 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.249 -0.907 . . . . 0.0 111.119 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.01 24.23 5.74 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.0 mttm -114.86 137.02 52.46 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -65.34 116.24 6.45 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.78 0.8 . . . . 0.0 110.462 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.487 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 63.2 m95 -122.66 151.05 41.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -133.52 5.19 3.71 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.429 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -132.75 141.39 48.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.774 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.7 p -135.06 141.17 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.655 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.864 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.4 tttt -109.59 121.09 44.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.813 -0.554 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.6 mm -115.5 114.07 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 109.142 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.523 HG13 ' OG ' ' A' ' 44' ' ' SER . 61.2 t -114.88 116.83 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.353 -0.842 . . . . 0.0 109.946 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.444 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -92.49 137.38 32.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.686 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -137.94 123.44 19.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.507 -178.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.8 tp60 166.43 133.46 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -87.02 95.05 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.928 2.419 . . . . 0.0 108.952 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.1 p90 -127.79 -7.25 5.59 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.273 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.12 178.65 6.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.0 110.527 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -156.96 -42.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.83 -36.7 5.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.49 -0.756 . . . . 0.0 109.669 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.41 147.67 34.33 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -87.5 178.43 3.38 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.286 2.657 . . . . 0.0 110.777 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER 178.93 -171.9 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.45 -112.1 0.49 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.907 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.593 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.7 mp -111.88 148.79 32.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.68 -0.894 . . . . 0.0 110.412 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -84.89 -27.66 26.5 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.621 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 52.1 p90 -176.03 169.8 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.673 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.8 m -150.15 134.69 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.161 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 17.3 mtt180 -145.63 113.98 6.67 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.531 -0.731 . . . . 0.0 109.855 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 128' ' ' VAL . 64.1 m-85 -93.3 152.56 19.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 133.54 20.81 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.396 -0.815 . . . . 0.0 108.805 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.424 ' CB ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.725 -0.609 . . . . 0.0 109.364 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.356 0.598 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' OE1' ' A' ' 53' ' ' GLU . 47.7 mm -79.67 134.72 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -108.24 113.85 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 109.955 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.942 HD12 HD23 ' A' ' 49' ' ' LEU . 3.3 tp -79.76 140.77 36.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.672 -0.643 . . . . 0.0 109.359 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -91.94 -65.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.531 -0.731 . . . . 0.0 109.519 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -160.39 173.22 15.95 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 22' ' ' GLU . 7.1 p -79.76 90.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.211 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG21 HH11 ' A' ' 127' ' ' ARG . 2.3 p -53.07 -55.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.171 -0.956 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.468 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.19 154.22 37.76 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.989 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.61 125.32 12.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 110.089 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -120.45 45.75 2.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.649 -0.657 . . . . 0.0 109.516 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.606 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.84 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.744 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.83 136.97 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -162.47 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.162 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -93.45 -69.41 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -60.74 2.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.731 . . . . 0.0 109.122 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -88.05 68.43 9.16 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -92.12 170.9 9.46 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.727 0.775 . . . . 0.0 110.219 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.55 -24.26 67.74 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.98 -0.45 . . . . 0.0 109.889 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -61.57 -19.56 62.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -65.5 -18.48 65.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.843 . . . . 0.0 109.157 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.0 mt -65.13 -25.12 67.62 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.3 mm? -60.08 -20.61 58.96 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.47 -0.769 . . . . 0.0 109.033 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -127.29 73.8 1.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.81 -51.25 30.35 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.651 -0.656 . . . . 0.0 110.845 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.92 79.12 8.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -162.22 31.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 109.618 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.2 p90 46.99 25.18 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.242 0.544 . . . . 0.0 111.765 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -126.62 126.05 42.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 108.972 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -123.48 169.83 11.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.33 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.754 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.5 t90 -74.18 141.07 45.53 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -143.19 130.57 21.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.48 151.73 3.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.463 -0.773 . . . . 0.0 110.239 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.41 -33.79 71.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.61 -0.681 . . . . 0.0 109.702 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.24 -157.66 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.72 167.05 18.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.412 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 138' ' ' LYS . . . 96.03 -34.96 4.59 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 3.9 mp0 51.79 104.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.944 . . . . 0.0 111.782 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 42' ' ' THR . 23.8 ttmt -117.31 -51.02 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.727 HG22 ' OG ' ' A' ' 133' ' ' SER . 4.1 p -158.9 105.01 1.76 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 18.7 pt -105.68 139.88 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.361 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.547 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -121.92 149.26 43.67 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.164 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -153.6 112.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.743 HG22 ' HG2' ' A' ' 129' ' ' LYS . 5.8 t -94.08 119.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -97.27 161.25 13.89 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.416 0.627 . . . . 0.0 109.941 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -107.78 145.28 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.38 0.61 . . . . 0.0 109.355 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 HD12 ' A' ' 6' ' ' LEU . 39.1 mt -104.95 133.67 49.34 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 31.9 tt0 -81.68 45.62 0.9 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.448 -0.783 . . . . 0.0 110.612 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 160.0 126.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -73.79 107.88 6.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.54 178.0 7.38 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.406 0.622 . . . . 0.0 109.588 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -89.92 177.23 6.54 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.0 mp -130.72 119.04 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.53 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -108.72 -29.0 8.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.63 -0.669 . . . . 0.0 109.435 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 20.8 m -149.26 146.35 27.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.0 t -131.8 162.07 40.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.454 0.645 . . . . 0.0 109.701 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 60' ' ' ILE . 34.7 t0 -141.79 136.07 30.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 HG11 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -156.58 132.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -106.1 131.74 10.79 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.48 128.03 34.36 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 122.185 -0.597 . . . . 0.0 110.244 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.7 71.33 1.7 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.3 7.45 88.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -84.06 -173.47 4.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.762 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -142.88 -51.65 0.37 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -103.09 130.8 50.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.672 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 60' ' ' ILE . 48.0 t -134.53 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.657 . . . . 0.0 109.575 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -105.56 151.36 24.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.761 -0.587 . . . . 0.0 109.486 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.7 t -141.53 122.99 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.855 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.2 mp -110.56 163.71 13.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG1' HD22 ' A' ' 87' ' ' LEU . 2.9 m -127.86 156.73 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.713 -0.617 . . . . 0.0 109.781 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.29 176.25 45.22 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 t -110.32 156.71 20.36 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.2 p -85.77 7.59 23.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.442 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 179.858 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.2 t0 . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.4 m-85 -113.16 -177.92 3.25 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.741 0.781 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -123.69 129.04 50.5 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.32 86.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 110.292 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.587 HD22 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tp -59.04 -54.41 47.36 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.66 120.73 10.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -57.42 172.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.559 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -57.31 134.06 55.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.3 p -105.34 126.89 52.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.413 0.625 . . . . 0.0 109.325 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 96.2 p -87.88 119.94 28.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 18.1 m-85 -110.21 -51.51 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.629 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.416 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 19.1 mtp -122.03 -162.71 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.508 0.671 . . . . 0.0 110.084 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.1 p -123.51 177.45 1.7 Allowed Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.79 11.53 3.31 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.929 2.419 . . . . 0.0 111.279 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 -36.72 3.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.314 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -81.65 -16.39 51.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.78 . . . . 0.0 110.226 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 m -59.44 -24.67 63.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -67.45 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 t -162.28 38.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 108.722 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.7 -22.32 6.73 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.96 119.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 109.935 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.416 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.9 OUTLIER 40.87 68.72 2.25 Favored Pre-proline 0 N--CA 1.508 2.449 0 O-C-N 121.949 -0.469 . . . . 0.0 111.233 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.1 -30.71 4.16 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.949 2.433 . . . . 0.0 110.52 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.61 82.58 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.665 -0.647 . . . . 0.0 109.647 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.9 171.99 7.54 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -127.29 172.84 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -155.82 145.9 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 109.144 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.4 mtt -123.71 153.7 40.49 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.45 0.643 . . . . 0.0 110.096 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.601 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.9 m-85 -114.8 161.33 18.34 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -131.3 -149.39 6.44 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 38.7 Cg_endo -74.72 -39.36 1.37 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.614 2.876 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.62 -28.29 69.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -89.99 3.77 52.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.662 -0.649 . . . . 0.0 110.598 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.968 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.61 139.66 53.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.013 -1.054 . . . . 0.0 110.521 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.7 p -59.6 130.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -74.84 -30.81 61.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.475 -0.766 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -20.63 65.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.506 -0.746 . . . . 0.0 110.217 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.98 -46.25 2.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.915 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.968 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.8 -39.55 25.76 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.165 -0.959 . . . . 0.0 111.439 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.13 -0.15 30.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.35 -0.843 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.7 mtpt -92.36 134.42 34.94 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -67.76 113.55 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -0.769 . . . . 0.0 110.766 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -116.31 163.85 15.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.11 7.41 3.41 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.585 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.501 HH11 HG21 ' A' ' 10' ' ' VAL . 19.4 mtm180 -137.39 149.45 46.96 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.3 p -134.77 138.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.956 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HG2' HG22 ' A' ' 46' ' ' VAL . 1.4 tmtm? -106.36 100.81 10.32 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.929 -0.482 . . . . 0.0 109.761 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.8 mm -97.14 118.7 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 44' ' ' SER . 34.2 t -121.95 122.28 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.343 -0.848 . . . . 0.0 109.613 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.5 t -100.57 138.94 36.95 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.727 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -138.25 132.2 31.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.507 -0.746 . . . . 0.0 111.427 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.727 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 151.19 134.79 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.52 103.83 1.12 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.918 2.412 . . . . 0.0 109.587 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -77.14 -62.54 1.62 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.462 0.649 . . . . 0.0 109.612 -179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.62 -161.58 1.37 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.879 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 16.4 mttm -136.29 34.13 2.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 109.389 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -77.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.12 158.19 37.75 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.977 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.6 Cg_endo -80.8 176.56 8.89 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.625 2.883 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -173.55 -166.11 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.78 -111.0 0.46 Allowed Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.771 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.585 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -117.93 149.94 40.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.598 -0.942 . . . . 0.0 110.465 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.7 m -83.67 -26.22 30.04 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -178.65 164.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.502 -0.749 . . . . 0.0 109.023 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 24' ' ' LEU . 26.3 m -140.17 138.37 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.27 149.42 32.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.582 -0.699 . . . . 0.0 109.589 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.645 ' CD1' HG13 ' A' ' 58' ' ' VAL . 58.7 m-85 -127.71 160.95 30.11 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.41 ' CA ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -155.14 120.42 4.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.275 -0.89 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.701 -0.624 . . . . 0.0 110.349 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' NZ ' ' A' ' 51' ' ' LYS . 68.0 mt -135.8 128.7 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.562 -0.711 . . . . 0.0 109.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.597 ' C ' HD22 ' A' ' 6' ' ' LEU . 41.3 mtt180 -120.08 -175.79 3.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.458 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.4 mm? -111.84 160.48 17.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.668 -0.645 . . . . 0.0 109.613 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -108.06 -48.07 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -160.59 162.25 32.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.28 86.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -51.37 -55.92 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.25 155.63 36.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.53 114.8 4.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -0.869 . . . . 0.0 110.336 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -104.67 47.38 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.487 ' HB2' HG22 ' A' ' 43' ' ' ILE . 3.3 t 151.87 111.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.889 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -161.1 127.63 3.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.064 -1.023 . . . . 0.0 109.834 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.7 150.21 24.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m -61.45 -55.17 34.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.877 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -60.52 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.358 -0.839 . . . . 0.0 108.859 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -102.48 85.45 2.61 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -93.46 163.48 13.56 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.513 0.673 . . . . 0.0 110.096 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.72 -22.01 64.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.838 -0.539 . . . . 0.0 110.007 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.5 tt0 -62.97 -20.73 65.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.819 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -65.45 -18.97 65.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 33' ' ' TRP . 15.5 mt -66.26 -26.06 67.17 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.28 -17.4 62.47 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.562 -0.712 . . . . 0.0 109.25 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HB3' HG21 ' A' ' 29' ' ' THR . 5.3 mmmm -113.12 65.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.22 -26.77 3.14 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.537 -0.727 . . . . 0.0 110.809 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' C ' HG23 ' A' ' 29' ' ' THR . 25.5 t0 -99.75 68.17 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 26' ' ' LYS . 73.9 p -154.97 -161.09 1.14 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -127.56 34.41 4.68 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.365 -0.834 . . . . 0.0 109.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -124.62 105.5 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 35.9 mttt -91.27 162.83 14.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.609 -0.682 . . . . 0.0 109.738 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.729 ' HB2' HD21 ' A' ' 24' ' ' LEU . 23.4 t90 -67.76 139.62 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 127.05 16.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -56.49 164.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 110.616 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -85.16 -30.55 23.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 -156.8 0.53 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.601 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -137.65 172.52 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.83 -25.35 25.56 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mt-10 45.3 51.0 9.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.687 -0.89 . . . . 0.0 112.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 11.7 ttpt -67.06 -59.21 3.66 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.779 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.1 p -160.44 133.79 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -134.54 152.77 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.274 -0.891 . . . . 0.0 110.554 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -129.69 150.37 51.03 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -149.66 106.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' A' ' 129' ' ' LYS . 2.9 t -90.89 118.46 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.729 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.38 158.2 16.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' N ' HD12 ' A' ' 6' ' ' LEU . 17.1 tm0? -104.75 131.21 52.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.554 -0.716 . . . . 0.0 109.683 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 4' ' ' ILE . 4.2 mm? -81.19 121.23 25.88 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -54.06 -6.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.761 ' NZ ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -153.66 150.39 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.877 -1.14 . . . . 0.0 108.033 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.87 111.3 22.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.77 . . . . 0.0 109.013 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.43 -178.59 6.32 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -84.34 -171.02 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.1 115.77 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.507 -0.746 . . . . 0.0 109.313 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.0 t-160 -101.36 -32.01 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.8 m -147.48 153.98 40.22 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.703 HG13 ' CD1' ' A' ' 149' ' ' PHE . 79.7 t -136.72 161.14 36.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.643 -0.661 . . . . 0.0 109.726 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.533 ' C ' HD12 ' A' ' 60' ' ' ILE . 27.5 t0 -139.11 139.24 37.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.617 -0.677 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -157.86 132.12 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -106.46 128.74 9.43 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -80.14 123.32 27.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.157 -0.614 . . . . 0.0 110.521 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 24.9 t0 -97.54 72.41 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 12.5 83.24 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 10.8 t -85.8 172.9 10.43 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.304 -1.115 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -134.8 -56.05 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.8 m-85 -102.26 122.89 45.1 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.702 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 60' ' ' ILE . 43.8 t -126.43 112.52 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.705 . . . . 0.0 109.85 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -104.36 142.47 34.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.71 HG13 HD13 ' A' ' 130' ' ' ILE . 22.2 t -131.08 128.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.967 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.6 mp -115.68 161.26 18.95 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -122.89 161.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.734 -0.604 . . . . 0.0 109.996 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 173.35 41.87 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 t -112.22 162.2 15.73 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.728 0.775 . . . . 0.0 109.833 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 13.0 t -86.27 6.19 30.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.055 -179.588 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.577 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.8 m-85 -106.45 -175.01 2.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.71 0.767 . . . . 0.0 109.061 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.644 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -122.66 126.6 47.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.06 87.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.688 -0.633 . . . . 0.0 110.637 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.1 tp -60.15 -51.82 67.95 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.695 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -146.41 122.69 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.25 -177.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.531 -0.731 . . . . 0.0 110.073 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 135.71 55.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.558 -0.714 . . . . 0.0 109.187 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.422 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.4 p -105.74 123.41 47.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.78 -0.575 . . . . 0.0 109.597 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.7 p -85.25 109.81 18.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 26.7 m-85 -104.65 -49.19 3.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 22.0 mtp -121.21 172.67 7.82 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.718 0.77 . . . . 0.0 110.724 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -104.47 179.38 0.95 Allowed Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.261 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.7 Cg_endo -86.66 16.39 1.97 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.964 2.443 . . . . 0.0 111.341 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 t -120.12 -50.94 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.235 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.16 -12.9 61.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 110.111 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t -58.79 -24.37 61.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -91.55 -73.17 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.07 37.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.82 -21.83 54.74 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.76 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -1.021 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.94 95.78 0.61 Allowed Pre-proline 0 C--N 1.292 -1.912 0 O-C-N 121.814 -0.554 . . . . 0.0 109.51 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.21 -25.95 4.54 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.948 2.432 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.6 119.41 25.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.738 -0.601 . . . . 0.0 109.786 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -147.08 174.43 11.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.52 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.3 m -135.95 166.68 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -154.73 153.88 31.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.452 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.43 156.99 39.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.48 0.657 . . . . 0.0 110.274 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE2' HD13 ' A' ' 88' ' ' LEU . 4.7 m-85 -118.08 167.45 11.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.65 -149.2 5.52 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.94 -39.84 1.1 Allowed 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 123.692 2.928 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.25 -27.87 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.533 -0.73 . . . . 0.0 109.833 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.0 mptp? -91.98 3.76 54.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.665 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.3 pp -123.46 139.86 53.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.022 -1.049 . . . . 0.0 110.549 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -60.42 130.62 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -74.46 -33.76 62.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.83 -21.17 66.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.271 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.68 -47.33 2.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 110.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.4 17.78 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.16 -0.963 . . . . 0.0 111.626 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.92 3.08 27.68 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.745 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 1.1 mtpm? -95.52 136.22 36.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -67.11 113.38 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.48 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.7 m95 -117.43 163.76 15.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.44 14.98 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -142.3 142.48 32.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.7 p -136.61 143.03 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 110.366 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 46' ' ' VAL . 2.5 tttt -111.62 110.43 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.766 -0.584 . . . . 0.0 109.892 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.71 HD13 HG13 ' A' ' 70' ' ' VAL . 47.4 mm -101.82 129.46 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 44' ' ' SER . 28.0 t -130.98 130.01 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.184 -0.947 . . . . 0.0 110.591 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 43' ' ' ILE . 9.7 t -99.71 149.23 23.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.779 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -150.26 118.77 6.48 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.609 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.03 112.24 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.3 97.19 1.11 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.342 2.028 . . . . 0.0 108.725 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.527 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -103.62 -11.42 17.7 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.407 -178.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.76 -167.38 2.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.072 -1.017 . . . . 0.0 110.065 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.78 -47.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.746 -0.597 . . . . 0.0 109.631 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.601 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p30 -108.2 -13.37 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.536 -0.727 . . . . 0.0 110.925 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 35.5 p -99.07 138.46 20.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.265 -0.897 . . . . 0.0 109.861 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.1 Cg_endo -88.2 -177.67 1.91 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.354 2.703 . . . . 0.0 110.502 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 174.52 -164.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 157.44 -115.24 0.65 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.206 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.564 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -120.8 162.29 20.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.685 -0.891 . . . . 0.0 110.84 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 13.7 m -99.14 -27.81 13.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 53.4 p90 -178.05 171.2 1.76 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 147' ' ' VAL . 35.7 m -149.01 123.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -130.26 110.92 11.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 128' ' ' VAL . 85.9 m-85 -90.94 161.97 14.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.238 -0.914 . . . . 0.0 109.105 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -157.33 136.29 11.69 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.666 ' CG2' HD12 ' A' ' 49' ' ' LEU . 61.4 mt -110.43 122.18 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.09 166.32 10.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.68 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.7 mp -103.93 160.19 15.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.697 -0.627 . . . . 0.0 109.557 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -110.23 -54.05 2.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -160.55 164.99 31.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -79.89 93.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.5 -0.75 . . . . 0.0 109.322 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG13 ' H ' ' A' ' 11' ' ' SER . 2.1 p -54.17 -58.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.246 -0.909 . . . . 0.0 110.272 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -121.03 151.67 39.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -143.83 124.3 13.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.995 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -121.5 46.21 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.534 -0.729 . . . . 0.0 109.586 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.09 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.18 143.05 31.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.243 -0.911 . . . . 0.0 109.114 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.25 -161.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 p -98.47 -57.37 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.436 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.67 66.31 4.42 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -82.67 171.94 13.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.53 -0.731 . . . . 0.0 109.893 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.37 -24.05 67.68 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.85 -19.28 63.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -65.78 -17.33 64.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.937 . . . . 0.0 109.322 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 33' ' ' TRP . 19.1 mt -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -62.06 -18.74 61.64 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.528 -0.732 . . . . 0.0 109.252 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 67.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.37 62.49 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.466 -0.771 . . . . 0.0 110.323 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.12 76.51 9.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.469 -0.769 . . . . 0.0 108.984 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 -154.2 0.37 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -130.71 36.48 3.9 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -142.5 121.51 12.86 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -113.19 -165.38 0.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 109.452 -179.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.717 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.4 t90 -81.9 139.67 34.53 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 125.19 16.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.64 148.83 6.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.766 . . . . 0.0 110.359 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.91 -20.22 56.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.94 -0.475 . . . . 0.0 110.228 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -138.82 -171.77 3.16 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.354 -0.841 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.32 -161.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.83 43.55 97.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.1 mm-40 -48.47 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.959 0.885 . . . . 0.0 111.328 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -102.78 -50.73 3.46 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.717 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.4 p -158.86 115.39 2.7 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.676 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.3 pt -120.52 148.69 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.4 -0.812 . . . . 0.0 109.617 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.731 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -125.82 146.97 49.57 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.455 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.5 p -152.32 106.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.8 t -92.38 121.03 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -98.72 160.17 14.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.77 53.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.679 -0.638 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -82.03 138.22 34.92 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.14 38.95 0.49 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.537 -0.727 . . . . 0.0 110.503 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 pttm 161.63 132.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -75.94 107.62 8.26 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -138.15 179.36 6.49 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.445 0.641 . . . . 0.0 109.455 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -90.96 174.75 7.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.14 119.06 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.8 . . . . 0.0 109.677 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.436 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.9 t60 -110.01 -29.31 8.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.5 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.1 m -145.53 154.42 42.17 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.8 t -138.99 163.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.616 -0.677 . . . . 0.0 109.76 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -145.06 125.83 14.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.3 mp -147.84 137.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.951 -1.093 . . . . 0.0 108.3 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.87 126.7 8.94 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.46 123.04 29.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 122.042 -0.681 . . . . 0.0 110.462 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.9 70.87 3.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.37 7.35 88.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -76.91 166.54 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -1.141 . . . . 0.0 109.603 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -127.91 -55.47 1.29 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -103.87 120.92 42.0 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.904 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.56 103.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 6.2 tt0 -86.88 147.04 25.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.415 0.626 . . . . 0.0 109.92 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HD23 ' A' ' 88' ' ' LEU . 56.7 t -136.92 119.52 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.708 HD11 HG22 ' A' ' 86' ' ' VAL . 1.1 mp -114.72 164.54 13.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.743 HG11 HD13 ' A' ' 87' ' ' LEU . 13.6 m -127.93 163.33 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 110.351 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.56 170.28 37.56 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -114.01 160.27 19.04 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 122.027 -0.69 . . . . 0.0 109.213 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 t -92.25 12.82 21.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.917 -179.829 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.64 157.59 29.24 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 145.91 42.58 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.708 HG22 HD11 ' A' ' 71' ' ' LEU . 43.6 t -65.8 90.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.763 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.743 HD13 HG11 ' A' ' 72' ' ' VAL . 1.2 tp -72.78 -58.43 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -117.6 117.55 29.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -61.79 171.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.617 -0.677 . . . . 0.0 109.174 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.54 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -64.24 132.67 50.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.84 121.09 39.34 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.1 p -87.19 93.13 9.29 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 25.0 m-85 -84.23 -52.93 5.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 110.403 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 22.2 mtp -121.33 -168.85 1.75 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.543 -0.723 . . . . 0.0 110.428 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.4 p -115.92 176.76 1.4 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.62 14.86 2.33 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.041 2.494 . . . . 0.0 111.32 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.0 p -121.19 -37.69 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.001 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.88 -24.9 32.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -58.53 -20.73 48.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.734 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -69.32 -84.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.23 39.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 108.745 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.65 -18.27 5.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.97 123.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -1.17 . . . . 0.0 110.159 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 6.5 p30 41.59 66.82 3.55 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 122.066 -0.396 . . . . 0.0 111.504 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.61 -29.89 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.746 2.298 . . . . 0.0 110.488 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.44 103.3 6.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.687 -0.633 . . . . 0.0 109.601 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.55 174.98 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.752 . . . . 0.0 109.104 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.3 m -140.32 141.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 2.5 mmt-85 -134.35 176.99 8.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 mtt -142.08 178.56 7.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.697 -0.627 . . . . 0.0 109.842 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 88' ' ' LEU . 1.3 m-85 -141.92 171.16 14.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.52 -148.05 5.26 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -75.04 -36.63 2.42 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.595 2.863 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.84 -31.78 73.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -81.95 1.75 33.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.715 -0.615 . . . . 0.0 110.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.967 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -130.59 137.84 49.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.167 -0.958 . . . . 0.0 109.639 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.899 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.3 p -56.96 163.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 117' ' ' VAL . 3.6 mtp180 -97.78 -40.63 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.884 . . . . 0.0 109.142 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.02 -17.63 57.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 110.23 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.899 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.42 -50.81 2.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.35 -39.26 21.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.311 -0.868 . . . . 0.0 111.447 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -78.17 -1.85 34.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 110.656 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 23.2 mtpt -91.77 133.7 35.39 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -68.0 111.27 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.825 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 80.1 m95 -113.27 163.46 14.78 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -135.9 10.18 3.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.267 -0.895 . . . . 0.0 110.312 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 75' ' ' SER . 14.6 mtm180 -142.55 139.53 31.44 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.752 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.0 p -130.14 142.07 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.835 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.7 tttt -109.1 114.19 27.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.668 -0.645 . . . . 0.0 109.843 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 45' ' ' VAL . 47.9 mm -105.78 119.64 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.731 HG22 ' HB3' ' A' ' 44' ' ' SER . 44.1 t -124.92 117.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 O-C-N 121.208 -0.932 . . . . 0.0 110.057 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.461 ' HB3' HG13 ' A' ' 43' ' ' ILE . 7.0 t -89.14 142.72 27.4 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.717 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -141.26 124.81 16.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.717 -0.614 . . . . 0.0 110.6 -178.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.6 tp-100 158.33 131.51 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.446 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.35 93.22 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.021 2.481 . . . . 0.0 109.432 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.2 p90 -127.07 15.31 7.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.595 -0.69 . . . . 0.0 111.034 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.63 -169.57 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -176.06 -40.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.97 -36.41 4.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.547 0.689 . . . . 0.0 109.662 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.85 150.84 38.62 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.89 -0.506 . . . . 0.0 109.657 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.95 -171.42 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.354 2.703 . . . . 0.0 110.623 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.85 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.574 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 152.38 -113.5 0.58 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.366 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.575 HD23 HG23 ' A' ' 60' ' ' ILE . 6.4 mp -124.08 151.51 43.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.732 -0.863 . . . . 0.0 110.992 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 48.9 m -86.45 -26.64 24.57 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.538 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 37.5 p90 -175.54 168.48 3.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.5 m -146.02 142.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.8 mtp85 -150.38 160.41 43.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 109.323 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CE2' HG11 ' A' ' 128' ' ' VAL . 38.7 m-85 -142.19 155.77 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 129.24 10.27 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.76 -0.587 . . . . 0.0 109.947 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 151' ' ' SER . 55.3 mt -143.17 126.74 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.72 . . . . 0.0 109.433 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.705 -0.622 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.798 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.1 mp -107.14 161.07 15.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.635 -0.665 . . . . 0.0 109.858 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' C ' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -109.05 -57.71 2.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.686 -0.634 . . . . 0.0 109.31 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -160.8 164.13 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.83 86.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG21 HH11 ' A' ' 127' ' ' ARG . 2.0 p -50.83 -57.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 110.391 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -125.7 153.51 43.79 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.6 p -149.09 146.04 27.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -135.78 46.58 2.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.764 -0.585 . . . . 0.0 109.644 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 153.19 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.64 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -158.36 142.8 15.97 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.133 -0.979 . . . . 0.0 109.519 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -173.55 3.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.18 -0.95 . . . . 0.0 109.564 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -85.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.383 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -56.08 22.47 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -97.01 76.65 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -92.42 169.04 10.87 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.43 -23.76 67.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.852 -0.53 . . . . 0.0 109.709 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.97 -16.83 60.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.857 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -64.52 -18.77 65.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.069 -1.019 . . . . 0.0 109.228 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.2 mt -65.59 -24.97 67.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.471 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.19 -21.39 59.36 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -119.14 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.79 7.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 29' ' ' THR . 10.3 m-20 -121.17 87.21 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.829 . . . . 0.0 109.848 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.95 -87.29 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -177.57 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 0.0 109.73 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.73 142.79 12.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 109.273 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.7 mtmt -127.03 -164.9 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.471 -0.768 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.815 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.1 t90 -88.46 140.25 29.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.45 129.49 17.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.05 148.48 6.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.406 -0.809 . . . . 0.0 110.379 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.14 -23.7 56.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.811 -0.555 . . . . 0.0 110.251 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -139.19 -175.88 4.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.96 -166.64 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 64.12 48.0 79.61 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mp0 -55.15 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.378 0.608 . . . . 0.0 111.026 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 39' ' ' GLY . 18.4 tttt -87.82 -53.49 4.73 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 133' ' ' SER . 37.6 p -155.8 114.92 3.54 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.687 HG21 ' HB2' ' A' ' 35' ' ' ALA . 12.5 pt -115.85 146.86 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.475 -0.766 . . . . 0.0 109.401 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -126.18 149.31 49.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.121 178.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.9 p -152.08 105.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.755 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.6 t -89.81 114.06 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.798 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.1 mp -96.35 163.92 12.87 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.587 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.16 136.39 48.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.692 -0.63 . . . . 0.0 109.876 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.8 134.22 34.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -70.91 20.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.381 -0.824 . . . . 0.0 112.284 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttt 176.61 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.714 -1.241 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -59.19 102.12 0.12 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.628 ' OE2' HG23 ' A' ' 4' ' ' ILE . 10.7 pt-20 -137.21 -177.41 4.76 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.483 0.659 . . . . 0.0 110.121 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -96.39 -177.71 4.05 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.49 121.26 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.428 ' O ' HD21 ' A' ' 116' ' ' LEU . 56.3 t60 -111.03 -29.3 7.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.697 -0.627 . . . . 0.0 109.344 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -148.08 146.31 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 149' ' ' PHE . 74.3 t -129.28 160.47 40.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.445 0.64 . . . . 0.0 109.751 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 2.7 m-20 -139.28 133.92 31.9 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -157.73 135.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -110.4 135.23 12.72 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.71 HD21 HG21 ' A' ' 68' ' ' VAL . 1.4 m-80 -88.04 132.66 34.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.138 -0.625 . . . . 0.0 110.739 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' N ' ' A' ' 145' ' ' SER . 7.0 t0 -113.22 58.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.31 -25.33 18.3 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 15.3 t -57.26 165.77 1.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -1.02 . . . . 0.0 109.908 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.72 -57.82 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.1 m-85 -98.94 118.48 35.79 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 62' ' ' ASN . 59.5 t -125.23 114.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.265 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.91 144.43 31.52 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 88' ' ' LEU . 5.0 t -123.13 125.41 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.54 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -112.09 161.31 16.65 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -125.43 151.11 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 0.0 109.96 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -173.25 166.81 39.37 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -115.93 157.12 25.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.981 -0.717 . . . . 0.0 109.552 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 t -88.05 10.42 19.17 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -104.83 -173.53 2.32 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -125.19 137.94 54.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 71' ' ' LEU . 37.1 t -66.22 87.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.573 -0.705 . . . . 0.0 110.727 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.691 HD13 HG11 ' A' ' 72' ' ' VAL . 11.1 tp -58.27 -47.76 82.61 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 70' ' ' VAL . 1.8 pp -143.18 120.76 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.393 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 88' ' ' LEU . 31.5 m -50.42 174.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 110.587 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -63.91 138.09 58.32 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.573 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.8 p -105.89 123.32 47.78 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -87.67 104.26 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 23.7 m-85 -100.38 -46.55 5.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 mtp -120.16 -170.95 2.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.2 p -126.66 -179.62 0.97 Allowed Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.86 9.42 4.15 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.882 2.388 . . . . 0.0 111.328 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.3 p -114.08 -55.08 2.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -63.0 -20.2 65.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.973 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -56.59 -27.26 57.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.239 -0.913 . . . . 0.0 110.141 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -87.73 -74.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 110.009 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.22 37.52 0.1 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.08 -24.06 35.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -1.004 . . . . 0.0 110.368 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 88.95 35.45 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.13 -18.63 16.23 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.959 2.439 . . . . 0.0 110.27 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.39 115.35 11.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.669 -0.644 . . . . 0.0 109.734 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -144.72 160.31 41.42 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 m -120.94 163.85 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.55 159.12 43.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.39 -0.819 . . . . 0.0 109.374 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.4 mtp -130.08 162.57 28.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.626 -0.671 . . . . 0.0 110.113 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -127.32 165.99 18.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -135.52 -150.11 5.93 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -75.68 -37.98 1.5 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.655 2.904 . . . . 0.0 110.731 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -65.4 -28.27 69.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.57 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -89.34 1.51 55.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.649 -0.657 . . . . 0.0 110.589 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.21 139.89 53.49 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.037 -1.039 . . . . 0.0 109.921 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.894 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -59.22 133.4 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -75.8 -29.99 58.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.338 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.32 -23.23 64.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.598 -0.688 . . . . 0.0 109.977 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.894 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.29 -45.55 3.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.67 -40.57 28.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.215 -0.928 . . . . 0.0 111.291 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -77.86 -3.03 39.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 110.547 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 26.5 mtpt -90.31 132.92 35.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -67.62 109.59 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.544 0.688 . . . . 0.0 110.73 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 87.3 m95 -109.09 164.03 12.79 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.5 6.63 3.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.525 HH11 HG21 ' A' ' 10' ' ' VAL . 35.8 mtm180 -145.99 145.9 30.8 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.74 -1.225 . . . . 0.0 107.919 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.88 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.9 p -132.73 142.46 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.348 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.755 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -105.09 116.17 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.754 -0.591 . . . . 0.0 109.797 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 45' ' ' VAL . 51.4 mm -108.07 119.53 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 44' ' ' SER . 30.6 t -124.7 122.89 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.138 -0.976 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.508 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -97.22 142.46 29.09 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.6 123.37 15.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.712 -0.618 . . . . 0.0 110.375 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.833 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 35.1 tp60 156.84 123.24 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.53 104.55 1.74 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.682 2.255 . . . . 0.0 108.884 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 2.0 p90 -132.0 -10.58 3.4 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.568 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.76 126.38 14.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.839 -1.163 . . . . 0.0 109.513 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -110.39 -26.58 9.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.843 -0.536 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.58 -43.66 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 110.262 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.09 145.74 32.38 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.822 -0.549 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.2 Cg_endo -87.03 166.19 8.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.33 2.687 . . . . 0.0 110.409 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -176.85 -165.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.98 -102.63 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 147' ' ' VAL . 5.6 mp -115.26 155.43 27.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.575 -0.956 . . . . 0.0 110.604 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 23.6 m -89.49 -27.51 20.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.531 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 50.1 p90 -178.09 162.31 1.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.6 m -138.64 141.29 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.0 mtp180 -145.79 160.63 41.48 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.478 0.656 . . . . 0.0 110.342 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.88 ' CE2' HG11 ' A' ' 128' ' ' VAL . 54.6 m-85 -142.24 156.88 45.32 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -157.01 136.73 12.37 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.9 p . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' OE1' ' A' ' 53' ' ' GLU . 62.2 mt -125.09 123.76 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -105.2 161.02 14.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.733 -0.604 . . . . 0.0 109.658 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -95.73 151.43 19.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.468 ' C ' HD11 ' A' ' 25' ' ' LEU . 43.3 ttt85 -103.93 -54.32 2.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 109.383 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.407 ' CE1' ' HD3' ' A' ' 7' ' ' ARG . 4.9 p-80 -160.54 166.49 28.97 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -83.69 93.97 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.772 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -53.15 -60.13 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.131 -0.981 . . . . 0.0 110.16 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.512 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.1 155.49 35.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -153.24 105.63 2.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.257 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -105.94 56.46 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 153.46 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -132.97 139.64 47.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.734 -1.229 . . . . 0.0 110.145 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.83 148.57 22.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 109.326 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.6 t -61.14 -52.86 63.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.582 -0.699 . . . . 0.0 110.155 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -58.55 8.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.344 -0.847 . . . . 0.0 109.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -110.16 86.99 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -92.29 166.65 12.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.552 0.692 . . . . 0.0 110.359 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.54 -23.52 67.03 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.3 tt0 -61.96 -18.44 60.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.339 -0.85 . . . . 0.0 109.724 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -65.27 -17.51 64.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.256 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.09 -25.68 67.9 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -58.09 -22.41 50.52 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.491 -0.756 . . . . 0.0 109.002 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -115.36 67.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.51 -25.83 4.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.739 . . . . 0.0 110.6 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' THR . 31.3 m-20 -122.03 88.78 3.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 0.0 109.796 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -157.98 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.583 -0.698 . . . . 0.0 109.236 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 44.2 p90 -178.16 35.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 28.5 mtm180 -157.17 137.53 12.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.2 mtmp? -120.53 -176.87 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.7 t90 -78.51 138.18 38.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -141.66 128.32 20.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.21 168.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.691 0.758 . . . . 0.0 111.21 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -79.16 -30.52 43.57 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.139 0.495 . . . . 0.0 109.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -120.36 -172.16 2.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.2 -165.23 1.1 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.15 45.29 96.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 1.3 mp0 -43.74 89.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.487 0.66 . . . . 0.0 112.075 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 42' ' ' THR . 10.6 pttt -103.02 -44.21 5.29 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.3 p -160.51 132.36 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.761 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -137.73 136.03 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.418 -0.801 . . . . 0.0 110.204 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -112.22 140.84 46.59 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.462 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.754 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -147.41 106.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 128' ' ' VAL . 10.8 t -91.36 121.53 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.673 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -100.42 168.98 9.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -114.14 148.07 37.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.712 -0.617 . . . . 0.0 109.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.522 HD12 ' CA ' ' A' ' 126' ' ' ASP . 18.1 mt -101.73 137.57 39.87 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.75 40.2 0.51 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.37 -0.831 . . . . 0.0 110.909 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 1.7 pttm 161.32 130.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 14.4 tt0 -75.55 110.6 10.07 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -140.25 -179.49 6.02 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.01 178.14 6.09 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.415 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -127.76 115.71 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -103.4 -30.83 10.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -148.1 159.03 44.34 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.8 t -141.91 158.23 20.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.48 0.657 . . . . 0.0 109.389 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.3 m-20 -140.13 137.89 34.81 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -158.25 130.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.8 132.33 10.96 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.7 126.72 36.07 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.301 -0.529 . . . . 0.0 110.366 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -97.7 64.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.93 60.26 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 72.0 m -55.57 158.2 3.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -1.1 . . . . 0.0 110.322 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -119.64 -58.65 1.88 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 133' ' ' SER . 19.5 m-85 -99.61 129.99 45.8 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.946 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 60' ' ' ILE . 53.8 t -130.43 111.84 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.629 . . . . 0.0 109.692 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -105.63 146.28 29.9 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.726 HG22 ' CD1' ' A' ' 130' ' ' ILE . 22.0 t -135.79 126.56 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.57 -0.706 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.59 160.46 18.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.659 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.2 m -121.49 157.82 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.789 -0.569 . . . . 0.0 109.894 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.18 172.45 42.61 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -114.04 158.78 20.76 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 122.041 -0.682 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -73.43 -4.97 36.91 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.797 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 t70 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.4 m-85 -101.36 -173.26 2.32 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.659 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -121.1 130.58 53.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.28 85.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.366 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.626 ' HB2' HG13 ' A' ' 72' ' ' VAL . 15.3 tp -58.03 -59.81 4.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -137.8 120.49 16.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.33 179.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.745 . . . . 0.0 110.325 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 134.4 53.58 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.601 -0.687 . . . . 0.0 109.153 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.1 p -107.87 125.85 51.96 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.441 0.639 . . . . 0.0 109.769 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 84.9 p -83.7 127.83 34.07 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CG ' ' HD3' ' A' ' 109' ' ' ARG . 22.8 m-85 -120.95 -48.21 2.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 81.4 mtp -121.95 -176.83 3.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.933 0.873 . . . . 0.0 111.352 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -120.55 173.93 3.37 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.57 9.48 4.08 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.911 2.407 . . . . 0.0 111.315 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.0 m -120.77 -35.03 3.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.35 -21.67 35.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.316 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.9 p -58.23 -22.13 50.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -0.805 . . . . 0.0 110.425 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -67.96 -83.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.338 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -162.45 39.2 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.74 -22.38 5.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.26 118.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -1.135 . . . . 0.0 110.396 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 41.21 77.44 0.43 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.929 -0.482 . . . . 0.0 111.366 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.12 -28.55 2.39 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.05 2.5 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.41 92.85 2.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -123.89 -176.13 3.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.724 . . . . 0.0 109.332 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.7 m -134.6 158.33 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.713 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' ' CG ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.94 159.78 41.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.8 mtm -135.57 166.23 23.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.0 110.295 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.0 m-85 -129.46 169.63 14.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -140.12 -148.57 5.19 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.7 -39.6 1.31 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.674 2.916 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.37 -28.83 69.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.493 -0.754 . . . . 0.0 109.648 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.59 54.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.658 -0.651 . . . . 0.0 110.598 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -123.51 138.76 54.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.05 -1.031 . . . . 0.0 110.38 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -59.37 130.34 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -33.44 63.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.786 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.95 66.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.334 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.96 -46.68 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.162 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.952 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.73 -38.55 21.92 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.143 -0.973 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.14 0.6 31.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 110.706 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.2 mtpp -92.54 135.81 33.75 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.41 113.2 5.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.744 0.783 . . . . 0.0 110.753 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.3 m95 -115.84 165.97 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.522 ' CA ' HD12 ' A' ' 49' ' ' LEU . 3.8 p30 -140.68 15.5 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.132 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.447 ' HD3' HG11 ' A' ' 10' ' ' VAL . 13.4 mtt180 -145.5 147.58 32.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -137.3 142.14 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.105 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.3 tttt -110.88 108.43 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.668 -0.645 . . . . 0.0 109.729 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.726 ' CD1' HG22 ' A' ' 70' ' ' VAL . 48.4 mm -101.96 127.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 44' ' ' SER . 61.0 t -132.47 115.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.522 ' HB3' HG13 ' A' ' 43' ' ' ILE . 3.1 t -85.55 149.68 25.2 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.726 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.9 122.9 9.41 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.264 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.73 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.45 94.68 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.008 2.472 . . . . 0.0 110.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -121.62 -17.55 7.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.0 111.285 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.48 169.49 8.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.462 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 24.9 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.793 -0.567 . . . . 0.0 109.634 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.79 -46.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.6 146.35 32.44 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.58 169.28 8.19 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.432 2.755 . . . . 0.0 110.898 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 179.49 -164.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.86 -105.93 0.26 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.193 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 60' ' ' ILE . 5.6 mp -115.79 154.67 29.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.937 . . . . 0.0 110.716 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 49.2 m -87.34 -27.99 22.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 52.6 p90 -179.24 167.67 1.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.514 -0.741 . . . . 0.0 109.509 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.5 m -142.46 131.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 14.7 mtt180 -139.07 121.66 16.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.028 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.694 ' CD1' HG13 ' A' ' 58' ' ' VAL . 67.5 m-85 -104.36 156.68 17.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.109 -0.995 . . . . 0.0 109.41 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -150.97 131.28 13.65 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.317 -0.865 . . . . 0.0 109.714 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.704 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG2' HD12 ' A' ' 49' ' ' LEU . 72.1 mt -117.67 124.71 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -104.78 164.8 11.51 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.455 0.645 . . . . 0.0 110.084 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.775 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -97.53 127.63 43.64 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.642 ' N ' HD13 ' A' ' 6' ' ' LEU . 3.7 ttt180 -82.11 -56.89 3.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.379 -0.825 . . . . 0.0 109.584 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.93 165.1 30.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.659 -0.651 . . . . 0.0 109.409 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -81.29 90.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.774 . . . . 0.0 109.307 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.731 HG21 ' NH1' ' A' ' 127' ' ' ARG . 1.8 p -54.37 -58.28 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.487 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -118.04 143.47 46.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.31 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -130.81 124.03 30.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -0.796 . . . . 0.0 109.711 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -124.59 42.24 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.3 m 153.93 76.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.64 141.46 26.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 108.987 -179.361 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -164.49 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.336 -0.853 . . . . 0.0 109.071 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -64.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -49.22 76.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 109.067 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.04 73.7 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -91.71 168.86 11.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.503 -0.748 . . . . 0.0 110.095 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.67 -23.01 67.12 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.616 ' HG3' HG12 ' A' ' 9' ' ' VAL . 1.6 tt0 -63.87 -17.49 63.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.8 -17.8 64.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 109.286 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 33' ' ' TRP . 21.1 mt -65.17 -24.28 67.34 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -58.54 -22.35 55.22 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.526 -0.734 . . . . 0.0 109.055 178.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -107.67 61.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.14 -25.23 4.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.425 -0.797 . . . . 0.0 110.708 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -118.35 76.58 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 28' ' ' ASP . 5.4 p -156.42 -95.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.774 . . . . 0.0 109.075 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -178.4 36.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.391 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -141.75 138.02 32.02 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 11.1 mttm -128.66 -178.69 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.422 -0.799 . . . . 0.0 110.807 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.704 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -80.98 140.46 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.43 129.07 17.13 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.37 150.8 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.496 -0.752 . . . . 0.0 110.909 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.25 -26.56 68.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -169.79 2.09 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.11 178.77 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.73 -30.74 8.78 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 18.4 mm-40 40.67 31.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.969 -0.724 . . . . 0.0 112.526 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 42' ' ' THR . 0.0 OUTLIER -51.57 -52.94 43.17 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.696 -0.627 . . . . 0.0 109.316 179.38 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.9 p -160.32 129.43 4.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.704 HD12 ' CH2' ' A' ' 33' ' ' TRP . 13.1 pt -130.2 141.72 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.86 . . . . 0.0 110.322 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.581 ' OG ' HG13 ' A' ' 131' ' ' VAL . 29.5 m -126.06 141.22 52.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.293 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.703 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.4 p -146.27 110.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 ' HD2' ' A' ' 129' ' ' LYS . 2.7 t -90.42 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.775 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.2 mp -100.09 157.6 16.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -99.89 145.58 27.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 109.834 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -97.96 140.35 32.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.28 33.81 0.24 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.417 -0.802 . . . . 0.0 111.115 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.4 pttm 161.22 138.39 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 10.0 tt0 -75.16 102.48 4.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -131.35 165.74 22.8 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.7 0.762 . . . . 0.0 109.786 -179.163 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 55' ' ' ILE . 15.9 mt-30 -76.15 -176.96 3.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 54' ' ' GLN . 1.9 mm -128.93 174.89 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.403 -0.81 . . . . 0.0 108.891 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.701 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.9 t60 -172.53 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.506 -0.746 . . . . 0.0 109.199 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -145.27 145.76 31.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 60' ' ' ILE . 83.5 t -130.64 163.36 36.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.665 0.745 . . . . 0.0 110.31 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 58' ' ' VAL . 11.8 t0 -133.5 131.97 40.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.692 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.46 129.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -99.36 122.71 7.66 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.92 117.92 17.3 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 122.13 -0.629 . . . . 0.0 110.145 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -102.2 73.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.95 21.91 72.91 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 -177.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 1.8 p -96.98 152.89 18.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.998 . . . . 0.0 109.857 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -114.36 -54.79 2.56 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.6 132.3 52.76 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.52 -0.738 . . . . 0.0 109.969 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.39 112.16 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.832 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -107.54 146.52 31.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.749 -0.595 . . . . 0.0 109.546 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.6 t -133.6 128.85 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.602 -0.686 . . . . 0.0 109.933 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.7 mp -115.03 158.84 21.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.792 ' CG1' HD22 ' A' ' 87' ' ' LEU . 5.4 m -119.6 154.48 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.47 173.36 46.02 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 t -114.71 155.47 26.59 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.98 -0.718 . . . . 0.0 109.831 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.9 p -63.67 -14.0 48.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 O-C-N 121.39 -0.819 . . . . 0.0 109.297 179.886 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.05 154.07 35.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.701 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.21 145.06 32.04 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.73 84.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.581 -0.7 . . . . 0.0 110.751 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -57.57 -59.62 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.8 pp -136.05 121.44 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.312 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.8 m -54.07 -179.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.663 -0.648 . . . . 0.0 110.178 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.14 135.31 51.93 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.241 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -104.62 127.69 52.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -85.33 95.72 9.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 16.6 m-85 -87.3 -52.43 5.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.591 -0.693 . . . . 0.0 109.693 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.3 mtp -120.68 -172.65 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.654 -0.654 . . . . 0.0 110.187 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 p -120.12 179.72 0.85 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.88 13.25 2.8 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.154 2.569 . . . . 0.0 111.47 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -53.26 2.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -63.68 -16.03 59.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 110.153 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -56.72 -21.01 24.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.828 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -87.6 0.13 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.181 -0.95 . . . . 0.0 110.362 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -162.03 38.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.102 -0.999 . . . . 0.0 108.655 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.35 -20.72 24.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.89 -79.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -1.036 . . . . 0.0 110.52 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.36 88.26 25.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.95 -20.54 10.16 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 123.032 2.488 . . . . 0.0 110.622 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.1 128.64 40.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.65 -0.656 . . . . 0.0 109.852 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.85 172.73 17.94 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.2 m -140.16 136.59 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.382 -0.824 . . . . 0.0 109.399 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 mmp_? -133.86 -179.23 5.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 110.282 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 mtm -141.99 178.34 7.59 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.391 0.615 . . . . 0.0 109.675 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.5 m-85 -135.43 166.82 22.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.03 -153.86 5.99 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.79 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.1 Cg_endo -74.3 -27.93 10.99 Favored 'Trans proline' 0 N--CA 1.504 2.136 0 C-N-CA 123.58 2.853 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.87 -42.45 62.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.9 9.54 30.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 111.165 -179.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -116.36 122.19 44.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 108.536 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -50.0 134.49 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.783 -0.573 . . . . 0.0 110.77 -177.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -69.2 -41.09 77.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.557 -0.714 . . . . 0.0 109.357 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.47 78.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 110.508 -179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -93.17 -35.25 13.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.448 -0.783 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.704 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.62 -30.72 2.44 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.518 -0.739 . . . . 0.0 110.789 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 16.75 24.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.485 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' NE1' ' A' ' 125' ' ' TRP . 4.3 mmtm -96.77 132.11 42.81 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -66.06 103.66 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.191 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.443 ' NE1' ' HB2' ' A' ' 123' ' ' LYS . 69.8 m95 -108.09 150.03 27.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t0 -128.84 4.12 5.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.697 -0.627 . . . . 0.0 109.694 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.8 mtt180 -141.76 149.58 40.63 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.8 p -140.36 140.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.187 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD2' HG22 ' A' ' 46' ' ' VAL . 3.5 tttm -106.16 116.74 32.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.703 -0.623 . . . . 0.0 109.747 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.582 ' CD1' HG13 ' A' ' 70' ' ' VAL . 46.5 mm -107.59 111.55 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.581 HG13 ' OG ' ' A' ' 44' ' ' SER . 40.9 t -119.58 120.33 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.414 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.0 t -95.68 149.03 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -142.94 130.66 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.459 -0.775 . . . . 0.0 111.19 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.8 OUTLIER 149.48 129.07 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.751 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.406 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.24 100.38 0.7 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.831 2.354 . . . . 0.0 109.659 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.511 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 1.2 p90 -131.66 40.35 3.4 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.739 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 -168.84 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -106.84 -35.84 6.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.07 142.21 24.55 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.5 Cg_endo -85.93 -176.1 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.174 2.582 . . . . 0.0 110.82 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 178.76 -162.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.616 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.14 -112.89 0.56 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.471 -1.347 . . . . 0.0 111.099 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.6 mp -114.2 158.86 20.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.567 -0.961 . . . . 0.0 110.75 -178.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.422 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 2.4 m -97.62 -28.45 13.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 122.042 -0.411 . . . . 0.0 109.958 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 43.5 p90 -176.38 171.88 2.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.693 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 60' ' ' ILE . 20.7 m -150.17 137.6 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.695 -0.628 . . . . 0.0 109.493 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 11.3 mmm-85 -144.04 108.55 4.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.531 -0.731 . . . . 0.0 109.102 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 128' ' ' VAL . 56.1 m-85 -87.31 155.03 20.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.338 -0.852 . . . . 0.0 109.354 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.46 124.93 6.34 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.495 -0.753 . . . . 0.0 109.363 178.715 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.67 -0.644 . . . . 0.0 110.474 -179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -142.27 146.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 167.04 15.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.933 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.669 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -95.61 136.8 35.54 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.722 -0.611 . . . . 0.0 109.461 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.602 ' N ' HD13 ' A' ' 6' ' ' LEU . 66.8 ttt180 -92.6 -56.42 3.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.805 . . . . 0.0 109.104 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.429 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 4.1 p-80 -161.33 162.99 31.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.3 p -79.14 91.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.534 HG12 ' C ' ' A' ' 47' ' ' LEU . 2.4 p -50.79 -55.99 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.317 -0.864 . . . . 0.0 110.47 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -122.14 153.37 38.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.415 -0.803 . . . . 0.0 109.372 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.74 120.36 17.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.424 -0.798 . . . . 0.0 109.509 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.8 m -123.56 42.02 3.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.806 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER 152.75 72.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.321 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.691 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -136.48 140.95 43.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.336 -0.852 . . . . 0.0 109.431 -179.052 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -165.92 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -101.74 -55.51 2.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -42.78 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -121.34 80.36 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.3 p -91.5 168.78 11.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.594 0.712 . . . . 0.0 110.042 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.12 -24.32 67.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.928 -0.483 . . . . 0.0 109.993 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -62.37 -18.54 61.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 109.835 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -65.37 -17.27 64.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' A' ' 147' ' ' VAL . 11.2 mt -64.91 -24.85 67.65 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.5 mm? -57.97 -22.46 49.29 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.498 -0.751 . . . . 0.0 109.039 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.2 65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.57 -24.41 13.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.394 -0.816 . . . . 0.0 110.406 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.33 81.36 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.634 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.4 p -158.1 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.437 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -177.84 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -158.39 167.7 28.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.553 -0.717 . . . . 0.0 109.446 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -160.32 -157.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.673 -0.642 . . . . 0.0 109.565 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 15.5 t90 -93.69 140.45 29.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.083 -1.01 . . . . 0.0 110.379 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -146.83 123.06 10.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.85 154.6 0.69 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.451 -0.781 . . . . 0.0 111.399 -178.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.66 -30.04 70.21 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -123.45 -172.1 2.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.73 -162.38 0.93 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.75 43.34 94.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 3.8 mm-40 -48.14 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.986 0.898 . . . . 0.0 111.364 -179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 42' ' ' THR . 8.8 pttp -111.62 -44.82 3.44 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.1 p -160.39 119.87 2.76 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.806 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.4 pt -128.02 147.39 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.507 -0.746 . . . . 0.0 109.355 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.584 ' OG ' HG22 ' A' ' 131' ' ' VAL . 31.5 m -128.23 147.6 50.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.661 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.0 p -154.29 117.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 128' ' ' VAL . 5.5 t -95.53 130.14 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.218 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.669 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.3 mt -102.61 167.4 9.94 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 12.2 tm0? -121.6 118.62 29.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.734 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.746 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -71.0 138.46 49.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -81.15 36.53 0.41 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.766 -0.584 . . . . 0.0 110.133 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 pttt 166.73 129.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.44 109.47 9.02 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.494 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.42 176.28 9.12 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.621 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -86.35 -174.24 4.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -141.26 130.29 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.741 . . . . 0.0 109.39 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.433 ' O ' HD21 ' A' ' 116' ' ' LEU . 4.6 t60 -119.57 -25.08 6.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -149.87 140.24 22.33 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' CD1' ' A' ' 149' ' ' PHE . 55.2 t -125.04 160.71 30.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.1 m-20 -140.74 135.06 31.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.506 -0.746 . . . . 0.0 109.416 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.4 mp -155.96 131.84 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -107.94 120.83 6.16 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.017 -1.564 . . . . 0.0 110.264 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.653 HD21 HG21 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -69.75 142.57 53.24 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.458 0.647 . . . . 0.0 111.11 -179.038 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 23.8 t0 -127.13 56.25 1.53 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.96 12.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t -57.75 170.16 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -1.006 . . . . 0.0 109.73 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.764 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -135.16 -56.83 0.81 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.461 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 24.3 m-85 -100.04 133.41 44.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.281 179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.653 HG21 HD21 ' A' ' 62' ' ' ASN . 67.9 t -134.74 107.51 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.944 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -97.34 129.8 44.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.697 HG13 HD13 ' A' ' 130' ' ' ILE . 37.8 t -122.18 124.4 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.762 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.0 mp -110.61 163.0 14.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.65 HG21 HD13 ' A' ' 87' ' ' LEU . 2.8 m -126.67 160.18 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.15 177.52 46.13 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 t -116.25 158.69 22.95 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.069 -0.665 . . . . 0.0 109.44 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -80.23 3.56 20.43 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.806 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 110.114 -179.905 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.6 t70 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.6 m-85 -113.17 -176.26 2.86 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -129.06 132.16 47.41 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.258 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 71' ' ' LEU . 35.5 t -62.31 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.685 -0.634 . . . . 0.0 110.453 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 72' ' ' VAL . 12.0 tp -60.13 -51.68 68.57 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -142.44 123.55 14.57 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.63 -173.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.886 -0.509 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.74 125.64 25.41 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 86.9 p -99.6 121.95 41.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -88.76 121.45 31.15 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 23.5 m-85 -120.58 -43.67 2.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.422 -0.798 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 33.0 mtp -120.22 -178.1 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.487 -0.758 . . . . 0.0 110.509 -178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -115.29 177.16 1.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.05 11.9 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.201 2.601 . . . . 0.0 111.251 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.48 -54.15 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.337 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 3.6 pt-20 -61.04 -18.42 57.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 20.7 t -54.82 -36.09 64.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.756 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -72.14 -82.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.037 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -162.85 37.49 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.37 -22.41 47.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.48 -77.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.958 . . . . 0.0 110.409 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -117.18 88.82 28.69 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.8 Cg_endo -77.23 -19.87 13.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.976 2.451 . . . . 0.0 110.261 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.87 135.06 29.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.754 -0.591 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.02 150.51 18.74 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 13.0 m -106.83 165.13 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 110.2 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -154.12 156.05 36.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.261 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.7 mtp -127.95 166.9 17.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.721 -179.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 88' ' ' LEU . 3.1 m-85 -131.61 159.08 39.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -132.64 -149.42 6.22 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.57 -39.76 1.32 Allowed 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 123.738 2.959 . . . . 0.0 110.594 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.72 -27.13 68.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.715 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -91.5 3.1 55.8 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.641 -0.662 . . . . 0.0 110.547 -179.633 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.96 139.35 54.16 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.92 -1.112 . . . . 0.0 110.392 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.908 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.5 p -60.17 130.57 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.12 61.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.708 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -21.39 65.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.908 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.86 -46.58 2.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.95 -38.08 21.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.151 -0.968 . . . . 0.0 111.51 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -82.05 2.78 29.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.338 -0.851 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.5 mttt -93.7 134.9 35.53 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -66.51 113.65 4.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.443 -0.786 . . . . 0.0 110.546 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.498 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 73.6 m95 -117.78 162.85 17.4 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.64 14.15 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.147 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -148.72 151.22 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.912 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.5 p -141.85 145.21 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 110.367 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.57 117.58 34.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.486 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 70' ' ' VAL . 50.0 mm -107.93 119.19 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.599 -0.688 . . . . 0.0 109.534 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.584 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.2 t -128.09 119.94 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.137 -0.977 . . . . 0.0 110.687 -179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.466 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.93 148.15 23.3 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.47 126.65 14.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 111.199 -179.091 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.764 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.4 OUTLIER 150.23 134.58 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.416 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.42 97.85 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.995 2.463 . . . . 0.0 109.965 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.6 p90 -128.77 14.49 6.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.0 110.81 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.03 -166.33 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -176.27 -42.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -113.27 -33.09 6.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.71 -0.619 . . . . 0.0 109.676 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.27 149.84 38.18 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.891 -0.505 . . . . 0.0 109.693 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.413 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.9 Cg_endo -85.52 -178.63 3.1 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.372 2.715 . . . . 0.0 110.285 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 179.88 -164.1 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.541 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 156.03 -112.89 0.54 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -135.47 162.04 33.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.325 -1.103 . . . . 0.0 110.251 178.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 2.7 m -82.24 -18.52 42.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.809 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 179.88 163.37 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.32 -0.863 . . . . 0.0 109.92 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.77 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.8 m -140.54 142.25 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 5.0 mtm180 -147.63 165.01 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.744 0.783 . . . . 0.0 110.524 -178.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.912 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.7 m-85 -145.28 154.61 42.54 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -158.63 145.94 17.72 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.087 -1.008 . . . . 0.0 109.283 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 -179.255 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 53' ' ' GLU . 48.4 mm -112.56 154.48 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -134.94 120.69 19.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.571 -0.706 . . . . 0.0 109.638 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 49' ' ' LEU . 1.2 mp -82.55 150.91 26.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -110.86 -53.28 2.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.69 166.24 29.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.655 -0.653 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.68 89.65 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 11' ' ' SER . 2.6 p -50.32 -55.89 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.258 -0.901 . . . . 0.0 110.777 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -122.29 152.49 40.02 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.12 -179.497 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -144.27 121.82 11.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 109.813 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -118.25 45.52 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.639 -0.663 . . . . 0.0 109.878 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.8 OUTLIER 152.19 73.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.732 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -138.44 142.33 39.5 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.244 -0.91 . . . . 0.0 109.448 -179.026 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.38 -162.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.469 -0.769 . . . . 0.0 109.333 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -97.55 -57.9 2.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.58 -0.7 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -65.66 0.7 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -88.77 67.7 8.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -86.44 171.32 11.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 -179.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.61 -24.7 67.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.573 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.9 tt0 -61.02 -19.4 61.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 109.688 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -65.76 -16.68 64.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 109.323 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.9 mt -65.02 -25.66 67.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.5 mm? -58.17 -22.74 52.74 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 65.28 0.67 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.36 -24.69 8.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.352 -0.842 . . . . 0.0 110.528 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 29' ' ' THR . 44.4 m-20 -119.53 81.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.807 . . . . 0.0 109.816 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -155.4 -88.08 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.424 -0.798 . . . . 0.0 109.502 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 42.8 p90 -177.6 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.006 -1.059 . . . . 0.0 110.187 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 4.9 mtm180 -157.47 142.67 17.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.5 -0.75 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -126.72 -159.47 0.93 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.347 -179.393 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.4 t90 -94.32 139.33 31.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.238 -0.913 . . . . 0.0 109.433 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -144.41 129.39 18.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.17 156.08 1.18 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -67.38 -23.99 65.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.845 -0.534 . . . . 0.0 110.202 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -136.45 -173.72 3.49 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.52 -164.27 1.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.45 45.89 88.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.6 mt-10 -54.79 84.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.694 0.759 . . . . 0.0 111.142 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 42' ' ' THR . 42.1 tttm -91.29 -52.28 4.89 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' OG ' ' A' ' 133' ' ' SER . 16.0 p -159.09 121.9 3.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 35' ' ' ALA . 19.0 pt -120.23 151.47 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -129.11 150.36 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.437 178.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.851 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -155.16 107.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.5 t -91.39 118.44 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -95.26 153.29 17.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -104.25 134.09 48.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.673 . . . . 0.0 109.715 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 6' ' ' LEU . 33.0 mt -90.17 134.79 34.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.07 43.85 0.73 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 110.448 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 pttt 166.94 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -74.94 106.37 6.42 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -136.28 -178.33 5.11 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.025 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -96.48 175.48 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.75 120.34 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 116' ' ' LEU . 74.4 t60 -107.68 -31.33 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 7.4 m -146.15 155.12 42.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 69.6 t -138.39 157.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.666 . . . . 0.0 109.548 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.57 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.7 m-20 -139.44 138.38 36.41 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.57 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.2 mp -159.05 135.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -115.0 134.79 11.85 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 65' ' ' SER . 1.2 m-80 -112.5 151.46 29.92 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 122.149 -0.618 . . . . 0.0 110.707 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -102.12 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.23 24.83 29.65 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 178.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.436 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 59.6 m -77.35 -174.45 3.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.517 -0.99 . . . . 0.0 109.831 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -147.2 -57.53 0.26 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.6 m-85 -99.25 135.28 40.88 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.929 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 93' ' ' PHE . 86.1 t -141.74 109.21 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.479 0.656 . . . . 0.0 109.685 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -99.78 139.23 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 130' ' ' ILE . 18.5 t -124.4 124.28 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.461 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.32 164.06 14.04 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.3 m -128.67 160.69 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.689 -0.632 . . . . 0.0 109.817 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.446 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.23 175.86 43.02 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 t -113.83 158.46 20.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -89.57 11.3 20.0 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 -179.928 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -108.05 -175.12 2.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -121.37 127.9 51.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.2 85.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.77 -0.581 . . . . 0.0 110.274 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.644 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -57.79 -53.88 53.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -143.81 122.66 12.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.257 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.35 -179.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 110.528 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 129.76 41.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.297 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 p -98.62 128.72 45.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 8.5 p -90.09 89.71 7.8 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.621 ' HE2' HG21 ' A' ' 68' ' ' VAL . 6.8 m-85 -73.45 -57.81 3.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.341 -0.85 . . . . 0.0 109.607 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.407 ' HE1' ' C ' ' A' ' 105' ' ' PRO . 3.2 mtm -121.3 -164.06 1.1 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.469 0.652 . . . . 0.0 110.187 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 5.8 p -130.64 -176.79 0.58 Allowed Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 41.6 Cg_endo -85.59 18.96 1.47 Allowed 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 123.086 2.524 . . . . 0.0 111.467 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.7 t -120.12 -40.71 2.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.12 -27.02 26.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 3.4 p -56.85 -22.26 35.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.512 -0.743 . . . . 0.0 110.475 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -83.87 -85.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.38 -0.825 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -163.01 38.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.37 -23.31 19.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.25 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.985 . . . . 0.0 110.579 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -119.48 95.26 49.16 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.9 Cg_endo -82.45 -17.99 7.25 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.172 2.582 . . . . 0.0 110.155 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.47 128.93 30.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.787 -0.571 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.26 145.7 15.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 16.0 m -98.71 -179.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 109.983 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.76 148.49 17.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.867 . . . . 0.0 109.407 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.8 mtt -127.15 157.39 39.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.491 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 88' ' ' LEU . 1.8 m-85 -128.82 166.49 18.95 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.22 -150.63 5.79 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.4 Cg_endo -75.51 -37.86 1.62 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.747 2.965 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -65.58 -26.52 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.464 -0.773 . . . . 0.0 109.6 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -91.94 1.97 56.84 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.643 -0.661 . . . . 0.0 110.663 -179.759 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -121.57 138.93 54.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.956 -1.09 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.905 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.2 p -58.25 130.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 -30.98 61.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 109.602 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -21.56 66.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.22 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.905 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.93 -46.24 2.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.304 -0.873 . . . . 0.0 110.104 -179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.97 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.65 -40.49 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.138 -0.976 . . . . 0.0 111.583 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -0.16 31.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.266 -0.896 . . . . 0.0 110.528 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.7 mtpp -91.0 133.93 34.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.95 112.58 4.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.636 0.731 . . . . 0.0 110.804 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.495 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 75.8 m95 -115.43 165.44 12.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.35 10.25 3.22 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.491 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -144.45 149.08 35.42 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -134.47 142.46 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.909 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' A' ' 46' ' ' VAL . 8.6 tttt -109.65 113.33 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.655 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.9 mm -106.93 123.73 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 44' ' ' SER . 41.0 t -128.46 121.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.275 -0.891 . . . . 0.0 110.533 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' CYS . . . . . 0.472 ' HB3' HG13 ' A' ' 43' ' ' ILE . 1.7 t -93.25 144.57 25.18 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.738 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.05 124.29 12.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 111.693 -178.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.6 OUTLIER 161.99 113.26 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.035 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.93 102.7 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.563 2.175 . . . . 0.0 110.305 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 134' ' ' GLN . 1.5 p90 -134.16 -9.06 2.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.539 -0.726 . . . . 0.0 112.137 -178.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -172.3 2.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.955 -1.091 . . . . 0.0 110.263 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -170.61 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.95 -31.9 6.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.66 -0.65 . . . . 0.0 109.683 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.67 148.08 37.04 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.845 -0.534 . . . . 0.0 109.719 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.91 -177.43 2.23 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.341 2.694 . . . . 0.0 110.539 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.49 -163.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.474 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 157.06 -128.09 2.08 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -119.59 162.38 19.04 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.354 -1.086 . . . . 0.0 110.17 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 m -84.91 -14.97 46.07 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 50.9 p90 171.65 169.05 0.09 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.204 -0.935 . . . . 0.0 109.936 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.783 HG22 ' HB3' ' A' ' 24' ' ' LEU . 29.5 m -141.1 143.32 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 41.6 mtm180 -149.57 167.31 26.69 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.6 m-85 -149.61 158.69 44.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.454 ' HE2' ' CG ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -155.04 123.18 5.87 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 0.0 109.74 179.386 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.46 70.74 4.12 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.48 2.786 . . . . 0.0 110.401 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.33 -175.15 4.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.42 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.721 ' CG2' HD12 ' A' ' 49' ' ' LEU . 40.2 mm -123.81 133.97 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -121.39 126.88 50.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.5 mp -79.57 155.14 28.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.588 -0.695 . . . . 0.0 109.141 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.01 -56.14 2.43 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -160.58 165.1 31.33 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.51 93.22 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.4 p -54.07 -54.61 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.24 -0.912 . . . . 0.0 110.339 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.78 150.99 40.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.484 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.4 p -137.9 121.19 16.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.546 -0.721 . . . . 0.0 109.646 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 m -124.47 41.54 3.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.537 -0.727 . . . . 0.0 109.407 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.672 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 154.4 73.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.81 140.63 29.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.345 -0.847 . . . . 0.0 108.744 -179.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.49 -163.06 0.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 109.084 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -96.47 -63.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.536 -0.728 . . . . 0.0 109.497 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -57.57 10.69 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 18.5 m170 -98.16 77.64 2.44 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.433 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -97.11 169.32 9.89 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.813 0.815 . . . . 0.0 110.549 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.794 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.07 -23.98 67.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.925 -0.484 . . . . 0.0 109.777 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 9' ' ' VAL . 7.5 tt0 -60.38 -19.29 55.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.278 -0.889 . . . . 0.0 109.574 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -65.59 -16.47 63.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.88 . . . . 0.0 109.28 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.2 mt -64.93 -26.6 68.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -61.2 -19.89 62.14 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.492 -0.755 . . . . 0.0 109.004 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -119.99 73.61 0.98 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.691 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . . . -44.86 -60.44 2.05 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.347 0.594 . . . . 0.0 110.705 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -67.33 -116.34 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p 50.47 -107.78 0.3 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.818 -1.176 . . . . 0.0 109.718 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -179.02 37.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.84 -1.163 . . . . 0.0 109.92 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 0.4 OUTLIER -148.8 149.67 31.75 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.532 -0.73 . . . . 0.0 109.461 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 15.4 mttt -131.69 -161.22 1.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.502 -0.749 . . . . 0.0 109.301 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.716 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.9 t90 -90.65 140.53 29.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.349 -0.844 . . . . 0.0 109.096 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 132.06 26.18 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.29 155.52 3.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.419 -0.801 . . . . 0.0 110.124 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.69 -21.65 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.798 -0.564 . . . . 0.0 110.182 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.9 ptmm? -141.67 -174.18 3.99 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.325 -0.86 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.2 -164.56 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.44 46.37 92.74 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -54.39 83.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.429 0.633 . . . . 0.0 111.529 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -91.9 -44.59 8.83 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.825 HG22 ' OG ' ' A' ' 133' ' ' SER . 5.7 p -161.39 134.13 6.13 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.716 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.9 pt -132.34 142.2 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.239 -0.913 . . . . 0.0 109.989 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.591 ' OG ' HG22 ' A' ' 131' ' ' VAL . 19.8 m -126.82 147.79 50.0 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.515 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.794 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.6 p -156.05 118.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.789 HG22 ' HG3' ' A' ' 129' ' ' LYS . 14.7 t -97.57 125.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -103.32 150.89 23.34 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -93.19 146.25 23.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.721 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.3 mm? -101.12 123.97 46.1 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.45 -2.6 0.07 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.448 -0.783 . . . . 0.0 112.112 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.99 135.75 3.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 109.132 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -75.57 111.71 11.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.567 ' CD ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -142.77 -177.98 5.58 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.297 0.57 . . . . 0.0 109.478 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.57 158.98 15.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.5 mp -113.08 124.07 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -113.83 -30.0 6.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 109.764 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.9 m -148.99 156.79 42.78 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.439 -0.788 . . . . 0.0 109.084 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 t -144.43 154.56 14.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.416 0.627 . . . . 0.0 109.833 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -139.15 101.64 4.32 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.565 HG23 HD23 ' A' ' 144' ' ' LEU . 5.0 mt -126.32 141.42 45.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -113.13 137.8 14.49 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -85.27 139.2 31.81 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 122.302 -0.528 . . . . 0.0 110.002 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -111.71 65.83 0.63 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -25.1 29.4 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 14.9 m -60.5 178.0 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.974 . . . . 0.0 110.152 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -135.94 -50.17 0.7 Allowed 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -102.32 132.36 48.34 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.709 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.6 t -134.84 108.88 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.503 -0.748 . . . . 0.0 110.083 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -102.51 145.51 29.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG13 HD13 ' A' ' 130' ' ' ILE . 21.4 t -132.02 128.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.097 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.514 HD11 HG22 ' A' ' 86' ' ' VAL . 3.0 mp -113.08 159.93 18.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 HD13 ' A' ' 87' ' ' LEU . 4.6 m -121.52 155.45 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.66 -0.65 . . . . 0.0 110.213 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.97 170.81 43.82 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.4 t -115.89 170.45 8.46 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.788 0.804 . . . . 0.0 110.144 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.4 p -76.24 -0.94 24.11 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.54 149.6 4.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 110.444 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.13 -62.06 3.73 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 135.61 -145.3 17.32 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.25 68.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.61 -0.935 . . . . 0.0 109.297 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.14 -49.4 4.48 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' OE1' HG21 ' A' ' 46' ' ' VAL . 4.1 mm-40 59.29 25.31 13.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -1.002 . . . . 0.0 109.853 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -149.55 21.04 0.93 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 0.0 109.92 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.59 50.76 2.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.35 -0.844 . . . . 0.0 109.631 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -119.66 151.72 38.26 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.73 144.22 40.02 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.352 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 71' ' ' LEU . 23.0 t -62.99 88.25 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.659 -0.651 . . . . 0.0 111.172 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG11 ' A' ' 72' ' ' VAL . 12.7 tp -61.16 -45.49 94.41 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.6 pp -146.58 124.83 12.21 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.39 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.613 ' O ' HD12 ' A' ' 88' ' ' LEU . 30.6 m -55.46 -175.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.726 -0.609 . . . . 0.0 110.118 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.58 133.31 45.66 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.54 -0.725 . . . . 0.0 109.404 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.1 p -98.26 125.07 43.19 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.2 p -91.48 102.97 15.64 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 23.7 m-85 -99.04 -47.02 5.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 109.375 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.442 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 51.2 mtp -120.08 -157.48 0.71 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.733 -0.604 . . . . 0.0 109.502 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 4.9 p -159.41 -170.86 0.26 Allowed Pre-proline 0 N--CA 1.484 1.226 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 49.6 Cg_endo -81.8 8.48 4.43 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.742 1.628 . . . . 0.0 110.431 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 t -83.2 -37.55 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -59.39 -34.61 72.65 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.9 t -73.64 -7.27 51.29 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.69 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -109.0 -52.39 2.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 110.533 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 m -120.94 35.86 4.76 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.141 -0.975 . . . . 0.0 111.692 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.07 6.68 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.175 -0.953 . . . . 0.0 111.849 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.93 89.02 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 p30 48.99 82.03 0.25 Allowed Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.442 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.9 Cg_endo -77.49 -25.9 7.73 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 123.542 2.828 . . . . 0.0 110.977 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.8 109.39 10.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.143 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.1 169.87 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.8 m -138.37 165.73 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 0.0 109.51 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 161.89 33.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.885 . . . . 0.0 110.027 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.9 mtm -123.25 164.47 18.68 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.311 0.577 . . . . 0.0 110.156 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.5 m-85 -132.26 101.78 5.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -80.13 -148.22 5.09 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.559 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.9 Cg_endo -75.05 -34.18 3.98 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 123.385 2.724 . . . . 0.0 110.759 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.18 -27.7 68.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.563 -0.711 . . . . 0.0 110.036 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 4.2 mtmt -94.48 4.3 54.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.657 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -126.95 142.71 51.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.953 -1.092 . . . . 0.0 110.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.9 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -62.65 137.4 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -33.76 56.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.48 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.72 -22.9 67.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.52 -0.738 . . . . 0.0 110.191 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.9 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -111.81 -46.99 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.373 -0.829 . . . . 0.0 110.199 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.17 -35.36 16.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.25 -0.906 . . . . 0.0 111.259 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 0.5 47.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.399 -0.813 . . . . 0.0 110.602 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.4 mttm -93.43 135.54 34.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -69.33 110.46 4.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 0.0 111.02 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.2 m95 -113.35 162.24 16.3 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.5 12.22 2.98 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.072 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.547 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.7 mtt180 -142.34 142.25 32.45 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.6 p -139.01 141.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.352 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.789 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.4 tttt -104.08 118.45 36.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.77 -0.581 . . . . 0.0 109.765 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 HG13 ' A' ' 70' ' ' VAL . 47.5 mm -107.33 119.34 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.591 HG22 ' OG ' ' A' ' 44' ' ' SER . 47.0 t -126.2 121.34 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 O-C-N 121.133 -0.98 . . . . 0.0 110.59 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.415 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -93.56 155.82 17.08 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.825 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -154.06 123.97 6.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.258 -0.901 . . . . 0.0 111.898 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HB2' ' O ' ' A' ' 133' ' ' SER . 1.7 tm0? 162.04 114.88 0.01 OUTLIER Pre-proline 0 N--CA 1.503 2.198 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -76.05 103.4 1.74 Allowed 'Trans proline' 0 N--CA 1.505 2.195 0 C-N-CA 122.636 2.224 . . . . 0.0 110.361 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 134' ' ' GLN . 2.0 p90 -135.2 -19.39 1.72 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.518 -0.738 . . . . 0.0 112.291 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 -175.27 2.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 0.0 110.379 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -163.18 -43.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.18 -34.73 6.29 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.544 0.688 . . . . 0.0 109.457 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 143.16 26.04 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.412 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.5 Cg_endo -87.69 -172.06 0.78 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.141 2.561 . . . . 0.0 110.861 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 176.8 -163.53 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.77 -121.39 1.02 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.859 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.565 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -114.17 158.39 21.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.752 -0.852 . . . . 0.0 110.1 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.424 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 4.1 m -92.49 -26.94 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 39.4 p90 -176.66 167.27 2.65 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 60' ' ' ILE . 27.2 m -147.02 122.7 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.691 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 14.6 mmm180 -132.54 110.0 10.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 110.205 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.765 ' CE2' HG11 ' A' ' 128' ' ' VAL . 41.1 m-85 -88.8 154.77 20.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 108.787 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 122.72 8.6 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.668 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.65 136.49 4.51 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 123.373 2.715 . . . . 0.0 110.499 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -160.13 -179.89 8.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 0.0 109.665 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 151' ' ' SER . 78.2 mt -140.63 125.99 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -107.8 154.12 21.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.783 -0.573 . . . . 0.0 109.653 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.657 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.2 mp -89.52 152.53 21.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.748 -0.595 . . . . 0.0 109.508 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -102.02 -56.46 2.27 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -160.86 165.24 30.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -79.97 91.05 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.0 109.098 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -53.95 -57.79 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.183 -0.948 . . . . 0.0 110.405 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -118.4 147.15 43.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.2 p -132.11 133.69 44.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.411 -0.806 . . . . 0.0 109.696 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.01 38.76 3.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 109.82 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.573 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.73 74.33 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -134.87 147.57 49.9 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.5 149.54 24.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.428 -0.795 . . . . 0.0 109.409 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.7 t -60.27 -61.02 2.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.465 -0.772 . . . . 0.0 109.967 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.412 ' HB ' ' CD2' ' A' ' 19' ' ' HIS . 0.2 OUTLIER -59.2 -44.51 92.24 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.403 -0.811 . . . . 0.0 109.08 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 29.7 m-70 -118.74 84.67 2.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -95.8 167.26 11.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.595 0.712 . . . . 0.0 110.277 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.729 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.75 -23.34 67.15 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.32 -18.38 58.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.727 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -64.47 -18.67 64.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.221 -0.925 . . . . 0.0 109.128 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 147' ' ' VAL . 9.6 mt -65.29 -26.98 68.31 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -60.12 -20.9 60.53 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.529 -0.732 . . . . 0.0 109.089 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -107.31 62.95 0.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.39 -25.26 5.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.405 -0.809 . . . . 0.0 110.57 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' HG23 ' A' ' 29' ' ' THR . 4.7 t0 -118.46 81.79 1.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.459 -0.775 . . . . 0.0 109.831 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -156.54 -82.74 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.421 -0.8 . . . . 0.0 109.507 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -177.88 -38.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.926 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -86.5 166.99 15.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.57 -0.706 . . . . 0.0 110.007 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.66 -160.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.724 ' CH2' HD12 ' A' ' 43' ' ' ILE . 18.6 t90 -81.74 139.67 34.72 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.138 -0.976 . . . . 0.0 109.838 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 19' ' ' HIS . 1.2 mtt180 -146.14 127.04 14.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.52 152.98 1.74 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.654 0.74 . . . . 0.0 111.041 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -61.56 -23.85 66.25 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 122.008 -0.433 . . . . 0.0 110.127 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.49 -174.93 3.95 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.367 -0.833 . . . . 0.0 108.992 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.58 -164.95 1.24 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.72 -0.612 . . . . 0.0 109.427 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.8 44.77 91.54 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 2.6 mm-40 -48.04 89.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.756 0.789 . . . . 0.0 111.625 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 39' ' ' GLY . 1.1 tttm -97.69 -57.35 2.26 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.618 HG22 ' OG ' ' A' ' 133' ' ' SER . 41.0 p -155.85 122.57 5.26 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.724 HD12 ' CH2' ' A' ' 33' ' ' TRP . 12.8 pt -124.03 147.61 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 109.797 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.592 ' OG ' HG22 ' A' ' 131' ' ' VAL . 12.9 m -129.37 144.63 51.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.076 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.729 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.9 p -151.74 116.27 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.3 t -97.03 121.17 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.657 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 mp -104.03 149.97 24.69 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -91.38 156.73 17.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.644 . . . . 0.0 109.518 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.453 HD12 ' CA ' ' A' ' 126' ' ' ASP . 48.6 mt -106.76 125.39 50.94 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -51.73 -9.3 0.08 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.381 -0.825 . . . . 0.0 112.253 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -161.11 140.64 10.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 0.0 109.138 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -75.2 111.48 10.49 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -145.73 178.72 7.94 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -85.51 -172.93 4.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.41 122.85 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 0.0 109.412 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -113.32 -28.45 7.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 109.511 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.2 m -149.29 160.69 43.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 63.4 t -146.38 160.12 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.326 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.544 ' O ' HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -131.55 130.74 42.67 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.544 HD13 ' O ' ' A' ' 59' ' ' ASP . 26.2 mm -139.31 118.42 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.41 116.46 4.33 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 24.3 m-80 -82.54 118.32 23.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.974 -0.721 . . . . 0.0 110.517 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.77 60.58 2.15 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.09 85.76 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.425 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 69.3 m -59.13 162.16 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -1.179 . . . . 0.0 110.157 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -123.37 -55.84 1.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.7 m-85 -102.99 118.97 38.0 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.616 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 HG21 ' A' ' 60' ' ' ILE . 50.7 t -122.24 109.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.15 143.66 32.63 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.752 HG13 HD13 ' A' ' 130' ' ' ILE . 11.0 t -133.1 124.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.87 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -111.34 163.23 14.19 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.0 m -127.94 161.79 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.684 -0.635 . . . . 0.0 109.861 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 174.26 176.08 42.36 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -110.9 158.83 18.3 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 t -88.9 11.33 18.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 118.36 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.74 104.13 0.67 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.76 -32.75 0.23 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB1' ' HB3' ' A' ' 83' ' ' ASP . . . -92.89 -46.28 7.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.65 -0.912 . . . . 0.0 109.534 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.91 -172.67 24.87 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -96.86 25.08 5.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.918 . . . . 0.0 109.761 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -133.29 22.09 4.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.49 -0.756 . . . . 0.0 109.575 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.553 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . 13.1 t70 -131.8 45.11 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.489 -0.757 . . . . 0.0 109.348 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.4 m-85 -88.84 -175.73 4.97 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -123.52 129.74 51.66 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -63.17 86.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.596 -0.69 . . . . 0.0 109.963 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 117' ' ' VAL . 24.6 tp -59.45 -59.59 5.21 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.549 HD11 HG23 ' A' ' 70' ' ' VAL . 1.5 pp -136.36 121.09 18.49 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.308 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.2 m -53.13 -179.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.697 -0.627 . . . . 0.0 110.602 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.69 131.77 46.69 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.7 p -99.31 117.52 33.93 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.775 -0.578 . . . . 0.0 109.764 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -75.02 69.43 1.93 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.443 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 36.4 t80 -59.48 -58.46 8.51 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.851 -0.53 . . . . 0.0 110.437 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.405 ' HG3' ' CD2' ' A' ' 93' ' ' PHE . 82.5 mtp -120.83 -177.19 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.737 0.78 . . . . 0.0 110.925 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.6 p -111.98 -179.43 0.64 Allowed Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.42 ' HB3' ' NE2' ' A' ' 134' ' ' GLN . 46.6 Cg_endo -86.02 12.24 3.09 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.999 2.466 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.8 p -120.77 -48.96 2.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 109.535 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.9 -7.33 50.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.548 -0.72 . . . . 0.0 110.627 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 87.4 p -83.21 -20.73 34.06 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.716 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.2 mmt85 -73.88 -86.43 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.276 -0.89 . . . . 0.0 109.794 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 t -161.99 38.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 108.937 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.41 -24.19 6.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.49 117.24 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.443 -1.033 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.68 72.61 1.01 Allowed Pre-proline 0 N--CA 1.508 2.446 0 O-C-N 121.801 -0.562 . . . . 0.0 111.393 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 41.3 Cg_endo -79.27 -30.16 2.75 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.88 2.387 . . . . 0.0 109.958 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -128.06 112.45 14.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 -168.25 2.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 67.1 t -121.29 163.04 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' N ' HG12 ' A' ' 108' ' ' VAL . 28.3 tpt180 -145.97 124.55 12.48 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtp -109.95 154.01 23.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -0.785 . . . . 0.0 110.5 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.495 ' HE1' ' CG1' ' A' ' 60' ' ' ILE . 7.9 m-85 -126.05 158.1 36.24 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.46 -149.95 6.74 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.24 -38.16 1.61 Allowed 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 123.798 2.999 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.45 -29.17 69.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.475 -0.765 . . . . 0.0 109.569 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -89.08 3.26 52.37 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.672 -0.642 . . . . 0.0 110.654 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.0 pp -125.23 139.76 53.44 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.039 -1.038 . . . . 0.0 110.506 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.3 p -60.66 132.66 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -34.55 62.3 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.821 -0.751 . . . . 0.0 109.406 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.24 65.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 110.437 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.62 -47.29 2.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 110.014 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.01 -38.58 23.93 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.197 -0.939 . . . . 0.0 111.438 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.15 2.48 27.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.359 -0.838 . . . . 0.0 110.661 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 22.6 mttt -94.61 135.0 36.58 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -66.59 112.85 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.534 -0.729 . . . . 0.0 110.787 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.493 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 76.4 m95 -116.85 164.36 14.79 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' CA ' HD12 ' A' ' 49' ' ' LEU . 5.1 p-10 -137.27 9.66 2.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' HD2' HG11 ' A' ' 10' ' ' VAL . 15.3 mtm180 -143.18 145.33 32.71 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.933 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.4 p -135.41 143.42 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.924 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HG3' HG22 ' A' ' 46' ' ' VAL . 15.2 tttt -107.71 115.57 30.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.721 -0.612 . . . . 0.0 109.7 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.752 HD13 HG13 ' A' ' 70' ' ' VAL . 49.0 mm -105.4 117.6 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 0.0 109.286 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.592 HG22 ' OG ' ' A' ' 44' ' ' SER . 46.5 t -125.01 117.8 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.111 -0.993 . . . . 0.0 110.429 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.44 ' HB3' HG13 ' A' ' 43' ' ' ILE . 10.9 t -92.46 148.66 21.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.618 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.1 123.97 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.525 -0.734 . . . . 0.0 111.466 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.7 134.11 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.403 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.86 98.2 0.5 Allowed 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 123.094 2.53 . . . . 0.0 110.207 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -129.77 2.98 4.93 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.357 -0.839 . . . . 0.0 111.373 -179.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 -170.91 2.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.942 -1.099 . . . . 0.0 109.701 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -170.38 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.688 -0.632 . . . . 0.0 109.338 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -113.55 -36.25 4.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.559 -0.713 . . . . 0.0 109.694 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -103.04 143.53 26.78 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 44.2 Cg_endo -87.39 174.53 5.06 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 123.236 2.624 . . . . 0.0 110.462 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.74 -164.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.33 -109.91 0.42 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.808 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.4 mp -112.25 144.94 40.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.726 -0.867 . . . . 0.0 110.61 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -80.54 -28.72 37.22 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.482 ' CE2' HG22 ' A' ' 108' ' ' VAL . 48.8 p90 -177.56 174.8 1.49 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.627 -0.67 . . . . 0.0 109.567 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 24' ' ' LEU . 27.7 m -150.63 130.55 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -143.34 107.79 4.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.506 -0.746 . . . . 0.0 110.157 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.933 ' CE2' HG11 ' A' ' 128' ' ' VAL . 83.1 m-85 -87.49 158.32 18.97 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.36 136.67 15.74 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.386 -0.821 . . . . 0.0 109.388 179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.752 -0.593 . . . . 0.0 109.626 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 19.8 ptt? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.64 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.6 Cg_endo -88.86 -11.62 3.79 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.428 2.085 . . . . 0.0 111.207 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.16 -165.55 0.78 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.854 ' CG2' HD11 ' A' ' 49' ' ' LEU . 83.1 mt -128.62 128.21 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -115.39 171.1 7.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -0.856 . . . . 0.0 110.319 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.684 HD21 HD22 ' A' ' 47' ' ' LEU . 3.1 mp -97.69 163.74 12.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.759 -0.588 . . . . 0.0 109.57 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.634 ' C ' HD11 ' A' ' 25' ' ' LEU . 6.3 ttt85 -121.84 -51.44 2.03 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -161.09 162.18 31.47 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.87 96.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.495 -0.753 . . . . 0.0 109.481 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -54.37 -60.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.166 -0.959 . . . . 0.0 109.996 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.71 159.14 30.06 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.2 p -158.28 136.63 10.93 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.26 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.9 t -141.75 59.77 1.48 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.679 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 157.22 59.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.738 0 CA-C-O 121.443 0.639 . . . . 0.0 109.965 -179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -139.23 144.14 38.32 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.72 -1.237 . . . . 0.0 110.34 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.84 174.63 6.7 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.249 -0.907 . . . . 0.0 109.193 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -74.25 -62.19 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.534 -0.729 . . . . 0.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -58.37 8.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -0.796 . . . . 0.0 109.016 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 9.7 m-70 -97.05 80.44 2.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -93.56 164.5 13.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.572 -0.705 . . . . 0.0 109.839 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.42 -21.08 66.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.869 -0.519 . . . . 0.0 109.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.05 -18.82 63.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.79 -18.12 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.868 . . . . 0.0 109.091 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.826 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.6 mt -65.13 -26.92 68.4 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.634 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.94 -20.58 58.26 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.493 -0.754 . . . . 0.0 109.003 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -115.18 68.55 0.71 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.3 -24.4 7.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.455 -0.778 . . . . 0.0 110.626 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -119.46 86.51 2.57 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.46 -0.775 . . . . 0.0 109.922 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.01 -83.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.516 -0.74 . . . . 0.0 109.427 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.9 p90 -177.8 -37.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.886 . . . . 0.0 110.159 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 16.7 tpp85 -86.43 134.6 33.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.36 -0.837 . . . . 0.0 109.995 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -114.62 -171.86 2.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.48 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.855 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -84.96 142.21 29.8 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 109.535 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -147.8 130.39 15.89 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.688 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.27 153.02 1.6 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.44 -0.787 . . . . 0.0 110.826 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.76 -19.79 52.54 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.951 -0.468 . . . . 0.0 110.315 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 -171.21 3.16 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.359 -0.838 . . . . 0.0 108.933 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.23 -172.4 2.34 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.75 48.97 77.03 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 35' ' ' ALA . 79.1 mm-40 -34.11 -88.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp 72.02 -60.07 0.54 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.531 -0.731 . . . . 0.0 109.109 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.635 HG22 ' OG ' ' A' ' 133' ' ' SER . 40.8 p -155.41 138.84 15.84 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.855 HD12 ' CH2' ' A' ' 33' ' ' TRP . 1.4 pt -145.73 140.73 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.55 -0.719 . . . . 0.0 109.085 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 131' ' ' VAL . 4.2 m -122.08 131.13 53.82 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.594 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.655 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -136.89 116.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.1 t -95.88 116.76 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.232 -0.918 . . . . 0.0 108.974 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.684 HD22 HD21 ' A' ' 6' ' ' LEU . 1.1 mp -101.11 157.02 17.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.641 -0.662 . . . . 0.0 109.76 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -96.3 163.56 13.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.691 -0.631 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.854 HD11 ' CG2' ' A' ' 4' ' ' ILE . 11.5 tp -108.52 124.78 50.98 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -59.84 2.59 0.07 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.342 -0.849 . . . . 0.0 112.471 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -175.97 134.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.657 -1.277 . . . . 0.0 108.93 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -74.79 111.0 9.55 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.644 0.735 . . . . 0.0 110.108 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -172.85 4.26 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' O ' HD11 ' A' ' 4' ' ' ILE . 14.4 mt-30 -90.61 -178.36 5.27 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -141.92 127.06 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 109.657 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.472 ' HA ' HD21 ' A' ' 116' ' ' LEU . 13.1 t-160 -115.82 -32.03 5.59 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.709 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.1 m -141.09 159.34 42.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.673 HG13 ' CD1' ' A' ' 149' ' ' PHE . 77.3 t -140.21 163.48 23.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.3 m-20 -140.23 127.53 21.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.691 . . . . 0.0 109.519 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 59' ' ' ASP . 1.1 mp -145.21 139.08 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -98.53 126.88 9.05 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.12 126.19 30.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 122.066 -0.667 . . . . 0.0 110.231 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -122.32 63.74 0.95 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 108.839 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.58 -31.47 8.31 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 91.7 p -62.21 173.39 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.647 -0.914 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -141.83 -53.45 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -93.61 125.69 38.36 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.265 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.87 113.07 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.003 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.0 121.97 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.766 ' CG2' HD12 ' A' ' 88' ' ' LEU . 31.5 t -113.74 127.75 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.507 -0.746 . . . . 0.0 110.223 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.65 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.1 mp -118.35 162.56 18.09 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 87' ' ' LEU . 3.4 m -131.19 159.79 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.665 -0.647 . . . . 0.0 109.861 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.432 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.97 178.1 45.51 Favored Glycine 0 N--CA 1.481 1.655 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 t -117.84 156.59 28.11 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.2 p -84.53 6.26 24.38 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.471 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.29 4.1 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.281 -0.887 . . . . 0.0 109.671 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.03 49.69 0.83 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.78 77.54 1.45 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.89 -45.86 9.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.929 . . . . 0.0 109.734 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.83 177.17 17.72 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -85.64 -17.24 36.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.704 -0.88 . . . . 0.0 110.218 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -95.78 35.36 1.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.826 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -116.4 27.84 8.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.503 -0.748 . . . . 0.0 109.432 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.65 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.8 m-85 -108.55 -175.01 2.66 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -120.98 126.14 49.19 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -61.58 85.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 0.0 110.422 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.909 HD13 HG21 ' A' ' 72' ' ' VAL . 6.5 tp -59.59 -61.14 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.766 HD12 ' CG2' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -121.9 130.1 53.09 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -68.73 -171.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 116.93 5.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.2 p -99.26 112.93 24.99 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.631 -0.668 . . . . 0.0 109.79 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -81.96 123.41 28.86 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 13.1 m-85 -116.61 -46.94 2.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.548 -0.72 . . . . 0.0 109.985 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -121.01 -166.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.523 0.678 . . . . 0.0 110.21 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.3 p -124.0 178.86 1.22 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.33 18.76 1.49 Allowed 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.307 2.672 . . . . 0.0 111.433 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 m -120.28 -54.88 2.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.673 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' CG ' ' HB2' ' A' ' 103' ' ' SER . 0.5 OUTLIER -56.98 -28.01 61.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.504 -0.748 . . . . 0.0 110.478 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 10.9 m -50.09 -25.36 3.39 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.477 -0.764 . . . . 0.0 111.011 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -80.95 -87.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.466 -0.771 . . . . 0.0 109.814 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 t -163.44 37.73 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.96 -22.56 38.25 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 98' ' ' GLU . 0.5 OUTLIER -170.41 -86.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.435 -1.038 . . . . 0.0 110.647 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.56 86.6 34.84 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.16 -23.9 20.74 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.797 2.331 . . . . 0.0 109.994 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -134.46 141.54 46.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 -163.99 1.58 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 72.5 t -136.88 154.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.12 150.58 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.367 -0.833 . . . . 0.0 108.908 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 50.2 mtm -129.21 171.93 11.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 0.0 110.292 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.608 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.6 m-85 -130.56 169.71 15.23 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.829 0.823 . . . . 0.0 109.566 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.82 -154.05 6.03 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.192 -2.363 . . . . 0.0 107.192 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.739 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -74.27 -26.78 12.13 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 123.527 2.818 . . . . 0.0 110.843 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -53.37 -41.84 66.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.651 -0.656 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.89 15.88 23.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.604 -0.685 . . . . 0.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -121.97 118.99 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -46.5 126.97 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.979 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -64.52 -39.5 93.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.431 -0.793 . . . . 0.0 109.4 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.89 91.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.497 -0.752 . . . . 0.0 110.663 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -88.39 -36.39 16.59 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.324 -0.86 . . . . 0.0 109.188 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.701 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.07 -42.76 6.4 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.64 -0.663 . . . . 0.0 111.361 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.22 11.43 30.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.981 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -92.25 130.14 38.03 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -66.32 108.81 2.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.49 -0.756 . . . . 0.0 110.113 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 68.6 m95 -116.47 163.32 16.23 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 49' ' ' LEU . 4.5 p-10 -140.15 15.1 2.43 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.103 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -147.75 149.84 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.4 p -141.58 144.15 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.974 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.663 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.2 tttt -105.77 134.97 48.03 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.455 ' HB ' HG13 ' A' ' 45' ' ' VAL . 46.9 mm -128.59 107.92 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.475 -0.765 . . . . 0.0 109.236 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 46.0 t -112.24 109.22 27.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 O-C-N 121.211 -0.93 . . . . 0.0 109.921 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.423 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.63 154.27 28.81 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.4 OUTLIER -157.06 120.94 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.303 -0.873 . . . . 0.0 110.843 -178.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.671 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 5.2 tp60 171.41 135.04 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.5 100.78 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.928 2.419 . . . . 0.0 109.044 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 38.0 p90 -147.27 15.2 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 111.483 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.39 -173.38 4.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.051 -1.031 . . . . 0.0 110.072 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -177.96 -39.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -116.05 -32.23 5.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.656 -0.653 . . . . 0.0 110.141 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.5 146.05 32.52 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.78 -0.575 . . . . 0.0 109.875 -179.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.2 Cg_endo -87.48 171.81 6.12 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 123.417 2.745 . . . . 0.0 110.614 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -178.95 -166.99 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 158.01 -106.75 0.3 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.084 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.505 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.6 mp -120.12 155.02 33.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.564 -0.962 . . . . 0.0 110.849 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 m -88.35 -27.47 21.62 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.0 p90 -177.1 170.48 2.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.537 -0.727 . . . . 0.0 109.227 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.2 m -146.99 142.06 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.505 -0.747 . . . . 0.0 109.467 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 21.1 mtm180 -150.56 166.14 31.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.637 -0.664 . . . . 0.0 109.534 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.823 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.7 m-85 -141.59 158.19 44.15 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.32 128.54 8.28 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.01 -1.056 . . . . 0.0 110.338 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.424 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.8 46.83 1.31 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.573 2.849 . . . . 0.0 110.539 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -160.16 -171.54 3.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.506 -0.746 . . . . 0.0 109.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -138.67 128.67 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 168.87 9.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.627 -0.671 . . . . 0.0 110.017 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.691 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.4 mp -103.26 156.29 17.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.706 -0.622 . . . . 0.0 109.755 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' C ' HD11 ' A' ' 25' ' ' LEU . 1.4 tpt180 -109.8 -52.0 2.82 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.93 168.41 24.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -84.01 93.8 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.252 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.544 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.7 p -52.99 -59.99 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.243 -0.91 . . . . 0.0 110.321 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.524 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -120.14 153.03 36.78 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 109.291 -179.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -138.59 133.7 32.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.536 -0.728 . . . . 0.0 109.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -133.95 42.64 2.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.702 . . . . 0.0 109.679 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.8 m 152.08 70.42 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.926 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -131.11 132.91 45.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.329 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.46 152.51 34.19 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.0 t -62.48 -62.16 1.94 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.473 -0.767 . . . . 0.0 109.804 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 -61.51 2.43 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 34' ' ' ARG . 43.3 m-70 -93.15 85.06 4.94 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 p -98.28 167.24 10.98 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.507 0.67 . . . . 0.0 110.236 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.702 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.51 -23.63 66.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.761 -0.587 . . . . 0.0 109.969 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.36 -19.21 54.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.239 -0.913 . . . . 0.0 109.774 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -65.5 -17.79 64.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.157 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.12 -25.41 67.76 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.472 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -57.61 -23.09 49.11 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 65.31 0.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.32 -24.95 8.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.448 -0.783 . . . . 0.0 110.537 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' THR . 6.3 m-20 -120.47 82.81 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 109.758 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -157.02 -85.28 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.501 -0.749 . . . . 0.0 109.398 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -177.48 34.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.138 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -160.82 142.12 11.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.346 -0.846 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.35 -169.04 1.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.735 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.6 t90 -80.54 136.74 36.33 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.6 mtp180 -142.1 125.69 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.736 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -55.51 169.4 0.31 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.765 0.793 . . . . 0.0 111.018 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -101.57 -22.71 14.42 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.988 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.9 -153.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 108.869 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.14 -174.35 4.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.059 -1.025 . . . . 0.0 109.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 89.75 -13.5 64.14 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 12.6 mt-10 46.08 93.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.41 -1.053 . . . . 0.0 112.013 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -133.41 -72.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.439 HG22 ' OG ' ' A' ' 133' ' ' SER . 31.1 p -153.91 139.5 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.736 HG21 ' HB2' ' A' ' 35' ' ' ALA . 8.9 pt -134.1 149.56 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.597 ' OG ' HG22 ' A' ' 131' ' ' VAL . 30.9 m -126.53 140.42 52.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.398 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.702 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -148.41 121.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.681 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.4 t -101.31 120.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.691 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.5 mp -98.08 168.63 10.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.691 -0.631 . . . . 0.0 109.985 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -111.39 142.76 43.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.803 -0.561 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD23 HD12 ' A' ' 6' ' ' LEU . 60.8 mt -97.07 135.26 39.31 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -79.63 37.89 0.36 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.48 -0.762 . . . . 0.0 111.262 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 pttt 165.58 127.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.39 108.12 9.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.41 -0.806 . . . . 0.0 109.429 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -178.6 5.96 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -87.34 -172.63 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.41 122.9 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.519 -0.738 . . . . 0.0 109.202 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.3 t-160 -109.41 -32.09 7.29 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.3 m -146.88 153.53 40.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 149' ' ' PHE . 70.5 t -137.51 158.7 34.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.674 -0.641 . . . . 0.0 109.564 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.517 ' O ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -137.2 138.55 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.706 HG23 HD23 ' A' ' 144' ' ' LEU . 1.0 OUTLIER -159.72 139.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -122.99 135.77 10.21 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -91.77 151.56 20.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.152 -0.617 . . . . 0.0 109.9 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.32 34.47 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.161 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.86 -17.14 8.21 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.518 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -60.78 -171.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.366 -1.079 . . . . 0.0 110.449 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.96 -40.88 0.84 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.48 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.05 140.43 39.87 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.509 -0.744 . . . . 0.0 111.322 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 93' ' ' PHE . 61.9 t -143.3 112.44 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.667 -0.645 . . . . 0.0 109.61 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.25 147.3 27.22 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.68 -0.638 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.667 HG13 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.27 131.55 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.897 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -117.32 167.34 11.32 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.72 HG23 ' HG2' ' A' ' 85' ' ' GLU . 5.6 m -130.61 159.0 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.703 -0.623 . . . . 0.0 109.568 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 176.31 173.8 42.27 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 t -115.62 161.07 19.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.601 0.715 . . . . 0.0 109.58 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -80.34 3.75 20.11 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.803 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.29 -174.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.154 -0.966 . . . . 0.0 110.143 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.64 106.23 0.92 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -140.59 -72.32 0.04 OUTLIER Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.04 43.55 14.32 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -1.006 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.17 122.55 1.33 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -62.77 -27.51 69.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.618 -0.931 . . . . 0.0 109.628 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -97.31 28.45 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.468 -0.77 . . . . 0.0 109.618 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -105.95 25.45 10.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.543 -0.723 . . . . 0.0 109.62 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.54 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -109.26 -175.54 2.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.72 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -121.11 127.4 51.57 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.39 86.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.759 -0.588 . . . . 0.0 110.17 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.599 HD22 ' CG1' ' A' ' 72' ' ' VAL . 15.3 tp -57.96 -50.65 72.64 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.67 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.7 OUTLIER -146.6 124.07 11.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -59.01 173.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -56.08 131.32 47.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 p -103.46 132.9 49.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 99.9 p -90.18 107.4 19.11 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 68' ' ' VAL . 7.2 m-30 -89.29 -51.36 5.61 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.418 -0.801 . . . . 0.0 109.691 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 mtp -120.89 -178.92 3.86 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.754 0.788 . . . . 0.0 110.519 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -99.98 179.63 1.0 Allowed Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -86.98 18.45 1.57 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.128 2.552 . . . . 0.0 111.445 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.3 m -120.31 -53.52 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.118 -0.989 . . . . 0.0 109.49 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -58.11 -18.99 28.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.452 -0.78 . . . . 0.0 110.635 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.4 t -49.04 -26.54 2.67 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.334 -0.854 . . . . 0.0 110.455 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -85.66 -85.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 t -164.06 37.47 0.08 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.36 -19.84 68.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.06 -83.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.42 -1.047 . . . . 0.0 110.686 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.6 p30 -111.84 82.15 3.88 Favored Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.78 -19.23 27.68 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.824 2.349 . . . . 0.0 110.776 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 127.79 40.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.699 -0.626 . . . . 0.0 109.567 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -157.73 176.69 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 17.4 m -134.57 -173.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.535 -0.728 . . . . 0.0 109.41 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -160.66 148.91 16.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.408 -0.807 . . . . 0.0 109.646 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.1 mtm -126.69 151.93 47.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.836 -0.54 . . . . 0.0 109.731 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CE2' HD13 ' A' ' 88' ' ' LEU . 3.6 m-85 -122.57 165.68 16.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.42 -148.3 5.3 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.6 Cg_endo -75.01 -40.19 0.97 Allowed 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 123.727 2.951 . . . . 0.0 111.152 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.2 -27.76 68.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.742 . . . . 0.0 109.782 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtmm -92.02 3.36 55.41 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.666 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.79 139.37 54.08 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.037 -1.04 . . . . 0.0 110.45 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.9 p -59.63 129.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -74.29 -32.48 62.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.558 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.0 -22.44 67.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.502 -0.749 . . . . 0.0 110.189 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.2 -47.07 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 110.152 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.949 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.99 19.39 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.099 -1.001 . . . . 0.0 111.63 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -81.52 2.23 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.368 -0.832 . . . . 0.0 110.707 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 27.6 mttt -93.51 136.02 34.19 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -67.19 113.22 4.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.413 -0.804 . . . . 0.0 110.546 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.484 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 78.8 m95 -116.94 164.53 14.55 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -139.86 14.82 2.49 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.065 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.401 ' HD3' HG21 ' A' ' 10' ' ' VAL . 6.7 mtt180 -144.38 146.95 32.82 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.0 p -138.19 140.78 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.036 -1.065 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.681 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -100.33 142.93 31.12 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.667 ' CD1' HG13 ' A' ' 70' ' ' VAL . 37.6 mm -138.24 107.51 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.597 HG22 ' OG ' ' A' ' 44' ' ' SER . 44.0 t -115.46 120.62 65.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 O-C-N 121.293 -0.879 . . . . 0.0 109.874 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 144' ' ' LEU . 2.2 t -94.22 150.71 20.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -155.1 143.02 20.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.09 -1.006 . . . . 0.0 112.206 -177.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.4 tp60 148.53 113.1 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -81.34 123.32 4.38 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.679 2.253 . . . . 0.0 110.562 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.563 ' CD1' ' HB3' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -146.78 6.16 0.91 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.016 -1.073 . . . . 0.0 113.165 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 -175.19 4.79 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.347 -1.471 . . . . 0.0 111.345 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 58.8 mmtt -137.03 -30.16 0.88 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.828 -0.545 . . . . 0.0 110.912 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.08 -9.01 6.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.798 -1.189 . . . . 0.0 111.924 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.56 148.97 37.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.947 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.11 -161.45 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 123.927 3.085 . . . . 0.0 110.632 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' CD1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p90 -178.69 -160.32 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA2' HD11 ' A' ' 43' ' ' ILE . . . 157.31 -165.37 33.32 Favored Glycine 0 N--CA 1.482 1.735 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.283 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.706 HD23 HG23 ' A' ' 60' ' ' ILE . 4.6 mp -99.27 150.58 21.95 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 122.063 -0.669 . . . . 0.0 109.569 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 p -76.79 -30.71 56.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 49.6 p90 -175.13 168.9 3.38 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.735 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.9 m -138.65 157.31 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 14.3 mtt180 -160.06 159.74 32.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.627 -0.67 . . . . 0.0 110.269 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.884 ' CE2' HG11 ' A' ' 128' ' ' VAL . 58.2 m-85 -150.38 153.4 35.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.95 142.91 18.97 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.15 -0.968 . . . . 0.0 110.107 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -89.91 20.47 1.04 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.684 2.922 . . . . 0.0 111.097 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -155.78 159.99 39.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.333 -0.855 . . . . 0.0 109.426 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' OE1' ' A' ' 53' ' ' GLU . 96.0 mt -139.15 130.16 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 167.27 10.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 109.632 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.779 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.2 mp -98.53 160.82 14.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.701 -0.624 . . . . 0.0 109.424 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.717 ' C ' HD11 ' A' ' 25' ' ' LEU . 7.2 tpt180 -116.78 -46.01 2.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.674 -0.641 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -161.19 -171.88 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.706 -0.621 . . . . 0.0 109.422 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -106.48 90.46 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 109.258 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 11' ' ' SER . 1.4 p -52.25 -62.98 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.206 -0.934 . . . . 0.0 110.55 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.551 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -118.55 155.1 31.48 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 24.5 p -161.53 126.47 3.51 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.748 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -137.61 68.18 1.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.4 p 153.4 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.777 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -122.34 144.0 49.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.978 -1.076 . . . . 0.0 110.765 -178.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -94.12 -168.37 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -68.73 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.444 -0.785 . . . . 0.0 109.825 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -51.82 65.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.0 71.41 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.4 p -89.81 169.56 11.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.734 . . . . 0.0 109.705 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.777 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -62.6 -25.18 67.95 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.668 -0.645 . . . . 0.0 109.768 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -60.4 -19.69 56.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.347 -0.846 . . . . 0.0 109.795 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -64.72 -19.94 66.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.102 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 47' ' ' LEU . 8.5 mt -65.83 -25.78 67.37 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.717 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -59.53 -20.82 58.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.43 -0.794 . . . . 0.0 109.014 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.24 73.08 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.26 -47.73 55.07 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.517 -0.739 . . . . 0.0 110.684 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.61 75.96 9.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.482 -0.761 . . . . 0.0 109.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.484 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -161.57 31.18 0.13 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.473 -0.767 . . . . 0.0 109.632 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.6 p90 47.15 25.57 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.315 0.579 . . . . 0.0 111.658 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -119.89 135.12 55.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.182 -0.949 . . . . 0.0 109.235 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 32.1 mttt -126.96 -178.63 4.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.499 -0.751 . . . . 0.0 109.953 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.82 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.4 t90 -94.43 137.25 33.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 mtp85 -139.78 128.12 22.68 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.93 164.72 0.24 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.424 -0.797 . . . . 0.0 110.327 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -72.4 -22.42 61.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.793 -0.567 . . . . 0.0 110.531 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.23 176.58 8.57 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.354 -0.841 . . . . 0.0 109.063 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.34 -176.06 5.74 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.71 -48.84 2.55 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 11.9 mp0 40.09 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.021 -0.694 . . . . 0.0 112.367 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' HG23 ' A' ' 42' ' ' THR . 8.2 ptpt -103.21 -43.35 5.48 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.676 HG22 ' OG ' ' A' ' 133' ' ' SER . 3.0 p -160.49 106.34 1.49 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.82 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.6 pt -107.32 136.66 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.497 -0.752 . . . . 0.0 110.5 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.456 ' N ' ' OG ' ' A' ' 14' ' ' SER . 55.6 p -115.61 134.98 54.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.38 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -142.3 101.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.641 HG22 ' HG3' ' A' ' 129' ' ' LYS . 5.0 t -90.33 118.16 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.098 -1.001 . . . . 0.0 108.965 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.779 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -103.02 166.37 10.48 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.295 0.569 . . . . 0.0 109.588 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -107.92 157.49 18.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.671 -0.643 . . . . 0.0 109.403 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.02 124.44 49.63 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.1 -7.31 0.08 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.391 -0.818 . . . . 0.0 112.297 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -161.8 140.99 9.79 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.731 -1.23 . . . . 0.0 109.414 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.27 109.32 8.68 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.509 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -143.74 175.9 9.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.59 -172.5 4.21 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.9 121.68 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -110.13 -30.55 7.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.2 m -146.03 154.69 42.15 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.76 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.9 t -137.9 158.67 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.706 ' C ' HD12 ' A' ' 60' ' ' ILE . 12.1 t0 -133.05 134.84 44.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.308 -0.87 . . . . 0.0 110.579 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.946 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -149.7 125.96 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.65 117.04 5.55 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.9 126.02 28.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.849 -0.795 . . . . 0.0 109.881 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -123.15 82.63 2.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.69 11.52 80.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 4.9 p -98.4 178.64 4.97 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -1.123 . . . . 0.0 109.824 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -140.07 -47.56 0.44 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.515 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -109.3 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.172 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.946 HG11 HG21 ' A' ' 60' ' ' ILE . 42.7 t -132.65 114.05 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.44 150.86 26.29 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.614 HG13 HD13 ' A' ' 130' ' ' ILE . 34.3 t -140.71 127.14 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.586 0.708 . . . . 0.0 110.079 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 3.6 mp -113.85 160.89 18.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 87' ' ' LEU . 2.4 m -125.41 155.55 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.55 -0.719 . . . . 0.0 110.151 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.19 169.69 42.77 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 28.9 t -119.92 165.43 14.64 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.723 0.773 . . . . 0.0 110.014 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -69.91 -9.36 54.68 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.63 145.57 28.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.264 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.02 36.5 4.07 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.38 -102.48 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.25 -33.8 73.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.567 -0.961 . . . . 0.0 109.441 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 140.94 131.85 2.76 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.62 74.74 8.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.597 -0.943 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -153.81 -46.01 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.23 -47.12 65.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.749 -0.594 . . . . 0.0 109.422 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 3.6 m-85 59.24 165.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.554 -0.717 . . . . 0.0 109.282 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.7 OUTLIER -101.69 129.63 47.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.1 86.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.798 -0.563 . . . . 0.0 110.373 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 72' ' ' VAL . 10.3 tp -59.98 -52.59 64.76 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.41 121.0 11.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.385 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 90' ' ' THR . 3.0 t -57.55 172.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.561 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -58.01 135.01 56.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.592 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 5.9 p -108.33 130.94 55.18 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.447 0.641 . . . . 0.0 109.64 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.9 OUTLIER -85.91 123.28 31.07 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 25.6 m-85 -123.05 -46.4 2.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.544 -0.722 . . . . 0.0 109.799 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.41 ' HE3' ' HA ' ' A' ' 105' ' ' PRO . 1.5 mtp -120.82 -165.7 1.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.702 -0.624 . . . . 0.0 109.872 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.9 p -126.58 175.77 3.03 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -87.56 15.42 2.15 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.31 2.674 . . . . 0.0 111.285 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 t -120.17 -42.13 2.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 0.0 109.337 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.09 -20.54 40.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.604 -0.685 . . . . 0.0 110.58 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.1 m -50.22 -25.98 4.19 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.273 -0.892 . . . . 0.0 110.765 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -85.12 -87.49 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.487 -0.758 . . . . 0.0 109.947 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -163.64 37.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.35 56.52 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.38 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.476 -1.014 . . . . 0.0 110.722 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.97 92.78 47.01 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 38.6 Cg_endo -73.04 -23.54 18.24 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.615 2.21 . . . . 0.0 110.016 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.97 143.54 51.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -148.2 -174.5 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.432 -0.792 . . . . 0.0 110.422 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 70.4 t -148.75 142.44 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -153.26 145.99 24.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.949 . . . . 0.0 109.863 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.2 mtm -125.78 152.58 45.21 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.308 0.575 . . . . 0.0 109.979 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 88' ' ' LEU . 6.7 m-85 -113.02 159.06 19.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -128.19 -149.6 7.06 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.538 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.67 -39.27 1.43 Allowed 'Trans proline' 0 N--CA 1.503 2.039 0 C-N-CA 123.76 2.973 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.74 -28.31 68.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.547 -0.72 . . . . 0.0 109.54 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 42.8 mttt -89.5 3.82 51.17 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.661 -0.649 . . . . 0.0 110.592 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -124.7 139.81 53.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.098 -1.001 . . . . 0.0 110.442 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.903 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.1 p -60.3 132.35 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -74.86 -34.36 62.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.23 -20.45 65.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.452 -0.78 . . . . 0.0 110.297 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.903 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.55 -47.94 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.353 -0.842 . . . . 0.0 110.045 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.1 -41.02 25.16 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.217 -0.927 . . . . 0.0 111.617 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.29 -2.18 33.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.414 -0.804 . . . . 0.0 110.642 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.4 mttm -90.98 133.63 35.13 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -65.71 113.11 4.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.593 -0.692 . . . . 0.0 110.392 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.468 ' CZ2' ' HG3' ' A' ' 85' ' ' GLU . 83.3 m95 -116.17 163.46 15.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -137.9 7.65 2.73 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.608 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -139.24 136.93 35.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.889 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.0 p -127.75 143.93 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.664 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.641 ' HG3' HG22 ' A' ' 46' ' ' VAL . 3.4 tttt -111.6 111.07 21.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.756 -0.59 . . . . 0.0 109.653 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.614 HD13 HG13 ' A' ' 70' ' ' VAL . 49.4 mm -101.77 128.3 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 0.0 109.09 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.25 117.74 41.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 O-C-N 121.44 -0.788 . . . . 0.0 109.644 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.15 142.39 27.35 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -140.15 127.83 21.73 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.387 -0.821 . . . . 0.0 111.162 -177.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.69 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 150.03 137.95 0.0 OUTLIER Pre-proline 0 N--CA 1.52 3.042 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.78 101.48 0.78 Allowed 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.107 2.538 . . . . 0.0 110.319 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -79.61 -60.62 2.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.4 -0.812 . . . . 0.0 108.889 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.88 160.59 22.32 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -106.11 26.61 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.54 -0.725 . . . . 0.0 110.084 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.34 -54.24 2.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.566 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 p -116.47 155.33 48.73 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 122.008 -0.433 . . . . 0.0 109.874 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.409 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.1 Cg_endo -83.73 166.18 13.54 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 123.459 2.772 . . . . 0.0 109.724 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -169.76 -163.02 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 0.0 109.496 -179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 160.89 -106.56 0.29 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -132.45 161.87 32.59 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.212 -1.17 . . . . 0.0 110.189 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 25.3 m -83.43 -17.69 41.26 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 122.036 -0.415 . . . . 0.0 110.916 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 48.6 p90 175.88 179.31 0.17 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.232 -0.918 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.513 ' CG1' HD12 ' A' ' 144' ' ' LEU . 35.3 m -154.66 128.24 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 150' ' ' HIS . 11.8 mtm180 -140.88 110.79 6.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.277 -0.89 . . . . 0.0 110.562 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.889 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.3 m-85 -88.64 158.57 18.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.412 -0.805 . . . . 0.0 108.859 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -156.07 139.59 15.89 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.293 -0.88 . . . . 0.0 109.512 179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.3 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.0 Cg_endo -84.0 74.68 4.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.932 2.421 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -133.95 178.66 6.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' SER . 40.3 mm -125.3 146.64 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -140.69 134.93 31.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 0.0 109.367 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.525 HD21 ' CD2' ' A' ' 149' ' ' PHE . 4.3 mm? -85.83 144.63 27.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.467 -0.771 . . . . 0.0 109.162 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -94.67 -50.94 4.94 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -160.83 167.78 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -78.67 89.95 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG12 ' C ' ' A' ' 47' ' ' LEU . 1.6 p -50.29 -58.94 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.292 -0.88 . . . . 0.0 110.427 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.52 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.47 158.92 31.69 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.5 p -153.42 136.34 15.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.675 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -130.01 46.74 2.6 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 154.56 94.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 123.075 0.55 . . . . 0.0 109.624 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.37 146.0 15.05 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.953 -1.092 . . . . 0.0 109.445 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.52 -168.11 1.56 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.268 -0.895 . . . . 0.0 109.612 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 -60.21 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.652 -0.655 . . . . 0.0 109.522 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -61.15 2.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.801 . . . . 0.0 108.918 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -97.11 77.54 2.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.9 p -90.2 168.26 12.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.576 -0.702 . . . . 0.0 109.937 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.35 -23.72 67.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -62.65 -17.92 61.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.791 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -65.01 -20.16 66.36 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.212 -0.93 . . . . 0.0 109.277 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.757 HD21 ' HB2' ' A' ' 33' ' ' TRP . 12.0 mt -66.29 -25.9 67.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -61.56 -20.16 62.96 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -109.44 64.07 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.6 7.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 0.0 110.563 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 29' ' ' THR . 18.9 t70 -118.65 80.43 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 109.819 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.1 p -155.13 -84.03 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.494 -0.754 . . . . 0.0 109.612 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' ARG . 43.7 p90 -179.23 -36.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -79.53 148.85 31.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.391 -0.818 . . . . 0.0 109.772 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 12.4 mttp -127.42 -165.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.639 -0.663 . . . . 0.0 109.541 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.791 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.8 t90 -91.73 141.77 28.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -144.83 126.88 15.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.04 151.71 4.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.76 . . . . 0.0 110.402 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.72 -24.28 67.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.939 -0.475 . . . . 0.0 110.288 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -138.48 -173.22 3.48 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.352 -0.843 . . . . 0.0 109.285 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.15 -163.92 1.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.785 -0.572 . . . . 0.0 109.487 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.07 45.76 95.43 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -47.71 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.582 0.706 . . . . 0.0 111.557 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 42' ' ' THR . 30.3 tttt -93.47 -56.68 2.84 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.673 HG22 ' OG ' ' A' ' 133' ' ' SER . 23.8 p -156.94 113.77 3.06 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.791 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.9 pt -114.61 132.22 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.573 -0.704 . . . . 0.0 109.874 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -114.57 146.71 40.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.504 178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.7 p -147.74 112.42 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 129' ' ' LYS . 4.6 t -95.54 119.33 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.3 -0.875 . . . . 0.0 108.946 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' C ' HG12 ' A' ' 10' ' ' VAL . 1.5 mp -99.25 160.37 14.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.777 -0.577 . . . . 0.0 109.646 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.422 ' N ' HD12 ' A' ' 6' ' ' LEU . 12.6 tm0? -111.85 125.97 54.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.5 -0.75 . . . . 0.0 109.905 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' OE2' ' A' ' 53' ' ' GLU . 14.2 mt -80.15 136.04 36.43 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 41.34 0.61 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.594 -0.691 . . . . 0.0 110.405 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.3 pttm 164.8 128.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -75.61 107.45 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.571 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -136.6 179.79 6.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.74 -0.6 . . . . 0.0 109.494 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -94.94 162.96 13.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -117.27 126.41 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.311 -0.868 . . . . 0.0 109.918 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.454 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.2 t60 -116.97 -30.19 5.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.694 -0.629 . . . . 0.0 109.849 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.5 m -148.98 158.73 44.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 0.0 108.876 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.71 HG12 HD12 ' A' ' 60' ' ' ILE . 61.3 t -147.82 161.32 7.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.804 0.811 . . . . 0.0 110.447 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -136.07 134.68 38.68 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.71 HD12 HG12 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -153.18 130.69 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -103.88 125.81 8.55 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -83.68 127.59 33.89 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.247 -0.561 . . . . 0.0 110.281 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.06 50.4 1.18 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.75 -24.23 24.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.442 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 29.1 t -57.12 161.39 3.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.386 -1.067 . . . . 0.0 109.919 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -121.83 -51.79 2.02 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.813 -0.554 . . . . 0.0 109.601 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 133' ' ' SER . 20.9 m-85 -96.25 126.59 41.57 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.176 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.0 t -130.19 111.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.596 -0.69 . . . . 0.0 109.734 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -106.29 146.76 29.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.737 -0.602 . . . . 0.0 109.553 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 130' ' ' ILE . 6.7 t -131.13 125.13 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -111.71 157.03 20.97 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -121.55 154.91 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 109.771 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.77 171.22 41.77 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.5 t -109.63 161.66 15.17 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 122.037 -0.684 . . . . 0.0 109.242 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.413 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 23.1 p -86.13 6.73 27.88 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.56 114.64 2.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.763 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.66 -69.79 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.46 75.99 0.75 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -177.27 37.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.617 -0.931 . . . . 0.0 109.459 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.76 115.82 0.66 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -87.67 -28.1 22.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.621 -0.929 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -97.47 28.53 3.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.484 -0.76 . . . . 0.0 109.628 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -111.84 34.37 4.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.545 -0.722 . . . . 0.0 109.272 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -107.97 -174.53 2.55 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -121.73 127.88 51.17 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.416 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.0 t -61.16 88.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.676 -0.64 . . . . 0.0 110.235 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' HB2' HG13 ' A' ' 72' ' ' VAL . 18.1 tp -59.65 -60.74 3.36 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD13 ' CE2' ' A' ' 111' ' ' PHE . 2.0 pp -135.85 119.78 17.46 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.346 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.51 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.2 m -51.34 174.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.49 -0.756 . . . . 0.0 110.278 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.13 133.59 53.25 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.509 -0.744 . . . . 0.0 109.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.7 p -102.88 122.26 44.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.33 0.586 . . . . 0.0 109.538 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.5 p -87.01 108.31 18.8 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.415 ' CE1' ' CB ' ' A' ' 109' ' ' ARG . 24.2 m-85 -93.48 -51.93 4.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.71 -0.619 . . . . 0.0 109.922 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.45 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 9.3 mtp -122.11 -167.9 1.63 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.658 0.742 . . . . 0.0 110.452 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.8 p -109.32 175.64 1.87 Allowed Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.46 10.65 3.63 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.897 2.398 . . . . 0.0 111.332 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -121.44 -35.57 3.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.61 -0.38 53.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.381 -0.824 . . . . 0.0 110.671 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 60.1 m -74.19 -30.54 62.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -68.37 -77.99 0.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.7 t -161.96 38.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -107.23 -24.74 6.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.54 120.62 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 109.981 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.45 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.2 68.63 2.15 Favored Pre-proline 0 N--CA 1.509 2.499 0 O-C-N 121.975 -0.453 . . . . 0.0 111.551 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -76.83 -30.38 4.73 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.877 2.385 . . . . 0.0 110.233 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.93 99.23 5.21 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.22 -164.13 1.34 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.606 -0.684 . . . . 0.0 109.404 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -148.8 151.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . 5.1 mmt180 -144.45 166.15 25.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.3 mtm -139.68 175.02 9.93 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.535 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.648 ' CE2' HD13 ' A' ' 88' ' ' LEU . 7.5 m-85 -134.36 169.04 17.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -141.49 -151.48 5.56 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.3 Cg_endo -76.45 -37.12 1.46 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.582 2.855 . . . . 0.0 110.617 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.03 -28.59 68.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 109.429 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -88.09 1.61 53.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.607 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.965 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.6 pp -124.02 139.76 53.63 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.979 -1.076 . . . . 0.0 110.345 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.0 p -59.11 130.37 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -74.7 -31.66 61.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.391 -0.818 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.93 66.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.92 -46.48 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.119 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.965 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.66 -38.5 21.34 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.158 -0.964 . . . . 0.0 111.51 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.68 -0.36 33.68 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 110.538 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 25.7 mtpt -92.41 135.15 34.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -68.23 111.46 4.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.513 -0.742 . . . . 0.0 110.887 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.5 m95 -113.5 162.36 16.25 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.484 ' CA ' HD12 ' A' ' 49' ' ' LEU . 4.4 p30 -135.36 9.0 3.43 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.681 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.7 mtm180 -140.77 142.39 34.73 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.768 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.8 p -133.9 142.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.241 -0.983 . . . . 0.0 110.816 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 46' ' ' VAL . 1.5 tttt -106.5 112.48 25.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.844 -0.535 . . . . 0.0 109.647 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.648 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.9 mm -104.83 117.19 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 44' ' ' SER . 42.6 t -120.14 120.65 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.201 -0.937 . . . . 0.0 110.62 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.405 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -95.6 136.0 36.55 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.673 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -139.31 123.44 17.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 111.017 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.6 tp60 165.14 128.77 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.159 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.98 90.53 0.9 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.875 2.383 . . . . 0.0 109.251 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 7.4 p90 -119.85 -12.45 9.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.738 . . . . 0.0 111.702 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.83 176.54 5.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.123 -0.986 . . . . 0.0 110.22 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -153.33 -42.77 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.65 -29.93 6.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.619 -0.675 . . . . 0.0 109.955 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -104.42 145.93 31.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 O-C-N 121.711 -0.618 . . . . 0.0 109.66 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 45.1 Cg_endo -87.78 -175.74 1.52 Allowed 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.356 2.704 . . . . 0.0 110.626 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 170.26 -166.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.95 -117.57 0.76 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.815 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 5.3 mp -114.83 158.43 21.92 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.711 -0.876 . . . . 0.0 110.18 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 32.3 m -96.17 -25.8 15.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.979 -0.451 . . . . 0.0 109.982 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -176.98 165.7 2.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.206 -0.934 . . . . 0.0 110.362 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.93 159.02 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 0.1 OUTLIER -160.49 101.22 1.35 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.231 -0.918 . . . . 0.0 110.955 -178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.768 ' CE2' HG11 ' A' ' 128' ' ' VAL . 34.5 m-85 -88.99 149.93 23.04 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 0.0 108.289 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -153.2 120.12 5.73 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.729 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 4' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.02 105.77 0.65 Allowed 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 123.468 2.779 . . . . 0.0 110.514 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -154.77 179.86 8.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.598 -0.689 . . . . 0.0 109.518 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' HB3' ' A' ' 151' ' ' SER . 33.6 mt -145.26 119.75 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -96.62 166.17 11.79 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.31 0.576 . . . . 0.0 109.605 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.701 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -103.3 153.05 20.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.71 -0.619 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.494 ' C ' HD11 ' A' ' 25' ' ' LEU . 41.8 ttt85 -102.49 -56.48 2.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.599 -0.688 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -160.97 161.46 31.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.651 -0.655 . . . . 0.0 109.274 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.623 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.75 93.51 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.572 -0.705 . . . . 0.0 109.1 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG13 ' H ' ' A' ' 11' ' ' SER . 2.5 p -54.66 -55.96 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.259 -0.901 . . . . 0.0 110.398 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.484 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -121.45 151.57 40.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -0.857 . . . . 0.0 109.058 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.5 p -143.7 112.26 6.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.371 -0.831 . . . . 0.0 110.274 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -105.95 43.7 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 43' ' ' ILE . 1.7 t 153.05 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.825 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -161.3 135.61 7.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 109.273 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -82.45 -163.1 0.64 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -0.796 . . . . 0.0 109.18 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.8 m -95.51 -70.37 0.72 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.755 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -54.92 25.3 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -93.9 68.57 3.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.6 p -90.92 176.13 6.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.474 -0.766 . . . . 0.0 110.271 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.62 -25.17 68.1 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.74 -16.4 57.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.446 -0.784 . . . . 0.0 109.918 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.07 -18.19 65.09 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.104 -0.997 . . . . 0.0 109.204 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' A' ' 33' ' ' TRP . 8.8 mt -66.0 -24.13 66.71 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -58.79 -21.01 55.09 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.459 -0.776 . . . . 0.0 109.06 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 29' ' ' THR . 0.8 OUTLIER -123.62 73.47 1.2 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.71 -22.03 21.55 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.462 -0.774 . . . . 0.0 110.233 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.51 101.41 9.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -172.71 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.508 -0.745 . . . . 0.0 109.117 179.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' OG1' ' A' ' 29' ' ' THR . 52.0 p90 -166.42 29.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.84 -1.162 . . . . 0.0 109.941 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.21 177.37 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.402 -0.811 . . . . 0.0 109.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -159.57 0.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.2 t90 -77.62 139.27 39.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.125 -0.985 . . . . 0.0 109.731 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -144.07 125.73 15.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.52 151.79 7.47 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.467 -0.771 . . . . 0.0 110.246 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -69.55 -29.82 67.48 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.874 -0.516 . . . . 0.0 109.722 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -114.47 -165.8 1.05 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.26 -162.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.66 44.5 97.79 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.4 mm-40 -43.1 91.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.933 0.873 . . . . 0.0 112.002 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.5 ttmt -101.98 -57.61 2.04 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.548 HG22 ' OG ' ' A' ' 133' ' ' SER . 75.2 p -154.51 121.43 5.56 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 7.1 pt -126.73 152.47 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.526 -0.733 . . . . 0.0 110.015 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.76 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -129.97 150.27 51.33 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.491 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.0 p -154.75 108.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 128' ' ' VAL . 19.4 t -92.15 120.76 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.701 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.4 mp -98.13 161.51 13.68 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -111.17 129.5 55.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.617 -0.677 . . . . 0.0 109.948 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD13 ' OE2' ' A' ' 53' ' ' GLU . 44.8 mt -84.73 142.64 29.69 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 36.91 0.33 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.486 -0.759 . . . . 0.0 111.324 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 pttm 163.22 138.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.205 -0.935 . . . . 0.0 108.797 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 13.4 tt0 -75.55 103.78 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -136.25 172.19 13.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.517 0.675 . . . . 0.0 109.787 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -85.18 179.01 7.32 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.6 mp -140.31 124.24 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.437 -0.79 . . . . 0.0 110.047 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 44.5 t60 -112.89 -29.5 7.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.609 -0.682 . . . . 0.0 109.2 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.428 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.4 m -143.07 157.14 44.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.04 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 149' ' ' PHE . 61.6 t -143.01 162.72 17.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.331 0.586 . . . . 0.0 109.938 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -142.35 100.77 3.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.631 HG23 HD23 ' A' ' 144' ' ' LEU . 1.5 mt -122.31 124.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -92.27 128.35 9.35 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' OD1' HG21 ' A' ' 68' ' ' VAL . 4.1 m-80 -84.02 120.69 26.43 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 122.173 -0.604 . . . . 0.0 110.194 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 5.8 t0 -93.64 69.58 4.11 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 3.21 89.52 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -64.79 -175.1 0.17 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.73 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -148.58 -55.23 0.2 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' ' HG3' ' A' ' 134' ' ' GLN . 28.0 m-85 -105.67 116.46 31.98 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.016 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 ' OD1' ' A' ' 62' ' ' ASN . 48.9 t -120.76 109.86 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.942 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.29 142.45 35.03 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.648 HG13 HD13 ' A' ' 130' ' ' ILE . 24.1 t -130.73 127.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.603 0.716 . . . . 0.0 109.854 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 86' ' ' VAL . 2.5 mp -112.68 162.23 15.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -122.45 157.58 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.647 -0.658 . . . . 0.0 110.375 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.72 166.85 38.83 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.2 t -109.45 153.26 24.29 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.843 -0.798 . . . . 0.0 109.867 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.426 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 47.6 t -84.4 8.64 15.59 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.32 119.57 9.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.199 -0.938 . . . . 0.0 109.735 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 66.45 -82.31 0.1 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 117.41 73.4 0.48 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.12 87.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.933 . . . . 0.0 109.459 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.27 -163.72 34.59 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -105.33 -20.88 13.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.581 -0.953 . . . . 0.0 110.029 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.49 27.96 3.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 109.923 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -118.09 40.25 3.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.043 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.405 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -102.96 -173.12 2.24 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.12 135.47 50.78 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 HD11 ' A' ' 71' ' ' LEU . 22.4 t -63.16 88.98 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.657 -0.652 . . . . 0.0 111.493 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.569 HD13 HG11 ' A' ' 72' ' ' VAL . 10.7 tp -64.5 -42.09 96.05 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 89' ' ' VAL . 2.3 pp -150.77 120.51 7.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.836 -0.745 . . . . 0.0 109.459 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.549 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.3 m -54.1 -178.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.697 -0.627 . . . . 0.0 110.293 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.51 133.56 47.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.47 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 p -98.51 117.92 34.02 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.258 0.551 . . . . 0.0 109.594 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.7 p -74.93 68.6 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -59.42 -59.07 6.03 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.875 -0.516 . . . . 0.0 110.261 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 68.2 mtp -121.23 -176.12 3.21 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.584 0.707 . . . . 0.0 110.713 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.9 p -114.66 179.77 0.73 Allowed Pre-proline 0 N--CA 1.49 1.548 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -86.72 11.06 3.39 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.102 2.535 . . . . 0.0 111.322 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.2 p -120.91 -39.37 2.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.289 -0.882 . . . . 0.0 109.955 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -83.43 0.33 46.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.534 -0.729 . . . . 0.0 110.768 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.8 t -78.64 -32.55 47.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -0.983 . . . . 0.0 110.165 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -82.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.678 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -161.69 38.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -106.93 -22.96 7.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 119.74 0.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.298 -1.119 . . . . 0.0 110.244 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 39.98 64.35 4.47 Favored Pre-proline 0 N--CA 1.508 2.45 0 O-C-N 121.921 -0.487 . . . . 0.0 111.534 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.468 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.6 Cg_endo -75.18 -30.66 6.68 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.889 2.393 . . . . 0.0 110.254 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.67 75.52 1.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.698 -0.627 . . . . 0.0 109.491 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -111.83 -169.56 1.49 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.59 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -129.98 165.11 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.346 -0.846 . . . . 0.0 109.197 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 21.5 tpt180 -143.26 134.46 25.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtm -110.72 158.92 18.1 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.036 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.8 m-85 -133.14 105.63 7.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -83.52 -147.4 7.52 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 116' ' ' LEU . 40.4 Cg_endo -74.51 -35.52 3.62 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 123.517 2.811 . . . . 0.0 110.809 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -65.62 -27.72 68.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.693 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -92.5 4.32 53.75 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.643 -0.661 . . . . 0.0 110.682 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -128.37 143.87 51.06 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.912 -1.118 . . . . 0.0 110.31 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.892 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.5 p -64.25 140.52 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.82 -35.05 44.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.523 -0.735 . . . . 0.0 109.075 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.69 -21.02 66.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.579 -0.701 . . . . 0.0 110.291 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.892 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.98 -47.15 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.1 -31.85 8.78 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.186 -0.946 . . . . 0.0 111.12 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -2.03 58.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.458 -0.776 . . . . 0.0 110.557 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 9.3 mtpp -92.02 135.14 34.19 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.0 mtm-85 -67.85 109.28 3.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.0 110.674 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.426 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 86.4 m95 -108.63 160.26 16.08 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 12.6 t70 -133.28 2.31 3.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 110.404 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.426 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -140.84 143.0 34.52 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.913 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -133.95 142.49 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.361 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.3 tttp -107.45 114.66 28.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.717 -0.615 . . . . 0.0 109.788 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.66 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 50.0 mm -104.97 122.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.76 HG22 ' HB3' ' A' ' 44' ' ' SER . 38.8 t -128.28 125.1 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 121.15 -0.969 . . . . 0.0 110.654 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 43' ' ' ILE . 18.0 t -97.93 145.92 25.98 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.66 130.03 17.73 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 0.0 111.495 -178.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.73 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 149.07 131.3 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.597 0 C-N-CA 123.911 0.884 . . . . 0.0 108.989 178.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -85.42 87.1 0.99 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.939 2.426 . . . . 0.0 109.967 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 3.4 p90 -113.86 -1.42 13.89 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 111.12 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.65 -171.74 2.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.042 -1.036 . . . . 0.0 109.476 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -164.23 -43.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.84 -32.5 5.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 0.0 109.887 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.34 149.8 36.65 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.885 -0.509 . . . . 0.0 109.702 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_endo -85.25 -169.79 0.67 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.437 2.758 . . . . 0.0 110.639 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 171.2 -162.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.3 -117.05 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.492 -1.337 . . . . 0.0 110.942 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.631 HD23 HG23 ' A' ' 60' ' ' ILE . 6.1 mp -118.0 145.92 44.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.847 -0.796 . . . . 0.0 110.351 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 m -81.38 -27.21 34.93 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.509 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 35.3 p90 -175.87 171.69 2.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.453 -0.779 . . . . 0.0 109.804 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.637 HG22 ' HB3' ' A' ' 24' ' ' LEU . 35.7 m -150.21 131.11 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -147.98 105.4 3.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.447 -0.783 . . . . 0.0 110.504 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.913 ' CE2' HG11 ' A' ' 128' ' ' VAL . 69.4 m-85 -86.3 157.83 19.82 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -152.9 136.01 15.63 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.373 -0.829 . . . . 0.0 109.651 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.677 ' HB3' HD11 ' A' ' 4' ' ' ILE . 82.3 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -86.41 94.43 0.54 Allowed 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.517 2.812 . . . . 0.0 110.391 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.66 171.75 18.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.56 -0.713 . . . . 0.0 109.771 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 151' ' ' SER . 48.6 mt -146.31 123.97 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -102.04 166.21 10.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.731 -0.606 . . . . 0.0 110.012 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.612 HD13 ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -98.09 138.94 34.65 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.612 ' N ' HD13 ' A' ' 6' ' ' LEU . 9.9 tpt180 -93.06 -56.24 3.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.126 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -161.06 160.6 30.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -79.49 91.18 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 127' ' ' ARG . 2.1 p -51.73 -56.24 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.229 -0.919 . . . . 0.0 110.215 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -124.06 155.25 38.66 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.251 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -146.75 134.4 21.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.799 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -129.32 47.66 2.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.519 -0.738 . . . . 0.0 110.184 -179.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.569 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.1 m 151.85 73.76 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -133.91 143.45 48.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -98.06 152.03 19.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -60.97 -54.43 45.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.013 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.97 -57.11 14.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.434 ' CE1' ' HD2' ' A' ' 31' ' ' ARG . 35.8 m-70 -107.25 78.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -86.21 163.45 17.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.53 -0.731 . . . . 0.0 109.695 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.787 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.4 -20.72 65.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.761 -0.587 . . . . 0.0 109.622 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.9 tt0 -64.74 -20.42 66.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -65.8 -16.78 64.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.19 -0.943 . . . . 0.0 109.273 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.718 ' HB3' HG22 ' A' ' 147' ' ' VAL . 13.7 mt -64.81 -23.28 67.19 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.2 mm? -57.15 -22.3 39.13 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.418 -0.801 . . . . 0.0 109.19 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.8 66.31 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.76 13.65 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.488 -0.757 . . . . 0.0 110.318 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -103.08 74.3 1.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.823 HG22 ' CD1' ' A' ' 30' ' ' TYR . 86.1 m -156.93 -98.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.823 ' CD1' HG22 ' A' ' 29' ' ' THR . 0.1 OUTLIER 176.25 44.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.804 -1.185 . . . . 0.0 110.356 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HD2' ' CE1' ' A' ' 19' ' ' HIS . 3.6 mmm-85 -141.54 100.35 3.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 144' ' ' LEU . 30.9 mtmt -83.62 146.38 28.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.637 -0.664 . . . . 0.0 109.692 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.71 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -62.7 114.9 3.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.203 -0.935 . . . . 0.0 108.583 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -116.88 127.1 53.94 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -49.21 168.81 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.731 0.777 . . . . 0.0 111.696 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -73.74 -32.73 63.99 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.768 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -124.85 -175.31 3.25 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 -166.56 1.39 Allowed 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.49 45.81 88.21 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.6 OUTLIER -43.03 89.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.52 0.676 . . . . 0.0 111.825 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' GLY . 7.3 tttp -93.44 -64.32 1.1 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.664 HG22 ' OG ' ' A' ' 133' ' ' SER . 64.1 p -152.47 113.65 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.71 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 24.5 pt -111.29 145.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.744 . . . . 0.0 110.384 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -123.89 150.49 44.59 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.522 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.787 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.7 p -152.27 107.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.0 t -92.43 122.04 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD21 HG21 ' A' ' 147' ' ' VAL . 1.3 mp -101.57 155.76 17.89 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -109.55 120.24 41.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.488 -0.758 . . . . 0.0 109.445 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.738 HD13 ' OE2' ' A' ' 53' ' ' GLU . 40.8 mt -71.54 143.35 49.96 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.36 31.27 0.18 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.637 -0.664 . . . . 0.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.0 pttm 165.01 138.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -75.92 109.74 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.738 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -140.98 165.66 26.93 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 151' ' ' SER . 18.9 mt-30 -77.4 -176.73 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -143.22 130.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.432 -0.793 . . . . 0.0 109.36 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.438 ' O ' HD21 ' A' ' 116' ' ' LEU . 45.9 t60 -116.81 -26.24 7.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.621 -0.674 . . . . 0.0 109.731 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -148.48 153.21 38.16 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.2 t -135.38 160.41 40.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.706 -0.621 . . . . 0.0 109.346 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.654 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -138.74 132.51 30.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.61 -0.681 . . . . 0.0 109.544 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.654 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.0 OUTLIER -152.4 128.01 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.646 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -104.01 114.62 4.81 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 118.882 -1.628 . . . . 0.0 109.91 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -70.68 138.37 50.59 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.28 0.562 . . . . 0.0 111.206 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -113.44 42.06 2.03 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 -19.4 10.84 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 20.9 p -56.76 -173.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.319 -1.106 . . . . 0.0 109.797 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -147.42 -44.43 0.17 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.3 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -108.35 117.26 33.68 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.746 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 60' ' ' ILE . 45.3 t -120.51 110.62 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -107.21 147.56 30.0 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG22 ' CD1' ' A' ' 130' ' ' ILE . 17.2 t -135.21 125.87 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 109.665 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -111.52 157.6 20.15 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.617 HG13 ' HB2' ' A' ' 87' ' ' LEU . 4.0 m -120.25 156.98 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.795 -0.566 . . . . 0.0 110.292 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.406 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.82 174.52 44.23 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 t -114.64 162.69 16.44 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.646 0.736 . . . . 0.0 109.719 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 91.3 p -68.79 -11.11 60.02 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.54 175.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.239 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.16 -109.41 3.64 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 173.98 -51.52 0.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.24 -49.08 7.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.652 -0.91 . . . . 0.0 109.312 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.2 -32.3 7.06 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.55 143.88 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.489 -1.007 . . . . 0.0 109.586 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 59.84 28.05 17.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.603 -0.686 . . . . 0.0 109.906 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.76 19.39 4.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.494 -0.754 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.4 151.06 41.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.13 147.67 28.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG22 HD11 ' A' ' 71' ' ' LEU . 40.6 t -68.93 86.22 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.587 -0.696 . . . . 0.0 110.697 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.617 ' HB2' HG13 ' A' ' 72' ' ' VAL . 19.7 tp -56.68 -54.98 39.81 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.411 ' CD2' ' HB ' ' A' ' 70' ' ' VAL . 1.7 pp -138.75 117.26 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.271 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.6 m -50.86 174.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.564 -0.71 . . . . 0.0 110.446 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 132.69 50.5 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -97.6 118.16 33.48 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.847 -0.533 . . . . 0.0 109.745 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.9 p -75.45 67.96 2.06 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 25.9 t80 -62.08 -51.61 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.885 -0.509 . . . . 0.0 110.494 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.525 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 20.2 mtp -120.3 -170.25 1.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.729 -0.607 . . . . 0.0 110.455 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 p -121.07 173.74 3.62 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -86.99 5.02 5.97 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.272 2.648 . . . . 0.0 111.451 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.8 m -120.74 -39.29 2.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.097 -1.002 . . . . 0.0 109.827 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.79 -17.19 61.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.527 -0.733 . . . . 0.0 110.266 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.4 t -58.16 -20.55 41.63 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 110.517 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -71.44 -86.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -162.61 38.7 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 108.578 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.39 -20.27 7.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.93 119.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -1.073 . . . . 0.0 110.198 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.525 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 40.86 70.31 1.62 Allowed Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.89 -0.506 . . . . 0.0 111.308 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.59 -30.63 3.82 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.906 2.404 . . . . 0.0 110.464 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -146.23 109.75 4.79 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HG3' ' CE2' ' A' ' 93' ' ' PHE . 5.6 ptm85 -153.08 -160.79 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.568 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -131.86 172.0 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.773 -1.205 . . . . 0.0 111.388 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HD3' ' CD1' ' A' ' 93' ' ' PHE . 13.9 tpt180 -145.64 147.14 31.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.2 mtp -126.99 158.12 37.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.688 . . . . 0.0 110.242 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 6.0 m-85 -126.51 163.95 22.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.99 -148.31 5.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.517 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.87 -38.52 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 123.8 3.0 . . . . 0.0 111.042 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.47 -26.7 68.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.502 -0.749 . . . . 0.0 109.701 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.55 2.37 56.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.641 -0.662 . . . . 0.0 110.71 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.5 pp -124.16 140.81 52.61 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.974 -1.079 . . . . 0.0 110.351 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.8 p -60.68 137.87 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -40.16 47.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.473 -0.767 . . . . 0.0 109.163 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.73 -20.88 59.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.595 -0.691 . . . . 0.0 110.679 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -114.8 -46.49 2.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.269 -0.894 . . . . 0.0 110.432 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.979 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.61 -35.08 12.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.253 -0.904 . . . . 0.0 111.311 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -87.13 7.08 29.64 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.356 -0.84 . . . . 0.0 110.659 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.1 mttm -98.93 137.61 37.23 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -68.8 113.1 5.95 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.751 0.786 . . . . 0.0 110.973 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.461 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 77.7 m95 -117.21 157.16 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -132.1 10.29 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.275 -0.891 . . . . 0.0 110.057 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.588 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.4 mtt180 -140.08 147.13 39.84 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.6 p -140.6 142.47 30.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.774 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 46' ' ' VAL . 12.7 tttt -112.77 107.31 15.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.679 -0.638 . . . . 0.0 109.718 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.757 ' CD1' HG22 ' A' ' 70' ' ' VAL . 46.4 mm -98.46 122.83 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.7 t -123.99 114.7 42.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -90.83 138.22 31.75 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.664 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -143.11 132.58 23.54 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.192 -0.943 . . . . 0.0 111.635 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.863 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER 157.02 134.01 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.591 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.92 96.39 0.57 Allowed 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 123.081 2.521 . . . . 0.0 109.807 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.4 p90 -128.16 -8.79 5.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.401 -0.812 . . . . 0.0 111.843 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.95 -175.41 3.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.074 -1.016 . . . . 0.0 110.02 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -161.31 -43.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -114.72 -30.84 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.593 -0.692 . . . . 0.0 110.029 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -104.17 142.95 25.68 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.732 -0.605 . . . . 0.0 109.762 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.9 Cg_endo -88.18 156.69 6.94 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.353 2.702 . . . . 0.0 110.323 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -161.48 -168.49 2.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 109.613 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.637 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 169.41 -101.96 0.18 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.04 163.64 32.25 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.474 -1.016 . . . . 0.0 109.64 178.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.414 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 50.5 m -85.09 -16.9 39.04 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.276 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.646 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 43.3 p90 -179.35 164.56 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.223 -0.923 . . . . 0.0 110.191 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 24' ' ' LEU . 25.3 m -139.12 149.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 9.0 mtp180 -154.34 164.26 38.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.76 . . . . 0.0 110.472 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.874 ' CE2' HG11 ' A' ' 128' ' ' VAL . 51.9 m-85 -144.59 152.2 40.17 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.434 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.62 136.18 16.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 109.188 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.1 p . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.739 -0.601 . . . . 0.0 109.845 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mtt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.62 -165.26 0.22 Allowed 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.513 2.809 . . . . 0.0 110.574 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -79.39 -160.91 0.28 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.582 -0.699 . . . . 0.0 109.149 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.404 HD13 ' OE1' ' A' ' 53' ' ' GLU . 52.5 mt -126.47 127.65 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -112.52 171.04 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.722 -0.611 . . . . 0.0 109.885 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.756 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.9 mp -101.81 162.51 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.787 -0.571 . . . . 0.0 109.506 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.702 ' C ' HD11 ' A' ' 25' ' ' LEU . 23.1 ttt180 -118.41 -47.64 2.54 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.444 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 3.1 p-80 -160.85 -168.73 2.17 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.7 p -104.94 96.87 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.705 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.5 p -56.43 -61.11 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.302 -0.874 . . . . 0.0 110.054 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.542 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -121.31 162.89 19.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 20.0 p -158.64 144.96 17.06 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.277 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -151.84 53.85 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.81 64.88 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.829 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -127.06 148.82 50.12 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.939 -1.101 . . . . 0.0 110.096 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -98.97 -165.37 1.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.79 -0.569 . . . . 0.0 109.561 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -66.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.6 -0.688 . . . . 0.0 109.651 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -34.82 77.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.483 -0.761 . . . . 0.0 109.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -123.69 74.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -90.71 172.19 8.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.598 0.713 . . . . 0.0 110.256 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.52 -25.89 67.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.799 -0.563 . . . . 0.0 109.619 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.06 -20.02 55.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.365 -0.834 . . . . 0.0 110.17 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -65.2 -19.47 65.99 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.204 -0.935 . . . . 0.0 109.286 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.9 mt -65.91 -25.05 66.97 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.702 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.91 -21.09 60.62 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.482 -0.761 . . . . 0.0 108.977 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.7 66.12 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.61 -22.75 23.83 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -0.756 . . . . 0.0 110.391 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' THR . 5.5 m-20 -118.91 77.39 1.18 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.728 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.2 p -154.28 -85.57 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.404 -0.81 . . . . 0.0 109.576 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.22 36.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.222 -0.924 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.32 158.33 29.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.497 -0.752 . . . . 0.0 109.506 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -148.3 -160.96 1.24 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.536 -0.727 . . . . 0.0 109.498 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.727 ' CH2' HD12 ' A' ' 43' ' ' ILE . 20.4 t90 -88.36 137.45 32.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 110.817 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.4 mtt-85 -142.5 121.7 13.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.29 158.77 0.24 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.464 -0.773 . . . . 0.0 111.035 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.51 -41.76 99.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.077 0.465 . . . . 0.0 110.28 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.48 -171.4 2.3 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.515 0.674 . . . . 0.0 109.241 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.59 -165.59 1.33 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.98 45.8 94.88 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp0 -51.92 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.461 0.648 . . . . 0.0 111.174 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 42' ' ' THR . 15.5 tttm -91.38 -50.08 5.99 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.5 p -158.66 124.89 4.59 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.727 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.1 pt -128.34 136.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.5 -0.75 . . . . 0.0 110.266 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.558 ' OG ' HG22 ' A' ' 131' ' ' VAL . 26.8 m -118.6 138.51 52.52 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.415 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.636 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.9 p -144.75 111.61 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.4 t -96.96 119.75 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.088 -1.008 . . . . 0.0 108.978 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.756 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -100.9 160.67 14.17 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.539 0.685 . . . . 0.0 110.284 -178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 7.1 tp-100 -98.28 148.41 23.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 126' ' ' ASP . 84.8 mt -99.57 123.81 44.18 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -52.59 -7.73 0.07 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.37 -0.831 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -164.2 139.03 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.786 -1.196 . . . . 0.0 108.874 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -74.69 113.58 12.12 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -147.41 179.77 7.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -85.16 -178.03 6.68 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.44 115.2 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 113' ' ' PRO . 59.6 t60 -105.22 -30.8 9.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.59 -0.694 . . . . 0.0 109.202 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.406 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 1.2 m -144.3 161.09 39.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 149' ' ' PHE . 99.1 t -145.35 159.03 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.28 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.608 ' O ' HD12 ' A' ' 60' ' ' ILE . 35.3 t0 -132.07 138.67 48.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.699 -0.626 . . . . 0.0 110.004 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -153.88 130.38 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -96.69 127.08 9.07 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -83.86 112.09 19.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 122.022 -0.693 . . . . 0.0 110.098 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.7 56.96 2.12 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.45 -17.94 58.38 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -53.42 161.72 0.92 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.316 -1.108 . . . . 0.0 110.555 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.735 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -123.46 -58.72 1.59 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 23.4 m-85 -101.68 133.19 46.77 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.611 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 60' ' ' ILE . 49.8 t -132.49 111.56 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.559 -0.713 . . . . 0.0 109.677 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -106.14 141.67 37.11 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.741 HG13 HD13 ' A' ' 130' ' ' ILE . 16.2 t -131.07 124.47 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.636 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.585 HD11 HG22 ' A' ' 86' ' ' VAL . 1.5 mp -109.31 162.48 14.28 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 87' ' ' LEU . 3.1 m -122.71 154.95 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.542 -0.724 . . . . 0.0 110.305 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.55 162.71 34.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.0 t -116.83 163.91 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.684 0.754 . . . . 0.0 109.872 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 t -77.08 -1.06 27.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -25.22 7.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.145 -0.972 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.11 -27.48 9.35 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.38 21.47 59.97 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.42 39.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.321 -1.105 . . . . 0.0 108.868 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.2 -75.03 0.47 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 63.94 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.7 -0.882 . . . . 0.0 109.104 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.16 28.66 4.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.179 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -126.62 37.7 4.25 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.228 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.06 -172.31 2.12 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.65 135.11 48.84 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 71' ' ' LEU . 43.7 t -61.76 88.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.671 -0.643 . . . . 0.0 111.263 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.9 tp -61.79 -55.63 28.05 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.705 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.7 pp -137.69 117.47 13.16 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.2 m -52.29 178.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.639 -0.663 . . . . 0.0 110.656 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.61 133.62 52.62 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.2 p -107.31 126.65 52.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.369 0.605 . . . . 0.0 109.656 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.8 p -86.47 117.87 25.53 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 26.3 m-85 -112.86 -48.18 3.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.929 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.437 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 83.3 mtp -121.2 -176.35 3.26 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.549 0.69 . . . . 0.0 110.468 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.413 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 6.7 p -111.84 -178.55 0.54 Allowed Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 43.0 Cg_endo -86.41 19.33 1.41 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 123.155 2.57 . . . . 0.0 111.432 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -120.19 -41.27 2.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.0 109.543 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.02 -24.9 66.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 34.8 p -45.97 -27.24 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.562 -0.711 . . . . 0.0 111.865 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -92.33 0.11 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.785 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.5 t -163.36 38.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.863 -1.148 . . . . 0.0 108.569 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.12 -26.55 18.52 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.93 115.77 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -1.026 . . . . 0.0 110.272 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 40.27 73.55 0.83 Allowed Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 121.685 -0.634 . . . . 0.0 111.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 39.7 Cg_endo -74.14 -28.23 11.02 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.557 2.171 . . . . 0.0 110.339 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -128.86 124.13 34.49 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.682 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.6 -170.13 3.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.729 -0.607 . . . . 0.0 109.403 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 40.6 t -132.82 159.99 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -160.11 141.22 12.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.762 . . . . 0.0 109.148 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.0 mtp -126.26 156.61 40.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.543 -0.723 . . . . 0.0 110.316 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.705 ' CE2' HD13 ' A' ' 88' ' ' LEU . 11.8 m-85 -110.93 172.28 6.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.33 -150.22 5.3 Favored Glycine 0 N--CA 1.482 1.727 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.7 Cg_endo -75.78 -38.04 1.44 Allowed 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.712 2.941 . . . . 0.0 110.9 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.03 -26.73 68.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.55 -0.719 . . . . 0.0 109.935 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -95.08 5.05 52.94 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.751 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.99 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -125.53 143.0 51.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.921 -1.112 . . . . 0.0 110.712 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.902 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -61.85 141.08 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -31.75 34.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.46 -0.775 . . . . 0.0 108.973 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -67.51 -15.89 63.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.552 -0.717 . . . . 0.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.902 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -120.23 -45.61 2.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.99 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.42 -40.27 25.43 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.302 -0.874 . . . . 0.0 111.305 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -84.27 4.92 28.76 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.63 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 11.8 mttm -97.19 135.71 38.75 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.92 111.35 4.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.528 -0.732 . . . . 0.0 110.886 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.419 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 88.6 m95 -115.38 165.02 13.43 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 49' ' ' LEU . 3.2 p30 -139.9 14.55 2.48 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.071 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.705 ' HD3' HG21 ' A' ' 10' ' ' VAL . 11.7 mtt180 -142.06 138.68 31.93 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.701 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.2 p -130.79 138.95 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.395 -0.816 . . . . 0.0 109.788 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.628 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.7 tttt -110.39 107.55 17.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.848 -0.532 . . . . 0.0 109.654 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 70' ' ' VAL . 50.7 mm -98.43 117.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.733 -0.604 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.558 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.8 t -124.07 110.97 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 121.16 -0.963 . . . . 0.0 109.72 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.463 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.5 t -84.94 147.3 26.8 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.68 129.94 22.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.349 -0.844 . . . . 0.0 111.753 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.735 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 0.5 OUTLIER 148.4 123.28 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.609 0 C-N-CA 123.719 0.808 . . . . 0.0 109.057 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -79.56 89.5 1.34 Allowed 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 122.777 2.318 . . . . 0.0 109.1 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 6.7 p90 -114.62 -22.33 9.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.585 -0.697 . . . . 0.0 111.41 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -173.18 2.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.893 . . . . 0.0 109.863 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -168.75 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -114.88 -36.15 4.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.902 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -105.07 145.09 30.07 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.836 -0.54 . . . . 0.0 109.727 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 45.0 Cg_endo -87.92 167.74 6.91 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.371 2.714 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -179.35 -169.86 0.16 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.84 -109.81 0.38 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.872 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.633 ' CD2' HG23 ' A' ' 60' ' ' ILE . 6.3 mp -109.69 152.13 26.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.903 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 34.5 m -87.84 -27.56 22.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.464 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 51.7 p90 -179.17 176.52 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.475 -0.765 . . . . 0.0 109.381 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.524 HG12 HG13 ' A' ' 60' ' ' ILE . 32.9 m -152.2 131.75 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 6.5 mtm180 -141.05 107.95 5.41 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.312 -0.867 . . . . 0.0 110.222 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 58' ' ' VAL . 80.7 m-85 -86.08 154.23 21.54 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.9 131.95 19.3 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.338 -0.851 . . . . 0.0 109.046 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.873 -0.517 . . . . 0.0 110.486 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.86 13.75 2.53 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.556 2.837 . . . . 0.0 111.327 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -78.47 165.92 23.2 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.228 -0.92 . . . . 0.0 109.214 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.626 ' CG2' HD12 ' A' ' 49' ' ' LEU . 43.9 mm -79.52 143.15 12.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -123.32 126.05 46.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 HD22 ' A' ' 47' ' ' LEU . 1.1 mp -83.87 147.43 27.54 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' C ' HD11 ' A' ' 25' ' ' LEU . 50.2 ttt85 -105.28 -58.71 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.564 -0.71 . . . . 0.0 109.377 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.96 178.16 9.65 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -85.41 89.44 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.574 -0.704 . . . . 0.0 109.24 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.528 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -51.42 -58.39 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.15 -0.969 . . . . 0.0 110.286 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.522 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -124.9 162.77 23.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.495 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 21.5 p -160.42 144.04 13.78 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.47 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 m -148.9 58.22 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.608 ' HB3' HG22 ' A' ' 43' ' ' ILE . 1.0 OUTLIER 153.78 58.21 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 123.093 0.557 . . . . 0.0 109.818 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.929 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -124.54 140.61 52.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.82 -1.175 . . . . 0.0 110.65 -179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.64 -162.84 0.89 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 m -99.06 -64.25 1.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 109.374 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -58.53 4.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.593 -0.692 . . . . 0.0 109.149 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -92.74 68.03 4.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 p -88.8 165.15 14.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 0.0 109.904 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.81 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -59.89 -23.94 63.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.644 -0.66 . . . . 0.0 110.368 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.46 -21.6 66.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.247 -0.908 . . . . 0.0 109.919 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -66.0 -16.82 64.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.878 . . . . 0.0 109.504 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.9 mt -65.28 -25.77 67.79 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -60.26 -21.3 61.72 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.58 65.42 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HB1' ' HE ' ' A' ' 148' ' ' ARG . . . -53.3 -24.32 11.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.396 -0.815 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -116.31 79.95 1.39 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.434 -0.791 . . . . 0.0 109.746 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 28' ' ' ASP . 2.0 p -157.2 -90.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.483 -0.76 . . . . 0.0 109.196 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -178.06 32.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.003 -1.061 . . . . 0.0 110.379 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -147.25 140.54 25.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.026 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.81 -160.41 0.99 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.775 ' CH2' HD12 ' A' ' 43' ' ' ILE . 17.6 t90 -97.58 136.19 38.33 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.147 -0.97 . . . . 0.0 109.64 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 3.9 tmm_? -142.6 120.54 12.04 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.48 154.76 3.3 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.193 -0.942 . . . . 0.0 110.427 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -78.93 -23.79 44.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.784 -0.572 . . . . 0.0 110.196 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.02 -158.94 0.59 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.423 -0.798 . . . . 0.0 109.368 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 139' ' ' ASP . . . -149.25 172.7 14.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 91.1 -15.62 60.57 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.504 ' HA ' ' CE1' ' A' ' 142' ' ' PHE . 2.6 mp0 59.52 117.72 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.618 -0.931 . . . . 0.0 111.418 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 42' ' ' THR . 16.8 ttmt -151.7 -71.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.684 HG22 ' OG ' ' A' ' 133' ' ' SER . 24.6 p -157.88 143.54 17.12 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.775 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -143.57 139.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.459 -0.776 . . . . 0.0 110.109 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.522 ' CB ' HG22 ' A' ' 131' ' ' VAL . 69.2 m -126.53 115.06 18.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.234 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.81 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.2 p -116.41 126.5 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.857 HG22 ' CD ' ' A' ' 129' ' ' LYS . 2.8 t -104.76 113.77 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.301 -0.875 . . . . 0.0 108.897 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.73 HD22 HD21 ' A' ' 6' ' ' LEU . 1.4 mp -97.61 169.34 9.77 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.558 0.694 . . . . 0.0 110.66 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.464 ' C ' HD22 ' A' ' 49' ' ' LEU . 11.9 tp60 -114.66 153.71 29.72 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.545 0.688 . . . . 0.0 109.608 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.626 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.0 mm? -104.86 131.98 51.67 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 5.7 tt0 -81.96 43.12 0.76 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.25 -0.906 . . . . 0.0 110.31 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 4.6 pttt 163.59 118.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 20.7 tt0 -63.23 104.66 0.62 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' CG ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.5 178.46 7.02 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.543 0.687 . . . . 0.0 110.177 -178.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.25 178.12 5.95 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.32 131.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.427 -0.796 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.572 ' HA ' HD21 ' A' ' 116' ' ' LEU . 6.4 t-160 -122.47 -32.35 3.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.731 -0.606 . . . . 0.0 110.0 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -141.97 161.44 37.97 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.681 HG13 ' CD1' ' A' ' 149' ' ' PHE . 58.4 t -146.67 164.1 8.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.899 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.584 ' O ' HD12 ' A' ' 60' ' ' ILE . 1.4 m-20 -139.28 134.77 33.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.639 -0.663 . . . . 0.0 109.616 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -146.71 118.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -81.86 99.75 2.03 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.83 125.25 22.93 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.905 . . . . 0.0 110.361 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -107.38 39.07 1.97 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.384 -0.823 . . . . 0.0 109.406 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.407 ' O ' ' CZ ' ' A' ' 136' ' ' TYR . . . 111.98 22.97 5.74 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.504 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -101.67 173.1 6.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -1.073 . . . . 0.0 110.382 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -128.8 -47.64 1.25 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HB3' ' OG1' ' A' ' 90' ' ' THR . 30.0 m-85 -108.41 120.6 42.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.732 -0.605 . . . . 0.0 110.767 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.63 111.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.458 -0.776 . . . . 0.0 109.287 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -107.86 143.62 36.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.696 -0.627 . . . . 0.0 110.197 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.632 HG13 ' CD1' ' A' ' 130' ' ' ILE . 38.9 t -132.09 129.57 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.454 0.645 . . . . 0.0 109.68 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.6 mp -117.46 160.17 21.63 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.7 ' CG1' HD22 ' A' ' 87' ' ' LEU . 7.5 m -123.48 172.57 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.559 -0.713 . . . . 0.0 110.159 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.34 170.64 29.55 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -113.21 160.73 17.97 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.822 0.82 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -81.86 8.13 11.08 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.93 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.02 -26.48 2.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.131 -0.981 . . . . 0.0 111.224 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.39 70.47 0.11 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.51 64.43 2.16 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.25 -63.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.538 -0.978 . . . . 0.0 109.132 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.28 79.13 0.29 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 84' ' ' TYR . 4.8 mp0 61.48 17.84 8.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.584 -0.951 . . . . 0.0 110.154 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 38.42 29.49 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.4 t0 42.15 48.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.428 0.633 . . . . 0.0 111.39 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 3.5 m-30 -48.24 160.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.603 0.716 . . . . 0.0 110.079 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -108.69 131.61 54.75 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 42.9 t -61.58 86.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.66 -0.65 . . . . 0.0 110.729 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.7 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -59.0 -61.18 2.83 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 pp -136.14 119.98 17.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.546 -0.721 . . . . 0.0 109.292 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -53.93 179.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.566 -0.709 . . . . 0.0 110.155 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -65.63 133.95 52.23 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.594 -0.691 . . . . 0.0 109.313 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HG ' ' HE2' ' A' ' 111' ' ' PHE . 8.5 p -98.22 119.11 36.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.82 -0.55 . . . . 0.0 109.676 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.2 p -75.53 69.49 2.29 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.416 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 28.4 t80 -63.42 -55.49 23.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.803 -0.561 . . . . 0.0 110.587 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.47 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 1.6 mtp -117.79 -176.48 3.04 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.679 0.752 . . . . 0.0 110.571 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.434 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -112.54 176.35 1.52 Allowed Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 41.5 Cg_endo -86.28 14.98 2.3 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 123.136 2.557 . . . . 0.0 111.518 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -120.09 -46.19 2.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.172 -0.955 . . . . 0.0 109.071 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -19.59 49.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.512 -0.742 . . . . 0.0 110.233 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 m -49.34 -26.87 3.43 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.319 -0.863 . . . . 0.0 110.64 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -85.95 -86.08 0.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.54 -0.725 . . . . 0.0 109.745 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -164.44 37.53 0.08 Allowed 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.43 -17.83 67.88 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.18 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.239 -1.154 . . . . 0.0 111.91 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.4 90.33 0.22 Allowed Pre-proline 0 C--N 1.29 -2.01 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.47 ' O ' ' HE1' ' A' ' 94' ' ' MET . 43.1 Cg_endo -81.21 -29.85 1.82 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.686 2.257 . . . . 0.0 110.315 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.6 129.94 50.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.653 -0.654 . . . . 0.0 109.273 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -160.21 -169.8 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.876 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.618 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 69.2 t -127.06 154.96 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HD3' ' CZ ' ' A' ' 111' ' ' PHE . 6.6 ttt-85 -143.1 131.94 22.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.1 mtp -111.81 143.34 42.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.72 -0.612 . . . . 0.0 110.054 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.6 m-85 -111.59 165.1 12.3 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.642 0.734 . . . . 0.0 109.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -147.88 -154.6 6.31 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.755 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.8 Cg_endo -74.91 -24.12 13.34 Favored 'Trans proline' 0 N--CA 1.505 2.193 0 C-N-CA 123.644 2.896 . . . . 0.0 110.873 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -50.53 -38.79 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.602 -0.686 . . . . 0.0 110.862 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -117.73 15.27 14.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.5 -0.75 . . . . 0.0 110.477 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.755 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -117.26 122.57 44.33 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.901 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -49.65 130.33 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.631 -0.668 . . . . 0.0 110.698 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -67.64 -37.69 82.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.738 . . . . 0.0 109.133 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.05 92.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.284 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.901 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -91.96 -36.41 13.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.311 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -44.98 -35.91 3.13 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.577 -0.702 . . . . 0.0 111.111 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.15 12.29 35.96 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.809 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -91.85 134.47 34.73 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.34 106.61 5.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.405 -0.809 . . . . 0.0 109.913 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 74.5 m95 -111.22 164.0 13.34 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 12.7 p30 -136.53 8.32 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.521 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.528 ' HD3' HG21 ' A' ' 10' ' ' VAL . 12.8 mtt-85 -136.99 144.55 43.37 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.74 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.1 p -137.4 138.67 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 0.0 110.783 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.857 ' CD ' HG22 ' A' ' 46' ' ' VAL . 33.9 tptt -104.3 129.57 52.14 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.632 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.8 mm -125.24 111.92 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.522 HG22 ' CB ' ' A' ' 44' ' ' SER . 47.9 t -117.92 119.73 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.44 -0.787 . . . . 0.0 110.36 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 152.18 20.11 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.684 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -160.06 132.45 6.4 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.643 -1.286 . . . . 0.0 113.949 -176.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.75 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 10.1 tp60 148.09 125.26 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.376 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.32 114.78 1.87 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.778 2.318 . . . . 0.0 109.23 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.504 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -117.18 0.87 12.41 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.694 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.39 -160.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.604 -1.31 . . . . 0.0 110.051 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 7.3 ttmm -151.95 23.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.441 -0.787 . . . . 0.0 110.011 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.792 ' O ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p-10 -149.05 -40.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.187 -0.946 . . . . 0.0 111.701 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.7 158.91 33.61 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.687 . . . . 0.0 111.54 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -84.3 -159.67 0.11 Allowed 'Trans proline' 0 N--CA 1.503 2.069 0 C-N-CA 124.039 3.159 . . . . 0.0 109.601 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 40' ' ' GLU . 21.2 p90 -178.85 -165.01 0.08 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.142 -0.974 . . . . 0.0 110.713 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.72 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 145.47 -128.57 3.17 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.72 HD13 ' C ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -144.91 165.04 29.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.725 -0.868 . . . . 0.0 110.241 178.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.3 p -79.14 -25.52 42.88 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.558 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.61 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 46.3 p90 -175.07 173.64 2.6 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.812 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 24' ' ' LEU . 18.0 m -149.63 130.3 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.463 ' HE ' ' HB1' ' A' ' 27' ' ' ALA . 63.2 mtt180 -142.05 116.33 9.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 110.756 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.74 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.0 m-85 -88.91 154.0 20.59 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -152.72 120.88 6.23 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.853 -0.53 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -87.85 -165.16 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 123.479 2.786 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -79.02 -168.79 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 109.183 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.473 HD13 ' OE1' ' A' ' 53' ' ' GLU . 53.6 mt -120.09 126.25 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.33 175.86 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.592 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.6 mp -112.35 158.92 19.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 0.0 109.968 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -55.54 2.31 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -160.74 169.82 22.01 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -80.61 91.41 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.562 -0.711 . . . . 0.0 109.152 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG13 ' H ' ' A' ' 11' ' ' SER . 1.7 p -52.24 -58.51 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.07 -1.019 . . . . 0.0 110.186 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.508 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.3 157.58 36.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 p -160.44 125.26 3.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.4 OUTLIER -118.53 57.19 0.86 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.659 ' HB3' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 154.33 88.68 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.555 0 C-N-CA 123.012 0.525 . . . . 0.0 109.674 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -160.24 144.08 14.07 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.87 -1.144 . . . . 0.0 109.494 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.02 -167.54 1.56 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.277 -0.889 . . . . 0.0 109.667 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -88.71 -62.77 1.41 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 109.685 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.38 -65.04 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -88.59 74.46 8.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -91.08 168.05 11.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.616 -0.678 . . . . 0.0 110.051 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -62.68 -24.09 67.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.881 -0.512 . . . . 0.0 109.62 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.74 -18.42 62.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -0.829 . . . . 0.0 109.967 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -64.96 -18.09 64.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.5 mt -65.33 -26.84 68.22 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.6 mm? -61.7 -20.02 63.01 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -116.31 65.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -23.37 18.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.425 -0.797 . . . . 0.0 110.399 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -120.43 78.47 1.37 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.52 -88.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.483 -0.761 . . . . 0.0 109.408 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -178.36 36.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -155.1 149.89 26.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.533 -0.729 . . . . 0.0 109.317 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -130.37 -170.41 2.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.574 -0.704 . . . . 0.0 109.959 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.817 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.9 t90 -88.54 139.67 30.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.47 -0.769 . . . . 0.0 109.032 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 126.19 17.33 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.68 152.38 2.86 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.307 -0.871 . . . . 0.0 110.111 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.1 -23.9 56.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.749 -0.595 . . . . 0.0 110.077 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -139.19 -169.79 2.74 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.421 -0.799 . . . . 0.0 108.965 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.25 -172.47 2.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.67 -0.644 . . . . 0.0 109.362 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 60.35 48.67 85.02 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 4.3 mt-10 -62.1 78.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.402 0.62 . . . . 0.0 110.65 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' C ' HG23 ' A' ' 42' ' ' THR . 15.9 tttt -66.14 -51.07 61.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.529 HG22 ' OG ' ' A' ' 133' ' ' SER . 59.3 p -156.94 124.78 5.47 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.786 HD12 ' CH2' ' A' ' 33' ' ' TRP . 4.1 pt -118.12 139.35 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.817 . . . . 0.0 110.4 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -115.5 140.36 49.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.135 178.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.6 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.4 p -146.1 107.98 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.9 t -92.35 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.292 -0.88 . . . . 0.0 108.894 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.592 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.2 mp -96.95 168.72 10.3 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.939 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.09 129.76 56.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.718 -0.614 . . . . 0.0 110.406 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.623 HD13 ' OE2' ' A' ' 53' ' ' GLU . 46.5 mt -85.4 135.35 33.91 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 1.9 pt-20 -79.89 41.6 0.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.436 -0.79 . . . . 0.0 111.099 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 3.6 pttm 161.98 136.2 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.1 tt0 -75.88 100.36 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.623 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -131.49 172.38 12.28 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.588 0.709 . . . . 0.0 109.862 -179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -87.7 170.03 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -128.48 122.81 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.467 -0.77 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -109.73 -32.97 6.9 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.7 m -144.8 155.2 43.38 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 60' ' ' ILE . 74.8 t -137.38 158.58 35.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.677 0.751 . . . . 0.0 109.98 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.5 m-20 -134.68 137.12 43.29 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -160.25 132.63 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.606 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -101.91 123.61 7.94 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.496 HD21 HG21 ' A' ' 68' ' ' VAL . 2.0 m-80 -83.15 130.73 35.13 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 122.304 -0.527 . . . . 0.0 110.67 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.34 64.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' A' ' 99' ' ' SER . . . 85.31 1.4 88.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.9 129.41 34.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 110.295 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 94' ' ' MET . . . -87.3 -57.73 2.85 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.713 -0.617 . . . . 0.0 110.076 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 133' ' ' SER . 16.4 m-85 -90.99 132.97 35.66 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.274 -0.891 . . . . 0.0 111.195 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 62' ' ' ASN . 82.3 t -139.24 106.84 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -102.32 146.88 27.39 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.698 HG13 ' CD1' ' A' ' 130' ' ' ILE . 22.2 t -135.71 121.1 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-O 121.64 0.733 . . . . 0.0 109.544 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.465 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.4 mp -108.78 163.01 13.65 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.677 HG11 HD13 ' A' ' 87' ' ' LEU . 2.6 m -121.34 161.02 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.646 -0.659 . . . . 0.0 110.553 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.36 167.8 38.05 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 t -108.78 155.12 21.13 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.83 -0.806 . . . . 0.0 109.552 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.438 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 60.5 p -89.54 12.69 15.89 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.69 -76.19 0.13 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.261 -0.899 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -116.24 90.66 0.52 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.84 159.01 28.81 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.22 -47.07 1.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.524 -0.986 . . . . 0.0 109.392 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.04 -135.92 1.91 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -107.21 -22.29 12.66 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.639 -0.918 . . . . 0.0 109.974 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -95.91 26.83 3.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -104.99 24.66 11.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.414 -0.804 . . . . 0.0 109.608 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.4 m-85 -107.17 -173.68 2.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.62 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.83 131.41 47.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.51 88.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.457 -0.777 . . . . 0.0 111.876 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.677 HD13 HG11 ' A' ' 72' ' ' VAL . 5.6 tp -64.94 -51.04 63.99 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.5 pp -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.486 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -56.81 172.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.563 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -57.59 130.57 46.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.364 -0.835 . . . . 0.0 110.229 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -97.75 123.99 41.92 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -90.95 81.62 5.66 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 109' ' ' ARG . 20.7 m-85 -70.86 -55.97 7.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.371 -0.831 . . . . 0.0 109.922 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.491 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 27.9 mtp -120.78 -163.31 1.01 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.685 -0.635 . . . . 0.0 109.638 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -128.85 178.12 1.82 Allowed Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.23 17.59 1.71 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 123.039 2.493 . . . . 0.0 111.089 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.7 m -120.61 -38.49 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 109.704 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -82.97 -29.55 28.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.469 -0.769 . . . . 0.0 109.337 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 76.1 p -60.49 -18.6 52.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.583 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -71.12 -85.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 109.624 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 t -161.27 38.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -117.6 -21.88 4.19 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.9 121.55 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.365 -1.079 . . . . 0.0 109.119 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.479 ' O ' ' HE1' ' A' ' 94' ' ' MET . 6.3 p30 43.16 83.92 0.2 Allowed Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.758 -0.589 . . . . 0.0 110.798 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.3 Cg_endo -82.76 -27.55 2.03 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.984 2.456 . . . . 0.0 109.992 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -145.73 86.24 1.72 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -114.71 127.45 55.76 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 12.6 m -79.76 165.82 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.512 -0.743 . . . . 0.0 109.517 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.18 169.61 22.02 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.0 mtt -141.89 165.15 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.508 -0.745 . . . . 0.0 110.204 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.1 m-85 -120.85 170.35 9.55 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -144.44 -148.28 4.83 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.1 Cg_endo -74.88 -40.02 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.694 2.929 . . . . 0.0 110.716 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -65.36 -27.24 68.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 109.73 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -93.44 3.7 55.15 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.693 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.976 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.3 pp -124.22 152.21 43.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.932 -1.105 . . . . 0.0 109.966 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.768 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 10.3 p -77.54 139.47 18.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -73.43 -29.92 62.88 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.638 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -68.6 -11.28 59.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.534 -0.729 . . . . 0.0 110.754 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.768 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -125.01 -46.04 1.84 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.121 -0.987 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.976 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.95 -29.08 11.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.538 -0.726 . . . . 0.0 110.604 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.48 -5.28 52.18 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.727 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 8.9 mtpt -91.16 133.08 35.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.158 -0.963 . . . . 0.0 108.52 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.81 110.65 3.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.48 -0.762 . . . . 0.0 110.541 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 83.9 m95 -110.72 158.94 18.08 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t70 -130.64 1.19 4.45 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.115 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -137.18 144.82 43.11 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 178.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.4 p -132.63 142.2 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.547 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.451 ' HG3' HG22 ' A' ' 46' ' ' VAL . 19.8 tttt -110.36 106.12 15.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.827 -0.546 . . . . 0.0 109.719 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.698 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.3 mm -100.57 131.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.327 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.6 t -134.01 122.54 41.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 130.24 46.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.77 125.29 28.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.289 -0.882 . . . . 0.0 111.692 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.625 ' HG2' ' CD2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER 170.44 141.44 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -90.71 95.06 0.25 Allowed 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.71 2.273 . . . . 0.0 110.228 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -120.92 -15.67 8.26 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.015 -1.053 . . . . 0.0 112.002 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.3 t -137.2 178.24 7.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.979 -1.076 . . . . 0.0 110.918 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -149.33 -47.34 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -105.07 -17.45 14.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.644 -0.66 . . . . 0.0 110.248 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.34 153.15 44.19 Favored Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.361 -0.837 . . . . 0.0 110.002 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.15 -171.76 1.02 Allowed 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.64 2.893 . . . . 0.0 110.9 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.448 ' N ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER 170.03 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 143.19 -121.93 1.8 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.944 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 143' ' ' GLY . 5.6 mp -122.69 162.44 21.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.447 -1.031 . . . . 0.0 110.521 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.2 m -92.78 -27.25 17.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 -179.88 166.6 1.3 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.523 -0.736 . . . . 0.0 109.182 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.1 m -139.56 145.4 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.292 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 43.5 mtm180 -149.68 159.09 44.63 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.442 0.639 . . . . 0.0 110.346 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.659 ' CD1' HG13 ' A' ' 58' ' ' VAL . 49.8 m-85 -139.13 156.01 47.46 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -151.55 127.98 10.68 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.104 -0.998 . . . . 0.0 109.521 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.908 -0.495 . . . . 0.0 110.456 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.59 96.82 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.434 2.756 . . . . 0.0 110.523 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -146.96 176.58 9.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.559 -0.713 . . . . 0.0 109.684 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.756 ' CG2' HD12 ' A' ' 49' ' ' LEU . 83.9 mt -142.19 152.55 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.725 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -140.08 -173.05 3.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.506 -179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.3 mm? -119.54 163.17 17.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.55 -0.718 . . . . 0.0 109.64 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.1 ttt-85 -114.43 -47.67 2.91 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -161.0 163.34 31.78 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -78.96 91.08 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.469 -0.77 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 11' ' ' SER . 2.4 p -51.27 -54.73 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.176 -0.952 . . . . 0.0 110.361 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.486 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -125.11 164.07 21.02 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.4 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 20.0 p -159.54 146.31 16.57 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.6 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -145.72 49.71 1.21 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.593 ' OG ' HG22 ' A' ' 43' ' ' ILE . 2.0 m 152.0 86.12 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.861 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -153.36 133.56 13.41 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.053 -1.029 . . . . 0.0 110.245 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.31 -175.14 4.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.369 -0.832 . . . . 0.0 109.688 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.5 t -84.94 -64.13 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.629 -0.67 . . . . 0.0 109.36 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -61.48 2.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -89.13 67.53 8.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.5 p -84.98 168.33 15.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.58 -0.7 . . . . 0.0 109.812 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.46 -22.4 66.95 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.34 -21.01 66.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 109.528 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -65.12 -18.46 65.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 109.014 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.806 HD21 ' HB2' ' A' ' 33' ' ' TRP . 11.2 mt -66.02 -26.87 67.73 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.513 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.3 mm? -61.96 -19.34 62.67 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.03 76.15 1.35 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -43.94 -59.77 2.14 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.33 0.586 . . . . 0.0 110.812 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.64 -119.08 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p 51.72 -105.78 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.666 -1.271 . . . . 0.0 109.57 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.71 40.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.847 -1.158 . . . . 0.0 110.277 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -154.11 148.51 26.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 0.0 109.836 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.2 OUTLIER -132.05 -159.72 0.99 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB2' HD21 ' A' ' 24' ' ' LEU . 14.5 t90 -97.12 140.05 32.2 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.456 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -149.0 126.7 11.74 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.42 142.25 10.74 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.429 -0.794 . . . . 0.0 110.876 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -63.83 -52.18 61.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.69 -0.631 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -152.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -135.78 -179.75 5.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.7 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 96.34 -24.05 32.12 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 9.8 mt-10 45.17 41.96 6.39 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.694 -0.886 . . . . 0.0 112.284 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 42' ' ' THR . 25.1 ttmt -59.81 -65.24 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 41' ' ' LYS . 61.0 p -158.76 124.05 4.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.4 pt -112.92 148.63 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.572 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -124.59 146.76 48.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.708 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -154.92 111.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 109.527 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.2 t -95.52 119.82 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 HG21 ' A' ' 147' ' ' VAL . 1.4 mp -98.27 161.04 13.9 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.453 0.644 . . . . 0.0 109.863 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -107.02 129.3 54.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.731 -0.606 . . . . 0.0 109.796 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.756 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -80.88 133.28 35.54 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -80.34 37.77 0.4 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.713 . . . . 0.0 110.425 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 pttt 165.67 126.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -76.29 108.86 9.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 109.225 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.78 -179.33 6.39 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' O ' HD11 ' A' ' 4' ' ' ILE . 27.3 mt-30 -87.94 178.39 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' O ' ' HB1' ' A' ' 121' ' ' ALA . 4.1 mp -138.04 137.9 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.333 -0.854 . . . . 0.0 109.829 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.697 ' O ' HD21 ' A' ' 116' ' ' LEU . 31.5 t60 -123.97 -34.73 2.94 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.706 -0.621 . . . . 0.0 109.895 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.6 m -137.1 163.4 30.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 149' ' ' PHE . 75.4 t -142.62 165.03 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.591 -0.693 . . . . 0.0 109.622 -178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -145.67 115.66 7.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.485 -0.759 . . . . 0.0 109.949 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.1 mp -133.14 120.21 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.68 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -79.14 89.03 1.19 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' HB2' ' CE2' ' A' ' 93' ' ' PHE . 5.3 m120 -71.41 119.12 15.1 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 122.089 -0.653 . . . . 0.0 110.845 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.82 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.66 22.99 13.96 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' HE2' ' A' ' 136' ' ' TYR . 39.3 p -52.91 -175.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.17 0.986 . . . . 0.0 112.022 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 134' ' ' GLN . . . -150.7 -54.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 133' ' ' SER . 44.7 m-85 -117.85 122.17 42.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.769 -0.582 . . . . 0.0 109.597 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.6 t -118.31 107.63 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.863 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -91.77 141.2 28.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.793 HG21 HD23 ' A' ' 88' ' ' LEU . 60.0 t -136.55 119.97 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.695 -0.628 . . . . 0.0 109.668 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD11 HG22 ' A' ' 86' ' ' VAL . 1.4 mp -116.95 163.28 16.44 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 87' ' ' LEU . 5.5 m -126.74 168.65 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.739 -0.601 . . . . 0.0 110.131 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 168.97 172.79 36.09 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.9 t -110.39 162.36 14.74 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.551 0.691 . . . . 0.0 109.26 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 127' ' ' ARG . 54.8 p -86.27 9.53 17.47 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.38 124.88 12.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.116 -0.99 . . . . 0.0 110.436 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.09 104.12 0.63 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.859 -1.297 . . . . 0.0 109.859 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.54 73.07 0.05 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.935 ' HB1' ' HB3' ' A' ' 83' ' ' ASP . . . -177.1 -48.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.59 -0.947 . . . . 0.0 109.262 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.94 -140.94 15.3 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -110.35 -23.11 11.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.926 . . . . 0.0 109.988 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 29.45 2.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.366 -0.834 . . . . 0.0 109.746 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.935 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . 2.5 t0 -115.93 35.77 4.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.406 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.3 m-85 -103.98 -174.65 2.59 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CG ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -131.15 135.88 47.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 71' ' ' LEU . 43.0 t -65.19 85.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.462 -0.774 . . . . 0.0 110.563 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HA ' HG12 ' A' ' 117' ' ' VAL . 4.1 tp -68.05 -64.98 0.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.793 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -112.47 114.0 26.47 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -62.15 172.12 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.554 -0.716 . . . . 0.0 109.227 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.554 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -55.05 127.23 28.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.28 -0.887 . . . . 0.0 109.318 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p -95.7 114.7 26.47 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.219 0.533 . . . . 0.0 109.737 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -74.68 68.97 1.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 94' ' ' MET . 15.8 t80 -61.66 -61.66 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.883 -0.511 . . . . 0.0 109.623 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -122.55 -168.9 1.81 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.524 -0.735 . . . . 0.0 109.877 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 p -116.41 176.72 1.43 Allowed Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -86.72 12.67 2.93 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.943 2.429 . . . . 0.0 111.27 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 t -121.68 -37.25 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.156 -0.965 . . . . 0.0 110.248 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -81.6 -22.04 37.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.804 . . . . 0.0 110.249 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.2 p -58.54 -21.03 51.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 110.718 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -69.28 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.4 t -161.95 38.95 0.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 108.663 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -115.87 -16.2 6.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.05 121.91 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -1.161 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.431 ' O ' ' CE ' ' A' ' 94' ' ' MET . 7.4 p30 41.61 59.35 9.22 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 122.182 -0.324 . . . . 0.0 111.024 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -76.02 -31.35 5.02 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 123.117 2.544 . . . . 0.0 111.506 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.91 112.55 5.65 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.573 -0.851 . . . . 0.0 110.86 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -160.89 -157.91 0.56 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.623 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -124.59 160.65 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.014 -1.054 . . . . 0.0 109.692 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.459 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 26.0 tpt180 -139.81 131.85 27.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.5 mtp -112.42 166.26 11.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.508 -0.745 . . . . 0.0 110.277 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 111' ' ' PHE . 9.8 m-85 -139.1 166.25 25.0 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.44 -146.66 5.04 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.7 Cg_endo -73.91 -36.7 3.33 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 123.828 3.019 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -64.5 -27.31 68.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -90.32 1.12 56.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.597 -0.69 . . . . 0.0 110.68 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.994 HD13 ' CB ' ' A' ' 121' ' ' ALA . 3.1 pp -129.96 147.27 51.7 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.105 -0.997 . . . . 0.0 109.583 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.704 HG12 ' HA ' ' A' ' 87' ' ' LEU . 10.9 p -71.74 139.16 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -71.5 -32.0 67.73 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 117' ' ' VAL . . . -64.05 -19.88 65.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.563 -0.71 . . . . 0.0 110.473 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -113.09 -49.42 2.92 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.994 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -50.96 -28.1 9.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.513 -0.742 . . . . 0.0 110.757 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 19.54 9.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.291 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 12.8 mtpt -118.34 133.88 55.51 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -67.18 111.61 4.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.568 -0.708 . . . . 0.0 111.07 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -117.15 164.53 14.62 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -139.17 13.49 2.62 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.945 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 75' ' ' SER . 5.6 mtt180 -143.67 144.22 31.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.869 HG11 ' CE2' ' A' ' 149' ' ' PHE . 8.8 p -138.64 139.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.399 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.46 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.2 tttt -105.49 124.28 49.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.478 ' HB ' HG13 ' A' ' 45' ' ' VAL . 50.2 mm -119.68 112.35 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.621 -0.674 . . . . 0.0 109.689 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.572 HG22 ' HB3' ' A' ' 44' ' ' SER . 29.6 t -113.78 118.84 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 O-C-N 121.21 -0.932 . . . . 0.0 109.546 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 93.56 7.32 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -92.48 128.68 38.42 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.639 ' HB2' ' CE2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER 173.91 69.6 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -174.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.21 92.04 0.33 Allowed 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 122.881 2.387 . . . . 0.0 108.768 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.639 ' CE2' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -120.78 -10.15 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.727 -177.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.413 ' CB ' ' OE1' ' A' ' 40' ' ' GLU . 32.6 t -128.77 -175.59 3.58 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.889 -1.132 . . . . 0.0 110.72 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 14.8 tttm -133.54 -33.52 1.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.698 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 1.5 p30 -126.24 -5.03 6.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.017 -1.052 . . . . 0.0 112.247 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.6 OUTLIER -110.93 150.4 41.82 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.946 -1.096 . . . . 0.0 110.678 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 51.2 Cg_endo -92.08 172.25 2.53 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 124.083 3.189 . . . . 0.0 110.559 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -179.47 -160.48 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.059 -1.026 . . . . 0.0 109.513 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.631 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 150.24 -112.02 0.53 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.747 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -142.9 161.91 36.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.064 -1.257 . . . . 0.0 111.733 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 5.5 m -83.26 -17.2 43.48 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.708 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.68 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 40.3 p90 -176.01 166.55 2.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.008 -1.058 . . . . 0.0 110.327 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 24' ' ' LEU . 20.2 m -145.1 137.78 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -149.89 163.27 38.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.997 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.869 ' CE2' HG11 ' A' ' 128' ' ' VAL . 55.9 m-85 -140.72 152.73 45.53 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.435 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -151.59 139.16 19.62 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 4' ' ' ILE . 6.1 p . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.3 Cg_endo -83.41 -25.7 2.48 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.883 2.388 . . . . 0.0 110.603 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -108.31 172.31 6.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.499 -0.751 . . . . 0.0 109.473 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.472 ' CG2' HD22 ' A' ' 49' ' ' LEU . 76.9 mt -142.14 127.98 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.05 172.21 7.0 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.523 -0.736 . . . . 0.0 109.694 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.738 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -100.16 134.88 42.44 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.592 -0.692 . . . . 0.0 109.525 -179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.655 ' N ' HD13 ' A' ' 6' ' ' LEU . 2.8 tpt85 -88.52 -61.52 1.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.41 ' CD2' ' HB3' ' A' ' 48' ' ' GLN . 3.4 p-80 -160.86 163.54 31.96 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -79.38 89.8 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.457 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.485 HG13 ' H ' ' A' ' 11' ' ' SER . 2.0 p -52.49 -55.63 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.177 -0.952 . . . . 0.0 109.973 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.46 161.05 25.6 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 15' ' ' GLN . 19.0 p -154.58 144.15 21.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.381 -0.824 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -141.12 46.72 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.747 -0.596 . . . . 0.0 109.498 179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 152.88 86.98 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.735 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -155.64 139.95 16.67 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.055 -1.028 . . . . 0.0 109.866 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.45 -161.8 0.4 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.253 -0.904 . . . . 0.0 109.832 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.49 -68.04 0.82 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.578 -0.701 . . . . 0.0 109.895 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -64.1 0.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.451 -0.781 . . . . 0.0 109.16 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -84.32 58.7 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.4 p -79.71 179.18 7.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.781 . . . . 0.0 109.555 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.749 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -65.06 -25.7 67.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.84 -15.85 59.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.45 -0.781 . . . . 0.0 109.762 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -65.42 -17.31 64.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.133 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.772 HD22 HG22 ' A' ' 147' ' ' VAL . 12.0 mt -64.76 -24.27 67.51 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 7' ' ' ARG . 4.2 mm? -55.77 -23.99 32.94 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.479 -0.763 . . . . 0.0 109.011 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' HG21 ' A' ' 29' ' ' THR . 31.9 mmtt -108.25 60.81 0.61 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.63 -27.57 64.84 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.986 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -108.05 64.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.585 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 26' ' ' LYS . 33.8 p -152.68 -90.62 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.342 -0.849 . . . . 0.0 109.605 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -178.1 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.075 -1.016 . . . . 0.0 110.082 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -128.47 147.47 50.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.045 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 20.1 mttp -132.5 176.08 8.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.413 -0.805 . . . . 0.0 110.204 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.696 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.0 t90 -88.48 139.49 30.43 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -144.67 130.5 19.21 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.97 146.47 8.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.427 -0.795 . . . . 0.0 110.025 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.12 -22.09 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.738 -0.601 . . . . 0.0 110.436 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 175.58 9.43 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.346 -0.846 . . . . 0.0 108.861 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.86 -166.1 1.31 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 68.14 44.3 77.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -48.28 89.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.513 0.673 . . . . 0.0 111.246 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 42' ' ' THR . 31.6 ttmt -97.8 -58.33 2.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.671 HG22 ' OG ' ' A' ' 133' ' ' SER . 33.5 p -156.29 118.43 4.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.686 HG21 ' HB2' ' A' ' 35' ' ' ALA . 18.0 pt -116.01 147.22 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.426 -0.796 . . . . 0.0 110.205 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.562 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -126.83 149.52 49.67 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.417 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.749 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.6 p -154.44 107.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 11' ' ' SER . 4.0 t -90.9 120.71 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.738 ' CB ' HD21 ' A' ' 6' ' ' LEU . 1.6 mp -100.11 163.29 12.49 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.456 0.646 . . . . 0.0 110.117 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 62.9 tp60 -116.55 117.64 30.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.748 HD13 ' OE2' ' A' ' 53' ' ' GLU . 35.9 mt -71.13 143.58 50.54 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -80.18 37.15 0.37 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.707 -0.621 . . . . 0.0 110.975 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttm 161.91 137.68 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 4.3 tt0 -76.93 108.14 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.748 ' OE2' HD13 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -137.6 176.78 8.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -87.25 179.79 6.56 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -140.5 133.06 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.885 . . . . 0.0 109.941 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.496 ' HA ' HD21 ' A' ' 116' ' ' LEU . 9.4 t-160 -120.4 -32.81 4.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 0.0 109.692 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 1.4 m -143.43 163.28 33.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.483 -0.761 . . . . 0.0 109.226 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG22 ' HD1' ' A' ' 149' ' ' PHE . 83.3 t -143.37 166.22 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.614 -0.679 . . . . 0.0 109.215 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.638 ' C ' HD13 ' A' ' 60' ' ' ILE . 5.0 t0 -137.66 102.07 4.65 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.0 110.114 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.638 HD13 ' C ' ' A' ' 59' ' ' ASP . 1.6 mm -115.18 117.98 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -85.31 114.45 3.97 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.09 127.74 33.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.798 -0.825 . . . . 0.0 110.671 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.5 67.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.4 -30.1 10.2 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.37 -172.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.555 -0.967 . . . . 0.0 109.62 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -155.0 -52.81 0.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.695 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.6 m-85 -99.93 123.13 43.84 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.839 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 60' ' ' ILE . 47.3 t -127.75 111.58 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.509 -0.744 . . . . 0.0 110.025 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -102.78 144.3 31.3 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.711 HG13 ' CD1' ' A' ' 130' ' ' ILE . 20.0 t -133.29 123.7 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 109.951 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.6 mp -111.47 158.84 18.67 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.788 ' CG1' HD22 ' A' ' 87' ' ' LEU . 3.4 m -120.67 158.3 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.728 -0.607 . . . . 0.0 110.361 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.44 174.26 44.54 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.3 t -115.78 159.67 21.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.659 0.742 . . . . 0.0 109.821 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.405 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 80.3 p -75.51 -5.14 43.72 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.643 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.69 -72.38 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.375 -0.828 . . . . 0.0 110.075 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.23 -70.28 1.03 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.63 29.23 66.56 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.79 -34.46 75.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.52 -0.988 . . . . 0.0 109.69 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.78 -150.99 15.95 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.13 28.79 3.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.687 -0.89 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -136.72 16.48 3.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 110.196 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -112.62 28.97 8.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.202 -0.936 . . . . 0.0 109.495 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.533 ' HB2' HD23 ' A' ' 71' ' ' LEU . 5.1 m-85 -109.42 -175.12 2.67 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -128.47 129.91 46.77 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 71' ' ' LEU . 38.9 t -59.34 87.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.806 -0.559 . . . . 0.0 111.222 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.788 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -59.96 -59.23 5.75 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD11 HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -137.23 124.06 21.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.54 -0.725 . . . . 0.0 109.209 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -54.72 -177.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 0.0 110.114 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.75 133.29 49.0 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.512 -0.743 . . . . 0.0 109.23 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 38.1 p -99.57 120.93 40.45 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.8 t -86.15 124.17 32.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 31.0 m-85 -118.67 -47.3 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.633 -0.667 . . . . 0.0 110.237 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 69.8 mtp -122.07 -174.65 2.94 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.603 0.716 . . . . 0.0 110.963 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.2 p -117.14 174.76 2.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.36 12.59 2.99 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 123.19 2.594 . . . . 0.0 111.563 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.4 -39.51 2.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.937 . . . . 0.0 109.754 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -80.2 -20.52 44.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.564 -0.71 . . . . 0.0 110.044 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.8 p -58.06 -22.75 51.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.396 -0.815 . . . . 0.0 110.547 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -68.3 -85.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.354 -0.841 . . . . 0.0 109.216 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 38.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.69 -17.96 7.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.35 117.43 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.094 -1.239 . . . . 0.0 110.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.8 OUTLIER 39.76 72.71 0.94 Allowed Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 121.944 -0.473 . . . . 0.0 111.963 178.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.7 -30.33 4.94 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.747 2.298 . . . . 0.0 109.62 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.97 115.21 18.17 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 -168.78 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.504 -0.747 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.632 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 41.3 t -144.75 131.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HD2' ' CD1' ' A' ' 93' ' ' PHE . 5.9 mmt85 -135.21 131.8 37.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.405 -0.809 . . . . 0.0 109.993 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.9 mtt -105.14 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.769 -0.582 . . . . 0.0 109.508 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.511 ' CE1' HG12 ' A' ' 60' ' ' ILE . 14.3 m-85 -140.26 163.98 31.31 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.74 0.781 . . . . 0.0 109.885 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -144.35 -153.68 5.93 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.743 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.6 Cg_endo -74.83 -24.3 13.35 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 123.602 2.868 . . . . 0.0 111.033 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.09 -43.71 41.42 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.564 -0.71 . . . . 0.0 111.166 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.48 13.12 20.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 110.656 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -114.76 121.0 41.97 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -48.94 130.57 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.756 -0.59 . . . . 0.0 110.736 -177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -66.86 -39.24 87.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.443 -0.786 . . . . 0.0 109.224 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.77 89.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.747 -0.596 . . . . 0.0 110.572 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -92.08 -34.9 14.19 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.41 -0.806 . . . . 0.0 109.373 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.72 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.11 -33.73 3.71 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.595 -0.69 . . . . 0.0 110.993 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.02 10.81 40.65 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.801 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 2.4 mmtt -92.9 133.13 36.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -72.35 104.57 3.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.514 -0.741 . . . . 0.0 110.312 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.413 ' CE2' ' HB3' ' A' ' 123' ' ' LYS . 72.0 m95 -110.4 157.54 19.44 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 52' ' ' GLU . 2.6 p30 -131.27 4.15 4.35 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.271 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 2.1 mtt180 -132.52 150.61 52.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.766 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -144.18 141.59 24.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.234 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.5 tttm -108.58 110.92 22.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.737 -0.602 . . . . 0.0 109.899 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.711 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.7 mm -104.71 118.9 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 44' ' ' SER . 39.9 t -122.56 122.1 65.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 O-C-N 121.26 -0.9 . . . . 0.0 110.03 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.541 ' SG ' HD22 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -95.62 145.72 25.04 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.671 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.35 126.71 12.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.922 . . . . 0.0 111.892 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.29 138.94 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HD2' ' HG2' ' A' ' 134' ' ' GLN . 43.8 Cg_endo -90.06 103.26 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 123.189 2.593 . . . . 0.0 110.178 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 65' ' ' SER . 5.4 p90 -137.17 -4.11 1.93 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.233 -0.917 . . . . 0.0 112.414 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 -173.86 3.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.847 -1.158 . . . . 0.0 110.463 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -173.44 -39.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -105.45 -42.08 5.32 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.647 0.736 . . . . 0.0 109.453 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 1.0 OUTLIER -107.97 145.33 31.18 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 44.5 Cg_endo -87.02 166.89 8.26 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 123.119 2.546 . . . . 0.0 110.507 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -171.44 -164.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.409 -0.807 . . . . 0.0 109.07 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.6 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 164.43 -106.84 0.28 Allowed Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.142 -1.028 . . . . 0.0 110.642 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -129.23 149.76 50.89 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 -179.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -71.72 -18.01 62.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 122.097 -0.377 . . . . 0.0 111.021 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.632 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 40.0 p90 179.07 178.11 0.48 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.209 -0.932 . . . . 0.0 110.589 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.772 HG22 HD22 ' A' ' 24' ' ' LEU . 15.7 m -155.65 129.79 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -141.82 156.39 45.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 109.474 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.766 ' CE2' HG11 ' A' ' 128' ' ' VAL . 39.6 m-85 -127.87 148.44 50.48 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.0 OUTLIER -146.63 130.44 17.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.458 -0.776 . . . . 0.0 109.273 179.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.748 -0.595 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.55 13.42 2.65 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.53 2.82 . . . . 0.0 111.277 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -160.86 176.55 11.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 49' ' ' LEU . 71.4 mt -121.57 123.26 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -104.47 173.06 6.47 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.437 0.637 . . . . 0.0 109.781 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.6 mp -103.07 165.7 10.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.667 -0.645 . . . . 0.0 109.57 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.611 ' C ' HD11 ' A' ' 25' ' ' LEU . 10.7 tpt180 -120.22 -47.39 2.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 48' ' ' GLN . 11.0 p-80 -161.0 -173.11 3.74 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.7 p -103.14 92.56 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.48 -0.762 . . . . 0.0 109.372 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG21 ' HD3' ' A' ' 127' ' ' ARG . 1.6 p -54.55 -60.58 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.142 -0.974 . . . . 0.0 110.216 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.544 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.31 163.63 18.31 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.444 ' HB2' ' CG ' ' A' ' 15' ' ' GLN . 19.7 p -160.05 149.37 17.71 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.059 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -152.31 51.91 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.681 -0.637 . . . . 0.0 109.975 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.715 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.63 65.96 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.939 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 1.1 mm100 -125.57 133.66 52.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.967 -1.083 . . . . 0.0 110.651 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.09 -175.5 5.67 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -64.12 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -56.66 12.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' CE1' ' NH1' ' A' ' 31' ' ' ARG . 88.8 m-70 -95.32 69.73 3.13 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -86.82 166.84 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.803 ' HB2' ' NE2' ' A' ' 15' ' ' GLN . . . -61.6 -24.33 66.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.701 -0.624 . . . . 0.0 109.849 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -62.51 -21.43 65.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.365 -0.835 . . . . 0.0 109.712 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -65.71 -19.7 66.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.783 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.6 mt -65.72 -24.92 67.09 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.611 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.3 mm? -60.62 -20.83 61.76 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -109.23 62.69 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.86 -24.84 6.75 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' THR . 1.1 m-20 -118.31 78.15 1.23 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 28' ' ' ASP . 3.1 p -157.29 -91.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.526 -0.734 . . . . 0.0 109.342 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -178.27 33.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 109.969 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' NH1' ' CE1' ' A' ' 19' ' ' HIS . 6.0 mmm180 -144.24 143.72 31.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.359 -0.838 . . . . 0.0 108.798 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -130.58 -162.67 1.23 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.361 -0.837 . . . . 0.0 109.324 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.783 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.6 t90 -96.87 136.08 37.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 109.383 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -143.1 125.93 16.11 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -53.73 160.06 1.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.332 -0.855 . . . . 0.0 110.753 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -83.24 -45.05 14.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -152.03 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.51 -168.31 2.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.903 . . . . 0.0 109.818 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' CA ' ' A' ' 138' ' ' LYS . . . 94.52 -22.62 36.35 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.589 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 12.1 mt-10 53.36 52.56 13.24 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.173 -1.193 . . . . 0.0 110.73 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -107.84 -103.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.38 -0.825 . . . . 0.0 109.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.54 HG22 ' OG ' ' A' ' 133' ' ' SER . 49.0 p -108.03 142.9 37.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.655 -1.278 . . . . 0.0 109.462 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.794 HG21 ' HB2' ' A' ' 35' ' ' ALA . 5.6 pt -145.21 147.03 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.673 -0.642 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.676 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.8 OUTLIER -121.15 142.74 49.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.721 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.2 p -151.06 106.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 129' ' ' LYS . 9.5 t -93.66 116.56 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.99 . . . . 0.0 108.911 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -102.29 152.7 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.923 -178.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.506 ' C ' HD22 ' A' ' 49' ' ' LEU . 8.4 tm0? -91.5 158.94 16.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.71 -0.619 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -107.22 124.94 50.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -52.29 -8.43 0.08 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.428 -0.795 . . . . 0.0 112.188 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.5 pttt -162.59 140.77 8.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.806 -1.184 . . . . 0.0 109.072 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -75.87 113.72 13.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -147.52 -176.46 5.25 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.87 172.34 8.53 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' O ' HD22 ' A' ' 116' ' ' LEU . 4.4 mp -128.72 120.04 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.393 -0.817 . . . . 0.0 109.509 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.502 ' O ' HD21 ' A' ' 116' ' ' LEU . 23.1 t60 -110.62 -29.37 8.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.592 -0.692 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -147.19 157.22 43.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.707 HG13 ' CD1' ' A' ' 149' ' ' PHE . 67.5 t -142.22 163.11 18.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.058 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 60' ' ' ILE . 7.0 m-20 -137.3 141.77 41.9 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 59' ' ' ASP . 0.7 OUTLIER -154.87 123.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -87.68 121.7 5.98 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.6 125.59 29.34 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.971 -0.723 . . . . 0.0 110.162 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' HB2' ' N ' ' A' ' 145' ' ' SER . 2.5 t0 -126.39 62.98 1.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.6 -28.9 13.91 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.454 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 p -56.75 166.57 0.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.643 -0.916 . . . . 0.0 110.191 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.746 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.32 -57.37 0.59 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -101.16 123.36 45.18 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.56 111.66 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 0.0 110.204 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -105.06 141.43 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 130' ' ' ILE . 35.5 t -130.78 127.23 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.52 -0.737 . . . . 0.0 110.028 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 HG22 ' A' ' 86' ' ' VAL . 1.9 mp -110.67 160.92 16.26 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.66 HG11 HD13 ' A' ' 87' ' ' LEU . 3.6 m -121.76 161.52 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.634 -0.666 . . . . 0.0 110.374 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 168.16 37.14 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.5 t -119.5 158.35 26.46 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.012 -0.699 . . . . 0.0 109.523 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.417 ' HB3' ' NE ' ' A' ' 127' ' ' ARG . 37.9 p -91.65 13.28 18.48 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.55 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 110.36 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -111.69 -37.36 1.58 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.19 112.13 4.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.09 -29.93 70.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.926 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.5 159.9 8.24 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 64.5 128.06 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.623 -0.928 . . . . 0.0 109.906 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 59.77 21.88 10.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.521 -0.737 . . . . 0.0 110.288 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -137.04 22.46 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 0.0 109.65 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -114.17 -175.48 2.69 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.739 ' CD ' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -139.52 135.79 33.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG22 HD11 ' A' ' 71' ' ' LEU . 24.3 t -58.08 89.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.636 -0.665 . . . . 0.0 111.952 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.66 HD13 HG11 ' A' ' 72' ' ' VAL . 12.6 tp -65.26 -54.0 35.83 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.631 HD13 ' CD2' ' A' ' 111' ' ' PHE . 2.1 pp -138.64 122.36 17.54 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.385 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.524 ' O ' HD12 ' A' ' 88' ' ' LEU . 27.2 m -54.76 -177.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.536 -0.728 . . . . 0.0 110.175 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 t -69.64 136.53 51.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.494 -0.754 . . . . 0.0 109.171 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 125.72 52.52 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.429 0.633 . . . . 0.0 109.961 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -83.79 104.68 14.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 109' ' ' ARG . 19.2 m-85 -101.89 -47.02 4.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 110.343 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.594 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 2.5 ttp -117.9 -178.5 3.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.496 -0.752 . . . . 0.0 110.012 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -114.89 173.76 2.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.3 Cg_endo -88.17 18.88 1.43 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.288 2.658 . . . . 0.0 111.292 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.32 -50.0 2.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HG2' ' ND2' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -57.65 -21.43 39.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.395 -0.816 . . . . 0.0 110.307 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.9 p -45.71 -27.82 0.89 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.489 -0.757 . . . . 0.0 111.453 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -78.09 0.45 Allowed 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.761 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.8 37.17 0.1 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.45 -27.52 59.28 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.27 -82.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.542 -0.975 . . . . 0.0 110.489 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.426 ' ND2' ' HG2' ' A' ' 98' ' ' GLU . 3.7 p30 -112.03 87.48 8.85 Favored Pre-proline 0 C--N 1.296 -1.735 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.594 ' O ' ' HE1' ' A' ' 94' ' ' MET . 37.5 Cg_endo -69.91 -24.93 28.42 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.651 2.234 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -136.43 148.1 47.59 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -157.68 -168.02 2.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.594 -0.691 . . . . 0.0 109.821 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 96.1 t -137.73 129.77 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 23.5 mmt-85 -137.81 150.48 47.23 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 37.4 mtm -134.43 166.51 22.68 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.596 0.712 . . . . 0.0 110.807 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.1 m-85 -119.76 171.13 8.62 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -142.65 -150.71 5.37 Favored Glycine 0 N--CA 1.483 1.8 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 40.1 Cg_endo -76.0 -37.43 1.57 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.677 2.918 . . . . 0.0 110.77 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.34 -26.14 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.526 -0.734 . . . . 0.0 109.763 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.96 2.16 56.15 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.652 -0.655 . . . . 0.0 110.74 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.984 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.6 pp -122.5 141.1 52.01 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.981 -1.074 . . . . 0.0 110.519 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.913 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -61.42 138.71 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -32.87 49.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.356 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.03 -18.12 65.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.503 -0.748 . . . . 0.0 110.42 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -117.19 -45.64 2.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.267 -0.895 . . . . 0.0 110.007 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -49.05 -39.58 28.05 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.342 -0.849 . . . . 0.0 111.08 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -81.37 1.18 34.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 15.9 mttt -94.04 134.27 36.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -68.58 112.43 5.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.446 -0.784 . . . . 0.0 110.919 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.429 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 79.4 m95 -115.14 166.44 11.82 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -139.66 12.31 2.5 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.714 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.73 ' HD3' HG21 ' A' ' 10' ' ' VAL . 7.8 mtt180 -146.92 141.5 26.59 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.93 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.8 p -131.79 143.79 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.579 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HG3' HG22 ' A' ' 46' ' ' VAL . 5.8 tttp -107.64 114.11 27.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.609 . . . . 0.0 109.48 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 149' ' ' PHE . 44.8 mm -105.5 115.48 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.648 -0.658 . . . . 0.0 109.599 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.676 HG22 ' HB3' ' A' ' 44' ' ' SER . 40.4 t -122.23 116.27 48.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.2 t -89.34 156.6 18.61 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -151.44 127.81 10.64 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.361 -0.837 . . . . 0.0 110.988 -178.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.746 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.0 tp60 149.32 136.11 0.0 OUTLIER Pre-proline 0 N--CA 1.519 3.002 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' GLU . 43.4 Cg_endo -85.89 91.29 0.66 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.906 2.404 . . . . 0.0 110.269 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.47 -0.38 57.45 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.491 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.0 t -168.3 -162.69 0.42 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.791 -1.193 . . . . 0.0 110.261 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' CA ' ' HA2' ' A' ' 39' ' ' GLY . 3.9 mtpt -138.89 -39.34 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.719 . . . . 0.0 110.134 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -117.17 -13.76 10.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.126 -0.984 . . . . 0.0 111.343 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -104.6 142.3 24.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.324 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 46.6 Cg_endo -88.03 177.13 3.56 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.479 2.786 . . . . 0.0 110.481 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 173.14 -163.27 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.594 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 165.37 -112.98 0.53 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.962 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -133.07 160.02 38.4 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.238 -1.154 . . . . 0.0 110.731 -179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 67.3 m -78.64 -21.86 47.77 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.752 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.512 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.5 p90 177.08 178.95 0.24 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.249 -0.907 . . . . 0.0 110.459 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 144' ' ' LEU . 33.7 m -154.21 129.16 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 3.2 mtt85 -139.95 114.4 9.23 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.766 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.93 ' CE2' HG11 ' A' ' 128' ' ' VAL . 73.0 m-85 -87.94 157.25 18.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.281 -0.887 . . . . 0.0 108.901 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -154.2 136.8 15.14 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.353 -0.842 . . . . 0.0 109.174 179.54 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.651 -0.655 . . . . 0.0 110.913 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.15 -51.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.438 2.758 . . . . 0.0 110.523 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.03 -173.16 4.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.75 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.749 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -141.04 128.74 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -113.42 151.33 31.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.926 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 47' ' ' LEU . 1.2 tp -84.74 149.47 25.75 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.628 ' C ' HD11 ' A' ' 25' ' ' LEU . 11.7 tpt85 -103.87 -50.26 3.44 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -161.03 -178.59 6.88 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -99.96 97.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG13 ' H ' ' A' ' 11' ' ' SER . 2.2 p -54.77 -59.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.329 -0.857 . . . . 0.0 110.442 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.541 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -121.54 154.25 36.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.147 -0.971 . . . . 0.0 108.75 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' CB ' ' OE1' ' A' ' 15' ' ' GLN . 23.8 p -143.4 125.26 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.239 -0.913 . . . . 0.0 110.715 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.3 m -127.51 50.1 2.05 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.587 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 154.23 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.87 ' OE1' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -110.41 146.23 36.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 109.883 -178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.34 -170.72 2.06 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.72 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.9 t -99.38 -68.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.785 . . . . 0.0 109.446 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -37.79 87.24 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -116.56 70.11 0.76 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.9 p -87.5 172.37 9.83 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.189 0.995 . . . . 0.0 109.53 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 24' ' ' LEU . . . -64.9 -24.98 67.69 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.231 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.78 -20.4 56.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.41 -0.807 . . . . 0.0 109.509 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.42 -20.5 66.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 7.3 mt -66.27 -26.94 67.58 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.628 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.2 mm? -61.65 -18.84 61.14 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.474 -0.766 . . . . 0.0 109.175 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -112.25 66.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.54 -45.4 56.87 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.541 -0.724 . . . . 0.0 110.366 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.86 78.98 7.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.058 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.0 -152.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -130.8 40.3 3.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.069 -1.02 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -149.83 136.55 19.32 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 -160.24 1.0 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.493 -0.755 . . . . 0.0 109.738 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.877 ' CH2' HD12 ' A' ' 43' ' ' ILE . 22.0 t90 -85.43 140.24 30.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.264 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.52 129.69 22.18 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.591 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.69 161.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.305 -0.872 . . . . 0.0 110.498 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.57 -30.08 66.68 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.971 -0.456 . . . . 0.0 110.021 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -174.24 3.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.5 -165.27 1.24 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.57 45.01 95.69 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -46.12 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 111.812 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' O ' HG23 ' A' ' 42' ' ' THR . 28.1 tttt -94.77 -56.4 2.79 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.686 HG22 ' OG ' ' A' ' 133' ' ' SER . 17.2 p -158.13 113.05 2.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.877 HD12 ' CH2' ' A' ' 33' ' ' TRP . 5.0 pt -111.13 139.65 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.608 -0.683 . . . . 0.0 109.527 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.523 ' OG ' HG13 ' A' ' 131' ' ' VAL . 50.6 m -126.27 122.65 36.12 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.523 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.87 HG23 ' OE1' ' A' ' 15' ' ' GLN . 7.2 p -123.23 125.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.864 HG22 ' HG3' ' A' ' 129' ' ' LYS . 3.5 t -104.48 113.3 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.631 HD22 HD21 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.08 171.09 8.25 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.364 0.602 . . . . 0.0 110.281 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.726 ' C ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -113.79 174.49 5.9 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.749 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.5 mm? -124.3 140.43 52.96 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -76.52 26.55 0.13 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.214 -0.929 . . . . 0.0 111.469 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.6 pttt 167.1 132.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -75.77 111.69 11.38 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.09 167.82 21.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.642 ' O ' HD13 ' A' ' 55' ' ' ILE . 21.8 mt-30 -72.26 -178.77 2.61 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 54' ' ' GLN . 2.6 mm -126.6 128.8 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.417 ' CE1' ' HG3' ' A' ' 113' ' ' PRO . 77.0 t60 -120.69 -38.97 2.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.468 -0.77 . . . . 0.0 109.793 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.7 m -147.11 162.46 38.8 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.642 HG13 ' CD1' ' A' ' 149' ' ' PHE . 89.4 t -147.37 162.42 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.661 -0.649 . . . . 0.0 109.706 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.461 ' N ' HG12 ' A' ' 58' ' ' VAL . 1.8 m-20 -139.92 127.83 22.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG23 ' CD2' ' A' ' 144' ' ' LEU . 0.7 OUTLIER -143.48 130.46 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -95.14 128.48 9.53 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.78 115.29 20.93 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.129 -0.63 . . . . 0.0 109.692 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -105.45 61.72 0.68 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.63 -29.08 12.72 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 86.3 p -60.62 173.63 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.761 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -139.88 -52.71 0.52 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.4 m-85 -95.34 123.99 39.14 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 60' ' ' ILE . 44.0 t -127.77 111.92 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.553 -0.717 . . . . 0.0 110.036 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -103.28 140.13 37.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG13 ' CD1' ' A' ' 130' ' ' ILE . 29.1 t -126.46 122.7 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.14 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.66 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.8 mp -112.13 162.01 15.89 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.879 HG21 HD13 ' A' ' 87' ' ' LEU . 3.2 m -129.14 160.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.577 -0.702 . . . . 0.0 110.275 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -179.15 174.8 46.74 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -112.03 160.27 17.65 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.799 0.809 . . . . 0.0 109.949 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.437 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 56.0 p -86.37 7.27 26.3 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.01 112.03 1.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.973 . . . . 0.0 110.103 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.9 -102.51 0.52 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.79 115.36 0.66 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 83' ' ' ASP . . . -63.24 -57.37 10.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.947 . . . . 0.0 109.339 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.03 26.29 3.31 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 69.84 -63.04 0.4 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.366 -1.079 . . . . 0.0 109.975 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -93.7 39.29 1.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 109.951 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.686 ' HB3' ' HB1' ' A' ' 79' ' ' ALA . 9.9 t70 -125.51 30.88 5.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.433 -0.792 . . . . 0.0 108.986 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.66 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -103.12 -174.43 2.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.488 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -119.32 124.77 47.45 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 t -61.12 85.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.798 -0.563 . . . . 0.0 110.446 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.879 HD13 HG21 ' A' ' 72' ' ' VAL . 3.4 tp -57.91 -56.29 23.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.462 -0.774 . . . . 0.0 109.195 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 111' ' ' PHE . 1.5 pp -140.41 124.57 17.6 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.629 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -55.92 172.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.542 ' H ' HG12 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -59.48 134.37 56.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.664 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 11.4 p -107.57 124.89 50.61 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.438 0.637 . . . . 0.0 109.594 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -84.27 125.03 31.86 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.442 ' CD1' ' CD ' ' A' ' 109' ' ' ARG . 28.7 m-85 -121.66 -43.31 2.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.513 ' HE1' ' O ' ' A' ' 105' ' ' PRO . 3.0 mtp -120.4 -165.28 1.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.658 . . . . 0.0 110.086 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.5 p -129.37 175.13 3.82 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.93 13.64 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 123.178 2.585 . . . . 0.0 111.257 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.6 m -120.36 -46.34 2.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.96 -22.92 29.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.535 -0.728 . . . . 0.0 110.682 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 136' ' ' TYR . 0.7 OUTLIER -50.13 -36.32 29.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 110.919 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -74.5 -84.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 109.853 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -163.59 37.29 0.09 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -81.66 -25.25 54.13 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.632 -0.922 . . . . 0.0 110.45 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.47 90.48 30.51 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.513 ' O ' ' HE1' ' A' ' 94' ' ' MET . 38.2 Cg_endo -72.25 -21.54 23.25 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.537 2.158 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.47 156.51 37.1 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -156.41 -175.18 5.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 0.0 110.228 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.621 HG13 ' HZ ' ' A' ' 146' ' ' PHE . 42.6 t -155.7 115.26 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' CD ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.49 165.69 19.37 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.378 -0.826 . . . . 0.0 109.679 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 48.4 mtt -140.43 175.46 9.58 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.497 0.665 . . . . 0.0 110.153 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 4.5 m-85 -136.7 159.0 43.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 116' ' ' LEU . . . -125.82 -155.01 8.85 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HA ' HD11 ' A' ' 116' ' ' LEU . 38.3 Cg_endo -75.42 -36.77 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.274 2.65 . . . . 0.0 110.529 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.45 -29.12 68.49 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 -2.72 44.36 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.383 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.551 HD12 ' CB ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -124.99 141.19 52.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.948 -1.095 . . . . 0.0 109.956 179.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.916 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.2 p -51.56 139.98 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.49 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.52 -39.2 62.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 109.157 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.56 -20.91 63.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 110.809 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.916 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.51 -43.64 3.03 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.874 . . . . 0.0 109.856 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.551 ' CB ' HD12 ' A' ' 116' ' ' LEU . . . -48.3 -32.56 7.52 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.249 -0.907 . . . . 0.0 111.119 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -96.01 24.23 5.74 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.229 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.0 mttm -114.86 137.02 52.46 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -65.34 116.24 6.45 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.78 0.8 . . . . 0.0 110.462 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.487 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 63.2 m95 -122.66 151.05 41.89 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -133.52 5.19 3.71 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.429 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -132.75 141.39 48.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 178.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.774 HG11 ' CE2' ' A' ' 149' ' ' PHE . 4.7 p -135.06 141.17 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.655 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.864 ' HG3' HG22 ' A' ' 46' ' ' VAL . 9.4 tttt -109.59 121.09 44.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.813 -0.554 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CD1' HG13 ' A' ' 70' ' ' VAL . 50.6 mm -115.5 114.07 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 109.142 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG13 ' OG ' ' A' ' 44' ' ' SER . 61.2 t -114.88 116.83 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 121.353 -0.842 . . . . 0.0 109.946 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.444 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -92.49 137.38 32.41 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.686 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -137.94 123.44 19.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 110.507 -178.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 4.8 tp60 166.43 133.46 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -87.02 95.05 0.48 Allowed 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.928 2.419 . . . . 0.0 108.952 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 40' ' ' GLU . 8.1 p90 -127.79 -7.25 5.59 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.273 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.12 178.65 6.07 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.0 110.527 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -156.96 -42.07 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -112.83 -36.7 5.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.49 -0.756 . . . . 0.0 109.669 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.41 147.67 34.33 Favored Pre-proline 0 C--N 1.299 -1.617 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.416 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.1 Cg_endo -87.5 178.43 3.38 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.286 2.657 . . . . 0.0 110.777 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER 178.93 -171.9 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.45 -112.1 0.49 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.907 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.593 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.7 mp -111.88 148.79 32.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.68 -0.894 . . . . 0.0 110.412 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -84.89 -27.66 26.5 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.621 ' HZ ' HG13 ' A' ' 108' ' ' VAL . 52.1 p90 -176.03 169.8 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.503 -0.748 . . . . 0.0 109.673 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.8 m -150.15 134.69 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.604 -0.685 . . . . 0.0 109.161 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 17.3 mtt180 -145.63 113.98 6.67 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.531 -0.731 . . . . 0.0 109.855 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.774 ' CE2' HG11 ' A' ' 128' ' ' VAL . 64.1 m-85 -93.3 152.56 19.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.44 -0.788 . . . . 0.0 109.203 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 133.54 20.81 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.396 -0.815 . . . . 0.0 108.805 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.424 ' CB ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.725 -0.609 . . . . 0.0 109.364 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.18 50.61 2.14 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 123.528 2.819 . . . . 0.0 110.648 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -160.92 158.37 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.552 -0.717 . . . . 0.0 109.454 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' OE1' ' A' ' 53' ' ' GLU . 47.7 mm -79.67 134.72 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -108.24 113.85 27.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.423 -0.798 . . . . 0.0 109.955 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.942 HD12 HD23 ' A' ' 49' ' ' LEU . 3.3 tp -79.76 140.77 36.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.672 -0.643 . . . . 0.0 109.359 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -91.94 -65.01 1.04 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.531 -0.731 . . . . 0.0 109.519 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -160.39 173.22 15.95 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.744 HG12 ' HG3' ' A' ' 22' ' ' GLU . 7.1 p -79.76 90.31 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.211 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG21 HH11 ' A' ' 127' ' ' ARG . 2.3 p -53.07 -55.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.171 -0.956 . . . . 0.0 110.122 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.468 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.19 154.22 37.76 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.669 -0.812 . . . . 0.0 108.989 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.7 p -146.61 125.32 12.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 110.089 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -120.45 45.75 2.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.649 -0.657 . . . . 0.0 109.516 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.606 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.84 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.744 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.83 136.97 23.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -162.47 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 0.0 109.162 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.9 t -93.45 -69.41 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -60.74 2.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.531 -0.731 . . . . 0.0 109.122 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -88.05 68.43 9.16 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.2 p -92.12 170.9 9.46 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.727 0.775 . . . . 0.0 110.219 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.55 -24.26 67.74 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.98 -0.45 . . . . 0.0 109.889 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.744 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -61.57 -19.56 62.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -65.5 -18.48 65.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -0.843 . . . . 0.0 109.157 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.839 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.0 mt -65.13 -25.12 67.62 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.3 mm? -60.08 -20.61 58.96 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.47 -0.769 . . . . 0.0 109.033 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -127.29 73.8 1.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.81 -51.25 30.35 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.651 -0.656 . . . . 0.0 110.845 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -86.92 79.12 8.87 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.0 109.571 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.49 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -162.22 31.3 0.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.508 -0.745 . . . . 0.0 109.618 -179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 29' ' ' THR . 22.2 p90 46.99 25.18 0.45 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.242 0.544 . . . . 0.0 111.765 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -126.62 126.05 42.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 0.0 108.972 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.8 mttp -123.48 169.83 11.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.33 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.754 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.5 t90 -74.18 141.07 45.53 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -143.19 130.57 21.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.48 151.73 3.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.463 -0.773 . . . . 0.0 110.239 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -70.41 -33.79 71.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.61 -0.681 . . . . 0.0 109.702 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.24 -157.66 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.72 167.05 18.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -0.837 . . . . 0.0 109.412 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 138' ' ' LYS . . . 96.03 -34.96 4.59 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 136' ' ' TYR . 3.9 mp0 51.79 104.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.944 . . . . 0.0 111.782 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' HG23 ' A' ' 42' ' ' THR . 23.8 ttmt -117.31 -51.02 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.727 HG22 ' OG ' ' A' ' 133' ' ' SER . 4.1 p -158.9 105.01 1.76 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' CZ3' ' A' ' 33' ' ' TRP . 18.7 pt -105.68 139.88 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.361 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.547 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -121.92 149.26 43.67 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.164 179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.9 p -153.6 112.29 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.743 HG22 ' HG2' ' A' ' 129' ' ' LYS . 5.8 t -94.08 119.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 6' ' ' LEU . 1.8 mp -97.27 161.25 13.89 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.416 0.627 . . . . 0.0 109.941 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -107.78 145.28 33.77 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.38 0.61 . . . . 0.0 109.355 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.942 HD23 HD12 ' A' ' 6' ' ' LEU . 39.1 mt -104.95 133.67 49.34 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 51' ' ' LYS . 31.9 tt0 -81.68 45.62 0.9 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.448 -0.783 . . . . 0.0 110.612 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER 160.0 126.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -73.79 107.88 6.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -135.54 178.0 7.38 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.406 0.622 . . . . 0.0 109.588 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -89.92 177.23 6.54 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 55' ' ' ILE . 5.0 mp -130.72 119.04 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.465 -0.772 . . . . 0.0 109.53 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -108.72 -29.0 8.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.63 -0.669 . . . . 0.0 109.435 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 20.8 m -149.26 146.35 27.54 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.0 t -131.8 162.07 40.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.454 0.645 . . . . 0.0 109.701 -178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 60' ' ' ILE . 34.7 t0 -141.79 136.07 30.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.679 HG21 HG11 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -156.58 132.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -106.1 131.74 10.79 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -84.48 128.03 34.36 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 122.185 -0.597 . . . . 0.0 110.244 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -99.7 71.33 1.7 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.3 7.45 88.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -84.06 -173.47 4.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -1.128 . . . . 0.0 109.762 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -142.88 -51.65 0.37 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -103.09 130.8 50.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.672 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.679 HG11 HG21 ' A' ' 60' ' ' ILE . 48.0 t -134.53 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.65 -0.657 . . . . 0.0 109.575 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -105.56 151.36 24.43 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.761 -0.587 . . . . 0.0 109.486 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.7 t -141.53 122.99 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.855 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.2 mp -110.56 163.71 13.45 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.587 ' CG1' HD22 ' A' ' 87' ' ' LEU . 2.9 m -127.86 156.73 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.713 -0.617 . . . . 0.0 109.781 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.29 176.25 45.22 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 t -110.32 156.71 20.36 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.2 p -85.77 7.59 23.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.442 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.99 171.61 2.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.88 -102.75 1.26 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.4 -139.93 3.12 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.68 80.85 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.578 -0.954 . . . . 0.0 109.558 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.73 149.41 18.12 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -110.26 -27.27 9.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.623 -0.928 . . . . 0.0 109.705 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -101.35 37.47 1.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.455 -0.778 . . . . 0.0 109.366 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -126.9 34.37 4.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.547 -0.721 . . . . 0.0 109.647 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.4 m-85 -113.16 -177.92 3.25 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.741 0.781 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.8 OUTLIER -123.69 129.04 50.5 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.32 86.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.676 -0.64 . . . . 0.0 110.292 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.587 HD22 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tp -59.04 -54.41 47.36 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -144.66 120.73 10.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.559 HG12 ' H ' ' A' ' 90' ' ' THR . 2.9 t -57.42 172.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.618 -0.676 . . . . 0.0 109.216 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.559 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -57.31 134.06 55.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.3 p -105.34 126.89 52.61 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.413 0.625 . . . . 0.0 109.325 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 96.2 p -87.88 119.94 28.73 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 18.1 m-85 -110.21 -51.51 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.629 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.416 ' CE ' ' O ' ' A' ' 104' ' ' ASN . 19.1 mtp -122.03 -162.71 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.508 0.671 . . . . 0.0 110.084 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.1 p -123.51 177.45 1.7 Allowed Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.79 11.53 3.31 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.929 2.419 . . . . 0.0 111.279 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.21 -36.72 3.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.314 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -81.65 -16.39 51.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.451 -0.78 . . . . 0.0 110.226 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.2 m -59.44 -24.67 63.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 110.176 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -67.45 -83.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 t -162.28 38.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 108.722 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -109.7 -22.32 6.73 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.96 119.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 109.935 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.416 ' O ' ' CE ' ' A' ' 94' ' ' MET . 0.9 OUTLIER 40.87 68.72 2.25 Favored Pre-proline 0 N--CA 1.508 2.449 0 O-C-N 121.949 -0.469 . . . . 0.0 111.233 179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.1 -30.71 4.16 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.949 2.433 . . . . 0.0 110.52 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.61 82.58 2.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.665 -0.647 . . . . 0.0 109.647 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.9 171.99 7.54 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -127.29 172.84 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 109.863 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -155.82 145.9 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 109.144 179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 1.4 mtt -123.71 153.7 40.49 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.45 0.643 . . . . 0.0 110.096 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.601 ' CD2' HD13 ' A' ' 88' ' ' LEU . 4.9 m-85 -114.8 161.33 18.34 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -131.3 -149.39 6.44 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 38.7 Cg_endo -74.72 -39.36 1.37 Allowed 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 123.614 2.876 . . . . 0.0 110.842 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.62 -28.29 69.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -89.99 3.77 52.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.662 -0.649 . . . . 0.0 110.598 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.968 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.61 139.66 53.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.013 -1.054 . . . . 0.0 110.521 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.906 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.7 p -59.6 130.53 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -74.84 -30.81 61.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.475 -0.766 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -20.63 65.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.506 -0.746 . . . . 0.0 110.217 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.906 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.98 -46.25 2.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.915 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.968 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.8 -39.55 25.76 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.165 -0.959 . . . . 0.0 111.439 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -79.13 -0.15 30.53 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.35 -0.843 . . . . 0.0 110.605 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.513 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.7 mtpt -92.36 134.42 34.94 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -67.76 113.55 5.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.469 -0.769 . . . . 0.0 110.766 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 74.5 m95 -116.31 163.85 15.4 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -135.11 7.41 3.41 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.585 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.501 HH11 HG21 ' A' ' 10' ' ' VAL . 19.4 mtm180 -137.39 149.45 46.96 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.582 HG11 ' CE2' ' A' ' 149' ' ' PHE . 3.3 p -134.77 138.31 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.956 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.743 ' HG2' HG22 ' A' ' 46' ' ' VAL . 1.4 tmtm? -106.36 100.81 10.32 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.929 -0.482 . . . . 0.0 109.761 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 70' ' ' VAL . 49.8 mm -97.14 118.7 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.58 -0.7 . . . . 0.0 109.557 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.547 HG22 ' HB3' ' A' ' 44' ' ' SER . 34.2 t -121.95 122.28 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.343 -0.848 . . . . 0.0 109.613 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 1.5 t -100.57 138.94 36.95 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.727 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -138.25 132.2 31.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.507 -0.746 . . . . 0.0 111.427 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.727 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 151.19 134.79 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.753 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.52 103.83 1.12 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.918 2.412 . . . . 0.0 109.587 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -77.14 -62.54 1.62 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.462 0.649 . . . . 0.0 109.612 -179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.62 -161.58 1.37 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.499 -0.48 . . . . 0.0 109.879 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 16.4 mttm -136.29 34.13 2.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.545 -0.722 . . . . 0.0 109.389 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -77.02 0.49 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.6 -0.688 . . . . 0.0 110.276 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.12 158.19 37.75 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.977 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.6 Cg_endo -80.8 176.56 8.89 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 123.625 2.883 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -173.55 -166.11 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 158.78 -111.0 0.46 Allowed Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.771 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.585 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -117.93 149.94 40.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.598 -0.942 . . . . 0.0 110.465 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.7 m -83.67 -26.22 30.04 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 51.5 p90 -178.65 164.97 1.65 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.502 -0.749 . . . . 0.0 109.023 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 24' ' ' LEU . 26.3 m -140.17 138.37 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.27 149.42 32.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.582 -0.699 . . . . 0.0 109.589 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.645 ' CD1' HG13 ' A' ' 58' ' ' VAL . 58.7 m-85 -127.71 160.95 30.11 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.41 ' CA ' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -155.14 120.42 4.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.275 -0.89 . . . . 0.0 109.321 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.701 -0.624 . . . . 0.0 110.349 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.33 120.75 1.87 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.482 2.788 . . . . 0.0 110.454 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -137.89 178.49 7.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.683 . . . . 0.0 109.545 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.761 HG23 ' NZ ' ' A' ' 51' ' ' LYS . 68.0 mt -135.8 128.7 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.562 -0.711 . . . . 0.0 109.26 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.597 ' C ' HD22 ' A' ' 6' ' ' LEU . 41.3 mtt180 -120.08 -175.79 3.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.458 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD22 ' C ' ' A' ' 5' ' ' ARG . 4.4 mm? -111.84 160.48 17.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.668 -0.645 . . . . 0.0 109.613 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttt-85 -108.06 -48.07 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -160.59 162.25 32.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.28 86.33 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 11' ' ' SER . 2.3 p -51.37 -55.92 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -123.25 155.63 36.81 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.8 p -152.53 114.8 4.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -0.869 . . . . 0.0 110.336 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -104.67 47.38 0.88 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.487 ' HB2' HG22 ' A' ' 43' ' ' ILE . 3.3 t 151.87 111.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.889 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -161.1 127.63 3.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.064 -1.023 . . . . 0.0 109.834 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.7 150.21 24.76 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.9 m -61.45 -55.17 34.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.5 -0.75 . . . . 0.0 109.877 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -60.52 3.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.358 -0.839 . . . . 0.0 108.859 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -102.48 85.45 2.61 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.2 p -93.46 163.48 13.56 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.513 0.673 . . . . 0.0 110.096 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -61.72 -22.01 64.99 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.838 -0.539 . . . . 0.0 110.007 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.591 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.5 tt0 -62.97 -20.73 65.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.819 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -65.45 -18.97 65.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.338 -0.851 . . . . 0.0 109.377 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 33' ' ' TRP . 15.5 mt -66.26 -26.06 67.17 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.28 -17.4 62.47 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.562 -0.712 . . . . 0.0 109.25 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HB3' HG21 ' A' ' 29' ' ' THR . 5.3 mmmm -113.12 65.85 0.65 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.22 -26.77 3.14 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.537 -0.727 . . . . 0.0 110.809 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' C ' HG23 ' A' ' 29' ' ' THR . 25.5 t0 -99.75 68.17 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.464 -0.772 . . . . 0.0 109.416 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.459 HG21 ' HB3' ' A' ' 26' ' ' LYS . 73.9 p -154.97 -161.09 1.14 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -127.56 34.41 4.68 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.365 -0.834 . . . . 0.0 109.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -124.62 105.5 9.39 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 35.9 mttt -91.27 162.83 14.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.609 -0.682 . . . . 0.0 109.738 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.729 ' HB2' HD21 ' A' ' 24' ' ' LEU . 23.4 t90 -67.76 139.62 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 127.05 16.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -56.49 164.19 1.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.475 -0.766 . . . . 0.0 110.616 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -85.16 -30.55 23.85 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.28 -156.8 0.53 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.601 ' HB1' ' C ' ' A' ' 139' ' ' ASP . . . -137.65 172.52 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.83 -25.35 25.56 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mt-10 45.3 51.0 9.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.687 -0.89 . . . . 0.0 112.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 42' ' ' THR . 11.7 ttpt -67.06 -59.21 3.66 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.779 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.1 p -160.44 133.79 6.78 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.693 HD12 ' CH2' ' A' ' 33' ' ' TRP . 10.1 pt -134.54 152.77 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.274 -0.891 . . . . 0.0 110.554 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB2' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -129.69 150.37 51.03 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.536 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.4 p -149.66 106.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.428 HG22 ' HG3' ' A' ' 129' ' ' LYS . 2.9 t -90.89 118.46 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.729 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.38 158.2 16.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' N ' HD12 ' A' ' 6' ' ' LEU . 17.1 tm0? -104.75 131.21 52.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.554 -0.716 . . . . 0.0 109.683 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 4' ' ' ILE . 4.2 mm? -81.19 121.23 25.88 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -54.06 -6.52 0.1 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.323 -0.861 . . . . 0.0 111.737 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.761 ' NZ ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -153.66 150.39 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.877 -1.14 . . . . 0.0 108.033 179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.87 111.3 22.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -0.77 . . . . 0.0 109.013 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.43 -178.59 6.32 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -84.34 -171.02 3.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.1 115.77 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.507 -0.746 . . . . 0.0 109.313 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.0 t-160 -101.36 -32.01 10.67 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.8 m -147.48 153.98 40.22 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.703 HG13 ' CD1' ' A' ' 149' ' ' PHE . 79.7 t -136.72 161.14 36.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.643 -0.661 . . . . 0.0 109.726 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.533 ' C ' HD12 ' A' ' 60' ' ' ILE . 27.5 t0 -139.11 139.24 37.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.617 -0.677 . . . . 0.0 109.57 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.581 HG21 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -157.86 132.12 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 146' ' ' PHE . . . -106.46 128.74 9.43 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -80.14 123.32 27.79 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 122.157 -0.614 . . . . 0.0 110.521 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 24.9 t0 -97.54 72.41 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 12.5 83.24 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 10.8 t -85.8 172.9 10.43 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.304 -1.115 . . . . 0.0 109.637 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 134' ' ' GLN . . . -134.8 -56.05 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.8 m-85 -102.26 122.89 45.1 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.702 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 60' ' ' ILE . 43.8 t -126.43 112.52 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.705 . . . . 0.0 109.85 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -104.36 142.47 34.5 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.71 HG13 HD13 ' A' ' 130' ' ' ILE . 22.2 t -131.08 128.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.547 -0.721 . . . . 0.0 109.967 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 84' ' ' TYR . 2.6 mp -115.68 161.26 18.95 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.644 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.7 m -122.89 161.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.734 -0.604 . . . . 0.0 109.996 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.31 173.35 41.87 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.1 t -112.22 162.2 15.73 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.728 0.775 . . . . 0.0 109.833 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . 13.0 t -86.27 6.19 30.88 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.1 -77.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -0.908 . . . . 0.0 110.055 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -126.96 80.35 0.36 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.14 -65.84 1.96 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 59.73 29.37 18.93 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.574 -0.957 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 172.25 12.95 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -107.37 33.97 3.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.503 -0.998 . . . . 0.0 109.508 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -122.98 -0.75 8.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.575 -0.703 . . . . 0.0 110.505 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -100.13 43.09 1.07 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 109.141 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.577 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.8 m-85 -106.45 -175.01 2.67 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.71 0.767 . . . . 0.0 109.061 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.644 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -122.66 126.6 47.94 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.06 87.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.688 -0.633 . . . . 0.0 110.637 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.624 ' HB2' HG13 ' A' ' 72' ' ' VAL . 14.1 tp -60.15 -51.82 67.95 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.695 HD13 ' CE2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -146.41 122.69 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.25 -177.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.531 -0.731 . . . . 0.0 110.073 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.94 135.71 55.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.558 -0.714 . . . . 0.0 109.187 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.422 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.4 p -105.74 123.41 47.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.78 -0.575 . . . . 0.0 109.597 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.7 p -85.25 109.81 18.61 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' CE1' ' HG2' ' A' ' 109' ' ' ARG . 26.7 m-85 -104.65 -49.19 3.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.422 -0.799 . . . . 0.0 110.209 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 22.0 mtp -121.21 172.67 7.82 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.718 0.77 . . . . 0.0 110.724 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -104.47 179.38 0.95 Allowed Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.261 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 95' ' ' SER . 42.7 Cg_endo -86.66 16.39 1.97 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.964 2.443 . . . . 0.0 111.341 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 t -120.12 -50.94 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.235 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.16 -12.9 61.71 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.559 -0.713 . . . . 0.0 110.111 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.6 t -58.79 -24.37 61.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.224 -0.922 . . . . 0.0 110.044 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -91.55 -73.17 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -163.07 37.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -84.82 -21.83 54.74 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.76 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.464 -1.021 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -167.94 95.78 0.61 Allowed Pre-proline 0 C--N 1.292 -1.912 0 O-C-N 121.814 -0.554 . . . . 0.0 109.51 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.21 -25.95 4.54 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.948 2.432 . . . . 0.0 110.265 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.6 119.41 25.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.738 -0.601 . . . . 0.0 109.786 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -147.08 174.43 11.57 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.3 m -135.95 166.68 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -154.73 153.88 31.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.452 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.43 156.99 39.73 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.48 0.657 . . . . 0.0 110.274 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE2' HD13 ' A' ' 88' ' ' LEU . 4.7 m-85 -118.08 167.45 11.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.65 -149.2 5.52 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.2 Cg_endo -74.94 -39.84 1.1 Allowed 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 123.692 2.928 . . . . 0.0 111.05 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.25 -27.87 68.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.533 -0.73 . . . . 0.0 109.833 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 2.0 mptp? -91.98 3.76 54.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.665 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.3 pp -123.46 139.86 53.59 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.022 -1.049 . . . . 0.0 110.549 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.904 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -60.42 130.62 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -74.46 -33.76 62.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.83 -21.17 66.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.446 -0.784 . . . . 0.0 110.271 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.904 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.68 -47.33 2.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 110.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.57 -37.4 17.78 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.16 -0.963 . . . . 0.0 111.626 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -81.92 3.08 27.68 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.745 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 1.1 mtpm? -95.52 136.22 36.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -67.11 113.38 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.497 -0.752 . . . . 0.0 110.712 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.48 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.7 m95 -117.43 163.76 15.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.44 14.98 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.113 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -142.3 142.48 32.54 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 178.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.726 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.7 p -136.61 143.03 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 110.366 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 46' ' ' VAL . 2.5 tttt -111.62 110.43 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.766 -0.584 . . . . 0.0 109.892 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.71 HD13 HG13 ' A' ' 70' ' ' VAL . 47.4 mm -101.82 129.46 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 44' ' ' SER . 28.0 t -130.98 130.01 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.184 -0.947 . . . . 0.0 110.591 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.481 ' HB3' HG13 ' A' ' 43' ' ' ILE . 9.7 t -99.71 149.23 23.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.779 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -150.26 118.77 6.48 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.609 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER 160.03 112.24 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.3 97.19 1.11 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.342 2.028 . . . . 0.0 108.725 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.527 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -103.62 -11.42 17.7 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.407 -178.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.76 -167.38 2.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.072 -1.017 . . . . 0.0 110.065 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -134.78 -47.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.746 -0.597 . . . . 0.0 109.631 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.601 ' C ' ' HB1' ' A' ' 38' ' ' ALA . 2.0 p30 -108.2 -13.37 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.536 -0.727 . . . . 0.0 110.925 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 35.5 p -99.07 138.46 20.61 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 121.265 -0.897 . . . . 0.0 109.861 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 140' ' ' SER . 43.1 Cg_endo -88.2 -177.67 1.91 Allowed 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.354 2.703 . . . . 0.0 110.502 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 174.52 -164.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 157.44 -115.24 0.65 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.206 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.564 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.9 mp -120.8 162.29 20.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.685 -0.891 . . . . 0.0 110.84 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 13.7 m -99.14 -27.81 13.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 53.4 p90 -178.05 171.2 1.76 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.479 -0.763 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 147' ' ' VAL . 35.7 m -149.01 123.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -130.26 110.92 11.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.726 ' CE2' HG11 ' A' ' 128' ' ' VAL . 85.9 m-85 -90.94 161.97 14.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.238 -0.914 . . . . 0.0 109.105 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -157.33 136.29 11.69 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -90.33 36.63 0.33 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.77 2.98 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -160.37 165.77 30.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.821 . . . . 0.0 109.35 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.666 ' CG2' HD12 ' A' ' 49' ' ' LEU . 61.4 mt -110.43 122.18 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.09 166.32 10.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.68 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.7 mp -103.93 160.19 15.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.697 -0.627 . . . . 0.0 109.557 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -110.23 -54.05 2.61 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -160.55 164.99 31.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -79.89 93.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.5 -0.75 . . . . 0.0 109.322 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG13 ' H ' ' A' ' 11' ' ' SER . 2.1 p -54.17 -58.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.246 -0.909 . . . . 0.0 110.272 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.514 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -121.03 151.67 39.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.314 -0.866 . . . . 0.0 109.196 -179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.5 p -143.83 124.3 13.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.995 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -121.5 46.21 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.534 -0.729 . . . . 0.0 109.586 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.676 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 153.09 77.83 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -143.18 143.05 31.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.243 -0.911 . . . . 0.0 109.114 -179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.25 -161.93 0.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.503 -0.748 . . . . 0.0 109.143 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 p -98.47 -57.37 2.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.591 -0.693 . . . . 0.0 109.436 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.573 -0.704 . . . . 0.0 109.136 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.67 66.31 4.42 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -82.67 171.94 13.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.53 -0.731 . . . . 0.0 109.893 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.836 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.37 -24.05 67.68 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.85 -19.28 63.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.697 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -65.78 -17.33 64.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.937 . . . . 0.0 109.322 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 33' ' ' TRP . 19.1 mt -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.5 mm? -62.06 -18.74 61.64 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.528 -0.732 . . . . 0.0 109.252 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.33 67.1 0.65 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.37 62.49 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.466 -0.771 . . . . 0.0 110.323 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.12 76.51 9.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.469 -0.769 . . . . 0.0 108.984 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 -154.2 0.37 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -130.71 36.48 3.9 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -142.5 121.51 12.86 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -113.19 -165.38 0.99 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 109.452 -179.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.717 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.4 t90 -81.9 139.67 34.53 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 125.19 16.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.64 148.83 6.64 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.474 -0.766 . . . . 0.0 110.359 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -59.91 -20.22 56.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.94 -0.475 . . . . 0.0 110.228 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -138.82 -171.77 3.16 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.354 -0.841 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.32 -161.9 0.91 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 63.83 43.55 97.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.939 -1.665 . . . . 0.0 108.939 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 2.1 mm-40 -48.47 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.959 0.885 . . . . 0.0 111.328 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -102.78 -50.73 3.46 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.717 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.4 p -158.86 115.39 2.7 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.676 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.3 pt -120.52 148.69 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.4 -0.812 . . . . 0.0 109.617 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.731 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -125.82 146.97 49.57 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.455 179.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.836 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.5 p -152.32 106.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 129' ' ' LYS . 10.8 t -92.38 121.03 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.68 HD22 ' CD2' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -98.72 160.17 14.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.33 131.77 53.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.679 -0.638 . . . . 0.0 109.667 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.666 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.2 mm? -82.03 138.22 34.92 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -81.14 38.95 0.49 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.537 -0.727 . . . . 0.0 110.503 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 pttm 161.63 132.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -75.94 107.62 8.26 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -138.15 179.36 6.49 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.445 0.641 . . . . 0.0 109.455 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -90.96 174.75 7.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.14 119.06 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.8 . . . . 0.0 109.677 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.436 ' O ' HD21 ' A' ' 116' ' ' LEU . 25.9 t60 -110.01 -29.31 8.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.5 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 5.1 m -145.53 154.42 42.17 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 149' ' ' PHE . 54.8 t -138.99 163.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.616 -0.677 . . . . 0.0 109.76 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.772 ' C ' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -145.06 125.83 14.29 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.772 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.3 mp -147.84 137.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.951 -1.093 . . . . 0.0 108.3 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.87 126.7 8.94 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.46 123.04 29.31 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 122.042 -0.681 . . . . 0.0 110.462 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -94.9 70.87 3.4 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.37 7.35 88.62 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -76.91 166.54 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -1.141 . . . . 0.0 109.603 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -127.91 -55.47 1.29 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -103.87 120.92 42.0 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.904 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.56 103.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 109.964 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 6.2 tt0 -86.88 147.04 25.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.415 0.626 . . . . 0.0 109.92 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG21 HD23 ' A' ' 88' ' ' LEU . 56.7 t -136.92 119.52 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.708 HD11 HG22 ' A' ' 86' ' ' VAL . 1.1 mp -114.72 164.54 13.92 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.743 HG11 HD13 ' A' ' 87' ' ' LEU . 13.6 m -127.93 163.33 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 110.351 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.56 170.28 37.56 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.4 t -114.01 160.27 19.04 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 122.027 -0.69 . . . . 0.0 109.213 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 t -92.25 12.82 21.08 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.8 -66.83 0.43 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.91 . . . . 0.0 109.917 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.7 55.82 0.56 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.55 88.23 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.78 84.48 7.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.932 . . . . 0.0 109.411 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.74 168.36 26.35 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -78.36 -2.08 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.655 -0.909 . . . . 0.0 110.488 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -97.13 25.47 5.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.968 . . . . 0.0 109.964 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -99.65 21.57 12.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.401 -0.812 . . . . 0.0 109.745 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.64 157.59 29.24 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' HG3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.0 145.91 42.58 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.273 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.708 HG22 HD11 ' A' ' 71' ' ' LEU . 43.6 t -65.8 90.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.534 -0.729 . . . . 0.0 110.763 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.743 HD13 HG11 ' A' ' 72' ' ' VAL . 1.2 tp -72.78 -58.43 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD23 HG21 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -117.6 117.55 29.7 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 90' ' ' THR . 2.8 t -61.79 171.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.617 -0.677 . . . . 0.0 109.174 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.54 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -64.24 132.67 50.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.84 121.09 39.34 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.1 p -87.19 93.13 9.29 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 25.0 m-85 -84.23 -52.93 5.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 110.403 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 22.2 mtp -121.33 -168.85 1.75 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.543 -0.723 . . . . 0.0 110.428 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.4 p -115.92 176.76 1.4 Allowed Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -86.62 14.86 2.33 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.041 2.494 . . . . 0.0 111.32 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 87.0 p -121.19 -37.69 2.91 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.206 -0.934 . . . . 0.0 110.001 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.88 -24.9 32.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -58.53 -20.73 48.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.734 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -69.32 -84.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.23 39.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 108.745 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.65 -18.27 5.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.97 123.52 0.11 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -1.17 . . . . 0.0 110.159 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 6.5 p30 41.59 66.82 3.55 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 122.066 -0.396 . . . . 0.0 111.504 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.61 -29.89 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.746 2.298 . . . . 0.0 110.488 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.44 103.3 6.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.687 -0.633 . . . . 0.0 109.601 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.55 174.98 8.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.752 . . . . 0.0 109.104 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.3 m -140.32 141.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 2.5 mmt-85 -134.35 176.99 8.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.3 mtt -142.08 178.56 7.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.697 -0.627 . . . . 0.0 109.842 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' HD21 ' A' ' 88' ' ' LEU . 1.3 m-85 -141.92 171.16 14.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -138.52 -148.05 5.26 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.5 Cg_endo -75.04 -36.63 2.42 Favored 'Trans proline' 0 N--CA 1.503 2.086 0 C-N-CA 123.595 2.863 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.84 -31.78 73.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -81.95 1.75 33.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.715 -0.615 . . . . 0.0 110.53 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.967 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -130.59 137.84 49.85 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.167 -0.958 . . . . 0.0 109.639 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.899 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.3 p -56.96 163.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 117' ' ' VAL . 3.6 mtp180 -97.78 -40.63 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.884 . . . . 0.0 109.142 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.02 -17.63 57.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 110.23 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.899 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.42 -50.81 2.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.35 -39.26 21.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.311 -0.868 . . . . 0.0 111.447 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -78.17 -1.85 34.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.354 -0.841 . . . . 0.0 110.656 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 23.2 mtpt -91.77 133.7 35.39 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -68.0 111.27 4.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.825 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.466 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 80.1 m95 -113.27 163.46 14.78 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -135.9 10.18 3.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.267 -0.895 . . . . 0.0 110.312 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 75' ' ' SER . 14.6 mtm180 -142.55 139.53 31.44 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.752 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.0 p -130.14 142.07 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 119.639 -0.825 . . . . 0.0 109.835 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.637 ' HG3' HG22 ' A' ' 46' ' ' VAL . 13.7 tttt -109.1 114.19 27.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.668 -0.645 . . . . 0.0 109.843 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 45' ' ' VAL . 47.9 mm -105.78 119.64 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.731 HG22 ' HB3' ' A' ' 44' ' ' SER . 44.1 t -124.92 117.94 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 O-C-N 121.208 -0.932 . . . . 0.0 110.057 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.461 ' HB3' HG13 ' A' ' 43' ' ' ILE . 7.0 t -89.14 142.72 27.4 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.717 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -141.26 124.81 16.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.717 -0.614 . . . . 0.0 110.6 -178.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.822 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 3.6 tp-100 158.33 131.51 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.446 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.35 93.22 0.66 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 123.021 2.481 . . . . 0.0 109.432 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.45 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.2 p90 -127.07 15.31 7.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.595 -0.69 . . . . 0.0 111.034 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.63 -169.57 3.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -176.06 -40.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.97 -36.41 4.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.547 0.689 . . . . 0.0 109.662 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.85 150.84 38.62 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.89 -0.506 . . . . 0.0 109.657 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.95 -171.42 0.96 Allowed 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.354 2.703 . . . . 0.0 110.623 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.85 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.574 ' O ' HD12 ' A' ' 144' ' ' LEU . . . 152.38 -113.5 0.58 Allowed Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.42 -1.371 . . . . 0.0 111.366 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.575 HD23 HG23 ' A' ' 60' ' ' ILE . 6.4 mp -124.08 151.51 43.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.732 -0.863 . . . . 0.0 110.992 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 48.9 m -86.45 -26.64 24.57 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.538 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 37.5 p90 -175.54 168.48 3.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.5 m -146.02 142.42 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.8 mtp85 -150.38 160.41 43.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.656 -0.653 . . . . 0.0 109.323 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CE2' HG11 ' A' ' 128' ' ' VAL . 38.7 m-85 -142.19 155.77 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.3 129.24 10.27 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.76 -0.587 . . . . 0.0 109.947 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.5 mmm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.2 Cg_endo -81.92 84.46 1.88 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.956 2.437 . . . . 0.0 110.372 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -133.79 171.05 14.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.575 -0.703 . . . . 0.0 109.422 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 151' ' ' SER . 55.3 mt -143.17 126.74 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.72 . . . . 0.0 109.433 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 177.75 4.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.705 -0.622 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.798 ' CD2' HD22 ' A' ' 47' ' ' LEU . 2.1 mp -107.14 161.07 15.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.635 -0.665 . . . . 0.0 109.858 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' C ' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -109.05 -57.71 2.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.686 -0.634 . . . . 0.0 109.31 179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -160.8 164.13 31.66 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -79.83 86.39 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG21 HH11 ' A' ' 127' ' ' ARG . 2.0 p -50.83 -57.16 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.302 -0.874 . . . . 0.0 110.391 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -125.7 153.51 43.79 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.6 p -149.09 146.04 27.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -135.78 46.58 2.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.764 -0.585 . . . . 0.0 109.644 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.658 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.9 m 153.19 92.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.64 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -158.36 142.8 15.97 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.133 -0.979 . . . . 0.0 109.519 179.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.13 -173.55 3.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.18 -0.95 . . . . 0.0 109.564 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -85.79 -65.35 1.02 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.559 -0.713 . . . . 0.0 109.383 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -56.08 22.47 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -97.01 76.65 2.7 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.0 p -92.42 169.04 10.87 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -63.43 -23.76 67.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.852 -0.53 . . . . 0.0 109.709 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.97 -16.83 60.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 109.857 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -64.52 -18.77 65.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.069 -1.019 . . . . 0.0 109.228 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 33' ' ' TRP . 9.2 mt -65.59 -24.97 67.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.471 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -59.19 -21.39 59.36 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -119.14 68.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.25 -24.79 7.9 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 29' ' ' THR . 10.3 m-20 -121.17 87.21 2.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.373 -0.829 . . . . 0.0 109.848 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.95 -87.29 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -177.57 34.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 0.0 109.73 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.73 142.79 12.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 109.273 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.7 mtmt -127.03 -164.9 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.471 -0.768 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.815 ' HB2' HD21 ' A' ' 24' ' ' LEU . 21.1 t90 -88.46 140.25 29.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.45 129.49 17.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -52.05 148.48 6.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.406 -0.809 . . . . 0.0 110.379 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -58.14 -23.7 56.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.811 -0.555 . . . . 0.0 110.251 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -139.19 -175.88 4.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.96 -166.64 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 64.12 48.0 79.61 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.2 mp0 -55.15 81.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.378 0.608 . . . . 0.0 111.026 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 39' ' ' GLY . 18.4 tttt -87.82 -53.49 4.73 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 133' ' ' SER . 37.6 p -155.8 114.92 3.54 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.687 HG21 ' HB2' ' A' ' 35' ' ' ALA . 12.5 pt -115.85 146.86 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.475 -0.766 . . . . 0.0 109.401 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.587 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -126.18 149.31 49.1 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.321 -0.951 . . . . 0.0 109.121 178.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.9 p -152.08 105.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.755 HG22 ' CG ' ' A' ' 129' ' ' LYS . 3.6 t -89.81 114.06 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.798 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.1 mp -96.35 163.92 12.87 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.587 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.16 136.39 48.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.692 -0.63 . . . . 0.0 109.876 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -84.8 134.22 34.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -70.91 20.25 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.381 -0.824 . . . . 0.0 112.284 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 pttt 176.61 124.11 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.714 -1.241 . . . . 0.0 108.967 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -59.19 102.12 0.12 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.628 ' OE2' HG23 ' A' ' 4' ' ' ILE . 10.7 pt-20 -137.21 -177.41 4.76 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.483 0.659 . . . . 0.0 110.121 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -96.39 -177.71 4.05 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.49 121.26 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.468 -0.77 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.428 ' O ' HD21 ' A' ' 116' ' ' LEU . 56.3 t60 -111.03 -29.3 7.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.697 -0.627 . . . . 0.0 109.344 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 2.8 m -148.08 146.31 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 149' ' ' PHE . 74.3 t -129.28 160.47 40.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.445 0.64 . . . . 0.0 109.751 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 2.7 m-20 -139.28 133.92 31.9 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 58' ' ' VAL . 0.9 OUTLIER -157.73 135.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -110.4 135.23 12.72 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.71 HD21 HG21 ' A' ' 68' ' ' VAL . 1.4 m-80 -88.04 132.66 34.19 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.138 -0.625 . . . . 0.0 110.739 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' N ' ' A' ' 145' ' ' SER . 7.0 t0 -113.22 58.18 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.31 -25.33 18.3 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 15.3 t -57.26 165.77 1.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -1.02 . . . . 0.0 109.908 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -133.72 -57.82 0.88 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' A' ' 133' ' ' SER . 22.1 m-85 -98.94 118.48 35.79 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.71 HG21 HD21 ' A' ' 62' ' ' ASN . 59.5 t -125.23 114.09 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.265 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.91 144.43 31.52 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.657 HG21 HD21 ' A' ' 88' ' ' LEU . 5.0 t -123.13 125.41 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.54 HD11 HG22 ' A' ' 86' ' ' VAL . 3.1 mp -112.09 161.31 16.65 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 87' ' ' LEU . 3.1 m -125.43 151.11 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.607 -0.683 . . . . 0.0 109.96 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -173.25 166.81 39.37 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.3 t -115.93 157.12 25.01 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.981 -0.717 . . . . 0.0 109.552 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.7 t -88.05 10.42 19.17 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.46 107.56 0.81 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.9 -74.44 0.48 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.4 166.17 12.38 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.64 -45.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.668 -0.901 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.08 161.08 11.55 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.55 -26.51 68.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.517 -0.99 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.67 29.43 3.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 0.0 109.707 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.46 28.4 8.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.481 -0.762 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' HB2' HD23 ' A' ' 71' ' ' LEU . 3.6 m-85 -104.83 -173.53 2.32 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -125.19 137.94 54.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.089 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 71' ' ' LEU . 37.1 t -66.22 87.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.573 -0.705 . . . . 0.0 110.727 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.691 HD13 HG11 ' A' ' 72' ' ' VAL . 11.1 tp -58.27 -47.76 82.61 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HG21 ' A' ' 70' ' ' VAL . 1.8 pp -143.18 120.76 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.393 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.499 ' O ' HD12 ' A' ' 88' ' ' LEU . 31.5 m -50.42 174.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 0.0 110.587 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -63.91 138.09 58.32 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.573 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 3.8 p -105.89 123.32 47.78 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -87.67 104.26 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 91' ' ' SER . 23.7 m-85 -100.38 -46.55 5.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.309 -0.869 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.7 mtp -120.16 -170.95 2.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.294 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.2 p -126.66 -179.62 0.97 Allowed Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.86 9.42 4.15 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.882 2.388 . . . . 0.0 111.328 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.3 p -114.08 -55.08 2.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -63.0 -20.2 65.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.601 -0.687 . . . . 0.0 109.973 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -56.59 -27.26 57.63 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.239 -0.913 . . . . 0.0 110.141 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -87.73 -74.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 110.009 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.22 37.52 0.1 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.08 -24.06 35.96 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.493 -1.004 . . . . 0.0 110.368 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 88.95 35.45 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.13 -18.63 16.23 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.959 2.439 . . . . 0.0 110.27 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.39 115.35 11.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.669 -0.644 . . . . 0.0 109.734 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -144.72 160.31 41.42 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 m -120.94 163.85 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.405 -0.809 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -152.55 159.12 43.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.39 -0.819 . . . . 0.0 109.374 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 23.4 mtp -130.08 162.57 28.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.626 -0.671 . . . . 0.0 110.113 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 2.6 m-85 -127.32 165.99 18.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -135.52 -150.11 5.93 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.542 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.2 Cg_endo -75.68 -37.98 1.5 Allowed 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.655 2.904 . . . . 0.0 110.731 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -65.4 -28.27 69.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.501 -0.749 . . . . 0.0 109.57 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -89.34 1.51 55.69 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.649 -0.657 . . . . 0.0 110.589 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.997 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -124.21 139.89 53.49 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.037 -1.039 . . . . 0.0 109.921 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.894 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.1 p -59.22 133.4 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -75.8 -29.99 58.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.487 -0.758 . . . . 0.0 109.338 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.32 -23.23 64.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.598 -0.688 . . . . 0.0 109.977 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.894 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -112.29 -45.55 3.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.997 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.67 -40.57 28.49 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.215 -0.928 . . . . 0.0 111.291 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -77.86 -3.03 39.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.756 . . . . 0.0 110.547 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 125' ' ' TRP . 26.5 mtpt -90.31 132.92 35.29 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -67.62 109.59 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.544 0.688 . . . . 0.0 110.73 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.431 ' CD1' ' O ' ' A' ' 123' ' ' LYS . 87.3 m95 -109.09 164.03 12.79 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.5 6.63 3.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.525 HH11 HG21 ' A' ' 10' ' ' VAL . 35.8 mtm180 -145.99 145.9 30.8 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.74 -1.225 . . . . 0.0 107.919 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.88 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.9 p -132.73 142.46 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.348 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.755 ' CG ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -105.09 116.17 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.754 -0.591 . . . . 0.0 109.797 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 45' ' ' VAL . 51.4 mm -108.07 119.53 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 44' ' ' SER . 30.6 t -124.7 122.89 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 121.138 -0.976 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.508 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -97.22 142.46 29.09 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -141.6 123.37 15.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.712 -0.618 . . . . 0.0 110.375 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.833 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 35.1 tp60 156.84 123.24 0.0 OUTLIER Pre-proline 0 N--CA 1.511 2.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.53 104.55 1.74 Allowed 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.682 2.255 . . . . 0.0 108.884 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 2.0 p90 -132.0 -10.58 3.4 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.568 -177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.76 126.38 14.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.839 -1.163 . . . . 0.0 109.513 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -110.39 -26.58 9.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.843 -0.536 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.58 -43.66 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 110.262 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.09 145.74 32.38 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.822 -0.549 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 43.2 Cg_endo -87.03 166.19 8.38 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.33 2.687 . . . . 0.0 110.409 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -176.85 -165.79 0.13 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 164.98 -102.63 0.2 Allowed Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 147' ' ' VAL . 5.6 mp -115.26 155.43 27.26 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.575 -0.956 . . . . 0.0 110.604 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 23.6 m -89.49 -27.51 20.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.531 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 50.1 p90 -178.09 162.31 1.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.6 m -138.64 141.29 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 12.0 mtp180 -145.79 160.63 41.48 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.478 0.656 . . . . 0.0 110.342 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.88 ' CE2' HG11 ' A' ' 128' ' ' VAL . 54.6 m-85 -142.24 156.88 45.32 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.443 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -157.01 136.73 12.37 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.162 -0.961 . . . . 0.0 109.7 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.776 ' HB3' HD11 ' A' ' 4' ' ' ILE . 4.9 p . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.95 144.85 7.41 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.599 2.866 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.1 169.09 24.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.522 -0.737 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.448 HD13 ' OE1' ' A' ' 53' ' ' GLU . 62.2 mt -125.09 123.76 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -105.2 161.02 14.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.733 -0.604 . . . . 0.0 109.658 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' CD2' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -95.73 151.43 19.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.468 ' C ' HD11 ' A' ' 25' ' ' LEU . 43.3 ttt85 -103.93 -54.32 2.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.66 -0.65 . . . . 0.0 109.383 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.407 ' CE1' ' HD3' ' A' ' 7' ' ' ARG . 4.9 p-80 -160.54 166.49 28.97 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -83.69 93.97 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.772 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 11' ' ' SER . 1.5 p -53.15 -60.13 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.131 -0.981 . . . . 0.0 110.16 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.512 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -122.1 155.49 35.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.0 -179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.4 p -153.24 105.63 2.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.257 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -105.94 56.46 0.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 43' ' ' ILE . 1.2 p 153.46 67.22 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.55 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -132.97 139.64 47.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.734 -1.229 . . . . 0.0 110.145 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.83 148.57 22.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 109.326 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.6 t -61.14 -52.86 63.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.582 -0.699 . . . . 0.0 110.155 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -58.55 8.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.344 -0.847 . . . . 0.0 109.121 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -110.16 86.99 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.3 p -92.29 166.65 12.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.552 0.692 . . . . 0.0 110.359 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.54 -23.52 67.03 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.3 tt0 -61.96 -18.44 60.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.339 -0.85 . . . . 0.0 109.724 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -65.27 -17.51 64.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.256 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 33' ' ' TRP . 10.0 mt -65.09 -25.68 67.9 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD11 ' C ' ' A' ' 7' ' ' ARG . 4.4 mm? -58.09 -22.41 50.52 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.491 -0.756 . . . . 0.0 109.002 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -115.36 67.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.51 -25.83 4.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.739 . . . . 0.0 110.6 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' THR . 31.3 m-20 -122.03 88.78 3.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.434 -0.791 . . . . 0.0 109.796 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -157.98 -88.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.583 -0.698 . . . . 0.0 109.236 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 44.2 p90 -178.16 35.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.118 -0.989 . . . . 0.0 109.614 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 28.5 mtm180 -157.17 137.53 12.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.474 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 1.2 mtmp? -120.53 -176.87 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.616 -0.677 . . . . 0.0 109.571 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.761 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.7 t90 -78.51 138.18 38.29 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -141.66 128.32 20.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -54.21 168.03 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.691 0.758 . . . . 0.0 111.21 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -79.16 -30.52 43.57 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.139 0.495 . . . . 0.0 109.686 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -120.36 -172.16 2.31 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.2 -165.23 1.1 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 62.15 45.29 96.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 136' ' ' TYR . 1.3 mp0 -43.74 89.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.487 0.66 . . . . 0.0 112.075 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 42' ' ' THR . 10.6 pttt -103.02 -44.21 5.29 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.726 HG22 ' OG ' ' A' ' 133' ' ' SER . 7.3 p -160.51 132.36 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.761 HD12 ' CH2' ' A' ' 33' ' ' TRP . 6.0 pt -137.73 136.03 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.418 -0.801 . . . . 0.0 110.204 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -112.22 140.84 46.59 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.462 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.754 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -147.41 106.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 128' ' ' VAL . 10.8 t -91.36 121.53 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.673 HD22 ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -100.42 168.98 9.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -114.14 148.07 37.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.712 -0.617 . . . . 0.0 109.649 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.522 HD12 ' CA ' ' A' ' 126' ' ' ASP . 18.1 mt -101.73 137.57 39.87 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -80.75 40.2 0.51 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.37 -0.831 . . . . 0.0 110.909 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 1.7 pttm 161.32 130.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 14.4 tt0 -75.55 110.6 10.07 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -140.25 -179.49 6.02 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -91.01 178.14 6.09 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.415 HD13 HG11 ' A' ' 72' ' ' VAL . 4.4 mp -127.76 115.71 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.42 ' CD2' ' HB3' ' A' ' 113' ' ' PRO . 13.1 t-160 -103.4 -30.83 10.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -148.1 159.03 44.34 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 149' ' ' PHE . 83.8 t -141.91 158.23 20.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.48 0.657 . . . . 0.0 109.389 -179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 148' ' ' ARG . 1.3 m-20 -140.13 137.89 34.81 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.631 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -158.25 130.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 146' ' ' PHE . . . -102.8 132.33 10.96 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -90.7 126.72 36.07 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.301 -0.529 . . . . 0.0 110.366 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -97.7 64.06 1.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.64 -16.93 60.26 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 72.0 m -55.57 158.2 3.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.33 -1.1 . . . . 0.0 110.322 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -119.64 -58.65 1.88 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 133' ' ' SER . 19.5 m-85 -99.61 129.99 45.8 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.946 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 60' ' ' ILE . 53.8 t -130.43 111.84 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.694 -0.629 . . . . 0.0 109.692 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -105.63 146.28 29.9 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.726 HG22 ' CD1' ' A' ' 130' ' ' ILE . 22.0 t -135.79 126.56 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.57 -0.706 . . . . 0.0 109.84 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.59 160.46 18.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.659 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.2 m -121.49 157.82 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.789 -0.569 . . . . 0.0 109.894 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 178.18 172.45 42.61 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 t -114.04 158.78 20.76 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 122.041 -0.682 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 m -73.43 -4.97 36.91 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.797 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.95 153.98 16.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.1 87.98 0.04 OUTLIER Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.2 160.55 16.32 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.31 37.28 20.37 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.538 -0.978 . . . . 0.0 109.517 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.06 -100.67 0.09 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 64.56 140.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.67 -0.9 . . . . 0.0 109.328 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 58.4 21.8 8.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.454 -0.778 . . . . 0.0 109.965 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -133.09 34.1 3.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 109.197 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.4 m-85 -101.36 -173.26 2.32 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.659 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -121.1 130.58 53.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.28 85.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.767 -0.583 . . . . 0.0 110.366 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.626 ' HB2' HG13 ' A' ' 72' ' ' VAL . 15.3 tp -58.03 -59.81 4.7 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.1 pp -137.8 120.49 16.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.5 m -53.33 179.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.509 -0.745 . . . . 0.0 110.325 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 134.4 53.58 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.601 -0.687 . . . . 0.0 109.153 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . 5.1 p -107.87 125.85 51.96 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.441 0.639 . . . . 0.0 109.769 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 84.9 p -83.7 127.83 34.07 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CG ' ' HD3' ' A' ' 109' ' ' ARG . 22.8 m-85 -120.95 -48.21 2.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 110.287 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.432 ' HE3' ' O ' ' A' ' 104' ' ' ASN . 81.4 mtp -121.95 -176.83 3.43 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.933 0.873 . . . . 0.0 111.352 -178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.1 p -120.55 173.93 3.37 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.57 9.48 4.08 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.911 2.407 . . . . 0.0 111.315 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.0 m -120.77 -35.03 3.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.196 -0.94 . . . . 0.0 110.228 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -82.35 -21.67 35.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 110.316 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 82.9 p -58.23 -22.13 50.86 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.411 -0.805 . . . . 0.0 110.425 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -67.96 -83.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.367 -0.833 . . . . 0.0 109.338 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 t -162.45 39.2 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -113.74 -22.38 5.4 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.26 118.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -1.135 . . . . 0.0 110.396 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.432 ' O ' ' HE3' ' A' ' 94' ' ' MET . 0.8 OUTLIER 41.21 77.44 0.43 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.929 -0.482 . . . . 0.0 111.366 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.12 -28.55 2.39 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.05 2.5 . . . . 0.0 109.993 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.41 92.85 2.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.754 -0.591 . . . . 0.0 109.428 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.0 mtt-85 -123.89 -176.13 3.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.541 -0.724 . . . . 0.0 109.332 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.7 m -134.6 158.33 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.56 -0.713 . . . . 0.0 109.846 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' ' CG ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.94 159.78 41.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.8 mtm -135.57 166.23 23.7 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.0 110.295 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.703 ' CD2' HD13 ' A' ' 88' ' ' LEU . 2.0 m-85 -129.46 169.63 14.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -140.12 -148.57 5.19 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.502 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.3 Cg_endo -74.7 -39.6 1.31 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.674 2.916 . . . . 0.0 111.146 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.37 -28.83 69.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.493 -0.754 . . . . 0.0 109.648 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.41 2.59 54.26 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.658 -0.651 . . . . 0.0 110.598 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.952 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.1 pp -123.51 138.76 54.5 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.05 -1.031 . . . . 0.0 110.38 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 9.2 p -59.37 130.34 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -33.44 63.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.786 . . . . 0.0 109.506 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.95 66.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.334 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -116.96 -46.68 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 110.162 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.952 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.73 -38.55 21.92 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.143 -0.973 . . . . 0.0 111.444 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.14 0.6 31.53 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 110.706 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 19.2 mtpp -92.54 135.81 33.75 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.41 113.2 5.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.744 0.783 . . . . 0.0 110.753 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.479 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 79.3 m95 -115.84 165.97 12.49 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.522 ' CA ' HD12 ' A' ' 49' ' ' LEU . 3.8 p30 -140.68 15.5 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.132 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.447 ' HD3' HG11 ' A' ' 10' ' ' VAL . 13.4 mtt180 -145.5 147.58 32.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG11 ' CE2' ' A' ' 149' ' ' PHE . 6.5 p -137.3 142.14 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.105 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.465 ' HG3' HG22 ' A' ' 46' ' ' VAL . 4.3 tttt -110.88 108.43 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.668 -0.645 . . . . 0.0 109.729 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.726 ' CD1' HG22 ' A' ' 70' ' ' VAL . 48.4 mm -101.96 127.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 44' ' ' SER . 61.0 t -132.47 115.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.522 ' HB3' HG13 ' A' ' 43' ' ' ILE . 3.1 t -85.55 149.68 25.2 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.726 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -148.9 122.9 9.41 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.264 -178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER 157.73 129.88 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -85.45 94.68 0.62 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.008 2.472 . . . . 0.0 110.255 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' SER . 0.9 OUTLIER -121.62 -17.55 7.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.401 -0.812 . . . . 0.0 111.285 -179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.48 169.49 8.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.462 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 24.9 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.793 -0.567 . . . . 0.0 109.634 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.79 -46.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.6 146.35 32.44 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -86.58 169.28 8.19 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 123.432 2.755 . . . . 0.0 110.898 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 179.49 -164.24 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.86 -105.93 0.26 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.193 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 60' ' ' ILE . 5.6 mp -115.79 154.67 29.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.607 -0.937 . . . . 0.0 110.716 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 49.2 m -87.34 -27.99 22.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 52.6 p90 -179.24 167.67 1.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.514 -0.741 . . . . 0.0 109.509 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 24' ' ' LEU . 33.5 m -142.46 131.4 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 14.7 mtt180 -139.07 121.66 16.28 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.5 -0.75 . . . . 0.0 110.028 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.694 ' CD1' HG13 ' A' ' 58' ' ' VAL . 67.5 m-85 -104.36 156.68 17.71 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.109 -0.995 . . . . 0.0 109.41 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -150.97 131.28 13.65 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.317 -0.865 . . . . 0.0 109.714 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.704 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.56 58.56 3.99 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.457 2.772 . . . . 0.0 110.508 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.6 177.5 10.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.461 -0.774 . . . . 0.0 109.309 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' CG2' HD12 ' A' ' 49' ' ' LEU . 72.1 mt -117.67 124.71 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -104.78 164.8 11.51 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.455 0.645 . . . . 0.0 110.084 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.775 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -97.53 127.63 43.64 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.642 ' N ' HD13 ' A' ' 6' ' ' LEU . 3.7 ttt180 -82.11 -56.89 3.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.379 -0.825 . . . . 0.0 109.584 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.93 165.1 30.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.659 -0.651 . . . . 0.0 109.409 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -81.29 90.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.461 -0.774 . . . . 0.0 109.307 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.731 HG21 ' NH1' ' A' ' 127' ' ' ARG . 1.8 p -54.37 -58.28 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.487 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -118.04 143.47 46.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.31 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.1 p -130.81 124.03 30.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -0.796 . . . . 0.0 109.711 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 14' ' ' SER . 2.3 m -124.59 42.24 3.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.657 -0.652 . . . . 0.0 109.557 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.649 ' OG ' HG22 ' A' ' 43' ' ' ILE . 1.3 m 153.93 76.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -146.64 141.46 26.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 108.987 -179.361 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.51 -164.49 1.18 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.336 -0.853 . . . . 0.0 109.071 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -64.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -49.22 76.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 109.067 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.04 73.7 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.9 p -91.71 168.86 11.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.503 -0.748 . . . . 0.0 110.095 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -64.67 -23.01 67.12 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.616 ' HG3' HG12 ' A' ' 9' ' ' VAL . 1.6 tt0 -63.87 -17.49 63.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.525 179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.8 -17.8 64.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 109.286 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 33' ' ' TRP . 21.1 mt -65.17 -24.28 67.34 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 25' ' ' LEU . 4.6 mm? -58.54 -22.35 55.22 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.526 -0.734 . . . . 0.0 109.055 178.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -107.67 61.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.14 -25.23 4.92 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.425 -0.797 . . . . 0.0 110.708 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -118.35 76.58 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 -179.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 28' ' ' ASP . 5.4 p -156.42 -95.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.774 . . . . 0.0 109.075 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -178.4 36.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.391 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -141.75 138.02 32.02 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 11.1 mttm -128.66 -178.69 4.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.422 -0.799 . . . . 0.0 110.807 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.704 ' CH2' HD12 ' A' ' 43' ' ' ILE . 21.8 t90 -80.98 140.46 35.2 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.43 129.07 17.13 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -50.37 150.8 2.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.496 -0.752 . . . . 0.0 110.909 -179.071 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -62.25 -26.56 68.45 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -169.79 2.09 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -104.11 178.77 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.507 -0.746 . . . . 0.0 109.481 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.73 -30.74 8.78 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 18.4 mm-40 40.67 31.34 0.11 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.969 -0.724 . . . . 0.0 112.526 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 42' ' ' THR . 0.0 OUTLIER -51.57 -52.94 43.17 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.696 -0.627 . . . . 0.0 109.316 179.38 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.594 HG22 ' OG ' ' A' ' 133' ' ' SER . 8.9 p -160.32 129.43 4.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.704 HD12 ' CH2' ' A' ' 33' ' ' TRP . 13.1 pt -130.2 141.72 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.86 . . . . 0.0 110.322 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.581 ' OG ' HG13 ' A' ' 131' ' ' VAL . 29.5 m -126.06 141.22 52.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.293 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.703 HG21 ' HB1' ' A' ' 21' ' ' ALA . 10.4 p -146.27 110.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.468 HG22 ' HD2' ' A' ' 129' ' ' LYS . 2.7 t -90.42 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.775 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.2 mp -100.09 157.6 16.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -99.89 145.58 27.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.751 -0.593 . . . . 0.0 109.834 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -97.96 140.35 32.44 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -79.28 33.81 0.24 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.417 -0.802 . . . . 0.0 111.115 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' CE ' ' HG2' ' A' ' 53' ' ' GLU . 2.4 pttm 161.22 138.39 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 10.0 tt0 -75.16 102.48 4.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -131.35 165.74 22.8 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.7 0.762 . . . . 0.0 109.786 -179.163 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.724 ' O ' HD13 ' A' ' 55' ' ' ILE . 15.9 mt-30 -76.15 -176.96 3.75 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 54' ' ' GLN . 1.9 mm -128.93 174.89 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.403 -0.81 . . . . 0.0 108.891 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.701 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.9 t60 -172.53 -41.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.506 -0.746 . . . . 0.0 109.199 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.1 m -145.27 145.76 31.39 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 60' ' ' ILE . 83.5 t -130.64 163.36 36.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.665 0.745 . . . . 0.0 110.31 -178.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.487 ' N ' HG12 ' A' ' 58' ' ' VAL . 11.8 t0 -133.5 131.97 40.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.692 HD12 HG12 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -154.46 129.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.664 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -99.36 122.71 7.66 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -74.92 117.92 17.3 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 122.13 -0.629 . . . . 0.0 110.145 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -102.2 73.76 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.95 21.91 72.91 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.394 -1.883 . . . . 0.0 108.394 -177.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 1.8 p -96.98 152.89 18.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.998 . . . . 0.0 109.857 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 134' ' ' GLN . . . -114.36 -54.79 2.56 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -106.6 132.3 52.76 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.52 -0.738 . . . . 0.0 109.969 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -133.39 112.16 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.476 -0.765 . . . . 0.0 109.832 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -107.54 146.52 31.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.749 -0.595 . . . . 0.0 109.546 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 130' ' ' ILE . 23.6 t -133.6 128.85 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.602 -0.686 . . . . 0.0 109.933 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 129' ' ' LYS . 2.7 mp -115.03 158.84 21.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.792 ' CG1' HD22 ' A' ' 87' ' ' LEU . 5.4 m -119.6 154.48 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.47 173.36 46.02 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.6 t -114.71 155.47 26.59 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.98 -0.718 . . . . 0.0 109.831 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.9 p -63.67 -14.0 48.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.36 150.08 46.99 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.39 -0.819 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.95 -96.18 0.75 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 174.25 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.57 -55.12 16.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.569 -0.96 . . . . 0.0 109.554 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.75 51.67 3.96 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -110.72 -62.88 1.47 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.62 -0.93 . . . . 0.0 109.358 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -100.99 30.66 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.578 -0.701 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -116.16 30.3 7.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.578 -0.702 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -120.05 154.07 35.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.701 ' HG2' ' HB2' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -106.21 145.06 32.04 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.73 84.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.581 -0.7 . . . . 0.0 110.751 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.792 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.7 tp -57.57 -59.62 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 111' ' ' PHE . 1.8 pp -136.05 121.44 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.312 178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.428 ' O ' HD12 ' A' ' 88' ' ' LEU . 29.8 m -54.07 -179.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.663 -0.648 . . . . 0.0 110.178 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.14 135.31 51.93 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.241 -179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -104.62 127.69 52.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -85.33 95.72 9.31 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 109' ' ' ARG . 16.6 m-85 -87.3 -52.43 5.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.591 -0.693 . . . . 0.0 109.693 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 18.3 mtp -120.68 -172.65 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.654 -0.654 . . . . 0.0 110.187 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 p -120.12 179.72 0.85 Allowed Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -85.88 13.25 2.8 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.154 2.569 . . . . 0.0 111.47 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 m -120.03 -53.26 2.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -63.68 -16.03 59.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 110.153 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -56.72 -21.01 24.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.828 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -87.6 0.13 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.181 -0.95 . . . . 0.0 110.362 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 44.6 t -162.03 38.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.102 -0.999 . . . . 0.0 108.655 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -96.35 -20.72 24.35 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.89 -79.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.439 -1.036 . . . . 0.0 110.52 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.36 88.26 25.67 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -78.95 -20.54 10.16 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 123.032 2.488 . . . . 0.0 110.622 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.1 128.64 40.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.65 -0.656 . . . . 0.0 109.852 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.85 172.73 17.94 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 2.2 m -140.16 136.59 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.382 -0.824 . . . . 0.0 109.399 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 1.5 mmp_? -133.86 -179.23 5.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 110.282 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 14.6 mtm -141.99 178.34 7.59 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.391 0.615 . . . . 0.0 109.675 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' PHE . 9.5 m-85 -135.43 166.82 22.28 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 116' ' ' LEU . . . -143.03 -153.86 5.99 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.974 -2.051 . . . . 0.0 107.974 178.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.79 ' HA ' HD23 ' A' ' 116' ' ' LEU . 38.1 Cg_endo -74.3 -27.93 10.99 Favored 'Trans proline' 0 N--CA 1.504 2.136 0 C-N-CA 123.58 2.853 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -51.87 -42.45 62.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.698 -0.626 . . . . 0.0 110.774 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -106.9 9.54 30.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.495 -0.753 . . . . 0.0 111.165 -179.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -116.36 122.19 44.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 0.0 108.536 -179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.909 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 7.6 p -50.0 134.49 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.783 -0.573 . . . . 0.0 110.77 -177.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.6 mtt-85 -69.2 -41.09 77.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.557 -0.714 . . . . 0.0 109.357 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.47 78.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.554 -0.716 . . . . 0.0 110.508 -179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.909 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -93.17 -35.25 13.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.448 -0.783 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.704 ' CB ' HD11 ' A' ' 116' ' ' LEU . . . -46.62 -30.72 2.44 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.518 -0.739 . . . . 0.0 110.789 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 16.75 24.59 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.485 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' NE1' ' A' ' 125' ' ' TRP . 4.3 mmtm -96.77 132.11 42.81 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -66.06 103.66 1.0 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.191 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.443 ' NE1' ' HB2' ' A' ' 123' ' ' LYS . 69.8 m95 -108.09 150.03 27.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 52' ' ' GLU . 4.7 t0 -128.84 4.12 5.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.697 -0.627 . . . . 0.0 109.694 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NH1' HG21 ' A' ' 10' ' ' VAL . 3.8 mtt180 -141.76 149.58 40.63 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.8 p -140.36 140.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.187 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD2' HG22 ' A' ' 46' ' ' VAL . 3.5 tttm -106.16 116.74 32.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.703 -0.623 . . . . 0.0 109.747 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.582 ' CD1' HG13 ' A' ' 70' ' ' VAL . 46.5 mm -107.59 111.55 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.581 HG13 ' OG ' ' A' ' 44' ' ' SER . 40.9 t -119.58 120.33 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.414 ' HB3' HG13 ' A' ' 43' ' ' ILE . 43.0 t -95.68 149.03 21.92 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.594 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -142.94 130.66 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.459 -0.775 . . . . 0.0 111.19 -178.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.803 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 0.8 OUTLIER 149.48 129.07 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.751 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.406 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.24 100.38 0.7 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.831 2.354 . . . . 0.0 109.659 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.511 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 1.2 p90 -131.66 40.35 3.4 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.739 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.68 -168.84 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 109.45 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.79 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -106.84 -35.84 6.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -107.07 142.21 24.55 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 41.5 Cg_endo -85.93 -176.1 2.06 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.174 2.582 . . . . 0.0 110.82 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 178.76 -162.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.616 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.14 -112.89 0.56 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.471 -1.347 . . . . 0.0 111.099 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.554 ' CD2' HG23 ' A' ' 60' ' ' ILE . 5.6 mp -114.2 158.86 20.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.567 -0.961 . . . . 0.0 110.75 -178.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.422 ' HA ' ' HB3' ' A' ' 32' ' ' LYS . 2.4 m -97.62 -28.45 13.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 122.042 -0.411 . . . . 0.0 109.958 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 61' ' ' GLY . 43.5 p90 -176.38 171.88 2.34 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.693 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.446 HG12 HG13 ' A' ' 60' ' ' ILE . 20.7 m -150.17 137.6 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.695 -0.628 . . . . 0.0 109.493 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 59' ' ' ASP . 11.3 mmm-85 -144.04 108.55 4.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.531 -0.731 . . . . 0.0 109.102 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 128' ' ' VAL . 56.1 m-85 -87.31 155.03 20.23 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.338 -0.852 . . . . 0.0 109.354 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -155.46 124.93 6.34 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.495 -0.753 . . . . 0.0 109.363 178.715 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.67 -0.644 . . . . 0.0 110.474 -179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 4.9 mtt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 1' ' ' MET . 43.1 Cg_endo -82.15 -27.68 2.29 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.913 2.409 . . . . 0.0 110.473 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.36 168.47 11.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.534 -0.729 . . . . 0.0 109.475 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.746 ' CG2' HD12 ' A' ' 49' ' ' LEU . 79.5 mt -142.27 146.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.03 167.04 15.87 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.933 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.669 HD21 ' CB ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -95.61 136.8 35.54 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.722 -0.611 . . . . 0.0 109.461 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.602 ' N ' HD13 ' A' ' 6' ' ' LEU . 66.8 ttt180 -92.6 -56.42 3.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.805 . . . . 0.0 109.104 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.429 ' CD2' ' CB ' ' A' ' 48' ' ' GLN . 4.1 p-80 -161.33 162.99 31.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.3 p -79.14 91.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.534 HG12 ' C ' ' A' ' 47' ' ' LEU . 2.4 p -50.79 -55.99 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.317 -0.864 . . . . 0.0 110.47 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -122.14 153.37 38.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.415 -0.803 . . . . 0.0 109.372 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -136.74 120.36 17.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.424 -0.798 . . . . 0.0 109.509 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.8 m -123.56 42.02 3.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.806 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER 152.75 72.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.321 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.691 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -136.48 140.95 43.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.336 -0.852 . . . . 0.0 109.431 -179.052 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -165.92 1.44 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 108.988 179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 t -101.74 -55.51 2.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.64 -42.78 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -121.34 80.36 1.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 24.3 p -91.5 168.78 11.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.594 0.712 . . . . 0.0 110.042 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.12 -24.32 67.08 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.928 -0.483 . . . . 0.0 109.993 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HG3' HG12 ' A' ' 9' ' ' VAL . 3.7 tt0 -62.37 -18.54 61.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.288 -0.882 . . . . 0.0 109.835 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -65.37 -17.27 64.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.77 ' HB3' HG22 ' A' ' 147' ' ' VAL . 11.2 mt -64.91 -24.85 67.65 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 HD13 ' HB3' ' A' ' 6' ' ' LEU . 4.5 mm? -57.97 -22.46 49.29 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.498 -0.751 . . . . 0.0 109.039 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.2 65.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.57 -24.41 13.62 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.394 -0.816 . . . . 0.0 110.406 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.59 ' O ' HG23 ' A' ' 29' ' ' THR . 0.9 OUTLIER -119.33 81.36 1.7 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.487 -0.758 . . . . 0.0 109.634 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.4 p -158.1 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.521 -0.737 . . . . 0.0 109.437 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -177.84 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -158.39 167.7 28.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.553 -0.717 . . . . 0.0 109.446 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' CB ' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -160.32 -157.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.673 -0.642 . . . . 0.0 109.565 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.693 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 15.5 t90 -93.69 140.45 29.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.083 -1.01 . . . . 0.0 110.379 -179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -146.83 123.06 10.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -48.85 154.6 0.69 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.451 -0.781 . . . . 0.0 111.399 -178.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.691 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -66.66 -30.04 70.21 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -123.45 -172.1 2.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.73 -162.38 0.93 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.75 43.34 94.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 3.8 mm-40 -48.14 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.986 0.898 . . . . 0.0 111.364 -179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 42' ' ' THR . 8.8 pttp -111.62 -44.82 3.44 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.674 HG22 ' OG ' ' A' ' 133' ' ' SER . 11.1 p -160.39 119.87 2.76 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.806 HG22 ' OG ' ' A' ' 14' ' ' SER . 11.4 pt -128.02 147.39 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.507 -0.746 . . . . 0.0 109.355 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.584 ' OG ' HG22 ' A' ' 131' ' ' VAL . 31.5 m -128.23 147.6 50.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.281 -0.968 . . . . 0.0 109.661 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.782 HG21 ' HB1' ' A' ' 21' ' ' ALA . 11.0 p -154.29 117.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 128' ' ' VAL . 5.5 t -95.53 130.14 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.218 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.669 ' CB ' HD21 ' A' ' 6' ' ' LEU . 2.3 mt -102.61 167.4 9.94 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 8' ' ' HIS . 12.2 tm0? -121.6 118.62 29.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.734 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.746 HD12 ' CG2' ' A' ' 4' ' ' ILE . 4.1 mm? -71.0 138.46 49.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -81.15 36.53 0.41 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.766 -0.584 . . . . 0.0 110.133 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 pttt 166.73 129.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -75.44 109.47 9.02 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.494 ' OE1' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -142.42 176.28 9.12 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.621 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -86.35 -174.24 4.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -141.26 130.29 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.657 0.741 . . . . 0.0 109.39 179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.433 ' O ' HD21 ' A' ' 116' ' ' LEU . 4.6 t60 -119.57 -25.08 6.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 150' ' ' HIS . 3.2 m -149.87 140.24 22.33 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' CD1' ' A' ' 149' ' ' PHE . 55.2 t -125.04 160.71 30.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.1 m-20 -140.74 135.06 31.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.506 -0.746 . . . . 0.0 109.416 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.625 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.4 mp -155.96 131.84 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -107.94 120.83 6.16 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.017 -1.564 . . . . 0.0 110.264 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.653 HD21 HG21 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -69.75 142.57 53.24 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.458 0.647 . . . . 0.0 111.11 -179.038 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 23.8 t0 -127.13 56.25 1.53 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.7 -26.96 12.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -177.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t -57.75 170.16 0.63 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.49 -1.006 . . . . 0.0 109.73 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.764 ' HB3' ' HG3' ' A' ' 134' ' ' GLN . . . -135.16 -56.83 0.81 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.461 ' CE2' ' HG2' ' A' ' 134' ' ' GLN . 24.3 m-85 -100.04 133.41 44.45 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.281 179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.653 HG21 HD21 ' A' ' 62' ' ' ASN . 67.9 t -134.74 107.51 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.944 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -97.34 129.8 44.57 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.697 HG13 HD13 ' A' ' 130' ' ' ILE . 37.8 t -122.18 124.4 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.762 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.0 mp -110.61 163.0 14.17 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.65 HG21 HD13 ' A' ' 87' ' ' LEU . 2.8 m -126.67 160.18 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 177.15 177.52 46.13 Favored Glycine 0 N--CA 1.481 1.688 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 t -116.25 158.69 22.95 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 122.069 -0.665 . . . . 0.0 109.44 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.4 t -80.23 3.56 20.43 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.806 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.37 157.04 3.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 110.114 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.02 104.12 0.69 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.08 -152.76 5.81 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 83' ' ' ASP . . . -67.54 -43.39 80.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.985 . . . . 0.0 109.481 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.4 -118.61 3.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -69.5 -25.07 63.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.947 . . . . 0.0 109.851 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -97.27 35.21 1.64 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.399 -0.813 . . . . 0.0 109.64 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 11.6 t70 -133.48 36.99 3.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.564 -0.71 . . . . 0.0 109.566 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.509 ' HB2' HD23 ' A' ' 71' ' ' LEU . 6.6 m-85 -113.17 -176.26 2.86 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 125' ' ' TRP . 0.5 OUTLIER -129.06 132.16 47.41 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.258 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 71' ' ' LEU . 35.5 t -62.31 86.29 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.685 -0.634 . . . . 0.0 110.453 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 72' ' ' VAL . 12.0 tp -60.13 -51.68 68.57 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -142.44 123.55 14.57 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.63 -173.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.886 -0.509 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.74 125.64 25.41 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . 86.9 p -99.6 121.95 41.94 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -88.76 121.45 31.15 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 91' ' ' SER . 23.5 m-85 -120.58 -43.67 2.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.422 -0.798 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.401 ' HE1' ' HA ' ' A' ' 105' ' ' PRO . 33.0 mtp -120.22 -178.1 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.487 -0.758 . . . . 0.0 110.509 -178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.6 p -115.29 177.16 1.25 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.05 11.9 3.12 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 123.201 2.601 . . . . 0.0 111.251 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -120.48 -54.15 2.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.297 -0.877 . . . . 0.0 109.337 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.4 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 3.6 pt-20 -61.04 -18.42 57.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.623 -0.673 . . . . 0.0 110.429 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 20.7 t -54.82 -36.09 64.61 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.279 -0.888 . . . . 0.0 110.756 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -72.14 -82.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.445 -0.784 . . . . 0.0 110.037 -179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 42.3 t -162.85 37.49 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -86.37 -22.41 47.86 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.48 -77.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.572 -0.958 . . . . 0.0 110.409 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -117.18 88.82 28.69 Favored Pre-proline 0 C--N 1.293 -1.854 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 41.8 Cg_endo -77.23 -19.87 13.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.976 2.451 . . . . 0.0 110.261 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.87 135.06 29.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.754 -0.591 . . . . 0.0 110.165 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.02 150.51 18.74 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.626 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 13.0 m -106.83 165.13 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 110.2 -179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -154.12 156.05 36.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 109.261 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.7 mtp -127.95 166.9 17.45 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.456 -0.777 . . . . 0.0 110.721 -179.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 88' ' ' LEU . 3.1 m-85 -131.61 159.08 39.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -132.64 -149.42 6.22 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HA ' ' CG ' ' A' ' 116' ' ' LEU . 39.5 Cg_endo -74.57 -39.76 1.32 Allowed 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 123.738 2.959 . . . . 0.0 110.594 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.72 -27.13 68.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.557 -0.715 . . . . 0.0 109.465 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -91.5 3.1 55.8 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.641 -0.662 . . . . 0.0 110.547 -179.633 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.956 HD13 ' CB ' ' A' ' 121' ' ' ALA . 2.4 pp -122.96 139.35 54.16 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.92 -1.112 . . . . 0.0 110.392 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.908 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.5 p -60.17 130.57 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.89 -30.12 61.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.708 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -21.39 65.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.514 -0.741 . . . . 0.0 110.194 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.908 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.86 -46.58 2.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.956 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.95 -38.08 21.93 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.151 -0.968 . . . . 0.0 111.51 -179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -82.05 2.78 29.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.338 -0.851 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 14.5 mttt -93.7 134.9 35.53 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -66.51 113.65 4.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.443 -0.786 . . . . 0.0 110.546 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.498 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 73.6 m95 -117.78 162.85 17.4 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -138.64 14.15 2.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.147 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -148.72 151.22 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.912 HG11 ' CE2' ' A' ' 149' ' ' PHE . 9.5 p -141.85 145.21 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 110.367 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.57 117.58 34.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.583 -0.698 . . . . 0.0 109.486 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.697 HD13 HG13 ' A' ' 70' ' ' VAL . 50.0 mm -107.93 119.19 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.599 -0.688 . . . . 0.0 109.534 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.584 HG22 ' OG ' ' A' ' 44' ' ' SER . 48.2 t -128.09 119.94 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.137 -0.977 . . . . 0.0 110.687 -179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.466 ' HB3' HG13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.93 148.15 23.3 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.47 126.65 14.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.404 -0.81 . . . . 0.0 111.199 -179.091 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.764 ' HG3' ' HB3' ' A' ' 66' ' ' ALA . 0.4 OUTLIER 150.23 134.58 0.0 OUTLIER Pre-proline 0 N--CA 1.51 2.543 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.416 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.42 97.85 0.63 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.995 2.463 . . . . 0.0 109.965 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 40' ' ' GLU . 10.6 p90 -128.77 14.49 6.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.553 -0.717 . . . . 0.0 110.81 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.03 -166.33 2.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.138 -0.976 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -176.27 -42.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -113.27 -33.09 6.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.71 -0.619 . . . . 0.0 109.676 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.27 149.84 38.18 Favored Pre-proline 0 C--N 1.299 -1.618 0 O-C-N 121.891 -0.505 . . . . 0.0 109.693 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.413 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 42.9 Cg_endo -85.52 -178.63 3.1 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.372 2.715 . . . . 0.0 110.285 179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.418 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 179.88 -164.1 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.541 ' C ' HD13 ' A' ' 144' ' ' LEU . . . 156.03 -112.89 0.54 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -135.47 162.04 33.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.325 -1.103 . . . . 0.0 110.251 178.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.456 ' HA ' ' CB ' ' A' ' 32' ' ' LYS . 2.7 m -82.24 -18.52 42.23 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.809 -178.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.618 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 48.7 p90 179.88 163.37 1.04 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.32 -0.863 . . . . 0.0 109.92 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.77 HG22 ' HB3' ' A' ' 24' ' ' LEU . 34.8 m -140.54 142.25 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 5.0 mtm180 -147.63 165.01 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.744 0.783 . . . . 0.0 110.524 -178.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.912 ' CE2' HG11 ' A' ' 128' ' ' VAL . 60.7 m-85 -145.28 154.61 42.54 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 0.1 OUTLIER -158.63 145.94 17.72 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.087 -1.008 . . . . 0.0 109.283 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.684 -0.635 . . . . 0.0 110.562 -179.255 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -89.64 20.96 0.97 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.661 2.908 . . . . 0.0 111.234 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -153.96 -170.83 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.254 -0.904 . . . . 0.0 109.253 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 53' ' ' GLU . 48.4 mm -112.56 154.48 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -134.94 120.69 19.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.571 -0.706 . . . . 0.0 109.638 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 49' ' ' LEU . 1.2 mp -82.55 150.91 26.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.623 -0.673 . . . . 0.0 109.511 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -110.86 -53.28 2.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.622 -0.674 . . . . 0.0 109.435 179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -160.69 166.24 29.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.655 -0.653 . . . . 0.0 109.511 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.2 p -79.68 89.65 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' H ' ' A' ' 11' ' ' SER . 2.6 p -50.32 -55.89 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.258 -0.901 . . . . 0.0 110.777 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.502 ' H ' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -122.29 152.49 40.02 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.12 -179.497 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 p -144.27 121.82 11.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 109.813 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -118.25 45.52 1.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.639 -0.663 . . . . 0.0 109.878 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.674 ' OG ' HG22 ' A' ' 43' ' ' ILE . 0.8 OUTLIER 152.19 73.83 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.732 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -138.44 142.33 39.5 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.244 -0.91 . . . . 0.0 109.448 -179.026 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.38 -162.63 0.86 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.469 -0.769 . . . . 0.0 109.333 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -97.55 -57.9 2.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.58 -0.7 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -65.66 0.7 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -88.77 67.7 8.38 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.495 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 15' ' ' GLN . 22.3 p -86.44 171.32 11.22 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.507 -0.745 . . . . 0.0 110.041 -179.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.851 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -62.61 -24.7 67.72 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.573 ' HG3' HG12 ' A' ' 9' ' ' VAL . 4.9 tt0 -61.02 -19.4 61.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -0.859 . . . . 0.0 109.688 179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -65.76 -16.68 64.01 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 109.323 178.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 147' ' ' VAL . 10.9 mt -65.02 -25.66 67.95 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 25' ' ' LEU . 4.5 mm? -58.17 -22.74 52.74 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 65.28 0.67 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.36 -24.69 8.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.352 -0.842 . . . . 0.0 110.528 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 29' ' ' THR . 44.4 m-20 -119.53 81.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.807 . . . . 0.0 109.816 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -155.4 -88.08 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.424 -0.798 . . . . 0.0 109.502 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 31' ' ' ARG . 42.8 p90 -177.6 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.006 -1.059 . . . . 0.0 110.187 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 30' ' ' TYR . 4.9 mtm180 -157.47 142.67 17.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.5 -0.75 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -126.72 -159.47 0.93 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.347 -179.393 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB2' HD21 ' A' ' 24' ' ' LEU . 20.4 t90 -94.32 139.33 31.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.238 -0.913 . . . . 0.0 109.433 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -144.41 129.39 18.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -51.17 156.08 1.18 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.387 -0.82 . . . . 0.0 110.619 -178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 15' ' ' GLN . . . -67.38 -23.99 65.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.845 -0.534 . . . . 0.0 110.202 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -136.45 -173.72 3.49 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.52 -164.27 1.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' LYS . . . 65.45 45.89 88.13 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 136' ' ' TYR . 1.6 mt-10 -54.79 84.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.694 0.759 . . . . 0.0 111.142 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 42' ' ' THR . 42.1 tttm -91.29 -52.28 4.89 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.738 HG22 ' OG ' ' A' ' 133' ' ' SER . 16.0 p -159.09 121.9 3.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 35' ' ' ALA . 19.0 pt -120.23 151.47 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.672 ' HB3' HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -129.11 150.36 50.53 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.437 178.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.851 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -155.16 107.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 129' ' ' LYS . 11.5 t -91.39 118.44 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.606 ' CD2' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -95.26 153.29 17.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -104.25 134.09 48.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.673 . . . . 0.0 109.715 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.525 HD23 ' CD1' ' A' ' 6' ' ' LEU . 33.0 mt -90.17 134.79 34.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -81.07 43.85 0.73 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.505 -0.747 . . . . 0.0 110.448 -179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.1 pttt 166.94 127.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -74.94 106.37 6.42 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -136.28 -178.33 5.11 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.416 0.627 . . . . 0.0 109.656 -179.025 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -96.48 175.48 6.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.75 120.34 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.498 ' O ' HD21 ' A' ' 116' ' ' LEU . 74.4 t60 -107.68 -31.33 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 7.4 m -146.15 155.12 42.51 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 149' ' ' PHE . 69.6 t -138.39 157.53 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.666 . . . . 0.0 109.548 -178.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.57 ' C ' HD12 ' A' ' 60' ' ' ILE . 1.7 m-20 -139.44 138.38 36.41 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.57 HD12 ' C ' ' A' ' 59' ' ' ASP . 1.2 mp -159.05 135.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 108' ' ' VAL . . . -115.0 134.79 11.85 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' OD1' ' HB2' ' A' ' 65' ' ' SER . 1.2 m-80 -112.5 151.46 29.92 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 122.149 -0.618 . . . . 0.0 110.707 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.34 -102.12 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.23 24.83 29.65 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 178.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.436 ' HA ' ' CE2' ' A' ' 136' ' ' TYR . 59.6 m -77.35 -174.45 3.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.517 -0.99 . . . . 0.0 109.831 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 134' ' ' GLN . . . -147.2 -57.53 0.26 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 133' ' ' SER . 17.6 m-85 -99.25 135.28 40.88 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.929 -178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG21 ' HE2' ' A' ' 93' ' ' PHE . 86.1 t -141.74 109.21 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.479 0.656 . . . . 0.0 109.685 179.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -99.78 139.23 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.655 HG13 ' CD1' ' A' ' 130' ' ' ILE . 18.5 t -124.4 124.28 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.461 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 84' ' ' TYR . 1.9 mp -113.32 164.06 14.04 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' HG2' ' A' ' 85' ' ' GLU . 4.3 m -128.67 160.69 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.689 -0.632 . . . . 0.0 109.817 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.446 ' HA2' ' CE3' ' A' ' 125' ' ' TRP . . . 175.23 175.86 43.02 Favored Glycine 0 N--CA 1.483 1.822 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 t -113.83 158.46 20.99 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -89.57 11.3 20.0 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.8 107.92 0.68 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.26 -86.12 0.42 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.6 163.19 9.57 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 59.99 35.83 21.54 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.512 -0.993 . . . . 0.0 109.67 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.99 98.94 2.5 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -115.89 -58.76 2.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.624 -0.927 . . . . 0.0 109.412 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -98.92 32.14 2.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.661 -0.649 . . . . 0.0 109.401 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -124.49 38.05 4.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.61 -0.681 . . . . 0.0 109.482 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 71' ' ' LEU . 4.9 m-85 -108.05 -175.12 2.69 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.673 ' HG2' HG23 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -121.37 127.9 51.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.2 85.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.77 -0.581 . . . . 0.0 110.274 -179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.644 HD22 ' CG1' ' A' ' 72' ' ' VAL . 11.9 tp -57.79 -53.88 53.16 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 111' ' ' PHE . 0.8 OUTLIER -143.81 122.66 12.7 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.257 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.1 m -53.35 -179.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.636 -0.665 . . . . 0.0 110.528 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.13 129.76 41.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.297 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.0 p -98.62 128.72 45.02 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 8.5 p -90.09 89.71 7.8 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.621 ' HE2' HG21 ' A' ' 68' ' ' VAL . 6.8 m-85 -73.45 -57.81 3.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.341 -0.85 . . . . 0.0 109.607 179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.407 ' HE1' ' C ' ' A' ' 105' ' ' PRO . 3.2 mtm -121.3 -164.06 1.1 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.469 0.652 . . . . 0.0 110.187 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' CD ' ' A' ' 96' ' ' PRO . 5.8 p -130.64 -176.79 0.58 Allowed Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 95' ' ' SER . 41.6 Cg_endo -85.59 18.96 1.47 Allowed 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 123.086 2.524 . . . . 0.0 111.467 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.7 t -120.12 -40.71 2.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -85.12 -27.02 26.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 3.4 p -56.85 -22.26 35.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.512 -0.743 . . . . 0.0 110.475 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -83.87 -85.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.38 -0.825 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 t -163.01 38.08 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.14 -0.975 . . . . 0.0 108.543 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -95.37 -23.31 19.65 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.25 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.526 -0.985 . . . . 0.0 110.579 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -119.48 95.26 49.16 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 42.9 Cg_endo -82.45 -17.99 7.25 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 123.172 2.582 . . . . 0.0 110.155 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.47 128.93 30.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.787 -0.571 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.26 145.7 15.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 16.0 m -98.71 -179.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.381 -0.824 . . . . 0.0 109.983 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HG2' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -159.76 148.49 17.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.867 . . . . 0.0 109.407 179.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.8 mtt -127.15 157.39 39.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.476 -0.765 . . . . 0.0 110.491 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 88' ' ' LEU . 1.8 m-85 -128.82 166.49 18.95 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 57' ' ' SER . . . -137.22 -150.63 5.79 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 116' ' ' LEU . 39.4 Cg_endo -75.51 -37.86 1.62 Allowed 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 123.747 2.965 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -65.58 -26.52 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.464 -0.773 . . . . 0.0 109.6 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -91.94 1.97 56.84 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.643 -0.661 . . . . 0.0 110.663 -179.759 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 121' ' ' ALA . 1.7 pp -121.57 138.93 54.11 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.956 -1.09 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.905 ' CG1' ' HB3' ' A' ' 120' ' ' ALA . 8.2 p -58.25 130.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.54 -30.98 61.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 109.602 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.86 -21.56 66.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.22 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.905 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -115.93 -46.24 2.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.304 -0.873 . . . . 0.0 110.104 -179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.97 ' CB ' HD13 ' A' ' 116' ' ' LEU . . . -48.65 -40.49 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.138 -0.976 . . . . 0.0 111.583 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -0.16 31.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.266 -0.896 . . . . 0.0 110.528 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 125' ' ' TRP . 13.7 mtpp -91.0 133.93 34.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -66.95 112.58 4.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.636 0.731 . . . . 0.0 110.804 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.495 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 75.8 m95 -115.43 165.44 12.98 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.35 10.25 3.22 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.491 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -144.45 149.08 35.42 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 149' ' ' PHE . 5.4 p -134.47 142.46 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.909 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.463 ' HG3' HG22 ' A' ' 46' ' ' VAL . 8.6 tttt -109.65 113.33 26.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.699 -0.626 . . . . 0.0 109.803 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.655 ' CD1' HG13 ' A' ' 70' ' ' VAL . 48.9 mm -106.93 123.73 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 44' ' ' SER . 41.0 t -128.46 121.49 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 121.275 -0.891 . . . . 0.0 110.533 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.472 ' HB3' HG13 ' A' ' 43' ' ' ILE . 1.7 t -93.25 144.57 25.18 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.738 ' OG ' HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -145.05 124.29 12.96 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 111.693 -178.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.6 OUTLIER 161.99 113.26 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.17 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.035 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.93 102.7 1.63 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.563 2.175 . . . . 0.0 110.305 179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 134' ' ' GLN . 1.5 p90 -134.16 -9.06 2.63 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.539 -0.726 . . . . 0.0 112.137 -178.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.67 -172.3 2.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.955 -1.091 . . . . 0.0 110.263 -179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -170.61 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.95 -31.9 6.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.66 -0.65 . . . . 0.0 109.683 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.67 148.08 37.04 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.845 -0.534 . . . . 0.0 109.719 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -86.91 -177.43 2.23 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.341 2.694 . . . . 0.0 110.539 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.49 -163.41 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.474 ' C ' HD23 ' A' ' 144' ' ' LEU . . . 157.06 -128.09 2.08 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.508 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -119.59 162.38 19.04 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.354 -1.086 . . . . 0.0 110.17 -179.581 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 m -84.91 -14.97 46.07 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.778 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' HA3' ' A' ' 61' ' ' GLY . 50.9 p90 171.65 169.05 0.09 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.204 -0.935 . . . . 0.0 109.936 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.783 HG22 ' HB3' ' A' ' 24' ' ' LEU . 29.5 m -141.1 143.32 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 59' ' ' ASP . 41.6 mtm180 -149.57 167.31 26.69 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 110.59 -178.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 128' ' ' VAL . 62.6 m-85 -149.61 158.69 44.4 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.454 ' HE2' ' CG ' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -155.04 123.18 5.87 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.276 -0.89 . . . . 0.0 109.74 179.386 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.928 . . . . . . . . 1 1 . 1 stop_ save_